District,S.No.,Parameters,Type,April,May,June,July,August,September,October,November,December,January,February,March,Total
Araria,1.1,Total number of pregnant women Registered for ANC,TOTAL,8914,8832,7572,7089,7481,7209,7107,5574,6093,6692,7137,7908,87608
Araria,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,5004,4726,4119,3801,3801,3693,3790,3019,3349,4012,4310,4601,48225
Araria,1.2,Number of Pregnant women registered under JSY,TOTAL,8914,8832,7572,7076,7481,7100,7101,5486,6055,6589,7056,7878,87140
Araria,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,3895,4090,4099,4232,4534,4672,4622,3950,4211,4637,4567,4329,51838
Araria,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,6190,6032,5332,4918,5010,5049,4805,3828,4049,4564,4872,5482,60131
Araria,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,6894,8336,7136,6816,7590,6009,6466,5444,5392,5985,5991,6700,78759
Araria,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,6705,6838,6372,5254,8407,5366,4951,4051,4682,4933,5731,6647,69937
Araria,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,17,149,424,220,211,82,35,109,69,90,13,29,1448
Araria,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,6,5,12,3,13,18,4,5,6,22,7,5,106
Araria,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,1996,1773,1843,1688,3237,2692,1437,759,870,790,878,815,18778
Araria,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,760,383,404,396,633,594,162,1,1,2,5,1,3342
Araria,1.8,Number of pregnancy test kits used at SC level,TOTAL,515,392,409,173,379,67,64,52,33,95,172,240,2591
Araria,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,145,157,93,132,122,129,132,124,129,117,145,66,1491
Araria,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,1427,1394,1291,1334,1506,1779,2115,1902,1923,1718,1708,1524,19621
Araria,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,1572,1551,1384,1466,1628,1908,2247,2026,2052,1835,1853,1590,21112
Araria,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,219,212,152,210,117,206,217,232,188,198,238,127,2316
Araria,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0,0,0,0,0,0,0,20,18,0,0,0,38
Araria,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,3093,3050,2949,3749,5146,6095,6211,5030,4219,3981,3896,3632,51051
Araria,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,2902,2825,2771,3475,4835,5710,5804,4802,4063,3785,3638,3406,48016
Araria,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1729,1271,899,471,1951,2005,5937,4422,4283,2348,3342,3024,31682
Araria,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,284,1274,1947,876,505,897,1716,2930,2797,2062,2021,2221,19530
Araria,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0,0,0,0,0,0,0,0,108,0,0,0,108
Araria,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,996,0,1023,0,3334,3864,NA,NA,NA,NA,NA,NA,9217
Araria,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,996,0,0,0,0,0,NA,NA,NA,NA,NA,NA,996
Araria,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,0
Araria,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,0
Araria,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Araria,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Araria,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,33,18,0,1,4,19,20,24,16,23,20,14,192
Araria,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,33,18,0,1,4,19,20,24,16,23,20,14,192
Araria,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,33,0,0,0,8,38,NA,NA,NA,NA,NA,NA,79
Araria,4.1.1.a,Number of male live births,TOTAL,2872,2357,2730,2715,5106,6220,4248,3659,3248,3027,2934,2663,41779
Araria,4.1.1.b,Number of female live births,TOTAL,2734,2173,2577,2434,4908,5582,4153,3625,3200,2927,2773,2527,39613
Araria,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,5606,4530,5307,5149,10014,11802,8401,7284,6448,5954,5707,5190,81392
Araria,4.1.2,Number of still births,TOTAL,89,77,105,90,152,162,111,117,76,88,68,53,1188
Araria,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,7,7,7,7,4,8,3,10,7,5,6,6,77
Araria,4.2.1,Number of Newborns weighed at birth,TOTAL,5194,4477,5210,5055,9941,11717,8325,7214,6371,5889,5613,5109,80115
Araria,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,666,573,681,496,4179,1306,1019,806,572,520,566,536,11920
Araria,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,5179,4509,5069,4978,9617,11451,8272,7224,6416,5875,5541,5116,79247
Araria,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,24,22,15,17,26,21,14,16,21,28,20,15,239
Araria,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,13,22,17,24,34,36,36,42,24,27,19,19,313
Araria,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,39,122,104,104,187,262,268,235,208,193,138,36,1896
Araria,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,76,166,136,145,247,319,318,293,253,248,177,70,2448
Araria,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0,0,0,0,50,188,NA,NA,NA,NA,NA,NA,238
Araria,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,653,649,587,797,1751,6661,2466,2094,1427,1768,1450,1231,21534
Araria,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,6,2,150,26,119,173,61,30,45,62,31,15,720
Araria,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,222,430,319,269,5164,8507,5144,4268,2634,2456,3129,4224,36766
Araria,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,76,11,34,48,60,75,26,27,12,19,8,24,420
Araria,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,3964,2767,3832,3656,7950,9572,5767,4902,4065,3424,3698,3333,56930
Araria,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1066,1288,1066,1391,2401,2519,1669,1599,1530,1379,1420,1461,18789
Araria,6.3,PNC maternal complications attended,TOTAL,0,11,3,0,75,282,54,43,22,51,31,17,589
Araria,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Araria,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Araria,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Araria,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Araria,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,32,12,42,20,72,78,13,25,19,28,38,48,427
Araria,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,976,385,884,482,1884,1656,505,562,649,623,713,754,10073
Araria,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,1008,397,926,502,1956,1734,518,587,668,651,751,802,10500
Araria,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,976,385,226,386,0,0,0,0,0,0,0,0,1973
Araria,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0,0,0,0,0,0,0,0,0,4,0,0,4
Araria,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Araria,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0,0,0,0,0,0,0,0,2,0,1,0,3
Araria,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0,0,0,0,0,0,0,0,2,4,1,0,7
Araria,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0,NA,0,0,0,0,NA,NA,NA,NA,NA,NA,0
Araria,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Araria,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,4,0,0,0,0,0,0,0,0,0,0,0,4
Araria,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Araria,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,4,0,0,0,0,0,0,0,0,0,0,0,4
Araria,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0,NA,0,0,0,0,NA,NA,NA,NA,NA,NA,0
Araria,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,24,34,15,78,19,189,367,213,1055,876,741,290,3901
Araria,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,7,4,0,38,33,8,196,53,336,323,435,135,1568
Araria,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,57,30,8,86,47,87,257,240,1025,950,877,351,4015
Araria,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,88,68,23,202,99,284,820,506,2416,2149,2053,776,9484
Araria,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,0,NA,0,0,21,108,NA,NA,NA,NA,NA,NA,129
Araria,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0,0,0,0,0,0,0,0,0,4,4,2,10
Araria,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,1,1
Araria,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0,0,0,0,5,37,12,14,45,44,49,39,245
Araria,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0,0,0,0,5,37,12,14,45,48,53,42,256
Araria,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0,NA,0,0,5,8,NA,NA,NA,NA,NA,NA,13
Araria,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,122,133,128,213,91,397,372,428,254,291,319,205,2953
Araria,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,13,19,10,29,19,23,41,26,27,96,72,82,457
Araria,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,NA,23,9,608,133,28,99,18,124,30,77,87,1236
Araria,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,86,45,52,73,95,151,79,134,133,119,90,68,1125
Araria,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,221,220,199,923,338,599,591,606,538,536,558,442,5771
Araria,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,129,95,97,186,343,334,136,117,174,246,192,123,2172
Araria,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,0,NA,6,0,110,173,NA,NA,NA,NA,NA,NA,289
Araria,9.06,Number of IUCD removals,TOTAL,109,86,73,127,115,140,104,70,94,77,86,82,1163
Araria,9.07,Number of Oral Pills cycles distributed,TOTAL,2103,2129,1914,5426,2177,2770,3354,2703,2746,1841,2011,2140,31314
Araria,9.08,Number of Condom pieces distributed,TOTAL,11844,12586,12537,16641,11999,16244,14050,12645,11753,11048,12572,12032,155951
Araria,9.09,Number of Centchroman (weekly) pills given,TOTAL,131,58,45,337,158,0,0,0,45,19,0,2,795
Araria,9.1,Number of Emergency Contraceptive Pills distributed,TOTAL,414,427,368,3202,477,689,1167,307,574,375,403,350,8753
Araria,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0,9,0,0,0,0,0,0,0,0,0,0,9
Araria,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Araria,9.11.2.a,Number of failures following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Araria,9.11.2.b,Number of failures following female sterilization,TOTAL,0,0,0,0,0,1,0,0,0,0,0,0,1
Araria,9.11.3.a,Number of deaths following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Araria,9.11.3.b,Number of deaths following female sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Araria,9.12,Number of Institutions having NSV trained doctors,TOTAL,NA,1,1,1,1,3,3,5,5,3,1,1,Data for this item can not be cumulated
Araria,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,6863,5794,6044,6463,9651,13282,10164,9093,8357,7326,7179,6564,96780
Araria,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,0,1,0,0,0,0,0,129,0,0,0,0,130
Araria,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,1280,792,553,392,140,95,49,30,17,8,1,0,3357
Araria,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,3607,2092,1377,935,490,292,177,104,44,17,2,1,9138
Araria,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,6688,6055,5233,5358,5501,6237,7819,8517,9753,8986,8101,6940,85188
Araria,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,5770,6704,5633,5445,5375,5604,5901,6250,7490,9675,8936,8208,80991
Araria,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,4009,5195,5394,5504,5208,5431,5521,4930,5777,7193,8436,8646,71244
Araria,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,4155,3294,4126,3915,7330,10537,6614,5694,4918,4437,4256,3871,63147
Araria,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,6754,6028,4968,5305,5458,6201,7878,8497,9716,8989,8085,6942,84821
Araria,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,7112,7592,6011,5759,5429,5643,6016,6282,7516,9681,8944,8205,84190
Araria,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,7406,7265,6418,6378,5635,5746,5757,5085,5823,7219,8393,8641,79766
Araria,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,3761,2585,3535,3263,6255,9187,5541,4641,3958,3642,3365,3079,52812
Araria,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,160,2,0,6,0,351,0,0,0,2,0,0,521
Araria,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,1410,910,600,413,152,298,43,29,15,4,1,0,3875
Araria,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,3617,2201,1411,1038,504,476,162,94,26,183,2,1,9715
Araria,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,5984,6683,6635,7684,7645,7745,7837,6238,6597,6391,6362,5930,81731
Araria,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,6277,5318,4300,5058,4768,4927,4915,4284,5274,6466,7311,7040,65938
Araria,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,5775,6374,6425,7583,7549,7461,7500,6051,6256,6262,6232,5701,79169
Araria,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2682,3210,3248,3660,3829,3832,3830,3042,3038,3007,3008,2830,39216
Araria,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2394,2832,2872,3493,3356,3524,3578,2833,2881,2750,2851,2581,35945
Araria,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,5076,6042,6120,7153,7185,7356,7408,5875,5919,5757,5859,5411,75161
Araria,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,6235,5407,4790,5182,4954,5147,5144,4278,5530,6536,7485,7382,68070
Araria,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,6238,5410,4827,5188,4953,5146,5145,4271,5520,6534,7484,7339,68055
Araria,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0,24,0,0,0,48,0,0,0,0,0,39,111
Araria,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1179,1096,813,1097,942,1177,1226,868,1250,1238,1356,1520,13762
Araria,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1053,1097,758,971,853,1052,1104,783,1206,1132,1259,1345,12613
Araria,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,2232,2193,1571,2068,1795,2229,2330,1651,2456,2370,2615,2865,26375
Araria,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,233,219,246,312,303,438,464,396,446,591,517,472,4637
Araria,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,862,910,885,875,909,1044,1049,907,1046,1037,919,875,11318
Araria,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1778,1987,1789,1908,1806,1920,1891,1894,1975,2067,1941,1909,22865
Araria,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0,0,0,6,0,8,25,0,0,0,0,0,39
Araria,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Araria,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,43,60,27,51,38,55,100,0,0,0,0,0,374
Araria,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,2693,2815,2706,2818,2696,2753,2774,2780,2755,2841,2748,2794,33173
Araria,10.4.2,Number of Immunisation sessions held during the month,TOTAL,2540,2684,2525,2742,2610,2702,2703,2586,2686,2763,2665,2695,31901
Araria,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,2166,2268,2135,2268,2223,2298,2322,2183,2415,2378,2315,2481,27452
Araria,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,5987,5287,4661,5165,4629,4538,4704,3902,4806,6143,7100,6523,63445
Araria,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,5222,5089,4518,4221,3466,3243,1930,1134,1237,315,89,36,30500
Araria,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,1517,1254,1304,1190,1078,824,488,66,300,133,0,0,8154
Araria,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,34,66,58,76,60,49,13,6,17,1,0,0,380
Araria,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Araria,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Araria,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Araria,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Araria,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Araria,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,44,25,52,13,119,132,16,0,25,50,12,9,497
Araria,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,1437,1531,1237,1757,1986,1691,1772,1224,1251,1024,1098,1167,17175
Araria,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,4,10,1,3,6,0,0,0,0,0,0,0,24
Araria,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Araria,13.1,Number of Patients operated for cataract,TOTAL,59,6,10,4,85,71,9,63,122,65,138,68,700
Araria,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,59,6,10,4,85,71,9,63,121,65,138,68,699
Araria,13.3,Number of School children detected with Refractive errors,TOTAL,0,0,0,0,0,0,0,0,0,0,10,0,10
Araria,13.4,Number of children provided free glasses,TOTAL,0,0,0,0,0,0,0,0,0,500,0,0,500
Araria,13.5,Number of eyes collected through eye donation,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Araria,13.6,Number of eyes utilised for corneal transplant,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Araria,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,2,1,2,1,2,5,3,4,3,3,4,4,Data for this item can not be cumulated
Araria,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,NA,NA,NA,NA,NA,9,11,9,10,9,10,7,Data for this item can not be cumulated
Araria,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,1952,1995,1935,1973,1983,2025,2026,1953,6382,1985,1987,1933,Data for this item can not be cumulated
Araria,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,2,1,2,1,2,5,3,4,4,4,4,4,Data for this item can not be cumulated
Araria,14.05,Number of RKS meetings held during the month,TOTAL,2,4,4,3,9,6,4,4,5,5,3,2,51
Araria,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,2,1,2,1,2,10,8,9,9,10,9,10,Data for this item can not be cumulated
Araria,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,1040,1236,949,1357,1728,1871,1930,1791,1950,1465,1111,1068,17496
Araria,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,2,1,2,1,2,4,2,3,3,4,4,3,Data for this item can not be cumulated
Araria,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,0,0,6,0,1,2,0,0,1,0,0,0,Data for this item can not be cumulated
Araria,14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,367,206,253,237,439,595,367,626,481,507,478,425,4981
Araria,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,746,404,400,607,646,824,517,850,696,789,695,622,7796
Araria,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,376,553,2064,428,1894,586,439,687,896,816,646,598,9983
Araria,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,3608,2626,2457,3543,4795,6942,5634,3763,3715,3771,3765,2808,47427
Araria,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,743,759,2317,665,2333,1181,806,1313,1377,1323,1124,1023,14964
Araria,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,4354,3030,2857,4150,5441,7766,6151,4613,4411,4560,4460,3430,55223
Araria,14.10.2.a,Number of death cases of Inpatient males,TOTAL,8,4,6,2,7,6,6,8,2,7,3,3,62
Araria,14.10.2.b,Number of death cases of Inpatient females,TOTAL,6,4,5,1,4,2,3,5,3,3,2,2,40
Araria,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,14,8,11,3,11,8,9,13,5,10,5,5,102
Araria,14.11,In-Patient Head Count at midnight,TOTAL,4902,3948,5381,4285,6564,8241,6632,5715,5766,5809,5701,4206,67150
Araria,14.12.1,OPD attendance (All),TOTAL,147576,131415,125478,129030,148616,166334,140325,123303,121070,123748,138934,145696,1641525
Araria,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,966,703,30,418,112,364,693,480,1745,1402,1512,539,8964
Araria,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,2,2,0,0,8,12,19,13,16,23,6,6,107
Araria,14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,1659,1764,1800,1344,3050,3062,2073,1818,1642,1242,1492,1355,22301
Araria,14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,14.14.a,Number of patients given AYUSH treatment,TOTAL,18159,16998,16508,15891,15044,20742,21419,14622,15234,15952,17368,17165,205102
Araria,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,1668,1348,1636,1508,1691,2182,2067,1880,1605,1417,2262,2563,21827
Araria,14.14.c,Number of Adolescents counselled,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Araria,15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,5515,4903,5841,3866,6792,3779,3011,2723,2983,3164,3197,3353,49127
Araria,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,1261,587,1026,433,426,413,170,123,117,98,91,76,4821
Araria,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,847,356,406,471,834,1446,366,417,344,783,790,616,7676
Araria,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,5,38,12,4,9,7,4,2,4,0,2,0,87
Araria,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,1276,421,594,793,932,970,637,541,883,908,983,681,9619
Araria,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,4,4,5,0,4,3,7,4,2,2,2,2,39
Araria,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,2149,1603,1927,1606,1451,2035,1575,1237,1505,1843,2116,2138,21185
Araria,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,2,0,1,1,2,31,0,1,2,17,0,0,57
Araria,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,4272,2380,2927,2870,3217,4451,2578,2195,2732,3534,3889,3435,38480
Araria,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,11,42,18,5,15,41,11,7,8,19,4,2,183
Araria,15.2,Number of Widal tests conducted,Number tested,1880,833,250,214,2261,2417,1218,984,598,489,398,0,11542
Araria,15.3.a,Number of VDRL tests conducted on males,Number tested,6,1,42,3,20,4,3,8,7,487,2,2,585
Araria,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,102,94,238,79,194,94,50,29,63,3,6,4,956
Araria,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,78,40,71,66,483,534,57,51,302,56,548,371,2657
Araria,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,186,135,351,148,697,632,110,88,372,546,556,377,4198
Araria,15.4.1,Number of blood smears examined for Malaria,TOTAL,749,602,1024,527,1326,699,661,536,374,241,237,173,7149
Araria,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,2,18,2,5,4,0,0,0,0,0,0,0,31
Araria,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0,0,4,2,4,0,0,0,0,0,0,0,10
Araria,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,1700,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1700
Araria,16.1.1,Stock position of DPT vaccines,2. Stocks Received,1093,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1093
Araria,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Araria,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,850,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,850
Araria,16.1.1,Stock position of DPT vaccines,5. Total Stock,1943,0,0,0,0,0,0,0,0,0,0,0,1943
Araria,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,450,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,450
Araria,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,2550,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2550
Araria,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Araria,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,1550,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1550
Araria,16.1.1A,Stock Position of Pentavalent,5. Total Stock,1450,0,0,0,0,0,0,0,0,0,0,0,1450
Araria,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,130,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,130
Araria,16.1.2,Stock position of OPV vaccines,2. Stocks Received,2000,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2000
Araria,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Araria,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,2080,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2080
Araria,16.1.2,Stock position of OPV vaccines,5. Total Stock,50,0,0,0,0,0,0,0,0,0,0,0,50
Araria,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,1280,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1280
Araria,16.1.3,Stock position of TT vaccines,2. Stocks Received,1500,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1500
Araria,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Araria,16.1.3,Stock position of TT vaccines,4. Stock Distributed,1430,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1430
Araria,16.1.3,Stock position of TT vaccines,5. Total Stock,1350,0,0,0,0,0,0,0,0,0,0,0,1350
Araria,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,16.1.4,Stock position of DT vaccines,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,16.1.4,Stock position of DT vaccines,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,16.1.4,Stock position of DT vaccines,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,16.1.4,Stock position of DT vaccines,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Araria,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,900,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,900
Araria,16.1.5,Stock position of BCG vaccines,2. Stocks Received,2500,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2500
Araria,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Araria,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,1750,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1750
Araria,16.1.5,Stock position of BCG vaccines,5. Total Stock,1650,0,0,0,0,0,0,0,0,0,0,0,1650
Araria,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,1300,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1300
Araria,16.1.6,Stock position of Measles vaccines,2. Stocks Received,2300,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2300
Araria,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Araria,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,3200,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,3200
Araria,16.1.6,Stock position of Measles vaccines,5. Total Stock,400,0,0,0,0,0,0,0,0,0,0,0,400
Araria,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,700,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,700
Araria,16.1.7,Stock position of JE vaccines,2. Stocks Received,2000,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2000
Araria,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Araria,16.1.7,Stock position of JE vaccines,4. Stock Distributed,2700,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2700
Araria,16.1.7,Stock position of JE vaccines,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Araria,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,1200,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1200
Araria,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,800,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,800
Araria,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Araria,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,1300,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1300
Araria,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,700,0,0,0,0,0,0,0,0,0,0,0,700
Araria,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Araria,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Araria,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Araria,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Araria,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Araria,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Araria,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,16.3.02,Stock Position of Gloves,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,16.3.02,Stock Position of Gloves,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,16.3.02,Stock Position of Gloves,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,16.3.02,Stock Position of Gloves,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Araria,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Araria,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Araria,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Araria,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Araria,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Araria,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Araria,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Araria,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Araria,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Araria,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,700,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,700
Araria,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,15000,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,15000
Araria,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Araria,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,7700,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,7700
Araria,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,8000,0,0,0,0,0,0,0,0,0,0,0,8000
Araria,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,24000,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,24000
Araria,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,85000,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,85000
Araria,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Araria,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,90000,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,90000
Araria,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,19000,0,0,0,0,0,0,0,0,0,0,0,19000
Araria,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,1200,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1200
Araria,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,8000,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,8000
Araria,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Araria,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,7500,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,7500
Araria,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,1700,0,0,0,0,0,0,0,0,0,0,0,1700
Araria,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,1,2,NA,NA,NA,3
Araria,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,1
Araria,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,NA,NA,NA,NA,NA,NA,NA,1,2,1,NA,NA,4
Araria,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,1,1,NA,NA,NA,2
Araria,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,1
Araria,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,NA,NA,NA,NA,NA,NA,NA,1,1,NA,1,NA,3
Araria,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,1,1,NA,NA,NA,2
Araria,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,NA,NA,NA,NA,NA,NA,NA,1,1,NA,NA,NA,2
Araria,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,3,NA,NA,NA,3
Araria,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,3,NA,NA,NA,3
Araria,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,1
Araria,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,1
Araria,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,1,1,1,2,NA,5
Araria,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,1,NA,2,3,NA,NA,6
Araria,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,NA,NA,NA,NA,NA,NA,1,1,3,4,2,NA,11
Araria,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,1,1,NA,NA,NA,NA,2
Araria,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,NA,NA,NA,NA,NA,NA,1,1,NA,NA,NA,NA,2
Araria,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,1,1,3,1,NA,6
Araria,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,1
Araria,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,NA,NA,NA,NA,NA,NA,NA,1,1,3,2,NA,7
Araria,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,1,1,NA,NA,NA,2
Araria,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,NA,NA,NA,NA,NA,NA,NA,1,1,NA,NA,NA,2
Araria,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,NA,NA,NA,NA,NA,2,NA,NA,NA,NA,NA,NA,2
Araria,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,1
Araria,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,NA,NA,NA,NA,NA,2,1,NA,NA,NA,NA,NA,3
Araria,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,3,NA,NA,NA,3
Araria,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,3,NA,NA,NA,3
Araria,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,1
Araria,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Araria,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,1
Araria,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,2,NA,NA,NA,1,NA,3
Araria,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,NA,NA,NA,NA,NA,1,5,NA,4,5,2,2,19
Araria,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,NA,NA,NA,NA,NA,21,12,8,5,3,NA,8,57
Araria,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,NA,NA,NA,NA,NA,22,19,8,9,8,3,10,79
Arwal,1.1,Total number of pregnant women Registered for ANC,TOTAL,1458,1438,1854,1590,1388,1140,1023,863,895,983,1228,1376,15236
Arwal,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,881,959,1061,1112,1005,820,770,587,637,685,885,936,10338
Arwal,1.2,Number of Pregnant women registered under JSY,TOTAL,1458,1438,1806,1590,1388,1140,1023,863,895,969,1228,1376,15174
Arwal,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,887,999,1096,1201,1191,1060,987,890,763,701,801,914,11490
Arwal,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,861,927,1202,921,831,693,626,520,524,604,756,791,9256
Arwal,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,1272,1586,1680,1579,1484,1231,1083,868,845,834,1028,1269,14759
Arwal,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,867,943,1391,1326,1335,1078,1043,735,635,535,806,881,11575
Arwal,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,6,NA,0,0,0,0,0,0,0,19,0,0,25
Arwal,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0,NA,0,0,0,0,0,0,0,0,0,0,0
Arwal,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,61,188,17,44,10,8,40,4,4,14,20,25,435
Arwal,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,NA,NA,NA,NA,2,3,7,7,5,4,4,2,34
Arwal,1.8,Number of pregnancy test kits used at SC level,TOTAL,606,134,114,154,120,93,117,98,103,122,135,181,1977
Arwal,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,36,18,10,7,7,56,47,52,33,36,31,30,363
Arwal,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,53,84,103,141,163,112,147,119,96,77,68,51,1214
Arwal,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,89,102,113,148,170,168,194,171,129,113,99,81,1577
Arwal,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,52,72,86,95,110,110,112,154,74,66,66,60,1057
Arwal,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Arwal,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,501,518,554,819,975,963,1112,1069,888,813,652,562,9426
Arwal,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,0,17,311,117,216,409,637,563,725,422,158,273,3848
Arwal,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,27,58,133,600,138,0,630,1183,1163,2980,1121,1127,9160
Arwal,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,32,0,0,661,114,10,880,358,1002,495,1737,2048,7337
Arwal,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0,NA,NA,0,0,0,0,0,0,0,0,0,0
Arwal,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,NA,NA,NA,NA,NA,NA,5,54,NA,NA,NA,1625,1684
Arwal,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,18,NA,NA,NA,NA,18
Arwal,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,17,NA,NA,NA,NA,17
Arwal,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0,NA,NA,0,0,0,0,0,0,0,0,0,0
Arwal,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,5,5,4,3,6,11,3,1,2,0,0,2,42
Arwal,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,5,5,4,3,6,11,3,1,2,0,0,2,42
Arwal,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,NA,NA,NA,NA,NA,NA,NA,4,NA,NA,NA,50,54
Arwal,4.1.1.a,Number of male live births,TOTAL,323,302,373,501,592,571,677,660,498,478,377,1187,6539
Arwal,4.1.1.b,Number of female live births,TOTAL,274,307,294,463,535,555,622,617,509,445,370,1075,6066
Arwal,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,597,609,667,964,1127,1126,1299,1277,1007,923,747,2262,12605
Arwal,4.1.2,Number of still births,TOTAL,14,15,10,11,18,11,12,21,13,12,9,9,155
Arwal,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,2,1,0,3,0,2,5,3,0,0,0,4,20
Arwal,4.2.1,Number of Newborns weighed at birth,TOTAL,587,609,651,934,1094,1085,1258,1268,973,908,724,2249,12340
Arwal,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,12,9,23,44,80,69,92,77,70,52,53,57,638
Arwal,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,595,608,661,954,1096,1097,1276,1277,994,900,733,2249,12440
Arwal,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0,0,0,154,58,24,24,16,12,56,63,25,432
Arwal,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,153,152,194,8,10,15,5,1,2,241,222,28,1031
Arwal,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,153,152,194,162,68,39,29,17,14,297,285,53,1463
Arwal,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,60,60
Arwal,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,38,28,158,134,155,231,333,349,207,170,154,144,2101
Arwal,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0,0,NA,0,0,0,0,0,0,0,0,0,0
Arwal,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,169,152,307,162,190,476,541,530,339,297,285,304,3752
Arwal,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0,0,0,NA,NA,0,NA,NA,NA,NA,NA,NA,0
Arwal,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,371,475,530,869,997,950,1033,1146,708,772,584,2177,10612
Arwal,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,315,401,344,584,657,666,784,828,562,535,447,2005,8128
Arwal,6.3,PNC maternal complications attended,TOTAL,10,NA,6,0,0,35,0,0,0,0,0,0,51
Arwal,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,0,NA,NA,0,0,0,0,0,0,0,0,0,0
Arwal,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0,NA,NA,0,0,0,0,0,0,0,0,0,0
Arwal,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,0,NA,NA,0,0,0,0,0,0,0,0,0,0
Arwal,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Arwal,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,12,12,9,26,55,18,20,23,24,23,27,25,274
Arwal,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,13,11,15,56,67,15,15,14,19,24,25,68,342
Arwal,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,25,23,24,82,122,33,35,37,43,47,52,93,616
Arwal,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0,NA,NA,0,12,0,0,0,0,0,0,0,12
Arwal,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0,NA,NA,0,0,0,0,0,2,1,1,0,4
Arwal,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,NA,NA,NA,0,0,1,0,2,0,0,NA,1,4
Arwal,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0,NA,NA,0,0,1,0,2,2,1,1,1,8
Arwal,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,NA,NA,NA,NA,NA,NA,NA,5,NA,NA,NA,50,55
Arwal,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0,NA,NA,0,0,0,0,0,0,0,0,0,0
Arwal,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0,NA,NA,0,0,0,0,0,0,0,0,0,0
Arwal,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,101,51,39,118,73,189,227,101,293,248,335,121,1896
Arwal,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,8,6,7,9,10,21,9,8,4,8,10,4,104
Arwal,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,109,57,46,127,83,210,236,109,297,256,345,125,2000
Arwal,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,NA,NA,NA,NA,NA,NA,NA,77,NA,NA,NA,2120,2197
Arwal,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0,NA,NA,5,4,0,5,0,0,0,0,0,14
Arwal,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,NA,NA,NA,NA,NA,9,0,NA,1,0,NA,NA,10
Arwal,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0,NA,NA,5,4,9,5,0,1,0,0,0,24
Arwal,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,55,77,86,375,52,65,45,46,183,45,45,61,1135
Arwal,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,42,57,79,239,48,55,61,51,149,47,52,57,937
Arwal,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,55,50,18,38,37,2,46,39,28,38,40,29,420
Arwal,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,152,184,183,652,137,122,152,136,360,130,137,147,2492
Arwal,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,53,52,18,38,35,61,18,39,25,37,36,26,438
Arwal,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,NA,NA,NA,NA,NA,NA,NA,208,NA,NA,NA,545,753
Arwal,9.06,Number of IUCD removals,TOTAL,52,48,40,97,70,44,68,48,42,65,50,56,680
Arwal,9.07,Number of Oral Pills cycles distributed,TOTAL,251,295,367,863,761,749,782,491,847,961,651,1020,8038
Arwal,9.08,Number of Condom pieces distributed,TOTAL,2310,1316,3796,5016,4225,8671,7551,6867,7281,5753,5394,37107,95287
Arwal,9.09,Number of Centchroman (weekly) pills given,TOTAL,65,37,37,97,63,103,28,59,58,43,11,1690,2291
Arwal,9.1,Number of Emergency Contraceptive Pills distributed,TOTAL,166,247,196,300,217,263,298,269,368,263,330,2700,5617
Arwal,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Arwal,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0,0,0,1,0,0,0,0,0,0,0,0,1
Arwal,9.11.2.a,Number of failures following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Arwal,9.11.2.b,Number of failures following female sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Arwal,9.11.3.a,Number of deaths following male sterilization,TOTAL,0,NA,NA,0,0,0,0,0,0,0,0,0,0
Arwal,9.11.3.b,Number of deaths following female sterilization,TOTAL,0,NA,NA,1,0,0,0,0,0,0,0,0,1
Arwal,9.12,Number of Institutions having NSV trained doctors,TOTAL,NA,NA,1,1,1,1,1,NA,1,1,1,1,Data for this item can not be cumulated
Arwal,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,751,898,992,1188,1450,1489,1685,1742,1462,1305,1124,952,15038
Arwal,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,7,7,1,0,0,0,0,0,0,0,0,0,15
Arwal,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,105,58,72,26,2,8,2,0,0,1,0,1,275
Arwal,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,336,239,141,69,29,15,8,6,13,1,2,1,860
Arwal,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,1018,1054,931,898,922,1240,1443,1559,1661,1593,1412,1354,15085
Arwal,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,1024,1238,1097,894,977,949,1115,1251,1476,1608,1511,1643,14783
Arwal,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,966,1192,1245,1014,1004,938,989,934,1118,1414,1434,1638,13886
Arwal,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,600,640,717,963,1176,1190,1338,1361,1075,956,797,652,11465
Arwal,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1073,967,966,913,907,1237,1431,1559,1643,1589,1552,1368,15205
Arwal,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1307,1328,1193,923,948,954,1084,1250,1442,1601,1513,1651,15194
Arwal,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1514,1501,1424,1158,1043,946,1042,943,1089,1389,1410,1624,15083
Arwal,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,447,453,511,744,925,935,1055,1034,851,795,655,556,8961
Arwal,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,0,8,1,4,15,0,0,0,0,0,0,0,28
Arwal,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,80,60,54,37,20,5,3,2,1,1,1,1,265
Arwal,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,342,254,150,95,36,18,19,7,3,1,2,1,928
Arwal,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1162,1143,1747,1702,1578,1379,1475,1172,1072,873,817,914,15034
Arwal,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,1489,711,1770,1554,1064,956,894,878,1097,1154,1218,1477,14262
Arwal,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,1058,1035,1485,1568,1442,1324,1260,1053,1078,824,842,903,13872
Arwal,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,555,558,866,755,762,694,737,586,512,434,444,486,7389
Arwal,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,506,523,795,768,703,615,686,547,435,402,379,447,6806
Arwal,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1061,1081,1661,1523,1465,1309,1423,1133,947,836,823,933,14195
Arwal,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1302,1396,1713,1409,1012,899,888,874,1087,1165,1287,1333,14365
Arwal,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1464,1402,1802,1406,1023,904,894,890,1092,1164,1285,1489,14815
Arwal,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Arwal,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,337,495,636,327,208,289,243,197,260,239,359,376,3966
Arwal,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,297,444,552,310,279,236,187,193,221,202,310,312,3543
Arwal,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,634,939,1188,637,487,525,430,390,481,441,669,688,7509
Arwal,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,35,59,3,0,12,3,27,10,7,9,34,35,234
Arwal,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,469,531,537,479,544,586,688,565,632,723,603,771,7128
Arwal,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,832,805,826,874,888,911,898,852,881,815,750,898,10230
Arwal,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,1,3,0,0,0,0,0,0,0,0,0,0,4
Arwal,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0,NA,NA,0,0,0,0,0,0,0,0,0,0
Arwal,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Arwal,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,880,912,934,977,941,1011,926,883,923,915,868,936,11106
Arwal,10.4.2,Number of Immunisation sessions held during the month,TOTAL,878,910,908,965,936,997,906,878,918,899,865,923,10983
Arwal,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,862,870,875,937,912,987,885,861,904,884,845,884,10706
Arwal,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,1240,1223,1494,1379,981,873,790,764,1022,1136,1211,1405,13518
Arwal,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,554,370,503,764,705,600,483,396,347,241,221,216,5400
Arwal,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,75,24,33,7,7,14,3,0,5,8,0,0,176
Arwal,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Arwal,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0,NA,NA,0,0,0,0,0,0,0,0,0,0
Arwal,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0,NA,NA,0,0,0,0,0,0,0,0,0,0
Arwal,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0,NA,NA,0,0,0,0,0,0,0,0,0,0
Arwal,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0,NA,NA,0,0,0,0,0,0,0,0,0,0
Arwal,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0,NA,NA,0,0,0,0,0,0,0,0,0,0
Arwal,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0,0,0,0,4,15,0,0,0,0,0,6,25
Arwal,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,14,30,0,32,73,0,27,10,0,0,0,19,205
Arwal,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Arwal,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0,NA,NA,0,0,0,0,0,9,0,0,0,9
Arwal,13.1,Number of Patients operated for cataract,TOTAL,0,NA,NA,0,201,116,213,126,200,0,0,465,1321
Arwal,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0,NA,NA,0,75,116,213,126,200,0,0,455,1185
Arwal,13.3,Number of School children detected with Refractive errors,TOTAL,63,NA,4,73,428,82,79,78,172,504,68,38,1589
Arwal,13.4,Number of children provided free glasses,TOTAL,0,NA,NA,0,0,0,0,0,0,107,0,0,107
Arwal,13.5,Number of eyes collected through eye donation,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,13.6,Number of eyes utilised for corneal transplant,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,NA,NA,1,1,1,1,1,1,1,1,1,1,Data for this item can not be cumulated
Arwal,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,NA,NA,3,6,8,9,7,9,8,7,8,7,Data for this item can not be cumulated
Arwal,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,460,435,383,416,448,429,426,429,448,435,433,430,Data for this item can not be cumulated
Arwal,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,NA,NA,1,1,1,1,1,1,1,1,1,1,Data for this item can not be cumulated
Arwal,14.05,Number of RKS meetings held during the month,TOTAL,5,3,12,18,11,8,8,8,8,9,10,11,111
Arwal,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,NA,NA,3,7,6,7,6,6,6,5,6,5,Data for this item can not be cumulated
Arwal,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,500,441,324,675,851,840,1035,769,689,831,536,711,8202
Arwal,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,NA,NA,1,1,1,1,1,1,1,1,1,1,Data for this item can not be cumulated
Arwal,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,NA,NA,1,1,1,0,0,0,0,NA,0,NA,Data for this item can not be cumulated
Arwal,14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,99,75,78,80,219,60,94,73,65,66,48,69,1026
Arwal,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,267,154,218,266,434,336,245,237,321,246,219,136,3079
Arwal,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,66,89,109,103,446,87,43,62,66,57,48,69,1245
Arwal,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,764,653,742,1073,1213,1309,1322,1200,1213,1147,1026,729,12391
Arwal,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,165,164,187,183,665,147,137,135,131,123,96,138,2271
Arwal,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,1031,807,960,1339,1647,1645,1567,1437,1534,1393,1245,865,15470
Arwal,14.10.2.a,Number of death cases of Inpatient males,TOTAL,0,NA,NA,0,4,0,0,0,0,0,0,0,4
Arwal,14.10.2.b,Number of death cases of Inpatient females,TOTAL,0,NA,NA,1,1,0,0,0,0,0,0,0,2
Arwal,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,0,NA,NA,1,5,0,0,0,0,0,0,0,6
Arwal,14.11,In-Patient Head Count at midnight,TOTAL,1437,1584,650,1664,1697,1610,1391,1690,1771,1575,1587,1150,17806
Arwal,14.12.1,OPD attendance (All),TOTAL,42577,44023,44673,49963,59783,59490,125203,87596,48466,48372,47843,44602,702591
Arwal,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,47,62,26,45,34,79,78,304,403,104,180,50,1412
Arwal,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,17,NA,NA,0,0,0,0,0,0,0,0,0,17
Arwal,14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,243,159,235,286,352,254,216,188,313,240,342,234,3062
Arwal,14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,14.14.a,Number of patients given AYUSH treatment,TOTAL,13918,17070,21319,25771,28413,27224,21888,22460,25650,23039,23325,22531,272608
Arwal,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,1203,1281,1356,1541,1144,1513,1253,1478,1026,1025,575,1007,14402
Arwal,14.14.c,Number of Adolescents counselled,TOTAL,51,45,NA,0,0,0,0,0,0,0,0,4,100
Arwal,15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,614,606,940,895,636,901,5473,601,633,603,705,532,13139
Arwal,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,5,4,4,2,2,3,7,7,5,4,6,3,52
Arwal,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,145,121,118,148,115,171,121,119,146,145,253,197,1799
Arwal,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,0,2,0,0,0,2,0,1,0,0,2,0,7
Arwal,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,179,152,135,162,86,170,194,124,249,238,369,211,2269
Arwal,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0,0,1,0,0,0,0,0,0,0,2,0,3
Arwal,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,305,118,182,225,198,132,159,151,161,306,354,323,2614
Arwal,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0,0,0,0,0,0,0,0,0,0,0,0,0
Arwal,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,629,391,435,535,399,473,474,394,556,689,976,731,6682
Arwal,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,0,2,1,0,0,2,0,1,0,0,4,0,10
Arwal,15.2,Number of Widal tests conducted,Number tested,0,NA,NA,0,35,48,68,56,66,58,66,80,477
Arwal,15.3.a,Number of VDRL tests conducted on males,Number tested,25,19,21,38,35,25,20,23,24,23,27,25,305
Arwal,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,23,14,32,23,18,20,15,14,19,24,25,68,295
Arwal,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,305,62,82,85,76,56,70,72,161,306,335,310,1920
Arwal,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,353,95,135,146,129,101,105,109,204,353,387,403,2520
Arwal,15.4.1,Number of blood smears examined for Malaria,TOTAL,9,9,30,36,14,73,89,23,21,13,35,31,383
Arwal,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,0,0,2,0,0,0,0,0,0,0,0,0,2
Arwal,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Arwal,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,2265,1790,2140,2140,2190,2040,1990,1890,1890,1830,1830,1680,23675
Arwal,16.1.1,Stock position of DPT vaccines,2. Stocks Received,NA,500,700,700,NA,NA,0,0,0,0,0,500,2400
Arwal,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,375,150,700,650,50,50,100,0,60,0,150,1960,4245
Arwal,16.1.1,Stock position of DPT vaccines,5. Total Stock,1890,2140,2140,2190,2140,1990,1890,1890,1830,1830,1680,220,21830
Arwal,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,100,145,295,595,1005,865,2065,1981,1663,1100,704,271,10789
Arwal,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,550,600,900,1000,NA,1632,216,0,0,0,96,288,5282
Arwal,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,505,450,600,590,140,432,300,318,563,396,529,339,5162
Arwal,16.1.1A,Stock Position of Pentavalent,5. Total Stock,145,295,595,1005,865,2065,1981,1663,1100,704,271,220,10909
Arwal,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,225,130,310,525,350,98,850,350,625,375,425,675,4938
Arwal,16.1.2,Stock position of OPV vaccines,2. Stocks Received,640,600,800,1000,NA,1575,200,650,200,300,500,130,6595
Arwal,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,735,420,585,1175,252,823,700,375,450,250,250,180,6195
Arwal,16.1.2,Stock position of OPV vaccines,5. Total Stock,130,310,525,350,98,850,350,625,375,425,675,625,5338
Arwal,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,1775,1065,1395,2428,2060,1746,996,446,846,846,776,496,14875
Arwal,16.1.3,Stock position of TT vaccines,2. Stocks Received,NA,750,1500,1000,NA,0,250,400,300,200,300,800,5500
Arwal,16.1.3,Stock position of TT vaccines,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,16.1.3,Stock position of TT vaccines,4. Stock Distributed,710,420,467,1368,314,750,800,0,300,270,580,600,6579
Arwal,16.1.3,Stock position of TT vaccines,5. Total Stock,1065,1395,2428,2060,1746,996,446,846,846,776,496,696,13796
Arwal,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,NA,0,NA,NA,NA,NA,0,0,NA,NA,NA,NA,0
Arwal,16.1.4,Stock position of DT vaccines,2. Stocks Received,NA,0,NA,NA,NA,NA,0,0,NA,NA,NA,NA,0
Arwal,16.1.4,Stock position of DT vaccines,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,16.1.4,Stock position of DT vaccines,4. Stock Distributed,NA,0,NA,NA,NA,NA,0,0,NA,NA,NA,NA,0
Arwal,16.1.4,Stock position of DT vaccines,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Arwal,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,325,350,750,1040,1290,885,435,535,635,335,295,295,7170
Arwal,16.1.5,Stock position of BCG vaccines,2. Stocks Received,350,550,650,1000,NA,NA,350,500,200,300,350,350,4600
Arwal,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,325,150,360,750,905,450,250,400,500,340,350,450,5230
Arwal,16.1.5,Stock position of BCG vaccines,5. Total Stock,350,750,1040,1290,385,435,535,635,335,295,295,195,6540
Arwal,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,300,260,30,400,380,NA,500,900,1150,325,325,550,5120
Arwal,16.1.6,Stock position of Measles vaccines,2. Stocks Received,900,500,1400,1500,NA,1850,900,1200,200,500,700,1000,10650
Arwal,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,940,730,1030,1520,380,1350,500,950,1025,500,475,800,10200
Arwal,16.1.6,Stock position of Measles vaccines,5. Total Stock,260,30,400,380,0,500,900,1150,325,325,550,750,5570
Arwal,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,340,210,260,650,380,50,1000,750,1550,400,700,750,7040
Arwal,16.1.7,Stock position of JE vaccines,2. Stocks Received,850,850,1500,1500,NA,2400,400,1100,0,500,0,800,9900
Arwal,16.1.7,Stock position of JE vaccines,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,16.1.7,Stock position of JE vaccines,4. Stock Distributed,980,800,1110,1770,330,1450,650,300,1150,200,0,600,9340
Arwal,16.1.7,Stock position of JE vaccines,5. Total Stock,210,260,650,380,50,1000,750,1550,400,700,700,950,7600
Arwal,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,525,250,450,900,945,892,842,742,692,692,642,800,8372
Arwal,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,NA,550,500,500,NA,NA,0,0,0,0,200,100,1850
Arwal,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,275,50,350,455,53,50,100,52,0,50,42,100,1577
Arwal,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,250,750,600,945,892,842,742,690,692,642,800,800,8645
Arwal,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,200,200,6315,315,315,315,NA,NA,0,NA,NA,NA,7660
Arwal,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,NA,6115,0,NA,NA,NA,NA,NA,2165,NA,NA,NA,8280
Arwal,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,NA,0,6000,NA,NA,315,NA,NA,2165,NA,NA,NA,8480
Arwal,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,200,6315,315,315,315,0,0,0,0,0,0,0,7460
Arwal,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,NA,0,63868,3000,3000,3000,NA,NA,0,NA,NA,NA,72868
Arwal,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,NA,68908,NA,NA,NA,NA,NA,NA,8170,NA,NA,NA,77078
Arwal,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,NA,5040,60868,NA,NA,3000,NA,NA,8170,NA,NA,NA,77078
Arwal,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0,63868,3000,3000,3000,0,0,0,0,0,0,0,72868
Arwal,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,3500,1500,9739,1000,1000,1000,NA,NA,0,NA,NA,NA,17739
Arwal,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,NA,8239,NA,NA,NA,NA,NA,NA,486,NA,NA,NA,8725
Arwal,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,2000,9739,8739,NA,NA,1000,NA,NA,486,NA,NA,NA,21964
Arwal,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,1500,0,1000,1000,1000,0,0,0,0,0,0,0,4500
Arwal,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,600,0,4494,200,200,200,100,100,0,NA,NA,NA,5894
Arwal,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,NA,4494,NA,NA,NA,NA,0,0,387,NA,NA,NA,4881
Arwal,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,600,0,4294,NA,NA,100,0,100,387,NA,NA,NA,5481
Arwal,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0,4494,200,200,200,100,100,0,0,0,0,0,5294
Arwal,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Arwal,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Arwal,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Arwal,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Arwal,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Arwal,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Arwal,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Arwal,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Arwal,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,2000,2000,3000,1500,500,200,NA,NA,NA,NA,0,8500,17700
Arwal,16.3.02,Stock Position of Gloves,2. Stocks Received,5000,2000,NA,NA,NA,NA,NA,NA,NA,NA,28000,0,35000
Arwal,16.3.02,Stock Position of Gloves,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,16.3.02,Stock Position of Gloves,4. Stock Distributed,1000,1000,1500,1000,300,200,NA,NA,NA,NA,19500,4500,29000
Arwal,16.3.02,Stock Position of Gloves,5. Total Stock,6000,3000,1500,500,200,0,0,0,0,0,8500,4000,23700
Arwal,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Arwal,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Arwal,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Arwal,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Arwal,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Arwal,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Arwal,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Arwal,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Arwal,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Arwal,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Arwal,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Arwal,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Arwal,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Arwal,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Arwal,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Arwal,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Arwal,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,27680,0,413000,NA,NA,NA,NA,NA,NA,NA,0,350000,790680
Arwal,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,NA,500000,NA,NA,NA,NA,NA,NA,NA,NA,950000,0,1450000
Arwal,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,27680,87000,413000,NA,NA,NA,NA,NA,NA,NA,600000,280000,1407680
Arwal,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0,413000,0,0,0,0,0,0,0,0,350000,70000,833000
Arwal,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Arwal,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Arwal,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Arwal,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Arwal,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Arwal,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Arwal,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Arwal,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Arwal,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,49,45,45,45,22,22,NA,NA,NA,NA,NA,NA,228
Arwal,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Arwal,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,NA,0,NA,23,NA,22,NA,NA,NA,NA,NA,NA,45
Arwal,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,49,45,45,22,22,0,0,0,0,0,0,0,183
Arwal,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,2000,0,NA,NA,29140,2140,2140,NA,NA,NA,NA,NA,35420
Arwal,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,NA,0,NA,53140,NA,NA,0,NA,NA,NA,NA,NA,53140
Arwal,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,NA,0,NA,24000,27000,NA,2140,NA,NA,NA,NA,NA,53140
Arwal,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,2000,0,0,29140,2140,2140,0,0,0,0,0,0,35420
Arwal,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,15200,12700,11200,10700,7500,5440,3450,6350,4350,750,3750,800,82190
Arwal,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,NA,0,0,NA,NA,NA,5000,0,0,5000,0,2500,12500
Arwal,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,1500,1000,500,3200,2050,3000,2100,2000,3600,2000,2950,3100,27000
Arwal,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,13700,11700,10700,7500,5450,2440,6350,4350,750,3750,800,200,67690
Arwal,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,24200,6000,0,18200,49400,25400,2400,37800,19800,1800,37800,10000,232800
Arwal,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,NA,45000,45000,50000,NA,NA,50000,0,0,50000,0,25000,265000
Arwal,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,18200,6000,26800,18800,24000,23000,14600,18000,18000,14000,27800,31200,240400
Arwal,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,6000,45000,18200,49400,25400,2400,37800,19800,1800,37800,10000,3800,257400
Arwal,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,4000,1500,300,5300,7800,4500,1500,5000,2200,100,3300,1400,36900
Arwal,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,NA,6500,6500,5000,NA,NA,5000,0,0,5000,0,2000,30000
Arwal,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,2500,1200,1500,2500,3300,3000,1500,2800,2100,1800,1900,2200,26300
Arwal,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,1500,6800,5300,7800,4500,1500,5000,2200,100,3300,1400,1200,40600
Arwal,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,1,1,NA,NA,2
Arwal,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,1
Arwal,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,2,1,NA,NA,3
Arwal,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,1
Arwal,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,1
Arwal,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,1
Arwal,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,1
Arwal,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,1
Arwal,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,1
Arwal,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Arwal,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,NA,NA,NA,1,NA,NA,NA,NA,NA,1,NA,NA,2
Arwal,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,NA,NA,NA,1,NA,NA,NA,NA,NA,1,NA,NA,2
Aurangabad,1.1,Total number of pregnant women Registered for ANC,TOTAL,5776,5801,6453,5920,5589,5281,5203,4670,4674,4013,6848,5547,65775
Aurangabad,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,4871,5322,5781,4960,4340,4411,3804,3198,2897,2767,4991,3919,51261
Aurangabad,1.2,Number of Pregnant women registered under JSY,TOTAL,5776,5801,6453,5920,5582,5281,5203,4670,4674,4013,5173,5529,64075
Aurangabad,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,5157,5051,4838,4409,4400,4424,4349,3883,3767,3236,4020,3685,51219
Aurangabad,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,3872,4003,4308,3674,3708,3596,3187,2718,2714,2593,3304,3355,41032
Aurangabad,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,4461,5257,5315,5590,5119,5187,4499,3443,3279,3433,3552,4276,53411
Aurangabad,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,4962,4970,4664,4163,3578,2815,3072,2539,2100,1421,1461,1450,37195
Aurangabad,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,52,94,74,72,515,46,36,21,69,13,27,49,1068
Aurangabad,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,6,3,7,5,18,10,4,4,3,8,21,18,107
Aurangabad,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,1245,1187,1358,1205,1098,1055,995,828,898,1137,1649,1655,14310
Aurangabad,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,36,33,22,65,23,0,8,0,22,29,34,52,324
Aurangabad,1.8,Number of pregnancy test kits used at SC level,TOTAL,148,166,150,161,311,209,165,96,90,124,232,341,2193
Aurangabad,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,169,211,227,545,358,533,603,510,470,381,513,351,4871
Aurangabad,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,747,704,814,884,1224,1304,1386,1391,1445,1266,1027,839,13031
Aurangabad,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,916,915,1041,1429,1582,1837,1989,1901,1915,1647,1540,1190,17902
Aurangabad,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,374,277,365,385,578,491,520,541,519,575,1031,739,6395
Aurangabad,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,19,3,0,8,19,0,8,0,5,5,5,5,77
Aurangabad,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1832,2006,2037,2974,3589,3329,3485,3575,3033,2781,2364,2112,33117
Aurangabad,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,1688,1952,2011,2897,3498,3307,3345,3552,3013,2763,2345,2077,32448
Aurangabad,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1564,1789,2020,2491,4670,3155,3537,3504,3171,2752,2375,2100,33128
Aurangabad,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1796,1093,854,1850,1019,2028,1748,3001,2326,1677,1651,3189,22232
Aurangabad,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0,0,0,0,0,0,0,0,1,0,0,1,2
Aurangabad,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,86,97,94,109,103,94,181,15,14,9,7,8,817
Aurangabad,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,0
Aurangabad,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,0
Aurangabad,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,9,6,6,11,14,14,16,21,20,14,16,19,166
Aurangabad,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,3,3,4,6,5,5,5,6,4,3,3,3,50
Aurangabad,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,1,2,2,0,4,7,4,2,NA,4,3,7,36
Aurangabad,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,13,11,12,17,23,26,25,29,24,21,22,29,252
Aurangabad,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,16,20,19,22,19,17,112,10,4,5,4,4,252
Aurangabad,4.1.1.a,Number of male live births,TOTAL,1447,1520,1822,2450,2640,2678,2876,2780,2521,2268,1989,1705,26696
Aurangabad,4.1.1.b,Number of female live births,TOTAL,1353,1458,1556,2064,2588,2532,2765,2661,2419,2123,1876,1587,24982
Aurangabad,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,2800,2978,3378,4514,5228,5210,5641,5441,4940,4391,3865,3292,51678
Aurangabad,4.1.2,Number of still births,TOTAL,46,45,33,47,83,57,57,73,44,42,26,25,578
Aurangabad,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,7,3,4,7,11,4,6,5,6,0,6,6,65
Aurangabad,4.2.1,Number of Newborns weighed at birth,TOTAL,2646,2848,3174,4331,5003,4910,5275,5083,4697,4118,3817,3265,49167
Aurangabad,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,117,179,144,315,289,387,376,408,343,240,304,341,3443
Aurangabad,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,2669,2855,3152,4413,5042,4984,5387,5229,4761,4223,3864,3231,49810
Aurangabad,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,25,23,0,2,12,11,12,19,18,64,91,79,356
Aurangabad,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,4,2,4,5,5,8,7,6,6,20,36,30,133
Aurangabad,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,4,12,4,4,8,0,NA,17,27,18,14,10,118
Aurangabad,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,33,37,8,11,25,19,19,42,51,102,141,119,607
Aurangabad,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,202,237,208,194,198,231,189,221,232,171,162,185,2430
Aurangabad,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,54,45,39,46,60,30,14,18,22,29,21,33,411
Aurangabad,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,155,182,135,186,239,932,885,1633,222,116,642,194,5521
Aurangabad,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,4,5,2,0,5,0,2,3,3,2,63,3,92
Aurangabad,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,996,1022,1336,2134,1864,1605,1797,2445,2300,2132,2275,1603,21509
Aurangabad,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,719,687,843,930,1314,1232,1365,1341,1259,1172,1285,1475,13622
Aurangabad,6.3,PNC maternal complications attended,TOTAL,0,0,0,0,0,0,4,2,2,6,19,14,47
Aurangabad,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,0,0,0,0,0,0,0,0,0,0,7,6,13
Aurangabad,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Aurangabad,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,0,0,0,0,0,0,0,0,0,0,7,6,13
Aurangabad,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0,0,0,0,0,0,0,22,0,0,0,0,22
Aurangabad,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,283,314,141,412,424,2,363,401,504,600,548,409,4401
Aurangabad,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,278,295,342,435,454,9,376,411,499,626,413,520,4658
Aurangabad,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,561,609,483,847,878,11,739,812,1003,1226,961,929,9059
Aurangabad,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0,0,0,0,0,8,0,0,0,0,56,0,64
Aurangabad,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,2,0,4,6,8,11,11,6,13,8,6,5,80
Aurangabad,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,1,1,1,4,1,2,2,3,3,2,2,2,24
Aurangabad,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0,0,0,1,0,1,0,3,0,1,0,3,9
Aurangabad,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,3,1,5,11,9,14,13,12,16,11,8,10,113
Aurangabad,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,NA,NA,2,0,NA,NA,NA,NA,0,NA,NA,NA,2
Aurangabad,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,9,0,0,0,0,0,0,0,0,0,0,0,9
Aurangabad,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Aurangabad,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0,0,0,0,0,NA,NA,0,0,0,NA,0,0
Aurangabad,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,9,0,0,0,0,0,0,0,0,0,0,0,9
Aurangabad,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,199,88,100,295,401,579,741,477,1092,1012,1203,747,6934
Aurangabad,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,32,32,26,65,112,146,241,260,296,431,727,232,2600
Aurangabad,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,15,9,0,9,24,27,37,67,74,58,156,63,539
Aurangabad,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,246,129,126,369,537,752,1019,804,1462,1501,2086,1042,10073
Aurangabad,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,NA,NA,17,26,40,54,32,38,76,100,354,2977,3714
Aurangabad,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,1,0,14,0,26,41,44,36,61,27,24,27,301
Aurangabad,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,15,14,10,26,69,95,0,0,0,0,0,5,234
Aurangabad,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0,0,0,0,1,NA,NA,0,0,0,1,0,2
Aurangabad,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,16,14,24,26,96,136,44,36,61,27,25,32,537
Aurangabad,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,1186,1728,1602,1473,934,1238,523,497,623,527,586,582,11499
Aurangabad,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,806,385,367,535,220,291,191,198,437,262,255,259,4206
Aurangabad,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,97,63,55,343,89,109,107,64,147,175,162,126,1537
Aurangabad,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,124,12,14,5,47,36,9,11,0,67,125,120,570
Aurangabad,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,2213,2188,2038,2356,1290,1674,830,770,1207,1031,1128,1087,17812
Aurangabad,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,180,184,259,158,98,401,322,394,519,553,420,337,3825
Aurangabad,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,NA,NA,8,11,11,11,10,9,19,13,23,12,127
Aurangabad,9.06,Number of IUCD removals,TOTAL,231,270,239,304,278,358,292,228,211,209,301,210,3131
Aurangabad,9.07,Number of Oral Pills cycles distributed,TOTAL,1359,1480,2243,2281,1810,2405,1549,1684,1498,1144,1143,1079,19675
Aurangabad,9.08,Number of Condom pieces distributed,TOTAL,8933,11316,13343,14202,7624,11873,8950,9432,8727,7310,9168,8433,119311
Aurangabad,9.09,Number of Centchroman (weekly) pills given,TOTAL,431,233,290,144,133,51,13,119,19,31,44,114,1622
Aurangabad,9.1,Number of Emergency Contraceptive Pills distributed,TOTAL,166,419,256,174,130,963,167,138,123,199,225,299,3259
Aurangabad,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Aurangabad,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,1,1
Aurangabad,9.11.2.a,Number of failures following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Aurangabad,9.11.2.b,Number of failures following female sterilization,TOTAL,0,1,0,0,0,0,0,0,0,0,0,0,1
Aurangabad,9.11.3.a,Number of deaths following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Aurangabad,9.11.3.b,Number of deaths following female sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Aurangabad,9.12,Number of Institutions having NSV trained doctors,TOTAL,NA,NA,4,4,4,4,11,5,7,8,13,10,Data for this item can not be cumulated
Aurangabad,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,3225,3601,3975,5286,5897,5760,5963,6202,5947,5051,4804,4105,59816
Aurangabad,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,33,22,16,4,5,6,1,1,0,0,0,0,88
Aurangabad,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,554,304,212,65,35,25,23,8,7,5,0,0,1238
Aurangabad,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,1322,774,521,404,129,76,36,27,14,9,0,0,3312
Aurangabad,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,3939,3978,4178,3884,4100,4984,5611,5627,6125,6037,5450,5051,58964
Aurangabad,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,4168,4656,4297,4025,3911,4392,4631,4914,5616,6089,5528,5694,57921
Aurangabad,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,3880,4641,4617,4215,4121,4067,4286,4168,4824,5607,5391,5997,55814
Aurangabad,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,2556,2873,3026,4206,4533,4609,4549,4868,4441,3562,3550,3128,45901
Aurangabad,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,4020,3552,4153,3841,4045,4979,5622,5633,6126,6037,5449,5051,58508
Aurangabad,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,4293,4411,4357,4041,3942,4397,4655,4915,5629,6094,5529,5697,57960
Aurangabad,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,4580,4702,4871,4351,4182,4023,4327,4184,4820,5612,5406,5984,57042
Aurangabad,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,1747,1738,2135,3004,3313,3266,3325,3713,3192,2763,2575,2436,33207
Aurangabad,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,46,54,12,18,1,0,1,0,0,0,0,0,132
Aurangabad,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,470,220,206,68,29,23,11,5,6,4,0,0,1042
Aurangabad,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,1272,689,534,380,125,58,36,15,10,7,0,0,3126
Aurangabad,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,3531,4895,5575,5911,6016,5897,5909,4953,4752,4099,3908,4032,59478
Aurangabad,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,4517,4604,5090,4511,3951,4174,4120,3842,4606,4628,5132,5268,54443
Aurangabad,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,3456,4866,5549,5898,5962,5916,5873,4884,4739,4083,3941,4001,59168
Aurangabad,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1816,2543,2801,3084,3072,3097,3176,2615,2430,2202,2057,2105,30998
Aurangabad,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1706,2345,2788,2803,2871,2796,2741,2331,2308,1878,1841,1916,28324
Aurangabad,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,3522,4888,5589,5887,5943,5893,5917,4946,4738,4080,3898,4021,59322
Aurangabad,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,4475,4595,5088,4575,3966,4205,4113,3857,4606,4638,5135,5260,54513
Aurangabad,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,4482,4595,5088,4568,3966,4216,4113,3857,4606,4648,5135,5263,54537
Aurangabad,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,17,88,0,24,0,66,0,4,29,0,0,0,228
Aurangabad,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,332,555,891,603,606,451,458,387,501,520,807,941,7052
Aurangabad,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,287,516,799,558,589,395,405,368,463,463,724,776,6343
Aurangabad,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,619,1071,1690,1161,1195,846,863,755,964,983,1531,1717,13395
Aurangabad,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,384,257,413,465,355,279,562,675,866,885,782,755,6678
Aurangabad,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,1081,1024,1286,1602,1340,1412,1495,1343,1222,1106,1169,1305,15385
Aurangabad,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1688,1167,1630,2161,2167,2281,2060,1871,1785,1631,1731,2005,22177
Aurangabad,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,2,0,1,0,0,3,0,0,0,0,0,0,6
Aurangabad,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Aurangabad,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,23,0,1,0,0,0,0,0,0,1,0,0,25
Aurangabad,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,2624,2813,2873,2869,2723,2871,2820,2813,2806,2806,2810,2812,33640
Aurangabad,10.4.2,Number of Immunisation sessions held during the month,TOTAL,2610,2813,2873,2877,2723,2871,2820,2813,2805,2806,2789,2804,33604
Aurangabad,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,2224,2446,2553,2592,2453,2603,2581,2547,2573,2540,2542,2593,30247
Aurangabad,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,4360,4592,5108,4564,3806,4203,3972,3964,4233,4509,4914,5092,53317
Aurangabad,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1975,2535,2750,2056,2153,2234,1796,1520,1517,1201,1177,1038,21952
Aurangabad,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,1076,1488,1219,640,889,1247,759,775,995,691,716,766,11261
Aurangabad,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,24,43,51,46,18,21,13,0,25,47,0,23,311
Aurangabad,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Aurangabad,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Aurangabad,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Aurangabad,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Aurangabad,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Aurangabad,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,3,3,0,0,2,8
Aurangabad,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,8,5,2,0,6,3,0,8,0,0,5,22,59
Aurangabad,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0,0,0,0,16,0,8,6,0,1,4,0,35
Aurangabad,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0,0,0,0,0,0,6,7,9,10,4,0,36
Aurangabad,13.1,Number of Patients operated for cataract,TOTAL,135,69,20,20,114,64,89,117,928,519,516,247,2838
Aurangabad,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,135,69,20,20,114,64,89,117,928,519,516,247,2838
Aurangabad,13.3,Number of School children detected with Refractive errors,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Aurangabad,13.4,Number of children provided free glasses,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Aurangabad,13.5,Number of eyes collected through eye donation,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Aurangabad,13.6,Number of eyes utilised for corneal transplant,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Aurangabad,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,NA,NA,1,1,2,1,1,2,3,3,4,3,Data for this item can not be cumulated
Aurangabad,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,NA,NA,21,21,19,21,11,15,18,17,19,16,Data for this item can not be cumulated
Aurangabad,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,2073,2233,2258,2297,2009,2297,2287,2192,2176,2139,2063,2050,Data for this item can not be cumulated
Aurangabad,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,NA,NA,1,1,2,1,1,2,2,3,4,3,Data for this item can not be cumulated
Aurangabad,14.05,Number of RKS meetings held during the month,TOTAL,6,8,8,9,181,166,17,10,11,11,12,33,472
Aurangabad,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,NA,NA,11,11,15,11,12,12,16,18,19,16,Data for this item can not be cumulated
Aurangabad,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,714,804,461,830,872,809,1306,889,1156,1725,1338,1303,12207
Aurangabad,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,NA,NA,1,1,2,1,1,1,2,2,2,2,Data for this item can not be cumulated
Aurangabad,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,1,NA,1,1,1,0,0,1,1,1,0,0,Data for this item can not be cumulated
Aurangabad,14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,1213,1140,803,768,894,595,647,531,506,470,415,648,8630
Aurangabad,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,1374,1269,999,1180,772,814,1155,1160,1068,971,1252,923,12937
Aurangabad,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,1266,1656,724,1102,798,743,868,774,582,564,465,1284,10826
Aurangabad,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,3727,3045,3817,4103,4540,4783,4422,4655,5224,5033,5107,4054,52510
Aurangabad,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,2479,2796,1527,1870,1692,1338,1515,1305,1088,1034,880,1932,19456
Aurangabad,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,5101,4314,4816,5283,5312,5597,5577,5815,6292,6004,6359,4977,65447
Aurangabad,14.10.2.a,Number of death cases of Inpatient males,TOTAL,9,6,3,6,8,0,3,0,8,9,2,8,62
Aurangabad,14.10.2.b,Number of death cases of Inpatient females,TOTAL,4,4,3,4,6,0,5,0,0,2,5,4,37
Aurangabad,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,13,10,6,10,14,0,8,0,8,11,7,12,99
Aurangabad,14.11,In-Patient Head Count at midnight,TOTAL,6155,6237,5819,5901,6374,6125,5974,5242,5390,4465,5281,4664,67627
Aurangabad,14.12.1,OPD attendance (All),TOTAL,214396,223545,202261,204703,211286,210422,163110,151829,154720,137618,152389,169274,2195553
Aurangabad,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,598,277,214,813,655,771,984,905,1284,1403,2008,1769,11681
Aurangabad,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,200,1002,122,15,0,0,0,2,26,0,4,180,1551
Aurangabad,14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,3558,1968,3339,4056,3247,3049,2402,2786,2800,2883,4131,3504,37723
Aurangabad,14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,14.14.a,Number of patients given AYUSH treatment,TOTAL,49705,52043,48347,56043,44549,49575,41623,40628,41665,38747,39335,42119,544379
Aurangabad,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,9337,7249,7063,9088,9543,10546,7678,8515,8063,7848,8005,7497,100432
Aurangabad,14.14.c,Number of Adolescents counselled,TOTAL,462,355,306,341,277,168,176,167,171,180,178,199,2980
Aurangabad,15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,5012,4654,4795,5224,4067,6098,4786,4507,5107,4977,5707,5672,60606
Aurangabad,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,81,122,74,123,89,136,88,116,52,104,144,147,1276
Aurangabad,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,175,206,132,215,219,190,67,163,223,513,333,411,2847
Aurangabad,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,4,2,6,6,7,1,0,1,4,4,5,6,46
Aurangabad,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,312,239,121,244,288,294,63,239,620,466,634,337,3857
Aurangabad,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,2,2,6,6,4,1,0,2,2,2,5,3,35
Aurangabad,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,412,324,272,447,512,466,111,315,486,509,546,566,4966
Aurangabad,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,2,1,0,0,0,0,0,0,0,1,1,0,5
Aurangabad,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,899,769,525,906,1019,950,241,717,1329,1488,1513,1314,11670
Aurangabad,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,8,5,12,12,11,2,0,3,6,7,11,9,86
Aurangabad,15.2,Number of Widal tests conducted,Number tested,38,126,21,166,60,103,37,57,65,19,43,73,808
Aurangabad,15.3.a,Number of VDRL tests conducted on males,Number tested,64,133,126,34,45,176,4,13,3,2,23,82,705
Aurangabad,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,47,144,114,28,51,264,6,4,5,5,20,75,763
Aurangabad,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,49,216,213,59,0,4,5,3,4,7,37,159,756
Aurangabad,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,160,493,453,121,96,444,15,20,12,14,80,316,2224
Aurangabad,15.4.1,Number of blood smears examined for Malaria,TOTAL,2353,2336,2602,2227,2652,3962,4861,3729,3106,1328,1987,1941,33084
Aurangabad,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,13,11,9,30,31,121,78,32,17,6,2,8,358
Aurangabad,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,1,0,0,5,8,4,4,7,2,0,1,0,32
Aurangabad,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,2250,1750,1800,3900,3000,2250,2950,2750,1700,2750,2200,NA,27300
Aurangabad,16.1.1,Stock position of DPT vaccines,2. Stocks Received,2000,5000,8250,2000,0,3600,0,NA,4000,1000,1500,NA,27350
Aurangabad,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,0
Aurangabad,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,2500,4950,6150,2900,750,2900,200,1050,2950,1550,1850,NA,27750
Aurangabad,16.1.1,Stock position of DPT vaccines,5. Total Stock,1750,1800,3900,3000,2250,2950,2750,1700,2750,2200,1850,0,26900
Aurangabad,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,2964,3614,3600,4400,6000,3408,9000,8208,2304,5952,5568,NA,55018
Aurangabad,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,6000,6700,10500,11232,0,13824,NA,NA,8640,6048,7680,NA,70624
Aurangabad,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,5350,6714,9700,9632,2592,8232,792,5904,4992,6432,7896,NA,68236
Aurangabad,16.1.1A,Stock Position of Pentavalent,5. Total Stock,3614,3600,4400,6000,3408,9000,8208,2304,5952,5568,5352,0,57406
Aurangabad,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,750,1925,1825,2200,8400,1600,7300,1425,1575,1600,1800,NA,30400
Aurangabad,16.1.2,Stock position of OPV vaccines,2. Stocks Received,6000,6100,10000,15000,0,13400,NA,8000,7000,8000,8000,NA,81500
Aurangabad,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,0
Aurangabad,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,4825,6200,9625,8800,6800,7700,5875,7850,6975,7800,7250,NA,79700
Aurangabad,16.1.2,Stock position of OPV vaccines,5. Total Stock,1925,1825,2200,8400,1600,7300,1425,1575,1600,1800,2550,0,32200
Aurangabad,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,4200,2650,3000,7400,4050,2150,6450,5400,2200,2900,3500,NA,43900
Aurangabad,16.1.3,Stock position of TT vaccines,2. Stocks Received,2000,8000,14000,4000,0,8350,NA,3000,5000,5000,6000,NA,55350
Aurangabad,16.1.3,Stock position of TT vaccines,3. Unusable Stock,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,0
Aurangabad,16.1.3,Stock position of TT vaccines,4. Stock Distributed,3550,7650,9600,7350,1900,4050,1050,6200,4300,4400,6450,NA,56500
Aurangabad,16.1.3,Stock position of TT vaccines,5. Total Stock,2650,3000,7400,4050,2150,6450,5400,2200,2900,3500,3050,0,42750
Aurangabad,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,0
Aurangabad,16.1.4,Stock position of DT vaccines,2. Stocks Received,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,0
Aurangabad,16.1.4,Stock position of DT vaccines,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,16.1.4,Stock position of DT vaccines,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,16.1.4,Stock position of DT vaccines,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Aurangabad,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,2600,3450,3400,5350,5150,950,5250,950,1200,3000,2250,NA,33550
Aurangabad,16.1.5,Stock position of BCG vaccines,2. Stocks Received,4000,5500,8000,8600,0,10450,NA,6000,7000,5000,5000,NA,59550
Aurangabad,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,0
Aurangabad,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,3150,5550,6050,8800,4200,6150,4300,5750,5200,5750,6100,NA,61000
Aurangabad,16.1.5,Stock position of BCG vaccines,5. Total Stock,3450,3400,5350,5150,950,5250,950,1200,3000,2250,1150,0,32100
Aurangabad,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,550,1400,400,3185,16100,1500,12300,4200,2000,9400,7900,NA,58935
Aurangabad,16.1.6,Stock position of Measles vaccines,2. Stocks Received,10000,5000,18985,29000,0,25500,NA,10000,16000,12500,13000,NA,139985
Aurangabad,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,0
Aurangabad,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,9150,6000,16200,16085,14600,14700,8100,12200,8600,14000,14550,NA,134185
Aurangabad,16.1.6,Stock position of Measles vaccines,5. Total Stock,1400,400,3185,16100,1500,12300,4200,2000,9400,7900,6350,0,64735
Aurangabad,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,350,950,750,300,10550,2400,4300,800,350,1450,2100,NA,24300
Aurangabad,16.1.7,Stock position of JE vaccines,2. Stocks Received,4000,4000,10000,19000,0,24400,NA,9000,9000,6000,8000,NA,93400
Aurangabad,16.1.7,Stock position of JE vaccines,3. Unusable Stock,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,0
Aurangabad,16.1.7,Stock position of JE vaccines,4. Stock Distributed,3450,4200,10450,8750,8150,22500,3500,9450,7900,5350,8350,NA,92050
Aurangabad,16.1.7,Stock position of JE vaccines,5. Total Stock,900,750,300,10550,2400,4300,800,350,1450,2100,1750,0,25650
Aurangabad,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,2750,2500,2500,3000,3350,2300,3155,3155,1705,3305,2850,NA,30570
Aurangabad,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,1000,6100,5100,3000,0,1055,NA,NA,3000,0,NA,NA,19255
Aurangabad,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,0
Aurangabad,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,1250,6100,4600,2650,1050,200,NA,1450,1400,455,1000,NA,20155
Aurangabad,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,2500,2500,3000,3350,2300,3155,3155,1705,3305,2850,1850,0,29670
Aurangabad,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Aurangabad,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Aurangabad,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Aurangabad,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Aurangabad,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Aurangabad,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Aurangabad,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,16.3.02,Stock Position of Gloves,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,16.3.02,Stock Position of Gloves,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,16.3.02,Stock Position of Gloves,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,16.3.02,Stock Position of Gloves,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Aurangabad,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Aurangabad,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Aurangabad,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Aurangabad,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Aurangabad,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Aurangabad,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Aurangabad,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0
Aurangabad,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,NA,NA,NA,1398,NA,NA,NA,NA,NA,NA,NA,NA,1398
Aurangabad,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0
Aurangabad,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0
Aurangabad,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0,0,0,1398,0,0,0,0,0,0,0,0,1398
Aurangabad,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Aurangabad,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,NA,NA,NA,66951,NA,NA,NA,NA,NA,NA,NA,NA,66951
Aurangabad,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0
Aurangabad,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0
Aurangabad,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,NA,NA,NA,16000,NA,NA,NA,NA,NA,NA,NA,NA,16000
Aurangabad,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0,0,0,50951,0,0,0,0,0,0,0,0,50951
Aurangabad,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,21300,14200,13600,14000,20800,14000,8000,4800,10000,15200,10600,NA,146500
Aurangabad,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0,8600,10000,10000,0,0,NA,10000,10000,0,NA,NA,48600
Aurangabad,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,0
Aurangabad,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,7100,9200,9600,3200,6800,6000,3200,4800,4800,4600,5600,NA,64900
Aurangabad,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,14200,13600,14000,20800,14000,8000,4800,10000,15200,10600,5000,0,130200
Aurangabad,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,170700,105900,102800,104500,170500,121300,77500,54300,94100,149700,99300,NA,1250600
Aurangabad,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0,90000,90000,80000,0,0,NA,80000,100000,0,NA,NA,440000
Aurangabad,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,0
Aurangabad,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,64800,93800,88300,14000,49200,43800,23200,40200,44400,50400,48000,NA,560100
Aurangabad,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,105900,102100,104500,170500,121300,77500,54300,94100,149700,99300,51300,0,1130500
Aurangabad,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,4200,0,1400,2600,30100,22650,15650,7900,10400,13400,6900,NA,115200
Aurangabad,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0,8000,8000,30000,0,0,NA,10000,10000,0,NA,NA,66000
Aurangabad,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,0
Aurangabad,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,4200,6700,6800,2500,7450,7000,7750,7500,7000,6500,6200,NA,69600
Aurangabad,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0,1300,2600,30100,22650,15650,7900,10400,13400,6900,700,0,111600
Aurangabad,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,10,10
Aurangabad,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1
Aurangabad,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1
Aurangabad,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1
Aurangabad,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1
Aurangabad,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,4,4,8
Aurangabad,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1,NA,2
Aurangabad,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,5,4,10
Aurangabad,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,1
Aurangabad,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,1
Aurangabad,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1,NA,2
Aurangabad,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,1
Aurangabad,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,1
Aurangabad,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,3,4
Aurangabad,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,1
Aurangabad,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,3,5
Aurangabad,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1
Aurangabad,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1
Aurangabad,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1
Aurangabad,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,1,3,5
Aurangabad,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,4,1,2,6,13
Aurangabad,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,5,1,3,10,19
Aurangabad,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,2,3
Aurangabad,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1
Aurangabad,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,3,4
Aurangabad,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1
Aurangabad,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1
Aurangabad,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,NA,2
Aurangabad,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,NA,2
Aurangabad,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,2,1,3,2,8
Aurangabad,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,2,1,3,2,8
Aurangabad,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1
Aurangabad,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1
Aurangabad,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,2
Aurangabad,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,2
Aurangabad,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,2
Aurangabad,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,1
Aurangabad,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,1
Aurangabad,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Aurangabad,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1
Aurangabad,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1,NA,2
Aurangabad,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1,1,3
Aurangabad,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,1
Aurangabad,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,3,1,4,2,10
Aurangabad,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,8,5,4,NA,17
Aurangabad,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,11,6,9,2,28
Banka,1.1,Total number of pregnant women Registered for ANC,TOTAL,5607,5019,5392,5464,4832,4197,4188,3618,3686,4288,4921,4945,56157
Banka,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,2950,2584,2632,2642,2392,2078,2209,1878,2014,2492,3025,3168,30064
Banka,1.2,Number of Pregnant women registered under JSY,TOTAL,5607,5019,5392,5464,4832,4197,4188,3618,3686,4288,4921,4945,56157
Banka,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,3728,3525,3771,3894,4394,4336,3968,3449,3246,3108,3028,3569,44016
Banka,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,3720,3325,3540,3475,3069,2712,2663,2422,2392,2842,3128,3008,36296
Banka,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,5058,4945,4973,4921,5270,4227,4072,3475,3347,3640,4012,4558,52498
Banka,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,3513,3517,3639,3533,4209,4133,3803,3410,3247,3134,3058,3573,42769
Banka,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,5,6,60,1,0,8,2,21,6,12,12,5,138
Banka,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,2,1,2,1,0,0,1,1,1,1,1,2,13
Banka,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,6111,6501,7009,7361,7467,7169,6402,5600,5607,5657,5924,6712,77520
Banka,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,2,0,0,2,2,0,1,6,20,15,20,2,70
Banka,1.8,Number of pregnancy test kits used at SC level,TOTAL,539,647,725,742,1074,965,1145,848,842,908,948,996,10379
Banka,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,28,33,28,45,33,67,27,30,28,32,19,14,384
Banka,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,345,355,439,501,523,510,630,568,438,473,431,320,5533
Banka,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,373,388,467,546,556,577,657,598,466,505,450,334,5917
Banka,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,187,234,228,265,202,217,273,201,166,206,188,152,2519
Banka,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,8,0,0,0,0,0,2,0,0,0,0,0,10
Banka,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1892,2015,1910,3033,3726,3734,4177,3552,3029,2933,2478,2336,34815
Banka,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,1273,1864,1753,2675,3321,3348,3851,3326,2825,2669,2272,2078,31255
Banka,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1020,1428,1175,2239,1729,3339,4323,3120,2851,2888,2414,4125,30651
Banka,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,692,337,1052,1394,877,2655,2557,1569,1800,1777,2078,6689,23477
Banka,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0,0,0,0,19,35,12,0,20,33,74,38,231
Banka,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,51,58,69,71,83,91,24,31,34,NA,NA,NA,512
Banka,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Banka,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,1,0,0,5,3,1,1,0,0,1,5,2,19
Banka,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,11,2,5,15,13,14,5,5,10,10,9,5,104
Banka,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,12,2,5,20,16,15,6,5,10,11,14,7,123
Banka,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,14,19,17,19,34,63,6,6,15,NA,NA,NA,193
Banka,4.1.1.a,Number of male live births,TOTAL,1222,1239,1203,1850,2184,2159,2459,2130,1756,1726,1489,1353,20770
Banka,4.1.1.b,Number of female live births,TOTAL,1027,1126,1136,1662,2043,2103,2307,1951,1689,1670,1384,1282,19380
Banka,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,2249,2365,2339,3512,4227,4262,4766,4081,3445,3396,2873,2635,40150
Banka,4.1.2,Number of still births,TOTAL,43,45,48,77,73,71,88,72,59,57,67,47,747
Banka,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,48,29,29,35,41,28,19,37,45,38,44,53,446
Banka,4.2.1,Number of Newborns weighed at birth,TOTAL,2155,2283,2255,3352,4109,4141,4596,3920,3324,3258,2746,2565,38704
Banka,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,137,151,148,240,314,360,401,320,307,304,222,226,3130
Banka,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,2202,2328,2264,3397,4193,4214,4687,4017,3343,3304,2806,2565,39320
Banka,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,3,0,0,0,0,0,0,212,165,47,37,37,501
Banka,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,2,2,3,9,8,7,11,7,8,17,31,12,117
Banka,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,15,5,7,21,28,27,23,22,17,43,31,22,261
Banka,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,20,7,10,30,36,34,34,241,190,107,99,71,879
Banka,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,20,7,10,30,36,34,28,29,25,80,99,70,468
Banka,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,2,2,3,4,4,4,4,4,4,6,18,19,74
Banka,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,16,5,7,26,32,27,24,25,21,77,91,63,414
Banka,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0,0,0,0,0,0,0,0,0,0,1,0,1
Banka,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1949,1796,1939,2757,3819,3783,4218,3560,3264,3050,2698,2396,35229
Banka,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1220,1096,1106,1619,1756,1779,2012,1847,1676,1618,1564,1411,18704
Banka,6.3,PNC maternal complications attended,TOTAL,0,5,0,0,0,11,2,0,5,4,3,0,30
Banka,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,10,7,1,1,6,1,3,1,11,10,10,9,70
Banka,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,2,0,0,0,1,0,1,1,0,0,0,1,6
Banka,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,12,7,1,1,7,1,4,2,11,10,10,10,76
Banka,7.2,Number of MTPs conducted at Private Facilities,TOTAL,17,37,17,18,17,27,18,16,36,33,42,38,316
Banka,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,287,317,231,315,357,369,268,246,286,265,294,259,3494
Banka,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,184,200,147,209,236,252,189,162,182,176,193,179,2309
Banka,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,471,517,378,524,593,621,457,408,468,441,487,438,5803
Banka,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Banka,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,2,0,0,1,0,2,0,0,0,1,2,3,11
Banka,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,1,0,0,1,0,1,0,0,1,0,0,0,4
Banka,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0,NA,1,0,0,0,0,0,0,0,0,0,1
Banka,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,3,0,1,2,0,3,0,0,1,1,2,3,16
Banka,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,1,0,1,3,0,1,0,0,0,2,0,1,9
Banka,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Banka,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Banka,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0,NA,0,0,0,0,0,0,0,0,0,0,0
Banka,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Banka,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,NA,NA,0,NA,0,0,NA,NA,NA,NA,NA,NA,0
Banka,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,158,114,43,161,84,335,462,274,903,1013,1228,707,5482
Banka,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,68,52,16,68,37,114,198,104,419,507,678,250,2511
Banka,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,7,3,0,0,1,17,4,7,12,17,21,8,97
Banka,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,233,169,59,229,122,466,664,385,1334,1537,1927,965,8090
Banka,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,20,52,34,35,38,90,123,107,173,154,90,79,995
Banka,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,39,35,16,49,56,83,121,108,120,144,115,75,961
Banka,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,14,6,5,33,41,71,65,33,71,43,15,37,434
Banka,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,5,4,6,7,6,11,7,11,7,11,5,5,85
Banka,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,58,45,27,89,103,165,193,152,198,198,135,117,1480
Banka,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,NA,NA,0,0,0,0,0,0,0,0,NA,NA,0
Banka,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,374,457,306,1227,356,549,664,361,679,382,382,404,6141
Banka,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,52,53,42,228,42,72,72,51,97,55,35,50,849
Banka,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,29,25,23,2,0,36,46,2,14,32,22,41,272
Banka,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,7,38,37,44,34,39,57,114,118,92,119,109,808
Banka,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,462,573,408,1501,432,696,839,528,908,561,558,604,8070
Banka,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,89,101,85,168,84,177,247,220,320,327,291,250,2359
Banka,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,NA,4,0,5,4,4,1,3,7,2,5,2,37
Banka,9.06,Number of IUCD removals,TOTAL,167,185,168,305,251,222,225,239,280,262,238,264,2806
Banka,9.07,Number of Oral Pills cycles distributed,TOTAL,1332,1120,1278,1235,1115,1333,1915,1527,1426,1185,1497,1549,16512
Banka,9.08,Number of Condom pieces distributed,TOTAL,4424,4473,3920,5175,4367,5171,7181,5964,5628,5760,6912,6626,65601
Banka,9.09,Number of Centchroman (weekly) pills given,TOTAL,5,0,0,15,28,0,0,0,0,0,0,8,56
Banka,9.1,Number of Emergency Contraceptive Pills distributed,TOTAL,527,513,309,395,242,428,498,532,456,444,575,508,5427
Banka,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Banka,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Banka,9.11.2.a,Number of failures following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Banka,9.11.2.b,Number of failures following female sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Banka,9.11.3.a,Number of deaths following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Banka,9.11.3.b,Number of deaths following female sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Banka,9.12,Number of Institutions having NSV trained doctors,TOTAL,NA,NA,NA,9,14,13,18,22,18,19,15,17,Data for this item can not be cumulated
Banka,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,2627,3028,3079,4453,4924,5245,5509,4913,4493,4155,3778,3439,49643
Banka,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,4,3,18,5,1,0,11,0,1,1,1,0,45
Banka,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,417,196,177,126,73,25,16,8,5,3,2,1,1049
Banka,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,1498,848,590,351,186,87,48,34,14,51,4,3,3714
Banka,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,3757,2925,3325,3228,3542,4157,4966,5157,5638,5344,4469,4349,50857
Banka,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,3856,3774,3450,3248,3489,3400,3926,4302,4792,5585,4928,5046,49796
Banka,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,3453,3611,3841,3251,3571,3397,3364,3457,3911,4623,4858,5325,46662
Banka,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1950,2146,2035,3147,3837,3819,4219,3471,3104,2946,2674,2503,35851
Banka,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,3951,2923,3377,3347,3593,4012,4972,4876,5398,5097,4672,4328,50546
Banka,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,4740,4200,3788,3447,3560,3285,3895,4038,4613,5189,5020,5146,50921
Banka,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,5379,4653,4782,3828,3893,3397,3444,3251,3842,4282,4768,5228,50747
Banka,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,1622,1777,1635,2566,3286,3233,3600,2994,2690,2688,2283,2065,30439
Banka,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,72,12,33,16,16,11,0,21,0,0,9,30,220
Banka,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,497,209,191,119,71,37,13,22,6,3,1,8,1177
Banka,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,1633,927,585,333,212,135,42,27,50,69,33,21,4067
Banka,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,4065,4935,6111,5662,4972,5457,4831,3967,3438,3051,2910,3272,52671
Banka,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,4405,4660,5112,4402,3640,4334,4032,3563,4105,4429,4896,4967,52545
Banka,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,3496,3808,4978,4296,4709,5165,4128,3779,3127,2869,2928,3069,46352
Banka,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2009,2362,3181,2751,2531,2698,2410,2048,1694,1540,1505,1629,26358
Banka,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1909,2211,2801,2616,2373,2532,2253,1853,1629,1389,1344,1508,24418
Banka,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,3918,4573,5982,5367,4904,5230,4663,3901,3323,2929,2849,3137,50776
Banka,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,4985,4371,4892,4105,3698,3989,3819,3354,4037,4464,4803,4698,51215
Banka,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,5034,4458,5018,4159,3799,3881,3842,3214,4002,4210,4923,4808,51348
Banka,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Banka,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,288,341,380,343,252,307,233,261,312,336,339,287,3679
Banka,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,246,314,335,304,217,255,206,243,269,284,306,254,3233
Banka,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,534,655,715,647,469,562,439,504,581,620,645,541,6912
Banka,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,156,141,169,129,141,232,276,241,241,399,593,357,3075
Banka,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,723,443,426,497,390,363,450,473,361,535,518,465,5644
Banka,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1439,729,637,746,738,702,984,614,880,1321,916,897,10603
Banka,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0,0,1,0,0,0,0,0,0,0,0,0,1
Banka,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Banka,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0,28,0,0,0,0,0,0,0,0,0,0,28
Banka,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,2266,2185,2236,2288,2290,2300,2259,2272,2270,2219,2209,2285,27079
Banka,10.4.2,Number of Immunisation sessions held during the month,TOTAL,2288,2149,2213,2287,2268,2297,2251,2256,2226,2188,2183,2274,26880
Banka,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,2087,1955,1975,2062,2066,2087,2061,2068,2073,2033,2015,2106,24588
Banka,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,4430,3933,4638,3580,3509,4021,3514,3441,3879,4307,4835,4789,48876
Banka,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,209,159,61,118,22,0,0,1,8,0,0,0,578
Banka,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,12,0,0,6,7,0,0,0,8,0,0,0,33
Banka,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,0,0,0,1,7,0,0,0,8,0,0,0,16
Banka,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Banka,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Banka,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Banka,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Banka,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Banka,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0,0,0,3,0,0,0,0,0,0,0,0,3
Banka,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,1831,1875,1811,1741,1747,1249,1194,837,762,551,593,629,14820
Banka,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Banka,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Banka,13.1,Number of Patients operated for cataract,TOTAL,0,0,0,0,0,0,0,96,298,225,279,121,1019
Banka,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0,0,0,0,0,0,0,96,204,225,279,121,925
Banka,13.3,Number of School children detected with Refractive errors,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Banka,13.4,Number of children provided free glasses,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Banka,13.5,Number of eyes collected through eye donation,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Banka,13.6,Number of eyes utilised for corneal transplant,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Banka,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,NA,NA,NA,1,2,4,4,3,4,4,3,4,Data for this item can not be cumulated
Banka,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,NA,NA,NA,11,10,14,16,17,17,17,15,15,Data for this item can not be cumulated
Banka,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,1423,1499,1488,1338,1214,1312,1327,1330,1485,1469,1491,1502,Data for this item can not be cumulated
Banka,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,NA,NA,NA,1,2,4,4,3,3,2,2,3,Data for this item can not be cumulated
Banka,14.05,Number of RKS meetings held during the month,TOTAL,27,7,6,5,4,6,4,6,8,8,9,7,97
Banka,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,NA,NA,NA,10,11,16,18,24,19,16,16,19,Data for this item can not be cumulated
Banka,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,129,101,82,214,254,235,417,275,356,777,998,1332,5170
Banka,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,NA,NA,NA,NA,NA,2,2,2,2,1,1,3,Data for this item can not be cumulated
Banka,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,2,3,2,1,0,0,0,0,1,1,0,2,Data for this item can not be cumulated
Banka,14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,900,1121,1055,1449,1707,1681,1756,1528,1369,1363,1293,1111,16333
Banka,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,438,557,359,531,831,1024,732,592,560,639,667,681,7611
Banka,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,820,980,962,1409,1655,1405,1659,1433,1337,2487,1222,1066,16435
Banka,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,3439,3203,2646,4824,5674,5728,6417,4995,5341,5429,5433,4472,57601
Banka,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,1720,2101,2017,2858,3362,3086,3415,2961,2706,3850,2515,2177,32768
Banka,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,3877,3760,3005,5355,6505,6752,7149,5587,5901,6068,6100,5153,65212
Banka,14.10.2.a,Number of death cases of Inpatient males,TOTAL,5,1,2,4,0,6,5,3,4,5,3,1,39
Banka,14.10.2.b,Number of death cases of Inpatient females,TOTAL,2,3,0,4,1,3,2,2,3,2,1,0,23
Banka,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,7,4,2,8,1,9,7,5,7,7,4,1,62
Banka,14.11,In-Patient Head Count at midnight,TOTAL,3786,3702,3554,5268,6180,6513,6884,4872,5338,5921,5587,5248,62853
Banka,14.12.1,OPD attendance (All),TOTAL,112319,112521,92629,119921,141349,132871,127192,103700,113193,109902,119870,118210,1403677
Banka,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,415,207,115,336,229,657,888,586,1772,1955,2451,1285,10896
Banka,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0,0,0,1,1,1,0,0,0,0,0,0,3
Banka,14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,2208,1751,1751,1936,3209,2129,2126,2016,1911,2035,2315,2390,25777
Banka,14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,14.14.a,Number of patients given AYUSH treatment,TOTAL,20995,17949,18731,23698,29978,23722,23854,18386,22541,22116,22275,19420,263665
Banka,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,138,200,84,89,399,324,222,169,123,347,220,375,2690
Banka,14.14.c,Number of Adolescents counselled,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Banka,15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,12955,11573,13258,13366,13626,13157,12461,11234,10956,11627,11376,12522,148111
Banka,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,64,47,69,38,13,36,40,49,42,74,118,21,611
Banka,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,10,0,292,3,320,391,134,3,386,412,356,326,2633
Banka,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,0,0,0,0,3,0,0,0,0,1,0,1,5
Banka,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,91,64,178,100,191,659,233,98,458,366,360,448,3246
Banka,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0,0,0,0,0,0,0,0,0,1,0,0,1
Banka,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,51,0,385,0,277,270,200,0,658,634,676,515,3666
Banka,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0,0,0,0,0,0,0,0,0,0,0,0,0
Banka,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,152,64,855,103,788,1320,567,101,1502,1412,1392,1289,9545
Banka,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,0,0,0,0,3,0,0,0,0,2,0,1,6
Banka,15.2,Number of Widal tests conducted,Number tested,38,0,0,0,0,0,0,0,0,0,0,0,38
Banka,15.3.a,Number of VDRL tests conducted on males,Number tested,0,0,0,0,320,200,0,0,0,0,300,322,1142
Banka,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,25,14,0,100,122,230,148,30,15,120,321,235,1360
Banka,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,0,0,0,0,277,81,0,0,0,0,500,525,1383
Banka,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,25,14,0,100,719,511,148,30,15,120,1121,1082,3885
Banka,15.4.1,Number of blood smears examined for Malaria,TOTAL,227,173,220,274,281,280,233,208,216,202,236,215,2765
Banka,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,0,1,0,0,0,2,3,0,1,0,0,1,8
Banka,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0,0,1,2,1,0,1,2,0,0,0,0,7
Banka,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,1000,NA,NA,NA,NA,NA,NA,1450,1050,NA,NA,NA,3500
Banka,16.1.1,Stock position of DPT vaccines,2. Stocks Received,1100,NA,NA,NA,NA,NA,NA,0,250,NA,NA,NA,1350
Banka,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,0
Banka,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,500,NA,NA,NA,NA,NA,NA,400,300,NA,NA,NA,1200
Banka,16.1.1,Stock position of DPT vaccines,5. Total Stock,1600,0,0,0,0,0,0,1050,1000,0,0,0,3650
Banka,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,400,NA,NA,NA,NA,NA,NA,1324,1400,NA,NA,NA,3124
Banka,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,1600,NA,NA,NA,NA,NA,NA,576,240,NA,NA,NA,2416
Banka,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,0
Banka,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,1280,NA,NA,NA,NA,NA,NA,500,1100,NA,NA,NA,2880
Banka,16.1.1A,Stock Position of Pentavalent,5. Total Stock,720,0,0,0,0,0,0,1400,540,0,0,0,2660
Banka,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,50,NA,NA,NA,NA,NA,NA,1025,425,NA,NA,NA,1500
Banka,16.1.2,Stock position of OPV vaccines,2. Stocks Received,1350,NA,NA,NA,NA,NA,NA,300,1000,NA,NA,NA,2650
Banka,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,0
Banka,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,1325,NA,NA,NA,NA,NA,NA,900,1425,NA,NA,NA,3650
Banka,16.1.2,Stock position of OPV vaccines,5. Total Stock,75,0,0,0,0,0,0,425,0,0,0,0,500
Banka,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,1000,NA,NA,NA,NA,NA,NA,2200,1700,NA,NA,NA,4900
Banka,16.1.3,Stock position of TT vaccines,2. Stocks Received,1000,NA,NA,NA,NA,NA,NA,0,300,NA,NA,NA,1300
Banka,16.1.3,Stock position of TT vaccines,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,0
Banka,16.1.3,Stock position of TT vaccines,4. Stock Distributed,950,NA,NA,NA,NA,NA,NA,500,1550,NA,NA,NA,3000
Banka,16.1.3,Stock position of TT vaccines,5. Total Stock,1050,0,0,0,0,0,0,1700,450,0,0,0,3200
Banka,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,16.1.4,Stock position of DT vaccines,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,16.1.4,Stock position of DT vaccines,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,16.1.4,Stock position of DT vaccines,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,16.1.4,Stock position of DT vaccines,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Banka,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,650,NA,NA,NA,NA,NA,NA,1050,700,NA,NA,NA,2400
Banka,16.1.5,Stock position of BCG vaccines,2. Stocks Received,950,NA,NA,NA,NA,NA,NA,0,500,NA,NA,NA,1450
Banka,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,0
Banka,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,250,NA,NA,NA,NA,NA,NA,350,600,NA,NA,NA,1200
Banka,16.1.5,Stock position of BCG vaccines,5. Total Stock,1350,0,0,0,0,0,0,700,600,0,0,0,2650
Banka,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,175,175,NA,NA,NA,NA,NA,975,825,NA,NA,NA,2150
Banka,16.1.6,Stock position of Measles vaccines,2. Stocks Received,2550,4450,NA,NA,NA,NA,NA,1600,1600,NA,NA,NA,10200
Banka,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,NA,0,NA,NA,NA,NA,NA,0,0,NA,NA,NA,0
Banka,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,2550,1850,NA,NA,NA,NA,NA,1750,2000,NA,NA,NA,8150
Banka,16.1.6,Stock position of Measles vaccines,5. Total Stock,175,2775,0,0,0,0,0,825,425,0,0,0,4200
Banka,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,500,NA,NA,NA,NA,NA,NA,300,500,NA,NA,NA,1300
Banka,16.1.7,Stock position of JE vaccines,2. Stocks Received,2500,NA,NA,NA,NA,NA,NA,2000,1800,NA,NA,NA,6300
Banka,16.1.7,Stock position of JE vaccines,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,0
Banka,16.1.7,Stock position of JE vaccines,4. Stock Distributed,2100,NA,NA,NA,NA,NA,NA,1800,1850,NA,NA,NA,5750
Banka,16.1.7,Stock position of JE vaccines,5. Total Stock,900,0,0,0,0,0,0,500,450,0,0,0,1850
Banka,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,1150,NA,NA,NA,NA,NA,NA,875,725,NA,NA,NA,2750
Banka,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,550,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,550
Banka,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,NA,0
Banka,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,425,NA,NA,NA,NA,NA,NA,150,0,NA,NA,NA,575
Banka,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,1275,0,0,0,0,0,0,725,725,0,0,0,2725
Banka,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Banka,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Banka,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Banka,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Banka,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Banka,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,12800,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,12800
Banka,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,100,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,100
Banka,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,12700,0,0,0,0,0,0,0,0,0,0,0,12700
Banka,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,16.3.02,Stock Position of Gloves,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,16.3.02,Stock Position of Gloves,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,16.3.02,Stock Position of Gloves,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,16.3.02,Stock Position of Gloves,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Banka,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Banka,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,79550,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,79550
Banka,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,23070,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,23070
Banka,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,56480,0,0,0,0,0,0,0,0,0,0,0,56480
Banka,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Banka,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Banka,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,504000,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,504000
Banka,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,418000,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,418000
Banka,16.3.07,Stock Position of IFA Tablets,5. Total Stock,86000,0,0,0,0,0,0,0,0,0,0,0,86000
Banka,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,110003,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,110003
Banka,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,26680,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,26680
Banka,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,83323,0,0,0,0,0,0,0,0,0,0,0,83323
Banka,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Banka,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Banka,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Banka,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,4300,NA,NA,NA,NA,8300,15300,13000,10800,NA,NA,NA,51700
Banka,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,12000,NA,NA,NA,NA,18000,0,0,0,NA,NA,NA,30000
Banka,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,NA,NA,NA,NA,NA,0,0,0,0,NA,NA,NA,0
Banka,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,400,NA,NA,NA,NA,11000,2300,2200,2200,NA,NA,NA,18100
Banka,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,15900,0,0,0,0,15300,13000,10800,8600,0,0,0,63600
Banka,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,21700,NA,NA,NA,NA,20800,95600,73600,63200,NA,NA,NA,274900
Banka,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,100000,NA,NA,NA,NA,160000,0,0,0,NA,NA,NA,260000
Banka,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,NA,NA,NA,NA,NA,0,0,0,0,NA,NA,NA,0
Banka,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,14700,NA,NA,NA,NA,85200,22000,10400,38400,NA,NA,NA,170700
Banka,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,107000,0,0,0,0,95600,73600,63200,24800,0,0,0,364200
Banka,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,3800,NA,NA,NA,NA,2800,6800,4700,2400,NA,NA,NA,20500
Banka,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,8000,NA,NA,NA,NA,10000,0,0,0,NA,NA,NA,18000
Banka,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,NA,NA,NA,NA,NA,0,0,0,0,NA,NA,NA,0
Banka,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,800,NA,NA,NA,NA,6000,2100,2300,0,NA,NA,NA,11200
Banka,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,11000,0,0,0,0,6800,4700,2400,2400,0,0,0,27300
Banka,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,NA,NA,NA,1,1,NA,NA,NA,NA,NA,NA,1,3
Banka,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,1
Banka,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,1
Banka,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,NA,1,NA,NA,1,NA,NA,1,6,3,4,2,18
Banka,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,1
Banka,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,NA,1,NA,NA,1,NA,NA,1,6,4,4,2,19
Banka,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,1,1,1,7,2,2,3,17
Banka,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,NA,2
Banka,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,NA,NA,NA,NA,NA,1,1,1,7,2,4,3,19
Banka,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,NA,NA,1,NA,1,NA,NA,NA,8,6,5,6,27
Banka,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,1
Banka,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,NA,NA,1,NA,1,NA,NA,NA,9,6,5,6,28
Banka,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,NA,1,NA,NA,NA,NA,NA,6,8,6,5,3,29
Banka,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,1,6,NA,NA,7
Banka,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,NA,1,NA,NA,NA,NA,NA,6,9,12,5,3,36
Banka,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,1
Banka,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,1
Banka,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,NA,1,1,1,1,NA,1,NA,5,2,2,4,18
Banka,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,NA,NA,NA,NA,NA,1,NA,NA,1,3,NA,1,6
Banka,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,NA,1,1,1,1,1,1,NA,6,5,2,5,24
Banka,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,1
Banka,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,1
Banka,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,1
Banka,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,1
Banka,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,1
Banka,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,1
Banka,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,1
Banka,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,1
Banka,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,1
Banka,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,1
Banka,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,NA,NA,NA,1,NA,1,1,NA,NA,1,3,1,8
Banka,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,NA,NA,NA,1,NA,1,1,NA,NA,1,3,1,8
Banka,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,NA,NA,NA,NA,NA,1,1,NA,3,1,NA,8,14
Banka,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,NA,NA,NA,NA,NA,1,1,NA,3,1,NA,8,14
Banka,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,NA,NA,NA,NA,NA,1,NA,NA,1,NA,1,1,4
Banka,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Banka,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,NA,NA,NA,NA,NA,1,NA,NA,1,NA,1,1,4
Begusarai,1.1,Total number of pregnant women Registered for ANC,TOTAL,7391,7005,7209,7601,7124,6825,6506,6121,6240,6632,7050,7145,82849
Begusarai,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,5819,5232,5279,5700,5268,4995,4880,4599,4869,5302,5896,5831,63670
Begusarai,1.2,Number of Pregnant women registered under JSY,TOTAL,7305,6904,7041,7534,7069,6736,6371,6037,6172,6474,7089,7034,81766
Begusarai,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,4988,4575,4886,4888,6035,4635,4483,4444,4546,5086,5272,5252,59090
Begusarai,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,3929,3735,3901,3938,3631,3506,3383,3243,3210,3496,3940,3849,43761
Begusarai,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,6476,6432,6519,6520,6568,6243,5847,5374,5311,5680,5528,6042,72540
Begusarai,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,7305,6811,6854,7252,6953,6664,6421,5936,6107,6443,7225,6839,80810
Begusarai,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,232,320,261,280,186,337,112,123,185,135,212,128,2511
Begusarai,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Begusarai,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,210,185,175,222,145,180,115,246,256,243,308,285,2570
Begusarai,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,0,0,18,0,0,0,0,0,0,0,0,0,18
Begusarai,1.8,Number of pregnancy test kits used at SC level,TOTAL,1928,1854,1698,1733,1829,1701,2283,2006,2370,2362,2313,2444,24521
Begusarai,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,150,205,264,291,278,361,263,257,279,256,252,174,3030
Begusarai,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,389,262,413,382,254,307,320,399,388,559,489,498,4660
Begusarai,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,539,467,677,673,532,668,583,656,667,815,741,672,7690
Begusarai,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,367,368,555,572,462,541,480,554,614,690,657,626,6486
Begusarai,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0,28,1,0,0,3,0,24,0,0,0,0,56
Begusarai,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,3016,3107,3532,5445,5914,5225,5640,5127,4905,5105,4450,3647,55113
Begusarai,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,2804,3086,3477,5354,5846,5150,5599,5090,4844,5049,4365,3567,54231
Begusarai,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1627,1717,2721,4846,3772,6393,5261,4362,5880,5417,5239,4609,51844
Begusarai,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1296,1192,2000,3936,1954,5265,4293,2825,6347,3996,5355,4388,42847
Begusarai,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Begusarai,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,226,201,348,361,288,288,247,270,177,352,253,245,3256
Begusarai,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Begusarai,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Begusarai,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Begusarai,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Begusarai,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Begusarai,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,3,2,1,6,6,2,3,5,10,3,5,2,48
Begusarai,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,3,2,1,6,6,2,3,5,10,3,5,2,48
Begusarai,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,66,55,91,102,88,74,84,73,63,46,38,86,866
Begusarai,4.1.1.a,Number of male live births,TOTAL,2220,2168,2541,3533,3591,3513,3532,3483,3271,3571,3191,2599,37213
Begusarai,4.1.1.b,Number of female live births,TOTAL,1947,1991,2373,3288,3477,3011,3327,3198,3062,3303,2948,2565,34490
Begusarai,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,4167,4159,4914,6821,7068,6524,6859,6681,6333,6874,6139,5164,71703
Begusarai,4.1.2,Number of still births,TOTAL,41,50,46,57,95,61,95,79,68,74,46,50,762
Begusarai,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,132,10,2,3,2,3,0,4,0,1,4,2,163
Begusarai,4.2.1,Number of Newborns weighed at birth,TOTAL,3698,3772,4454,6517,6816,6291,6648,6460,6121,6452,5735,4691,67655
Begusarai,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,113,101,145,195,231,201,333,232,187,198,158,134,2228
Begusarai,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,3716,3771,4448,6523,6849,6430,6499,6435,6106,6465,5739,4699,67680
Begusarai,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0,0,2,1,0,0,0,0,12,0,0,0,15
Begusarai,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Begusarai,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,3,2,0,6,6,2,3,4,3,4,5,2,40
Begusarai,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,3,2,2,7,6,2,3,4,15,4,5,2,55
Begusarai,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Begusarai,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,630,700,799,1180,1307,1147,1557,1260,1094,1124,905,754,12457
Begusarai,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,415,12,6,18,6,2,19,16,7,0,0,0,501
Begusarai,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,806,1091,1010,1844,2018,1951,2323,1944,1745,1122,903,752,17509
Begusarai,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,13,9,18,17,24,10,3,4,4,6,5,3,116
Begusarai,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1959,2057,2749,3996,4124,3763,4461,4411,4118,4477,3615,2964,42694
Begusarai,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1868,1745,2148,2677,2549,2452,2555,2552,2742,2526,2285,2104,28203
Begusarai,6.3,PNC maternal complications attended,TOTAL,0,0,0,0,155,2,0,0,0,0,0,0,157
Begusarai,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,0,10,0,0,2,1,0,4,2,6,0,0,25
Begusarai,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Begusarai,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,0,10,0,0,2,1,0,4,2,6,0,0,25
Begusarai,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0,0,0,0,0,0,0,0,0,0,0,176,176
Begusarai,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,8,7,121,7,121,8,9,8,10,11,9,9,328
Begusarai,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,7,9,163,6,158,7,6,5,9,6,6,5,387
Begusarai,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,15,16,284,13,279,15,15,13,19,17,15,14,715
Begusarai,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Begusarai,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,1,1,0,14,1,1,1,2,3,19,3,8,54
Begusarai,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Begusarai,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,2,0,0,1,1,0,0,0,9,8,5,0,26
Begusarai,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,3,1,0,15,2,1,1,2,12,27,8,8,80
Begusarai,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0,0,0,2,0,0,0,0,0,0,0,0,2
Begusarai,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Begusarai,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Begusarai,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Begusarai,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Begusarai,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Begusarai,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,127,87,88,1584,164,567,907,658,3576,1774,2624,3142,15298
Begusarai,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0,9,0,0,2,1,0,0,26,6,8,1,53
Begusarai,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,6,3,3,81,9,30,68,62,370,302,237,239,1410
Begusarai,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,133,99,91,1665,175,598,975,720,3972,2082,2869,3382,16761
Begusarai,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,0,0,0,149,0,0,183,436,693,575,495,686,3217
Begusarai,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,9,4,0,18,13,10,23,12,29,22,34,29,203
Begusarai,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Begusarai,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,1,0,0,4,0,0,0,0,19,21,28,23,96
Begusarai,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,10,4,0,22,13,10,23,12,48,43,62,52,299
Begusarai,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Begusarai,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,589,592,592,739,500,485,506,491,732,599,631,683,7139
Begusarai,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,435,397,384,1093,331,296,286,340,728,649,792,594,6325
Begusarai,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,7,0,5,0,0,0,3,6,7,16,12,14,70
Begusarai,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,10,13,6,10,11,7,9,0,0,0,0,0,66
Begusarai,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,1041,1002,987,1842,842,788,804,837,1467,1264,1435,1291,13600
Begusarai,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,215,386,190,687,439,498,258,373,943,666,728,664,6047
Begusarai,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Begusarai,9.06,Number of IUCD removals,TOTAL,268,330,441,352,387,228,220,285,326,330,337,357,3861
Begusarai,9.07,Number of Oral Pills cycles distributed,TOTAL,1536,2028,1509,3308,1540,2237,1711,1524,1875,2717,2748,2291,25024
Begusarai,9.08,Number of Condom pieces distributed,TOTAL,7349,4045,5726,20061,6282,10685,5926,7649,7073,18251,8628,8943,110618
Begusarai,9.09,Number of Centchroman (weekly) pills given,TOTAL,75,47,66,75,53,95,58,37,65,62,102,89,824
Begusarai,9.1,Number of Emergency Contraceptive Pills distributed,TOTAL,319,277,361,1196,290,845,262,278,567,1199,746,649,6989
Begusarai,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Begusarai,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Begusarai,9.11.2.a,Number of failures following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Begusarai,9.11.2.b,Number of failures following female sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Begusarai,9.11.3.a,Number of deaths following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Begusarai,9.11.3.b,Number of deaths following female sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Begusarai,9.12,Number of Institutions having NSV trained doctors,TOTAL,1,NA,NA,NA,NA,NA,10,14,8,10,9,10,Data for this item can not be cumulated
Begusarai,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,4462,4395,5306,7279,7236,7078,7112,6862,6817,7290,6641,5775,76253
Begusarai,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,10,78,5,4,1,2,3,3,3,0,4,0,113
Begusarai,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,1068,682,634,151,55,35,9,9,5,2,5,0,2655
Begusarai,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,2430,1436,1048,905,206,79,45,39,9,7,5,5,6214
Begusarai,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,5959,5183,5646,5622,5776,6796,7405,7300,7355,7854,7381,7146,79423
Begusarai,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,5416,5813,5302,5418,5244,5607,6187,6522,6695,7431,7436,7326,74397
Begusarai,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,4248,4996,5274,5075,5357,5318,5571,5594,6170,7073,6989,7449,69114
Begusarai,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,3638,3734,4312,6490,6505,6030,6202,5796,5636,6126,5533,4656,64658
Begusarai,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,5937,5120,5677,5632,5731,6819,7409,7241,7565,7788,7386,7223,79528
Begusarai,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,6374,6123,5885,5675,5278,5589,6170,6479,6686,7422,7446,7338,76465
Begusarai,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,6677,6157,6287,6093,5575,5337,5564,5599,6084,7093,6997,7451,74914
Begusarai,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,2765,3068,3422,5587,5081,5268,5114,4976,4560,4981,4533,3553,52908
Begusarai,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,267,284,342,363,389,44,14,4,2,30,1,25,1765
Begusarai,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,956,638,623,495,409,44,34,16,4,26,1,20,3266
Begusarai,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,2391,1351,1025,951,559,97,55,60,8,25,1,21,6544
Begusarai,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,6034,6234,6136,7581,6647,6527,6818,6204,5718,6016,5960,6192,76067
Begusarai,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,7154,6027,5597,6376,5457,5352,5554,5214,5745,6443,6838,6872,72629
Begusarai,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Begusarai,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,3133,3325,3365,3953,3533,3470,3561,3319,2983,3186,3194,3328,40350
Begusarai,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2843,2908,2757,3528,3096,3036,3165,2851,2700,2791,2826,2846,35347
Begusarai,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,5976,6233,6122,7481,6629,6506,6726,6170,5683,5977,6020,6174,75697
Begusarai,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,7187,5949,5678,6329,5446,5345,5537,5206,5743,6443,6846,6859,72568
Begusarai,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,7195,5901,5682,6338,5448,5346,5539,5196,5713,6442,6842,6862,72504
Begusarai,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Begusarai,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,3496,3053,3012,3269,2789,2675,2869,2880,3003,3325,3525,3666,37562
Begusarai,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,3226,2702,2600,3073,2506,2290,2673,2413,2655,2991,3304,3180,33613
Begusarai,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,6722,5755,5612,6342,5295,4965,5542,5293,5658,6316,6829,6846,71175
Begusarai,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,470,414,476,472,586,519,545,688,766,788,822,939,7485
Begusarai,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,793,759,835,924,871,891,935,837,1052,1018,1054,1218,11187
Begusarai,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1110,1033,1110,1275,1196,1283,1300,1033,1433,1304,1284,1461,14822
Begusarai,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Begusarai,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Begusarai,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Begusarai,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,3062,3028,3041,3348,2978,3039,3066,3022,3057,3038,3036,3098,36813
Begusarai,10.4.2,Number of Immunisation sessions held during the month,TOTAL,3058,3023,3035,3332,2974,3034,3063,3017,3057,3045,3035,3097,36770
Begusarai,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,2824,2752,2763,3076,2730,2784,2800,2739,2795,2802,2798,2868,33731
Begusarai,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Begusarai,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,6005,5935,4955,5613,5172,4501,3753,3779,3547,3666,3444,3609,53979
Begusarai,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,1636,900,670,871,826,425,253,255,252,322,314,328,7052
Begusarai,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,0,0,0,0,0,3,8,0,0,31,0,0,42
Begusarai,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Begusarai,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Begusarai,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Begusarai,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Begusarai,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Begusarai,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0,0,8,5,0,0,5,0,0,87,0,10,115
Begusarai,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,1311,1466,1604,1843,1838,1546,934,724,698,641,577,607,13789
Begusarai,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0,0,0,2,0,10,0,0,0,0,0,0,12
Begusarai,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0,0,2,0,0,2,0,0,0,0,0,0,4
Begusarai,13.1,Number of Patients operated for cataract,TOTAL,77,207,65,112,120,100,79,560,513,447,490,616,3386
Begusarai,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,2,2,0,0,0,0,0,0,0,0,0,0,4
Begusarai,13.3,Number of School children detected with Refractive errors,TOTAL,0,0,0,0,0,0,0,5,0,0,0,0,5
Begusarai,13.4,Number of children provided free glasses,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Begusarai,13.5,Number of eyes collected through eye donation,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Begusarai,13.6,Number of eyes utilised for corneal transplant,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Begusarai,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,NA,NA,NA,NA,NA,NA,2,2,2,2,2,2,Data for this item can not be cumulated
Begusarai,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,NA,NA,NA,NA,NA,NA,20,27,24,21,26,26,Data for this item can not be cumulated
Begusarai,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,2168,2296,2304,2323,2301,2316,2305,2172,2067,2099,2103,2187,Data for this item can not be cumulated
Begusarai,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,NA,NA,NA,NA,NA,NA,2,2,2,2,2,2,Data for this item can not be cumulated
Begusarai,14.05,Number of RKS meetings held during the month,TOTAL,13,14,163,15,16,14,17,15,18,19,19,18,341
Begusarai,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,NA,2,16,16,15,16,17,21,19,19,20,18,Data for this item can not be cumulated
Begusarai,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,2210,1796,2028,3092,3112,2284,2633,2216,2624,2524,2193,2536,29248
Begusarai,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,NA,NA,NA,NA,NA,NA,NA,1,1,1,1,1,Data for this item can not be cumulated
Begusarai,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,1,1,1,1,1,1,1,0,0,0,0,0,Data for this item can not be cumulated
Begusarai,14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,398,233,424,493,517,533,464,467,451,528,644,738,5890
Begusarai,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,996,1029,1052,1089,1132,1089,1221,1176,1193,1276,1013,1091,13357
Begusarai,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,538,166,449,421,530,509,475,499,510,536,552,701,5886
Begusarai,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,3537,3695,4013,6523,6340,5699,5876,5601,6099,5202,5147,4382,62114
Begusarai,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,936,399,873,914,1047,1042,939,966,961,1064,1196,1439,11776
Begusarai,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,4533,4724,5065,7612,7472,6788,7097,6777,7292,6478,6160,5473,75471
Begusarai,14.10.2.a,Number of death cases of Inpatient males,TOTAL,5,5,4,7,16,9,0,0,0,0,0,0,46
Begusarai,14.10.2.b,Number of death cases of Inpatient females,TOTAL,3,6,7,8,5,8,0,0,0,0,0,0,37
Begusarai,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,8,11,11,15,21,17,0,0,0,0,0,0,83
Begusarai,14.11,In-Patient Head Count at midnight,TOTAL,5055,5169,5261,6805,7556,6876,7150,6643,6992,7031,6958,5753,77249
Begusarai,14.12.1,OPD attendance (All),TOTAL,134478,130248,141065,157627,161863,165339,153755,157915,153674,153252,152770,161606,1823592
Begusarai,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,13,10,7,23,20,9,42,13,18,13,19,19,206
Begusarai,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0,0,0,0,4,3,0,0,0,0,0,0,7
Begusarai,14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,92,739,964,1313,1229,1205,165,101,113,117,87,163,6288
Begusarai,14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,14.14.a,Number of patients given AYUSH treatment,TOTAL,23818,18787,15871,20461,21480,32608,24723,20582,19899,18188,15940,15820,248177
Begusarai,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,4077,3587,4085,4376,4989,4775,3949,3464,3684,3639,3179,4944,48748
Begusarai,14.14.c,Number of Adolescents counselled,TOTAL,19,32,39,42,34,65,29,31,27,21,19,23,381
Begusarai,15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,1334,1272,1422,1930,1923,2007,1295,1549,1813,926,1784,1957,19212
Begusarai,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,30,66,59,62,35,62,30,20,17,13,49,107,550
Begusarai,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,413,524,363,283,320,219,351,267,421,249,320,278,4008
Begusarai,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,19,22,23,21,23,35,9,28,31,22,15,27,275
Begusarai,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,398,256,327,609,437,582,380,746,1422,927,902,912,7898
Begusarai,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,9,19,25,12,22,18,11,27,15,13,21,16,208
Begusarai,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,694,863,871,889,884,662,585,572,612,632,743,848,8855
Begusarai,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,1,1,1,1,2,1,0,0,0,0,0,0,7
Begusarai,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,1505,1643,1561,1781,1641,1463,1316,1585,2455,1808,1965,2038,20761
Begusarai,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,29,42,49,34,47,54,20,55,46,35,36,43,490
Begusarai,15.2,Number of Widal tests conducted,Number tested,0,82,249,0,0,0,0,0,0,0,0,4,335
Begusarai,15.3.a,Number of VDRL tests conducted on males,Number tested,312,322,0,5,0,0,0,0,0,0,0,22,661
Begusarai,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,55,39,0,0,0,0,0,0,0,0,0,80,174
Begusarai,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,0,0,0,0,0,0,0,0,0,0,0,3,3
Begusarai,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,367,361,0,5,0,0,0,0,0,0,0,105,838
Begusarai,15.4.1,Number of blood smears examined for Malaria,TOTAL,28,22,22,18,39,82,74,37,27,0,0,0,349
Begusarai,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,0,0,1,0,0,0,0,0,0,0,0,0,1
Begusarai,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Begusarai,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,1065,945,1945,645,917,1254,1617,1329,NA,NA,NA,NA,9717
Begusarai,16.1.1,Stock position of DPT vaccines,2. Stocks Received,1000,2000,0,1000,1000,1000,500,0,NA,NA,NA,NA,6500
Begusarai,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0,0,0,0,0,0,0,0,NA,NA,NA,NA,0
Begusarai,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,1120,1000,1300,728,663,637,788,610,NA,NA,NA,NA,6846
Begusarai,16.1.1,Stock position of DPT vaccines,5. Total Stock,945,1945,645,917,1254,1617,1329,719,0,0,0,0,9371
Begusarai,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,1375,1685,3085,2127,1491,2342,2265,2378,NA,NA,NA,NA,16748
Begusarai,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,3000,3300,1152,1152,1728,1440,1728,0,NA,NA,NA,NA,13500
Begusarai,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0,0,0,0,0,0,0,0,NA,NA,NA,NA,0
Begusarai,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,2690,1900,2110,1788,877,1517,1615,1920,NA,NA,NA,NA,14417
Begusarai,16.1.1A,Stock Position of Pentavalent,5. Total Stock,1685,3085,2127,1491,2342,2265,2378,458,0,0,0,0,15831
Begusarai,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,1015,675,1975,2475,2975,3047,2762,2537,NA,NA,NA,NA,17461
Begusarai,16.1.2,Stock position of OPV vaccines,2. Stocks Received,2000,4000,3000,3000,2000,1500,2000,0,NA,NA,NA,NA,17500
Begusarai,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0,0,0,0,0,0,0,0,NA,NA,NA,NA,0
Begusarai,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,2340,2700,2500,2500,1928,1785,2225,2105,NA,NA,NA,NA,18083
Begusarai,16.1.2,Stock position of OPV vaccines,5. Total Stock,675,1975,2475,2975,3047,2762,2537,432,0,0,0,0,16878
Begusarai,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,1474,1744,3794,2044,740,1550,2908,1558,NA,NA,NA,NA,15812
Begusarai,16.1.3,Stock position of TT vaccines,2. Stocks Received,1500,3500,0,1000,2000,3000,1500,0,NA,NA,NA,NA,12500
Begusarai,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0,0,0,0,0,0,0,0,NA,NA,NA,NA,0
Begusarai,16.1.3,Stock position of TT vaccines,4. Stock Distributed,1230,1450,1750,2304,1190,1642,2850,1108,NA,NA,NA,NA,13524
Begusarai,16.1.3,Stock position of TT vaccines,5. Total Stock,1744,3794,2044,740,1550,2908,1558,450,0,0,0,0,14788
Begusarai,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0,0,0,0,0,0,0,0,NA,NA,NA,NA,0
Begusarai,16.1.4,Stock position of DT vaccines,2. Stocks Received,0,0,0,0,0,0,0,0,NA,NA,NA,NA,0
Begusarai,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0,0,0,0,0,0,0,0,NA,NA,NA,NA,0
Begusarai,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0,0,0,0,0,0,0,0,NA,NA,NA,NA,0
Begusarai,16.1.4,Stock position of DT vaccines,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Begusarai,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,1673,2098,3028,1912,1404,1635,1928,1789,NA,NA,NA,NA,15467
Begusarai,16.1.5,Stock position of BCG vaccines,2. Stocks Received,1500,2000,0,1000,1000,1300,1000,0,NA,NA,NA,NA,7800
Begusarai,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0,0,0,0,0,0,0,0,NA,NA,NA,NA,0
Begusarai,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,1075,1070,1116,1508,769,1007,1139,1085,NA,NA,NA,NA,8769
Begusarai,16.1.5,Stock position of BCG vaccines,5. Total Stock,2098,3028,1912,1404,1635,1928,1789,704,0,0,0,0,14498
Begusarai,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,1350,1450,855,1505,3055,4247,3929,3727,NA,NA,NA,NA,20118
Begusarai,16.1.6,Stock position of Measles vaccines,2. Stocks Received,4000,3100,4870,5000,4000,2300,3000,0,NA,NA,NA,NA,26270
Begusarai,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0,0,0,0,0,0,0,0,NA,NA,NA,NA,0
Begusarai,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,3945,3650,4220,3450,2808,2618,3202,3397,NA,NA,NA,NA,27290
Begusarai,16.1.6,Stock position of Measles vaccines,5. Total Stock,1405,900,1505,3055,4247,3929,3727,330,0,0,0,0,19098
Begusarai,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0,0,0,0,0,0,0,0,NA,NA,NA,NA,0
Begusarai,16.1.7,Stock position of JE vaccines,2. Stocks Received,0,0,0,0,0,0,0,0,NA,NA,NA,NA,0
Begusarai,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0,0,0,0,0,0,0,0,NA,NA,NA,NA,0
Begusarai,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0,0,0,0,0,0,0,0,NA,NA,NA,NA,0
Begusarai,16.1.7,Stock position of JE vaccines,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Begusarai,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,1255,1020,1820,1020,901,591,954,663,NA,NA,NA,NA,8224
Begusarai,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,600,1400,0,1000,0,500,250,0,NA,NA,NA,NA,3750
Begusarai,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0,0,0,0,0,0,0,0,NA,NA,NA,NA,0
Begusarai,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,835,600,800,1119,310,137,541,365,NA,NA,NA,NA,4707
Begusarai,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,1020,1820,1020,901,591,954,663,298,0,0,0,0,7267
Begusarai,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,0,0,0,0,0,0,0,0,NA,NA,NA,NA,0
Begusarai,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0,0,0,0,0,0,0,0,NA,NA,NA,NA,0
Begusarai,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0,0,0,0,0,0,0,0,NA,NA,NA,NA,0
Begusarai,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,0,0,0,0,0,0,0,0,NA,NA,NA,NA,0
Begusarai,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Begusarai,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,0,0,0,0,0,0,0,0,NA,NA,NA,NA,0
Begusarai,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0,0,0,0,0,0,0,0,NA,NA,NA,NA,0
Begusarai,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0,0,0,0,0,0,0,0,NA,NA,NA,NA,0
Begusarai,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,0,0,0,0,0,0,0,0,NA,NA,NA,NA,0
Begusarai,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Begusarai,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0,0,0,0,0,0,0,0,NA,NA,NA,NA,0
Begusarai,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0,0,0,0,0,0,0,0,NA,NA,NA,NA,0
Begusarai,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0,0,0,0,0,0,0,0,NA,NA,NA,NA,0
Begusarai,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0,0,0,0,0,0,0,0,NA,NA,NA,NA,0
Begusarai,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Begusarai,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0,0,0,0,0,0,0,0,NA,NA,NA,NA,0
Begusarai,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0,0,0,0,0,0,0,0,NA,NA,NA,NA,0
Begusarai,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0,0,0,0,0,0,0,0,NA,NA,NA,NA,0
Begusarai,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0,0,0,0,0,0,0,0,NA,NA,NA,NA,0
Begusarai,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Begusarai,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,0,0,0,0,0,0,0,0,NA,NA,NA,NA,0
Begusarai,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0,0,0,0,0,0,0,0,NA,NA,NA,NA,0
Begusarai,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0,0,0,0,0,0,0,0,NA,NA,NA,NA,0
Begusarai,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0,0,0,0,0,0,0,0,NA,NA,NA,NA,0
Begusarai,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Begusarai,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0,0,0,0,0,0,0,0,NA,NA,NA,NA,0
Begusarai,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0,0,0,0,0,0,0,0,NA,NA,NA,NA,0
Begusarai,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0,0,0,0,0,0,0,0,NA,NA,NA,NA,0
Begusarai,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0,0,0,0,0,0,0,0,NA,NA,NA,NA,0
Begusarai,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Begusarai,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0,0,0,0,0,0,0,0,NA,NA,NA,NA,0
Begusarai,16.3.02,Stock Position of Gloves,2. Stocks Received,0,0,0,0,0,0,0,0,NA,NA,NA,NA,0
Begusarai,16.3.02,Stock Position of Gloves,3. Unusable Stock,0,0,0,0,0,0,0,0,NA,NA,NA,NA,0
Begusarai,16.3.02,Stock Position of Gloves,4. Stock Distributed,0,0,0,0,0,0,0,0,NA,NA,NA,NA,0
Begusarai,16.3.02,Stock Position of Gloves,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Begusarai,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0,0,0,0,0,0,0,0,NA,NA,NA,NA,0
Begusarai,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0,0,0,0,0,0,0,0,NA,NA,NA,NA,0
Begusarai,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0,0,0,0,0,0,0,0,NA,NA,NA,NA,0
Begusarai,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0,0,0,0,0,0,0,0,NA,NA,NA,NA,0
Begusarai,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Begusarai,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0,0,0,0,0,0,0,0,NA,NA,NA,NA,0
Begusarai,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0,0,0,0,0,0,0,0,NA,NA,NA,NA,0
Begusarai,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0,0,0,0,0,0,0,0,NA,NA,NA,NA,0
Begusarai,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0,0,0,0,0,0,0,0,NA,NA,NA,NA,0
Begusarai,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Begusarai,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0,0,0,0,0,0,0,0,NA,NA,NA,NA,0
Begusarai,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0,0,0,0,0,0,0,0,NA,NA,NA,NA,0
Begusarai,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0,0,0,0,0,0,0,0,NA,NA,NA,NA,0
Begusarai,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0,0,0,0,0,0,0,0,NA,NA,NA,NA,0
Begusarai,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Begusarai,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0,0,0,0,0,0,0,0,NA,NA,NA,NA,0
Begusarai,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0,0,0,0,0,0,0,0,NA,NA,NA,NA,0
Begusarai,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0,0,0,0,0,0,0,0,NA,NA,NA,NA,0
Begusarai,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0,0,0,0,0,0,0,0,NA,NA,NA,NA,0
Begusarai,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Begusarai,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,0,0,0,0,0,0,0,0,NA,NA,NA,NA,0
Begusarai,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0,0,0,0,0,0,0,0,NA,NA,NA,NA,0
Begusarai,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0,0,0,0,0,0,0,0,NA,NA,NA,NA,0
Begusarai,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0,0,0,0,0,0,0,0,NA,NA,NA,NA,0
Begusarai,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Begusarai,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0,0,0,0,0,0,0,0,NA,NA,NA,NA,0
Begusarai,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0,0,0,0,0,0,0,0,NA,NA,NA,NA,0
Begusarai,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0,0,0,0,0,0,0,0,NA,NA,NA,NA,0
Begusarai,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0,0,0,0,0,0,0,0,NA,NA,NA,NA,0
Begusarai,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Begusarai,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0,0,0,0,0,0,0,0,NA,NA,NA,NA,0
Begusarai,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0,0,0,0,0,0,0,0,NA,NA,NA,NA,0
Begusarai,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0,0,0,0,0,0,0,0,NA,NA,NA,NA,0
Begusarai,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0,0,0,0,0,0,0,0,NA,NA,NA,NA,0
Begusarai,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Begusarai,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,0,0,0,0,0,0,0,0,NA,NA,NA,NA,0
Begusarai,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0,0,0,0,0,0,0,0,NA,NA,NA,NA,0
Begusarai,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0,0,0,0,0,0,0,0,NA,NA,NA,NA,0
Begusarai,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0,0,0,0,0,0,0,0,NA,NA,NA,NA,0
Begusarai,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Begusarai,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,0,0,0,0,0,0,0,0,NA,NA,NA,NA,0
Begusarai,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0,0,0,0,0,0,0,0,NA,NA,NA,NA,0
Begusarai,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0,0,0,0,0,0,0,0,NA,NA,NA,NA,0
Begusarai,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,0,0,0,0,0,0,0,0,NA,NA,NA,NA,0
Begusarai,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Begusarai,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,9100,800,5400,2127,3600,4807,4817,9211,NA,NA,NA,NA,39862
Begusarai,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0,10000,6000,6000,6000,6000,10000,0,NA,NA,NA,NA,44000
Begusarai,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0,0,0,0,0,0,0,0,NA,NA,NA,NA,0
Begusarai,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,8300,5400,9273,4527,4793,5990,5606,7700,NA,NA,NA,NA,51589
Begusarai,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,800,5400,2127,3600,4807,4817,9211,1511,0,0,0,0,32273
Begusarai,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,45200,16600,19000,51400,47800,55218,70611,50611,NA,NA,NA,NA,356440
Begusarai,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,50000,48000,90000,60000,60000,60000,32000,0,NA,NA,NA,NA,400000
Begusarai,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0,0,0,0,0,0,0,0,NA,NA,NA,NA,0
Begusarai,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,78600,45600,57600,63600,52582,44607,52000,19600,NA,NA,NA,NA,414189
Begusarai,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,16600,19000,51400,47800,55218,70611,50611,31011,0,0,0,0,342251
Begusarai,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,3700,0,1700,2700,2800,4983,5839,7339,NA,NA,NA,NA,29061
Begusarai,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0,5000,5000,5000,5000,5000,5000,0,NA,NA,NA,NA,30000
Begusarai,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0,0,0,0,0,0,0,0,NA,NA,NA,NA,0
Begusarai,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,3700,3300,4000,4900,2817,4144,3500,5100,NA,NA,NA,NA,31461
Begusarai,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0,1700,2700,2800,4983,5839,7339,2239,0,0,0,0,27600
Begusarai,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,1
Begusarai,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,1
Begusarai,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,NA,NA,NA,1,1,NA,1,NA,NA,NA,1,2,6
Begusarai,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,NA,NA,NA,1,1,NA,1,NA,NA,NA,1,2,6
Begusarai,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,NA,1,1,2,3,4,3,1,2,1,NA,2,20
Begusarai,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,NA,1,1,2,3,4,3,1,2,1,NA,2,20
Begusarai,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,3,NA,2,1,NA,1,1,1,NA,1,6,2,18
Begusarai,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,3,NA,2,1,NA,1,1,1,NA,1,6,2,18
Begusarai,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Begusarai,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,1.1,Total number of pregnant women Registered for ANC,TOTAL,7023,8129,6495,7610,7216,6473,6102,5379,5065,5957,6518,7458,79425
Bhagalpur,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,3360,3296,2887,2891,3283,2749,2638,2398,2283,2805,3004,3278,34872
Bhagalpur,1.2,Number of Pregnant women registered under JSY,TOTAL,7021,8129,6492,7610,7198,6473,6102,5377,4967,5865,6408,7033,78675
Bhagalpur,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,3717,4106,4008,4641,5087,4915,4846,4330,3799,3840,3557,3816,50662
Bhagalpur,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,4369,4910,3837,4417,4159,3703,3483,3163,3023,3532,3832,4149,46577
Bhagalpur,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,6316,7708,6516,6624,7735,6503,6068,4982,4570,5493,5196,6248,73959
Bhagalpur,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,3838,3919,3057,2569,2497,2046,1657,1559,1390,1403,1482,1920,27337
Bhagalpur,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,227,220,115,129,205,159,723,160,97,107,136,165,2443
Bhagalpur,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,3,2,13,7,25,15,16,24,17,16,5,12,155
Bhagalpur,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,2389,2543,2440,2834,3263,2715,3055,2300,2078,2469,2756,3040,31882
Bhagalpur,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,4,17,10,26,89,24,245,31,27,13,23,25,534
Bhagalpur,1.8,Number of pregnancy test kits used at SC level,TOTAL,14,46,24,189,131,203,379,352,343,366,170,184,2401
Bhagalpur,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,104,86,109,122,139,194,206,204,186,215,171,170,1906
Bhagalpur,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,548,550,772,747,964,918,971,1022,848,912,780,664,9696
Bhagalpur,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,652,636,881,869,1103,1112,1177,1226,1034,1127,951,834,11602
Bhagalpur,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,282,286,468,435,530,557,610,619,486,518,447,399,5637
Bhagalpur,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0,0,0,0,26,2,0,13,6,0,5,0,52
Bhagalpur,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,2726,2916,2625,4739,5641,5498,5908,5001,4378,4365,4055,3918,51770
Bhagalpur,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,2068,2175,2218,4159,4495,4563,4784,4156,3407,3251,3049,2934,41259
Bhagalpur,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1941,2302,2222,3280,3107,7985,5121,3608,4802,3353,6982,5331,50034
Bhagalpur,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1160,1615,1867,2251,1585,6653,3198,3008,3136,2203,6435,6300,39411
Bhagalpur,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Bhagalpur,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,643,434,229,404,468,545,521,175,102,54,NA,NA,3575
Bhagalpur,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0,0,0,0,0,0,0,0,22,0,0,0,22
Bhagalpur,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0,1,0,6,4,3,0,0,3,0,0,0,17
Bhagalpur,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,110,123,110,150,190,145,174,134,135,112,105,122,1610
Bhagalpur,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,110,124,110,156,194,148,174,134,160,112,105,122,1649
Bhagalpur,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,82,69,16,56,52,43,25,85,33,5,NA,NA,466
Bhagalpur,4.1.1.a,Number of male live births,TOTAL,1729,1779,1738,2855,3425,3307,3547,3288,2761,2747,2607,2367,32150
Bhagalpur,4.1.1.b,Number of female live births,TOTAL,1555,1531,1630,2612,3143,3120,3330,2846,2570,2645,2337,2249,29568
Bhagalpur,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,3284,3310,3368,5467,6568,6427,6877,6134,5331,5392,4944,4616,61718
Bhagalpur,4.1.2,Number of still births,TOTAL,67,52,71,96,155,143,139,102,77,99,90,83,1174
Bhagalpur,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,34,35,31,42,30,31,20,27,12,14,37,40,353
Bhagalpur,4.2.1,Number of Newborns weighed at birth,TOTAL,2891,3182,3177,5133,6340,6272,6652,5930,5154,5205,4787,4463,59186
Bhagalpur,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,194,215,208,260,328,369,379,390,319,309,314,289,3574
Bhagalpur,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,3102,3166,3225,5093,5886,6304,6727,5947,5186,5229,4826,4530,59221
Bhagalpur,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0,0,0,0,0,13,2,8,20,15,10,16,84
Bhagalpur,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,9,5,14
Bhagalpur,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,117,117,119,176,174,152,201,184,155,171,178,154,1898
Bhagalpur,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,117,117,119,176,174,165,203,192,175,186,197,175,1996
Bhagalpur,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,358,524,493,462,1291,732,1349,1254,1148,1446,1074,896,11027
Bhagalpur,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,11,7,13,8,28,1,583,558,516,481,453,391,3050
Bhagalpur,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,189,184,270,611,1036,397,1186,1103,1312,1352,922,886,9448
Bhagalpur,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,17,33,13,31,40,35,18,34,12,8,46,34,321
Bhagalpur,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,2067,1775,2243,3074,3966,4004,4540,4151,3497,3408,3063,2982,38770
Bhagalpur,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1561,1257,1481,2143,2216,2943,2812,3225,1983,2094,1831,1896,25442
Bhagalpur,6.3,PNC maternal complications attended,TOTAL,2,0,9,380,3,332,376,299,231,282,242,246,2402
Bhagalpur,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,7,1,2,22,8,13,13,15,11,11,26,16,145
Bhagalpur,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0,0,0,7,11,1,1,2,7,6,4,16,55
Bhagalpur,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,7,1,2,29,19,14,14,17,18,17,30,32,200
Bhagalpur,7.2,Number of MTPs conducted at Private Facilities,TOTAL,26,23,86,47,42,44,85,85,94,83,0,0,615
Bhagalpur,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,76,69,48,51,46,68,31,51,38,26,58,19,581
Bhagalpur,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,702,272,664,792,652,304,562,509,713,648,731,502,7051
Bhagalpur,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,778,341,712,843,698,372,593,560,751,674,789,521,7632
Bhagalpur,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0,0,253,401,352,0,309,301,397,362,389,203,2967
Bhagalpur,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0,0,0,2,0,1,1,3,0,2,6,4,19
Bhagalpur,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0,0,0,1,0,0,0,0,0,1,2,0,4
Bhagalpur,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,1,0,0,0,0,1,0,11,0,0,0,1,14
Bhagalpur,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,1,0,0,3,0,2,1,14,0,3,8,5,37
Bhagalpur,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,10,6,4,3,5,5,3,4,14,8,NA,NA,62
Bhagalpur,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Bhagalpur,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Bhagalpur,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0,0,0,0,0,0,0,0,12,0,0,0,12
Bhagalpur,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0,0,0,0,0,0,0,0,12,0,0,0,12
Bhagalpur,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,151,53,8,364,106,410,364,544,1157,759,1191,729,5836
Bhagalpur,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,59,48,10,149,78,155,165,68,484,320,486,373,2395
Bhagalpur,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,5,43,5,29,20,27,41,109,102,86,124,116,707
Bhagalpur,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,215,144,23,542,204,592,570,721,1743,1165,1801,1218,8938
Bhagalpur,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,141,114,84,160,143,156,116,110,187,158,NA,NA,1369
Bhagalpur,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,30,28,4,78,41,108,75,58,86,80,69,87,744
Bhagalpur,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,22,21,10,61,30,75,86,153,81,68,89,83,779
Bhagalpur,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,11,37,42,57,83,67,83,75,148,112,124,50,889
Bhagalpur,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,63,86,56,196,154,250,244,286,315,260,282,220,2412
Bhagalpur,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,242,241,206,1137,423,426,339,342,350,275,309,288,4578
Bhagalpur,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,83,86,48,542,156,104,89,119,130,113,143,143,1756
Bhagalpur,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,13,15,10,91,7,8,112,81,69,79,119,137,741
Bhagalpur,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,24,95,54,63,27,39,91,53,71,89,48,67,721
Bhagalpur,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,362,437,318,1833,613,577,631,595,620,556,619,635,7796
Bhagalpur,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,224,177,78,399,303,278,315,198,191,184,211,351,2909
Bhagalpur,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,81,54,24,40,48,54,37,27,NA,34,NA,NA,399
Bhagalpur,9.06,Number of IUCD removals,TOTAL,160,98,84,217,148,151,139,173,152,203,117,107,1749
Bhagalpur,9.07,Number of Oral Pills cycles distributed,TOTAL,1888,1814,1521,3805,2898,2545,1975,2004,1666,1956,1453,1408,24933
Bhagalpur,9.08,Number of Condom pieces distributed,TOTAL,10410,7784,8858,21126,13442,13667,10366,10726,9077,8494,8197,7895,130042
Bhagalpur,9.09,Number of Centchroman (weekly) pills given,TOTAL,177,0,8,23,23,81,0,70,9,0,12,0,403
Bhagalpur,9.1,Number of Emergency Contraceptive Pills distributed,TOTAL,97,58,30,546,1650,363,268,237,193,137,94,90,3763
Bhagalpur,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Bhagalpur,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0,0,0,0,0,1,0,0,0,0,0,1,2
Bhagalpur,9.11.2.a,Number of failures following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Bhagalpur,9.11.2.b,Number of failures following female sterilization,TOTAL,1,0,1,1,0,0,0,0,2,0,0,0,5
Bhagalpur,9.11.3.a,Number of deaths following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Bhagalpur,9.11.3.b,Number of deaths following female sterilization,TOTAL,0,0,0,0,0,0,0,0,2,0,1,0,3
Bhagalpur,9.12,Number of Institutions having NSV trained doctors,TOTAL,1,3,1,2,1,2,3,6,6,5,8,9,Data for this item can not be cumulated
Bhagalpur,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,3357,4233,3915,7339,7394,8640,8323,8710,6205,8078,6103,7006,79303
Bhagalpur,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,60,38,34,18,11,18,16,16,8,6,2,3,230
Bhagalpur,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,525,330,284,181,109,62,31,44,29,15,1,9,1620
Bhagalpur,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,2022,1420,775,781,322,162,127,63,52,36,7,11,5778
Bhagalpur,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,4984,4990,4360,4714,5630,5964,8228,8546,8095,8074,7009,6802,77396
Bhagalpur,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,5331,5936,4805,4248,5410,5129,5961,6626,7276,8818,7514,7434,74488
Bhagalpur,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,4697,5619,5163,4799,5183,4945,5266,5256,6072,7653,7659,7895,70207
Bhagalpur,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,2572,2605,2793,4944,5988,5489,6252,5118,4518,4999,4402,4422,54102
Bhagalpur,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,5017,4901,4281,4719,5753,5842,8104,8364,8167,8008,7043,6816,77015
Bhagalpur,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,5812,5867,4759,4386,5566,5166,5879,6494,7293,8853,7557,7471,75103
Bhagalpur,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,6585,6759,5678,5107,5425,5098,5330,5157,5713,7727,7721,7935,74235
Bhagalpur,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,2118,2479,2081,3853,4698,4216,5070,3935,3587,3809,3469,3239,42554
Bhagalpur,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,205,60,17,25,0,0,2,6,6,0,1,1,323
Bhagalpur,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,675,313,290,148,64,34,14,18,13,7,0,4,1580
Bhagalpur,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,2091,1410,793,541,374,206,57,49,41,13,22,3,5600
Bhagalpur,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,6254,6635,6727,8005,8194,7249,7665,6134,5312,4951,4502,4439,76067
Bhagalpur,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,7759,6694,5425,5714,5406,5182,5419,4973,5594,6441,6751,7076,72434
Bhagalpur,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,4796,5587,5847,6776,7910,7185,7509,6119,5127,4810,4415,4301,70382
Bhagalpur,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,3155,3411,3592,4130,4134,3613,3806,3101,2695,2484,2264,2268,38653
Bhagalpur,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2845,3038,3223,3753,3770,3320,3534,2782,2363,2169,1961,1981,34739
Bhagalpur,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,6000,6449,6815,7883,7904,6933,7340,5883,5058,4653,4225,4249,73392
Bhagalpur,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,6610,6722,5718,6448,5999,5196,5265,5069,5474,6328,6031,7186,72046
Bhagalpur,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,6619,6583,5453,6410,6040,5228,5240,4928,5485,6261,6558,6986,71791
Bhagalpur,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,11,37,0,20,0,0,0,33,0,0,0,22,123
Bhagalpur,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1501,1714,1291,1580,1309,1158,1214,1098,1218,1534,1451,1829,16897
Bhagalpur,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1314,1342,1136,1338,1147,1009,1095,951,1125,1303,1318,1648,14726
Bhagalpur,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,2815,3056,2427,2918,2456,2167,2309,2049,2343,2837,2769,3477,31623
Bhagalpur,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,448,488,390,469,423,492,501,573,627,584,410,519,5924
Bhagalpur,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,856,748,816,861,918,869,831,902,799,1014,723,798,10135
Bhagalpur,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1107,976,1007,1298,1135,1321,1237,1269,1194,1163,1237,1235,14179
Bhagalpur,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0,0,1,0,0,5,0,0,0,0,0,0,6
Bhagalpur,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Bhagalpur,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,3,5,3,3,3,7,6,5,2,1,2,0,40
Bhagalpur,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,2707,2594,2693,2670,2708,2885,2885,2891,2900,2899,2899,2899,33630
Bhagalpur,10.4.2,Number of Immunisation sessions held during the month,TOTAL,2707,2593,2680,2679,2706,2884,2879,2890,2945,2896,2897,2897,33653
Bhagalpur,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,2505,2445,2258,2483,2546,2506,2528,2541,2545,2562,2566,2591,30076
Bhagalpur,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,6602,6072,5378,5789,5817,5218,5039,4678,5016,6008,6155,6598,68370
Bhagalpur,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,3102,3394,2656,2806,2503,2088,2110,1653,1328,1053,964,701,24358
Bhagalpur,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,641,746,464,506,454,364,365,307,319,357,298,147,4968
Bhagalpur,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,45,92,112,86,99,83,63,27,10,18,12,15,662
Bhagalpur,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,13,0,0,0,0,0,0,0,0,0,0,0,13
Bhagalpur,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Bhagalpur,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0,1,1,0,0,0,0,0,1,0,0,0,3
Bhagalpur,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,1,0,0,0,0,0,0,0,0,0,0,1,2
Bhagalpur,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Bhagalpur,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,33,19,3,0,0,5,1,1,3,1,6,12,84
Bhagalpur,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,2015,1455,1958,2384,2938,2843,1938,1278,1053,828,700,642,20032
Bhagalpur,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,3,5,29,22,11,14,11,9,6,14,10,12,146
Bhagalpur,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,15,12,18,18,31,20,27,25,55,72,74,35,402
Bhagalpur,13.1,Number of Patients operated for cataract,TOTAL,0,16,12,12,813,0,13,26,26,37,46,56,1057
Bhagalpur,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0,16,12,12,813,0,13,26,26,37,46,56,1057
Bhagalpur,13.3,Number of School children detected with Refractive errors,TOTAL,1,1,2,0,0,0,0,0,0,0,0,0,4
Bhagalpur,13.4,Number of children provided free glasses,TOTAL,0,0,0,0,0,0,0,0,0,30,0,0,30
Bhagalpur,13.5,Number of eyes collected through eye donation,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Bhagalpur,13.6,Number of eyes utilised for corneal transplant,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Bhagalpur,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,NA,1,NA,NA,NA,NA,5,4,4,4,4,4,Data for this item can not be cumulated
Bhagalpur,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,NA,NA,NA,NA,NA,NA,10,14,10,12,12,12,Data for this item can not be cumulated
Bhagalpur,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,2431,2222,2423,2419,2444,2431,2330,2363,2398,2424,2418,2510,Data for this item can not be cumulated
Bhagalpur,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,NA,2,1,1,1,1,6,6,5,6,6,6,Data for this item can not be cumulated
Bhagalpur,14.05,Number of RKS meetings held during the month,TOTAL,10,11,8,8,8,3,0,4,10,13,16,14,105
Bhagalpur,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,NA,2,1,1,1,1,15,16,16,15,15,14,Data for this item can not be cumulated
Bhagalpur,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,1031,881,831,1561,928,1581,1810,1692,1465,1952,1452,1669,16853
Bhagalpur,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,NA,2,1,1,1,1,4,5,5,5,5,6,Data for this item can not be cumulated
Bhagalpur,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,3,2,2,2,1,1,0,0,29,0,0,0,Data for this item can not be cumulated
Bhagalpur,14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,896,892,684,1346,1770,1477,1692,1573,1256,1298,1239,1096,15219
Bhagalpur,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,1570,1584,1600,1599,1589,1673,2286,1722,1432,1379,1708,1468,19610
Bhagalpur,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,779,976,616,1184,1810,1330,1490,1320,1179,1209,896,1331,14120
Bhagalpur,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,3882,3508,3328,6023,6192,6948,7023,6725,6839,6593,6911,6210,70182
Bhagalpur,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,1675,1868,1300,2530,3580,2807,3182,2893,2435,2507,2135,2427,29339
Bhagalpur,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,5452,5092,4928,7622,7781,8621,9309,8447,8271,7972,8619,7678,89792
Bhagalpur,14.10.2.a,Number of death cases of Inpatient males,TOTAL,177,179,187,164,224,218,317,231,246,187,182,165,2477
Bhagalpur,14.10.2.b,Number of death cases of Inpatient females,TOTAL,96,118,86,107,119,111,123,123,107,85,105,116,1296
Bhagalpur,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,273,297,273,271,343,329,440,354,353,272,287,281,3773
Bhagalpur,14.11,In-Patient Head Count at midnight,TOTAL,7604,7123,6783,9555,10089,10289,10845,11177,9736,9533,10373,10405,113512
Bhagalpur,14.12.1,OPD attendance (All),TOTAL,161503,154122,130883,165200,150526,181140,162103,154623,172343,156953,167669,164588,1921653
Bhagalpur,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,641,487,430,1472,662,1034,1081,1180,2191,1764,2339,1916,15197
Bhagalpur,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,285,183,0,0,26,67,0,0,0,0,0,0,561
Bhagalpur,14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,3155,3513,3188,3767,3386,3638,3527,3527,3614,3424,3589,3775,42103
Bhagalpur,14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,14.14.a,Number of patients given AYUSH treatment,TOTAL,44942,38586,35463,37131,29934,37476,37468,34829,38527,35723,36859,34972,441910
Bhagalpur,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,6362,4361,4597,7175,7547,8674,6929,5473,7013,7233,6176,5483,77023
Bhagalpur,14.14.c,Number of Adolescents counselled,TOTAL,282,24,307,679,56,437,515,106,78,64,68,57,2673
Bhagalpur,15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,6173,6498,6651,7484,8299,7552,8287,7801,8676,8623,10643,10736,97423
Bhagalpur,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,135,136,132,136,193,150,629,632,182,231,195,199,2950
Bhagalpur,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,286,87,400,420,273,509,571,551,1084,230,589,425,5425
Bhagalpur,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,12,5,23,16,21,30,30,38,17,9,16,33,250
Bhagalpur,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,305,89,345,564,443,438,476,864,1003,848,1381,1086,7842
Bhagalpur,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,4,6,22,12,12,19,21,150,92,124,126,129,717
Bhagalpur,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,1120,119,795,1190,771,697,607,719,419,806,1392,1588,10223
Bhagalpur,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0,0,4,1,1,1,0,15,1,0,54,92,169
Bhagalpur,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,1711,295,1540,2174,1487,1644,1654,2134,2506,1884,3362,3099,23490
Bhagalpur,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,16,11,49,29,34,50,51,203,110,133,196,254,1136
Bhagalpur,15.2,Number of Widal tests conducted,Number tested,37,41,3,30,55,81,129,81,26,21,406,246,1156
Bhagalpur,15.3.a,Number of VDRL tests conducted on males,Number tested,2,2,64,75,4,20,108,42,11,5,11,43,387
Bhagalpur,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,0,0,31,422,41,104,257,79,97,15,307,433,1786
Bhagalpur,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,4,28,12,493,161,438,278,266,327,45,404,386,2842
Bhagalpur,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,6,30,107,990,206,562,643,387,435,65,722,862,5015
Bhagalpur,15.4.1,Number of blood smears examined for Malaria,TOTAL,231,305,188,450,363,611,585,721,429,236,289,246,4654
Bhagalpur,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,2,2,2,6,2,5,24,37,14,0,8,3,105
Bhagalpur,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,1,2,2,4,2,3,11,26,14,2,4,0,71
Bhagalpur,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,465,2315,2895,NA,765,900,NA,NA,NA,NA,NA,NA,7340
Bhagalpur,16.1.1,Stock position of DPT vaccines,2. Stocks Received,2500,1600,0,NA,1000,0,NA,NA,NA,NA,NA,NA,5100
Bhagalpur,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0,0,0,NA,NA,0,NA,NA,NA,NA,NA,NA,0
Bhagalpur,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,650,1020,980,NA,865,670,NA,NA,NA,NA,NA,NA,4185
Bhagalpur,16.1.1,Stock position of DPT vaccines,5. Total Stock,2315,2895,1915,0,900,230,0,0,0,0,0,0,8255
Bhagalpur,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,105,265,1355,NA,490,178,NA,NA,NA,NA,NA,NA,2393
Bhagalpur,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,1500,3100,1000,NA,480,2128,NA,NA,NA,NA,NA,NA,8208
Bhagalpur,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0,0,0,NA,NA,0,NA,NA,NA,NA,NA,NA,0
Bhagalpur,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,1340,2010,1490,NA,782,1852,NA,NA,NA,NA,NA,NA,7474
Bhagalpur,16.1.1A,Stock Position of Pentavalent,5. Total Stock,265,1355,865,0,188,454,0,0,0,0,0,0,3127
Bhagalpur,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,395,0,1190,NA,130,180,NA,NA,NA,NA,NA,NA,1895
Bhagalpur,16.1.2,Stock position of OPV vaccines,2. Stocks Received,1500,0,2000,NA,2400,3000,NA,NA,NA,NA,NA,NA,8900
Bhagalpur,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0,0,0,NA,NA,0,NA,NA,NA,NA,NA,NA,0
Bhagalpur,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,1295,0,1710,NA,2350,2990,NA,NA,NA,NA,NA,NA,8345
Bhagalpur,16.1.2,Stock position of OPV vaccines,5. Total Stock,600,0,1480,0,180,190,0,0,0,0,0,0,2450
Bhagalpur,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,615,1015,995,NA,200,950,NA,NA,NA,NA,NA,NA,3775
Bhagalpur,16.1.3,Stock position of TT vaccines,2. Stocks Received,1500,2000,1500,NA,2000,1500,NA,NA,NA,NA,NA,NA,8500
Bhagalpur,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0,0,0,NA,NA,0,NA,NA,NA,NA,NA,NA,0
Bhagalpur,16.1.3,Stock position of TT vaccines,4. Stock Distributed,1100,2020,1545,NA,1250,1750,NA,NA,NA,NA,NA,NA,7665
Bhagalpur,16.1.3,Stock position of TT vaccines,5. Total Stock,1015,995,950,0,950,700,0,0,0,0,0,0,4610
Bhagalpur,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0,0,0,NA,NA,0,NA,NA,NA,NA,NA,NA,0
Bhagalpur,16.1.4,Stock position of DT vaccines,2. Stocks Received,0,0,0,NA,NA,0,NA,NA,NA,NA,NA,NA,0
Bhagalpur,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0,0,0,NA,NA,0,NA,NA,NA,NA,NA,NA,0
Bhagalpur,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0,0,0,NA,NA,0,NA,NA,NA,NA,NA,NA,0
Bhagalpur,16.1.4,Stock position of DT vaccines,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Bhagalpur,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,590,1020,2280,NA,295,120,NA,NA,NA,NA,NA,NA,4305
Bhagalpur,16.1.5,Stock position of BCG vaccines,2. Stocks Received,1000,2200,0,NA,750,2500,NA,NA,NA,NA,NA,NA,6450
Bhagalpur,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0,0,0,NA,NA,0,NA,NA,NA,NA,NA,NA,0
Bhagalpur,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,570,940,990,NA,945,1950,NA,NA,NA,NA,NA,NA,5395
Bhagalpur,16.1.5,Stock position of BCG vaccines,5. Total Stock,1020,2280,1290,0,100,670,0,0,0,0,0,0,5360
Bhagalpur,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,315,215,390,NA,160,650,NA,NA,NA,NA,NA,NA,1730
Bhagalpur,16.1.6,Stock position of Measles vaccines,2. Stocks Received,2500,3900,3000,NA,3000,4020,NA,NA,NA,NA,NA,NA,16420
Bhagalpur,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0,0,0,NA,NA,0,NA,NA,NA,NA,NA,NA,0
Bhagalpur,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,2600,3725,3060,NA,2510,4150,NA,NA,NA,NA,NA,NA,16045
Bhagalpur,16.1.6,Stock position of Measles vaccines,5. Total Stock,215,390,330,0,650,520,0,0,0,0,0,0,2105
Bhagalpur,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,125,175,575,NA,300,830,NA,NA,NA,NA,NA,NA,2005
Bhagalpur,16.1.7,Stock position of JE vaccines,2. Stocks Received,2500,4100,4000,NA,2500,4000,NA,NA,NA,NA,NA,NA,17100
Bhagalpur,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0,0,0,NA,NA,0,NA,NA,NA,NA,NA,NA,0
Bhagalpur,16.1.7,Stock position of JE vaccines,4. Stock Distributed,2450,3700,3265,NA,1970,4550,NA,NA,NA,NA,NA,NA,15935
Bhagalpur,16.1.7,Stock position of JE vaccines,5. Total Stock,175,575,1310,0,830,280,0,0,0,0,0,0,3170
Bhagalpur,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,285,2060,3335,NA,2275,178,NA,NA,NA,NA,NA,NA,8133
Bhagalpur,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,2000,2400,0,NA,0,2128,NA,NA,NA,NA,NA,NA,6528
Bhagalpur,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0,0,0,NA,NA,0,NA,NA,NA,NA,NA,NA,0
Bhagalpur,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,225,1125,110,NA,450,1852,NA,NA,NA,NA,NA,NA,3762
Bhagalpur,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,2060,3335,3225,0,1825,454,0,0,0,0,0,0,10899
Bhagalpur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Bhagalpur,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Bhagalpur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Bhagalpur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Bhagalpur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Bhagalpur,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Bhagalpur,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,16.3.02,Stock Position of Gloves,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,16.3.02,Stock Position of Gloves,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,16.3.02,Stock Position of Gloves,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,16.3.02,Stock Position of Gloves,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Bhagalpur,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Bhagalpur,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Bhagalpur,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Bhagalpur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Bhagalpur,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Bhagalpur,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Bhagalpur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Bhagalpur,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Bhagalpur,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Bhagalpur,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,3600,10000,11400,NA,10800,5800,NA,NA,NA,NA,NA,NA,41600
Bhagalpur,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,12000,10000,0,NA,0,16800,NA,NA,NA,NA,NA,NA,38800
Bhagalpur,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0,0,0,NA,NA,0,NA,NA,NA,NA,NA,NA,0
Bhagalpur,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,5600,8600,4800,NA,5000,9000,NA,NA,NA,NA,NA,NA,33000
Bhagalpur,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,10000,11400,6600,0,5800,13600,0,0,0,0,0,0,47400
Bhagalpur,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,23800,73000,94400,NA,92200,59400,NA,NA,NA,NA,NA,NA,342800
Bhagalpur,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,100000,100000,0,NA,0,220000,NA,NA,NA,NA,NA,NA,420000
Bhagalpur,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0,0,0,NA,NA,0,NA,NA,NA,NA,NA,NA,0
Bhagalpur,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,50200,79200,55000,NA,33600,67200,NA,NA,NA,NA,NA,NA,285200
Bhagalpur,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,73600,93800,39400,0,58600,212200,0,0,0,0,0,0,477600
Bhagalpur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,1600,4700,6700,NA,2100,8400,NA,NA,NA,NA,NA,NA,23500
Bhagalpur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,8000,10000,0,NA,10000,20100,NA,NA,NA,NA,NA,NA,48100
Bhagalpur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0,0,0,NA,NA,0,NA,NA,NA,NA,NA,NA,0
Bhagalpur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,4900,8000,5500,NA,3700,9700,NA,NA,NA,NA,NA,NA,31800
Bhagalpur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,4700,6700,1200,0,8400,18800,0,0,0,0,0,0,39800
Bhagalpur,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,NA,NA,NA,NA,NA,NA,NA,9,7,5,10,4,35
Bhagalpur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,1,2,2,4,2,11
Bhagalpur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,1,5,8,3,NA,17
Bhagalpur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,NA,NA,NA,NA,NA,NA,NA,2,7,10,7,2,28
Bhagalpur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,1,7,5,15,23,51
Bhagalpur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,1,14,6,4,4,29
Bhagalpur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,NA,NA,NA,NA,NA,NA,NA,2,21,11,19,27,80
Bhagalpur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,8,24,26,20,19,97
Bhagalpur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,12,2,3,2,19
Bhagalpur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,NA,NA,NA,NA,NA,NA,NA,8,36,28,23,21,116
Bhagalpur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,1,20,29,49,16,12,127
Bhagalpur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,9,20,19,10,7,65
Bhagalpur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,NA,NA,NA,NA,NA,NA,1,29,49,68,26,19,192
Bhagalpur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,27,33,17,7,84
Bhagalpur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,1,1,6,4,3,3,18
Bhagalpur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,NA,NA,NA,NA,NA,NA,1,1,33,37,20,10,102
Bhagalpur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,4,2,1,4,11
Bhagalpur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,5,NA,6
Bhagalpur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,5,2,6,4,17
Bhagalpur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,1,3,NA,4,7,15
Bhagalpur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,1,1,2,1,1,6
Bhagalpur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,NA,NA,NA,NA,NA,NA,NA,2,4,2,5,8,21
Bhagalpur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,6,47,28,34,18,133
Bhagalpur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,2,17,10,13,15,57
Bhagalpur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,NA,NA,NA,NA,NA,NA,NA,8,64,38,47,33,190
Bhagalpur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,3,2,1,2,8
Bhagalpur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,3,2,1,2,8
Bhagalpur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,2,1,4
Bhagalpur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,7,NA,3,10
Bhagalpur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,NA,NA,NA,NA,NA,NA,1,NA,NA,7,2,4,14
Bhagalpur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1,3,5
Bhagalpur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1,3,5
Bhagalpur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,1
Bhagalpur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,1
Bhagalpur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,1,NA,1,NA,NA,2
Bhagalpur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,NA,NA,NA,NA,NA,NA,NA,1,NA,1,NA,NA,2
Bhagalpur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,1,1,4,1,1,8
Bhagalpur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,NA,NA,NA,NA,NA,NA,NA,1,1,4,1,1,8
Bhagalpur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,1,1,2,2,2,2,10
Bhagalpur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,NA,NA,NA,NA,NA,NA,1,1,2,2,2,2,10
Bhagalpur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,5,18,10,7,10,50
Bhagalpur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,NA,NA,NA,NA,NA,NA,NA,5,18,10,7,10,50
Bhagalpur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,1,2,NA,NA,1,4
Bhagalpur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,1
Bhagalpur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,NA,NA,NA,NA,NA,NA,NA,1,3,NA,NA,1,5
Bhagalpur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,1,NA,3,NA,1,1,6
Bhagalpur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,NA,NA,NA,NA,NA,NA,1,NA,3,NA,1,1,6
Bhagalpur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,1
Bhagalpur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,5,NA,1,NA,NA,1,7
Bhagalpur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,1
Bhagalpur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,NA,NA,NA,NA,NA,NA,5,2,1,NA,NA,1,9
Bhagalpur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,2,2,NA,NA,4
Bhagalpur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1
Bhagalpur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,2,2,NA,1,5
Bhagalpur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhagalpur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,2,3,1,7,13
Bhagalpur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,1,1,NA,1,1,4
Bhagalpur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,NA,NA,NA,NA,NA,NA,NA,1,3,3,2,8,17
Bhagalpur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,1
Bhagalpur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,NA,NA,NA,NA,NA,1,2,3,2,11,6,1,26
Bhagalpur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,2,2,11,8,1,24
Bhagalpur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,NA,NA,NA,NA,NA,1,2,5,4,23,14,2,51
Bhojpur,1.1,Total number of pregnant women Registered for ANC,TOTAL,4155,4004,3783,4785,3774,3586,3330,2795,3384,3543,3552,4084,44775
Bhojpur,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1786,1566,1552,1785,1605,1560,1656,1658,2607,2250,1907,2331,22263
Bhojpur,1.2,Number of Pregnant women registered under JSY,TOTAL,4155,4004,3783,4785,3774,3586,3330,2787,3384,3543,3534,4084,44749
Bhojpur,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,2052,2087,1981,2375,2119,2095,2158,2017,2488,2171,2181,2512,26236
Bhojpur,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,3114,2993,2840,3499,2773,2513,2450,2019,2265,2294,2377,2555,31692
Bhojpur,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,3971,4115,3224,3965,3941,3638,3351,2728,3143,2962,2931,3472,41441
Bhojpur,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,2901,3167,3450,3074,2232,1943,1650,1261,725,427,424,371,21625
Bhojpur,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,45,55,18,13,139,123,32,27,62,15,26,20,575
Bhojpur,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,6,8,6,5,5,3,12,11,11,6,4,9,86
Bhojpur,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,51,158,119,200,177,232,236,232,326,288,118,85,2222
Bhojpur,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,4,8,3,5,5,4,39,3,2,3,152,172,400
Bhojpur,1.8,Number of pregnancy test kits used at SC level,TOTAL,525,514,416,816,760,672,834,600,734,464,505,418,7258
Bhojpur,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,42,33,53,41,52,130,86,81,92,67,76,76,829
Bhojpur,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,181,190,222,251,228,219,333,296,264,291,281,258,3014
Bhojpur,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,223,223,275,292,280,349,419,377,356,358,357,334,3843
Bhojpur,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,198,188,242,257,241,292,374,332,373,357,327,254,3435
Bhojpur,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0,0,0,1,0,0,0,0,2,0,6,0,9
Bhojpur,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,2248,2477,2395,3306,4041,4012,3926,3755,3365,3210,2751,2656,38142
Bhojpur,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,1760,1706,2082,3118,3651,3409,3199,3282,2833,3065,2642,2417,33164
Bhojpur,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,2230,3813,2113,2911,2939,1299,3794,2840,3000,2949,2346,2538,32772
Bhojpur,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,552,433,637,613,500,851,1462,1159,631,834,717,1204,9593
Bhojpur,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0,0,0,0,3,5,0,0,0,0,0,0,8
Bhojpur,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,NA,NA,NA,NA,215,556,479,874,NA,826,851,635,4436
Bhojpur,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Bhojpur,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Bhojpur,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,43,67,52,63,96,78,63,38,64,76,66,81,787
Bhojpur,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,43,67,52,63,96,78,63,38,64,76,66,81,787
Bhojpur,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,NA,NA,NA,NA,801,378,316,641,NA,335,352,295,3118
Bhojpur,4.1.1.a,Number of male live births,TOTAL,1297,1418,1387,1864,2233,2189,2266,2040,1950,1913,1647,1580,21784
Bhojpur,4.1.1.b,Number of female live births,TOTAL,1134,1249,1244,1687,2020,2082,2026,2004,1715,1630,1451,1375,19617
Bhojpur,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,2431,2667,2631,3551,4253,4271,4292,4044,3665,3543,3098,2955,41401
Bhojpur,4.1.2,Number of still births,TOTAL,53,46,57,72,76,83,71,76,50,53,36,38,711
Bhojpur,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,28,3,0,0,4,0,1,2,1,1,0,2,42
Bhojpur,4.2.1,Number of Newborns weighed at birth,TOTAL,2248,2572,2537,3416,4039,4151,3975,3921,3495,3383,2997,2915,39649
Bhojpur,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,172,234,362,288,328,337,362,291,416,383,300,334,3807
Bhojpur,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,2351,2619,2597,3424,4200,4122,4127,4010,3622,3450,3033,2930,40485
Bhojpur,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0,0,0,0,0,0,0,0,10,19,6,4,39
Bhojpur,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Bhojpur,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,57,120,138,155,188,174,82,49,72,85,71,83,1274
Bhojpur,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,57,120,138,155,188,174,82,49,82,104,77,87,1313
Bhojpur,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,57,120,138,155,188,174,82,49,82,104,77,87,1313
Bhojpur,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0,0,0,0,0,0,0,0,0,7,0,0,7
Bhojpur,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,57,120,138,155,188,174,82,49,82,104,77,87,1313
Bhojpur,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,10,32,13,72,39,17,10,14,22,21,34,28,312
Bhojpur,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,592,767,889,1124,1563,1507,1619,2022,2217,3122,2711,2582,20715
Bhojpur,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,826,873,689,1093,1089,1126,1097,1174,979,1032,1220,1175,12373
Bhojpur,6.3,PNC maternal complications attended,TOTAL,2,0,0,0,0,0,0,0,0,0,0,0,2
Bhojpur,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,1,0,0,0,0,0,0,0,4,1,0,0,6
Bhojpur,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0,2,0,0,0,0,0,0,2,0,0,0,4
Bhojpur,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,1,2,0,0,0,0,0,0,6,1,0,0,10
Bhojpur,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0,131,132,145,66,136,88,109,127,174,202,193,1503
Bhojpur,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,34,37,46,72,71,64,78,54,62,86,77,72,753
Bhojpur,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,404,332,270,266,274,256,281,271,332,325,314,197,3522
Bhojpur,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,438,369,316,338,345,320,359,325,394,411,391,269,4275
Bhojpur,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Bhojpur,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,2,0,0,3,2,8,5,6,15,7,12,5,65
Bhojpur,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0,0,0,1,0,0,1,2,1,1,2,1,9
Bhojpur,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,2,3,1,11,2,1,2,1,1,3,1,0,28
Bhojpur,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,4,3,1,15,4,9,8,9,17,11,15,6,102
Bhojpur,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,3,3,4,3,3,2,1,1,4,4,1,7,36
Bhojpur,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Bhojpur,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Bhojpur,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0,0,0,0,0,0,0,29,0,0,0,0,29
Bhojpur,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0,0,0,0,0,0,0,29,0,0,0,0,29
Bhojpur,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,132,10,0,230,188,402,417,355,789,523,650,366,4062
Bhojpur,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,27,32,14,101,63,89,158,131,215,150,237,138,1355
Bhojpur,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,4,15,17,23,32,40,27,14,50,42,40,34,338
Bhojpur,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,163,57,31,354,283,531,602,500,1054,715,927,538,5755
Bhojpur,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,362,296,297,278,366,485,391,770,1076,861,1167,760,7109
Bhojpur,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0,0,0,0,0,0,2,8,0,0,5,0,15
Bhojpur,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Bhojpur,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,25,12,20,26,10,19,20,36,66,47,59,26,366
Bhojpur,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,25,12,20,26,10,19,22,44,66,47,64,26,381
Bhojpur,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,204,174,198,1471,326,390,317,304,520,266,295,351,4816
Bhojpur,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,47,39,26,375,44,95,47,113,248,124,118,94,1370
Bhojpur,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,40,13,11,17,4,13,21,22,143,110,94,85,573
Bhojpur,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,24,31,20,16,51,35,63,35,141,64,55,59,594
Bhojpur,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,315,257,255,1879,425,533,448,474,1052,564,562,589,7353
Bhojpur,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,52,4,7,50,59,27,58,41,212,146,121,116,893
Bhojpur,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,18,29,24,32,9,19,18,10,19,19,29,47,273
Bhojpur,9.06,Number of IUCD removals,TOTAL,159,189,181,341,327,204,197,176,197,218,135,153,2477
Bhojpur,9.07,Number of Oral Pills cycles distributed,TOTAL,2553,3083,3325,5622,2414,2574,2550,2343,2332,1434,2179,1528,31937
Bhojpur,9.08,Number of Condom pieces distributed,TOTAL,9972,9846,9791,29928,11798,9437,9146,8601,9297,6882,7726,10455,132879
Bhojpur,9.09,Number of Centchroman (weekly) pills given,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Bhojpur,9.1,Number of Emergency Contraceptive Pills distributed,TOTAL,1585,1790,1188,3829,921,759,700,663,454,254,327,380,12850
Bhojpur,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0,0,0,0,1,0,0,0,0,0,0,0,1
Bhojpur,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0,0,0,6,9,8,0,0,0,0,0,0,23
Bhojpur,9.11.2.a,Number of failures following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Bhojpur,9.11.2.b,Number of failures following female sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Bhojpur,9.11.3.a,Number of deaths following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Bhojpur,9.11.3.b,Number of deaths following female sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Bhojpur,9.12,Number of Institutions having NSV trained doctors,TOTAL,NA,NA,NA,NA,2,1,5,6,6,3,3,2,Data for this item can not be cumulated
Bhojpur,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,3549,3544,3413,4866,5225,5667,5751,5409,5810,5177,4650,4222,57283
Bhojpur,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,44,4,23,6,5,14,4,2,1,32,3,2,140
Bhojpur,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,577,324,208,214,95,90,35,26,14,28,15,11,1637
Bhojpur,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,1735,1015,627,580,284,182,104,80,59,75,12,40,4793
Bhojpur,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,4544,3913,3227,4221,3803,4651,5402,5288,5736,5791,5035,5090,56701
Bhojpur,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,4418,4155,3267,3897,3960,3916,4241,4471,5287,5754,5008,5603,53977
Bhojpur,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,3273,3603,3161,3752,3663,3748,3756,3659,4242,4926,4791,5305,47879
Bhojpur,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,2558,2460,2318,3364,4239,4217,4198,4225,4192,3835,3285,3151,42042
Bhojpur,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,4464,3846,3165,4162,4117,4447,5467,5125,5710,5785,5436,5128,56852
Bhojpur,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,4759,4235,3277,3994,3970,3985,4233,4314,5217,5404,5145,5914,54447
Bhojpur,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,4603,4340,3586,4191,3843,3808,3790,3555,4340,4828,4919,5318,51121
Bhojpur,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,1925,1738,2282,2734,3517,3051,3284,3250,3023,2971,2690,2518,32983
Bhojpur,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,50,11,35,15,20,13,200,4,23,1,1,2,375
Bhojpur,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,589,321,202,233,112,85,60,16,52,13,5,15,1703
Bhojpur,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,1751,1119,541,602,336,171,132,118,100,33,38,8,4949
Bhojpur,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,3946,3991,4043,5697,5031,4960,4994,4131,4121,3287,3318,3585,51104
Bhojpur,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,3473,3197,3100,4102,3748,3543,3555,3110,3537,4039,4011,4481,43896
Bhojpur,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,2760,3864,2982,5049,4634,4793,4920,4015,3865,3160,3237,3482,46761
Bhojpur,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2059,1820,1858,2646,2270,2342,2556,2082,2038,1798,1709,1863,25041
Bhojpur,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1765,1585,1614,2202,1968,2043,2255,1843,1923,1549,1539,1629,21915
Bhojpur,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,3824,3405,3472,4848,4238,4385,4811,3925,3961,3347,3248,3492,46956
Bhojpur,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,4269,3882,3431,4696,3668,3584,3714,3115,3603,3834,4098,4531,46425
Bhojpur,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,4522,3847,3488,4621,3645,3543,3707,3083,3587,3824,4008,4531,46406
Bhojpur,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0,0,111,0,0,0,0,0,0,0,0,0,111
Bhojpur,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1215,1130,1000,1480,1148,1189,1252,932,991,1178,1249,1341,14105
Bhojpur,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,997,975,965,1250,984,997,1058,890,906,1058,1155,1247,12482
Bhojpur,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,2212,2105,1965,2730,2132,2186,2310,1822,1897,2236,2404,2588,26587
Bhojpur,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,695,709,666,813,470,572,583,572,609,336,545,435,7005
Bhojpur,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,1268,1182,1152,1718,1211,1218,1315,1286,1215,1089,1220,1226,15100
Bhojpur,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1756,1685,1563,2647,2250,1907,2021,1934,1500,1613,1675,1810,22361
Bhojpur,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0,0,0,0,0,0,2,14,0,0,0,0,16
Bhojpur,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Bhojpur,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Bhojpur,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,3691,3256,3283,3566,3074,3313,3379,3078,3261,3413,3068,3287,39669
Bhojpur,10.4.2,Number of Immunisation sessions held during the month,TOTAL,3645,3195,3035,3533,3098,3276,3298,3005,3223,3400,2992,3237,38937
Bhojpur,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,3047,2616,2212,2860,2530,2755,2814,2589,2842,2897,2633,2832,32627
Bhojpur,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,2875,3678,2756,3712,3437,3350,3446,3022,3384,3515,3659,4206,41040
Bhojpur,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,833,703,563,709,811,788,479,549,216,195,126,116,6088
Bhojpur,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,463,478,328,572,523,421,373,257,132,146,98,126,3917
Bhojpur,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,60,81,43,79,74,78,120,109,53,52,29,48,826
Bhojpur,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Bhojpur,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Bhojpur,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Bhojpur,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Bhojpur,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Bhojpur,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,16,0,0,0,0,0,0,0,2,0,0,0,18
Bhojpur,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,166,291,198,332,154,305,335,270,178,153,156,164,2702
Bhojpur,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Bhojpur,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Bhojpur,13.1,Number of Patients operated for cataract,TOTAL,2,0,46,72,35,81,2,90,105,577,109,10,1129
Bhojpur,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,2,0,0,1,0,0,32,207,9,460,201,73,985
Bhojpur,13.3,Number of School children detected with Refractive errors,TOTAL,0,0,0,0,0,0,0,0,9,28,0,0,37
Bhojpur,13.4,Number of children provided free glasses,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Bhojpur,13.5,Number of eyes collected through eye donation,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Bhojpur,13.6,Number of eyes utilised for corneal transplant,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Bhojpur,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,NA,NA,2,2,3,2,3,2,2,2,3,3,Data for this item can not be cumulated
Bhojpur,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,NA,NA,4,10,16,17,15,13,14,11,15,16,Data for this item can not be cumulated
Bhojpur,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,1885,1871,1734,1614,1607,1591,1618,1661,1652,1597,1654,1635,Data for this item can not be cumulated
Bhojpur,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,NA,NA,2,1,4,2,4,4,5,5,5,4,Data for this item can not be cumulated
Bhojpur,14.05,Number of RKS meetings held during the month,TOTAL,13,13,14,13,14,16,11,12,15,9,15,13,158
Bhojpur,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,NA,NA,8,12,16,13,15,14,16,16,18,15,Data for this item can not be cumulated
Bhojpur,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,487,354,311,1138,1381,1165,1504,1333,1483,1181,981,1329,12647
Bhojpur,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,NA,NA,1,1,4,3,3,3,5,5,4,3,Data for this item can not be cumulated
Bhojpur,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,NA,NA,NA,0,1,1,1,1,1,1,1,1,Data for this item can not be cumulated
Bhojpur,14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,1103,1147,1107,1125,1188,1124,1364,1480,1225,1126,999,1008,13996
Bhojpur,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,2433,2807,2416,2567,2493,2821,3085,2689,2410,2591,2261,2641,31214
Bhojpur,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,1020,1089,1101,1136,1166,1202,1399,1462,975,1208,1079,1058,13895
Bhojpur,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,3599,4506,4165,4980,5383,5479,6050,5577,5552,4774,4485,4495,59045
Bhojpur,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,2123,2236,2208,2261,2354,2326,2763,2942,2200,2334,2078,2066,27891
Bhojpur,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,6032,7313,6581,7547,7876,8300,9135,8266,7962,7365,6746,7136,90259
Bhojpur,14.10.2.a,Number of death cases of Inpatient males,TOTAL,15,13,21,12,14,10,13,12,15,20,16,29,190
Bhojpur,14.10.2.b,Number of death cases of Inpatient females,TOTAL,15,8,22,15,11,13,8,12,10,24,16,18,172
Bhojpur,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,30,21,43,27,25,23,21,24,25,44,32,47,362
Bhojpur,14.11,In-Patient Head Count at midnight,TOTAL,2703,4099,3063,3629,3866,4027,4153,3947,5177,4175,3908,3442,46189
Bhojpur,14.12.1,OPD attendance (All),TOTAL,127382,141397,129046,147177,147090,147366,130308,126945,136605,122512,131697,119962,1607487
Bhojpur,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,328,330,226,334,330,574,650,551,1235,826,923,609,6916
Bhojpur,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0,0,27,0,0,0,0,0,0,0,0,0,27
Bhojpur,14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,4423,4746,4420,4621,4877,4521,4216,4238,3815,3693,2140,2105,47815
Bhojpur,14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,14.14.a,Number of patients given AYUSH treatment,TOTAL,15241,16978,14988,13253,18381,16790,13872,14649,16559,15402,14952,15721,186786
Bhojpur,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,5077,4818,4753,4579,5088,4736,4407,4640,5339,6770,5330,3752,59289
Bhojpur,14.14.c,Number of Adolescents counselled,TOTAL,108,119,110,677,0,0,25,0,20,50,57,60,1226
Bhojpur,15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,719,496,610,616,605,799,848,1066,876,786,863,708,8992
Bhojpur,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,4,15,19,35,34,28,25,20,7,20,14,38,259
Bhojpur,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,51,21,141,128,143,151,168,93,135,600,225,205,2061
Bhojpur,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,2,4,3,29,38,41,41,24,33,2,3,0,220
Bhojpur,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,119,41,228,215,276,261,418,262,417,364,668,376,3645
Bhojpur,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,2,5,11,2,5,5,6,3,158,2,3,1,203
Bhojpur,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,120,82,447,424,441,418,306,384,380,337,759,373,4471
Bhojpur,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0,1,0,0,0,0,1,0,1,4,25,0,32
Bhojpur,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,290,144,816,767,860,830,892,739,932,1301,1652,954,10177
Bhojpur,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,4,10,14,31,43,46,48,27,192,8,31,1,455
Bhojpur,15.2,Number of Widal tests conducted,Number tested,0,0,5,5,0,10,0,8,9,18,20,5,80
Bhojpur,15.3.a,Number of VDRL tests conducted on males,Number tested,0,5,0,5,2,3,0,0,20,8,12,2,57
Bhojpur,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,0,0,10,3,2,2,0,0,20,8,6,2,53
Bhojpur,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,0,0,0,4,4,0,3,0,20,0,7,0,38
Bhojpur,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,0,5,10,12,8,5,3,0,60,16,25,4,148
Bhojpur,15.4.1,Number of blood smears examined for Malaria,TOTAL,40,22,61,50,17,27,19,9,0,23,0,0,268
Bhojpur,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Bhojpur,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Bhojpur,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,3250,NA,4350,4900,NA,3600,3050,2550,NA,NA,NA,1200,22900
Bhojpur,16.1.1,Stock position of DPT vaccines,2. Stocks Received,1000,NA,1800,0,NA,0,0,0,NA,NA,NA,0,2800
Bhojpur,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0,NA,0,0,NA,0,0,0,NA,NA,NA,0,0
Bhojpur,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,0,NA,1650,750,NA,550,500,500,NA,NA,NA,950,4900
Bhojpur,16.1.1,Stock position of DPT vaccines,5. Total Stock,4250,0,4500,4150,0,3050,2550,2050,0,0,0,250,20800
Bhojpur,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,1400,NA,2450,3242,NA,2400,3360,3336,NA,NA,NA,NA,16188
Bhojpur,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,2000,NA,2592,1152,NA,2592,1152,576,NA,NA,NA,NA,10064
Bhojpur,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0,NA,0,0,NA,0,0,0,NA,NA,NA,NA,0
Bhojpur,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,1450,NA,1800,1130,NA,1632,1176,1656,NA,NA,NA,NA,8844
Bhojpur,16.1.1A,Stock Position of Pentavalent,5. Total Stock,1950,0,3242,3264,0,3360,3336,2256,0,0,0,0,17408
Bhojpur,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,1350,NA,2400,2375,NA,975,850,150,NA,NA,NA,2925,11025
Bhojpur,16.1.2,Stock position of OPV vaccines,2. Stocks Received,2000,NA,2200,2000,NA,2200,1000,2000,NA,NA,NA,0,11400
Bhojpur,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0,NA,0,0,NA,0,0,0,NA,NA,NA,0,0
Bhojpur,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,1700,NA,2950,1725,NA,2325,1700,1700,NA,NA,NA,1325,13425
Bhojpur,16.1.2,Stock position of OPV vaccines,5. Total Stock,1650,0,1650,2650,0,850,150,450,0,0,0,1600,9000
Bhojpur,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,2600,NA,3350,4400,NA,1700,2850,2450,NA,NA,NA,4150,21500
Bhojpur,16.1.3,Stock position of TT vaccines,2. Stocks Received,1000,NA,3000,0,NA,2000,1000,2500,NA,NA,NA,0,9500
Bhojpur,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0,NA,0,0,NA,0,0,0,NA,NA,NA,0,0
Bhojpur,16.1.3,Stock position of TT vaccines,4. Stock Distributed,250,NA,1950,1300,NA,850,1400,1200,NA,NA,NA,1450,8400
Bhojpur,16.1.3,Stock position of TT vaccines,5. Total Stock,3350,0,4400,3100,0,2850,2450,3750,0,0,0,2700,22600
Bhojpur,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,0,0
Bhojpur,16.1.4,Stock position of DT vaccines,2. Stocks Received,0,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,0,0
Bhojpur,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,0,0
Bhojpur,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,0,0
Bhojpur,16.1.4,Stock position of DT vaccines,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Bhojpur,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,1750,NA,2850,3000,NA,1800,1950,1850,NA,NA,NA,3750,16950
Bhojpur,16.1.5,Stock position of BCG vaccines,2. Stocks Received,1200,NA,1700,1000,NA,1700,1500,1200,NA,NA,NA,0,8300
Bhojpur,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0,NA,0,0,NA,0,0,0,NA,NA,NA,0,0
Bhojpur,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,900,NA,1550,1100,NA,1550,1600,1450,NA,NA,NA,1400,9550
Bhojpur,16.1.5,Stock position of BCG vaccines,5. Total Stock,2050,0,3000,2900,0,1950,1850,1600,0,0,0,2350,15700
Bhojpur,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,1750,NA,1150,1950,NA,800,1600,1750,NA,NA,NA,1350,10350
Bhojpur,16.1.6,Stock position of Measles vaccines,2. Stocks Received,3000,NA,4000,4000,NA,4100,3000,2000,NA,NA,NA,2500,22600
Bhojpur,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0,NA,0,0,NA,0,0,0,NA,NA,NA,0,0
Bhojpur,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,2550,NA,4500,3050,NA,3300,2850,2450,NA,NA,NA,3100,21800
Bhojpur,16.1.6,Stock position of Measles vaccines,5. Total Stock,2200,0,650,2900,0,1600,1750,1300,0,0,0,750,11150
Bhojpur,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,150,NA,1600,2300,NA,NA,1450,1700,NA,NA,NA,1400,8600
Bhojpur,16.1.7,Stock position of JE vaccines,2. Stocks Received,3000,NA,4000,4000,NA,NA,3000,2000,NA,NA,NA,2500,18500
Bhojpur,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0,NA,0,0,NA,NA,0,0,NA,NA,NA,0,0
Bhojpur,16.1.7,Stock position of JE vaccines,4. Stock Distributed,1950,NA,3200,1300,NA,NA,2750,2450,NA,NA,NA,2950,14600
Bhojpur,16.1.7,Stock position of JE vaccines,5. Total Stock,1200,0,2400,5000,0,0,1700,1250,0,0,0,950,12500
Bhojpur,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,3100,NA,3450,3600,NA,2750,2150,1850,NA,NA,NA,1000,17900
Bhojpur,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,1000,NA,1200,0,NA,0,0,0,NA,NA,NA,0,2200
Bhojpur,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0,NA,0,0,NA,0,0,0,NA,NA,NA,0,0
Bhojpur,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,700,NA,1300,550,NA,600,300,500,NA,NA,NA,350,4300
Bhojpur,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,3400,0,3350,3050,0,2150,1850,1350,0,0,0,650,15800
Bhojpur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,1850,1350,NA,50,NA,13900,12700,NA,2838,19305,NA,17305,69298
Bhojpur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0,0,NA,20600,NA,0,0,NA,142527,0,NA,0,163127
Bhojpur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0,0,NA,0,NA,0,0,NA,0,0,NA,0,0
Bhojpur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,500,1300,NA,6650,NA,1200,0,NA,18120,600,NA,200,28570
Bhojpur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,1350,50,0,14000,0,12700,12700,0,127245,18705,0,17105,203855
Bhojpur,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,34660,29620,NA,3920,NA,45416,29666,NA,19586,143993,NA,100833,407694
Bhojpur,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0,0,NA,221246,NA,0,0,NA,9721,0,NA,0,230967
Bhojpur,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0,0,NA,0,NA,0,0,NA,0,0,NA,0,0
Bhojpur,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,540,25700,NA,179250,NA,15750,0,NA,2768,23120,NA,0,247128
Bhojpur,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,34120,3920,0,45916,0,29666,29666,0,26539,120873,0,100833,391533
Bhojpur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,18300,13300,NA,0,NA,8048,5448,NA,2848,9801,NA,6212,63957
Bhojpur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0,0,NA,37448,NA,0,0,NA,8505,0,NA,0,45953
Bhojpur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0,0,NA,0,NA,0,0,NA,0,0,NA,0,0
Bhojpur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,5000,13300,NA,29100,NA,2600,0,NA,1300,2200,NA,0,53500
Bhojpur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,13300,0,0,8348,0,5448,5448,0,10053,7601,0,6212,56410
Bhojpur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,19980,19980,NA,0,NA,6138,4488,NA,2838,11904,NA,9004,74332
Bhojpur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0,0,NA,24288,NA,0,0,NA,10876,0,NA,0,35164
Bhojpur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0,0,NA,0,NA,0,0,NA,0,0,NA,0,0
Bhojpur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0,4080,NA,18150,NA,1650,0,NA,1810,1800,NA,0,27490
Bhojpur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,19980,15900,0,6138,0,4488,4488,0,11904,10104,0,9004,82006
Bhojpur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0
Bhojpur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0
Bhojpur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0
Bhojpur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0
Bhojpur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Bhojpur,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0,11000,8300,7800,NA,NA,NA,0,NA,2400,200,0,29700
Bhojpur,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,2100,0,0,0,NA,NA,NA,5000,NA,0,0,0,7100
Bhojpur,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0,0,0,0,NA,NA,NA,0,NA,0,0,0,0
Bhojpur,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,10000,2700,500,4000,NA,NA,NA,4100,NA,2200,0,0,23500
Bhojpur,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,-7900,8300,7800,3800,0,0,0,900,0,200,200,0,13300
Bhojpur,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,30190,14190,13690,13690,NA,NA,NA,0,NA,NA,NA,0,71760
Bhojpur,16.3.02,Stock Position of Gloves,2. Stocks Received,0,0,0,0,NA,NA,NA,0,NA,NA,NA,0,0
Bhojpur,16.3.02,Stock Position of Gloves,3. Unusable Stock,0,0,0,0,NA,NA,NA,0,NA,NA,NA,0,0
Bhojpur,16.3.02,Stock Position of Gloves,4. Stock Distributed,16000,500,0,5000,NA,NA,NA,0,NA,NA,NA,0,21500
Bhojpur,16.3.02,Stock Position of Gloves,5. Total Stock,14190,13690,13690,8690,0,0,0,0,0,0,0,0,50260
Bhojpur,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0,0,NA,0,NA,NA,NA,0,NA,NA,NA,0,0
Bhojpur,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0,0,NA,0,NA,NA,NA,0,NA,NA,NA,0,0
Bhojpur,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0,0,NA,0,NA,NA,NA,0,NA,NA,NA,0,0
Bhojpur,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0,0,NA,0,NA,NA,NA,0,NA,NA,NA,0,0
Bhojpur,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Bhojpur,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,45000,28000,27000,25500,NA,NA,NA,2000,NA,NA,NA,0,127500
Bhojpur,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0,0,0,0,NA,NA,NA,0,NA,NA,NA,0,0
Bhojpur,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0,0,0,0,NA,NA,NA,0,NA,NA,NA,0,0
Bhojpur,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,17000,1000,0,6000,NA,NA,NA,0,NA,NA,NA,0,24000
Bhojpur,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,28000,27000,27000,19500,0,0,0,2000,0,0,0,0,103500
Bhojpur,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0,0,NA,0,NA,NA,NA,0,NA,NA,NA,0,0
Bhojpur,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0,0,NA,0,NA,NA,NA,0,NA,NA,NA,0,0
Bhojpur,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0,0,NA,0,NA,NA,NA,0,NA,NA,NA,0,0
Bhojpur,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0,0,NA,0,NA,NA,NA,0,NA,NA,NA,0,0
Bhojpur,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Bhojpur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0,0,NA,0,NA,NA,NA,0,NA,NA,NA,0,0
Bhojpur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0,0,NA,0,NA,NA,NA,0,NA,NA,NA,0,0
Bhojpur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0,0,NA,0,NA,NA,NA,0,NA,NA,NA,0,0
Bhojpur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0,0,NA,0,NA,NA,NA,0,NA,NA,NA,0,0
Bhojpur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Bhojpur,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,4100000,90000,70000,24400,NA,NA,NA,0,NA,1600,NA,0,4286000
Bhojpur,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0,0,0,0,NA,NA,NA,0,NA,0,NA,0,0
Bhojpur,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0,0,0,0,NA,NA,NA,0,NA,0,NA,0,0
Bhojpur,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,320000,20000,16000,24400,NA,NA,NA,0,NA,1600,NA,0,382000
Bhojpur,16.3.07,Stock Position of IFA Tablets,5. Total Stock,3780000,70000,54000,0,0,0,0,0,0,0,0,0,3904000
Bhojpur,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0,0,NA,0,NA,NA,NA,0,NA,NA,NA,10000,10000
Bhojpur,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0,0,NA,0,NA,NA,NA,0,NA,NA,10000,0,10000
Bhojpur,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0,0,NA,0,NA,NA,NA,0,NA,NA,NA,0,0
Bhojpur,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0,0,NA,0,NA,NA,NA,0,NA,NA,NA,10000,10000
Bhojpur,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0,0,0,0,0,0,0,0,0,0,10000,0,10000
Bhojpur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0,5500,5000,5000,NA,NA,NA,0,NA,NA,NA,0,15500
Bhojpur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,8300,0,0,0,NA,NA,NA,0,NA,NA,100000,10000,118300
Bhojpur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0,0,0,0,NA,NA,NA,0,NA,NA,NA,0,0
Bhojpur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,2800,500,0,2500,NA,NA,NA,0,NA,NA,NA,1050,6850
Bhojpur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,5500,5000,5000,2500,0,0,0,0,0,0,100000,8950,126950
Bhojpur,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,2300,2300,2300,2300,NA,NA,NA,2100,NA,NA,NA,2100,13400
Bhojpur,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0,0,0,0,NA,NA,NA,0,NA,NA,NA,0,0
Bhojpur,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0,0,0,0,NA,NA,NA,0,NA,NA,NA,0,0
Bhojpur,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0,0,0,200,NA,NA,NA,0,NA,NA,NA,0,200
Bhojpur,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,2300,2300,2300,2100,0,0,0,2100,0,0,0,2100,13200
Bhojpur,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,177026,12026,10826,6626,NA,NA,NA,67480,NA,NA,NA,57480,331464
Bhojpur,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0,0,0,215663,NA,NA,NA,0,NA,NA,NA,0,215663
Bhojpur,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0,0,0,0,NA,NA,NA,0,NA,NA,NA,0,0
Bhojpur,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,165000,1200,4200,76600,NA,NA,NA,0,NA,NA,NA,5000,252000
Bhojpur,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,12026,10826,6626,145689,0,0,0,67480,0,0,0,52480,295127
Bhojpur,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,9200,NA,13200,6600,18200,13400,NA,NA,NA,NA,NA,0,60600
Bhojpur,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0,NA,0,18000,0,20000,NA,NA,NA,NA,NA,15000,53000
Bhojpur,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0,NA,0,0,0,0,NA,NA,NA,NA,NA,0,0
Bhojpur,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,5000,NA,6600,6400,4800,9000,NA,NA,NA,NA,NA,7800,39600
Bhojpur,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,4200,0,6600,18200,13400,24400,0,0,0,0,0,7200,74000
Bhojpur,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,62470,NA,88800,36000,178400,130400,NA,NA,NA,NA,NA,207000,703070
Bhojpur,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0,NA,0,200000,0,200000,NA,NA,NA,NA,NA,50000,450000
Bhojpur,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0,NA,0,0,0,0,NA,NA,NA,NA,NA,0,0
Bhojpur,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,34130,NA,52800,57600,48000,62400,NA,NA,NA,NA,NA,70000,324930
Bhojpur,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,28340,0,36000,178400,130400,268000,0,0,0,0,0,187000,828140
Bhojpur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,6228,NA,8000,3000,12500,8600,NA,NA,NA,NA,NA,1400,39728
Bhojpur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0,NA,0,15000,0,15000,NA,NA,NA,NA,NA,16000,46000
Bhojpur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0,NA,0,0,0,0,NA,NA,NA,NA,NA,0,0
Bhojpur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,3800,NA,5000,5500,3900,7000,NA,NA,NA,NA,NA,6300,31500
Bhojpur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,2428,0,3000,12500,8600,16600,0,0,0,0,0,11100,54228
Bhojpur,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,1,NA,2
Bhojpur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,4,NA,5
Bhojpur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,NA,NA,NA,NA,NA,NA,1,1,NA,NA,5,NA,7
Bhojpur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,2,NA,NA,1,5,NA,8
Bhojpur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,NA,2
Bhojpur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,NA,NA,NA,NA,NA,NA,2,NA,NA,1,7,NA,10
Bhojpur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,18,19
Bhojpur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,18,19
Bhojpur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,1,NA,2,1,NA,4
Bhojpur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,1
Bhojpur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,NA,NA,NA,NA,NA,NA,NA,1,NA,3,1,NA,5
Bhojpur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,2,NA,NA,NA,NA,2
Bhojpur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,NA,NA,NA,NA,NA,NA,NA,2,NA,NA,NA,NA,2
Bhojpur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,1
Bhojpur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,1
Bhojpur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1,NA,2
Bhojpur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1,NA,2
Bhojpur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,1
Bhojpur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,1
Bhojpur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,1
Bhojpur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,1
Bhojpur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,1
Bhojpur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,1
Bhojpur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,1
Bhojpur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Bhojpur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,1
Bhojpur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,2
Bhojpur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,NA,NA,3,NA,NA,NA,1,3,NA,NA,18,15,40
Bhojpur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,NA,NA,4,NA,NA,NA,NA,1,NA,NA,13,14,32
Bhojpur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,NA,NA,7,NA,NA,NA,1,4,NA,NA,31,31,74
Buxar,1.1,Total number of pregnant women Registered for ANC,TOTAL,3991,3899,4095,4070,3935,3399,3002,2689,2866,3085,3094,3432,41557
Buxar,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,2336,2186,2370,2438,2423,2138,1996,1799,1798,1830,1880,2013,25207
Buxar,1.2,Number of Pregnant women registered under JSY,TOTAL,3991,3899,4095,4070,3935,3399,3002,2690,2866,3085,3094,3432,41558
Buxar,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,2801,2872,3070,3366,3422,3345,2997,2846,2862,2486,2445,2603,35115
Buxar,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,2450,2451,2624,2625,2430,2056,1907,1662,1722,1783,1817,2092,25619
Buxar,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,3288,3800,3611,3824,3753,3567,3023,2444,2649,2631,2702,2965,38257
Buxar,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1030,1965,3524,3326,3300,3363,3007,2881,2218,1018,358,353,26343
Buxar,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,23,11,18,4,3,6,5,6,6,2,8,5,97
Buxar,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,12,0,2,1,1,1,0,1,0,1,2,2,23
Buxar,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,96,77,40,8,363,120,164,203,151,405,363,373,2363
Buxar,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,2,8,0,2,10,3,2,7,0,18,2,35,89
Buxar,1.8,Number of pregnancy test kits used at SC level,TOTAL,240,212,224,162,254,196,244,216,263,174,273,319,2777
Buxar,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,70,71,62,97,128,111,140,134,139,99,121,74,1246
Buxar,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,189,185,231,227,211,242,249,223,212,227,188,196,2580
Buxar,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,259,256,293,324,339,353,389,357,351,326,309,270,3826
Buxar,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,151,164,221,213,199,227,268,220,204,269,178,174,2488
Buxar,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Buxar,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1216,1282,1365,1815,2218,2287,2140,2154,1836,1762,1592,1543,21210
Buxar,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,975,1171,1238,1666,2066,2092,2134,2151,1830,1759,1581,1535,20198
Buxar,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1254,1275,1398,1750,1716,2161,1947,1612,1755,1691,2184,1513,20256
Buxar,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,887,1080,1127,1511,1396,2004,1847,1163,1922,1651,2073,1634,18295
Buxar,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Buxar,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,0,0,0,0,0,0,29,278,197,392,NA,NA,896
Buxar,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0,0,0,0,0,0,0,0,0,0,NA,NA,0
Buxar,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0,0,0,0,0,0,0,0,0,0,NA,NA,0
Buxar,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0,0,0,0,0,0,0,0,0,0,NA,NA,0
Buxar,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Buxar,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,7,5,4,9,5,6,9,7,6,4,13,7,82
Buxar,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,7,5,4,9,5,6,9,7,6,4,13,7,82
Buxar,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,0,0,0,0,0,0,0,0,0,0,NA,NA,0
Buxar,4.1.1.a,Number of male live births,TOTAL,716,785,878,1114,1342,1408,1353,1501,1245,1281,977,907,13507
Buxar,4.1.1.b,Number of female live births,TOTAL,696,736,741,1021,1206,1213,1176,1278,1166,1194,908,897,12232
Buxar,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1412,1521,1619,2135,2548,2621,2529,2779,2411,2475,1885,1804,25739
Buxar,4.1.2,Number of still births,TOTAL,28,21,15,18,25,34,26,28,27,18,26,15,281
Buxar,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,5,5,5,7,1,0,6,2,5,5,1,7,49
Buxar,4.2.1,Number of Newborns weighed at birth,TOTAL,1366,1453,1519,2025,2461,2525,2403,2440,2311,2380,1831,1768,24482
Buxar,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,73,113,133,180,216,267,289,342,208,175,169,138,2303
Buxar,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1392,1445,1545,2049,2485,2562,2457,2488,2338,2429,1849,1776,24815
Buxar,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,7,12,19
Buxar,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,7,5,4,9,5,6,9,7,5,4,13,7,81
Buxar,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,7,5,4,9,5,6,9,7,5,4,20,19,100
Buxar,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0,0,0,0,0,0,0,0,0,0,NA,NA,0
Buxar,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,7,5,4,9,5,6,9,7,1,1,2,5,61
Buxar,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0,0,0,0,0,0,0,0,0,0,2,0,2
Buxar,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,7,5,3,9,5,0,12,7,1,1,296,307,653
Buxar,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,4,1,1,2,1,4,3,1,2,1,4,4,28
Buxar,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,742,1250,1310,1755,1795,2038,1694,1583,1432,1450,1436,1468,17953
Buxar,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,714,838,892,929,1176,1361,1325,1246,1269,1243,1151,1004,13148
Buxar,6.3,PNC maternal complications attended,TOTAL,0,0,0,0,0,0,16,15,0,8,0,0,39
Buxar,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,2,4,4,7,0,1,0,1,3,3,2,3,30
Buxar,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Buxar,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,2,4,4,7,0,1,0,1,3,3,2,3,30
Buxar,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0,0,31,38,0,20,15,24,47,41,62,47,325
Buxar,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,45,37,51,41,63,71,53,59,70,103,39,48,680
Buxar,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,89,66,97,90,81,73,57,60,134,111,93,67,1018
Buxar,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,134,103,148,131,144,144,110,119,204,214,132,115,1698
Buxar,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Buxar,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0,0,0,5,2,2,1,7,4,0,1,0,22
Buxar,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0,0,0,0,1,1,0,1,1,0,1,1,6
Buxar,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0,0,0,5,3,3,1,8,5,0,2,1,28
Buxar,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0,0,NA,NA,0,0,0,0,0,0,0,NA,0
Buxar,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Buxar,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Buxar,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Buxar,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0,0,NA,NA,0,0,0,0,0,0,0,NA,0
Buxar,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,90,52,41,419,162,442,461,354,636,587,737,411,4392
Buxar,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,38,10,5,66,29,60,80,119,171,154,158,123,1013
Buxar,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,128,62,46,485,191,502,541,473,807,741,895,534,5405
Buxar,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,0,0,48,40,38,67,71,78,128,117,138,74,799
Buxar,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,22,6,3,11,0,3,22,20,25,18,28,17,175
Buxar,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,10,2,1,11,12,12,15,8,3,15,14,19,122
Buxar,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,32,8,4,22,12,15,37,28,28,33,42,36,297
Buxar,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0,0,NA,NA,0,0,0,0,0,0,0,NA,0
Buxar,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,248,284,285,387,337,349,322,310,391,299,263,290,3765
Buxar,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,79,84,73,441,109,143,163,193,263,126,139,178,1991
Buxar,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,20,6,5,108,14,64,51,37,20,94,49,36,504
Buxar,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,347,374,363,936,460,556,536,540,674,519,451,504,6260
Buxar,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,64,88,101,205,196,131,151,158,156,137,118,132,1637
Buxar,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,0,0,14,22,10,10,13,17,16,16,34,24,176
Buxar,9.06,Number of IUCD removals,TOTAL,129,135,151,137,180,174,163,168,183,149,127,137,1833
Buxar,9.07,Number of Oral Pills cycles distributed,TOTAL,1055,1079,808,1034,1206,1100,944,961,1025,805,793,677,11487
Buxar,9.08,Number of Condom pieces distributed,TOTAL,4031,3649,4715,4254,5328,6426,5974,5985,5860,5896,3749,4292,60159
Buxar,9.09,Number of Centchroman (weekly) pills given,TOTAL,0,0,0,0,0,0,0,0,0,23,6,0,29
Buxar,9.1,Number of Emergency Contraceptive Pills distributed,TOTAL,259,268,137,258,284,332,321,286,330,300,170,197,3142
Buxar,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Buxar,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Buxar,9.11.2.a,Number of failures following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Buxar,9.11.2.b,Number of failures following female sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Buxar,9.11.3.a,Number of deaths following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Buxar,9.11.3.b,Number of deaths following female sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Buxar,9.12,Number of Institutions having NSV trained doctors,TOTAL,1,NA,4,4,4,4,5,5,6,5,8,6,Data for this item can not be cumulated
Buxar,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,2224,2278,2465,3196,3664,4145,3739,3803,3783,3326,3089,2845,38557
Buxar,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,57,4,13,8,4,2,0,2,0,0,0,0,90
Buxar,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,475,277,170,137,115,59,21,16,25,9,5,3,1312
Buxar,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,1419,788,471,369,253,129,105,60,53,25,8,7,3687
Buxar,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,3027,2614,2610,2665,2915,3276,3670,3925,3945,4062,3397,3449,39555
Buxar,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,3005,2992,2586,2644,2652,2910,2914,3125,3751,4063,3360,3813,37815
Buxar,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,2290,2592,2757,2623,2740,2744,2598,2519,3009,3482,3433,3807,34594
Buxar,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1404,1458,1584,2063,2548,2575,2474,2515,2311,2031,1846,1612,24421
Buxar,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,3086,2503,2513,2613,2831,3207,3719,3732,3988,3965,3327,3478,38962
Buxar,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,3542,3241,2679,2767,2641,2843,2974,2998,3727,4041,3363,3810,38626
Buxar,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,3533,3443,3142,3010,2889,2777,2665,2494,3134,3433,3436,3821,37777
Buxar,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,1137,1218,1308,1689,2082,2115,1858,1957,1659,1638,1530,1386,19577
Buxar,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,61,8,6,20,3,1,1,0,11,0,0,0,111
Buxar,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,496,300,171,161,100,67,27,21,25,7,0,0,1375
Buxar,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,1452,804,474,373,267,140,131,48,54,17,2,6,3768
Buxar,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,2606,2818,3311,3862,4191,3823,3644,3099,2878,2698,2242,2545,37717
Buxar,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,2821,2535,2634,2773,2889,2854,2503,2257,2705,2970,3001,3292,33234
Buxar,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,2663,2908,3073,3456,3709,3419,3435,2619,2598,2627,2127,2387,35021
Buxar,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1370,1453,1774,1966,2184,1987,1891,1655,1485,1406,1158,1322,19651
Buxar,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1226,1296,1564,1824,1869,1795,1688,1414,1331,1228,1000,1175,17410
Buxar,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,2596,2749,3338,3790,4053,3782,3579,3069,2816,2634,2158,2497,37061
Buxar,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,3141,2713,2826,2856,2826,2799,2461,2201,2744,3030,2978,3093,33668
Buxar,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,3126,2639,2795,2866,2739,2714,2478,2151,2755,3036,2986,3244,33529
Buxar,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0,0,0,0,0,0,9,16,0,0,0,29,54
Buxar,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,616,542,813,868,643,614,529,594,571,342,469,396,6997
Buxar,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,498,489,690,724,561,530,457,471,499,295,383,344,5941
Buxar,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,1114,1031,1503,1592,1204,1144,986,1065,1070,637,852,740,12938
Buxar,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,223,236,289,314,110,471,665,596,855,1317,1114,976,7166
Buxar,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,632,579,757,879,683,902,876,783,763,830,846,871,9401
Buxar,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1287,1197,1304,1675,1334,1460,1496,1448,1213,1452,1360,1417,16643
Buxar,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0,4,0,0,0,0,0,0,1,0,0,0,5
Buxar,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Buxar,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,7,4,2,6,7,5,0,0,2,6,0,7,46
Buxar,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1959,1920,1954,2097,1978,2021,1922,1857,1961,1898,1846,1948,23361
Buxar,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1936,1911,1916,2079,1967,1983,1869,1783,1922,1872,1737,1898,22873
Buxar,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1644,1565,1662,1795,1733,1747,1652,1575,1723,1682,1579,1715,20072
Buxar,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,2651,2727,2584,2632,2686,2607,2380,2015,2348,2974,2788,3184,31576
Buxar,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,491,464,543,416,83,85,39,30,22,50,19,27,2269
Buxar,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,110,107,61,46,18,31,17,13,0,0,0,6,409
Buxar,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,5,11,32,8,8,17,15,0,0,0,0,0,96
Buxar,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Buxar,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Buxar,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Buxar,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Buxar,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Buxar,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,1,0,3,0,4
Buxar,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,595,668,595,1287,1079,860,980,736,731,289,457,499,8776
Buxar,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Buxar,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Buxar,13.1,Number of Patients operated for cataract,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Buxar,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Buxar,13.3,Number of School children detected with Refractive errors,TOTAL,0,6,9,5,1,4,2,5,5,6,0,0,43
Buxar,13.4,Number of children provided free glasses,TOTAL,0,6,9,5,1,4,2,5,5,6,9,6,58
Buxar,13.5,Number of eyes collected through eye donation,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Buxar,13.6,Number of eyes utilised for corneal transplant,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Buxar,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,1,NA,NA,1,1,1,2,2,2,2,2,2,Data for this item can not be cumulated
Buxar,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,NA,NA,1,2,4,4,5,11,10,9,9,9,Data for this item can not be cumulated
Buxar,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,1110,979,966,1081,1039,1112,1067,1062,1072,1060,1060,1066,Data for this item can not be cumulated
Buxar,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,1,NA,NA,1,1,2,2,2,2,2,2,2,Data for this item can not be cumulated
Buxar,14.05,Number of RKS meetings held during the month,TOTAL,10,12,13,13,12,12,12,13,11,11,10,10,139
Buxar,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,1,NA,2,3,8,9,9,10,11,11,12,11,Data for this item can not be cumulated
Buxar,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,385,487,359,627,702,952,794,787,875,827,717,930,8442
Buxar,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,1,NA,NA,1,1,1,2,2,2,2,2,2,Data for this item can not be cumulated
Buxar,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,0,NA,NA,1,1,0,0,0,0,0,0,0,Data for this item can not be cumulated
Buxar,14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,117,328,455,243,322,421,338,326,289,141,151,172,3303
Buxar,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,475,676,554,505,760,622,778,708,750,228,263,365,6684
Buxar,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,209,321,289,236,248,288,273,369,409,117,128,123,3010
Buxar,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,1480,1710,1774,2312,2676,2740,2530,2671,2165,2413,2510,2329,27310
Buxar,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,326,649,744,479,570,709,611,695,698,258,279,295,6313
Buxar,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,1955,2386,2328,2817,3436,3362,3308,3379,2915,2641,2773,2694,33994
Buxar,14.10.2.a,Number of death cases of Inpatient males,TOTAL,6,14,12,7,6,7,7,5,5,4,3,3,79
Buxar,14.10.2.b,Number of death cases of Inpatient females,TOTAL,5,6,8,7,4,6,7,2,5,8,4,9,71
Buxar,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,11,20,20,14,10,13,14,7,10,12,7,12,150
Buxar,14.11,In-Patient Head Count at midnight,TOTAL,3749,3857,3879,4338,4986,4942,4543,4274,3936,3879,4124,4008,50515
Buxar,14.12.1,OPD attendance (All),TOTAL,86176,81215,78064,92455,95525,94100,82697,75065,89765,77192,77627,81059,1010940
Buxar,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,145,91,68,588,251,425,612,526,903,768,973,559,5909
Buxar,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Buxar,14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,1498,1376,1246,1759,1828,1632,1683,1399,1884,1445,2130,2003,19883
Buxar,14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,14.14.a,Number of patients given AYUSH treatment,TOTAL,24476,22533,21357,22211,22757,22172,20087,19874,21992,20235,19198,17094,253986
Buxar,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,1010,938,993,815,701,913,818,754,798,671,947,900,10258
Buxar,14.14.c,Number of Adolescents counselled,TOTAL,0,21,29,28,50,43,26,34,23,0,0,0,254
Buxar,15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,694,977,986,963,812,923,653,759,745,771,921,1084,10288
Buxar,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,8,21,13,18,291,20,11,13,11,25,13,40,484
Buxar,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,325,156,243,289,216,218,169,157,164,352,255,208,2752
Buxar,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,1,3,7,2,3,7,4,3,4,2,4,8,48
Buxar,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,225,112,197,242,154,215,106,115,313,270,301,276,2526
Buxar,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,2,0,5,6,5,3,1,1,0,1,0,6,30
Buxar,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,380,239,333,388,365,346,238,247,306,453,480,324,4099
Buxar,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0,0,0,0,0,1,0,0,3,1,0,1,6
Buxar,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,930,507,773,919,735,779,513,519,783,1075,1036,808,9377
Buxar,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,3,3,12,8,8,11,5,4,7,4,4,15,84
Buxar,15.2,Number of Widal tests conducted,Number tested,0,0,0,0,0,0,0,0,0,0,640,543,1183
Buxar,15.3.a,Number of VDRL tests conducted on males,Number tested,0,0,0,0,0,0,0,0,0,0,0,0,0
Buxar,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,0,0,0,0,0,0,0,0,0,0,0,0,0
Buxar,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,0,0,0,0,0,0,0,0,0,0,0,0,0
Buxar,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,0,0,0,0,0,0,0,0,0,0,0,0,0
Buxar,15.4.1,Number of blood smears examined for Malaria,TOTAL,6,2,4,7,0,0,0,0,0,0,0,1,20
Buxar,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,0,0,1,0,0,0,0,0,0,0,0,0,1
Buxar,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Buxar,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,0,0,0,1900,1650,1200,950,900,850,550,NA,NA,8000
Buxar,16.1.1,Stock position of DPT vaccines,2. Stocks Received,0,0,0,0,0,0,250,350,0,0,NA,NA,600
Buxar,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0,0,0,0,0,0,NA,0,0,0,NA,NA,0
Buxar,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,0,0,0,250,450,250,300,400,300,200,NA,NA,2150
Buxar,16.1.1,Stock position of DPT vaccines,5. Total Stock,0,0,0,1650,1200,950,900,850,550,350,0,0,6450
Buxar,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,0,0,0,3146,4128,3004,2580,2908,3238,1820,NA,NA,20824
Buxar,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,0,0,0,1728,0,0,1152,1152,0,1152,NA,NA,5184
Buxar,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0,0,0,0,0,0,NA,0,0,0,NA,NA,0
Buxar,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,0,0,0,746,1474,424,824,822,1418,528,NA,NA,6236
Buxar,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0,0,0,4128,2654,2580,2908,3238,1820,2444,0,0,19772
Buxar,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,0,0,0,1100,725,800,1350,1300,1823,625,NA,NA,7723
Buxar,16.1.2,Stock position of OPV vaccines,2. Stocks Received,0,0,0,1100,1400,1400,1100,1523,500,2000,NA,NA,9023
Buxar,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0,0,0,0,0,0,NA,0,0,0,NA,NA,0
Buxar,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,0,0,0,1475,1325,850,1150,1000,1698,725,NA,NA,8223
Buxar,16.1.2,Stock position of OPV vaccines,5. Total Stock,0,0,0,725,800,1350,1300,1823,625,1900,0,0,8523
Buxar,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,0,0,0,1300,2900,3350,4750,4500,4809,3300,NA,NA,24909
Buxar,16.1.3,Stock position of TT vaccines,2. Stocks Received,0,0,0,2000,2000,2000,0,1159,0,500,NA,NA,7659
Buxar,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0,0,0,0,0,0,NA,0,0,0,NA,NA,0
Buxar,16.1.3,Stock position of TT vaccines,4. Stock Distributed,0,0,0,400,1550,600,750,850,1509,750,NA,NA,6409
Buxar,16.1.3,Stock position of TT vaccines,5. Total Stock,0,0,0,2900,3350,4750,4000,4809,3300,3050,0,0,26159
Buxar,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Buxar,16.1.4,Stock position of DT vaccines,2. Stocks Received,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Buxar,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Buxar,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Buxar,16.1.4,Stock position of DT vaccines,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Buxar,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,0,0,0,750,950,1050,1300,1450,1400,800,NA,NA,7700
Buxar,16.1.5,Stock position of BCG vaccines,2. Stocks Received,0,0,0,1100,1050,1100,1000,1000,600,2000,NA,NA,7850
Buxar,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0,0,0,0,0,0,NA,0,0,0,NA,NA,0
Buxar,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,0,0,0,900,950,850,850,1050,1200,800,NA,NA,6600
Buxar,16.1.5,Stock position of BCG vaccines,5. Total Stock,0,0,0,950,1050,1300,1450,1400,800,2000,0,0,8950
Buxar,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,0,0,0,650,1350,1550,2650,1900,2300,2170,NA,NA,12570
Buxar,16.1.6,Stock position of Measles vaccines,2. Stocks Received,0,0,0,2600,2600,2600,1000,2000,2020,1000,NA,NA,13820
Buxar,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0,0,0,0,0,0,NA,0,0,0,NA,NA,0
Buxar,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,0,0,0,1900,2400,1500,1650,1600,2150,1670,NA,NA,12870
Buxar,16.1.6,Stock position of Measles vaccines,5. Total Stock,0,0,0,1350,1550,2650,2000,2300,2170,1500,0,0,13520
Buxar,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0,0,0,1300,1900,2100,3700,1700,2300,2200,NA,NA,15200
Buxar,16.1.7,Stock position of JE vaccines,2. Stocks Received,0,0,0,2600,2000,2620,0,2000,2000,1000,NA,NA,12220
Buxar,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0,0,0,0,0,0,NA,0,0,0,NA,NA,0
Buxar,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0,0,0,2000,1800,1220,2000,1400,2100,1700,NA,NA,12220
Buxar,16.1.7,Stock position of JE vaccines,5. Total Stock,0,0,0,1900,2100,3500,1700,2300,2200,1500,0,0,15200
Buxar,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,0,0,0,1050,550,300,100,500,850,550,NA,NA,3900
Buxar,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0,0,0,0,0,0,500,500,0,0,NA,NA,1000
Buxar,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,NA,0,0,0,0,0,NA,0,0,0,NA,NA,0
Buxar,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,NA,0,0,500,250,200,100,150,372,200,NA,NA,1772
Buxar,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0,0,0,550,300,100,500,850,478,350,0,0,3128
Buxar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,0,0,0,0,0,0,0,0,0,0,NA,NA,0
Buxar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0,0,0,0,0,0,0,0,0,0,NA,NA,0
Buxar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,NA,NA,0
Buxar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,0,0,0,0,0,0,0,0,0,0,NA,NA,0
Buxar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Buxar,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,0,0,0,0,0,0,0,0,0,0,NA,NA,0
Buxar,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0,0,0,0,0,0,0,0,0,0,NA,NA,0
Buxar,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,NA,NA,0
Buxar,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,0,0,0,0,0,0,0,0,0,0,NA,NA,0
Buxar,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Buxar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0,0,0,0,0,0,0,0,0,0,NA,NA,0
Buxar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0,0,0,0,0,0,0,0,0,0,NA,NA,0
Buxar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,NA,NA,0
Buxar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0,0,0,0,0,0,0,0,0,0,NA,NA,0
Buxar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Buxar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0,0,0,0,0,0,0,0,0,0,NA,NA,0
Buxar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0,0,0,0,0,0,0,0,0,0,NA,NA,0
Buxar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,NA,NA,0
Buxar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0,0,0,0,0,0,0,0,0,0,NA,NA,0
Buxar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Buxar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,0,0,0,0,0,0,0,0,0,0,NA,NA,0
Buxar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0,0,0,0,0,0,0,0,0,0,NA,NA,0
Buxar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,NA,NA,0
Buxar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0,0,0,0,0,0,0,0,0,0,NA,NA,0
Buxar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Buxar,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0,0,0,0,0,0,0,0,0,0,NA,NA,0
Buxar,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0,0,0,0,0,0,0,0,0,0,NA,NA,0
Buxar,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,NA,NA,0
Buxar,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0,0,0,0,0,0,0,0,0,0,NA,NA,0
Buxar,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Buxar,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0,0,0,0,0,0,0,0,0,0,NA,NA,0
Buxar,16.3.02,Stock Position of Gloves,2. Stocks Received,0,0,0,0,0,0,0,0,0,0,NA,NA,0
Buxar,16.3.02,Stock Position of Gloves,3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,NA,NA,0
Buxar,16.3.02,Stock Position of Gloves,4. Stock Distributed,0,0,0,0,0,0,0,0,0,0,NA,NA,0
Buxar,16.3.02,Stock Position of Gloves,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Buxar,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0,0,0,0,0,0,0,0,0,0,NA,NA,0
Buxar,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0,0,0,0,0,0,0,0,0,0,NA,NA,0
Buxar,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,NA,NA,0
Buxar,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0,0,0,0,0,0,0,0,0,0,NA,NA,0
Buxar,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Buxar,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0,0,0,0,0,0,0,0,0,0,NA,NA,0
Buxar,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0,0,0,0,0,0,0,0,0,0,NA,NA,0
Buxar,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,NA,NA,0
Buxar,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0,0,0,0,0,0,0,0,0,0,NA,NA,0
Buxar,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Buxar,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0,0,0,0,0,0,0,0,0,0,NA,NA,0
Buxar,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0,0,0,0,0,0,0,0,0,0,NA,NA,0
Buxar,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,NA,NA,0
Buxar,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0,0,0,0,0,0,0,0,0,0,NA,NA,0
Buxar,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Buxar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0,0,0,0,0,0,0,0,0,0,NA,NA,0
Buxar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0,0,0,0,0,0,0,0,0,0,NA,NA,0
Buxar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,NA,NA,0
Buxar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0,0,0,0,0,0,0,0,0,0,NA,NA,0
Buxar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Buxar,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,0,0,0,0,0,0,0,0,0,0,NA,NA,0
Buxar,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0,0,0,0,0,0,0,0,0,0,NA,NA,0
Buxar,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,NA,NA,0
Buxar,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0,0,0,0,0,0,0,0,0,0,NA,NA,0
Buxar,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Buxar,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0,0,0,0,0,0,0,0,0,0,NA,NA,0
Buxar,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0,0,0,0,0,0,0,0,0,0,NA,NA,0
Buxar,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,NA,NA,0
Buxar,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0,0,0,0,0,0,0,0,0,0,NA,NA,0
Buxar,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Buxar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0,0,0,0,0,0,0,0,0,0,NA,NA,0
Buxar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0,0,0,0,0,0,0,0,0,0,NA,NA,0
Buxar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,NA,NA,0
Buxar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0,0,0,0,0,0,0,0,0,0,NA,NA,0
Buxar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Buxar,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,0,0,0,0,0,0,0,0,0,0,NA,NA,0
Buxar,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0,0,0,0,0,0,0,0,0,0,NA,NA,0
Buxar,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,NA,NA,0
Buxar,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0,0,0,0,0,0,0,0,0,0,NA,NA,0
Buxar,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Buxar,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,0,0,0,0,0,0,0,0,0,0,NA,NA,0
Buxar,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0,0,0,0,0,0,0,0,0,0,NA,NA,0
Buxar,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,NA,NA,0
Buxar,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,0,0,0,0,0,0,0,0,0,0,NA,NA,0
Buxar,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Buxar,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,0,0,0,0,4600,9800,15700,21300,16400,13900,NA,NA,81700
Buxar,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0,0,0,10000,10000,10000,10000,0,5000,0,NA,NA,45000
Buxar,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,NA,NA,0
Buxar,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,0,0,0,5400,4800,4100,4400,4900,7300,4600,NA,NA,35500
Buxar,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0,0,0,4600,9800,15700,21300,16400,14100,9300,0,0,91200
Buxar,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,0,0,0,15600,77800,77000,99200,89200,47400,40200,NA,NA,446400
Buxar,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0,0,0,100000,50000,50000,30000,0,50000,0,NA,NA,280000
Buxar,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,NA,NA,0
Buxar,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,0,0,0,37800,50800,27800,40000,41800,57200,25600,NA,NA,281000
Buxar,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0,0,0,77800,77000,99200,89200,47400,40200,14600,0,0,445400
Buxar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,0,0,0,1200,6300,9200,15300,17600,13800,12600,NA,NA,76000
Buxar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0,0,0,10000,8000,10000,7000,0,5000,0,NA,NA,40000
Buxar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,NA,NA,0
Buxar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,0,0,0,4900,5100,3900,4700,3800,6200,4300,NA,NA,32900
Buxar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0,0,0,6300,9200,15300,17600,13800,12600,8300,0,0,83100
Buxar,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,2,NA,NA,NA,NA,2
Buxar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,NA,NA,NA,NA,NA,NA,NA,2,NA,NA,NA,NA,2
Buxar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,1
Buxar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,1
Buxar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,1
Buxar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,1
Buxar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,1
Buxar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,1
Buxar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,1
Buxar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,1
Buxar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1,1,3
Buxar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1,1,3
Buxar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,1,1,3
Buxar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,1,1,3
Buxar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Buxar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,NA,NA,NA,1,NA,NA,NA,NA,1,1,NA,1,4
Buxar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,1,1,NA,NA,NA,2
Buxar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,NA,NA,NA,1,NA,NA,NA,1,2,1,NA,1,6
Darbhanga,1.1,Total number of pregnant women Registered for ANC,TOTAL,9316,9824,8636,9508,9428,8079,7850,6593,7255,7278,7763,8414,99944
Darbhanga,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,3982,4491,4242,4328,4039,3588,3335,3037,3591,3831,4042,4315,46821
Darbhanga,1.2,Number of Pregnant women registered under JSY,TOTAL,9262,9810,8605,9488,9402,8040,7844,6576,7223,7278,7752,8414,99694
Darbhanga,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,5046,5456,5374,5721,5948,5789,5715,5030,5288,5202,4966,5190,64725
Darbhanga,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,6776,7052,6433,6733,6328,5707,5526,4611,5105,5268,5746,5881,71166
Darbhanga,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,8020,9155,8137,8428,8494,7963,7404,6067,6280,6413,5997,6968,89326
Darbhanga,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,4917,3737,3312,2824,1654,1268,1224,829,706,693,550,538,22252
Darbhanga,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,72,73,28,52,68,19,99,41,52,60,57,87,708
Darbhanga,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,4,1,1,0,0,1,0,0,3,0,0,0,10
Darbhanga,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,500,445,285,400,457,450,340,242,266,295,251,248,4179
Darbhanga,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,9,6,4,5,7,6,4,2,3,4,0,2,52
Darbhanga,1.8,Number of pregnancy test kits used at SC level,TOTAL,175,112,96,171,54,37,100,65,106,155,219,215,1505
Darbhanga,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,563,523,570,625,646,672,685,725,783,640,663,507,7602
Darbhanga,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,1561,1453,1567,1579,1832,1889,1941,1966,1954,1981,1820,1782,21325
Darbhanga,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,2124,1976,2137,2204,2478,2561,2626,2691,2737,2621,2483,2289,28927
Darbhanga,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,1436,1463,1293,1611,1605,1729,1787,1777,1951,1874,1809,1617,19952
Darbhanga,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0,18,4,6,1,0,0,14,25,0,1,1,70
Darbhanga,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,2546,2631,2973,4297,4896,4731,4912,4906,4746,4385,3894,3363,48280
Darbhanga,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,1990,2463,2824,3787,4594,4350,4780,4548,4326,4204,3732,3231,44829
Darbhanga,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1324,1313,2112,1424,1196,1489,1958,1563,1330,3298,3756,5591,26354
Darbhanga,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,689,616,958,654,122,471,985,823,571,646,992,6074,13601
Darbhanga,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Darbhanga,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,0,0,0,0,857,1031,1456,1546,1234,1100,998,940,9162
Darbhanga,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0,0,0,0,0,0,0,0,0,NA,NA,NA,0
Darbhanga,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0,0,0,0,0,0,0,0,0,NA,NA,NA,0
Darbhanga,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0,0,0,0,0,0,0,0,0,NA,NA,NA,0
Darbhanga,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Darbhanga,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Darbhanga,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,116,119,132,185,229,212,145,220,240,165,171,162,2096
Darbhanga,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,116,119,132,185,229,212,145,220,240,165,171,162,2096
Darbhanga,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,0,0,0,0,154,130,238,325,311,285,310,287,2040
Darbhanga,4.1.1.a,Number of male live births,TOTAL,2470,2408,2697,3426,4266,3724,3970,4628,4460,4274,3843,3461,43627
Darbhanga,4.1.1.b,Number of female live births,TOTAL,2287,2165,2412,3113,3948,3532,3590,4428,4227,3814,3488,3063,40067
Darbhanga,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,4757,4573,5109,6539,8214,7256,7560,9056,8687,8088,7331,6524,83694
Darbhanga,4.1.2,Number of still births,TOTAL,54,52,61,93,87,87,64,148,88,102,101,107,1044
Darbhanga,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,85,30,20,40,28,30,23,23,27,23,20,16,365
Darbhanga,4.2.1,Number of Newborns weighed at birth,TOTAL,4270,3879,4569,6126,7633,6891,7032,7106,8314,7723,6946,6256,76745
Darbhanga,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,151,217,231,345,510,402,432,556,690,624,462,371,4991
Darbhanga,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,4557,4094,4491,6379,8114,7209,7409,7495,8623,7932,7039,6496,79838
Darbhanga,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,20,22,18,12,12,13,15,18,3,3,11,11,158
Darbhanga,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0,0,3,0,0,0,0,0,0,0,0,11,14
Darbhanga,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,0,0,0,0,0,0,0,0,0,0,55,48,103
Darbhanga,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,20,22,21,12,12,13,15,18,3,3,66,70,275
Darbhanga,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0,0,0,0,0,0,0,0,0,NA,NA,NA,0
Darbhanga,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,6,8,8,4,8,4,6,7,0,3,52,53,159
Darbhanga,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0,0,0,0,0,0,0,0,3,0,4,5,12
Darbhanga,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,10,14,10,5,112,9,9,0,0,3,52,60,284
Darbhanga,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Darbhanga,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1761,1718,1937,2127,2688,2545,2560,2642,2791,3004,2707,2487,28967
Darbhanga,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1772,1636,1467,1934,1767,2191,2163,2350,2358,2411,2199,2002,24250
Darbhanga,6.3,PNC maternal complications attended,TOTAL,5,0,17,0,9,27,12,0,0,12,10,5,97
Darbhanga,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,5,0,0,10,5,12,17,8,6,8,27,8,106
Darbhanga,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0,0,0,2,7,6,8,9,5,7,19,4,67
Darbhanga,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,5,0,0,12,12,18,25,17,11,15,46,12,173
Darbhanga,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0,0,0,0,2,0,0,0,0,0,0,0,2
Darbhanga,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,65,43,59,36,67,65,53,52,57,90,4,0,591
Darbhanga,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,78,75,71,46,76,75,65,60,75,120,7,0,748
Darbhanga,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,143,118,130,82,143,140,118,112,132,210,11,0,1339
Darbhanga,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Darbhanga,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0,1,0,1,0,0,0,1,0,3,2,1,9
Darbhanga,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0,0,0,1,0,0,0,0,0,0,1,0,2
Darbhanga,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0,0,0,0,1,0,0,0,0,0,0,0,1
Darbhanga,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0,1,0,2,1,0,0,1,0,3,3,1,12
Darbhanga,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0,0,0,0,0,0,0,0,0,0,NA,NA,0
Darbhanga,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Darbhanga,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Darbhanga,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Darbhanga,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Darbhanga,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0,0,0,0,0,0,0,0,0,0,NA,NA,0
Darbhanga,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,114,112,84,725,292,556,529,423,2739,1913,1504,635,9626
Darbhanga,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,22,13,16,70,27,58,37,38,220,231,108,36,876
Darbhanga,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,52,46,61,68,101,78,171,139,92,140,102,90,1140
Darbhanga,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,188,171,161,863,420,692,737,600,3051,2284,1714,761,11642
Darbhanga,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,65,45,0,75,94,81,97,146,403,1692,1410,5340,9448
Darbhanga,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,4,0,0,1,0,0,0,0,0,0,7,2,14
Darbhanga,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Darbhanga,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0,0,0,0,0,0,1,0,0,0,0,0,1
Darbhanga,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,4,0,0,1,0,0,1,0,0,0,7,2,15
Darbhanga,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0,0,0,0,0,0,0,0,0,NA,NA,NA,0
Darbhanga,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,616,568,621,1051,825,724,737,699,610,670,632,567,8320
Darbhanga,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,410,526,430,533,337,447,451,353,562,535,404,404,5392
Darbhanga,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,42,39,31,90,33,63,73,74,103,89,74,44,755
Darbhanga,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,4,12,5,6,8,69,60,71,36,36,58,43,408
Darbhanga,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,1072,1145,1087,1680,1203,1303,1321,1197,1311,1330,1168,1058,14875
Darbhanga,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,55,47,68,205,41,160,152,108,114,135,150,146,1381
Darbhanga,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,NA,NA,0,0,0,0,0,0,0,NA,NA,NA,0
Darbhanga,9.06,Number of IUCD removals,TOTAL,318,370,306,314,251,224,252,272,258,360,266,236,3427
Darbhanga,9.07,Number of Oral Pills cycles distributed,TOTAL,2972,3281,3099,4394,2650,2748,2868,2685,2682,2770,5137,2395,37681
Darbhanga,9.08,Number of Condom pieces distributed,TOTAL,16908,17675,17886,17926,15107,16795,15496,14771,16193,17083,13997,14865,194702
Darbhanga,9.09,Number of Centchroman (weekly) pills given,TOTAL,483,178,253,78,50,203,100,69,62,73,112,73,1734
Darbhanga,9.1,Number of Emergency Contraceptive Pills distributed,TOTAL,71,5,314,66,73,62,161,189,86,148,216,303,1694
Darbhanga,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Darbhanga,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Darbhanga,9.11.2.a,Number of failures following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Darbhanga,9.11.2.b,Number of failures following female sterilization,TOTAL,1,0,0,0,0,0,0,0,0,0,0,0,1
Darbhanga,9.11.3.a,Number of deaths following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Darbhanga,9.11.3.b,Number of deaths following female sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Darbhanga,9.12,Number of Institutions having NSV trained doctors,TOTAL,NA,NA,4,4,7,5,7,8,8,7,9,6,Data for this item can not be cumulated
Darbhanga,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,7073,6771,6441,7707,9845,9456,10413,9992,10576,10077,10306,10031,108688
Darbhanga,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,110,63,86,14,3,10,7,17,49,2,4,5,370
Darbhanga,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,1902,1158,422,315,163,104,85,85,98,106,101,718,5257
Darbhanga,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,4409,2866,1275,822,445,322,260,162,161,84,37,805,11648
Darbhanga,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,8861,7312,5819,6447,6940,7543,9138,8821,10128,9981,10104,10415,101509
Darbhanga,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,8662,8794,6816,6562,6351,6537,7167,7375,8499,9447,9298,10661,96169
Darbhanga,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,6509,7872,7447,7156,6396,6160,6360,6316,7042,7953,8419,9953,87583
Darbhanga,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,2785,2814,2792,4440,8467,4822,5083,5140,4695,5062,4378,4023,54501
Darbhanga,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,9283,7528,5939,6564,7089,7436,9022,8772,9939,10050,10195,10536,102353
Darbhanga,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,10212,9464,7109,6783,6475,6636,7233,7346,8474,9383,9313,10754,99182
Darbhanga,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,10181,10144,8452,7653,6773,6294,6434,6351,6921,7971,8454,9537,95165
Darbhanga,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,1566,1774,1602,3004,3841,3251,3560,3413,3186,3275,2945,2763,34180
Darbhanga,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,200,143,71,57,22,2,49,2,4,1,1,24,576
Darbhanga,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,1977,1259,473,292,124,88,78,27,31,27,68,606,5050
Darbhanga,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,4394,2926,1312,793,438,267,235,68,172,58,32,794,11489
Darbhanga,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,7816,8809,8025,8935,8877,8764,9296,7523,8065,7276,7105,7414,97905
Darbhanga,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,8422,7216,5725,6660,6383,6056,5979,5159,6496,6734,7893,7877,80600
Darbhanga,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,7638,7845,7110,8902,8558,8645,9047,7004,7804,6971,6994,7119,93637
Darbhanga,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,3967,4619,4176,4664,4617,4606,4767,3933,4107,3745,3670,3799,50670
Darbhanga,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,3621,4148,3833,4205,4212,4088,4433,3576,3805,3286,3252,3343,45802
Darbhanga,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,7588,8767,8009,8869,8829,8694,9200,7509,7912,7031,6922,7142,96472
Darbhanga,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,8685,7943,6451,7149,6472,5949,5845,5054,6240,6566,7871,8080,82305
Darbhanga,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,8734,7954,6436,7171,6475,5920,5865,5039,6244,6571,7849,8048,82306
Darbhanga,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Darbhanga,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1744,1442,1373,1612,1234,1195,1225,1032,1202,1305,1652,1427,16443
Darbhanga,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1642,1330,1283,1460,1131,1147,1137,859,988,1172,1513,1336,14998
Darbhanga,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,3386,2772,2656,3072,2365,2342,2362,1891,2190,2477,3165,2763,31441
Darbhanga,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,1078,1020,730,1138,1262,1530,1555,1503,1358,1500,1665,1547,15886
Darbhanga,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,1632,1672,1407,1783,1831,1820,2011,1696,1942,1868,1826,1859,21347
Darbhanga,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,2709,2641,2203,2767,3553,2973,3407,2763,3330,3795,3182,2902,36225
Darbhanga,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Darbhanga,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Darbhanga,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Darbhanga,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,3739,3787,3759,3801,3459,3665,3695,3650,3729,3709,3667,3723,44383
Darbhanga,10.4.2,Number of Immunisation sessions held during the month,TOTAL,3788,3755,3438,3712,3364,3428,3508,3206,3523,3447,3520,3713,42402
Darbhanga,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,2867,2863,2595,2874,2743,2699,2780,2615,2802,2747,2792,2912,33289
Darbhanga,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,7132,6964,5718,7185,6006,5974,5996,4959,6373,6326,7242,7935,77810
Darbhanga,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,6696,6992,6792,7591,7575,7145,6679,5614,4702,3945,2791,2674,69196
Darbhanga,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,1951,1558,1406,1668,1559,1375,1408,1018,1271,1287,844,727,16072
Darbhanga,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,212,307,242,286,347,288,320,266,200,173,191,140,2972
Darbhanga,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0,0,0,1,3,0,0,0,0,0,0,0,4
Darbhanga,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0,0,0,2,0,0,0,0,0,0,0,0,2
Darbhanga,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0,0,0,1,0,0,0,0,0,0,0,0,1
Darbhanga,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0,0,1,0,0,0,0,0,0,0,0,0,1
Darbhanga,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Darbhanga,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,24,18,29,69,6,0,0,0,0,0,4,15,165
Darbhanga,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,507,561,586,825,1033,1180,944,779,686,750,712,785,9348
Darbhanga,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,5,14,26,25,9,7,0,2,4,0,0,4,96
Darbhanga,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,42,5,46,50,28,34,30,28,23,19,15,10,330
Darbhanga,13.1,Number of Patients operated for cataract,TOTAL,59,98,56,87,74,79,68,69,68,52,62,69,841
Darbhanga,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Darbhanga,13.3,Number of School children detected with Refractive errors,TOTAL,4,7,7,6,5,7,5,2,5,7,6,4,65
Darbhanga,13.4,Number of children provided free glasses,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Darbhanga,13.5,Number of eyes collected through eye donation,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Darbhanga,13.6,Number of eyes utilised for corneal transplant,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Darbhanga,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,NA,NA,3,3,3,3,3,3,3,3,3,3,Data for this item can not be cumulated
Darbhanga,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,NA,NA,29,29,33,31,33,33,33,34,32,32,Data for this item can not be cumulated
Darbhanga,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,2016,2259,1628,2073,2191,2194,2296,2240,2320,2342,2339,2398,Data for this item can not be cumulated
Darbhanga,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,NA,NA,3,3,4,4,3,3,3,3,3,3,Data for this item can not be cumulated
Darbhanga,14.05,Number of RKS meetings held during the month,TOTAL,7,8,5,27,9,8,10,10,12,9,11,9,125
Darbhanga,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,NA,NA,22,22,24,19,22,22,22,20,22,21,Data for this item can not be cumulated
Darbhanga,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,32,84,127,431,1116,1136,1424,1256,1380,1613,1271,1630,11500
Darbhanga,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,NA,NA,3,3,3,3,3,3,3,3,3,3,Data for this item can not be cumulated
Darbhanga,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,NA,NA,4,4,1,0,0,0,0,0,0,0,Data for this item can not be cumulated
Darbhanga,14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,2404,2012,2526,1662,1816,2584,1672,1521,1753,1556,1625,1536,22667
Darbhanga,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,3076,2599,2426,2393,2584,3222,2431,2110,2244,1999,2311,2113,29508
Darbhanga,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,1972,2095,2218,1924,1923,2330,1852,2236,1929,2208,1874,1431,23992
Darbhanga,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,4645,5752,4581,6830,6518,6400,6705,6745,7900,7454,6868,6808,77206
Darbhanga,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,4376,4107,4744,3586,3739,4914,3524,3757,3682,3764,3499,2967,46659
Darbhanga,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,7721,8351,7007,9223,9102,9622,9136,8855,10144,9453,9179,8921,106714
Darbhanga,14.10.2.a,Number of death cases of Inpatient males,TOTAL,1,1,3,1,0,1,1,0,0,0,0,16,24
Darbhanga,14.10.2.b,Number of death cases of Inpatient females,TOTAL,2,0,1,0,0,2,0,1,0,0,0,16,22
Darbhanga,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,3,1,4,1,0,3,1,1,0,0,0,32,46
Darbhanga,14.11,In-Patient Head Count at midnight,TOTAL,5731,5965,6788,6477,6529,5408,5521,5485,7582,7722,7351,6711,77270
Darbhanga,14.12.1,OPD attendance (All),TOTAL,211781,212045,212425,236956,254102,254857,231014,225730,253372,246709,261293,248743,2849027
Darbhanga,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,1281,1090,93,1324,1028,1518,1213,1345,3616,2254,1822,635,17219
Darbhanga,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0,0,0,5,0,0,0,0,0,0,0,0,5
Darbhanga,14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,4974,5540,4362,4665,4968,5133,5040,5192,5301,5040,4530,3567,58312
Darbhanga,14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,14.14.a,Number of patients given AYUSH treatment,TOTAL,32076,31938,28793,38321,40020,37890,35746,38656,41216,48574,46404,44187,463821
Darbhanga,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,15759,9351,9305,9469,10645,10562,9347,7624,7872,7379,8906,8469,114688
Darbhanga,14.14.c,Number of Adolescents counselled,TOTAL,178,14,265,183,618,486,177,234,847,439,181,86,3708
Darbhanga,15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,1040,751,1197,1012,999,1163,988,1225,1395,1420,1182,823,13195
Darbhanga,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,13,3,18,26,18,19,17,13,15,23,8,18,191
Darbhanga,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,179,96,235,343,536,137,212,406,351,520,754,486,4255
Darbhanga,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,2,0,8,6,1,4,3,0,7,2,11,5,49
Darbhanga,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,219,93,394,473,402,165,175,467,1343,1514,1359,870,7474
Darbhanga,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0,0,2,9,1,1,3,1,8,3,5,4,37
Darbhanga,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,215,84,329,900,1269,364,557,434,642,1140,1320,746,8000
Darbhanga,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0,0,0,0,0,0,0,0,0,0,0,0,0
Darbhanga,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,613,273,958,1716,2207,666,944,1307,2336,3174,3433,2102,19729
Darbhanga,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,2,0,10,15,2,5,6,1,15,5,16,9,86
Darbhanga,15.2,Number of Widal tests conducted,Number tested,0,22,0,19,0,0,0,0,0,0,8,0,49
Darbhanga,15.3.a,Number of VDRL tests conducted on males,Number tested,0,0,0,0,0,0,0,0,0,0,0,0,0
Darbhanga,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,0,0,0,0,0,0,0,0,0,0,0,0,0
Darbhanga,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,0,0,0,0,0,0,0,0,0,0,82,89,171
Darbhanga,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,0,0,0,0,0,0,0,0,0,0,82,89,171
Darbhanga,15.4.1,Number of blood smears examined for Malaria,TOTAL,46,9,13,19,9,14,9,26,16,0,5,5,171
Darbhanga,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,4,0,0,0,0,0,0,0,0,0,0,0,4
Darbhanga,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Darbhanga,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,10000,7950,2950,4950,4273,2210,1903,1131,331,333,118,98,36247
Darbhanga,16.1.1,Stock position of DPT vaccines,2. Stocks Received,2000,0,8000,2660,0,0,2000,0,1000,500,1000,1750,18910
Darbhanga,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,NA,0,0,0,0,0,0,0,0,0,0,0,0
Darbhanga,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,4050,5000,6000,4900,1168,2000,2772,800,998,715,1020,1150,30573
Darbhanga,16.1.1,Stock position of DPT vaccines,5. Total Stock,7950,2950,4950,2710,3105,210,1131,331,333,118,98,698,24584
Darbhanga,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,3200,9400,4600,4950,4726,12912,2851,643,0,652,1517,70,45521
Darbhanga,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,11700,6000,8064,2660,0,0,0,1848,3712,3120,2016,3936,43056
Darbhanga,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,NA,0,8500,0,0,0,0,0,0,0,0,0,8500
Darbhanga,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,5500,10800,4164,4900,1710,7016,2208,2491,3060,2255,3463,3148,50715
Darbhanga,16.1.1A,Stock Position of Pentavalent,5. Total Stock,9400,4600,0,2710,3016,5896,643,0,652,1517,70,858,29362
Darbhanga,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,8500,0,500,1500,210,2700,2093,1348,893,483,995,1475,20697
Darbhanga,16.1.2,Stock position of OPV vaccines,2. Stocks Received,1000,11000,11000,10275,4475,10000,2000,2000,3000,2600,2500,1500,61350
Darbhanga,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,NA,0,10000,0,0,0,0,0,0,0,0,0,10000
Darbhanga,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,9500,9500,1500,9500,2928,9100,2745,2455,3410,2088,2020,2253,56999
Darbhanga,16.1.2,Stock position of OPV vaccines,5. Total Stock,0,1500,0,2275,1757,3600,1348,893,483,995,1475,722,15048
Darbhanga,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,4911,18111,9611,7611,5756,6911,463,1501,89,1471,2819,1644,60898
Darbhanga,16.1.3,Stock position of TT vaccines,2. Stocks Received,16000,0,7000,3000,2000,3000,3000,0,4000,3000,1000,3000,45000
Darbhanga,16.1.3,Stock position of TT vaccines,3. Unusable Stock,NA,0,9000,0,0,0,0,0,0,0,0,0,9000
Darbhanga,16.1.3,Stock position of TT vaccines,4. Stock Distributed,2800,8500,7611,7700,5103,4500,1962,1412,2618,1652,1975,2100,47933
Darbhanga,16.1.3,Stock position of TT vaccines,5. Total Stock,18111,9611,0,2911,2653,5411,1501,89,1471,2819,1844,2544,48965
Darbhanga,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,NA,0,0,NA,NA,NA,0,0,0,0,NA,0,0
Darbhanga,16.1.4,Stock position of DT vaccines,2. Stocks Received,NA,0,0,NA,NA,NA,0,0,0,0,NA,0,0
Darbhanga,16.1.4,Stock position of DT vaccines,3. Unusable Stock,NA,0,0,NA,NA,NA,0,0,0,0,NA,0,0
Darbhanga,16.1.4,Stock position of DT vaccines,4. Stock Distributed,NA,0,0,NA,NA,NA,0,0,0,0,NA,0,0
Darbhanga,16.1.4,Stock position of DT vaccines,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Darbhanga,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,8867,4767,9767,7067,2969,6367,1942,2024,1841,1611,488,860,48570
Darbhanga,16.1.5,Stock position of BCG vaccines,2. Stocks Received,1600,10000,4000,4000,0,4000,2000,1867,2000,600,3000,2000,35067
Darbhanga,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,NA,0,6700,0,0,0,0,0,0,0,0,0,6700
Darbhanga,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,5700,5000,7067,5700,1789,8000,1918,2050,2230,1723,2628,2370,46175
Darbhanga,16.1.5,Stock position of BCG vaccines,5. Total Stock,4767,9767,0,5367,1180,2367,2024,1841,1611,488,860,490,30762
Darbhanga,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,11626,926,26,1826,5157,6326,2638,888,433,794,949,2149,33738
Darbhanga,16.1.6,Stock position of Measles vaccines,2. Stocks Received,3200,11000,20000,20000,5000,12000,2000,3000,4000,4000,5000,4000,93200
Darbhanga,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,NA,0,18200,0,0,0,0,0,0,0,0,0,18200
Darbhanga,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,13900,11900,1826,20500,6671,10000,3750,3455,3639,3845,3800,4002,87288
Darbhanga,16.1.6,Stock position of Measles vaccines,5. Total Stock,926,26,0,1326,3486,8326,888,433,794,949,2149,2147,21450
Darbhanga,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,11000,3400,7400,14000,1820,3000,979,69,769,69,704,354,43564
Darbhanga,16.1.7,Stock position of JE vaccines,2. Stocks Received,3000,14000,14000,0,4000,8000,3000,3500,3000,4000,4000,4000,64500
Darbhanga,16.1.7,Stock position of JE vaccines,3. Unusable Stock,NA,0,7400,0,0,0,0,0,0,0,0,0,7400
Darbhanga,16.1.7,Stock position of JE vaccines,4. Stock Distributed,10600,10000,14000,10000,3971,7000,3910,2800,3700,3365,4350,3611,77307
Darbhanga,16.1.7,Stock position of JE vaccines,5. Total Stock,3400,7400,0,4000,1849,4000,69,769,69,704,354,743,23357
Darbhanga,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,3007,5207,2207,2307,3792,407,2862,2401,1776,1301,1131,561,26959
Darbhanga,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,40000,0,4000,1000,0,0,0,0,0,0,0,0,45000
Darbhanga,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,NA,3000,3900,0,0,0,0,0,0,0,0,0,6900
Darbhanga,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,1800,2207,2307,2900,511,407,461,625,475,170,570,50,12483
Darbhanga,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,41207,0,0,407,3281,0,2401,1776,1301,1131,561,511,52576
Darbhanga,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Darbhanga,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Darbhanga,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Darbhanga,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Darbhanga,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Darbhanga,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Darbhanga,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,16.3.02,Stock Position of Gloves,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,16.3.02,Stock Position of Gloves,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,16.3.02,Stock Position of Gloves,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,16.3.02,Stock Position of Gloves,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Darbhanga,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Darbhanga,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Darbhanga,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Darbhanga,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Darbhanga,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Darbhanga,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Darbhanga,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Darbhanga,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Darbhanga,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Darbhanga,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,1400,1400,2600,1600,1500,7500,7250,24850,13250,650,3250,5050,70300
Darbhanga,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,11000,12000,12000,12000,14000,10000,28000,0,0,13000,16000,10500,138500
Darbhanga,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,NA,0,13000,0,0,0,0,0,0,0,0,0,13000
Darbhanga,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,11000,10800,1600,12100,8000,10250,10400,11600,12600,10400,14200,12200,125150
Darbhanga,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,1400,2600,0,1500,7500,7250,24850,13250,650,3250,5050,3350,70650
Darbhanga,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,25740,29940,34940,35140,37140,62940,49604,183004,101404,21804,46804,51804,680264
Darbhanga,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,100000,100000,100000,100000,100000,60000,200000,0,0,100000,100000,50000,1010000
Darbhanga,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,NA,0,99800,0,0,0,0,0,0,0,0,0,99800
Darbhanga,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,95800,34940,35140,98000,74200,73336,66600,81600,79600,75000,95000,86000,895216
Darbhanga,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,29940,95000,0,37140,62940,49604,183004,101404,21804,46804,51804,15804,695248
Darbhanga,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,1300,500,0,600,1400,3350,3938,11338,1938,0,100,2400,26864
Darbhanga,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,6000,8000,8000,8000,8000,8000,16000,0,0,8000,12000,10000,92000
Darbhanga,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,NA,0,7400,0,0,0,0,0,0,0,0,0,7400
Darbhanga,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,6800,8500,600,7200,6050,7412,8600,9400,1938,7900,9700,9000,83100
Darbhanga,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,500,0,0,1400,3350,3938,11338,1938,0,100,2400,3400,28364
Darbhanga,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,NA,NA,1
Darbhanga,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,NA,NA,1
Darbhanga,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,NA,1
Darbhanga,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,NA,1
Darbhanga,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,1
Darbhanga,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,1
Darbhanga,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Darbhanga,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1
Darbhanga,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,1
Darbhanga,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,1,2
East Champaran,1.1,Total number of pregnant women Registered for ANC,TOTAL,11167,10714,10444,11552,10144,10838,10614,8446,9577,11958,11622,12219,129295
East Champaran,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,5779,5649,5326,5723,5346,5151,5077,4014,4838,7979,8055,8360,71297
East Champaran,1.2,Number of Pregnant women registered under JSY,TOTAL,11207,10714,10444,11552,10144,10838,10614,8446,9577,11958,11622,12219,129335
East Champaran,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,6714,6634,6708,7449,7005,7248,7393,6604,6995,8730,9328,10194,91002
East Champaran,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,9070,8618,8456,9345,8107,8486,8354,6463,7711,8191,8791,8970,100562
East Champaran,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,9738,10698,9847,10240,10116,10275,10131,8713,8816,9702,9432,10859,118567
East Champaran,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,6198,6228,5589,6018,5323,4862,4257,3495,3367,3576,2988,2921,54822
East Champaran,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,83,121,17,71,59,44,76,68,33,9,13,67,661
East Champaran,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0,0,4,0,0,3,13,5,3,0,1,2,31
East Champaran,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,113,140,58,77,56,30,43,34,50,63,145,136,945
East Champaran,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,8,12,10,11,13,15,12,13,11,9,13,21,148
East Champaran,1.8,Number of pregnancy test kits used at SC level,TOTAL,877,858,907,1003,687,761,933,716,813,963,1172,1223,10913
East Champaran,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,353,388,438,513,531,657,564,503,533,591,605,502,6178
East Champaran,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,1641,1349,1505,1718,1771,1991,2116,2175,2436,2248,2375,2219,23544
East Champaran,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,1994,1737,1943,2231,2302,2648,2680,2678,2969,2839,2980,2721,29722
East Champaran,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,779,586,646,712,740,831,940,840,990,1063,1734,1385,11246
East Champaran,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,4,17,0,0,0,0,0,13,0,0,0,0,34
East Champaran,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,3737,4004,3639,5796,6442,6184,5851,5889,5428,5442,5183,4293,61888
East Champaran,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,3408,3509,3263,5205,5740,5457,5353,5361,4865,5368,4967,3895,56391
East Champaran,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,2851,2911,1419,3367,3685,4289,4124,3976,3986,3943,4361,3834,42746
East Champaran,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,2352,2346,1118,2226,2128,2647,2636,2850,2918,2875,3465,3066,30627
East Champaran,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
East Champaran,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,387,410,429,286,389,366,516,1017,1175,1747,1302,1878,9902
East Champaran,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0
East Champaran,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0
East Champaran,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0
East Champaran,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
East Champaran,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0,0,0,0,0,0,0,0,1,0,0,1,2
East Champaran,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,9,7,3,7,7,5,13,13,4,14,19,16,117
East Champaran,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
East Champaran,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,9,7,3,7,7,5,13,13,5,14,19,17,119
East Champaran,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,85,93,114,85,94,88,130,181,276,434,355,887,2822
East Champaran,4.1.1.a,Number of male live births,TOTAL,3078,2917,2986,4250,4616,4614,4446,4295,4218,4158,4175,3553,47306
East Champaran,4.1.1.b,Number of female live births,TOTAL,3002,2784,2551,4012,4477,4497,4466,4263,4123,4079,3946,3452,45652
East Champaran,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,6080,5701,5537,8262,9093,9111,8912,8558,8341,8237,8121,7005,92958
East Champaran,4.1.2,Number of still births,TOTAL,51,52,54,71,79,103,80,71,71,68,54,54,808
East Champaran,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,7,7,4,8,10,9,6,5,3,2,9,7,77
East Champaran,4.2.1,Number of Newborns weighed at birth,TOTAL,5514,5218,4982,7425,8117,8228,7929,7875,7688,7561,7381,6690,84608
East Champaran,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,167,177,167,278,274,300,382,397,361,226,204,206,3139
East Champaran,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,6048,5605,5447,7918,8665,8731,8475,8493,8292,8190,8126,6999,90989
East Champaran,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,8,17,19,11,37,28,12,14,23,66,121,154,510
East Champaran,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0,0,0,0,0,0,0,3,9,19,17,17,65
East Champaran,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,0,0,0,0,0,0,0,0,0,15,0,0,15
East Champaran,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
East Champaran,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,8,17,19,11,37,28,12,17,32,100,138,171,590
East Champaran,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
East Champaran,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,8,5,12,9,12,20,20,17,24,94,84,88,393
East Champaran,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0,0,0,0,0,2,0,0,0,0,2,1,5
East Champaran,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,2,12,8,2,14,26,16,13,20,92,96,101,402
East Champaran,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
East Champaran,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,2147,2343,2502,3249,3516,3672,3784,3692,3960,6028,5848,4100,44841
East Champaran,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,2294,1633,2097,2581,2773,2727,2650,2569,2788,5697,5242,3821,36872
East Champaran,6.3,PNC maternal complications attended,TOTAL,49,0,5,11,6,6,6,2,2,17,2,1,107
East Champaran,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,5,6,5,7,8,7,5,3,5,3,5,5,64
East Champaran,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
East Champaran,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,5,6,5,7,8,7,5,3,5,3,5,5,64
East Champaran,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
East Champaran,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,155,151,141,216,195,227,195,188,187,161,189,223,2228
East Champaran,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,162,131,156,199,165,190,155,166,180,183,221,250,2158
East Champaran,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,317,282,297,415,360,417,350,354,367,344,410,473,4386
East Champaran,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
East Champaran,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,1,20,48,13,0,60,6,17,11,28,134,18,356
East Champaran,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0,0,0,1,0,0,0,0,0,0,2,1,4
East Champaran,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0,0,0,2,0,0,0,5,0,1,3,0,11
East Champaran,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
East Champaran,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,1,20,48,16,0,60,6,22,11,29,139,19,371
East Champaran,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,10,NA,NA,NA,NA,NA,NA,11,3,9,22,41,96
East Champaran,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
East Champaran,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
East Champaran,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
East Champaran,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
East Champaran,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
East Champaran,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
East Champaran,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,253,160,132,757,148,672,468,849,2806,2172,2563,1687,12667
East Champaran,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,80,26,24,219,83,136,109,168,643,416,544,287,2735
East Champaran,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,53,32,22,37,37,35,57,53,137,118,159,82,822
East Champaran,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
East Champaran,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,386,218,178,1013,268,843,634,1070,3586,2706,3266,2056,16224
East Champaran,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,289,391,425,644,618,530,439,1065,764,1213,1880,9629,17887
East Champaran,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0,12,0,0,0,0,0,0,3,5,1,1,22
East Champaran,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,2,1,0,7,6,1,9,6,8,10,12,12,74
East Champaran,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,3,2,2,2,2,2,2,7,3,4,5,5,39
East Champaran,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
East Champaran,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,5,15,2,9,8,3,11,13,14,19,18,18,135
East Champaran,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,NA,NA,NA,32,26,24,21,3,5,8,41,87,247
East Champaran,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,266,232,370,338,251,317,250,255,265,389,712,679,4324
East Champaran,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,209,125,197,552,300,405,338,223,208,757,435,613,4362
East Champaran,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,25,29,30,61,45,35,47,61,68,228,302,70,1001
East Champaran,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,6,7,4,5,4,5,5,4,3,96,12,3,154
East Champaran,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
East Champaran,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,506,393,601,956,600,762,640,543,544,1470,1461,1365,9841
East Champaran,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,232,202,133,216,287,472,185,220,203,750,379,406,3685
East Champaran,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,NA,NA,NA,252,442,680,575,676,799,944,1538,6605,12511
East Champaran,9.06,Number of IUCD removals,TOTAL,247,375,344,194,156,184,169,128,158,278,206,250,2689
East Champaran,9.07,Number of Oral Pills cycles distributed,TOTAL,2254,3635,2756,4271,2667,2310,2083,1325,2468,3787,5179,6010,38745
East Champaran,9.08,Number of Condom pieces distributed,TOTAL,8486,7021,8338,8500,7797,9646,7711,6864,7084,13068,16272,19239,120026
East Champaran,9.09,Number of Centchroman (weekly) pills given,TOTAL,0,0,0,0,1,2,0,0,0,0,0,0,3
East Champaran,9.1,Number of Emergency Contraceptive Pills distributed,TOTAL,110,54,80,178,134,79,104,84,52,96,169,286,1426
East Champaran,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
East Champaran,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
East Champaran,9.11.2.a,Number of failures following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
East Champaran,9.11.2.b,Number of failures following female sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
East Champaran,9.11.3.a,Number of deaths following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
East Champaran,9.11.3.b,Number of deaths following female sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
East Champaran,9.12,Number of Institutions having NSV trained doctors,TOTAL,NA,NA,4,6,6,4,7,8,6,5,7,7,Data for this item can not be cumulated
East Champaran,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,9474,9155,8226,11449,12552,14503,14594,14005,15012,14144,13698,11775,148587
East Champaran,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,3,0,0,0,0,0,0,0,0,0,0,2,5
East Champaran,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,2746,1598,834,696,347,256,153,50,42,26,8,12,6768
East Champaran,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,6347,3936,2349,1952,995,643,440,213,164,60,58,26,17183
East Champaran,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,11713,9187,8171,9366,8833,11402,13407,12318,14543,15226,13989,13555,141710
East Champaran,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,10022,10599,9029,9242,8749,9128,11001,11171,13244,14994,14518,14843,136540
East Champaran,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,6635,8741,8843,9169,8362,8761,9482,9627,11712,13882,13791,14454,123459
East Champaran,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,4549,4936,4669,6827,7650,8539,8223,7811,7442,7046,7207,5538,80437
East Champaran,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,11393,9134,8135,9259,8713,11321,13470,12303,14536,15239,14056,13735,141294
East Champaran,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,12442,11839,9695,9817,8923,9316,11200,11227,13293,15013,14513,14902,142180
East Champaran,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,12259,12018,10826,10806,9158,9317,9892,9707,11803,13943,13652,14413,137794
East Champaran,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,3283,3335,3261,4829,5677,6207,6049,5951,5275,5179,5156,3954,58156
East Champaran,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,34,0,0,0,0,0,0,0,0,0,0,0,34
East Champaran,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,2868,1520,988,738,352,250,136,42,35,21,4,3,6957
East Champaran,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,6348,3817,2392,2005,973,658,417,189,149,56,51,10,17065
East Champaran,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,9395,9929,9811,11334,9915,11086,11726,9842,10806,11086,10861,11391,127182
East Champaran,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,8991,7479,7463,8890,7208,7844,8274,7460,9540,11187,11046,11449,106831
East Champaran,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,8693,9539,9327,10913,9402,10826,11593,9342,10762,11096,10759,11327,123579
East Champaran,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,4614,5032,5038,5785,5109,5667,6028,5039,5452,5724,5431,5825,64744
East Champaran,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,4249,4459,4426,5297,4494,5206,5514,4486,5059,5155,4932,5303,58580
East Champaran,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,8863,9491,9464,11082,9603,10873,11542,9525,10511,10879,10363,11128,123324
East Champaran,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,9294,8270,7662,9098,7613,8076,8439,7559,9864,11434,11172,11604,110085
East Champaran,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,9295,8265,7648,9076,7571,8066,8439,7558,9860,11435,11174,11593,109980
East Champaran,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0,0,0,0,0,0,0,0,0,0,0,2,2
East Champaran,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2277,2286,1982,2381,1877,2540,2368,2105,2818,3481,3014,3589,30718
East Champaran,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2116,1986,1766,2097,1665,2370,2140,1916,2464,3137,2763,3325,27745
East Champaran,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,4393,4272,3748,4478,3542,4910,4508,4021,5282,6618,5777,6914,58463
East Champaran,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,1398,1231,1449,1649,1590,2112,2370,2569,2607,3115,2857,2837,25784
East Champaran,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,2401,2345,2037,2199,2006,2119,2295,2296,2237,2636,2611,2421,27603
East Champaran,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,3749,3735,3394,3662,3510,3630,3954,3842,4210,4607,4697,4574,47564
East Champaran,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0,0,0,9,0,0,0,4,2,11,3,2,31
East Champaran,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
East Champaran,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,15,0,2,0,0,0,2,52,0,0,1,0,72
East Champaran,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,5062,4951,5029,5159,4965,4853,4957,4878,4965,4913,4906,4867,59505
East Champaran,10.4.2,Number of Immunisation sessions held during the month,TOTAL,4839,4811,4638,4997,4667,4694,4866,4541,4874,4820,4717,4774,57238
East Champaran,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,3067,3194,3135,3281,3046,3183,3254,3065,3246,3311,3212,3353,38347
East Champaran,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,8663,7760,6941,8432,6967,7777,8220,7148,9541,11134,10754,11215,104552
East Champaran,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,8450,9223,8770,10245,8962,9932,10546,8780,9426,9185,9125,8967,111611
East Champaran,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,4012,3486,3847,4224,3627,3947,3977,3737,4276,4996,4738,5357,50224
East Champaran,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,0,11,0,0,14,2,0,0,0,0,0,0,27
East Champaran,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
East Champaran,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
East Champaran,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
East Champaran,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
East Champaran,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
East Champaran,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,1,52,6,45,14,2,25,21,4,12,30,39,251
East Champaran,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,1399,1441,1525,1795,3046,1779,1290,898,1289,1762,1041,1307,18572
East Champaran,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,20,0,2,0,11,0,6,0,2,0,0,0,41
East Champaran,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
East Champaran,13.1,Number of Patients operated for cataract,TOTAL,282,345,188,244,441,495,789,0,0,20,0,0,2804
East Champaran,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,198,305,175,319,425,488,512,0,0,365,0,0,2787
East Champaran,13.3,Number of School children detected with Refractive errors,TOTAL,0,0,0,0,0,0,0,0,6,114,330,315,765
East Champaran,13.4,Number of children provided free glasses,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
East Champaran,13.5,Number of eyes collected through eye donation,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
East Champaran,13.6,Number of eyes utilised for corneal transplant,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
East Champaran,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,NA,NA,2,4,4,3,4,4,4,4,4,4,Data for this item can not be cumulated
East Champaran,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,NA,NA,13,16,16,14,13,19,21,22,19,19,Data for this item can not be cumulated
East Champaran,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,3192,3201,2852,2916,3083,2847,2911,2877,3045,3073,3075,3136,Data for this item can not be cumulated
East Champaran,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,NA,NA,3,4,4,3,4,3,3,3,3,3,Data for this item can not be cumulated
East Champaran,14.05,Number of RKS meetings held during the month,TOTAL,11,11,12,12,8,1,0,1,4,7,11,7,85
East Champaran,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,NA,NA,19,22,22,19,20,21,23,25,28,27,Data for this item can not be cumulated
East Champaran,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,1780,1239,1599,2578,2446,2389,3841,2904,2771,3427,2736,2820,30530
East Champaran,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,NA,NA,3,2,3,1,2,1,2,4,3,3,Data for this item can not be cumulated
East Champaran,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,3,3,2,2,1,1,1,1,0,0,0,0,Data for this item can not be cumulated
East Champaran,14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
East Champaran,14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
East Champaran,14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
East Champaran,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,844,1140,1092,1500,1575,1401,1548,1619,1508,1568,1500,1114,16409
East Champaran,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,2638,2499,2283,2587,2287,2129,2475,2465,2625,2493,2505,2641,29627
East Champaran,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,1130,1295,1208,1623,1899,1489,1572,1655,1445,1380,1328,1108,17132
East Champaran,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,3954,4082,3691,5623,5847,6312,5848,6855,7814,7700,8225,6061,72012
East Champaran,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,1974,2435,2300,3123,3474,2890,3120,3274,2953,2948,2828,2222,33541
East Champaran,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,6592,6581,5974,8210,8134,8441,8323,9320,10439,10193,10730,8702,101639
East Champaran,14.10.2.a,Number of death cases of Inpatient males,TOTAL,1,2,5,8,7,9,3,6,4,7,4,6,62
East Champaran,14.10.2.b,Number of death cases of Inpatient females,TOTAL,5,4,2,4,3,6,5,2,5,2,1,1,40
East Champaran,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,6,6,7,12,10,15,8,8,9,9,5,7,102
East Champaran,14.11,In-Patient Head Count at midnight,TOTAL,6803,7051,6488,9072,9654,9229,9064,9678,10795,10166,10625,8939,107564
East Champaran,14.12.1,OPD attendance (All),TOTAL,271427,255991,240492,285613,289906,287860,301997,280488,295761,316381,324602,372004,3522522
East Champaran,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,2168,357,235,881,260,549,523,661,3028,2560,2993,1525,15740
East Champaran,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0,0,0,0,0,0,0,0,9,0,0,0,9
East Champaran,14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
East Champaran,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,2495,2469,2029,2822,2571,2234,2603,2362,2930,2804,2938,2401,30658
East Champaran,14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
East Champaran,14.14.a,Number of patients given AYUSH treatment,TOTAL,28948,35767,32874,32635,35931,37196,36802,28857,31382,34803,44022,60987,440204
East Champaran,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,10855,11104,9695,11438,10827,10887,11353,10574,11222,10797,10344,10164,129260
East Champaran,14.14.c,Number of Adolescents counselled,TOTAL,1716,515,910,1598,1759,1611,1502,1204,1071,724,524,1165,14299
East Champaran,15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
East Champaran,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,791,1053,1211,1227,1165,897,907,773,809,660,1206,1224,11923
East Champaran,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,20,27,29,19,16,21,17,14,12,17,21,15,228
East Champaran,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,650,431,986,937,1274,1351,1312,1095,1191,1457,1302,1102,13088
East Champaran,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,27,12,34,32,34,21,20,19,28,31,31,42,331
East Champaran,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,741,490,1021,977,1017,1000,1138,1278,2623,2763,2757,1860,17665
East Champaran,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,10,18,24,25,35,15,10,17,16,11,22,28,231
East Champaran,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,781,465,1940,1899,2125,2442,2739,2553,2761,2791,2906,2611,26013
East Champaran,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,3,0,2,1,7,2,1,3,3,2,1,1,26
East Champaran,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,2172,1386,3947,3813,4416,4793,5189,4926,6575,7011,6965,5573,56766
East Champaran,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,40,30,60,58,76,38,31,39,47,44,54,71,588
East Champaran,15.2,Number of Widal tests conducted,Number tested,0,0,0,0,0,0,0,0,84,120,329,385,918
East Champaran,15.3.a,Number of VDRL tests conducted on males,Number tested,0,0,0,0,0,0,0,0,0,25,295,352,672
East Champaran,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,0,0,0,0,0,0,0,0,0,64,316,488,868
East Champaran,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,0,0,0,0,0,0,0,0,0,361,764,1327,2452
East Champaran,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,0,0,0,0,0,0,0,0,0,450,1375,2167,3992
East Champaran,15.4.1,Number of blood smears examined for Malaria,TOTAL,15,20,61,44,37,38,37,19,44,32,2,5,354
East Champaran,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
East Champaran,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
East Champaran,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,2250,1700,1450,1650,1450,1450,2200,1050,950,2300,2338,1163,19951
East Champaran,16.1.1,Stock position of DPT vaccines,2. Stocks Received,2000,1000,2000,1000,1000,2000,0,1000,3000,1488,0,2000,16488
East Champaran,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
East Champaran,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,2550,1250,1800,1200,1000,1250,1150,1100,1650,1450,1175,1650,17225
East Champaran,16.1.1,Stock position of DPT vaccines,5. Total Stock,1700,1450,1650,1450,1450,2200,1050,950,2300,2338,1163,1513,19214
East Champaran,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,4700,3150,3900,700,2250,4450,5100,1950,3050,4850,4038,2250,40388
East Champaran,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,2000,3000,0,4000,5000,3000,0,4000,6000,3140,0,1275,31415
East Champaran,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
East Champaran,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,3550,2250,3200,2450,2800,2350,3150,2900,5100,3952,4005,2575,38282
East Champaran,16.1.1A,Stock Position of Pentavalent,5. Total Stock,3150,3900,700,2250,4450,5100,1950,3050,3950,4038,33,950,33521
East Champaran,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,3225,1475,1175,3000,2130,4305,5155,1130,2000,4250,3825,NA,31670
East Champaran,16.1.2,Stock position of OPV vaccines,2. Stocks Received,1000,3000,5300,2000,5000,4000,0,4000,6000,3100,0,NA,33400
East Champaran,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,NA,0
East Champaran,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,2750,3300,3475,2870,2825,3150,4005,2000,3750,3425,1575,NA,33125
East Champaran,16.1.2,Stock position of OPV vaccines,5. Total Stock,1475,1175,3000,2130,4305,5155,1150,3130,4250,3925,2250,0,31945
East Champaran,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,2875,2125,1875,NA,2875,625,4175,1375,2025,3800,3450,NA,25200
East Champaran,16.1.3,Stock position of TT vaccines,2. Stocks Received,2000,2000,2000,NA,0,6000,0,3000,4500,2000,0,NA,21500
East Champaran,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0,0,0,NA,0,0,0,0,0,0,0,NA,0
East Champaran,16.1.3,Stock position of TT vaccines,4. Stock Distributed,2750,2250,2650,NA,2250,2450,2800,2350,2725,2350,2150,NA,24725
East Champaran,16.1.3,Stock position of TT vaccines,5. Total Stock,2125,1875,1225,0,625,4175,1375,2025,3800,3450,1300,0,21975
East Champaran,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0,0,0,NA,0,0,0,0,0,0,0,NA,0
East Champaran,16.1.4,Stock position of DT vaccines,2. Stocks Received,0,0,0,NA,0,0,0,0,0,0,0,NA,0
East Champaran,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0,0,0,NA,0,0,0,0,0,0,0,NA,0
East Champaran,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0,0,0,NA,0,0,0,0,0,0,0,NA,0
East Champaran,16.1.4,Stock position of DT vaccines,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
East Champaran,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,2050,600,1100,NA,1750,2000,2650,1300,2350,3750,3150,NA,20700
East Champaran,16.1.5,Stock position of BCG vaccines,2. Stocks Received,1100,3000,3000,NA,3000,4000,2000,4000,5000,2900,2000,NA,30000
East Champaran,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0,0,0,NA,0,0,0,0,0,0,0,NA,0
East Champaran,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,2550,2500,2850,NA,2750,3350,3350,2950,3600,3500,3100,NA,30500
East Champaran,16.1.5,Stock position of BCG vaccines,5. Total Stock,600,1100,1250,0,2000,2650,1300,2350,3750,3150,2050,0,20200
East Champaran,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,4700,1300,600,NA,450,2000,4790,1990,3240,2840,1390,NA,23300
East Champaran,16.1.6,Stock position of Measles vaccines,2. Stocks Received,2000,4000,6500,NA,6000,8000,2000,6000,5000,4000,4000,NA,47500
East Champaran,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0,0,0,NA,0,0,0,0,0,0,0,NA,0
East Champaran,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,5400,4700,5250,NA,4450,5210,4800,4600,5400,5450,4540,NA,49800
East Champaran,16.1.6,Stock position of Measles vaccines,5. Total Stock,1300,600,1850,0,2000,4790,1990,3390,2840,1390,850,0,21000
East Champaran,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,3740,990,690,NA,990,1490,4290,2390,3790,3490,1890,NA,23750
East Champaran,16.1.7,Stock position of JE vaccines,2. Stocks Received,2500,4500,6500,NA,5000,8000,3000,6000,5000,3100,3700,NA,47300
East Champaran,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0,0,0,NA,0,0,0,0,0,0,0,NA,0
East Champaran,16.1.7,Stock position of JE vaccines,4. Stock Distributed,525,4800,5250,NA,4500,5200,4900,4600,5300,4700,5300,NA,45075
East Champaran,16.1.7,Stock position of JE vaccines,5. Total Stock,5715,690,1940,0,1490,4290,2390,3790,3490,1890,290,0,25975
East Champaran,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,2205,1505,2255,NA,700,200,2150,1800,1500,2000,1400,NA,15715
East Champaran,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,1000,1500,0,NA,0,2500,0,0,1000,0,0,NA,6000
East Champaran,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0,0,0,NA,0,0,0,0,0,0,0,NA,0
East Champaran,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,1700,750,800,NA,500,550,350,300,500,600,350,NA,6400
East Champaran,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,1505,2255,1455,0,200,2150,1800,1500,2000,1400,1050,0,15315
East Champaran,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,7100,7100,7100,NA,700,700,700,700,700,24143,7693,NA,56636
East Champaran,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,7000,7000,7000,NA,32960,32960,32960,32960,49343,50043,50043,NA,302269
East Champaran,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0,0,0,NA,0,0,0,0,0,0,0,NA,0
East Champaran,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,4900,490,4900,NA,8400,16300,19900,19900,25900,42350,43950,NA,186990
East Champaran,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,9200,13610,9200,0,25260,17360,13760,13760,24143,31836,13786,0,171915
East Champaran,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,68798,68798,68798,NA,8720,8720,8720,8720,8720,281510,78510,NA,610014
East Champaran,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,100000,100000,100000,NA,390145,390145,390145,390145,664695,673015,673015,NA,3871305
East Champaran,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0,0,0,NA,0,0,0,0,0,0,0,NA,0
East Champaran,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,160078,160078,160078,NA,193840,324880,370240,370240,391905,594505,614505,NA,3340349
East Champaran,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,8720,8720,8720,0,205025,73985,28625,28625,281510,360020,137020,0,1140970
East Champaran,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,3734,3734,3734,NA,550,550,550,550,550,48637,12037,NA,74626
East Champaran,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,20000,20000,20000,NA,55810,55810,55810,55810,74537,75087,75087,NA,507951
East Champaran,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0,0,0,NA,0,0,0,0,0,0,0,NA,0
East Champaran,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,21434,21434,21434,NA,13800,22250,25800,25800,33450,63050,65850,NA,314302
East Champaran,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,2300,2300,2300,0,42560,34110,30560,30560,41637,60674,21274,0,268275
East Champaran,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0,0,0,NA,500,500,500,500,500,30210,7210,NA,39920
East Champaran,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,10000,10000,10000,NA,33660,33600,33660,33660,55110,55110,55110,NA,329910
East Champaran,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0,0,0,NA,0,0,0,0,0,0,0,NA,0
East Champaran,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,9000,9000,9000,NA,10300,17100,19800,19800,24900,47900,50100,NA,216900
East Champaran,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,1000,1000,1000,0,23860,17000,14360,14360,30710,37420,12220,0,152930
East Champaran,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,65,65,65,NA,0,0,0,0,NA,0,0,NA,195
East Champaran,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0,0,0,NA,0,0,0,0,NA,0,0,NA,0
East Champaran,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0,0,0,NA,0,0,0,0,NA,0,0,NA,0
East Champaran,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,65,65,65,NA,0,0,0,0,NA,0,0,NA,195
East Champaran,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
East Champaran,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,4000,4000,4000,NA,0,0,0,0,0,0,0,NA,12000
East Champaran,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,9804,9804,9804,NA,0,0,0,0,0,0,0,NA,29412
East Champaran,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0,0,0,NA,0,0,0,0,0,NA,0,NA,0
East Champaran,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,13804,13804,13804,NA,0,0,0,0,0,0,0,NA,41412
East Champaran,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
East Champaran,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0,0,0,NA,5000,5000,5000,5000,5000,0,0,NA,25000
East Champaran,16.3.02,Stock Position of Gloves,2. Stocks Received,0,0,0,NA,0,0,0,0,0,0,0,NA,0
East Champaran,16.3.02,Stock Position of Gloves,3. Unusable Stock,0,0,0,NA,0,0,0,0,0,0,0,NA,0
East Champaran,16.3.02,Stock Position of Gloves,4. Stock Distributed,0,0,0,NA,5000,5000,5000,5000,5000,0,0,NA,25000
East Champaran,16.3.02,Stock Position of Gloves,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
East Champaran,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0,0,0,NA,0,0,0,0,0,0,0,NA,0
East Champaran,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0,0,0,NA,0,0,0,0,0,0,0,NA,0
East Champaran,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0,0,0,NA,0,0,0,0,0,0,0,NA,0
East Champaran,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0,0,0,NA,0,0,0,0,0,0,0,NA,0
East Champaran,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
East Champaran,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0,0,0,NA,30000,30000,30000,30000,30000,0,0,NA,150000
East Champaran,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,101600,101600,101600,NA,0,0,0,0,0,0,0,NA,304800
East Champaran,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0,0,0,NA,0,0,0,0,0,0,0,NA,0
East Champaran,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,96600,96600,96600,NA,30000,30000,30000,30000,30000,0,0,NA,439800
East Champaran,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,5000,5000,5000,0,0,0,0,0,0,0,0,0,15000
East Champaran,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0,0,0,NA,0,0,0,0,0,0,0,NA,0
East Champaran,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0,0,0,NA,0,0,0,0,0,0,0,NA,0
East Champaran,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0,0,0,NA,0,0,0,0,0,0,0,NA,0
East Champaran,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0,0,0,NA,0,0,0,0,0,0,0,NA,0
East Champaran,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
East Champaran,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0,0,0,NA,0,0,0,0,0,0,0,NA,0
East Champaran,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0,0,0,NA,0,0,0,0,0,0,0,NA,0
East Champaran,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0,0,0,NA,0,0,0,0,0,0,0,NA,0
East Champaran,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0,0,0,NA,0,0,0,0,0,0,0,NA,0
East Champaran,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
East Champaran,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,415000,415000,415000,NA,0,0,0,0,0,0,0,NA,1245000
East Champaran,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,949800,949800,949800,NA,0,0,0,0,0,0,0,NA,2849400
East Champaran,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0,0,0,NA,0,0,0,0,0,0,0,NA,0
East Champaran,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,639800,639800,639800,NA,0,0,0,0,0,0,0,NA,1919400
East Champaran,16.3.07,Stock Position of IFA Tablets,5. Total Stock,725000,725000,725000,0,0,0,0,0,0,0,0,0,2175000
East Champaran,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0,0,0,NA,0,0,0,0,0,0,0,NA,0
East Champaran,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0,0,0,NA,0,0,0,0,0,0,0,NA,0
East Champaran,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,NA,0,0,NA,0,0,0,0,0,0,0,NA,0
East Champaran,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0,0,0,NA,0,0,0,0,0,0,0,NA,0
East Champaran,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
East Champaran,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,6000,6000,6000,NA,0,0,0,0,0,0,0,NA,18000
East Champaran,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,10000,10000,10000,NA,0,0,0,0,0,0,0,NA,30000
East Champaran,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0,0,0,NA,0,0,0,0,0,0,0,NA,0
East Champaran,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,16000,16000,16000,NA,0,0,0,0,0,0,0,NA,48000
East Champaran,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
East Champaran,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,900,900,900,NA,200,200,200,200,200,0,0,NA,3700
East Champaran,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,27250,27250,27250,NA,0,0,0,0,0,0,0,NA,81750
East Champaran,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0,0,0,NA,0,0,0,0,0,0,0,NA,0
East Champaran,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,27030,27030,27030,NA,200,200,200,200,200,0,0,NA,82090
East Champaran,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,1120,1120,1120,0,0,0,0,0,0,0,0,0,3360
East Champaran,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,0,0,0,NA,350966,350966,350966,350966,350966,267170,267170,NA,2289170
East Champaran,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,27250,724548,724548,NA,414810,414810,414810,414810,414810,765776,765776,NA,5081948
East Champaran,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0,0,0,NA,0,0,0,0,0,0,0,NA,0
East Champaran,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,27030,101100,101100,NA,422600,455600,483606,483606,498606,498606,558606,NA,3630460
East Champaran,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,220,623448,623448,0,343176,310176,282170,282170,267170,534340,474340,0,3740658
East Champaran,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,NA,13300,8600,NA,23100,10300,23000,26400,27000,38000,20400,NA,190100
East Champaran,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,10000,7000,22000,NA,0,30000,20000,15500,30000,0,0,NA,134500
East Champaran,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,NA,0,0,NA,0,0,0,0,0,0,0,NA,0
East Champaran,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,12700,11700,15100,NA,12800,17300,16600,27000,19000,17600,17400,NA,167200
East Champaran,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,-2700,8600,15500,0,10300,23000,26400,14900,38000,20400,3000,0,157400
East Champaran,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,NA,63440,43200,NA,111000,10600,135200,92200,107600,254800,120200,NA,938240
East Champaran,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,NA,100000,190000,NA,0,240000,72000,80000,280000,0,0,NA,962000
East Champaran,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0,0,0,NA,0,0,0,0,0,0,0,NA,0
East Champaran,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,120000,120240,137200,NA,100400,115400,115000,64600,132800,134600,120000,NA,1160240
East Champaran,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,-120000,43200,96000,0,10600,135200,92200,107600,254800,120200,200,0,740000
East Champaran,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,8400,6300,4300,NA,14300,2500,19000,20700,22900,38500,24900,NA,161800
East Champaran,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,NA,10000,20000,NA,0,30000,15000,15000,30000,0,0,NA,120000
East Champaran,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,NA,0,0,NA,0,0,0,0,0,0,0,NA,0
East Champaran,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,NA,12000,13000,NA,11800,13500,13300,12800,14400,13600,12200,NA,116600
East Champaran,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,8400,4300,11300,0,2500,19000,20700,22900,38500,24900,12700,0,165200
East Champaran,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,3,NA,4
East Champaran,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
East Champaran,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
East Champaran,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
East Champaran,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
East Champaran,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
East Champaran,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
East Champaran,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,2,1,5,4,12
East Champaran,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,1
East Champaran,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,2,1,6,4,13
East Champaran,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,1,NA,NA,2,14,NA,17
East Champaran,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1,NA,2
East Champaran,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,NA,NA,NA,NA,NA,NA,1,NA,NA,3,15,NA,19
East Champaran,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,1,3
East Champaran,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,1
East Champaran,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,2,1,4
East Champaran,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,3,2,5
East Champaran,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
East Champaran,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,3,2,5
East Champaran,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,6,2,8
East Champaran,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
East Champaran,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,6,2,8
East Champaran,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
East Champaran,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,1
East Champaran,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,1
East Champaran,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,2,7
East Champaran,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,1
East Champaran,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,6,2,8
East Champaran,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
East Champaran,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
East Champaran,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
East Champaran,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
East Champaran,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
East Champaran,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
East Champaran,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
East Champaran,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
East Champaran,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
East Champaran,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
East Champaran,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,1
East Champaran,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,1
East Champaran,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
East Champaran,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
East Champaran,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
East Champaran,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
East Champaran,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
East Champaran,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
East Champaran,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,1,2
East Champaran,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,1,2
East Champaran,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
East Champaran,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
East Champaran,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
East Champaran,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
East Champaran,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
East Champaran,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,1
East Champaran,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1,2
East Champaran,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,1,3
East Champaran,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
East Champaran,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
East Champaran,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,1,NA,1,NA,1,3
East Champaran,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,NA,NA,NA,NA,NA,NA,NA,1,NA,1,NA,1,3
East Champaran,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
East Champaran,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1
East Champaran,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
East Champaran,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1
East Champaran,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
East Champaran,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
East Champaran,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
East Champaran,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
East Champaran,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
East Champaran,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
East Champaran,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
East Champaran,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
East Champaran,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
East Champaran,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,2
East Champaran,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
East Champaran,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,2
East Champaran,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
East Champaran,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1
East Champaran,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
East Champaran,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1
East Champaran,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
East Champaran,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,1,2,3,2,8
East Champaran,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
East Champaran,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,1,2,3,2,8
East Champaran,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
East Champaran,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
East Champaran,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
East Champaran,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
East Champaran,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
East Champaran,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1
East Champaran,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
East Champaran,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1
East Champaran,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
East Champaran,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
East Champaran,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
East Champaran,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
East Champaran,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
East Champaran,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,NA,2
East Champaran,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
East Champaran,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,NA,2
East Champaran,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
East Champaran,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
East Champaran,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1
East Champaran,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1
East Champaran,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,1,2
East Champaran,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,NA,NA,NA,NA,NA,2,NA,NA,1,3,3,2,11
East Champaran,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,NA,NA,NA,NA,NA,4,2,3,3,7,12,7,38
East Champaran,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,NA,NA,NA,NA,NA,6,2,4,4,10,15,10,51
Gaya,1.1,Total number of pregnant women Registered for ANC,TOTAL,10035,10456,11063,11285,9076,9536,8648,7404,8576,8492,9413,9236,113220
Gaya,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,6120,5713,6019,6727,5028,5111,4735,4225,4824,5271,5857,5710,65340
Gaya,1.2,Number of Pregnant women registered under JSY,TOTAL,9668,10010,11024,11159,8614,9500,8633,7363,8569,8474,9404,9197,111615
Gaya,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,7358,7305,7783,8335,7491,8154,7833,6975,7512,6738,6520,6199,88203
Gaya,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,6784,7045,7327,7916,6026,5982,5540,4744,5480,5519,6262,6023,74648
Gaya,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,8278,9068,9169,10031,8595,7477,6800,5632,5866,5857,6126,7108,90007
Gaya,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,8210,7436,6934,6505,6056,7755,6924,6131,6289,6420,6242,7026,81928
Gaya,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,241,415,121,127,300,203,295,148,201,261,297,279,2888
Gaya,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,13,10,17,14,9,15,21,15,17,20,22,28,201
Gaya,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,1296,522,459,949,964,1377,603,532,860,747,957,806,10072
Gaya,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,7,893,5,4,5,4,27,6,20,7,44,30,1052
Gaya,1.8,Number of pregnancy test kits used at SC level,TOTAL,315,195,235,329,401,407,611,629,704,726,844,866,6262
Gaya,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,152,156,164,177,204,190,190,197,203,240,296,205,2374
Gaya,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,1796,1670,1735,1992,2092,2458,2491,2443,2501,2427,2186,1760,25551
Gaya,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,1948,1826,1899,2169,2296,2648,2681,2640,2704,2667,2482,1965,27925
Gaya,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,897,933,936,1191,1320,1437,1456,1439,1488,1686,1678,1306,15767
Gaya,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0,5,0,2,6,14,6,9,18,22,11,36,129
Gaya,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,2931,3190,2852,4531,5017,5001,5180,4975,4628,4212,3411,3095,49023
Gaya,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,2448,2638,2372,3728,4230,4137,4225,4121,3764,3316,2752,2425,40156
Gaya,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,2675,3070,2775,4113,5356,4958,5444,4735,4842,4120,3680,3513,49281
Gaya,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1310,2166,2627,3340,2904,3536,3957,3049,3160,3394,2976,3611,36030
Gaya,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0,0,0,0,0,6,0,0,0,0,2,0,8
Gaya,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,NA,NA,NA,NA,NA,NA,248,487,323,366,152,193,1769
Gaya,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gaya,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gaya,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gaya,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,3,0,0,0,1,2,3,1,0,8,0,3,21
Gaya,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gaya,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,101,114,162,110,91,129,187,113,207,210,71,59,1554
Gaya,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gaya,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,104,114,162,110,92,131,190,114,207,218,71,62,1575
Gaya,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,NA,NA,NA,NA,NA,NA,36,24,41,36,51,39,227
Gaya,4.1.1.a,Number of male live births,TOTAL,2707,2729,2615,3458,3821,3829,4056,3916,3689,3610,3195,2737,40362
Gaya,4.1.1.b,Number of female live births,TOTAL,2352,2358,2315,3235,3579,3799,3824,3731,3431,3358,2855,2432,37269
Gaya,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,5059,5087,4930,6693,7400,7628,7880,7647,7120,6968,6050,5169,77631
Gaya,4.1.2,Number of still births,TOTAL,75,111,92,88,131,104,124,86,82,134,134,51,1212
Gaya,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,15,25,15,10,9,5,3,6,2,2,1,15,108
Gaya,4.2.1,Number of Newborns weighed at birth,TOTAL,4591,4783,4585,6264,6779,7040,7332,7144,6594,6285,5452,4653,71502
Gaya,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,285,312,345,389,526,484,627,611,593,576,455,439,5642
Gaya,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,4693,4817,4648,6491,7121,7377,7593,7328,6835,6544,5664,4829,73940
Gaya,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,23,39,30,28,42,63,85,78,75,136,100,105,804
Gaya,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gaya,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,121,133,84,129,106,138,115,124,106,113,82,70,1321
Gaya,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gaya,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,144,172,114,157,148,201,200,202,181,249,182,175,2125
Gaya,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gaya,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,1195,1328,1348,1561,1863,1809,1493,1671,1253,1327,784,793,16425
Gaya,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,325,49,345,540,532,519,497,530,433,467,552,375,5164
Gaya,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,1344,1301,1474,1559,1858,1655,1668,1787,1469,1511,878,905,17409
Gaya,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,3,1,1,3,0,2,0,2,2,2,1,0,17
Gaya,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,2601,2701,2765,4052,4472,4489,4680,4301,4258,4209,4012,3292,45832
Gaya,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,2688,2410,2368,3388,3626,4022,3955,3945,4008,3557,3130,2654,39751
Gaya,6.3,PNC maternal complications attended,TOTAL,4,5,3,1,3,2,2,2,3,2,4,0,31
Gaya,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,1,2,1,2,2,0,2,2,2,4,71,20,109
Gaya,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0,0,1,0,0,0,1,0,0,0,1,0,3
Gaya,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,1,2,2,2,2,0,3,2,2,4,72,20,112
Gaya,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Gaya,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,405,591,539,272,475,475,497,536,704,561,554,468,6077
Gaya,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,751,763,411,414,809,736,840,642,861,748,682,613,8270
Gaya,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,1156,1354,950,686,1284,1211,1337,1178,1565,1309,1236,1081,14347
Gaya,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0,21,0,0,0,0,1,0,0,0,0,2,24
Gaya,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,5,19,17,17,32,5,6,5,36,9,20,10,181
Gaya,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gaya,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0,1,1,0,0,8,7,6,7,4,3,2,39
Gaya,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gaya,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,5,20,18,17,32,13,13,11,43,13,23,12,220
Gaya,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,NA,NA,NA,NA,18,10,10,4,9,8,5,4,68
Gaya,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0,0,0,78,0,0,0,0,0,0,0,0,78
Gaya,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gaya,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Gaya,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gaya,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0,0,0,78,0,0,0,0,0,0,0,0,78
Gaya,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,0
Gaya,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,259,225,198,858,508,1339,1477,706,2840,2855,2556,1082,14903
Gaya,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gaya,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,69,67,62,76,73,118,157,147,370,308,338,149,1934
Gaya,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gaya,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,328,292,260,934,581,1457,1634,853,3210,3163,2894,1231,16837
Gaya,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,NA,NA,NA,NA,197,235,245,345,742,609,309,170,2852
Gaya,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,17,48,34,23,32,156,73,45,85,76,74,41,704
Gaya,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gaya,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,61,57,64,61,75,112,115,88,101,97,86,77,994
Gaya,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gaya,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,78,105,98,84,107,268,188,133,186,173,160,118,1698
Gaya,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,NA,NA,NA,NA,NA,NA,NA,1,12,5,9,4,31
Gaya,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,735,572,663,1023,559,799,763,723,1212,1061,1129,741,9980
Gaya,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,439,360,287,761,430,484,444,378,664,512,567,325,5651
Gaya,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gaya,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,59,122,66,225,174,176,184,160,195,143,119,96,1719
Gaya,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gaya,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,1233,1054,1016,2009,1163,1459,1391,1261,2071,1716,1815,1162,17350
Gaya,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,259,228,166,361,342,328,299,271,311,314,311,238,3428
Gaya,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,NA,NA,NA,NA,30,111,77,162,212,178,132,32,934
Gaya,9.06,Number of IUCD removals,TOTAL,467,590,457,516,442,561,478,491,747,872,783,407,6811
Gaya,9.07,Number of Oral Pills cycles distributed,TOTAL,6218,3944,3233,4223,4458,4092,5234,6140,5847,5693,6927,6535,62544
Gaya,9.08,Number of Condom pieces distributed,TOTAL,16853,13609,16153,20010,21174,23485,20395,21814,27765,25146,25623,25635,257662
Gaya,9.09,Number of Centchroman (weekly) pills given,TOTAL,419,424,349,308,327,241,373,309,323,162,165,261,3661
Gaya,9.1,Number of Emergency Contraceptive Pills distributed,TOTAL,793,1210,762,851,686,1013,1026,907,1058,1168,1149,1112,11735
Gaya,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0,0,0,3,0,7,0,3,2,0,0,0,15
Gaya,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0,10,0,2,0,8,0,34,2,0,0,0,56
Gaya,9.11.2.a,Number of failures following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Gaya,9.11.2.b,Number of failures following female sterilization,TOTAL,0,0,0,0,1,0,0,0,0,0,0,0,1
Gaya,9.11.3.a,Number of deaths following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Gaya,9.11.3.b,Number of deaths following female sterilization,TOTAL,0,0,0,0,1,0,0,0,0,0,0,0,1
Gaya,9.12,Number of Institutions having NSV trained doctors,TOTAL,NA,NA,NA,NA,9,7,7,10,9,9,9,11,Data for this item can not be cumulated
Gaya,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,7289,6180,6102,8151,8758,10432,11281,10364,11314,9624,8837,7508,105840
Gaya,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,116,15,84,33,60,135,87,113,146,251,1,3,1044
Gaya,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,1452,777,486,408,137,131,207,136,160,190,18,6,4108
Gaya,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,3709,2101,1129,1203,513,278,263,160,173,228,45,37,9839
Gaya,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,8708,6749,6366,7038,6724,8529,10410,10059,11009,10983,9983,9488,106046
Gaya,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,8083,8528,6757,7004,6681,6749,8104,8087,10185,10665,10496,10728,102067
Gaya,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,6484,7580,7544,7358,6499,6350,6965,6715,8259,9681,9960,10567,93962
Gaya,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,3569,3680,3542,4857,5972,6546,7000,6402,6100,5636,5099,4621,63024
Gaya,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,8703,6550,6334,7047,6381,7896,10101,9616,11184,10689,9675,9371,103547
Gaya,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,9290,8998,7067,7090,6344,6375,7801,7986,10103,10326,10049,10504,101933
Gaya,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,9694,9319,8408,8116,6520,6161,6794,6447,8103,9507,9576,10099,98744
Gaya,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,2451,2687,2317,3535,4167,4280,4871,4508,4954,4511,4144,3261,45686
Gaya,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,373,400,221,26,235,15,199,265,28,341,13,0,2116
Gaya,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,1437,894,497,362,211,105,251,278,50,328,9,0,4422
Gaya,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,3658,2300,1216,1040,630,324,302,335,38,344,31,13,10231
Gaya,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,8920,9216,8713,10249,9107,9924,10392,8401,8246,6384,7555,7714,104821
Gaya,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,9710,7643,6428,6768,5847,5985,6987,5755,7803,6903,8574,9376,87779
Gaya,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,7881,8705,8208,9577,8808,9344,9763,7755,7841,6280,6550,6927,97639
Gaya,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,4500,4537,4428,5193,4463,4783,4971,4127,4282,3298,3882,4073,52537
Gaya,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,3898,4028,4011,4871,4180,4563,4629,3729,3923,2969,3375,3490,47666
Gaya,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,8398,8565,8439,10064,8643,9346,9600,7856,8205,6267,7257,7563,100203
Gaya,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,9685,8241,7112,7716,6105,6239,6878,6119,8086,7988,9074,9807,93050
Gaya,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,9709,8171,7106,7672,5963,6019,6746,5973,7948,7839,8869,9527,91542
Gaya,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,70,56,21,24,23,7,12,14,8,8,8,0,251
Gaya,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2394,2300,1985,2365,2063,2083,1987,1960,2610,2499,2771,2844,27861
Gaya,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2236,2080,1786,2182,1783,1843,1833,1739,2289,2232,2468,2593,25064
Gaya,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,4630,4380,3771,4547,3846,3926,3820,3699,4899,4731,5239,5437,52925
Gaya,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,364,427,499,610,648,916,1168,1130,1200,1308,1376,1454,11100
Gaya,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,2537,2319,2043,2431,2464,2553,2624,2404,2828,2756,2781,2759,30499
Gaya,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,3207,2880,2604,3187,3248,3417,3286,3031,3310,3576,3530,3641,38917
Gaya,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,6,1,4,0,7,9,5,0,0,0,6,0,38
Gaya,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0,0,0,1,0,9,0,0,0,0,0,0,10
Gaya,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,2,0,5,0,7,9,0,0,0,0,0,0,23
Gaya,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,5308,5226,4993,5180,4955,5338,5348,5187,5295,5296,5153,5239,62518
Gaya,10.4.2,Number of Immunisation sessions held during the month,TOTAL,5258,5140,4912,5169,4705,5022,5077,4872,5089,5051,4929,5014,60238
Gaya,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,4807,4783,4506,4731,4144,4384,4690,4461,4647,4661,4571,4629,55014
Gaya,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,9479,8713,7016,7617,5941,11692,11441,6308,7748,7535,7993,8823,100306
Gaya,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,3663,4017,3319,3842,3498,3818,3740,2911,3023,2108,2235,2007,38181
Gaya,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,1510,3351,1266,1350,1144,1075,1173,1057,1030,1019,1146,894,16015
Gaya,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,209,253,198,197,277,199,234,225,331,374,349,313,3159
Gaya,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0,9,0,5,0,0,0,0,0,0,0,0,14
Gaya,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Gaya,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Gaya,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0,0,0,2,0,0,0,0,0,0,0,0,2
Gaya,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Gaya,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,20,13,28,19,6,0,0,0,0,14,79,4,183
Gaya,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,1946,2346,2283,2669,3059,2771,1986,1761,1449,1261,1209,1132,23872
Gaya,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,8,3,70,3,73,93,71,207,0,0,12,54,594
Gaya,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,20,10,19,19,12,8,0,0,2,4,9,12,115
Gaya,13.1,Number of Patients operated for cataract,TOTAL,0,8,0,0,0,0,0,17349,6521,0,13,22,23913
Gaya,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0,8,0,0,0,0,0,0,0,0,13,22,43
Gaya,13.3,Number of School children detected with Refractive errors,TOTAL,1,0,0,5,0,2,1,2,3,2,2,0,18
Gaya,13.4,Number of children provided free glasses,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Gaya,13.5,Number of eyes collected through eye donation,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Gaya,13.6,Number of eyes utilised for corneal transplant,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Gaya,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,NA,NA,NA,NA,2,3,3,3,3,2,3,3,Data for this item can not be cumulated
Gaya,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,NA,NA,NA,NA,23,25,25,27,26,26,25,26,Data for this item can not be cumulated
Gaya,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,2845,2680,2638,2923,2730,2900,2927,2867,2896,2906,2924,2899,Data for this item can not be cumulated
Gaya,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,NA,NA,NA,NA,2,4,3,4,3,2,4,4,Data for this item can not be cumulated
Gaya,14.05,Number of RKS meetings held during the month,TOTAL,35,33,44,37,52,40,38,43,44,44,43,43,496
Gaya,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,NA,NA,NA,NA,20,24,24,24,24,24,25,24,Data for this item can not be cumulated
Gaya,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,2277,2020,1981,2911,2566,2280,2982,2455,2637,2585,2036,2346,29076
Gaya,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,NA,NA,NA,NA,1,2,1,1,1,1,2,2,Data for this item can not be cumulated
Gaya,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,NA,NA,NA,NA,NA,1,0,0,0,NA,0,0,Data for this item can not be cumulated
Gaya,14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gaya,14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gaya,14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gaya,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,2082,2104,2246,2463,2658,2550,2661,2569,2270,2055,1908,1802,27368
Gaya,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,2666,2555,2526,2157,2900,2695,2765,2002,2015,2370,2658,2660,29969
Gaya,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,2249,2082,1959,2409,2642,2609,2528,2358,2343,2091,1914,1638,26822
Gaya,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,4768,4951,4405,6112,6749,6700,6948,6106,7065,6831,6462,4892,71989
Gaya,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,4331,4186,4205,4872,5300,5159,5189,4927,4613,4146,3822,3440,54190
Gaya,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,7434,7506,6931,8269,9649,9395,9713,8108,9080,9201,9120,7552,101958
Gaya,14.10.2.a,Number of death cases of Inpatient males,TOTAL,54,58,98,2,62,58,41,44,2,84,55,66,624
Gaya,14.10.2.b,Number of death cases of Inpatient females,TOTAL,67,45,54,4,29,33,48,48,4,64,58,53,507
Gaya,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,121,103,152,6,91,91,89,92,6,148,113,119,1131
Gaya,14.11,In-Patient Head Count at midnight,TOTAL,7038,7169,7666,9329,9690,11323,12599,11596,13139,12489,11395,8609,122042
Gaya,14.12.1,OPD attendance (All),TOTAL,271626,273194,259957,278599,316254,318098,290753,269248,299319,290566,290508,269582,3427704
Gaya,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,1437,1172,505,1180,1163,2012,1619,1043,3335,3338,3172,1458,21434
Gaya,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,75,45,73,98,76,569,42,14,123,86,0,0,1201
Gaya,14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gaya,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,4191,3602,3242,3804,4067,4200,4614,4562,4760,4817,4768,4717,51344
Gaya,14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gaya,14.14.a,Number of patients given AYUSH treatment,TOTAL,45211,46484,41916,49026,53059,47317,51766,45356,51310,50007,47074,37286,565812
Gaya,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,8037,5410,6707,8860,7363,10050,9761,7097,8328,8426,8181,6758,94978
Gaya,14.14.c,Number of Adolescents counselled,TOTAL,401,842,323,878,793,1047,881,820,757,677,723,653,8795
Gaya,15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gaya,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,3223,3391,3298,2049,4028,4685,2220,1219,2545,3227,4306,3645,37836
Gaya,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,83,128,55,32,52,78,147,64,242,168,299,238,1586
Gaya,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,425,425,391,62,430,445,249,96,495,688,680,501,4887
Gaya,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,28,26,26,0,29,28,22,3,10,23,30,21,246
Gaya,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,474,439,631,58,439,635,265,143,903,832,871,693,6383
Gaya,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,17,16,18,1,21,23,16,1,13,17,23,27,193
Gaya,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,1020,1059,193,345,773,161,75,63,1121,569,1265,1170,7814
Gaya,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,4,9,2,0,0,0,0,0,2,0,0,1,18
Gaya,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,1919,1923,1215,465,1642,1241,589,302,2519,2089,2816,2364,19084
Gaya,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,49,51,46,1,50,51,38,4,25,40,53,49,457
Gaya,15.2,Number of Widal tests conducted,Number tested,24,84,83,29,165,47,32,193,192,66,86,142,1143
Gaya,15.3.a,Number of VDRL tests conducted on males,Number tested,0,46,56,2,41,2,0,34,27,44,57,35,344
Gaya,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,0,18,18,0,21,20,0,18,22,16,27,18,178
Gaya,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,279,489,500,174,121,590,79,120,158,138,280,298,3226
Gaya,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,279,553,574,176,183,612,79,172,207,198,364,351,3748
Gaya,15.4.1,Number of blood smears examined for Malaria,TOTAL,1165,1004,1389,1422,1556,2284,2091,1049,1319,1436,1511,1510,17736
Gaya,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,10,8,11,6,25,69,20,13,29,12,17,13,233
Gaya,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,4,5,14,6,14,8,5,8,20,17,15,12,128
Gaya,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,4544,NA,2504,4654,4635,3795,3145,2790,2050,2385,1950,1500,33952
Gaya,16.1.1,Stock position of DPT vaccines,2. Stocks Received,2000,NA,3400,1500,0,2200,0,0,2250,0,1000,500,12850
Gaya,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0,NA,0,0,0,0,0,0,0,0,0,0,0
Gaya,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,1570,NA,1250,1519,840,2850,355,740,1915,435,1450,1980,14904
Gaya,16.1.1,Stock position of DPT vaccines,5. Total Stock,4974,0,4654,4635,3795,3145,2790,2050,2385,1950,1500,20,31898
Gaya,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,2650,NA,3315,4591,5349,3695,4461,2427,2705,1509,1691,1776,34169
Gaya,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,5400,NA,4376,4052,0,3240,0,3240,2016,3240,3240,3456,32260
Gaya,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0,NA,0,0,0,0,0,0,0,0,0,0,0
Gaya,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,1865,NA,3100,3294,1645,2474,2034,3262,3212,3058,3251,3840,31035
Gaya,16.1.1A,Stock Position of Pentavalent,5. Total Stock,6185,0,4591,5349,3704,4461,2427,2405,1509,1691,1680,1392,35394
Gaya,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,5264,NA,1594,1819,1544,1388,713,688,613,288,0,1000,14911
Gaya,16.1.2,Stock position of OPV vaccines,2. Stocks Received,3000,NA,3900,3300,2700,2750,2750,2750,2713,2750,2750,1075,30438
Gaya,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0,NA,0,0,0,0,0,0,0,0,0,0,0
Gaya,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,2975,NA,3675,3575,2756,3425,2775,2825,3075,3038,1750,1725,31594
Gaya,16.1.2,Stock position of OPV vaccines,5. Total Stock,5289,0,1819,1544,1488,713,688,613,251,0,1000,350,13755
Gaya,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,7316,NA,5031,7766,8516,7124,3579,1921,3581,2841,2056,3606,53337
Gaya,16.1.3,Stock position of TT vaccines,2. Stocks Received,3000,NA,5500,4000,1000,0,300,4000,2000,2000,4150,4250,30200
Gaya,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0,NA,0,0,0,0,0,0,0,0,0,0,0
Gaya,16.1.3,Stock position of TT vaccines,4. Stock Distributed,2195,NA,7766,3250,2392,3545,1958,3240,2740,2785,2600,2200,34671
Gaya,16.1.3,Stock position of TT vaccines,5. Total Stock,8121,0,2765,8516,7124,3579,1921,2681,2841,2056,3606,5656,48866
Gaya,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0,NA,0,0,0,0,0,NA,NA,0,0,0,0
Gaya,16.1.4,Stock position of DT vaccines,2. Stocks Received,0,NA,0,0,0,0,0,NA,NA,0,0,0,0
Gaya,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0,NA,0,0,0,0,0,NA,NA,0,0,0,0
Gaya,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0,NA,0,0,0,0,0,NA,NA,0,0,0,0
Gaya,16.1.4,Stock position of DT vaccines,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Gaya,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,2899,NA,759,1850,3440,3669,2729,2659,2109,1400,1250,1230,23994
Gaya,16.1.5,Stock position of BCG vaccines,2. Stocks Received,2000,NA,3100,4250,2000,2000,2000,2000,2000,2000,2000,2000,25350
Gaya,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0,NA,0,0,0,0,0,0,0,0,0,0,0
Gaya,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,2489,NA,2009,2660,1771,2940,2070,2550,2709,2150,2020,2030,25398
Gaya,16.1.5,Stock position of BCG vaccines,5. Total Stock,2410,0,1850,3440,3669,2729,2659,2109,1400,1250,1230,1200,23946
Gaya,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,4110,NA,560,1780,1990,2798,948,1020,1860,500,1430,2410,19406
Gaya,16.1.6,Stock position of Measles vaccines,2. Stocks Received,6000,NA,7300,6000,5200,3000,4000,5200,1850,5200,5200,3000,51950
Gaya,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0,NA,6080,0,0,0,0,0,0,0,0,0,6080
Gaya,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,4110,NA,1780,5650,4382,4850,3928,4360,3210,4370,4220,4220,45080
Gaya,16.1.6,Stock position of Measles vaccines,5. Total Stock,6000,0,0,2130,2808,948,1020,1860,500,1330,2410,1190,20196
Gaya,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,3329,NA,405,1885,2390,3168,8708,1761,2180,2370,1390,2160,29746
Gaya,16.1.7,Stock position of JE vaccines,2. Stocks Received,6000,NA,7300,6000,5200,14000,0,1100,5200,2500,5150,3000,55450
Gaya,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0,NA,5820,0,0,0,0,0,0,0,0,0,5820
Gaya,16.1.7,Stock position of JE vaccines,4. Stock Distributed,3309,NA,1885,5495,4422,8460,7500,2630,5010,3480,4380,3950,50521
Gaya,16.1.7,Stock position of JE vaccines,5. Total Stock,6020,0,0,2390,3168,8708,1208,231,2370,1390,2160,1210,28855
Gaya,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,2749,NA,2504,2636,3086,2986,2186,2185,2301,2806,2276,2426,28141
Gaya,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,1000,NA,3400,1550,500,0,0,0,1100,0,500,4000,12050
Gaya,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0,NA,0,0,0,0,0,0,0,0,0,2160,2160
Gaya,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,1863,NA,1250,1100,600,800,425,585,595,530,350,3650,11748
Gaya,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,1886,0,4654,3086,2986,2186,1761,1600,2806,2276,2426,616,26283
Gaya,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,50,NA,27505,20200,15400,15400,12750,11550,11550,11550,10950,10950,147855
Gaya,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0,NA,0,0,0,0,0,0,0,0,0,13452,13452
Gaya,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0,NA,0,0,0,0,0,0,0,0,0,0,0
Gaya,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,25,NA,7305,4800,2650,2650,1200,600,600,600,900,9342,30672
Gaya,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,25,0,20200,15400,12750,12750,11550,10950,10950,10950,10050,15060,130635
Gaya,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,12000,NA,163310,368516,250676,250676,134096,122096,122096,122096,116096,94456,1756114
Gaya,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0,NA,0,0,0,0,0,0,0,0,0,0,0
Gaya,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0,NA,0,0,0,0,0,0,0,0,0,0,0
Gaya,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,1950,NA,90720,117840,56200,116580,12000,6000,6000,6000,21640,0,434930
Gaya,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,10050,0,72590,250676,194476,134096,122096,116096,116096,116096,94456,94456,1321184
Gaya,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,600,NA,27180,19780,11380,11380,5880,4680,4680,4680,4080,1080,95400
Gaya,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0,NA,0,0,0,0,0,0,0,0,0,0,0
Gaya,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0,NA,0,0,0,0,0,0,0,0,0,0,0
Gaya,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,100,NA,7400,8400,5500,5500,1200,600,600,600,3000,0,32900
Gaya,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,500,0,19780,11380,5880,5880,4680,4080,4080,4080,1080,1080,62500
Gaya,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,NA,NA,27978,18378,9328,9328,5378,5178,5178,5178,5178,3978,95080
Gaya,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,NA,NA,0,0,0,0,0,0,0,0,0,0,0
Gaya,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,NA,NA,0,0,0,0,0,0,0,0,0,0,0
Gaya,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,NA,NA,9600,9050,3950,3950,200,0,0,0,1200,0,27950
Gaya,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0,0,18378,9328,5378,5378,5178,5178,5178,5178,3978,3978,67130
Gaya,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0
Gaya,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0
Gaya,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0
Gaya,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0
Gaya,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Gaya,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,NA,NA,NA,NA,0,NA,0,0,0,0,0,NA,0
Gaya,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,NA,NA,NA,NA,0,NA,0,0,0,0,0,NA,0
Gaya,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,NA,NA,NA,NA,0,NA,0,0,0,0,0,NA,0
Gaya,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,NA,NA,NA,NA,0,NA,0,0,0,0,0,NA,0
Gaya,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Gaya,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,NA,NA,NA,NA,0,NA,0,0,0,0,0,NA,0
Gaya,16.3.02,Stock Position of Gloves,2. Stocks Received,NA,NA,NA,NA,0,NA,0,0,0,0,0,NA,0
Gaya,16.3.02,Stock Position of Gloves,3. Unusable Stock,NA,NA,NA,NA,0,NA,0,0,0,0,0,NA,0
Gaya,16.3.02,Stock Position of Gloves,4. Stock Distributed,NA,NA,NA,NA,0,NA,0,0,0,0,0,NA,0
Gaya,16.3.02,Stock Position of Gloves,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Gaya,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,NA,NA,NA,NA,0,NA,0,0,0,0,0,NA,0
Gaya,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,NA,NA,NA,NA,0,NA,0,0,0,0,0,NA,0
Gaya,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,NA,NA,NA,NA,0,NA,0,0,0,0,0,NA,0
Gaya,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,NA,NA,NA,NA,0,NA,0,0,0,0,0,NA,0
Gaya,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Gaya,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,NA,NA,NA,NA,0,NA,0,0,0,0,0,NA,0
Gaya,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,NA,NA,NA,NA,0,NA,0,0,0,0,0,NA,0
Gaya,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,NA,NA,NA,NA,0,NA,0,0,0,0,0,NA,0
Gaya,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,NA,NA,NA,NA,0,NA,0,0,0,0,0,NA,0
Gaya,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Gaya,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,NA,NA,NA,NA,0,NA,0,0,0,0,0,NA,0
Gaya,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,NA,NA,NA,NA,0,NA,0,0,0,0,0,NA,0
Gaya,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,NA,NA,NA,NA,0,NA,0,0,0,0,0,NA,0
Gaya,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,NA,NA,NA,NA,0,NA,0,0,0,0,0,NA,0
Gaya,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Gaya,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,NA,NA,NA,NA,0,NA,0,0,0,0,0,NA,0
Gaya,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,NA,NA,NA,NA,0,NA,0,0,0,0,0,NA,0
Gaya,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,NA,NA,NA,NA,0,NA,0,0,0,0,0,NA,0
Gaya,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,NA,NA,NA,NA,0,NA,0,0,0,0,0,NA,0
Gaya,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Gaya,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,NA,NA,NA,NA,0,NA,0,0,0,0,0,NA,0
Gaya,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,NA,NA,NA,NA,0,NA,0,0,0,0,0,NA,0
Gaya,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,NA,NA,NA,NA,0,NA,0,0,0,0,0,NA,0
Gaya,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,NA,NA,NA,NA,0,NA,0,0,0,0,0,NA,0
Gaya,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Gaya,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,NA,NA,NA,NA,0,NA,0,0,0,0,0,NA,0
Gaya,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,NA,NA,NA,NA,0,NA,0,0,0,0,0,NA,0
Gaya,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,NA,NA,NA,NA,0,NA,0,0,0,0,0,NA,0
Gaya,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,NA,NA,NA,NA,0,NA,0,0,0,0,0,NA,0
Gaya,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Gaya,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,NA,NA,NA,NA,0,NA,0,0,0,0,0,NA,0
Gaya,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,NA,NA,NA,NA,0,NA,0,0,0,0,0,NA,0
Gaya,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,NA,NA,NA,NA,0,NA,0,0,0,0,0,NA,0
Gaya,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,NA,NA,NA,NA,0,NA,0,0,0,0,0,NA,0
Gaya,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Gaya,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,NA,NA,NA,NA,0,NA,0,0,0,0,0,NA,0
Gaya,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,NA,NA,NA,NA,0,NA,0,0,0,0,0,NA,0
Gaya,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,NA,NA,NA,NA,0,NA,0,0,0,0,0,NA,0
Gaya,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,NA,NA,NA,NA,0,NA,0,0,0,0,0,NA,0
Gaya,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Gaya,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,NA,NA,NA,NA,0,NA,0,0,0,0,0,NA,0
Gaya,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,NA,NA,NA,NA,0,NA,0,0,0,0,0,NA,0
Gaya,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,NA,NA,NA,NA,0,NA,0,0,0,0,0,NA,0
Gaya,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,NA,NA,NA,NA,0,NA,0,0,0,0,0,NA,0
Gaya,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Gaya,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,2250,NA,10030,11740,20860,10490,19266,8956,1256,7800,1000,11400,105048
Gaya,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,12000,NA,12000,0,0,200000,0,0,20856,0,22000,0,266856
Gaya,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0,NA,0,0,0,0,0,0,0,0,0,0,0
Gaya,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,5160,NA,10290,10880,10370,192090,10310,7700,14312,6800,11200,8900,288012
Gaya,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,9090,0,11740,860,10490,18400,8956,1256,7800,1000,11800,2500,83892
Gaya,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,2570,NA,2400,101200,200000,97000,186200,85000,17400,188200,91200,277600,1248770
Gaya,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,7000,NA,150000,0,0,200000,0,0,300000,0,303000,0,960000
Gaya,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0,NA,0,0,0,0,0,0,0,0,0,0,0
Gaya,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,3553,NA,51200,89100,103000,110800,101200,67600,129200,97000,116600,111000,980253
Gaya,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,6017,0,101200,12100,97000,186200,85000,17400,188200,91200,277600,166600,1228517
Gaya,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,2570,NA,8637,13022,5227,18444,29294,24094,18094,40894,34794,30694,225764
Gaya,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,7000,NA,10000,0,20000,18000,0,0,30000,0,4000,5000,94000
Gaya,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0,NA,0,0,0,0,0,0,0,0,0,0,0
Gaya,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,3253,NA,5615,7795,6783,7150,5200,5800,6000,6100,8100,12294,74090
Gaya,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,6317,0,13022,5227,18444,29294,24094,18294,42094,34794,30694,23400,245674
Gaya,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,NA,NA,NA,NA,NA,1,3,NA,NA,NA,NA,NA,4
Gaya,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gaya,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gaya,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gaya,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,1
Gaya,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gaya,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,1
Gaya,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,2,NA,NA,NA,NA,2
Gaya,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,1
Gaya,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,NA,NA,NA,NA,NA,NA,NA,2,1,NA,NA,NA,3
Gaya,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,1,1,NA,1,NA,1,NA,4
Gaya,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gaya,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,NA,NA,NA,NA,NA,1,1,NA,1,NA,1,NA,4
Gaya,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1
Gaya,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gaya,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1
Gaya,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gaya,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,NA,1
Gaya,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,NA,1
Gaya,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,1
Gaya,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1,NA,2
Gaya,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,NA,NA,NA,NA,NA,NA,NA,1,NA,1,1,NA,3
Gaya,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gaya,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gaya,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gaya,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,1,1,NA,1,1,NA,4
Gaya,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,2,NA,NA,NA,NA,2
Gaya,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,NA,NA,NA,NA,NA,NA,1,3,NA,1,1,NA,6
Gaya,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gaya,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gaya,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,1
Gaya,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,1
Gaya,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gaya,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,1
Gaya,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gaya,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,1
Gaya,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gaya,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,1,NA,2
Gaya,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,1,NA,6
Gaya,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,NA,NA,NA,NA,NA,1,NA,NA,NA,5,2,NA,8
Gaya,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gaya,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gaya,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gaya,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gaya,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gaya,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gaya,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,1
Gaya,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,1
Gaya,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gaya,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gaya,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gaya,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gaya,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gaya,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,1,1,1,2,5
Gaya,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,NA,NA,2
Gaya,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,1,3,1,2,7
Gaya,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gaya,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gaya,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,1,NA,2
Gaya,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,1,NA,2
Gaya,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gaya,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gaya,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gaya,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gaya,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gaya,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,2,NA,9,11,2,2,26
Gaya,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gaya,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,NA,NA,NA,NA,NA,NA,2,NA,9,11,2,2,26
Gaya,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gaya,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,1
Gaya,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gaya,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,1
Gaya,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gaya,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,1,1,NA,1,3
Gaya,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gaya,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,1,1,NA,1,3
Gaya,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gaya,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gaya,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gaya,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gaya,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gaya,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,NA,NA,NA,NA,NA,1,2,3,5,NA,NA,NA,11
Gaya,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gaya,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,NA,NA,NA,NA,NA,1,2,3,5,NA,NA,NA,11
Gaya,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,1
Gaya,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1
Gaya,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1
Gaya,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,2,3
Gaya,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gaya,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,1
Gaya,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gaya,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,1
Gaya,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gaya,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,NA,1
Gaya,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gaya,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,NA,1
Gaya,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gaya,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gaya,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,1,NA,1,1,NA,3,6
Gaya,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,NA,NA,NA,NA,NA,NA,1,NA,1,1,NA,3,6
Gaya,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gaya,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gaya,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,5,4,2,3,6,2,22
Gaya,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,NA,NA,NA,NA,NA,NA,5,4,2,3,6,2,22
Gaya,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,1
Gaya,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,NA,NA,NA,NA,1,5,NA,NA,1,NA,NA,3,10
Gaya,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,8,9,10,11,10,6,54
Gaya,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,NA,NA,NA,NA,1,5,8,9,11,12,10,9,65
Gopalganj,1.1,Total number of pregnant women Registered for ANC,TOTAL,6360,5099,4747,7083,7190,7820,6545,6028,6880,6889,7577,8315,80533
Gopalganj,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,3691,2948,2768,3648,4469,4448,3762,3587,4178,4324,5019,5580,48422
Gopalganj,1.2,Number of Pregnant women registered under JSY,TOTAL,6360,5099,4747,7083,7189,7781,6442,5917,6862,6889,7550,8315,80234
Gopalganj,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,3624,3094,2881,3818,4396,4555,4511,4383,4792,4988,5500,5478,52020
Gopalganj,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,4650,3759,3380,4682,4764,4834,4244,3752,4445,4547,4927,5408,53392
Gopalganj,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,4227,3957,3472,4303,5227,5360,4706,4283,4558,4831,4900,5703,55527
Gopalganj,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1994,1755,1317,1177,348,436,303,285,615,305,2612,3545,14692
Gopalganj,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,29,21,25,89,14,25,26,59,28,64,96,83,559
Gopalganj,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,2,3,3,7,1,3,2,14,14,10,14,9,82
Gopalganj,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,373,58,386,624,637,753,620,632,1056,1302,1250,1123,8814
Gopalganj,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,24,0,29,65,43,45,31,25,21,26,23,29,361
Gopalganj,1.8,Number of pregnancy test kits used at SC level,TOTAL,65,157,177,525,1032,1008,1097,966,1264,1193,1448,1693,10625
Gopalganj,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,147,89,121,147,158,146,143,110,127,133,144,111,1576
Gopalganj,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,417,389,402,430,480,503,540,504,591,613,528,623,6020
Gopalganj,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,564,478,523,577,638,649,683,614,718,746,672,734,7596
Gopalganj,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,448,387,496,534,612,621,649,579,685,689,619,685,7004
Gopalganj,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,24,0,0,0,0,0,0,0,0,0,0,0,24
Gopalganj,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,2328,2011,1940,3643,3949,3628,3838,3408,3301,3347,3168,2951,37512
Gopalganj,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,2087,1983,1915,3611,3919,3595,3773,3373,3097,3317,3132,2916,36718
Gopalganj,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,879,2608,1714,3224,3544,3909,3642,3893,3322,3347,3168,3072,36322
Gopalganj,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,581,1842,1125,1830,1460,3805,3488,3987,3712,2659,3989,3571,32049
Gopalganj,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Gopalganj,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,60,100,94,119,124,136,105,158,103,571,418,403,2391
Gopalganj,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Gopalganj,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Gopalganj,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Gopalganj,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Gopalganj,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Gopalganj,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,26,18,25,32,30,32,53,37,41,29,41,35,399
Gopalganj,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gopalganj,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,26,18,25,32,30,32,53,37,41,29,41,35,399
Gopalganj,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,27,45,45,58,63,66,51,61,72,99,80,81,748
Gopalganj,4.1.1.a,Number of male live births,TOTAL,1582,1249,1282,2185,2379,2189,2230,2008,2066,2145,1972,1904,23191
Gopalganj,4.1.1.b,Number of female live births,TOTAL,1282,1201,1156,1994,2167,2058,2244,1991,1927,1918,1833,1758,21529
Gopalganj,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,2864,2450,2438,4179,4546,4247,4474,3999,3993,4063,3805,3662,44720
Gopalganj,4.1.2,Number of still births,TOTAL,39,54,36,61,62,56,64,58,44,48,54,36,612
Gopalganj,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,9,1,8,2,10,5,6,11,11,16,16,17,112
Gopalganj,4.2.1,Number of Newborns weighed at birth,TOTAL,2732,2333,2309,4076,4447,4191,4413,3924,3902,3982,3725,3608,43642
Gopalganj,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,146,146,137,220,215,288,273,255,232,216,204,283,2615
Gopalganj,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,2819,2408,2404,4154,4541,4223,4443,3977,3973,4044,3789,3672,44447
Gopalganj,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,17,0,2,3,8,15,17,20,14,30,40,37,203
Gopalganj,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0,0,0,0,8,0,0,2,5,2,7,8,32
Gopalganj,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,41,44,49,51,57,60,71,64,60,55,91,92,735
Gopalganj,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gopalganj,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,58,44,51,54,73,75,88,86,79,87,138,137,970
Gopalganj,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Gopalganj,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,58,44,31,60,63,102,142,148,112,148,224,189,1321
Gopalganj,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,3,3,3,2,3,5,2,7,3,5,16,11,63
Gopalganj,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,49,26,225,104,56,87,49,69,65,98,115,156,1099
Gopalganj,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0,0,23,0,24,23,17,17,27,18,19,23,191
Gopalganj,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,2002,1732,1920,3044,4229,3917,4277,3875,3857,3874,3657,3356,39740
Gopalganj,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1179,1074,863,1316,1679,2080,2572,2015,2348,2657,2683,2512,22978
Gopalganj,6.3,PNC maternal complications attended,TOTAL,8,11,11,7,4,6,4,7,5,32,23,22,140
Gopalganj,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,0,0,0,0,1,0,0,0,2,0,4,2,9
Gopalganj,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Gopalganj,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,0,0,0,0,1,0,0,0,2,0,4,2,9
Gopalganj,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Gopalganj,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,53,90,163,100,322,180,106,75,114,160,335,143,1841
Gopalganj,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,315,13,313,360,656,436,316,189,299,304,592,432,4225
Gopalganj,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,368,103,476,460,978,616,422,264,413,464,927,575,6066
Gopalganj,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Gopalganj,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,1,0,1,1,0,1,2,2,0,1,3,3,15
Gopalganj,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,1,1
Gopalganj,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0,1,1,0,0,0,3,1,0,0,0,3,9
Gopalganj,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gopalganj,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,1,1,2,1,0,1,5,3,0,1,3,7,25
Gopalganj,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Gopalganj,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Gopalganj,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Gopalganj,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Gopalganj,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gopalganj,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Gopalganj,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Gopalganj,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,176,56,17,284,195,510,433,363,842,732,893,802,5303
Gopalganj,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,31,14,3,64,32,80,91,80,291,223,281,202,1392
Gopalganj,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,51,28,17,65,57,78,114,84,170,183,281,205,1333
Gopalganj,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gopalganj,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,258,98,37,413,284,668,638,527,1303,1138,1455,1209,8028
Gopalganj,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,2,NA,NA,NA,NA,NA,NA,6,15,735,626,NA,1384
Gopalganj,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0,0,0,0,2,0,19,3,9,3,10,17,63
Gopalganj,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0,0,0,2,0,4,2,3,6,3,3,6,29
Gopalganj,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,7,8,2,9,11,8,11,9,12,15,13,5,110
Gopalganj,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gopalganj,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,7,8,2,11,13,12,32,15,27,21,26,28,202
Gopalganj,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0,NA,NA,NA,NA,NA,NA,NA,NA,15,0,NA,15
Gopalganj,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,327,225,251,520,337,448,280,324,557,550,609,582,5010
Gopalganj,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,34,35,22,57,48,45,56,82,89,204,163,156,991
Gopalganj,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,5,3,3,39,11,29,38,18,70,15,18,25,274
Gopalganj,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,11,20,11,10,13,31,31,29,87,91,76,72,482
Gopalganj,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gopalganj,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,377,283,287,626,409,553,405,453,803,860,866,835,6757
Gopalganj,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,127,84,81,195,201,183,97,186,244,260,279,260,2197
Gopalganj,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gopalganj,9.06,Number of IUCD removals,TOTAL,152,167,152,161,173,162,162,147,220,231,229,215,2171
Gopalganj,9.07,Number of Oral Pills cycles distributed,TOTAL,1220,691,1023,1452,2179,2282,1978,1924,2160,2000,2392,2431,21732
Gopalganj,9.08,Number of Condom pieces distributed,TOTAL,8653,7289,7158,9694,12457,13169,11715,13041,13222,14612,15117,14681,140808
Gopalganj,9.09,Number of Centchroman (weekly) pills given,TOTAL,5,112,0,38,11,39,45,41,77,78,51,45,542
Gopalganj,9.1,Number of Emergency Contraceptive Pills distributed,TOTAL,50,81,169,201,332,588,466,449,645,594,437,621,4633
Gopalganj,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0,0,0,0,4,0,0,0,0,0,0,0,4
Gopalganj,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0,0,0,0,0,0,0,0,0,1,0,0,1
Gopalganj,9.11.2.a,Number of failures following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Gopalganj,9.11.2.b,Number of failures following female sterilization,TOTAL,0,0,1,2,0,0,0,0,0,0,0,0,3
Gopalganj,9.11.3.a,Number of deaths following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Gopalganj,9.11.3.b,Number of deaths following female sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Gopalganj,9.12,Number of Institutions having NSV trained doctors,TOTAL,NA,NA,NA,NA,NA,1,3,4,4,4,4,4,Data for this item can not be cumulated
Gopalganj,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,3941,3300,3562,5691,5901,6098,5732,5123,5901,6129,5962,5714,63054
Gopalganj,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,48,6,31,48,3,2,0,0,0,0,0,0,138
Gopalganj,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,777,343,310,292,185,167,92,66,86,64,31,29,2442
Gopalganj,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,1900,987,690,770,417,326,205,106,161,105,143,43,5853
Gopalganj,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,4950,3592,3145,4736,4445,5386,5777,5642,6232,6516,6172,6037,62630
Gopalganj,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,4451,3818,3320,4242,4326,4553,4649,5148,5907,6378,6235,6015,59042
Gopalganj,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,3461,3296,3152,4205,4175,4292,4022,4327,5318,6166,6069,6298,54781
Gopalganj,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,2499,1855,2467,3172,4628,4401,4442,4069,4470,4498,4427,4240,45168
Gopalganj,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,4639,3356,3341,4700,4525,5244,5800,5457,6204,6517,6415,6278,62476
Gopalganj,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,4611,3807,3660,4385,4370,4420,4741,5063,5851,6403,6312,6138,59761
Gopalganj,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,4647,3752,3686,4601,4466,4320,4160,4287,5328,6213,6262,6411,58133
Gopalganj,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,1809,1716,1986,3035,3841,3571,3644,3182,3214,3349,3168,2717,35232
Gopalganj,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,79,55,36,26,18,8,35,14,7,1,52,11,342
Gopalganj,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,1035,495,404,313,201,168,124,62,78,41,73,28,3022
Gopalganj,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,2289,1249,843,946,528,395,227,119,130,72,78,26,6902
Gopalganj,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,3200,3861,5192,6639,6018,5996,5528,4917,3799,5062,4677,5684,60573
Gopalganj,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,2843,2748,4272,5871,4979,4836,4532,3837,3502,5440,5091,6750,54701
Gopalganj,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,2041,2760,4531,6337,5606,5309,4216,4304,4074,4575,4250,4973,52976
Gopalganj,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1585,1847,2785,3446,3039,3055,2886,2639,1933,2638,2458,2941,31252
Gopalganj,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1394,1594,2356,3075,2790,2666,2578,2203,1753,2361,2168,2621,27559
Gopalganj,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,2979,3441,5141,6521,5829,5721,5464,4842,3686,4999,4626,5562,58811
Gopalganj,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,4396,3499,3901,5536,4887,4546,4136,3605,4670,5297,5749,5892,56114
Gopalganj,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,4389,3497,3919,5580,4868,4595,4117,3591,4679,5288,5757,5914,56194
Gopalganj,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0,0,19,0,0,0,0,0,0,0,0,0,19
Gopalganj,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,472,409,788,1156,1090,1146,1141,1084,787,1423,1459,1874,12829
Gopalganj,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,451,363,689,1086,986,1033,996,1043,690,1223,1363,1787,11710
Gopalganj,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,923,772,1477,2242,2076,2179,2137,2127,1477,2646,2822,3661,24539
Gopalganj,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,1482,1049,1151,1246,1000,1256,1198,1214,1493,1608,1637,1652,15986
Gopalganj,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,1260,1021,978,882,883,1093,948,989,1006,980,1126,1042,12208
Gopalganj,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1794,1419,1454,1391,1430,1732,1381,1344,1658,1626,1680,1777,18686
Gopalganj,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,21,0,9,45,7,2,0,0,0,0,0,0,84
Gopalganj,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Gopalganj,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,5,0,0,46,0,0,0,0,0,0,0,64,115
Gopalganj,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,2267,1948,2273,2318,2290,2297,2212,2260,2263,2274,2263,2291,26956
Gopalganj,10.4.2,Number of Immunisation sessions held during the month,TOTAL,2234,1920,2185,2263,2258,2239,2134,2120,2230,2249,2220,2261,26313
Gopalganj,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,2101,1750,1508,2093,2085,2052,1977,1984,2061,2068,2051,2103,23833
Gopalganj,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,2036,2411,3931,5644,4899,4578,3325,3362,4138,4916,5160,5836,50236
Gopalganj,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,2184,2083,2153,3052,1850,1396,1132,1038,813,759,645,904,18009
Gopalganj,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,419,284,195,495,73,157,173,151,167,140,134,188,2576
Gopalganj,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,136,54,46,30,2,121,30,40,30,44,37,35,605
Gopalganj,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Gopalganj,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Gopalganj,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Gopalganj,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Gopalganj,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Gopalganj,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0,5,2,0,0,0,0,0,0,3,20,7,37
Gopalganj,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,813,571,596,818,945,1219,1135,872,1016,829,888,1063,10765
Gopalganj,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0,0,0,0,12,0,0,0,9,0,0,0,21
Gopalganj,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,6,6,11,33,11,16,8,11,6,11,1,4,124
Gopalganj,13.1,Number of Patients operated for cataract,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Gopalganj,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Gopalganj,13.3,Number of School children detected with Refractive errors,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Gopalganj,13.4,Number of children provided free glasses,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Gopalganj,13.5,Number of eyes collected through eye donation,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Gopalganj,13.6,Number of eyes utilised for corneal transplant,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Gopalganj,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,NA,NA,NA,NA,NA,2,3,5,5,5,5,5,Data for this item can not be cumulated
Gopalganj,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,NA,NA,NA,NA,NA,NA,10,11,11,12,10,9,Data for this item can not be cumulated
Gopalganj,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,2121,1724,2047,2104,2078,2064,1801,1632,1885,1911,1868,1896,Data for this item can not be cumulated
Gopalganj,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,NA,NA,NA,NA,NA,2,3,4,5,5,5,5,Data for this item can not be cumulated
Gopalganj,14.05,Number of RKS meetings held during the month,TOTAL,3,3,3,0,3,1,1,2,5,1,3,4,29
Gopalganj,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,NA,NA,NA,NA,NA,2,11,13,14,12,13,13,Data for this item can not be cumulated
Gopalganj,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,974,933,715,1147,1527,1228,1510,1745,1606,1582,1137,1151,15255
Gopalganj,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,NA,NA,NA,NA,NA,1,2,3,3,3,3,3,Data for this item can not be cumulated
Gopalganj,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,Data for this item can not be cumulated
Gopalganj,14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gopalganj,14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gopalganj,14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gopalganj,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,1423,1270,1193,1929,2203,1944,2082,1868,1815,1837,1831,1712,21107
Gopalganj,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,1188,903,987,1058,891,1177,998,1561,912,794,1325,1223,13017
Gopalganj,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,1218,1163,1147,1919,2117,1893,2087,1958,1704,1637,1696,1595,20134
Gopalganj,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,3087,2742,2565,4385,4829,4861,4447,4361,5168,4517,4876,4414,50252
Gopalganj,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,2641,2433,2340,3848,4320,3837,4169,3826,3519,3474,3527,3307,41241
Gopalganj,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,4275,3645,3552,5443,5720,6038,5445,5922,6080,5311,6201,5637,63269
Gopalganj,14.10.2.a,Number of death cases of Inpatient males,TOTAL,15,13,22,0,20,23,19,22,26,13,18,27,218
Gopalganj,14.10.2.b,Number of death cases of Inpatient females,TOTAL,17,16,16,0,17,22,13,19,18,20,14,13,185
Gopalganj,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,32,29,38,0,37,45,32,41,44,33,32,40,403
Gopalganj,14.11,In-Patient Head Count at midnight,TOTAL,6427,5829,5408,8809,8963,9145,8832,7905,7117,8192,9114,8171,93912
Gopalganj,14.12.1,OPD attendance (All),TOTAL,94094,78990,83115,115127,149625,162964,135123,145061,161524,158469,171632,171477,1627201
Gopalganj,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,269,113,62,458,331,714,718,583,1352,1195,1506,1111,8412
Gopalganj,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,35,0,0,0,2,0,0,0,0,0,0,1,38
Gopalganj,14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gopalganj,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,1046,1092,839,1087,1145,1534,1172,1250,1133,1060,1251,1242,13851
Gopalganj,14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gopalganj,14.14.a,Number of patients given AYUSH treatment,TOTAL,18726,16627,13259,30400,62752,60724,45778,50767,63488,62226,65254,63449,553450
Gopalganj,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,3176,3368,2281,3578,3708,5628,4265,3857,4001,3808,4119,3704,45493
Gopalganj,14.14.c,Number of Adolescents counselled,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Gopalganj,15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gopalganj,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,894,1086,952,1372,1690,1781,1832,1276,1694,1900,2336,2195,19008
Gopalganj,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,59,81,72,173,69,111,87,304,66,70,65,34,1191
Gopalganj,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,47,192,430,157,412,470,426,625,1010,765,657,623,5814
Gopalganj,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,5,12,17,0,29,22,23,26,16,9,18,26,203
Gopalganj,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,66,200,473,170,507,526,497,852,1172,988,1302,902,7655
Gopalganj,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,2,8,12,0,20,14,16,11,9,6,11,15,124
Gopalganj,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,36,539,894,155,936,843,862,901,1091,1364,1623,1870,11114
Gopalganj,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,2,1,1,0,1,2,1,1,1,2,0,1,13
Gopalganj,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,149,931,1797,482,1855,1839,1785,2378,3273,3117,3582,3395,24583
Gopalganj,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,9,21,30,0,50,38,40,38,26,17,29,42,340
Gopalganj,15.2,Number of Widal tests conducted,Number tested,0,0,0,2,0,0,6,0,0,5,0,0,13
Gopalganj,15.3.a,Number of VDRL tests conducted on males,Number tested,66,74,63,131,756,198,87,59,84,412,350,124,2404
Gopalganj,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,0,0,0,337,0,0,0,23,18,15,65,28,486
Gopalganj,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,398,593,421,143,609,586,160,72,361,374,735,677,5129
Gopalganj,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,464,667,484,611,1365,784,247,154,463,801,1150,829,8019
Gopalganj,15.4.1,Number of blood smears examined for Malaria,TOTAL,63,24,21,62,78,98,74,53,73,44,56,31,677
Gopalganj,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,2,0,0,0,10,0,0,1,2,0,0,0,15
Gopalganj,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Gopalganj,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,575,1975,1500,400,1250,825,NA,940,6700,NA,NA,NA,14165
Gopalganj,16.1.1,Stock position of DPT vaccines,2. Stocks Received,1000,500,0,1500,500,500,NA,500,10000,NA,NA,NA,14500
Gopalganj,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0,0,0,0,0,0,NA,0,0,NA,NA,NA,0
Gopalganj,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,600,975,1100,650,925,815,NA,820,3700,NA,NA,NA,9585
Gopalganj,16.1.1,Stock position of DPT vaccines,5. Total Stock,975,1500,400,1250,825,510,0,620,13000,0,0,0,19080
Gopalganj,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,1850,2520,1420,300,1562,1920,NA,1230,4260,NA,NA,NA,15062
Gopalganj,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,0,1500,1500,1512,10008,552,NA,552,20640,NA,NA,NA,36264
Gopalganj,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0,0,0,0,0,0,NA,0,0,NA,NA,NA,0
Gopalganj,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,1330,2600,2620,250,650,1210,NA,1356,16060,NA,NA,NA,26076
Gopalganj,16.1.1A,Stock Position of Pentavalent,5. Total Stock,520,1420,300,1562,10920,1262,0,426,8840,0,0,0,25250
Gopalganj,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,925,1500,450,250,1050,875,NA,200,500,NA,NA,NA,5750
Gopalganj,16.1.2,Stock position of OPV vaccines,2. Stocks Received,1000,1000,2000,1700,1500,1500,NA,1500,50000,NA,NA,NA,60200
Gopalganj,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0,0,0,0,0,0,NA,0,0,NA,NA,NA,0
Gopalganj,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,1050,2050,2200,900,1675,1600,NA,1675,28500,NA,NA,NA,39650
Gopalganj,16.1.2,Stock position of OPV vaccines,5. Total Stock,875,450,250,1050,875,775,0,25,22000,0,0,0,26300
Gopalganj,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,1550,1525,1100,850,1220,1285,NA,1915,5650,NA,NA,NA,15095
Gopalganj,16.1.3,Stock position of TT vaccines,2. Stocks Received,1000,1500,2000,1000,1500,3000,NA,500,25000,NA,NA,NA,35500
Gopalganj,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0,0,0,0,0,0,NA,0,0,NA,NA,NA,0
Gopalganj,16.1.3,Stock position of TT vaccines,4. Stock Distributed,1425,1925,2250,630,1435,1450,NA,1850,7650,NA,NA,NA,18615
Gopalganj,16.1.3,Stock position of TT vaccines,5. Total Stock,1125,1100,850,1220,1285,2835,0,565,23000,0,0,0,31980
Gopalganj,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0,0,0,0,0,0,NA,0,0,NA,NA,NA,0
Gopalganj,16.1.4,Stock position of DT vaccines,2. Stocks Received,0,0,0,0,0,0,NA,0,0,NA,NA,NA,0
Gopalganj,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0,0,0,0,0,0,NA,0,0,NA,NA,NA,0
Gopalganj,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0,0,0,0,0,0,NA,0,0,NA,NA,NA,0
Gopalganj,16.1.4,Stock position of DT vaccines,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Gopalganj,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,400,850,700,700,1700,1500,NA,110,600,NA,NA,NA,6560
Gopalganj,16.1.5,Stock position of BCG vaccines,2. Stocks Received,1000,1000,1700,1700,1000,500,NA,1000,14000,NA,NA,NA,21900
Gopalganj,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0,0,0,0,0,0,NA,0,0,NA,NA,NA,0
Gopalganj,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,1050,1150,1700,700,1200,1220,NA,1050,8800,NA,NA,NA,16870
Gopalganj,16.1.5,Stock position of BCG vaccines,5. Total Stock,350,700,700,1700,1500,780,0,60,5800,0,0,0,11590
Gopalganj,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,0,1825,1175,125,1300,200,NA,185,75,NA,NA,NA,4885
Gopalganj,16.1.6,Stock position of Measles vaccines,2. Stocks Received,1500,3000,2000,3000,1600,4000,NA,1500,9500,NA,NA,NA,26100
Gopalganj,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0,0,0,0,0,0,NA,0,0,NA,NA,NA,0
Gopalganj,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,1475,3650,3050,1825,2700,3715,NA,1670,8775,NA,NA,NA,26860
Gopalganj,16.1.6,Stock position of Measles vaccines,5. Total Stock,25,1175,125,1300,200,485,0,15,800,0,0,0,4125
Gopalganj,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0,1510,1050,1400,2000,600,NA,0,0,NA,NA,NA,6560
Gopalganj,16.1.7,Stock position of JE vaccines,2. Stocks Received,1000,3000,4000,3000,1500,1000,NA,1500,13500,NA,NA,NA,28500
Gopalganj,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0,0,0,0,0,0,NA,0,0,NA,NA,NA,0
Gopalganj,16.1.7,Stock position of JE vaccines,4. Stock Distributed,990,3460,3650,2400,2900,1600,NA,1500,13450,NA,NA,NA,29950
Gopalganj,16.1.7,Stock position of JE vaccines,5. Total Stock,10,1050,1400,2000,600,0,0,0,50,0,0,0,5110
Gopalganj,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,1325,1100,800,950,1050,1100,NA,800,7000,NA,NA,NA,14125
Gopalganj,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0,500,1000,500,500,500,NA,250,10000,NA,NA,NA,13250
Gopalganj,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0,0,0,0,0,0,NA,0,0,NA,NA,NA,0
Gopalganj,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,625,800,850,400,450,400,NA,350,3500,NA,NA,NA,7375
Gopalganj,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,700,800,950,1050,1100,1200,0,700,13500,0,0,0,20000
Gopalganj,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,NA,NA,NA,15820,NA,NA,NA,12980,0,NA,NA,NA,28800
Gopalganj,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,NA,NA,NA,0,NA,NA,NA,0,0,NA,NA,NA,0
Gopalganj,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,0,NA,NA,NA,0,0,NA,NA,NA,0
Gopalganj,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,NA,NA,NA,8900,NA,NA,NA,0,0,NA,NA,NA,8900
Gopalganj,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0,0,0,6920,0,0,0,12980,0,0,0,0,19900
Gopalganj,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,NA,NA,NA,149660,NA,NA,NA,21844,0,NA,NA,NA,171504
Gopalganj,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,NA,NA,NA,0,NA,NA,NA,0,0,NA,NA,NA,0
Gopalganj,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,0,NA,NA,NA,0,0,NA,NA,NA,0
Gopalganj,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,NA,NA,NA,149660,NA,NA,NA,0,0,NA,NA,NA,149660
Gopalganj,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,21844,0,0,0,0,21844
Gopalganj,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,NA,NA,NA,19206,NA,NA,NA,1415,0,NA,NA,NA,20621
Gopalganj,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,NA,NA,NA,0,NA,NA,NA,0,0,NA,NA,NA,0
Gopalganj,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,0,NA,NA,NA,0,0,NA,NA,NA,0
Gopalganj,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,NA,NA,NA,18206,NA,NA,NA,0,0,NA,NA,NA,18206
Gopalganj,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0,0,0,1000,0,0,0,1415,0,0,0,0,2415
Gopalganj,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,NA,NA,NA,9598,NA,NA,NA,8700,0,NA,NA,NA,18298
Gopalganj,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,NA,NA,NA,0,NA,NA,NA,0,0,NA,NA,NA,0
Gopalganj,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,0,NA,NA,NA,0,0,NA,NA,NA,0
Gopalganj,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,NA,NA,NA,8950,NA,NA,NA,0,0,NA,NA,NA,8950
Gopalganj,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0,0,0,648,0,0,0,8700,0,0,0,0,9348
Gopalganj,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,NA,NA,NA,16150,NA,NA,NA,0,0,NA,NA,NA,16150
Gopalganj,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,NA,NA,NA,0,NA,NA,NA,0,0,NA,NA,NA,0
Gopalganj,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,0,NA,NA,NA,0,0,NA,NA,NA,0
Gopalganj,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,NA,NA,NA,5570,NA,NA,NA,0,0,NA,NA,NA,5570
Gopalganj,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0,0,0,10580,0,0,0,0,0,0,0,0,10580
Gopalganj,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,NA,NA,NA,600,NA,NA,NA,0,0,NA,NA,NA,600
Gopalganj,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,NA,NA,NA,0,NA,NA,NA,0,0,NA,NA,NA,0
Gopalganj,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,NA,NA,NA,0,NA,NA,NA,0,0,NA,NA,NA,0
Gopalganj,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,NA,NA,NA,300,NA,NA,NA,0,0,NA,NA,NA,300
Gopalganj,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0,0,0,300,0,0,0,0,0,0,0,0,300
Gopalganj,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,NA,NA,NA,49000,NA,NA,NA,24300,16800,NA,NA,NA,90100
Gopalganj,16.3.02,Stock Position of Gloves,2. Stocks Received,NA,NA,NA,0,NA,NA,NA,0,0,NA,NA,NA,0
Gopalganj,16.3.02,Stock Position of Gloves,3. Unusable Stock,NA,NA,NA,0,NA,NA,NA,0,0,NA,NA,NA,0
Gopalganj,16.3.02,Stock Position of Gloves,4. Stock Distributed,NA,NA,NA,4000,NA,NA,NA,2000,1000,NA,NA,NA,7000
Gopalganj,16.3.02,Stock Position of Gloves,5. Total Stock,0,0,0,45000,0,0,0,22300,15800,0,0,0,83100
Gopalganj,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,NA,NA,NA,0,NA,NA,NA,0,0,NA,NA,NA,0
Gopalganj,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,NA,NA,NA,0,NA,NA,NA,0,0,NA,NA,NA,0
Gopalganj,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,NA,NA,NA,0,NA,NA,NA,0,0,NA,NA,NA,0
Gopalganj,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,NA,NA,NA,0,NA,NA,NA,0,0,NA,NA,NA,0
Gopalganj,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Gopalganj,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,NA,NA,NA,4000,NA,NA,NA,0,0,NA,NA,NA,4000
Gopalganj,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,NA,NA,NA,0,NA,NA,NA,0,0,NA,NA,NA,0
Gopalganj,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,NA,NA,NA,0,NA,NA,NA,0,0,NA,NA,NA,0
Gopalganj,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,NA,NA,NA,4000,NA,NA,NA,0,0,NA,NA,NA,4000
Gopalganj,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Gopalganj,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,NA,NA,NA,0,NA,NA,NA,0,0,NA,NA,NA,0
Gopalganj,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,NA,NA,NA,0,NA,NA,NA,0,0,NA,NA,NA,0
Gopalganj,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,NA,NA,NA,0,NA,NA,NA,0,0,NA,NA,NA,0
Gopalganj,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,NA,NA,NA,0,NA,NA,NA,0,0,NA,NA,NA,0
Gopalganj,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Gopalganj,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,NA,NA,NA,0,NA,NA,NA,0,0,NA,NA,NA,0
Gopalganj,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,NA,NA,NA,0,NA,NA,NA,0,0,NA,NA,NA,0
Gopalganj,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,NA,NA,NA,0,NA,NA,NA,0,0,NA,NA,NA,0
Gopalganj,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,NA,NA,NA,0,NA,NA,NA,0,0,NA,NA,NA,0
Gopalganj,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Gopalganj,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,NA,NA,NA,0,NA,NA,NA,0,0,NA,NA,NA,0
Gopalganj,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,NA,NA,NA,0,NA,NA,NA,0,0,NA,NA,NA,0
Gopalganj,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,NA,NA,NA,0,NA,NA,NA,0,0,NA,NA,NA,0
Gopalganj,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,NA,NA,NA,0,NA,NA,NA,0,0,NA,NA,NA,0
Gopalganj,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Gopalganj,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,NA,NA,NA,0,NA,NA,NA,0,0,NA,NA,NA,0
Gopalganj,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,NA,NA,NA,0,NA,NA,NA,0,0,NA,NA,NA,0
Gopalganj,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,NA,NA,NA,0,NA,NA,NA,0,0,NA,NA,NA,0
Gopalganj,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,NA,NA,NA,0,NA,NA,NA,0,0,NA,NA,NA,0
Gopalganj,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Gopalganj,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,NA,NA,NA,27800,NA,NA,NA,252000,130000,NA,NA,NA,409800
Gopalganj,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,NA,NA,NA,0,NA,NA,NA,0,0,NA,NA,NA,0
Gopalganj,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,NA,NA,NA,0,NA,NA,NA,0,0,NA,NA,NA,0
Gopalganj,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,NA,NA,NA,4000,NA,NA,NA,60500,35000,NA,NA,NA,99500
Gopalganj,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0,0,0,23800,0,0,0,191500,95000,0,0,0,310300
Gopalganj,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,NA,NA,NA,0,NA,NA,NA,0,0,NA,NA,NA,0
Gopalganj,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,NA,NA,NA,0,NA,NA,NA,0,0,NA,NA,NA,0
Gopalganj,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,NA,NA,NA,0,NA,NA,NA,0,0,NA,NA,NA,0
Gopalganj,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,NA,NA,NA,0,NA,NA,NA,0,0,NA,NA,NA,0
Gopalganj,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Gopalganj,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,NA,NA,NA,0,NA,NA,NA,0,0,NA,NA,NA,0
Gopalganj,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,NA,NA,NA,0,NA,NA,NA,0,0,NA,NA,NA,0
Gopalganj,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,NA,NA,NA,0,NA,NA,NA,0,0,NA,NA,NA,0
Gopalganj,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,NA,NA,NA,0,NA,NA,NA,0,0,NA,NA,NA,0
Gopalganj,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Gopalganj,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,4600,0,2600,0,3800,11600,NA,10000,1600,NA,NA,NA,34200
Gopalganj,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0,10000,0,10000,15000,0,NA,0,0,NA,NA,NA,35000
Gopalganj,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0,0,0,0,0,0,NA,0,0,NA,NA,NA,0
Gopalganj,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,4600,7400,2600,6200,7200,9400,NA,8400,1600,NA,NA,NA,47400
Gopalganj,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0,2600,0,3800,11600,2200,0,1600,0,0,0,0,21800
Gopalganj,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,73600,33600,80600,31800,121800,193400,NA,172400,100800,NA,NA,NA,808000
Gopalganj,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0,120000,0,150000,150000,0,NA,0,0,NA,NA,NA,420000
Gopalganj,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0,0,0,0,0,0,NA,0,0,NA,NA,NA,0
Gopalganj,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,40000,73000,48800,60000,78400,57800,NA,71600,32000,NA,NA,NA,461600
Gopalganj,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,33600,80600,31800,121800,193400,135600,0,100800,68800,0,0,0,766400
Gopalganj,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,6200,2900,5800,4400,6500,9900,NA,7500,3300,NA,NA,NA,46500
Gopalganj,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0,10000,0,7000,10000,0,NA,0,0,NA,NA,NA,27000
Gopalganj,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0,0,0,0,0,0,NA,0,0,NA,NA,NA,0
Gopalganj,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,3300,7100,1400,4900,6600,6200,NA,4200,1700,NA,NA,NA,35400
Gopalganj,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,2900,5800,4400,6500,9900,3700,0,3300,1600,0,0,0,38100
Gopalganj,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1,NA,2
Gopalganj,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gopalganj,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gopalganj,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gopalganj,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,NA,NA,2
Gopalganj,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gopalganj,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,NA,NA,2
Gopalganj,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,2,NA,NA,3,NA,5
Gopalganj,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,1,1,NA,NA,2
Gopalganj,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,NA,NA,NA,NA,NA,NA,NA,2,1,1,3,NA,7
Gopalganj,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,1,NA,3,2,NA,6
Gopalganj,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,1,2,1,NA,4
Gopalganj,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,NA,NA,NA,NA,NA,NA,NA,1,1,5,3,NA,10
Gopalganj,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gopalganj,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gopalganj,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gopalganj,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,1
Gopalganj,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gopalganj,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,1
Gopalganj,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,1
Gopalganj,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gopalganj,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,1
Gopalganj,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gopalganj,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gopalganj,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gopalganj,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,3,NA,1,NA,1,5
Gopalganj,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,1,NA,1,NA,1,3
Gopalganj,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,NA,NA,NA,NA,NA,NA,NA,4,NA,2,NA,2,8
Gopalganj,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gopalganj,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gopalganj,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gopalganj,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gopalganj,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gopalganj,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gopalganj,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gopalganj,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gopalganj,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,1
Gopalganj,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,2,2,NA,1,5
Gopalganj,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,6,3,NA,1,10
Gopalganj,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,9,5,NA,2,16
Gopalganj,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gopalganj,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gopalganj,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gopalganj,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gopalganj,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gopalganj,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gopalganj,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gopalganj,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gopalganj,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gopalganj,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gopalganj,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gopalganj,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gopalganj,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gopalganj,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,2,1,NA,1,4
Gopalganj,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,6,4,NA,6,16
Gopalganj,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,8,5,NA,7,20
Gopalganj,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gopalganj,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gopalganj,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gopalganj,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gopalganj,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gopalganj,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gopalganj,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gopalganj,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gopalganj,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gopalganj,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gopalganj,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gopalganj,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gopalganj,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gopalganj,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gopalganj,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gopalganj,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gopalganj,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gopalganj,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,NA,1,3
Gopalganj,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gopalganj,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,NA,1,3
Gopalganj,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gopalganj,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gopalganj,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gopalganj,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gopalganj,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gopalganj,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,1,NA,1,1,NA,3
Gopalganj,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gopalganj,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,NA,NA,NA,NA,NA,NA,NA,1,NA,1,1,NA,3
Gopalganj,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,1
Gopalganj,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,2,2,NA,3,7
Gopalganj,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1
Gopalganj,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,2,3,NA,4,9
Gopalganj,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gopalganj,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,1
Gopalganj,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gopalganj,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,1
Gopalganj,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gopalganj,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gopalganj,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gopalganj,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gopalganj,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gopalganj,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,1
Gopalganj,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gopalganj,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,1
Gopalganj,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gopalganj,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,1
Gopalganj,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,1
Gopalganj,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,1,1,NA,NA,2
Gopalganj,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Gopalganj,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,2,NA,1,1,NA,4
Gopalganj,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,1
Gopalganj,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,NA,NA,NA,NA,NA,NA,NA,3,NA,1,1,NA,5
Jamui,1.1,Total number of pregnant women Registered for ANC,TOTAL,4468,3672,2489,4709,3701,3413,3482,3136,3135,3388,3966,3846,43405
Jamui,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,2314,1963,1371,2692,2117,1945,1831,1606,1673,2591,2141,2228,24472
Jamui,1.2,Number of Pregnant women registered under JSY,TOTAL,4468,3672,2489,4688,3701,3413,3482,3136,3135,3388,3966,3846,43384
Jamui,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,2639,2510,1934,3119,2853,2911,2791,2520,2485,2397,2389,2525,31073
Jamui,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,3716,3055,2152,3872,2983,2777,2645,2371,2425,2710,3157,3137,35000
Jamui,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,3788,3597,2291,3943,4039,3387,3002,2610,2594,2669,2837,3266,38023
Jamui,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,2443,2818,1728,3759,2947,2928,2550,2834,2273,2454,2481,2850,32065
Jamui,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,58,17,67,54,39,70,25,72,89,31,61,22,605
Jamui,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0,3,0,2,1,1,0,4,1,3,2,0,17
Jamui,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,875,436,339,707,1204,740,823,777,1094,742,849,752,9338
Jamui,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,8,5,5,9,7,10,28,32,33,28,20,23,208
Jamui,1.8,Number of pregnancy test kits used at SC level,TOTAL,380,320,224,424,504,618,916,622,447,529,847,854,6685
Jamui,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,407,337,239,402,425,410,393,417,415,327,372,340,4484
Jamui,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,733,583,426,835,711,703,778,807,788,857,837,623,8681
Jamui,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,1140,920,665,1237,1136,1113,1171,1224,1203,1184,1209,963,13165
Jamui,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,791,677,484,867,783,755,774,704,869,893,853,638,9088
Jamui,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,5,0,0,9,0,0,0,0,0,0,0,0,14
Jamui,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1529,1548,1523,2459,2851,2907,2831,2872,2361,2295,1960,1673,26809
Jamui,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,1347,1386,1414,2176,2759,2601,2743,2660,2139,2228,1922,1585,24960
Jamui,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1253,833,767,1667,1915,1620,1348,2253,2030,2209,1722,1558,19175
Jamui,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1189,821,625,1468,1780,1320,1148,2015,1831,2105,1924,1485,17711
Jamui,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Jamui,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,NA,0,NA,NA,0,0,259,234,256,276,295,305,1625
Jamui,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,NA,0,NA,NA,0,0,0,0,0,0,0,0,0
Jamui,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,NA,0,NA,NA,0,0,0,0,0,0,0,0,0
Jamui,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,NA,0,NA,NA,0,0,0,0,0,0,0,0,0
Jamui,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Jamui,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Jamui,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,42,36,45,51,41,45,58,48,52,34,35,29,516
Jamui,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,42,36,45,51,41,45,58,48,52,34,35,29,516
Jamui,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,NA,0,NA,NA,0,0,178,132,145,143,135,141,874
Jamui,4.1.1.a,Number of male live births,TOTAL,1453,1259,1172,1936,1959,2112,2142,2228,1916,1875,1732,1528,21312
Jamui,4.1.1.b,Number of female live births,TOTAL,1191,1184,997,1679,1973,1869,2070,2026,1862,1847,1687,1375,19760
Jamui,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,2644,2443,2169,3615,3932,3981,4212,4254,3778,3722,3419,2903,41072
Jamui,4.1.2,Number of still births,TOTAL,34,22,24,77,67,58,47,54,43,31,30,37,524
Jamui,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,0,0,0,2,1,7,1,0,0,0,1,0,12
Jamui,4.2.1,Number of Newborns weighed at birth,TOTAL,2451,2306,2079,3350,3493,3871,3736,3760,3256,3705,3202,2706,37915
Jamui,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,89,167,135,213,386,334,353,400,232,215,280,118,2922
Jamui,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,2570,2361,2116,3497,3593,3930,3899,3816,3384,3700,3336,2890,39092
Jamui,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0,19,0,0,7,3,4,6,8,4,6,7,64
Jamui,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0,0,0,0,0,0,0,3,9,4,0,0,16
Jamui,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,42,39,45,51,12,26,32,22,25,27,25,51,397
Jamui,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,42,58,45,51,19,29,36,31,42,35,31,58,477
Jamui,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,NA,0,NA,NA,0,0,0,0,0,0,0,17,17
Jamui,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,66,40,157,287,265,99,149,28,286,324,329,362,2392
Jamui,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0,8,112,30,1,1,0,4,1,3,2,0,162
Jamui,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,42,39,68,689,261,481,160,8,239,505,333,322,3147
Jamui,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,31,25,22,26,5,3,3,5,1,2,2,6,131
Jamui,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1740,1418,1260,2243,2299,2422,2493,2376,2211,2324,2228,1785,24799
Jamui,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1311,863,820,1354,1248,1207,1480,1253,1445,1453,1422,1122,14978
Jamui,6.3,PNC maternal complications attended,TOTAL,0,0,0,0,0,0,0,0,0,2,1,0,3
Jamui,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Jamui,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Jamui,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Jamui,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Jamui,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,96,106,117,137,154,60,114,110,132,117,102,91,1336
Jamui,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,222,247,203,243,257,150,220,229,257,286,269,205,2788
Jamui,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,318,353,320,380,411,210,334,339,389,403,371,296,4124
Jamui,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Jamui,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Jamui,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0,0,0,2,1,0,0,0,1,0,0,0,4
Jamui,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,2,2
Jamui,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0,0,0,2,1,0,0,0,1,0,0,2,6
Jamui,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,NA,0,1,NA,0,2,3,4,5,7,0,1,23
Jamui,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Jamui,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Jamui,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0,0,0,0,NA,NA,0,0,0,0,0,0,0
Jamui,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Jamui,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,NA,0,NA,NA,0,0,0,0,0,0,0,0,0
Jamui,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,35,15,0,86,7,136,227,178,594,417,683,397,2775
Jamui,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,6,6,0,26,2,20,14,79,331,305,602,223,1614
Jamui,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,12,14,9,17,10,7,31,41,66,57,116,57,437
Jamui,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,53,35,9,129,19,163,272,298,991,779,1401,677,4826
Jamui,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,88,118,58,75,76,150,186,134,313,247,392,196,2033
Jamui,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Jamui,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Jamui,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,12,13,9,8,9,8,14,19,12,12,11,12,139
Jamui,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,12,13,9,8,9,8,14,19,12,12,11,12,139
Jamui,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,NA,0,NA,NA,0,NA,2,2,0,0,0,0,4
Jamui,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,167,133,102,389,171,176,225,211,272,259,252,403,2760
Jamui,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,28,34,12,80,17,50,50,45,71,83,75,151,696
Jamui,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,2,NA,0,2,6,6,2,4,13,26,30,28,119
Jamui,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,69,8,86,9,11,6,6,6,12,53,9,9,284
Jamui,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,266,175,200,480,205,238,283,266,368,421,366,591,3859
Jamui,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,90,23,13,168,59,78,60,26,39,85,115,173,929
Jamui,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,3,NA,3,28,2,9,10,16,4,3,5,4,87
Jamui,9.06,Number of IUCD removals,TOTAL,88,94,60,119,292,123,139,116,132,125,107,131,1526
Jamui,9.07,Number of Oral Pills cycles distributed,TOTAL,995,948,850,2011,1835,1910,1799,1457,1447,1272,1531,3011,19066
Jamui,9.08,Number of Condom pieces distributed,TOTAL,6959,4787,4506,11862,5557,6399,6911,5687,6881,5751,6494,6899,78693
Jamui,9.09,Number of Centchroman (weekly) pills given,TOTAL,145,192,251,254,399,218,211,208,133,115,190,158,2474
Jamui,9.1,Number of Emergency Contraceptive Pills distributed,TOTAL,694,698,497,681,731,612,706,578,712,627,773,884,8193
Jamui,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0,0,0,1,0,0,0,0,0,0,0,0,1
Jamui,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0,0,0,0,0,0,10,0,0,0,0,0,10
Jamui,9.11.2.a,Number of failures following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Jamui,9.11.2.b,Number of failures following female sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Jamui,9.11.3.a,Number of deaths following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Jamui,9.11.3.b,Number of deaths following female sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Jamui,9.12,Number of Institutions having NSV trained doctors,TOTAL,NA,NA,NA,NA,NA,3,6,1,4,4,4,4,Data for this item can not be cumulated
Jamui,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,2971,2260,1756,3743,4077,4376,4198,4187,3949,3917,3605,2980,42019
Jamui,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,138,117,79,110,85,22,10,24,24,4,4,3,620
Jamui,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,828,491,175,220,118,63,43,44,15,9,6,3,2015
Jamui,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,1715,1024,406,455,245,180,129,84,24,14,8,6,4290
Jamui,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,3698,2636,1594,3228,3013,3489,4155,4342,4378,4236,4092,3705,42566
Jamui,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,3364,3157,1835,2990,2743,3159,3347,3771,4089,4454,4155,4084,41148
Jamui,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,2535,2740,2029,3024,2575,2909,3062,3145,3537,3997,4133,4108,37794
Jamui,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1563,1323,1366,2429,2733,3191,3083,3011,2725,2517,2243,1823,28007
Jamui,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,3893,2748,1599,3323,2998,3374,4136,4280,4417,4280,4147,3770,42965
Jamui,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,4060,3519,2004,3072,2777,3034,3317,3737,4074,4424,4200,4094,42312
Jamui,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,4314,3579,2345,3497,2703,2979,3058,3128,3519,3980,4218,4143,41463
Jamui,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,1278,1184,1183,2071,2354,2915,2767,2575,2266,2316,2016,1692,24617
Jamui,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,447,166,114,152,62,48,18,22,59,0,0,0,1088
Jamui,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,917,558,255,496,111,109,62,57,46,2,1,0,2614
Jamui,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,1932,1083,521,552,312,203,129,74,82,5,2,1,4896
Jamui,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,3929,3536,2342,4669,3748,3997,3789,3268,3074,2880,2998,2786,41016
Jamui,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,3565,2269,943,2301,1721,2699,2709,2621,2861,2991,3569,3275,31524
Jamui,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,3232,2852,1872,3576,3244,3236,3234,2877,2672,2751,2915,2794,35255
Jamui,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1908,1647,1164,2205,1886,2000,1938,1672,1537,1463,1498,1459,20377
Jamui,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1690,1449,946,1939,1708,1862,1743,1504,1420,1358,1357,1331,18307
Jamui,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,3598,3096,2110,4144,3594,3862,3681,3176,2957,2821,2855,2790,38684
Jamui,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,3609,2550,1542,2928,2460,2863,2735,2745,2961,3192,3670,3327,34582
Jamui,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,3606,2552,1543,2926,2438,2869,2705,2805,2967,3186,3648,3325,34570
Jamui,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0,0,0,47,0,0,0,0,0,0,0,0,47
Jamui,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,901,627,452,810,625,1036,1016,971,1066,1136,1196,981,10817
Jamui,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,854,575,376,762,573,953,927,892,967,1074,1101,925,9979
Jamui,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,1755,1202,828,1572,1198,1989,1943,1863,2033,2210,2297,1906,20796
Jamui,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,216,157,70,180,135,267,325,216,254,309,570,435,3134
Jamui,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,1207,1092,736,1288,1125,1231,1282,1201,1253,1277,1308,1293,14293
Jamui,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1274,1264,866,1326,1271,1302,1349,1379,1325,1377,1380,1484,15597
Jamui,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0,0,0,30,0,0,0,0,0,0,0,0,30
Jamui,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Jamui,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0,0,0,30,0,0,0,0,0,0,0,0,30
Jamui,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,2110,1960,2062,2179,1909,2034,2005,2349,2062,2081,2065,2062,24878
Jamui,10.4.2,Number of Immunisation sessions held during the month,TOTAL,2065,1904,1629,2170,1882,2011,1984,2289,2051,2065,2047,2039,24136
Jamui,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1773,1584,1250,1891,1621,1812,1764,2028,1824,1783,1765,1774,20869
Jamui,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,3162,2162,1125,2482,2108,1992,2008,1999,2283,2696,2994,2873,27884
Jamui,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,749,568,326,534,448,446,422,353,384,599,76,60,4965
Jamui,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,445,230,125,287,216,258,308,333,377,484,41,70,3174
Jamui,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,48,63,54,28,25,9,0,18,0,33,0,0,278
Jamui,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Jamui,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Jamui,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Jamui,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Jamui,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Jamui,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,17,0,0,4,0,1,7,0,0,0,0,5,34
Jamui,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,288,180,227,346,432,398,191,163,165,220,201,138,2949
Jamui,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,8,4,5,23,17,93,21,6,62,47,21,9,316
Jamui,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Jamui,13.1,Number of Patients operated for cataract,TOTAL,0,0,0,0,0,71,75,161,343,317,498,317,1782
Jamui,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0,0,0,0,0,71,75,161,343,317,498,317,1782
Jamui,13.3,Number of School children detected with Refractive errors,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Jamui,13.4,Number of children provided free glasses,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Jamui,13.5,Number of eyes collected through eye donation,TOTAL,0,0,0,0,0,NA,0,0,0,0,0,0,0
Jamui,13.6,Number of eyes utilised for corneal transplant,TOTAL,0,0,0,0,0,NA,0,0,0,0,0,0,0
Jamui,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,NA,NA,NA,NA,NA,4,4,4,4,4,4,4,Data for this item can not be cumulated
Jamui,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,NA,NA,NA,NA,NA,12,11,9,9,10,8,10,Data for this item can not be cumulated
Jamui,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,1335,1318,1229,1318,1437,1397,1390,1382,1418,1426,1420,1530,Data for this item can not be cumulated
Jamui,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,NA,NA,NA,NA,NA,3,3,3,3,4,4,3,Data for this item can not be cumulated
Jamui,14.05,Number of RKS meetings held during the month,TOTAL,9,9,7,9,9,12,9,10,9,11,10,15,119
Jamui,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,NA,NA,NA,NA,NA,11,12,9,10,11,10,10,Data for this item can not be cumulated
Jamui,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,714,657,574,1132,801,699,1056,1220,917,652,515,780,9717
Jamui,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,NA,NA,NA,NA,NA,1,2,2,3,3,3,2,Data for this item can not be cumulated
Jamui,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,Data for this item can not be cumulated
Jamui,14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,677,647,718,1026,1019,1223,1161,1150,1001,954,834,775,11185
Jamui,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,278,232,167,219,278,307,250,296,304,220,207,242,3000
Jamui,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,616,596,631,870,1370,1175,1123,1054,944,984,842,717,10922
Jamui,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,2281,930,1911,3063,3287,3434,3607,3580,3216,3458,3364,2799,34930
Jamui,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,1293,1243,1349,1896,2389,2398,2284,2204,1945,1938,1676,1492,22107
Jamui,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,2559,1162,2078,3282,3565,3741,3857,3876,3520,3678,3571,3041,37930
Jamui,14.10.2.a,Number of death cases of Inpatient males,TOTAL,8,12,8,5,8,6,12,10,8,7,3,5,92
Jamui,14.10.2.b,Number of death cases of Inpatient females,TOTAL,5,5,4,13,6,4,13,9,4,6,6,9,84
Jamui,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,13,17,12,18,14,10,25,19,12,13,9,14,176
Jamui,14.11,In-Patient Head Count at midnight,TOTAL,2591,2259,1798,2906,3665,3275,3082,2929,3167,4844,4267,3275,38058
Jamui,14.12.1,OPD attendance (All),TOTAL,68940,63433,56984,62740,64451,74306,60909,54514,69665,78782,64549,78222,797495
Jamui,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,2170,62,62,194,59,207,304,241,1076,870,1189,732,7166
Jamui,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,7,0,4,5,7,9,4,5,4,7,11,6,69
Jamui,14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,1089,842,930,1046,662,318,334,801,1114,1572,1514,1341,11563
Jamui,14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,14.14.a,Number of patients given AYUSH treatment,TOTAL,8723,8116,9018,5789,5837,6912,5507,5047,5869,6378,7660,6465,81321
Jamui,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,692,855,830,1119,1257,1296,1308,776,874,747,772,790,11316
Jamui,14.14.c,Number of Adolescents counselled,TOTAL,179,68,196,228,198,240,245,235,231,348,346,358,2872
Jamui,15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,2187,1733,1511,2300,2677,3077,3154,2595,2722,2903,3139,2721,30719
Jamui,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,30,13,14,43,34,48,53,64,65,59,67,50,540
Jamui,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,134,32,304,212,216,86,430,373,437,432,454,358,3468
Jamui,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,1,1,3,4,2,4,3,2,6,3,2,6,37
Jamui,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,103,62,129,179,120,72,248,201,339,322,563,232,2570
Jamui,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,2,0,3,4,3,3,2,4,5,3,3,3,35
Jamui,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,227,105,331,501,532,443,588,562,722,576,697,655,5939
Jamui,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,1,0,0,0,0,0,0,0,0,0,0,0,1
Jamui,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,464,199,764,892,868,601,1266,1136,1498,1330,1714,1245,11977
Jamui,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,4,1,6,8,5,7,5,6,11,6,5,9,73
Jamui,15.2,Number of Widal tests conducted,Number tested,22,8,8,32,0,127,106,42,132,0,0,0,477
Jamui,15.3.a,Number of VDRL tests conducted on males,Number tested,96,106,117,131,154,100,114,110,257,117,102,109,1513
Jamui,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,222,247,203,240,257,205,220,229,257,286,269,449,3084
Jamui,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,132,112,118,108,162,121,588,562,585,576,796,606,4466
Jamui,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,450,465,438,479,573,426,922,901,1099,979,1167,1164,9063
Jamui,15.4.1,Number of blood smears examined for Malaria,TOTAL,388,445,236,424,726,735,549,608,336,312,294,378,5431
Jamui,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,43,17,5,34,38,62,53,28,16,17,15,29,357
Jamui,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,12,8,5,23,11,32,10,34,11,6,8,7,167
Jamui,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,1350,NA,2900,2700,3450,2750,2650,2400,1750,900,450,0,21300
Jamui,16.1.1,Stock position of DPT vaccines,2. Stocks Received,1500,NA,0,0,0,0,0,0,0,0,0,500,2000
Jamui,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0,NA,0,0,0,0,0,0,0,0,0,0,0
Jamui,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,1150,NA,200,650,700,100,250,650,1200,450,450,500,6300
Jamui,16.1.1,Stock position of DPT vaccines,5. Total Stock,1700,0,2700,2050,2750,2650,2400,1750,550,450,0,0,17000
Jamui,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,450,NA,1900,950,1900,750,912,2906,1922,522,544,580,13336
Jamui,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,1400,NA,0,1800,0,1008,2880,0,0,1152,1440,1440,11120
Jamui,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0,NA,0,0,0,0,0,0,0,0,0,0,0
Jamui,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,1000,NA,950,850,1150,846,886,984,1400,1130,1404,1256,11856
Jamui,16.1.1A,Stock Position of Pentavalent,5. Total Stock,850,0,950,1900,750,912,2906,1922,522,544,580,764,12600
Jamui,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,400,NA,175,900,1200,0,25,1325,125,0,0,25,4175
Jamui,16.1.2,Stock position of OPV vaccines,2. Stocks Received,1200,NA,1600,1550,0,1200,2500,0,1200,1200,1200,1000,12650
Jamui,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0,NA,0,0,0,0,0,0,0,0,0,0,0
Jamui,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,1600,NA,875,1250,1200,1175,1200,1200,1325,1200,1175,1025,13225
Jamui,16.1.2,Stock position of OPV vaccines,5. Total Stock,0,0,900,1200,0,25,1325,125,0,0,25,0,3600
Jamui,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,1500,NA,3650,3200,3900,2900,2200,2750,1750,500,1050,1450,24850
Jamui,16.1.3,Stock position of TT vaccines,2. Stocks Received,2000,NA,0,2250,0,0,1000,0,0,1000,1000,500,7750
Jamui,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0,NA,0,0,0,0,0,0,0,0,0,0,0
Jamui,16.1.3,Stock position of TT vaccines,4. Stock Distributed,1150,NA,450,1550,1000,700,550,1000,1250,450,600,900,9600
Jamui,16.1.3,Stock position of TT vaccines,5. Total Stock,2350,0,3200,3900,2900,2200,2650,1750,500,1050,1450,1050,23000
Jamui,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,16.1.4,Stock position of DT vaccines,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,16.1.4,Stock position of DT vaccines,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,16.1.4,Stock position of DT vaccines,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,16.1.4,Stock position of DT vaccines,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Jamui,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,450,NA,1250,1650,1500,150,50,1800,650,600,200,0,8300
Jamui,16.1.5,Stock position of BCG vaccines,2. Stocks Received,900,NA,1300,1200,0,850,2600,0,1150,1000,1000,1000,11000
Jamui,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0,NA,0,0,0,0,0,0,0,0,0,0,0
Jamui,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,1150,NA,900,1350,1350,950,850,1150,1200,1400,1200,1000,12500
Jamui,16.1.5,Stock position of BCG vaccines,5. Total Stock,200,0,1650,1500,150,50,1800,650,600,200,0,0,6800
Jamui,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,500,NA,350,1650,2350,150,200,3000,1200,550,750,1050,11750
Jamui,16.1.6,Stock position of Measles vaccines,2. Stocks Received,2250,NA,3000,3000,0,2250,4550,0,1500,1800,2250,1000,21600
Jamui,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0,NA,0,0,0,0,0,0,0,0,0,0,0
Jamui,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,1500,NA,1700,2300,2200,2200,1750,1800,2150,1600,1950,1850,21000
Jamui,16.1.6,Stock position of Measles vaccines,5. Total Stock,1250,0,1650,2350,150,200,3000,1200,550,750,1050,200,12350
Jamui,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,1020,NA,1740,3240,3590,1330,330,3230,1480,180,930,980,18050
Jamui,16.1.7,Stock position of JE vaccines,2. Stocks Received,2250,NA,3000,3000,0,1000,4550,0,900,2300,1900,1000,19900
Jamui,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0,NA,0,0,0,0,0,0,0,0,0,0,0
Jamui,16.1.7,Stock position of JE vaccines,4. Stock Distributed,2370,NA,1500,2650,2260,2000,1650,1750,2200,1550,1850,1960,21740
Jamui,16.1.7,Stock position of JE vaccines,5. Total Stock,900,0,3240,3590,1330,330,3230,1480,180,930,980,20,16210
Jamui,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,1350,NA,3350,3100,3250,2550,2550,2350,2150,1900,1850,1650,26050
Jamui,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,1100,NA,0,1000,0,0,0,0,0,0,0,0,2100
Jamui,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0,NA,0,0,0,0,0,0,0,0,0,0,0
Jamui,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,500,NA,250,850,700,0,200,200,250,50,200,50,3250
Jamui,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,1950,0,3100,3250,2550,2550,2350,2150,1900,1850,1650,1600,24900
Jamui,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Jamui,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,NA,13390,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,13390
Jamui,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Jamui,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,NA,1996,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1996
Jamui,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0,11394,0,0,0,0,0,0,0,0,0,0,11394
Jamui,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Jamui,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,NA,148435,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,148435
Jamui,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Jamui,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,NA,22121,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,22121
Jamui,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0,126314,0,0,0,0,0,0,0,0,0,0,126314
Jamui,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Jamui,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,NA,23245,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,23245
Jamui,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Jamui,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,NA,3464,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,3464
Jamui,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0,19781,0,0,0,0,0,0,0,0,0,0,19781
Jamui,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Jamui,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,NA,14610,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,14610
Jamui,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Jamui,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,NA,1793,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1793
Jamui,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0,12817,0,0,0,0,0,0,0,0,0,0,12817
Jamui,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Jamui,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Jamui,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Jamui,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Jamui,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Jamui,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Jamui,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,16.3.02,Stock Position of Gloves,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,16.3.02,Stock Position of Gloves,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,16.3.02,Stock Position of Gloves,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,16.3.02,Stock Position of Gloves,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Jamui,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Jamui,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Jamui,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Jamui,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Jamui,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Jamui,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Jamui,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Jamui,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Jamui,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Jamui,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,5400,NA,3200,0,4800,0,5100,1100,9900,4200,12000,4400,50100
Jamui,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0,NA,0,12000,0,10000,0,12000,0,12000,0,0,46000
Jamui,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0,NA,0,0,0,0,0,0,0,0,0,0,0
Jamui,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,3600,NA,3200,7200,4800,4900,4000,3200,5700,4200,7600,4200,52600
Jamui,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,1800,0,0,4800,0,5100,1100,9900,4200,12000,4400,200,43500
Jamui,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,59400,NA,55800,15000,56000,20000,52600,19000,74600,34400,84400,23000,494200
Jamui,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0,NA,0,78000,0,80000,0,80000,0,80000,0,70000,388000
Jamui,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0,NA,0,0,0,0,0,0,0,0,0,0,0
Jamui,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,40400,NA,40800,37000,36000,47400,33600,24400,40200,30000,61400,44400,435600
Jamui,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,19000,0,15000,56000,20000,52600,19000,74600,34400,84400,23000,48600,446600
Jamui,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,5600,NA,4900,1200,3400,100,4600,0,5800,900,12000,5200,43700
Jamui,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0,NA,0,8000,0,10000,0,8000,0,12000,0,6000,44000
Jamui,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0,NA,0,0,0,0,0,0,0,0,0,0,0
Jamui,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,5300,NA,3700,5500,3300,5500,4600,2200,4900,900,6800,5700,48400
Jamui,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,300,0,1200,3700,100,4600,0,5800,900,12000,5200,5500,39300
Jamui,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1
Jamui,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1
Jamui,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,1
Jamui,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,1
Jamui,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,NA,NA,NA,NA,NA,11,11,10,NA,1,NA,NA,33
Jamui,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,NA,NA,NA,NA,NA,11,11,10,NA,1,NA,NA,33
Jamui,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,1
Jamui,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,1
Jamui,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,NA,NA,2
Jamui,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,NA,NA,2
Jamui,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,1
Jamui,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,1
Jamui,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,1
Jamui,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,1
Jamui,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jamui,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,1,NA,1,NA,NA,2
Jamui,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,1,NA,6,NA,NA,7
Jamui,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,NA,NA,NA,NA,NA,NA,NA,2,NA,7,NA,NA,9
Jehanabad,1.1,Total number of pregnant women Registered for ANC,TOTAL,2618,2519,2645,2640,2323,2053,1680,1360,1546,1576,1897,2089,24946
Jehanabad,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1456,1546,1649,1559,1500,1300,1021,848,956,996,1164,1289,15284
Jehanabad,1.2,Number of Pregnant women registered under JSY,TOTAL,2618,2519,2645,2644,2326,2053,1683,1360,1544,1576,1897,2099,24964
Jehanabad,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1623,1917,1917,1818,1984,2035,1624,1570,1515,1197,1218,1247,19665
Jehanabad,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1892,1891,1853,1879,1682,1403,1218,887,1028,1068,1297,1460,17558
Jehanabad,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,2255,2429,2221,2504,2496,2309,1939,1538,1462,1403,1567,1928,24051
Jehanabad,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1586,1768,2044,1554,1492,1383,1194,855,652,527,375,398,13828
Jehanabad,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,24,10,94,48,40,17,12,48,21,38,22,13,387
Jehanabad,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0,1,4,0,3,1,2,0,0,0,0,2,13
Jehanabad,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,475,395,427,454,500,370,232,203,238,276,345,237,4152
Jehanabad,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,3,3,2,54,239,11,3,0,0,12,21,15,363
Jehanabad,1.8,Number of pregnancy test kits used at SC level,TOTAL,365,270,224,314,277,229,254,171,281,215,240,210,3050
Jehanabad,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,3,21,17,36,21,39,24,33,23,19,23,20,279
Jehanabad,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,69,53,59,65,81,99,92,103,90,85,60,67,923
Jehanabad,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,72,74,76,101,102,138,116,136,113,104,83,87,1202
Jehanabad,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,70,53,64,82,89,105,81,85,73,78,70,57,907
Jehanabad,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Jehanabad,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,786,947,967,1358,1684,1728,1850,1749,1490,1359,1068,971,15957
Jehanabad,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,493,577,664,925,1237,1251,1253,1168,965,864,751,632,10780
Jehanabad,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,565,936,1184,1614,1813,1750,1855,1733,1438,1293,1303,905,16389
Jehanabad,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,286,492,500,1241,1487,1239,1007,1223,430,1226,706,1144,10981
Jehanabad,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Jehanabad,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,NA,NA,NA,NA,81,145,174,243,218,77,158,139,1235
Jehanabad,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Jehanabad,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Jehanabad,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Jehanabad,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,19,17,13,8,20,22,15,15,11,10,3,19,172
Jehanabad,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,19,17,13,8,20,22,15,15,11,10,3,19,172
Jehanabad,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,NA,NA,NA,NA,NA,32,56,83,59,28,30,37,325
Jehanabad,4.1.1.a,Number of male live births,TOTAL,442,515,541,667,911,993,976,977,809,768,614,572,8785
Jehanabad,4.1.1.b,Number of female live births,TOTAL,404,482,490,759,845,841,968,882,772,660,523,470,8096
Jehanabad,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,846,997,1031,1426,1756,1834,1944,1859,1581,1428,1137,1042,16881
Jehanabad,4.1.2,Number of still births,TOTAL,12,25,25,30,28,35,30,27,22,29,16,17,296
Jehanabad,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,5,3,5,5,8,0,4,4,7,3,2,3,49
Jehanabad,4.2.1,Number of Newborns weighed at birth,TOTAL,846,998,1020,1419,1738,1826,1930,1835,1555,1408,1125,1019,16719
Jehanabad,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,277,153,144,224,275,320,357,329,316,196,172,146,2909
Jehanabad,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,816,972,979,1383,1702,1805,1911,1825,1549,1379,1097,1019,16437
Jehanabad,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,4,59,1,0,2,10,18,16,39,29,2,1,181
Jehanabad,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Jehanabad,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,5,18,5,0,23,13,9,23,26,7,13,17,159
Jehanabad,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,9,77,6,0,25,23,27,39,65,36,15,18,340
Jehanabad,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,9,20,10,8,33,19,15,20,28,2,0,3,167
Jehanabad,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,6,5,7,0,34,8,4,0,0,0,0,12,76
Jehanabad,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,59,70,17,17,142,34,23,46,76,177,0,109,770
Jehanabad,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,5,0,15,6,8,11,9,8,6,9,13,6,96
Jehanabad,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,639,821,839,1280,1645,1637,1692,1669,1359,1317,1033,929,14860
Jehanabad,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,515,602,800,1311,1390,1453,928,1205,1056,1082,975,688,12005
Jehanabad,6.3,PNC maternal complications attended,TOTAL,0,8,20,0,4,29,34,47,76,70,44,40,372
Jehanabad,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,1,0,0,6,0,0,0,0,0,0,0,0,7
Jehanabad,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0,0,0,1,0,0,0,0,0,0,0,0,1
Jehanabad,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,1,0,0,7,0,0,0,0,0,0,0,0,8
Jehanabad,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Jehanabad,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,179,184,176,168,160,190,139,118,144,105,208,120,1891
Jehanabad,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,130,118,123,104,131,155,137,115,126,111,152,96,1498
Jehanabad,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,309,302,299,272,291,345,276,233,270,216,360,216,3389
Jehanabad,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0,0,10,0,19,0,0,0,0,0,0,0,29
Jehanabad,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0,2,1,1,0,0,0,0,1,1,1,0,7
Jehanabad,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Jehanabad,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0,0,NA,1,1,0,0,0,0,0,0,0,2
Jehanabad,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0,2,1,2,1,0,0,0,1,1,1,0,9
Jehanabad,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Jehanabad,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Jehanabad,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0,0,NA,0,0,0,0,0,0,0,0,0,0
Jehanabad,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Jehanabad,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,119,89,93,181,292,362,369,194,382,410,429,195,3115
Jehanabad,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,14,0,0,7,5,2,8,2,3,9,2,2,54
Jehanabad,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,9,17,9,11,18,10,12,7,12,29,17,11,162
Jehanabad,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,142,106,102,199,315,374,389,203,397,448,448,208,3331
Jehanabad,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,NA,NA,NA,NA,NA,NA,115,NA,NA,20,NA,717,852
Jehanabad,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,1,3,0,4,4,21,45,32,32,32,23,14,211
Jehanabad,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Jehanabad,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,11,6,7,3,6,7,8,5,4,6,0,4,67
Jehanabad,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,12,9,7,7,10,28,53,37,36,38,23,18,278
Jehanabad,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,186,250,198,568,270,421,411,297,462,279,576,319,4237
Jehanabad,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,168,128,168,425,199,371,345,281,342,242,365,169,3203
Jehanabad,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,0,NA,0,3,0,1,1,1,3,0,2,1,12
Jehanabad,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,19,9,18,16,13,17,13,14,11,11,16,18,175
Jehanabad,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,373,387,384,1012,482,810,770,593,818,532,959,507,7627
Jehanabad,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,85,82,47,163,126,133,193,139,140,140,100,84,1432
Jehanabad,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,9.06,Number of IUCD removals,TOTAL,73,80,80,165,116,145,126,103,157,120,165,112,1442
Jehanabad,9.07,Number of Oral Pills cycles distributed,TOTAL,1077,952,1031,1583,1096,1375,1266,1294,1260,1140,1155,956,14185
Jehanabad,9.08,Number of Condom pieces distributed,TOTAL,7666,7213,7414,11783,6594,7087,7332,7278,6382,5227,5246,5778,85000
Jehanabad,9.09,Number of Centchroman (weekly) pills given,TOTAL,0,0,0,19,65,50,0,16,6,14,15,0,185
Jehanabad,9.1,Number of Emergency Contraceptive Pills distributed,TOTAL,545,538,648,497,250,425,364,348,249,207,198,191,4460
Jehanabad,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0,0,0,0,1,1,0,0,0,0,0,0,2
Jehanabad,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,1,0,1,0,1,2,0,0,0,1,0,0,6
Jehanabad,9.11.2.a,Number of failures following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Jehanabad,9.11.2.b,Number of failures following female sterilization,TOTAL,0,0,1,0,0,0,0,0,0,1,1,0,3
Jehanabad,9.11.3.a,Number of deaths following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Jehanabad,9.11.3.b,Number of deaths following female sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Jehanabad,9.12,Number of Institutions having NSV trained doctors,TOTAL,NA,NA,NA,2,3,2,2,2,3,3,3,3,Data for this item can not be cumulated
Jehanabad,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,1395,1434,1630,2239,2674,2869,2967,2382,2675,2313,1967,1692,26237
Jehanabad,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,0,7,6,4,4,3,0,0,13,0,5,1,43
Jehanabad,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,90,55,54,30,14,20,10,7,17,4,0,1,302
Jehanabad,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,418,198,124,126,61,35,23,6,23,27,3,23,1067
Jehanabad,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,1899,1510,1488,1643,1868,2258,2627,2530,2839,2762,2358,2210,25992
Jehanabad,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,1996,1978,1700,1652,1672,1845,2081,2033,2633,2647,2517,2730,25484
Jehanabad,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,1941,2024,1826,1844,1708,1708,1833,1754,2103,2311,2409,2654,24115
Jehanabad,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1104,1180,1352,1830,2194,2316,2397,1870,2077,1793,1540,1318,20971
Jehanabad,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1905,1445,1474,1640,1878,2262,2636,2546,2837,2721,2360,2217,25921
Jehanabad,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,2079,2062,1734,1669,1673,1860,2100,2049,2630,2649,2503,2630,25638
Jehanabad,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,2307,2128,1885,1933,1786,1729,1850,1758,2112,2323,2417,2702,24930
Jehanabad,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,734,753,840,1235,1484,1465,1592,1561,1368,1177,1011,894,14114
Jehanabad,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,1,21,10,1,1,1,0,0,0,0,0,0,35
Jehanabad,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,94,57,48,24,11,15,7,6,8,1,0,3,274
Jehanabad,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,413,153,135,115,52,44,18,5,10,5,2,20,972
Jehanabad,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1983,2231,2352,2920,2967,2893,2573,1966,1743,1432,1446,1466,25972
Jehanabad,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,2637,2371,1999,2063,2091,1907,1655,1539,1879,1918,2118,2400,24577
Jehanabad,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,1774,2016,1935,2495,2774,2904,2569,1988,1728,1449,1450,1490,24572
Jehanabad,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1698,1116,1090,1447,1531,1413,1269,1043,838,747,752,764,13708
Jehanabad,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1463,987,1027,1368,1410,1216,1160,914,742,654,631,669,12241
Jehanabad,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,3161,2103,2117,2815,2941,2629,2429,1957,1580,1401,1383,1433,25949
Jehanabad,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,2516,2234,2079,2140,2090,1903,1650,1521,1859,1918,2153,2402,24465
Jehanabad,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,2497,2237,2112,2138,2093,1896,1644,1520,1855,1929,2142,2396,24459
Jehanabad,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0,0,0,0,69,70,62,0,0,0,0,0,201
Jehanabad,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,131,42,23,92,112,74,34,38,88,64,127,78,903
Jehanabad,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,160,51,34,56,95,89,33,29,84,38,94,57,820
Jehanabad,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,291,93,57,148,207,163,67,67,172,102,221,135,1723
Jehanabad,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,239,204,237,261,167,202,420,451,605,792,815,818,5211
Jehanabad,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,809,768,785,847,767,719,913,876,935,791,816,835,9861
Jehanabad,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1283,1164,1214,1251,1352,1264,1468,1277,1430,1261,1265,1311,15540
Jehanabad,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0,0,0,0,0,1,0,0,0,0,0,0,1
Jehanabad,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Jehanabad,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,5,3,0,4,5,0,3,7,6,3,1,0,37
Jehanabad,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1292,1329,1288,1436,1346,1352,1277,1248,1284,1267,1213,1282,15614
Jehanabad,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1283,1324,1295,1436,1342,1358,1274,1247,1270,1270,1210,1284,15593
Jehanabad,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1088,1108,987,1223,1157,1165,1074,1020,1074,1070,1039,1108,13113
Jehanabad,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,2398,2110,1916,1812,2023,1884,1661,1507,1874,1914,2145,2361,23605
Jehanabad,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,27,18,0,0,0,0,0,0,0,0,0,0,45
Jehanabad,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,33,13,0,0,0,0,0,0,0,0,0,0,46
Jehanabad,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Jehanabad,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Jehanabad,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Jehanabad,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Jehanabad,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Jehanabad,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Jehanabad,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,13,22,0,37,0,0,0,0,0,9,47,6,134
Jehanabad,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,779,1098,970,1266,1205,933,812,693,680,485,524,593,10038
Jehanabad,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,3,3,0,0,3,0,4,0,10,7,6,10,46
Jehanabad,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0,0,0,0,0,0,0,5,0,0,0,0,5
Jehanabad,13.1,Number of Patients operated for cataract,TOTAL,145,60,0,96,64,59,0,0,0,0,0,69,493
Jehanabad,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,145,60,0,96,64,59,0,0,0,0,0,69,493
Jehanabad,13.3,Number of School children detected with Refractive errors,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Jehanabad,13.4,Number of children provided free glasses,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Jehanabad,13.5,Number of eyes collected through eye donation,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Jehanabad,13.6,Number of eyes utilised for corneal transplant,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Jehanabad,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,NA,NA,1,2,2,2,2,2,2,2,2,2,Data for this item can not be cumulated
Jehanabad,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,NA,NA,6,11,11,12,11,11,12,12,11,11,Data for this item can not be cumulated
Jehanabad,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,758,605,657,725,755,765,755,743,732,726,755,787,Data for this item can not be cumulated
Jehanabad,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,NA,NA,1,1,2,2,2,2,1,2,2,2,Data for this item can not be cumulated
Jehanabad,14.05,Number of RKS meetings held during the month,TOTAL,9,14,6,8,7,7,8,5,7,12,13,10,106
Jehanabad,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,NA,NA,5,8,11,12,12,10,10,11,11,11,Data for this item can not be cumulated
Jehanabad,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,895,467,556,908,872,1034,1080,1006,1004,866,690,734,10112
Jehanabad,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,NA,NA,1,1,1,1,1,1,1,1,1,1,Data for this item can not be cumulated
Jehanabad,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,1,NA,0,0,0,0,0,0,0,0,0,0,Data for this item can not be cumulated
Jehanabad,14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,441,556,595,616,709,723,671,633,562,476,421,465,6868
Jehanabad,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,1095,1177,1130,830,1214,1269,1079,1077,1083,695,753,885,12287
Jehanabad,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,483,562,368,644,754,626,571,564,560,575,401,429,6537
Jehanabad,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,1718,1820,1767,1845,2035,2188,2428,2205,2359,2518,1861,2079,24823
Jehanabad,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,924,1118,963,1260,1463,1349,1242,1197,1122,1051,822,894,13405
Jehanabad,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,2813,2997,2897,2675,3249,3457,3507,3282,3442,3213,2614,2964,37110
Jehanabad,14.10.2.a,Number of death cases of Inpatient males,TOTAL,0,0,1,0,1,1,2,0,1,1,0,0,7
Jehanabad,14.10.2.b,Number of death cases of Inpatient females,TOTAL,0,0,0,0,3,2,1,1,0,0,0,2,9
Jehanabad,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,0,0,1,0,4,3,3,1,1,1,0,2,16
Jehanabad,14.11,In-Patient Head Count at midnight,TOTAL,2694,1993,2927,3229,4197,4266,4315,4189,4293,4167,3540,3844,43654
Jehanabad,14.12.1,OPD attendance (All),TOTAL,99523,93817,91875,101360,108197,101782,91491,82180,86116,84353,82409,78582,1101685
Jehanabad,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,172,133,123,213,339,425,453,255,444,503,485,250,3795
Jehanabad,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Jehanabad,14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,2610,2555,3117,2988,2945,2832,2584,2205,2597,2484,2450,2462,31829
Jehanabad,14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,14.14.a,Number of patients given AYUSH treatment,TOTAL,23144,21515,20944,22998,24004,22283,21111,18401,18618,19186,19326,17059,248589
Jehanabad,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,1907,1761,1970,2028,2384,2207,1902,1862,1901,2108,2427,1920,24377
Jehanabad,14.14.c,Number of Adolescents counselled,TOTAL,29,76,14,14,79,50,28,24,27,28,20,44,433
Jehanabad,15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,1458,2186,1421,2941,2702,3031,2192,998,2445,2106,2556,2078,26114
Jehanabad,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,37,15,18,26,185,204,21,33,113,28,21,100,801
Jehanabad,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,587,673,405,646,486,434,161,372,564,494,595,534,5951
Jehanabad,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,0,0,0,4,96,3,0,4,25,1,0,0,133
Jehanabad,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,234,252,71,168,192,337,168,208,306,344,747,227,3254
Jehanabad,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0,0,3,1,25,2,0,1,3,0,0,2,37
Jehanabad,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,600,730,395,677,721,765,1013,548,712,532,413,631,7737
Jehanabad,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0,0,3,1,0,0,0,0,0,1,3,4,12
Jehanabad,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,1421,1655,871,1491,1399,1536,1342,1128,1582,1370,1755,1392,16942
Jehanabad,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,0,0,6,6,121,5,0,5,28,2,3,6,182
Jehanabad,15.2,Number of Widal tests conducted,Number tested,37,43,15,4,183,133,86,179,57,95,138,138,1108
Jehanabad,15.3.a,Number of VDRL tests conducted on males,Number tested,60,37,21,204,32,61,42,3,10,67,17,4,558
Jehanabad,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,14,15,4,27,38,22,29,6,6,15,2,15,193
Jehanabad,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,3,36,60,123,11,5,16,0,0,47,36,35,372
Jehanabad,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,77,88,85,354,81,88,87,9,16,129,55,54,1123
Jehanabad,15.4.1,Number of blood smears examined for Malaria,TOTAL,29,42,32,37,38,70,109,88,47,43,36,36,607
Jehanabad,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,7,0,0,0,0,0,1,0,1,0,0,0,9
Jehanabad,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,6,0,0,0,0,0,0,0,0,0,0,0,6
Jehanabad,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,1100,900,900,1200,1050,1650,300,700,1000,900,850,650,11200
Jehanabad,16.1.1,Stock position of DPT vaccines,2. Stocks Received,0,600,500,0,900,0,850,600,0,0,250,250,3950
Jehanabad,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Jehanabad,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,200,600,200,150,300,1350,450,300,100,50,450,350,4500
Jehanabad,16.1.1,Stock position of DPT vaccines,5. Total Stock,900,900,1200,1050,1650,300,700,1000,900,850,650,550,10650
Jehanabad,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,850,400,700,960,1056,1752,936,1416,1368,792,408,96,10734
Jehanabad,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,0,950,1152,600,1176,0,864,864,0,288,576,576,7046
Jehanabad,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Jehanabad,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,450,650,892,504,480,816,384,912,576,672,888,456,7680
Jehanabad,16.1.1A,Stock Position of Pentavalent,5. Total Stock,400,700,960,1056,1752,936,1416,1368,792,408,96,216,10100
Jehanabad,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,1150,700,1000,600,850,1100,125,425,300,425,581,817,8073
Jehanabad,16.1.2,Stock position of OPV vaccines,2. Stocks Received,0,1050,500,1000,1000,0,1000,700,1000,14700,14400,0,35350
Jehanabad,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Jehanabad,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,450,750,900,750,750,975,700,825,575,14544,14164,467,35850
Jehanabad,16.1.2,Stock position of OPV vaccines,5. Total Stock,700,1000,600,850,1100,125,425,300,725,581,817,350,7573
Jehanabad,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,1000,600,800,600,1000,1450,400,1450,1200,1250,850,800,11400
Jehanabad,16.1.3,Stock position of TT vaccines,2. Stocks Received,0,1000,750,1000,1350,0,1400,1050,500,0,500,250,7800
Jehanabad,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Jehanabad,16.1.3,Stock position of TT vaccines,4. Stock Distributed,400,800,950,600,900,1050,350,1300,450,400,550,400,8150
Jehanabad,16.1.3,Stock position of TT vaccines,5. Total Stock,600,800,600,1000,1450,400,1450,1200,1250,850,800,650,11050
Jehanabad,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0,0,0,0,0,0,0,0,0,0,0,0,0
Jehanabad,16.1.4,Stock position of DT vaccines,2. Stocks Received,0,0,0,0,0,0,0,0,0,0,0,0,0
Jehanabad,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Jehanabad,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0,0,0,0,0,0,0,0,0,0,0,0,0
Jehanabad,16.1.4,Stock position of DT vaccines,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Jehanabad,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,850,450,750,750,1200,1850,950,1000,750,500,400,600,10050
Jehanabad,16.1.5,Stock position of BCG vaccines,2. Stocks Received,0,750,850,1000,1000,0,500,500,500,500,800,500,6900
Jehanabad,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Jehanabad,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,400,450,850,550,350,900,450,750,750,600,600,350,7000
Jehanabad,16.1.5,Stock position of BCG vaccines,5. Total Stock,450,750,750,1200,1850,950,1000,750,500,400,600,750,9950
Jehanabad,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,1000,800,600,1000,1800,2650,1050,800,950,1550,1350,550,14100
Jehanabad,16.1.6,Stock position of Measles vaccines,2. Stocks Received,2000,1000,2000,2000,1900,0,1000,1500,1400,1300,500,1300,15900
Jehanabad,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Jehanabad,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,2200,1200,1600,1200,1050,1600,1250,1350,800,1500,1300,650,15700
Jehanabad,16.1.6,Stock position of Measles vaccines,5. Total Stock,800,600,1000,1800,2650,1050,800,950,1550,1350,550,1200,14300
Jehanabad,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,1200,100,100,200,1300,2020,350,500,750,1300,1750,700,10270
Jehanabad,16.1.7,Stock position of JE vaccines,2. Stocks Received,0,1300,2000,2000,1900,0,1500,2000,1500,1500,500,1000,15200
Jehanabad,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Jehanabad,16.1.7,Stock position of JE vaccines,4. Stock Distributed,1100,1200,1900,900,1180,1670,1350,1750,950,1050,1550,700,15300
Jehanabad,16.1.7,Stock position of JE vaccines,5. Total Stock,100,200,200,1300,2020,350,500,750,1300,1750,700,1000,10170
Jehanabad,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,500,350,1000,1150,1100,1400,950,1000,950,750,700,800,10650
Jehanabad,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0,800,500,0,600,0,100,300,0,0,500,0,2800
Jehanabad,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Jehanabad,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,150,150,350,50,300,450,50,350,200,50,400,100,2600
Jehanabad,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,350,1000,1150,1100,1400,950,1000,950,750,700,800,700,10850
Jehanabad,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,11380,3600,2400,2400,2480,2300,909,909,800,0,750,150,28078
Jehanabad,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0,0,0,0,0,3509,0,0,0,0,0,0,3509
Jehanabad,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Jehanabad,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,7780,1200,0,0,0,4900,0,109,50,0,600,0,14639
Jehanabad,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,3600,2400,2400,2400,2480,909,909,800,750,0,150,150,16948
Jehanabad,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,97540,14900,6960,6960,6960,5940,12840,12840,9840,9840,9840,2800,197260
Jehanabad,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0,0,0,0,0,58800,0,0,0,0,0,0,58800
Jehanabad,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Jehanabad,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,82640,7940,0,0,0,51900,0,3000,0,0,7040,0,152520
Jehanabad,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,14900,6960,6960,6960,6960,12840,12840,9840,9840,9840,2800,2800,103540
Jehanabad,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,20390,3670,870,870,870,870,1181,1181,981,881,881,0,32645
Jehanabad,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0,0,0,0,0,4011,0,0,0,0,0,0,4011
Jehanabad,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Jehanabad,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,16720,2800,0,0,0,3700,0,200,100,0,881,0,24401
Jehanabad,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,3670,870,870,870,870,1181,1181,981,881,881,0,0,12255
Jehanabad,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,13620,1400,0,0,0,0,487,487,487,487,487,0,17455
Jehanabad,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0,0,0,0,0,4487,0,0,0,0,0,0,4487
Jehanabad,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Jehanabad,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,12220,1400,0,0,0,4000,0,0,0,0,487,0,18107
Jehanabad,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,1400,0,0,0,0,487,487,487,487,487,0,0,3835
Jehanabad,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,0,0,0,0,0,0,0,0,0,0,0,0,0
Jehanabad,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0,0,0,0,0,737,0,0,0,0,0,0,737
Jehanabad,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Jehanabad,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0,0,0,0,0,600,0,0,0,0,0,0,600
Jehanabad,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0,0,0,0,0,137,0,0,0,0,0,0,137
Jehanabad,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,1000,0,0,0,0,0,0,0,0,0,0,0,1000
Jehanabad,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0,0,0,0,0,0,0,0,0,0,0,0,0
Jehanabad,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Jehanabad,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,1000,0,0,0,0,0,0,0,0,0,0,0,1000
Jehanabad,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Jehanabad,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,5500,5000,2500,1000,900,200,14400,6400,5600,9900,47200,36420,135020
Jehanabad,16.3.02,Stock Position of Gloves,2. Stocks Received,0,0,0,2000,0,20000,0,0,8000,50000,0,0,80000
Jehanabad,16.3.02,Stock Position of Gloves,3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Jehanabad,16.3.02,Stock Position of Gloves,4. Stock Distributed,500,2500,1500,2100,700,5800,8000,800,3700,12700,10780,7920,57000
Jehanabad,16.3.02,Stock Position of Gloves,5. Total Stock,5000,2500,1000,900,200,14400,6400,5600,9900,47200,36420,28500,158020
Jehanabad,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0,0,0,0,0,0,0,0,0,0,0,0,0
Jehanabad,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0,0,0,0,0,0,0,0,0,0,0,0,0
Jehanabad,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Jehanabad,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0,0,0,0,0,0,0,0,0,0,0,0,0
Jehanabad,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Jehanabad,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,1600,130,0,0,0,0,65,15,0,0,0,0,1810
Jehanabad,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0,0,0,0,0,200,0,0,0,0,0,0,200
Jehanabad,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Jehanabad,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,1470,130,0,0,0,135,50,15,0,0,0,0,1800
Jehanabad,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,130,0,0,0,0,65,15,0,0,0,0,0,210
Jehanabad,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,25,25,25,25,20,20,20,10,5,0,0,0,175
Jehanabad,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0,0,0,0,0,0,0,0,0,0,0,0,0
Jehanabad,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Jehanabad,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0,0,0,5,0,0,10,5,5,0,0,0,25
Jehanabad,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,25,25,25,20,20,20,10,5,0,0,0,0,150
Jehanabad,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0,0,0,0,0,0,0,0,0,0,0,0,0
Jehanabad,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0,0,0,0,0,0,0,0,0,0,0,0,0
Jehanabad,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Jehanabad,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0,0,0,0,0,0,0,0,0,0,0,0,0
Jehanabad,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Jehanabad,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,200000,49930,0,0,0,0,5100,1200,0,0,0,0,256230
Jehanabad,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0,0,0,0,0,9000,0,0,0,0,0,0,9000
Jehanabad,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Jehanabad,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,150070,49930,0,0,0,3900,3900,900,0,0,0,0,208700
Jehanabad,16.3.07,Stock Position of IFA Tablets,5. Total Stock,49930,0,0,0,0,5100,1200,300,0,0,0,0,56530
Jehanabad,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,25713,0,0,0,0,0,0,0,0,0,0,0,25713
Jehanabad,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0,0,0,0,0,0,0,0,0,0,0,0,0
Jehanabad,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Jehanabad,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,25713,0,0,0,0,0,0,0,0,0,0,0,25713
Jehanabad,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Jehanabad,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0,0,0,0,0,0,0,0,0,0,0,0,0
Jehanabad,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0,0,0,0,0,0,0,0,0,0,0,0,0
Jehanabad,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Jehanabad,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0,0,0,0,0,0,0,0,0,0,0,0,0
Jehanabad,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Jehanabad,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,0,0,0,0,0,0,0,0,0,0,0,0,0
Jehanabad,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0,0,0,0,0,0,0,0,0,0,0,0,0
Jehanabad,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Jehanabad,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0,0,0,0,0,0,0,0,0,0,0,0,0
Jehanabad,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Jehanabad,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,30398,10398,7398,0,0,0,0,0,0,149200,141200,78540,417134
Jehanabad,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0,0,0,89730,0,0,0,0,200000,0,0,0,289730
Jehanabad,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Jehanabad,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,20000,3000,7398,89730,0,0,0,0,50800,8000,62660,33600,275188
Jehanabad,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,10398,7398,0,0,0,0,0,0,149200,141200,78540,44940,431676
Jehanabad,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,9500,7800,5700,8400,6000,9800,7200,4000,7000,4200,600,6800,77000
Jehanabad,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0,0,6000,0,7000,0,0,7500,0,0,10000,0,30500
Jehanabad,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Jehanabad,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,1700,2100,3300,2400,3200,2600,3200,4500,2800,3600,3800,1600,34800
Jehanabad,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,7800,5700,8400,6000,9800,7200,4000,7000,4200,600,6800,5200,72700
Jehanabad,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,58000,28000,11000,26000,7000,65200,29200,7600,59200,33200,37200,64000,425600
Jehanabad,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0,0,70000,0,70000,0,0,80000,0,30000,60000,0,310000
Jehanabad,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Jehanabad,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,30000,17000,55000,19000,11800,36000,21600,28400,26000,26000,33200,26000,330000
Jehanabad,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,28000,11000,26000,7000,65200,29200,7600,59200,33200,37200,64000,38000,405600
Jehanabad,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,19500,9200,3000,5500,2200,7500,3250,500,18200,6400,8600,14000,97850
Jehanabad,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0,0,7000,0,8000,1000,0,28500,0,10000,10000,0,64500
Jehanabad,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Jehanabad,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,10300,6200,4500,3300,2700,5250,2750,10800,11800,7800,4600,4900,74900
Jehanabad,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,9200,3000,5500,2200,7500,3250,500,18200,6400,8600,14000,9100,87450
Jehanabad,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,NA,1
Jehanabad,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,NA,1
Jehanabad,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,1
Jehanabad,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Jehanabad,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,1
Kaimur Bhabua,1.1,Total number of pregnant women Registered for ANC,TOTAL,3842,3536,3551,3756,3468,2719,2642,2114,2336,2450,3159,3373,36946
Kaimur Bhabua,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1294,1167,1366,1318,1215,1000,904,782,937,1057,1658,1879,14577
Kaimur Bhabua,1.2,Number of Pregnant women registered under JSY,TOTAL,3842,3536,3551,3756,3466,2719,2642,2114,2336,2450,3159,3373,36944
Kaimur Bhabua,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1491,1601,1731,1947,2226,1934,1874,1627,1740,1808,2119,2448,22546
Kaimur Bhabua,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,2358,2162,2142,2266,2152,1686,1614,1315,1421,1445,1890,1902,22353
Kaimur Bhabua,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,3504,3535,2865,3170,3312,2612,2334,2058,2141,2106,2492,3080,33209
Kaimur Bhabua,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1234,832,598,1067,830,1065,700,389,343,421,911,319,8709
Kaimur Bhabua,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,68,18,151,191,14,8,13,3,1,3,97,95,662
Kaimur Bhabua,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0,0,0,0,1,1,4,0,0,1,4,0,11
Kaimur Bhabua,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,381,377,636,382,350,265,240,243,221,192,363,252,3902
Kaimur Bhabua,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,22,17,32,23,17,24,10,8,16,18,4,11,202
Kaimur Bhabua,1.8,Number of pregnancy test kits used at SC level,TOTAL,33,19,7,10,0,29,14,11,33,6,22,11,195
Kaimur Bhabua,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,42,50,36,25,2,52,51,32,51,71,50,12,474
Kaimur Bhabua,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,101,102,96,134,178,160,189,170,165,178,152,186,1811
Kaimur Bhabua,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,143,152,132,159,180,212,240,202,216,249,202,198,2285
Kaimur Bhabua,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,138,147,116,153,173,212,240,202,212,249,193,198,2233
Kaimur Bhabua,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0,0,0,4,0,0,0,0,0,0,0,0,4
Kaimur Bhabua,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1311,1479,1415,2009,2726,2820,2970,2506,2057,1871,1633,1555,24352
Kaimur Bhabua,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,1308,1474,1408,2009,2721,2820,2968,2504,2053,1867,1620,1540,24292
Kaimur Bhabua,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1095,736,1007,999,472,921,2569,1893,2137,1305,1272,1293,15699
Kaimur Bhabua,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,196,81,547,503,77,289,2067,1690,785,701,1308,1307,9551
Kaimur Bhabua,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Kaimur Bhabua,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,NA,NA,NA,NA,NA,NA,382,312,263,217,163,151,1488
Kaimur Bhabua,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0
Kaimur Bhabua,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0
Kaimur Bhabua,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0
Kaimur Bhabua,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Kaimur Bhabua,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Kaimur Bhabua,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,5,7,7,2,1,0,2,2,4,4,13,15,62
Kaimur Bhabua,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,5,7,7,2,1,0,2,2,4,4,13,15,62
Kaimur Bhabua,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,NA,NA,NA,NA,NA,NA,16,23,6,5,8,9,67
Kaimur Bhabua,4.1.1.a,Number of male live births,TOTAL,741,832,843,1109,1512,1543,1782,1540,1324,1201,1033,986,14446
Kaimur Bhabua,4.1.1.b,Number of female live births,TOTAL,704,783,703,1033,1368,1469,1768,1499,1236,1121,937,909,13530
Kaimur Bhabua,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1445,1615,1546,2142,2880,3012,3550,3039,2560,2322,1970,1895,27976
Kaimur Bhabua,4.1.2,Number of still births,TOTAL,13,21,23,23,32,32,43,32,28,20,28,23,318
Kaimur Bhabua,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,1,0,1,2,1,2,1,5,0,0,1,1,15
Kaimur Bhabua,4.2.1,Number of Newborns weighed at birth,TOTAL,1448,1601,1531,2149,2688,3012,3550,3039,2557,2320,1969,1892,27756
Kaimur Bhabua,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,136,195,144,241,264,325,377,222,239,179,130,186,2638
Kaimur Bhabua,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1609,1604,1530,2149,2811,3011,3550,3037,2556,2318,1948,1877,28000
Kaimur Bhabua,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,3,0,0,0,0,0,0,0,0,0,148,17,168
Kaimur Bhabua,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,23,0,23
Kaimur Bhabua,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,NA,NA,NA,3,16,NA,NA,18,15,36,79,46,213
Kaimur Bhabua,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,3,0,0,3,16,0,0,18,15,36,250,63,404
Kaimur Bhabua,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,392,15,282,287,447,359,731,651,531,476,593,392,5156
Kaimur Bhabua,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,21,0,0,0,0,0,0,0,0,0,0,0,21
Kaimur Bhabua,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,457,15,224,287,443,359,731,651,531,508,497,392,5095
Kaimur Bhabua,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,9,9,0,27,27,0,3,0,2,0,47,3,127
Kaimur Bhabua,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1337,1347,1410,2088,2644,2722,3456,2818,2445,2246,1909,1839,26261
Kaimur Bhabua,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,440,245,367,504,1557,1516,457,315,434,358,349,379,6921
Kaimur Bhabua,6.3,PNC maternal complications attended,TOTAL,0,0,1,0,0,0,0,0,0,2,0,0,3
Kaimur Bhabua,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Kaimur Bhabua,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Kaimur Bhabua,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Kaimur Bhabua,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Kaimur Bhabua,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,0,0,0,0,0,21,0,0,0,0,0,0,21
Kaimur Bhabua,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,0,0,0,0,0,282,0,0,0,0,0,0,282
Kaimur Bhabua,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,0,0,0,0,0,303,0,0,0,0,0,0,303
Kaimur Bhabua,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Kaimur Bhabua,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,1,0,0,1,0,0,0,0,0,2,3,2,9
Kaimur Bhabua,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0,0,0,0,0,0,0,0,1,0,0,0,1
Kaimur Bhabua,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,2,NA,1,NA,NA,NA,NA,1,1,3,0,0,8
Kaimur Bhabua,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,3,0,1,1,0,0,0,1,2,5,3,2,18
Kaimur Bhabua,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,NA,NA,NA,NA,0,0,0,0,NA,NA,NA,6,6
Kaimur Bhabua,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Kaimur Bhabua,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0,0,0,0,0,0,0,0,NA,0,0,0,0
Kaimur Bhabua,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0
Kaimur Bhabua,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Kaimur Bhabua,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,NA,NA,NA,NA,0,0,0,0,NA,NA,NA,NA,0
Kaimur Bhabua,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,72,0,0,227,10,273,461,307,986,1262,1098,636,5332
Kaimur Bhabua,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,23,0,0,29,40,55,146,252,254,311,169,92,1371
Kaimur Bhabua,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,40,11,5,24,26,68,150,120,272,279,368,107,1470
Kaimur Bhabua,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,135,11,5,280,76,396,757,679,1512,1852,1635,835,8173
Kaimur Bhabua,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,NA,NA,50,117,35,286,428,419,272,888,157,1068,3720
Kaimur Bhabua,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0,0,0,0,0,0,0,0,1,0,0,0,1
Kaimur Bhabua,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Kaimur Bhabua,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,7,7
Kaimur Bhabua,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0,0,0,0,0,0,0,0,1,0,0,7,8
Kaimur Bhabua,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,NA,NA,NA,NA,0,0,0,0,NA,NA,NA,NA,0
Kaimur Bhabua,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,40,30,26,77,38,33,30,42,77,54,68,52,567
Kaimur Bhabua,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,62,33,14,84,24,232,203,228,271,68,285,266,1770
Kaimur Bhabua,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,19,23,1,13,11,2,24,5,10,10,59,84,261
Kaimur Bhabua,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,116,112,79,112,29,179,72,222,95,118,155,186,1475
Kaimur Bhabua,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,237,198,120,286,102,446,329,497,453,250,567,588,4073
Kaimur Bhabua,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,88,1,23,110,95,139,150,228,99,145,202,239,1519
Kaimur Bhabua,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,NA,NA,115,56,21,76,83,117,16,38,63,72,657
Kaimur Bhabua,9.06,Number of IUCD removals,TOTAL,38,36,18,28,22,14,9,13,20,15,49,60,322
Kaimur Bhabua,9.07,Number of Oral Pills cycles distributed,TOTAL,523,476,347,1250,880,491,781,741,2462,1416,2407,555,12329
Kaimur Bhabua,9.08,Number of Condom pieces distributed,TOTAL,3362,1647,4085,6590,6421,5477,6391,7197,7099,8066,8771,8005,73111
Kaimur Bhabua,9.09,Number of Centchroman (weekly) pills given,TOTAL,129,50,32,60,22,13,26,2,5,0,9,2,350
Kaimur Bhabua,9.1,Number of Emergency Contraceptive Pills distributed,TOTAL,329,186,83,134,78,31,40,41,28,38,483,123,1594
Kaimur Bhabua,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0,0,0,0,0,0,0,4,0,0,0,0,4
Kaimur Bhabua,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,22,0,0,0,0,32,0,3,0,0,0,0,57
Kaimur Bhabua,9.11.2.a,Number of failures following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Kaimur Bhabua,9.11.2.b,Number of failures following female sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Kaimur Bhabua,9.11.3.a,Number of deaths following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Kaimur Bhabua,9.11.3.b,Number of deaths following female sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Kaimur Bhabua,9.12,Number of Institutions having NSV trained doctors,TOTAL,NA,2,2,3,3,3,3,1,3,3,5,8,Data for this item can not be cumulated
Kaimur Bhabua,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,2146,2154,2006,3123,3685,3919,4138,3812,3615,3173,3093,2424,37288
Kaimur Bhabua,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,7,10,25,21,2,10,1,0,4,1,39,151,271
Kaimur Bhabua,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,348,199,207,134,77,54,43,36,51,34,30,136,1349
Kaimur Bhabua,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,1162,573,421,372,212,140,83,53,124,90,47,142,3419
Kaimur Bhabua,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,2799,2213,2396,2399,2544,2712,3702,3737,4149,3856,3920,3292,37719
Kaimur Bhabua,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,2801,2578,2339,2398,2409,2339,2615,3112,3420,3913,3730,3996,35650
Kaimur Bhabua,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,2233,2391,2396,2352,2498,2158,2322,2317,2682,3099,3460,3863,31771
Kaimur Bhabua,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1313,1376,1075,1801,2368,2560,1959,2411,2029,1932,1518,1449,21791
Kaimur Bhabua,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,2775,2216,2148,2440,2599,2737,3806,3732,4128,3840,4134,3292,37847
Kaimur Bhabua,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,3164,2735,2349,2542,2453,2398,2596,3028,3453,3916,3711,4034,36379
Kaimur Bhabua,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,3379,3012,2685,2708,2736,2230,2345,2378,2698,3160,3515,3926,34772
Kaimur Bhabua,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,1109,1220,1064,1540,1996,1804,2388,1917,1725,1535,1258,1297,18853
Kaimur Bhabua,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,31,59,123,19,136,129,207,20,34,12,46,0,816
Kaimur Bhabua,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,370,239,253,140,215,166,208,53,71,29,28,9,1781
Kaimur Bhabua,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,1094,602,468,352,326,228,196,72,125,83,52,48,3646
Kaimur Bhabua,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1855,2784,2975,4081,4242,3359,3445,2818,2496,2146,2096,2453,34750
Kaimur Bhabua,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,2863,3305,2644,2924,2751,2208,2304,2082,2476,2539,3388,4221,33705
Kaimur Bhabua,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0,0,1,0,0,0,0,0,0,0,0,0,1
Kaimur Bhabua,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,981,1500,1645,2006,2157,1746,1742,1473,1281,1279,1115,1184,18109
Kaimur Bhabua,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,810,1313,1425,1938,2037,1649,1599,1246,1118,1119,1001,1034,16289
Kaimur Bhabua,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1791,2813,3070,3944,4194,3395,3341,2719,2399,2398,2116,2218,34398
Kaimur Bhabua,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,3159,3089,2721,2894,2783,2219,2345,2082,2463,2638,3594,4155,34142
Kaimur Bhabua,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,7186,3104,2750,2885,2797,2211,2328,2087,2458,2635,3592,4205,38238
Kaimur Bhabua,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0,48,0,0,0,0,0,0,0,0,0,0,48
Kaimur Bhabua,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,448,456,378,349,340,366,247,264,339,286,290,331,4094
Kaimur Bhabua,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,385,424,359,268,346,340,223,221,336,271,269,283,3725
Kaimur Bhabua,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,833,880,737,617,686,706,470,485,675,557,559,614,7819
Kaimur Bhabua,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,71,79,115,178,211,196,215,98,189,89,487,526,2454
Kaimur Bhabua,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,416,302,305,472,440,380,427,384,356,452,485,542,4961
Kaimur Bhabua,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,561,470,409,728,626,613,598,622,693,776,874,852,7822
Kaimur Bhabua,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0,11,27,11,5,0,29,0,0,0,0,0,83
Kaimur Bhabua,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Kaimur Bhabua,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Kaimur Bhabua,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1570,1581,1621,1773,1612,1709,1720,1631,1778,1726,1719,1760,20200
Kaimur Bhabua,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1552,1550,1580,1724,1594,1577,1619,1487,1618,1519,1637,1707,19164
Kaimur Bhabua,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1369,1478,1303,1567,1513,1468,1543,1389,1561,1495,1573,1608,17867
Kaimur Bhabua,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Kaimur Bhabua,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,44,36,0,0,0,0,0,0,0,0,0,0,80
Kaimur Bhabua,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Kaimur Bhabua,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Kaimur Bhabua,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,5,0,0,0,5
Kaimur Bhabua,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Kaimur Bhabua,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Kaimur Bhabua,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Kaimur Bhabua,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Kaimur Bhabua,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,17,13,0,0,0,3,0,0,0,0,0,1,34
Kaimur Bhabua,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,55,115,318,204,261,146,183,129,71,56,56,24,1618
Kaimur Bhabua,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Kaimur Bhabua,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Kaimur Bhabua,13.1,Number of Patients operated for cataract,TOTAL,0,0,0,0,0,0,0,0,0,111,526,611,1248
Kaimur Bhabua,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0,0,0,0,0,0,0,0,0,111,526,611,1248
Kaimur Bhabua,13.3,Number of School children detected with Refractive errors,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Kaimur Bhabua,13.4,Number of children provided free glasses,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Kaimur Bhabua,13.5,Number of eyes collected through eye donation,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Kaimur Bhabua,13.6,Number of eyes utilised for corneal transplant,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Kaimur Bhabua,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,NA,2,3,3,3,2,2,3,3,3,3,4,Data for this item can not be cumulated
Kaimur Bhabua,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,NA,NA,5,8,4,3,5,3,1,3,7,4,Data for this item can not be cumulated
Kaimur Bhabua,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,1135,1048,976,994,961,917,945,993,1049,1032,1048,978,Data for this item can not be cumulated
Kaimur Bhabua,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,NA,2,3,3,3,1,2,2,3,3,3,4,Data for this item can not be cumulated
Kaimur Bhabua,14.05,Number of RKS meetings held during the month,TOTAL,3,3,2,3,1,1,3,2,3,4,5,6,36
Kaimur Bhabua,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,NA,2,10,10,8,6,9,7,7,9,8,9,Data for this item can not be cumulated
Kaimur Bhabua,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,113,117,26,189,50,4,9,87,62,169,91,361,1278
Kaimur Bhabua,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,NA,1,1,1,1,NA,1,2,1,2,3,3,Data for this item can not be cumulated
Kaimur Bhabua,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,NA,2,1,1,1,NA,NA,NA,NA,NA,NA,0,Data for this item can not be cumulated
Kaimur Bhabua,14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,110,116,184,149,186,234,197,174,133,179,191,216,2069
Kaimur Bhabua,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,397,467,332,294,500,471,369,321,498,529,507,567,5252
Kaimur Bhabua,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,83,144,132,92,263,217,210,239,225,147,137,120,2009
Kaimur Bhabua,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,2714,2587,2216,3353,3837,3915,3934,4042,4222,4379,4641,3244,43084
Kaimur Bhabua,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,193,260,316,241,449,451,407,413,358,326,328,336,4078
Kaimur Bhabua,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,3111,3054,2548,3647,4337,4386,4303,4363,4720,4908,5148,3811,48336
Kaimur Bhabua,14.10.2.a,Number of death cases of Inpatient males,TOTAL,0,2,5,3,1,2,2,2,0,1,1,3,22
Kaimur Bhabua,14.10.2.b,Number of death cases of Inpatient females,TOTAL,0,2,0,2,3,2,4,4,1,2,3,0,23
Kaimur Bhabua,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,0,4,5,5,4,4,6,6,1,3,4,3,45
Kaimur Bhabua,14.11,In-Patient Head Count at midnight,TOTAL,4754,3701,4062,3811,4721,5639,6258,5326,5191,5159,5854,5132,59608
Kaimur Bhabua,14.12.1,OPD attendance (All),TOTAL,97915,72149,94343,100765,101924,121668,98580,110671,91888,101916,109873,105819,1207511
Kaimur Bhabua,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,42,9,17,3,27,34,78,122,70,82,31,31,546
Kaimur Bhabua,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,3,0,0,0,0,0,0,0,0,0,0,0,3
Kaimur Bhabua,14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,1117,895,1155,1558,1781,1824,1502,1667,2077,2260,2268,1661,19765
Kaimur Bhabua,14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,14.14.a,Number of patients given AYUSH treatment,TOTAL,35814,19910,25703,28915,25090,31765,29300,34051,41442,35016,42348,35413,384767
Kaimur Bhabua,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,1666,948,1858,1546,2012,1235,1830,1911,1608,1526,1628,1387,19155
Kaimur Bhabua,14.14.c,Number of Adolescents counselled,TOTAL,0,0,0,0,0,0,48,0,45,50,22,52,217
Kaimur Bhabua,15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,624,584,994,974,664,569,443,475,545,723,713,495,7803
Kaimur Bhabua,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,27,20,33,29,20,12,15,11,19,12,5,12,215
Kaimur Bhabua,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,25,0,303,407,524,515,300,416,628,339,696,657,4810
Kaimur Bhabua,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,2,0,2,4,3,3,1,2,2,2,1,0,22
Kaimur Bhabua,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,23,0,112,154,126,228,216,214,169,114,279,87,1722
Kaimur Bhabua,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,1,0,2,3,2,2,2,2,0,0,1,0,15
Kaimur Bhabua,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,28,0,268,175,463,33,282,297,531,540,586,485,3688
Kaimur Bhabua,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0,0,0,1,1,0,0,0,0,0,0,0,2
Kaimur Bhabua,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,76,0,683,736,1113,776,798,927,1328,993,1561,1229,10220
Kaimur Bhabua,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,3,0,4,8,6,5,3,4,2,2,2,0,39
Kaimur Bhabua,15.2,Number of Widal tests conducted,Number tested,109,74,82,0,0,2,0,1,228,152,142,202,992
Kaimur Bhabua,15.3.a,Number of VDRL tests conducted on males,Number tested,0,0,0,3,1,0,1,5,86,48,46,38,228
Kaimur Bhabua,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,145,150,188,78,18,0,15,57,12,11,6,70,750
Kaimur Bhabua,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,213,208,230,120,38,0,31,63,42,80,59,119,1203
Kaimur Bhabua,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,358,358,418,201,57,0,47,125,140,139,111,227,2181
Kaimur Bhabua,15.4.1,Number of blood smears examined for Malaria,TOTAL,115,73,211,254,299,637,218,206,178,160,180,319,2850
Kaimur Bhabua,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,2,1,8,7,9,40,19,18,10,7,6,15,142
Kaimur Bhabua,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,1,1,5,5,7,41,15,22,9,6,5,11,128
Kaimur Bhabua,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,NA,4800,NA,NA,NA,NA,4050,NA,600,NA,350,NA,9800
Kaimur Bhabua,16.1.1,Stock position of DPT vaccines,2. Stocks Received,NA,2000,NA,NA,NA,NA,0,NA,0,NA,0,NA,2000
Kaimur Bhabua,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,NA,0,NA,NA,NA,NA,0,NA,NA,NA,0,NA,0
Kaimur Bhabua,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,NA,2400,NA,NA,NA,NA,150,NA,260,NA,350,NA,3160
Kaimur Bhabua,16.1.1,Stock position of DPT vaccines,5. Total Stock,0,4400,0,0,0,0,3900,0,340,0,0,0,8640
Kaimur Bhabua,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,NA,200,NA,NA,NA,NA,750,NA,912,NA,864,NA,2726
Kaimur Bhabua,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,NA,1500,NA,NA,NA,NA,1440,NA,1464,NA,0,NA,4404
Kaimur Bhabua,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,NA,0,NA,NA,NA,NA,0,NA,NA,NA,0,NA,0
Kaimur Bhabua,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,NA,1500,NA,NA,NA,NA,846,NA,1992,NA,288,NA,4626
Kaimur Bhabua,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0,200,0,0,0,0,1344,0,384,0,576,0,2504
Kaimur Bhabua,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,NA,5600,NA,NA,NA,NA,700,NA,1000,NA,600,NA,7900
Kaimur Bhabua,16.1.2,Stock position of OPV vaccines,2. Stocks Received,NA,1200,NA,NA,NA,NA,1300,NA,500,NA,500,NA,3500
Kaimur Bhabua,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,NA,0,NA,NA,NA,NA,0,NA,NA,NA,0,NA,0
Kaimur Bhabua,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,NA,1300,NA,NA,NA,NA,700,NA,750,NA,500,NA,3250
Kaimur Bhabua,16.1.2,Stock position of OPV vaccines,5. Total Stock,0,5500,0,0,0,0,1300,0,750,0,600,0,8150
Kaimur Bhabua,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,NA,2500,NA,NA,NA,NA,1300,NA,475,NA,1700,NA,5975
Kaimur Bhabua,16.1.3,Stock position of TT vaccines,2. Stocks Received,NA,2000,NA,NA,NA,NA,1900,NA,250,NA,0,NA,4150
Kaimur Bhabua,16.1.3,Stock position of TT vaccines,3. Unusable Stock,NA,0,NA,NA,NA,NA,0,NA,NA,NA,0,NA,0
Kaimur Bhabua,16.1.3,Stock position of TT vaccines,4. Stock Distributed,NA,1000,NA,NA,NA,NA,1900,NA,700,NA,450,NA,4050
Kaimur Bhabua,16.1.3,Stock position of TT vaccines,5. Total Stock,0,3500,0,0,0,0,1300,0,25,0,1250,0,6075
Kaimur Bhabua,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,NA,0,NA,NA,NA,NA,0,NA,NA,NA,0,NA,0
Kaimur Bhabua,16.1.4,Stock position of DT vaccines,2. Stocks Received,NA,0,NA,NA,NA,NA,0,NA,NA,NA,0,NA,0
Kaimur Bhabua,16.1.4,Stock position of DT vaccines,3. Unusable Stock,NA,0,NA,NA,NA,NA,0,NA,NA,NA,0,NA,0
Kaimur Bhabua,16.1.4,Stock position of DT vaccines,4. Stock Distributed,NA,0,NA,NA,NA,NA,0,NA,NA,NA,0,NA,0
Kaimur Bhabua,16.1.4,Stock position of DT vaccines,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Kaimur Bhabua,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,NA,1500,NA,NA,NA,NA,650,NA,50,NA,0,NA,2200
Kaimur Bhabua,16.1.5,Stock position of BCG vaccines,2. Stocks Received,NA,1500,NA,NA,NA,NA,900,NA,600,NA,750,NA,3750
Kaimur Bhabua,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,NA,0,NA,NA,NA,NA,0,NA,NA,NA,0,NA,0
Kaimur Bhabua,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,NA,2000,NA,NA,NA,NA,800,NA,250,NA,750,NA,3800
Kaimur Bhabua,16.1.5,Stock position of BCG vaccines,5. Total Stock,0,1000,0,0,0,0,750,0,400,0,0,0,2150
Kaimur Bhabua,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,NA,2000,NA,NA,NA,NA,2400,NA,600,NA,0,NA,5000
Kaimur Bhabua,16.1.6,Stock position of Measles vaccines,2. Stocks Received,NA,2000,NA,NA,NA,NA,0,NA,450,NA,2000,NA,4450
Kaimur Bhabua,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,NA,0,NA,NA,NA,NA,0,NA,NA,NA,0,NA,0
Kaimur Bhabua,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,NA,2400,NA,NA,NA,NA,1900,NA,1050,NA,1100,NA,6450
Kaimur Bhabua,16.1.6,Stock position of Measles vaccines,5. Total Stock,0,1600,0,0,0,0,500,0,0,0,900,0,3000
Kaimur Bhabua,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,NA,0,NA,NA,NA,NA,0,NA,NA,NA,0,NA,0
Kaimur Bhabua,16.1.7,Stock position of JE vaccines,2. Stocks Received,NA,0,NA,NA,NA,NA,0,NA,NA,NA,0,NA,0
Kaimur Bhabua,16.1.7,Stock position of JE vaccines,3. Unusable Stock,NA,0,NA,NA,NA,NA,0,NA,NA,NA,0,NA,0
Kaimur Bhabua,16.1.7,Stock position of JE vaccines,4. Stock Distributed,NA,0,NA,NA,NA,NA,0,NA,NA,NA,0,NA,0
Kaimur Bhabua,16.1.7,Stock position of JE vaccines,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Kaimur Bhabua,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,NA,1200,NA,NA,NA,NA,1600,NA,1350,NA,250,NA,4400
Kaimur Bhabua,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,NA,1000,NA,NA,NA,NA,0,NA,0,NA,0,NA,1000
Kaimur Bhabua,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,NA,0,NA,NA,NA,NA,0,NA,NA,NA,0,NA,0
Kaimur Bhabua,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,NA,1600,NA,NA,NA,NA,900,NA,200,NA,0,NA,2700
Kaimur Bhabua,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0,600,0,0,0,0,700,0,1150,0,250,0,2700
Kaimur Bhabua,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,0
Kaimur Bhabua,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,0
Kaimur Bhabua,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,0
Kaimur Bhabua,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,0
Kaimur Bhabua,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Kaimur Bhabua,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,0
Kaimur Bhabua,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,0
Kaimur Bhabua,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,0
Kaimur Bhabua,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,0
Kaimur Bhabua,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Kaimur Bhabua,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,0
Kaimur Bhabua,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,0
Kaimur Bhabua,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,0
Kaimur Bhabua,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,0
Kaimur Bhabua,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Kaimur Bhabua,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,0
Kaimur Bhabua,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,0
Kaimur Bhabua,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,0
Kaimur Bhabua,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,0
Kaimur Bhabua,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Kaimur Bhabua,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,0
Kaimur Bhabua,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,0
Kaimur Bhabua,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,0
Kaimur Bhabua,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,0
Kaimur Bhabua,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Kaimur Bhabua,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,0
Kaimur Bhabua,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,0
Kaimur Bhabua,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,0
Kaimur Bhabua,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,0
Kaimur Bhabua,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Kaimur Bhabua,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,0
Kaimur Bhabua,16.3.02,Stock Position of Gloves,2. Stocks Received,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,0
Kaimur Bhabua,16.3.02,Stock Position of Gloves,3. Unusable Stock,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,0
Kaimur Bhabua,16.3.02,Stock Position of Gloves,4. Stock Distributed,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,0
Kaimur Bhabua,16.3.02,Stock Position of Gloves,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Kaimur Bhabua,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,0
Kaimur Bhabua,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,0
Kaimur Bhabua,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,0
Kaimur Bhabua,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,0
Kaimur Bhabua,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Kaimur Bhabua,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,0
Kaimur Bhabua,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,0
Kaimur Bhabua,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,0
Kaimur Bhabua,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,0
Kaimur Bhabua,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Kaimur Bhabua,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,0
Kaimur Bhabua,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,0
Kaimur Bhabua,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,0
Kaimur Bhabua,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,0
Kaimur Bhabua,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Kaimur Bhabua,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,0
Kaimur Bhabua,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,0
Kaimur Bhabua,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,0
Kaimur Bhabua,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,0
Kaimur Bhabua,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Kaimur Bhabua,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,0
Kaimur Bhabua,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,0
Kaimur Bhabua,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,0
Kaimur Bhabua,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,0
Kaimur Bhabua,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Kaimur Bhabua,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,0
Kaimur Bhabua,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,0
Kaimur Bhabua,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,0
Kaimur Bhabua,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,0
Kaimur Bhabua,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Kaimur Bhabua,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,0
Kaimur Bhabua,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,0
Kaimur Bhabua,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,0
Kaimur Bhabua,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,0
Kaimur Bhabua,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Kaimur Bhabua,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,0
Kaimur Bhabua,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,0
Kaimur Bhabua,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,0
Kaimur Bhabua,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,0
Kaimur Bhabua,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Kaimur Bhabua,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,0
Kaimur Bhabua,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,0
Kaimur Bhabua,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,0
Kaimur Bhabua,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,0
Kaimur Bhabua,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Kaimur Bhabua,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,NA,5000,NA,NA,NA,NA,5800,NA,200,NA,2000,NA,13000
Kaimur Bhabua,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,NA,0,NA,NA,NA,NA,0,NA,12600,NA,14600,NA,27200
Kaimur Bhabua,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,NA,0,NA,NA,NA,NA,0,NA,NA,NA,0,NA,0
Kaimur Bhabua,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,NA,2900,NA,NA,NA,NA,3200,NA,5400,NA,2200,NA,13700
Kaimur Bhabua,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0,2100,0,0,0,0,2600,0,7400,0,14400,0,26500
Kaimur Bhabua,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,NA,85600,NA,NA,NA,NA,21000,NA,4800,NA,32000,NA,143400
Kaimur Bhabua,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,NA,0,NA,NA,NA,NA,0,NA,68000,NA,90000,NA,158000
Kaimur Bhabua,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,NA,0,NA,NA,NA,NA,0,NA,NA,NA,0,NA,0
Kaimur Bhabua,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,NA,49000,NA,NA,NA,NA,21000,NA,65600,NA,30000,NA,165600
Kaimur Bhabua,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0,36600,0,0,0,0,0,0,7200,0,92000,0,135800
Kaimur Bhabua,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,NA,200,NA,NA,NA,NA,400,NA,600,NA,2400,NA,3600
Kaimur Bhabua,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,NA,1500,NA,NA,NA,NA,1600,NA,2000,NA,9800,NA,14900
Kaimur Bhabua,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,NA,0,NA,NA,NA,NA,0,NA,NA,NA,0,NA,0
Kaimur Bhabua,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,NA,1500,NA,NA,NA,NA,1600,NA,1500,NA,1400,NA,6000
Kaimur Bhabua,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0,200,0,0,0,0,400,0,1100,0,10800,0,12500
Kaimur Bhabua,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,NA,NA,1
Kaimur Bhabua,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,NA,NA,1
Kaimur Bhabua,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,NA,NA,1
Kaimur Bhabua,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,NA,NA,1
Kaimur Bhabua,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,NA,NA,1
Kaimur Bhabua,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,NA,NA,1
Kaimur Bhabua,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,NA,NA,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,1
Kaimur Bhabua,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,NA,NA,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,1
Kaimur Bhabua,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kaimur Bhabua,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,1.1,Total number of pregnant women Registered for ANC,TOTAL,9582,9071,8070,8000,9153,8484,8407,7882,7848,8145,9054,9716,103412
Katihar,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,5923,5851,5077,5240,5999,5192,5184,5177,5020,5303,5987,6441,66394
Katihar,1.2,Number of Pregnant women registered under JSY,TOTAL,9582,9071,8070,8000,9153,8484,8407,7882,7848,8145,9054,9716,103412
Katihar,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,5828,6515,6294,6171,6544,6575,6752,6861,6530,6279,6945,7024,78318
Katihar,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,6455,6205,5306,5096,5720,5297,5119,4835,4812,5223,5987,6122,66177
Katihar,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,7249,8083,7223,6731,7678,7505,6999,6079,5983,6020,6502,7291,83343
Katihar,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,5173,3543,3018,3025,2169,1947,1450,1275,881,1667,3485,3671,31304
Katihar,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,41,11,175,180,303,265,90,51,96,125,113,64,1514
Katihar,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,2,2,5,2,3,4,4,3,3,7,9,12,56
Katihar,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,1535,1358,1292,1291,1585,1580,2199,2445,2363,2348,3069,3081,24146
Katihar,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,0,0,1,1,45,86,26,20,35,21,31,50,316
Katihar,1.8,Number of pregnancy test kits used at SC level,TOTAL,1607,1358,1387,2087,2933,2317,2512,2691,2282,2222,2755,2806,26957
Katihar,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,292,335,353,410,381,403,411,398,368,382,355,332,4420
Katihar,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,1200,1232,1291,1281,1485,1706,1743,1705,1478,1501,1569,1350,17541
Katihar,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,1492,1567,1644,1691,1866,2109,2154,2103,1846,1883,1924,1682,21961
Katihar,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,1302,1153,1260,1336,1367,1407,1403,1507,1324,1378,1499,1206,16142
Katihar,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0,3,4,0,0,0,0,0,0,1,0,0,8
Katihar,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,2944,2888,2924,4442,5573,5674,5812,4935,4636,4415,4136,3761,52140
Katihar,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,2708,2699,2734,4111,5073,5172,5267,4433,4144,3921,3759,3370,47391
Katihar,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,0,82,9,243,2,14113,14016,6644,3129,4050,6554,5921,54763
Katihar,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,0,20,0,702,236,11662,11441,4626,2090,2377,3542,7062,43758
Katihar,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Katihar,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,NA,NA,NA,NA,NA,NA,68,240,450,320,295,2697,4070
Katihar,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,1,1,2,4,1,0,8,0,0,0,0,0,17
Katihar,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Katihar,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,73,71,60,75,40,36,33,32,30,35,33,74,592
Katihar,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,74,72,62,79,41,36,41,32,30,35,33,74,609
Katihar,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,NA,NA,NA,NA,NA,NA,35,65,105,20,15,1892,2132
Katihar,4.1.1.a,Number of male live births,TOTAL,2240,2184,2347,3059,3817,3837,4031,3525,3267,3207,3075,2702,37291
Katihar,4.1.1.b,Number of female live births,TOTAL,2125,2203,2168,2963,3499,3822,3798,3414,3125,3023,2943,2679,35762
Katihar,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,4365,4387,4515,6022,7316,7659,7829,6939,6392,6230,6018,5381,73053
Katihar,4.1.2,Number of still births,TOTAL,85,97,85,133,152,149,155,118,109,92,64,76,1315
Katihar,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,17,22,17,18,20,14,11,17,30,20,19,25,230
Katihar,4.2.1,Number of Newborns weighed at birth,TOTAL,4306,4300,4378,5894,7176,7545,7727,6818,6183,6201,5973,5369,71870
Katihar,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,582,711,281,415,566,465,517,445,529,443,422,342,5718
Katihar,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,4303,4258,4376,5876,7082,7554,7721,6815,6381,6078,5941,5314,71699
Katihar,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,6,1,75,76,46,20,13,22,22,38,75,71,465
Katihar,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Katihar,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,87,96,102,94,73,64,51,53,63,66,57,94,900
Katihar,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,93,97,177,170,119,84,64,75,85,104,132,165,1365
Katihar,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,1208,68,1243,1396,867,877,617,697,701,968,945,1082,10669
Katihar,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0,0,24,24,35,20,45,50,51,94,155,163,661
Katihar,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,72,54,97,55,103,108,65,91,114,136,645,668,2208
Katihar,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,7,10,18,7,11,11,10,9,5,8,11,11,118
Katihar,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,2833,2550,3153,4302,5813,5158,5395,5241,5010,4757,5112,4332,53656
Katihar,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,2225,2148,2502,2948,3488,3330,4538,3789,3451,3299,3306,3004,38028
Katihar,6.3,PNC maternal complications attended,TOTAL,0,0,2,2,14,0,0,18,1,9,1,2,49
Katihar,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,3,1,0,1,2,1,1,4,12,10,6,20,61
Katihar,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0,0,0,1,1,0,0,0,0,9,0,0,11
Katihar,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,3,1,0,2,3,1,1,4,12,19,6,20,72
Katihar,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0,0,0,0,0,0,0,0,0,9,0,0,9
Katihar,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,441,2,292,2,220,340,302,341,338,267,254,280,3079
Katihar,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,666,3,819,3,1085,1026,913,769,875,798,881,929,8767
Katihar,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,1107,5,1111,5,1305,1366,1215,1110,1213,1065,1135,1209,11846
Katihar,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Katihar,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0,0,0,1,1,2,0,0,0,0,0,0,4
Katihar,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Katihar,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,1,0,0,1,0,0,2,0,0,0,1,0,5
Katihar,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,1,0,0,2,1,2,2,0,0,0,1,0,9
Katihar,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,NA,NA,1,NA,0,0,0,NA,NA,NA,NA,NA,1
Katihar,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0,4,0,0,0,0,0,0,0,0,0,0,4
Katihar,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Katihar,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Katihar,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0,4,0,0,0,0,0,0,0,0,0,0,4
Katihar,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,127,42,95,252,170,412,638,771,1641,1013,1623,1029,7813
Katihar,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,3,8,4,61,25,25,58,88,240,121,124,86,843
Katihar,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,161,27,40,70,64,57,78,92,288,167,232,205,1481
Katihar,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,291,77,139,383,259,494,774,951,2169,1301,1979,1320,10137
Katihar,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,68,64,50,262,129,61,140,257,605,540,528,2865,5569
Katihar,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,2,2,0,18,5,240,17,7,12,27,32,25,387
Katihar,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0,0,1,4,3,1,6,6,8,6,5,8,48
Katihar,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,26,15,21,31,15,14,10,22,14,22,21,24,235
Katihar,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,28,17,22,53,23,255,33,35,34,55,58,57,670
Katihar,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,1080,1130,1130,1861,1240,1398,1332,1371,1560,1281,1346,1327,16056
Katihar,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,229,186,194,413,209,236,251,257,335,387,340,466,3503
Katihar,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,8,3,8,47,22,9,22,16,48,15,15,16,229
Katihar,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,58,39,39,92,122,222,258,183,275,262,174,165,1889
Katihar,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,1375,1358,1371,2413,1593,1865,1863,1827,2218,1945,1875,1974,21677
Katihar,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,119,113,133,210,186,280,283,236,376,400,309,336,2981
Katihar,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,5,7,8,5,7,7,8,7,9,8,7,10,88
Katihar,9.06,Number of IUCD removals,TOTAL,582,531,606,741,666,672,635,704,630,626,598,606,7597
Katihar,9.07,Number of Oral Pills cycles distributed,TOTAL,2653,2545,2766,5186,4504,3988,3760,3554,3452,3187,2809,2489,40893
Katihar,9.08,Number of Condom pieces distributed,TOTAL,15261,10749,12438,24375,23766,21759,19803,19924,20302,17254,26018,19884,231533
Katihar,9.09,Number of Centchroman (weekly) pills given,TOTAL,72,61,45,120,35,96,71,150,62,2,20,42,776
Katihar,9.1,Number of Emergency Contraceptive Pills distributed,TOTAL,544,851,576,535,295,367,468,411,453,290,745,591,6126
Katihar,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0,0,0,0,0,5,0,0,0,0,0,0,5
Katihar,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Katihar,9.11.2.a,Number of failures following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Katihar,9.11.2.b,Number of failures following female sterilization,TOTAL,1,0,0,1,0,0,0,0,0,0,0,0,2
Katihar,9.11.3.a,Number of deaths following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Katihar,9.11.3.b,Number of deaths following female sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Katihar,9.12,Number of Institutions having NSV trained doctors,TOTAL,NA,NA,1,1,1,2,2,6,3,2,3,2,Data for this item can not be cumulated
Katihar,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,6543,6259,5611,7176,8935,9907,10263,8785,8312,8181,8383,7788,96143
Katihar,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,278,180,73,62,47,43,50,33,64,98,19,35,982
Katihar,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,1843,1004,556,437,164,172,180,88,66,83,29,41,4663
Katihar,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,3875,2428,1374,1145,601,417,430,242,145,114,72,57,10900
Katihar,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,7134,6353,5377,5207,6138,7103,9034,9276,8916,8342,8179,8019,89078
Katihar,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,6227,7345,5875,5243,5403,6117,6791,7460,7872,9017,8405,8169,83924
Katihar,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,4194,5782,6027,5409,5350,5605,6134,6119,6318,7566,8659,8328,75491
Katihar,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,3466,3310,3298,4833,6367,6463,6778,5620,5319,4901,5050,4012,59417
Katihar,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,7695,6675,5569,4966,5796,7278,8855,8331,9291,8459,8135,8171,89221
Katihar,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,7642,8188,6591,5441,5015,6174,6792,6744,7859,9177,8617,8247,86487
Katihar,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,7194,7779,7258,6320,5384,5719,6404,5691,6474,7483,8335,8441,82482
Katihar,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,2654,2348,2044,3871,4654,4769,4838,3975,3838,3578,3471,2923,42963
Katihar,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,230,113,74,16,26,57,14,6,21,4,0,0,561
Katihar,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,1748,1017,542,412,192,153,107,53,66,20,2,0,4312
Katihar,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,3834,2579,1518,1122,643,502,344,205,132,31,4,3,10917
Katihar,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,6736,7118,7310,8067,8031,7967,8744,6994,6602,5697,5635,5796,84697
Katihar,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,6903,5503,5141,5700,5240,5252,5764,5400,5851,6546,7339,8090,72729
Katihar,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Katihar,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,3303,3489,3693,4060,4009,3992,4392,3633,3435,3005,2933,2983,42927
Katihar,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,3058,3239,3455,3871,3741,3714,4108,3305,3076,2685,2693,2766,39711
Katihar,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,6361,6728,7148,7931,7750,7706,8500,6938,6511,5690,5626,5749,82638
Katihar,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,7171,6412,5471,5966,5415,5481,5920,5410,5764,6815,7416,8108,75349
Katihar,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,7151,6383,5461,5777,5188,5397,5704,4983,5798,6744,7313,8075,73974
Katihar,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Katihar,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1201,1032,1074,1715,1593,1322,1490,1384,1482,1566,1572,1909,17340
Katihar,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1126,987,943,1512,1272,1195,1238,1156,1300,1360,1352,1682,15123
Katihar,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,2327,2019,2017,3227,2865,2517,2728,2540,2782,2926,2924,3591,32463
Katihar,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,220,222,219,342,325,355,772,947,894,971,1044,1034,7345
Katihar,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,1193,1138,1040,1205,1198,1259,1405,1410,1322,1440,1330,1268,15208
Katihar,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,2423,1672,1592,2020,1837,1940,2184,2173,2048,2448,2364,2198,24899
Katihar,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,26,31,10,23,13,16,7,40,25,10,0,7,208
Katihar,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Katihar,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,57,37,1,41,23,30,30,34,12,26,10,8,309
Katihar,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,3721,3758,3708,3752,3521,3713,3930,3712,3821,3872,3770,3835,45113
Katihar,10.4.2,Number of Immunisation sessions held during the month,TOTAL,3720,3774,3725,3745,3504,3693,3921,3711,3751,3836,3762,3831,44973
Katihar,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,3402,3459,3393,3513,3308,3448,3694,3456,3534,3597,3566,3636,42006
Katihar,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Katihar,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,4402,4466,4109,4195,3683,3541,3069,2214,1989,1549,1455,1083,35755
Katihar,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,1436,1006,880,1319,1196,1370,1062,1230,1067,1156,1335,826,13883
Katihar,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,87,22,37,24,0,3,33,18,153,29,36,22,464
Katihar,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Katihar,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Katihar,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Katihar,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Katihar,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Katihar,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,19,34,5,8,0,1,1,1,0,10,16,4,99
Katihar,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,228,212,180,399,301,191,145,94,82,76,70,59,2037
Katihar,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0,0,0,5,4,8,9,4,0,0,0,6,36
Katihar,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0,0,0,0,0,0,0,0,15,8,5,5,33
Katihar,13.1,Number of Patients operated for cataract,TOTAL,38,0,0,0,14,14,0,46,153,201,111,170,747
Katihar,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,38,0,0,0,14,14,0,46,153,201,111,170,747
Katihar,13.3,Number of School children detected with Refractive errors,TOTAL,11,7,13,8,10,15,0,15,6,0,7,1,93
Katihar,13.4,Number of children provided free glasses,TOTAL,5,0,0,0,0,0,0,9,20,8,0,0,42
Katihar,13.5,Number of eyes collected through eye donation,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Katihar,13.6,Number of eyes utilised for corneal transplant,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Katihar,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,NA,NA,4,4,4,4,4,4,4,4,4,4,Data for this item can not be cumulated
Katihar,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,NA,NA,13,13,14,12,19,19,14,13,14,14,Data for this item can not be cumulated
Katihar,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,2114,2104,2167,2139,2164,1954,2132,2148,2113,2152,2159,2177,Data for this item can not be cumulated
Katihar,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,NA,NA,4,4,4,4,4,4,3,4,4,4,Data for this item can not be cumulated
Katihar,14.05,Number of RKS meetings held during the month,TOTAL,7,10,6,9,12,10,11,8,11,8,9,11,112
Katihar,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,NA,NA,17,17,15,16,17,15,14,14,12,13,Data for this item can not be cumulated
Katihar,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,766,803,716,1294,1349,1273,1578,1579,1231,1356,939,1148,14032
Katihar,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,NA,NA,NA,NA,3,4,4,4,4,4,4,4,Data for this item can not be cumulated
Katihar,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,1,1,3,3,0,0,0,0,0,0,0,0,Data for this item can not be cumulated
Katihar,14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,705,716,496,746,649,542,609,593,549,542,529,470,7146
Katihar,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,1386,665,935,984,964,710,820,679,728,758,861,906,10396
Katihar,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,862,823,500,830,808,771,636,622,686,666,527,533,8264
Katihar,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,4341,2840,3747,5592,6191,6917,7298,6454,7643,6355,6717,6225,70320
Katihar,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,1567,1539,996,1576,1457,1313,1245,1215,1235,1208,1056,1003,15410
Katihar,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,5727,3505,4682,6576,7155,7627,8118,7133,8371,7113,7578,7131,80716
Katihar,14.10.2.a,Number of death cases of Inpatient males,TOTAL,37,12,11,14,16,14,14,20,15,11,7,7,178
Katihar,14.10.2.b,Number of death cases of Inpatient females,TOTAL,70,11,14,14,14,11,8,7,11,8,5,14,187
Katihar,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,107,23,25,28,30,25,22,27,26,19,12,21,365
Katihar,14.11,In-Patient Head Count at midnight,TOTAL,7572,3611,6722,8627,9327,9708,10220,9800,10403,9769,9579,9076,104414
Katihar,14.12.1,OPD attendance (All),TOTAL,166014,161023,148343,173865,182408,190849,176392,161939,167147,154926,160610,169277,2012793
Katihar,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,-211,338,425,837,531,966,1081,1100,2259,1460,2068,1381,12235
Katihar,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,5,151,32,0,0,28,0,0,0,0,0,0,216
Katihar,14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,3165,2822,3095,4075,3710,4152,3850,3824,4127,3470,3271,3379,42940
Katihar,14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,14.14.a,Number of patients given AYUSH treatment,TOTAL,15819,17270,18336,22446,22821,23714,21968,19477,20019,19273,17801,17277,236221
Katihar,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,9625,8600,6301,11930,12480,14112,12647,11431,11359,7918,9975,10277,126655
Katihar,14.14.c,Number of Adolescents counselled,TOTAL,197,619,696,331,217,378,366,361,682,941,1021,863,6672
Katihar,15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,7002,7253,6203,7293,8134,8161,11256,7679,8040,8146,8263,8056,95486
Katihar,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,56,2069,78,68,77,73,38,37,58,59,91,77,2781
Katihar,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,539,398,295,1322,1028,1320,1260,977,1033,1530,1151,857,11710
Katihar,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,1,0,11,17,10,10,10,8,5,10,14,11,107
Katihar,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,1340,1377,920,1932,1640,1715,2043,2162,2293,1648,3462,1266,21798
Katihar,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,3,0,12,14,9,7,9,9,3,4,11,8,89
Katihar,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,481,181,337,1227,990,1167,940,862,711,758,1104,1545,10303
Katihar,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0,0,0,1,0,2,0,0,1,0,0,0,4
Katihar,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,2360,1956,1552,4481,3658,4202,4243,4001,4037,3936,5717,3668,43811
Katihar,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,4,0,23,32,19,19,19,17,9,14,25,19,200
Katihar,15.2,Number of Widal tests conducted,Number tested,119,96,88,152,250,164,166,152,97,74,209,155,1722
Katihar,15.3.a,Number of VDRL tests conducted on males,Number tested,247,239,185,148,8,14,9,10,19,27,26,30,962
Katihar,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,1,0,0,0,188,159,51,50,166,105,130,136,986
Katihar,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,5,1,0,0,0,0,41,26,125,96,318,149,761
Katihar,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,253,240,185,148,196,173,101,86,310,228,474,315,2709
Katihar,15.4.1,Number of blood smears examined for Malaria,TOTAL,268,304,595,501,643,662,674,568,449,425,601,790,6480
Katihar,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,2,7,7,10,15,11,12,24,9,6,5,4,112
Katihar,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0,9,0,1,2,2,4,1,0,1,0,1,21
Katihar,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,1518,1570,2416,924,1138,1272,1423,1206,NA,503,NA,NA,11970
Katihar,16.1.1,Stock position of DPT vaccines,2. Stocks Received,500,2500,0,1500,1750,500,1000,500,NA,1000,NA,NA,9250
Katihar,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,448,1654,1492,1286,1616,349,1217,1706,NA,1007,NA,NA,10775
Katihar,16.1.1,Stock position of DPT vaccines,5. Total Stock,1570,2416,924,1138,1272,1423,1206,0,0,496,0,0,10445
Katihar,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,830,1323,2352,2070,1525,1826,2098,1229,NA,1627,NA,NA,14880
Katihar,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,2100,3300,2100,1500,2700,1200,1152,1440,NA,1440,NA,NA,16932
Katihar,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,1607,2271,2382,2045,2399,928,2021,2669,NA,2553,NA,NA,18875
Katihar,16.1.1A,Stock Position of Pentavalent,5. Total Stock,1323,2352,2070,1525,1826,2098,1229,0,0,514,0,0,12937
Katihar,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,295,413,556,612,143,176,145,161,NA,374,NA,NA,2875
Katihar,16.1.2,Stock position of OPV vaccines,2. Stocks Received,2000,3300,2500,2000,2250,2250,2250,2250,NA,2500,NA,NA,21300
Katihar,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,1882,3157,2444,2469,2217,2281,2084,2411,NA,2635,NA,NA,21580
Katihar,16.1.2,Stock position of OPV vaccines,5. Total Stock,413,556,612,143,176,145,311,0,0,239,0,0,2595
Katihar,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,1155,1286,2830,2106,1861,2387,1624,2241,NA,1154,NA,NA,16644
Katihar,16.1.3,Stock position of TT vaccines,2. Stocks Received,2000,4000,2000,2000,3250,500,3000,1250,NA,1500,NA,NA,19500
Katihar,16.1.3,Stock position of TT vaccines,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,16.1.3,Stock position of TT vaccines,4. Stock Distributed,1869,2456,2724,2245,2724,1263,2383,3491,NA,2337,NA,NA,21492
Katihar,16.1.3,Stock position of TT vaccines,5. Total Stock,1286,2830,2106,1861,2387,1624,2241,0,0,317,0,0,14652
Katihar,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,16.1.4,Stock position of DT vaccines,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,16.1.4,Stock position of DT vaccines,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,16.1.4,Stock position of DT vaccines,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,16.1.4,Stock position of DT vaccines,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Katihar,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,520,1049,1777,1365,843,1293,1413,558,NA,277,NA,NA,9095
Katihar,16.1.5,Stock position of BCG vaccines,2. Stocks Received,1250,3200,1500,1000,2000,1750,1000,1500,NA,2000,NA,NA,15200
Katihar,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,721,2472,1912,1522,1550,1630,1575,2058,NA,1684,NA,NA,15124
Katihar,16.1.5,Stock position of BCG vaccines,5. Total Stock,1049,1777,1365,843,1293,1413,838,0,0,593,0,0,9171
Katihar,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,160,501,577,493,1081,1238,NA,858,NA,299,NA,NA,5207
Katihar,16.1.6,Stock position of Measles vaccines,2. Stocks Received,4000,3350,5000,4700,4300,4000,NA,4000,NA,4300,NA,NA,33650
Katihar,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,3659,3274,5084,4112,4143,2641,NA,4858,NA,3553,NA,NA,31324
Katihar,16.1.6,Stock position of Measles vaccines,5. Total Stock,501,577,493,1081,1238,2597,0,0,0,1046,0,0,7533
Katihar,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,16.1.7,Stock position of JE vaccines,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,16.1.7,Stock position of JE vaccines,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,16.1.7,Stock position of JE vaccines,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,16.1.7,Stock position of JE vaccines,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Katihar,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,210,458,1361,1106,956,1146,2597,1702,NA,1376,NA,NA,10912
Katihar,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,750,3300,500,500,1000,1000,2000,0,NA,0,NA,NA,9050
Katihar,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,NA,NA,NA,NA,NA,NA,3739,NA,NA,49,NA,NA,3788
Katihar,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,502,2397,755,650,810,153,NA,1702,NA,808,NA,NA,7777
Katihar,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,458,1361,1106,956,1146,1993,858,0,0,519,0,0,8397
Katihar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Katihar,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Katihar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Katihar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Katihar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Katihar,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Katihar,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,16.3.02,Stock Position of Gloves,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,16.3.02,Stock Position of Gloves,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,16.3.02,Stock Position of Gloves,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,16.3.02,Stock Position of Gloves,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Katihar,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Katihar,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Katihar,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Katihar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Katihar,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Katihar,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Katihar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Katihar,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Katihar,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Katihar,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Katihar,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Katihar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Katihar,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,2,1,NA,NA,NA,NA,NA,3
Katihar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,1
Katihar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,NA,NA,NA,NA,NA,2,1,NA,1,NA,NA,NA,4
Katihar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,1,1,NA,2,NA,NA,NA,4
Katihar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,NA,NA,NA,NA,NA,1,1,NA,2,NA,NA,NA,4
Katihar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,1
Katihar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,1
Katihar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,NA,NA,NA,NA,NA,NA,1,NA,NA,1,NA,NA,2
Katihar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,1
Katihar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,1
Katihar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,NA,NA,NA,NA,NA,NA,2,NA,NA,NA,NA,NA,2
Katihar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,NA,NA,NA,NA,1,NA,1,NA,1,NA,1,1,5
Katihar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,NA,NA,NA,NA,1,NA,1,NA,1,NA,1,1,5
Katihar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,NA,NA,NA,NA,2,NA,NA,1,NA,NA,NA,NA,3
Katihar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,NA,NA,NA,NA,2,NA,NA,1,NA,NA,NA,NA,3
Katihar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,1
Katihar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,1
Katihar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,NA,NA,1
Katihar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,NA,NA,1
Katihar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,1
Katihar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,2,NA,NA,NA,2
Katihar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,NA,NA,NA,NA,NA,NA,1,NA,2,NA,NA,NA,3
Katihar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,NA,NA,NA,NA,2,NA,NA,NA,NA,NA,NA,NA,2
Katihar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Katihar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,NA,NA,NA,NA,2,NA,NA,NA,NA,NA,NA,NA,2
Khagaria,1.1,Total number of pregnant women Registered for ANC,TOTAL,4965,5292,5032,4779,4627,4046,4029,4145,4127,4558,4705,5043,55348
Khagaria,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,3374,3507,3400,3241,3173,2803,2623,3076,2966,3651,3793,4066,39673
Khagaria,1.2,Number of Pregnant women registered under JSY,TOTAL,4965,5292,5032,4779,4627,4046,4029,4145,4127,4558,4705,5043,55348
Khagaria,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,3276,3779,3809,3877,3856,3746,3653,4103,4144,4217,4351,4591,47402
Khagaria,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,2689,2996,2751,2535,2434,2126,2187,1962,2032,2211,2445,2683,29051
Khagaria,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,4816,5086,4805,4322,4871,4195,3939,3843,3793,4321,4023,4549,52563
Khagaria,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,2469,2515,1909,1068,680,430,253,271,305,1099,783,901,12683
Khagaria,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,19,29,8,1,18,4,1,0,0,0,3,0,83
Khagaria,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Khagaria,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,512,699,956,400,529,559,788,552,667,591,735,770,7758
Khagaria,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,1,8,9,0,6,2,2,4,1,4,3,6,46
Khagaria,1.8,Number of pregnancy test kits used at SC level,TOTAL,743,588,403,366,606,373,231,243,121,77,66,98,3915
Khagaria,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,165,168,200,206,288,286,318,303,246,237,218,167,2802
Khagaria,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,370,421,485,496,522,671,710,658,578,615,548,562,6636
Khagaria,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,535,589,685,702,810,957,1028,961,824,852,766,729,9438
Khagaria,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,209,255,292,355,484,559,551,464,465,574,485,477,5170
Khagaria,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Khagaria,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1836,1945,2024,2980,3717,3660,3849,3371,3105,2794,2390,2271,33942
Khagaria,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,1818,1940,2023,2980,3716,3644,3818,3334,3063,2757,2352,2252,33697
Khagaria,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,588,1083,2026,1876,2846,4198,3504,3414,4629,2427,3579,2556,32726
Khagaria,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,103,110,122,219,43,697,1760,860,1148,473,911,338,6784
Khagaria,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Khagaria,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,NA,NA,NA,NA,16,3,2,3,5,NA,NA,NA,29
Khagaria,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,NA,NA,NA,NA,0,0,0,0,0,NA,NA,NA,0
Khagaria,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,NA,NA,NA,NA,0,0,0,0,0,NA,NA,NA,0
Khagaria,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,NA,NA,NA,NA,0,0,0,0,0,NA,NA,NA,0
Khagaria,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Khagaria,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Khagaria,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,1,5,1,0,1,0,0,0,3,1,3,0,15
Khagaria,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,1,5,1,0,1,0,0,0,3,1,3,0,15
Khagaria,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,NA,NA,NA,NA,5,1,1,1,2,NA,NA,NA,10
Khagaria,4.1.1.a,Number of male live births,TOTAL,1225,1305,1406,1918,2376,2335,2434,2144,1935,1823,1605,1586,22092
Khagaria,4.1.1.b,Number of female live births,TOTAL,1132,1219,1274,1735,2134,2265,2409,2176,1977,1794,1542,1397,21054
Khagaria,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,2357,2524,2680,3653,4510,4600,4843,4320,3912,3617,3147,2983,43146
Khagaria,4.1.2,Number of still births,TOTAL,31,36,33,48,63,49,51,40,36,40,26,27,480
Khagaria,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,1,0,0,1,6,2,6,3,2,1,4,1,27
Khagaria,4.2.1,Number of Newborns weighed at birth,TOTAL,2094,2224,2391,3307,4174,4203,4410,3890,3515,3292,2896,2707,39103
Khagaria,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,118,132,175,179,316,286,283,289,234,195,152,178,2537
Khagaria,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,2221,2417,2519,3511,4345,4430,4718,4114,3772,3458,3023,2875,41403
Khagaria,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0,0,0,0,0,0,3,0,4,7,7,6,27
Khagaria,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Khagaria,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,11,13,3,5,3,6,2,7,4,7,8,8,77
Khagaria,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,11,13,3,5,3,6,5,7,8,14,15,14,104
Khagaria,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,11,9,3,5,16,6,2,7,8,14,17,11,109
Khagaria,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,11,9,3,5,3,6,2,7,4,7,8,0,65
Khagaria,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,15,105,3,5,54,32,5,7,4,28,24,23,305
Khagaria,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,11,9,15,11,11,14,8,15,14,10,13,26,157
Khagaria,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1710,1882,1597,2961,3624,3552,3654,3302,3066,2743,2480,2305,32876
Khagaria,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1179,920,1242,1113,1328,2255,2439,2086,1917,1802,1290,1143,18714
Khagaria,6.3,PNC maternal complications attended,TOTAL,0,8,0,0,6,5,0,0,0,0,0,0,19
Khagaria,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Khagaria,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Khagaria,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Khagaria,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Khagaria,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,2,3,2,152,230,2,82,62,66,40,2,51,694
Khagaria,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,4,3,4,223,435,2,367,374,290,424,0,418,2544
Khagaria,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,6,6,6,375,665,4,449,436,356,464,2,469,3238
Khagaria,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Khagaria,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0,0,0,0,0,0,0,0,1,0,0,0,1
Khagaria,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0,0,0,2,0,0,1,0,1,0,0,0,4
Khagaria,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,1,0,0,1,1,0,0,1,1,2,3,0,10
Khagaria,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,1,0,0,3,1,0,1,1,3,2,3,0,15
Khagaria,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Khagaria,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Khagaria,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Khagaria,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Khagaria,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,31,0,2,699,82,389,271,385,1331,655,770,469,5084
Khagaria,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,22,10,3,244,23,64,58,98,251,146,189,106,1214
Khagaria,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,26,22,13,64,30,45,55,47,183,107,156,123,871
Khagaria,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,79,32,18,1007,135,498,384,530,1765,908,1115,698,7169
Khagaria,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,NA,NA,NA,68,40,32,31,38,40,40,NA,NA,289
Khagaria,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0,0,0,0,0,2,1,2,14,8,8,17,52
Khagaria,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Khagaria,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0,0,0,0,2,5,4,5,13,7,13,14,63
Khagaria,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0,0,0,0,2,7,5,7,27,15,21,31,115
Khagaria,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,121,224,154,735,195,258,291,263,271,220,217,212,3161
Khagaria,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,213,114,143,328,151,83,59,125,138,86,39,121,1600
Khagaria,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,15,14,10,157,139,110,88,42,44,91,119,99,928
Khagaria,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,7,3,2,244,146,160,90,95,235,196,138,112,1428
Khagaria,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,356,355,309,1464,631,611,528,525,688,593,513,544,7117
Khagaria,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,249,317,190,452,337,288,180,210,337,318,261,207,3346
Khagaria,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,9.06,Number of IUCD removals,TOTAL,113,185,133,229,205,192,157,128,190,165,120,130,1947
Khagaria,9.07,Number of Oral Pills cycles distributed,TOTAL,967,924,746,879,880,1100,815,1396,1409,1519,1191,1103,12929
Khagaria,9.08,Number of Condom pieces distributed,TOTAL,4562,8941,5059,4321,5347,5620,5365,9955,9695,8885,7363,6667,81780
Khagaria,9.09,Number of Centchroman (weekly) pills given,TOTAL,50,28,4,75,105,2,0,0,0,0,5,0,269
Khagaria,9.1,Number of Emergency Contraceptive Pills distributed,TOTAL,31,33,71,110,117,146,139,372,415,292,295,173,2194
Khagaria,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Khagaria,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Khagaria,9.11.2.a,Number of failures following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Khagaria,9.11.2.b,Number of failures following female sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Khagaria,9.11.3.a,Number of deaths following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Khagaria,9.11.3.b,Number of deaths following female sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Khagaria,9.12,Number of Institutions having NSV trained doctors,TOTAL,NA,NA,NA,NA,NA,1,1,2,3,4,4,5,Data for this item can not be cumulated
Khagaria,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,2598,2696,2960,4118,5235,5230,5578,4919,4947,4574,4114,3688,50657
Khagaria,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,0,0,12,3,0,0,2,3,5,0,0,0,25
Khagaria,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,495,239,201,100,53,37,12,8,11,5,1,0,1162
Khagaria,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,1726,1017,631,405,230,108,68,47,27,14,0,0,4273
Khagaria,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,3830,3719,3545,3361,3950,4179,4932,5329,5107,5169,4727,4350,52198
Khagaria,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,4048,4245,3897,3495,3794,3872,4029,4505,4851,5296,4913,5033,51978
Khagaria,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,3493,4128,3996,3608,3990,3750,3793,3895,4110,4978,4774,5196,49711
Khagaria,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,2038,2020,2184,3250,4182,4105,4209,3702,3576,3322,2993,2780,38361
Khagaria,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,3861,3731,3592,3396,3973,4223,4957,5277,5102,5160,4748,4349,52369
Khagaria,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,4637,4411,4104,3697,3847,3891,4074,4547,4844,5297,4918,5044,53311
Khagaria,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,5125,5102,4621,3995,4167,3839,3850,3914,4107,4988,4769,5227,53704
Khagaria,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,1688,1787,1914,2830,3417,3402,3483,3113,2849,2603,2294,2156,31536
Khagaria,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,0,0,1,0,0,0,1,0,5,0,0,0,7
Khagaria,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,513,242,183,101,56,35,12,8,8,4,0,0,1162
Khagaria,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,1708,986,618,415,229,111,69,46,23,14,0,0,4219
Khagaria,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,3824,4348,4743,5069,5277,5079,4765,4544,3990,4075,3586,3941,53241
Khagaria,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,4617,4446,4117,4236,4190,3982,3643,3907,4148,4654,4769,4796,51505
Khagaria,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Khagaria,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1843,2073,2409,2726,2765,2634,2495,2336,2070,2103,1866,2030,27350
Khagaria,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1712,1818,2174,2308,2471,2343,2229,2157,1858,1862,1664,1800,24396
Khagaria,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,3555,3891,4583,5034,5236,4977,4724,4493,3928,3965,3530,3830,51746
Khagaria,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,4598,4492,4359,4168,4131,3959,3661,3914,4160,4658,4807,4843,51750
Khagaria,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,4690,4489,4330,4181,4128,3954,3661,3910,4160,4658,4807,4844,51812
Khagaria,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Khagaria,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,78,24,211,139,138,286,575,421,389,449,599,467,3776
Khagaria,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,76,22,196,116,138,278,541,356,352,384,559,414,3432
Khagaria,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,154,46,407,255,276,564,1116,777,741,833,1158,881,7208
Khagaria,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,425,413,374,422,613,1127,1474,1533,1599,1746,1573,1377,12676
Khagaria,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,489,402,374,348,372,550,716,716,835,929,730,721,7182
Khagaria,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,700,564,635,784,727,958,959,1066,1195,1158,1088,1105,10939
Khagaria,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Khagaria,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Khagaria,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Khagaria,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1760,1775,1813,1809,1806,1798,1736,1740,1760,1747,1749,1771,21264
Khagaria,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1768,1772,1805,1823,1812,1793,1735,1738,1760,1745,1717,1761,21229
Khagaria,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1559,1538,1634,1605,1630,1617,1590,1600,1638,1627,1597,1641,19276
Khagaria,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Khagaria,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,349,377,206,97,663,1064,597,21,511,492,419,525,5321
Khagaria,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,43,0,0,0,179,0,517,792,477,510,584,222,3324
Khagaria,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,0,0,0,0,0,0,25,0,20,0,0,0,45
Khagaria,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Khagaria,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Khagaria,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Khagaria,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Khagaria,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Khagaria,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0,0,0,5,0,0,0,0,0,0,0,0,5
Khagaria,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,4358,4496,3971,4016,6114,3190,2547,2272,1894,1467,1670,2167,38162
Khagaria,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0,0,0,5,0,0,0,0,0,0,0,0,5
Khagaria,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Khagaria,13.1,Number of Patients operated for cataract,TOTAL,47,0,30,28,0,71,0,34,70,147,19,27,473
Khagaria,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,47,0,27,28,0,71,0,34,70,147,19,27,470
Khagaria,13.3,Number of School children detected with Refractive errors,TOTAL,0,0,0,0,0,0,207,510,0,0,0,0,717
Khagaria,13.4,Number of children provided free glasses,TOTAL,0,0,0,0,0,0,0,220,0,0,0,0,220
Khagaria,13.5,Number of eyes collected through eye donation,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Khagaria,13.6,Number of eyes utilised for corneal transplant,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Khagaria,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,NA,NA,NA,NA,NA,1,2,2,2,2,2,2,Data for this item can not be cumulated
Khagaria,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,NA,NA,NA,NA,NA,7,8,7,7,8,8,9,Data for this item can not be cumulated
Khagaria,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,1484,1531,1609,1620,1376,1073,1236,1250,1042,1068,1037,1087,Data for this item can not be cumulated
Khagaria,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,NA,NA,NA,NA,NA,1,2,2,2,2,2,2,Data for this item can not be cumulated
Khagaria,14.05,Number of RKS meetings held during the month,TOTAL,6,3,5,3,3,5,5,4,4,6,6,4,54
Khagaria,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,NA,NA,NA,NA,NA,6,7,7,7,9,8,9,Data for this item can not be cumulated
Khagaria,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,682,567,512,1060,901,912,1048,971,875,842,485,977,9832
Khagaria,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,NA,NA,NA,NA,NA,1,2,2,2,2,2,2,Data for this item can not be cumulated
Khagaria,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,Data for this item can not be cumulated
Khagaria,14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,530,585,598,875,1037,961,970,943,827,736,640,644,9346
Khagaria,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,772,901,768,1558,900,1892,945,884,816,559,586,743,11324
Khagaria,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,504,480,545,774,1337,912,924,835,859,728,628,612,9138
Khagaria,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,1834,1917,2107,3663,3570,3618,3626,3695,3727,3148,2918,2639,36462
Khagaria,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,1034,1065,1143,1649,2374,1873,1894,1778,1686,1464,1268,1256,18484
Khagaria,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,2606,2818,2875,5221,4470,5510,4571,4579,4543,3707,3504,3382,47786
Khagaria,14.10.2.a,Number of death cases of Inpatient males,TOTAL,7,5,12,7,5,6,11,8,9,3,8,3,84
Khagaria,14.10.2.b,Number of death cases of Inpatient females,TOTAL,3,6,3,5,3,2,4,4,5,1,4,4,44
Khagaria,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,10,11,15,12,8,8,15,12,14,4,12,7,128
Khagaria,14.11,In-Patient Head Count at midnight,TOTAL,3726,3974,4127,6497,6426,7444,6548,5925,6372,5594,4828,4735,66196
Khagaria,14.12.1,OPD attendance (All),TOTAL,91692,83034,82973,93257,89927,87240,77415,72479,80638,78806,87469,99753,1024683
Khagaria,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,97,42,31,947,175,529,417,562,1605,803,1049,643,6900
Khagaria,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Khagaria,14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,1059,1103,1191,1485,1503,1415,1340,1308,1073,1179,1117,1127,14900
Khagaria,14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,14.14.a,Number of patients given AYUSH treatment,TOTAL,11848,11611,10371,11930,11563,13019,10601,8699,10222,10592,11869,13072,135397
Khagaria,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,2984,2368,1798,2754,2537,2846,2053,1341,2396,3254,4121,4173,32625
Khagaria,14.14.c,Number of Adolescents counselled,TOTAL,120,77,197,75,73,31,90,75,94,111,109,54,1106
Khagaria,15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,1180,1536,1096,1416,1343,1463,862,960,1091,1485,1572,1447,15451
Khagaria,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,6,12,42,17,2,0,1,2,0,3,5,6,96
Khagaria,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,331,208,466,352,466,426,386,331,186,365,322,366,4205
Khagaria,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,10,8,18,13,5,7,3,4,3,7,8,8,94
Khagaria,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,220,224,367,351,525,717,475,584,696,1082,1145,815,7201
Khagaria,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,11,2,6,10,9,6,4,3,3,5,5,15,79
Khagaria,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,624,398,651,647,590,738,575,647,605,858,905,779,8017
Khagaria,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0,0,3,2,2,2,3,0,0,0,1,0,13
Khagaria,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,1175,830,1484,1350,1581,1881,1436,1562,1487,2305,2372,1960,19423
Khagaria,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,21,10,27,25,16,15,10,7,6,12,14,23,186
Khagaria,15.2,Number of Widal tests conducted,Number tested,0,34,115,0,15,90,22,41,26,0,2,0,345
Khagaria,15.3.a,Number of VDRL tests conducted on males,Number tested,22,3,2,0,4,28,7,5,17,6,10,50,154
Khagaria,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,15,5,8,98,269,25,22,49,52,7,29,0,579
Khagaria,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,136,35,82,74,433,68,18,20,37,34,133,257,1327
Khagaria,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,173,43,92,172,706,121,47,74,106,47,172,307,2060
Khagaria,15.4.1,Number of blood smears examined for Malaria,TOTAL,180,129,175,113,208,351,311,262,109,40,10,0,1888
Khagaria,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,0,0,0,2,0,0,0,0,0,0,0,0,2
Khagaria,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Khagaria,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,325,300,900,400,300,500,900,850,550,500,50,0,5575
Khagaria,16.1.1,Stock position of DPT vaccines,2. Stocks Received,1500,1000,0,1000,1000,0,500,0,500,0,500,500,6500
Khagaria,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Khagaria,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,1525,1075,350,1050,400,250,550,350,550,450,550,452,7552
Khagaria,16.1.1,Stock position of DPT vaccines,5. Total Stock,300,225,550,350,900,250,850,500,500,50,0,48,4523
Khagaria,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,0,326,502,700,700,600,800,27,391,348,15,202,4611
Khagaria,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,1600,2100,1440,2016,1152,0,576,1673,1152,1440,2016,2016,17181
Khagaria,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Khagaria,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,1274,1924,1524,1574,574,300,1349,1450,1483,1773,1815,1810,16850
Khagaria,16.1.1A,Stock Position of Pentavalent,5. Total Stock,326,502,418,1142,1278,300,27,250,60,15,216,408,4942
Khagaria,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,20,600,430,150,1250,950,550,320,900,420,300,600,6490
Khagaria,16.1.2,Stock position of OPV vaccines,2. Stocks Received,1400,2000,2000,3000,1000,0,1000,2000,1000,1000,2000,500,16900
Khagaria,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Khagaria,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,820,2170,2280,2030,950,550,1230,1420,1480,1120,1770,1070,16890
Khagaria,16.1.2,Stock position of OPV vaccines,5. Total Stock,600,430,150,1120,1300,400,320,900,420,300,530,30,6500
Khagaria,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,1478,0,522,900,760,750,1200,740,750,700,525,857,9182
Khagaria,16.1.3,Stock position of TT vaccines,2. Stocks Received,2000,2000,1320,2000,1000,0,500,1000,1000,500,1000,1000,13320
Khagaria,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Khagaria,16.1.3,Stock position of TT vaccines,4. Stock Distributed,1478,1478,878,1400,760,350,960,990,725,675,668,1053,11415
Khagaria,16.1.3,Stock position of TT vaccines,5. Total Stock,2000,522,964,1500,1000,400,740,750,1025,525,857,804,11087
Khagaria,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0,0,0,0,0,0,0,0,0,0,0,0,0
Khagaria,16.1.4,Stock position of DT vaccines,2. Stocks Received,0,0,0,0,0,0,0,0,0,0,0,0,0
Khagaria,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Khagaria,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0,0,0,0,0,0,0,0,0,0,0,0,0
Khagaria,16.1.4,Stock position of DT vaccines,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Khagaria,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,50,100,250,200,350,850,450,50,200,500,950,1650,5600
Khagaria,16.1.5,Stock position of BCG vaccines,2. Stocks Received,1000,1000,1000,1600,2000,0,500,2000,2000,2000,2000,1000,16100
Khagaria,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Khagaria,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,950,850,1000,1250,850,450,900,1850,1700,1550,1300,2378,15028
Khagaria,16.1.5,Stock position of BCG vaccines,5. Total Stock,100,250,250,550,1500,400,50,200,500,950,1650,272,6672
Khagaria,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,0,80,60,40,820,2400,900,130,60,330,650,1800,7270
Khagaria,16.1.6,Stock position of Measles vaccines,2. Stocks Received,2600,3000,3000,4000,4000,0,1000,3000,3000,3000,3000,1400,31000
Khagaria,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Khagaria,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,2520,3020,2870,3310,2420,800,1770,3070,2730,2680,1830,2661,29681
Khagaria,16.1.6,Stock position of Measles vaccines,5. Total Stock,80,60,190,730,2400,1600,130,60,330,650,1820,539,8589
Khagaria,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0,0,0,0,0,0,0,0,0,0,0,0,0
Khagaria,16.1.7,Stock position of JE vaccines,2. Stocks Received,0,0,0,0,0,0,0,0,0,0,0,0,0
Khagaria,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Khagaria,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0,0,0,0,0,0,0,0,0,0,0,0,0
Khagaria,16.1.7,Stock position of JE vaccines,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Khagaria,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,0,280,1000,600,950,600,1800,1500,1350,1215,1250,1300,11845
Khagaria,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,1000,1000,0,1000,1000,0,250,0,0,0,500,0,4750
Khagaria,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,720,0,0,0,0,0,0,0,0,0,0,0,720
Khagaria,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,280,970,320,600,250,326,550,430,135,285,450,300,4896
Khagaria,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0,310,680,1000,1700,274,1500,1070,1215,930,1300,1000,10979
Khagaria,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,9270,6300,9000,350,105,0,0,300,0,4750,5365,400,35840
Khagaria,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0,0,0,0,0,0,0,0,5365,0,0,5800,11165
Khagaria,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Khagaria,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,0,0,8500,0,0,0,0,100,0,0,5365,5800,19765
Khagaria,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,9270,6300,500,350,105,0,0,200,5365,4750,0,400,27240
Khagaria,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,139498,132848,131000,4000,3200,1000,20000,1500,0,19194,69662,1000,522902
Khagaria,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0,0,0,0,0,0,0,0,89902,0,0,67000,156902
Khagaria,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Khagaria,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,0,0,115000,0,0,0,0,0,0,0,69662,67000,251662
Khagaria,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,139498,132848,16000,4000,3200,1000,20000,1500,89902,19194,0,1000,428142
Khagaria,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,20344,15884,19000,100,500,50,500,340,0,3135,6132,200,66185
Khagaria,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0,0,0,0,0,0,0,0,6132,0,0,4800,10932
Khagaria,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Khagaria,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0,0,18500,0,0,50,0,0,0,0,6132,4800,29482
Khagaria,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,20344,15884,500,100,500,0,500,340,6132,3135,0,200,47635
Khagaria,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,12984,8664,12000,100,1000,100,500,200,0,1514,6860,100,44022
Khagaria,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0,0,0,0,0,0,0,0,6860,0,0,5500,12360
Khagaria,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Khagaria,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0,0,11000,0,0,50,0,0,0,0,6860,5500,23410
Khagaria,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,12984,8664,1000,100,1000,50,500,200,6860,1514,0,100,32972
Khagaria,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,0,0,0,0,0,NA,0,0,0,0,0,NA,0
Khagaria,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0,0,0,0,0,NA,0,0,0,0,0,NA,0
Khagaria,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0,0,0,0,0,NA,0,0,0,0,0,NA,0
Khagaria,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0,0,0,0,0,NA,0,0,0,0,0,NA,0
Khagaria,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Khagaria,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,35700,31700,23200,23200,13200,9200,0,0,0,0,0,0,136200
Khagaria,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0,0,0,0,0,0,0,0,0,0,0,20000,20000
Khagaria,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Khagaria,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,4000,4500,4000,10000,6000,9200,0,0,0,0,0,4000,41700
Khagaria,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,31700,27200,19200,13200,7200,0,0,0,0,0,0,16000,114500
Khagaria,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,500,400,300,200,3200,100,0,50,20000,20000,20000,20000,84750
Khagaria,16.3.02,Stock Position of Gloves,2. Stocks Received,0,0,0,0,0,0,0,0,0,0,0,0,0
Khagaria,16.3.02,Stock Position of Gloves,3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Khagaria,16.3.02,Stock Position of Gloves,4. Stock Distributed,0,100,100,150,2450,50,0,50,2400,9700,10300,12100,37400
Khagaria,16.3.02,Stock Position of Gloves,5. Total Stock,500,300,200,50,750,50,0,0,17600,10300,9700,7900,47350
Khagaria,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0,0,0,0,0,0,0,0,0,0,0,0,0
Khagaria,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0,0,0,0,0,0,0,0,0,0,0,0,0
Khagaria,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Khagaria,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0,0,0,0,0,0,0,0,0,0,0,0,0
Khagaria,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Khagaria,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0,0,0,0,0,0,0,0,11600,11600,11600,1700,36500
Khagaria,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0,0,0,0,0,0,0,0,0,0,0,93900,93900
Khagaria,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Khagaria,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0,0,0,0,0,0,0,0,3600,7600,8500,100,19800
Khagaria,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0,0,0,0,0,0,0,0,8000,4000,3100,95500,110600
Khagaria,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,80,80,0,0,0,0,0,0,0,0,0,0,160
Khagaria,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0,0,0,0,0,0,0,0,0,0,0,0,0
Khagaria,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Khagaria,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0,0,0,0,0,0,0,0,0,0,0,0,0
Khagaria,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,80,80,0,0,0,0,0,0,0,0,0,0,160
Khagaria,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0,0,0,0,0,0,0,0,0,0,0,0,0
Khagaria,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0,0,0,0,0,0,0,0,0,0,0,0,0
Khagaria,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Khagaria,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0,0,0,0,0,0,0,0,0,0,0,0,0
Khagaria,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Khagaria,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,0,0,0,0,0,0,20000,0,240000,240000,70400,238300,808700
Khagaria,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0,0,0,0,0,0,0,0,0,0,240000,0,240000
Khagaria,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Khagaria,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0,0,0,0,0,0,3000,0,70000,103600,72100,99000,347700
Khagaria,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0,0,0,0,0,0,17000,0,170000,136400,238300,139300,701000
Khagaria,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0,0,0,2860,506,0,0,0,0,0,0,0,3366
Khagaria,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0,0,0,0,0,0,0,0,0,0,0,10000,10000
Khagaria,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Khagaria,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0,0,0,2354,506,0,0,0,0,0,0,0,2860
Khagaria,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0,0,0,506,0,0,0,0,0,0,0,10000,10506
Khagaria,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0,0,9538,0,4600,10000,10000,0,388000,388000,388200,82750,1281088
Khagaria,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0,0,0,0,0,0,0,0,0,0,0,10000,10000
Khagaria,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Khagaria,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0,0,4800,0,4400,200,5700,0,33000,228050,305050,3000,584200
Khagaria,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0,0,4738,0,200,9800,4300,0,355000,159950,83150,89750,706888
Khagaria,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,1000,1000,0,0,0,0,0,0,0,0,0,0,2000
Khagaria,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0,0,0,0,0,0,0,0,0,0,0,0,0
Khagaria,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Khagaria,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0,1000,0,0,0,0,0,0,0,0,0,0,1000
Khagaria,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,1000,0,0,0,0,0,0,0,0,0,0,0,1000
Khagaria,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,0,835,4350,4785,1728,4928,524,5524,5000,5000,5000,50000,87674
Khagaria,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0,0,0,0,0,0,5000,0,0,0,0,0,5000
Khagaria,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Khagaria,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,0,835,1900,2650,700,3800,0,1700,2976,3576,3576,1000,22713
Khagaria,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0,0,2450,2135,1028,1128,5524,3824,2024,1424,1424,49000,69961
Khagaria,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,200,100,7000,7000,6000,5000,5000,2000,1000,2000,1000,4000,40300
Khagaria,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,6600,10000,0,10000,5000,0,5000,5000,5000,5000,5000,2000,58600
Khagaria,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Khagaria,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,6700,6100,0,5800,2800,3000,8000,6000,5800,6000,2000,5800,58000
Khagaria,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,100,4000,7000,11200,8200,2000,2000,1000,200,1000,4000,200,40900
Khagaria,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,2400,0,5000,5000,10000,12000,12000,10000,7000,10000,10000,40000,123400
Khagaria,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,50000,72000,0,180000,50000,0,36000,50000,50000,50000,40000,20000,598000
Khagaria,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Khagaria,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,52400,72000,0,115000,22600,6000,38000,53000,47000,50000,10000,44200,510200
Khagaria,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0,0,5000,70000,37400,6000,10000,7000,10000,10000,40000,15800,211200
Khagaria,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,0,0,1000,1000,4000,2000,2000,1100,800,1200,800,3300,17200
Khagaria,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,4500,5000,0,10000,5000,0,5000,5000,5000,4000,5000,2000,50500
Khagaria,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Khagaria,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,4300,4400,0,6200,2700,1500,5900,5300,3600,4400,2500,4500,45300
Khagaria,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,200,600,1000,4800,6300,500,1100,800,2200,800,3300,800,22400
Khagaria,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1
Khagaria,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1
Khagaria,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1
Khagaria,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1
Khagaria,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,1
Khagaria,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,1
Khagaria,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Khagaria,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,2,NA,NA,NA,NA,NA,2
Khagaria,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,NA,NA,NA,NA,NA,NA,2,NA,NA,NA,NA,NA,2
Kishanganj,1.1,Total number of pregnant women Registered for ANC,TOTAL,6475,5789,6086,6778,6696,6041,6164,3879,4525,3984,3935,5654,66006
Kishanganj,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,2215,2000,2073,2412,2351,1995,2051,1268,1765,1796,1684,1602,23212
Kishanganj,1.2,Number of Pregnant women registered under JSY,TOTAL,4739,4022,4365,4968,4965,4472,4614,2360,3844,3482,3266,3482,48579
Kishanganj,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,2410,2228,2322,2664,2799,2703,2841,2377,2900,2890,2891,2358,31383
Kishanganj,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,3210,2782,2990,3533,3303,3012,2965,1594,2325,2154,1994,1987,31849
Kishanganj,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,4118,4550,3980,4690,4974,4255,4679,2631,3457,3460,2953,3096,46843
Kishanganj,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,4620,3014,2563,3094,2469,2278,1183,930,768,627,548,72,22166
Kishanganj,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,57,150,61,124,128,144,156,128,119,118,84,51,1320
Kishanganj,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,6,3,17,8,15,0,9,10,11,10,8,2,99
Kishanganj,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,986,1098,1220,1559,1634,1021,1459,1179,1283,1082,1238,1176,14935
Kishanganj,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,168,184,176,187,168,221,229,207,183,223,216,20,2182
Kishanganj,1.8,Number of pregnancy test kits used at SC level,TOTAL,244,524,535,689,466,267,168,59,56,71,75,129,3283
Kishanganj,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,13,21,33,57,54,80,28,41,48,40,52,52,519
Kishanganj,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,1148,1023,841,1106,1053,1160,1370,881,1245,1353,1336,1197,13713
Kishanganj,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,1161,1044,874,1163,1107,1240,1398,922,1293,1393,1388,1249,14232
Kishanganj,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,500,407,349,455,521,451,526,385,428,561,596,586,5765
Kishanganj,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,3,6,0,5,7,0,0,4,0,0,0,0,25
Kishanganj,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1438,1399,1227,1567,1822,1655,1879,1891,2034,2159,2063,1763,20897
Kishanganj,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,1414,1373,1198,1535,1770,1527,1813,1850,1974,2043,2041,1757,20295
Kishanganj,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1336,1332,645,59,734,796,1275,696,1757,6938,1277,2937,19782
Kishanganj,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,258,382,175,150,671,149,456,453,644,1390,643,2120,7491
Kishanganj,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Kishanganj,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,310,282,273,313,339,348,316,336,302,350,336,0,3505
Kishanganj,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0
Kishanganj,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0
Kishanganj,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0
Kishanganj,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Kishanganj,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Kishanganj,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,10,6,11,7,8,10,18,10,31,33,20,6,170
Kishanganj,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,10,6,11,7,8,10,18,10,31,33,20,6,170
Kishanganj,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,115,90,90,117,121,137,131,140,140,157,143,0,1381
Kishanganj,4.1.1.a,Number of male live births,TOTAL,1506,1407,1219,1594,1616,1639,1848,1556,1812,2025,1921,1573,19716
Kishanganj,4.1.1.b,Number of female live births,TOTAL,1337,1248,1132,1443,1612,1567,1698,1500,1774,1833,1790,1415,18349
Kishanganj,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,2843,2655,2351,3037,3228,3206,3546,3056,3586,3858,3711,2988,38065
Kishanganj,4.1.2,Number of still births,TOTAL,59,62,63,56,77,64,74,83,74,90,87,42,831
Kishanganj,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,48,53,102,60,62,99,12,52,31,19,21,14,573
Kishanganj,4.2.1,Number of Newborns weighed at birth,TOTAL,2220,1939,1658,2446,2777,2658,2923,2712,2800,2915,2839,2266,30153
Kishanganj,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,161,182,184,185,259,220,354,332,269,310,248,185,2889
Kishanganj,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,2581,2417,2077,2677,3008,2967,3264,2864,3207,3554,3426,2904,34946
Kishanganj,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,33,8,8,2,5,7,3,2,27,77,44,56,272
Kishanganj,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Kishanganj,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,70,65,70,54,22,70,26,30,46,44,29,28,554
Kishanganj,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,103,73,78,56,27,77,29,32,73,121,73,84,826
Kishanganj,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,290,NA,NA,NA,NA,NA,NA,133,139,148,145,0,855
Kishanganj,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,393,355,170,369,362,218,345,352,236,430,212,83,3525
Kishanganj,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,50,23,25,16,20,19,24,12,14,20,10,8,241
Kishanganj,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,301,355,349,369,362,425,345,352,351,221,188,31,3649
Kishanganj,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,72,57,63,58,52,46,42,56,39,40,29,10,564
Kishanganj,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1776,1734,1293,1748,2129,1984,2273,2176,2220,2452,2196,1894,23875
Kishanganj,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1192,967,912,1339,1385,1539,1581,1299,1452,1704,1465,1335,16170
Kishanganj,6.3,PNC maternal complications attended,TOTAL,138,0,1,2,1,0,0,0,0,2,2,1,147
Kishanganj,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Kishanganj,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Kishanganj,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Kishanganj,7.2,Number of MTPs conducted at Private Facilities,TOTAL,40,45,91,47,51,90,82,66,135,138,0,0,785
Kishanganj,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,117,0,0,153,54,117,193,200,207,206,172,203,1622
Kishanganj,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,120,0,0,120,39,120,311,342,356,222,258,316,2204
Kishanganj,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,237,0,0,273,93,237,504,542,563,428,430,519,3826
Kishanganj,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,1861,1483,1786,2843,2640,1878,2432,2074,2102,2437,2794,3457,27787
Kishanganj,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0,3,3,5,10,10,0,0,0,1,0,1,33
Kishanganj,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0,0,NA,0,0,0,0,0,0,0,0,0,0
Kishanganj,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0,1,0,0,0,0,0,1,0,0,0,0,2
Kishanganj,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0,4,3,5,10,10,0,1,0,1,0,1,35
Kishanganj,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,NA,NA,NA,NA,NA,0,0,NA,0,18,0,0,18
Kishanganj,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0,0,2,0,0,0,0,0,0,0,0,0,2
Kishanganj,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0,0,NA,0,0,0,0,0,0,0,0,0,0
Kishanganj,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0,0,2,0,0,0,0,0,0,0,0,0,2
Kishanganj,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,NA,2,NA,4,1,1,2,NA,0,10,4,3,27
Kishanganj,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,96,79,47,115,90,219,268,139,486,247,494,404,2684
Kishanganj,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0,0,0,4,0,3,2,7,18,21,15,9,79
Kishanganj,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,NA,13,6,26,27,40,26,40,71,56,81,118,504
Kishanganj,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,96,92,53,145,117,262,296,186,575,324,590,531,3267
Kishanganj,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,49,NA,NA,NA,35,50,19,12,6,24,20,55,270
Kishanganj,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Kishanganj,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Kishanganj,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,40,6,0,11,3,2,7,2,11,12,11,4,109
Kishanganj,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,40,6,0,11,3,2,7,2,11,12,11,4,109
Kishanganj,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,30,21,26,27,33,47,40,15,5,12,15,12,283
Kishanganj,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,188,187,212,1057,263,218,338,175,374,305,271,275,3863
Kishanganj,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,11,18,12,51,18,55,64,19,55,63,65,69,500
Kishanganj,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,5,6,7,5,4,6,6,5,5,7,6,5,67
Kishanganj,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,91,69,118,97,41,91,45,48,63,61,67,53,844
Kishanganj,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,295,280,349,1210,326,370,453,247,497,436,409,402,5274
Kishanganj,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,103,111,73,123,108,72,112,88,78,92,122,114,1196
Kishanganj,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,7,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,7
Kishanganj,9.06,Number of IUCD removals,TOTAL,95,105,101,215,162,124,95,75,109,147,131,164,1523
Kishanganj,9.07,Number of Oral Pills cycles distributed,TOTAL,586,580,722,2215,678,596,552,808,680,822,945,768,9952
Kishanganj,9.08,Number of Condom pieces distributed,TOTAL,12895,3017,4082,15748,2801,12061,2505,4634,5831,6914,5643,4741,80872
Kishanganj,9.09,Number of Centchroman (weekly) pills given,TOTAL,0,4,3,0,5,2,0,30,20,0,0,0,64
Kishanganj,9.1,Number of Emergency Contraceptive Pills distributed,TOTAL,266,89,106,269,114,266,53,195,215,238,227,211,2249
Kishanganj,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Kishanganj,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Kishanganj,9.11.2.a,Number of failures following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Kishanganj,9.11.2.b,Number of failures following female sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Kishanganj,9.11.3.a,Number of deaths following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Kishanganj,9.11.3.b,Number of deaths following female sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Kishanganj,9.12,Number of Institutions having NSV trained doctors,TOTAL,1,NA,NA,NA,NA,2,2,2,2,2,2,2,Data for this item can not be cumulated
Kishanganj,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,4203,3439,3092,3879,3826,3869,5071,3537,4686,4945,4540,4213,49300
Kishanganj,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,154,57,36,27,48,51,38,28,37,31,0,4,511
Kishanganj,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,938,492,284,222,121,169,140,52,51,36,9,6,2520
Kishanganj,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,2111,1157,789,607,314,321,213,87,126,47,17,10,5799
Kishanganj,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,5361,3617,3526,3872,3217,3543,4530,2776,4219,4557,4280,4629,48127
Kishanganj,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,4279,4507,3933,4355,3661,3622,4177,2764,3397,4280,3894,4607,47476
Kishanganj,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,2316,3362,4001,4438,3729,3763,4253,2482,3116,3530,3557,4184,42731
Kishanganj,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1898,1842,1672,2210,2346,2193,2595,2225,2442,2539,2246,2029,26237
Kishanganj,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,5353,3662,3565,3790,3286,3652,4643,2806,4266,4597,4283,4635,48538
Kishanganj,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,5139,4903,4209,4457,3835,3774,4388,2852,3467,4347,3913,4614,49898
Kishanganj,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,4439,4352,4663,4834,4015,4133,4423,2623,3276,3620,3570,4208,48156
Kishanganj,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,1149,1052,976,1293,1499,1443,1544,1606,1680,1801,1719,1554,17316
Kishanganj,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,186,204,107,173,156,110,190,140,34,0,0,0,1300
Kishanganj,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,805,450,270,175,97,133,80,34,36,4,1,0,2085
Kishanganj,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,2029,1089,715,494,257,274,111,42,57,6,1,0,5075
Kishanganj,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,4324,3548,3864,4774,4338,4798,5847,3111,4127,3616,3225,2962,48534
Kishanganj,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,5537,3805,3802,4304,4921,7453,7653,3147,4256,4446,4540,4441,58305
Kishanganj,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0,0,0,0,0,1,0,0,0,0,0,0,1
Kishanganj,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1964,1787,1862,2317,2114,2226,2802,1570,2049,1788,1593,1504,23576
Kishanganj,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1803,1578,1704,2346,2099,2132,2744,1431,1933,1631,1526,1340,22267
Kishanganj,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,3767,3365,3566,4663,4213,4358,5546,3001,3982,3419,3119,2844,45843
Kishanganj,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,5436,4316,4591,5283,5417,7226,7809,3160,4229,4499,4597,4697,61260
Kishanganj,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,5379,4296,4580,5264,5469,6943,7713,3105,4191,4475,4578,4489,60482
Kishanganj,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,17,20,16,0,16,18,9,20,15,12,0,0,143
Kishanganj,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1021,874,802,986,1015,1643,1530,757,948,754,911,742,11983
Kishanganj,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,990,814,704,943,1005,1549,1452,689,889,693,820,720,11268
Kishanganj,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,2011,1688,1506,1929,2020,3192,2982,1446,1837,1447,1731,1462,23251
Kishanganj,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,194,127,84,158,404,2114,3717,1398,869,423,576,506,10570
Kishanganj,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,425,240,213,298,270,218,368,227,322,299,197,199,3276
Kishanganj,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,661,380,355,388,367,328,562,367,335,721,292,262,5018
Kishanganj,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,2,16,0,1,1,0,0,0,0,0,0,0,20
Kishanganj,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Kishanganj,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0,4,3,33,9,21,33,2,2,19,15,20,161
Kishanganj,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,2560,2521,2575,2604,2461,2441,2455,2421,2350,2312,2303,2351,29354
Kishanganj,10.4.2,Number of Immunisation sessions held during the month,TOTAL,2440,2203,2215,2558,2315,2296,2361,1573,1985,2075,2088,2117,26226
Kishanganj,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1770,1552,1580,1899,1632,1722,1842,1137,1435,1650,1656,1665,19540
Kishanganj,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0,2,0,0,0,0,0,0,0,0,0,0,2
Kishanganj,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,4129,3596,3827,4700,3994,3863,4480,2451,2136,1097,957,866,36096
Kishanganj,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,2012,1471,1803,1932,2061,2930,2355,1003,1202,748,751,725,18993
Kishanganj,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,85,71,62,1000,662,187,84,84,21,15,17,22,2310
Kishanganj,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0,0,1,0,0,0,0,0,3,0,0,0,4
Kishanganj,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Kishanganj,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Kishanganj,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0,0,1,0,0,0,1,1,0,1,0,0,4
Kishanganj,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Kishanganj,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0,2,3,5,1,5,0,0,1,0,0,0,17
Kishanganj,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,959,555,535,828,623,761,658,554,641,634,281,333,7362
Kishanganj,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0,0,0,0,0,7,10,23,37,26,0,13,116
Kishanganj,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,52,33,25,25,31,42,30,21,56,51,0,65,431
Kishanganj,13.1,Number of Patients operated for cataract,TOTAL,314,410,362,380,331,341,285,360,430,574,0,0,3787
Kishanganj,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,310,409,361,375,330,340,284,354,421,570,0,0,3754
Kishanganj,13.3,Number of School children detected with Refractive errors,TOTAL,2,14,5,0,0,0,0,0,0,0,2,1,24
Kishanganj,13.4,Number of children provided free glasses,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Kishanganj,13.5,Number of eyes collected through eye donation,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Kishanganj,13.6,Number of eyes utilised for corneal transplant,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Kishanganj,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,NA,NA,NA,NA,NA,2,2,2,2,2,2,2,Data for this item can not be cumulated
Kishanganj,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,NA,NA,NA,NA,NA,9,6,7,7,7,7,7,Data for this item can not be cumulated
Kishanganj,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,1246,1130,1154,1254,1257,1235,1287,969,1177,1232,1234,1241,Data for this item can not be cumulated
Kishanganj,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,NA,NA,NA,NA,NA,2,2,2,2,2,2,2,Data for this item can not be cumulated
Kishanganj,14.05,Number of RKS meetings held during the month,TOTAL,10,6,7,6,5,6,6,6,6,9,7,6,80
Kishanganj,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,NA,NA,NA,NA,NA,11,11,11,11,11,11,11,Data for this item can not be cumulated
Kishanganj,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,897,858,765,874,855,897,1095,1089,1009,1339,1163,1212,12053
Kishanganj,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,NA,NA,NA,NA,NA,1,2,1,1,2,2,2,Data for this item can not be cumulated
Kishanganj,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,Data for this item can not be cumulated
Kishanganj,14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,885,945,919,678,372,967,805,724,805,1026,341,315,8782
Kishanganj,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,3085,2606,2455,2465,1295,2392,2411,2412,2487,2490,1202,1200,26500
Kishanganj,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,660,752,608,872,400,672,678,661,741,702,300,261,7307
Kishanganj,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,3838,4528,4063,4445,2776,4667,4899,4574,5001,5237,3272,2935,50235
Kishanganj,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,1545,1697,1527,1550,772,1639,1483,1385,1546,1728,641,576,16089
Kishanganj,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,6923,7134,6518,6910,4071,7059,7310,6986,7488,7727,4474,4135,76735
Kishanganj,14.10.2.a,Number of death cases of Inpatient males,TOTAL,75,84,66,65,4,89,84,80,83,89,1,1,721
Kishanganj,14.10.2.b,Number of death cases of Inpatient females,TOTAL,46,50,42,33,1,52,61,66,50,54,1,1,457
Kishanganj,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,121,134,108,98,5,141,145,146,133,143,2,2,1178
Kishanganj,14.11,In-Patient Head Count at midnight,TOTAL,4655,4465,3966,4621,4129,4500,4962,5073,5304,5697,4893,4443,56708
Kishanganj,14.12.1,OPD attendance (All),TOTAL,107392,104727,100733,110381,68769,112542,97630,81517,84131,88471,53473,48293,1058059
Kishanganj,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,1738,1597,1491,1633,127,1675,1460,1375,1836,1876,548,446,15802
Kishanganj,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,69,77,73,59,12,58,64,67,63,183,0,0,725
Kishanganj,14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,2777,2862,2570,2698,1134,2677,2239,2440,2381,2830,1089,1226,26923
Kishanganj,14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,14.14.a,Number of patients given AYUSH treatment,TOTAL,6722,9920,8415,8218,11274,9498,7854,6390,7388,7295,8554,6240,97768
Kishanganj,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,4193,2336,6416,7175,2348,6222,4374,4079,4980,5645,2969,3223,53960
Kishanganj,14.14.c,Number of Adolescents counselled,TOTAL,273,20,57,422,132,276,35,27,754,1226,1153,769,5144
Kishanganj,15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,4357,4451,4687,5155,1634,4572,4040,5014,5111,5408,1881,2033,48343
Kishanganj,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,868,742,763,1028,46,895,801,875,676,846,43,64,7647
Kishanganj,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,425,38,731,382,510,929,386,254,596,1465,812,764,7292
Kishanganj,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,7,3,16,13,13,17,3,7,13,15,21,13,141
Kishanganj,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,274,42,376,159,266,502,175,106,296,1049,566,662,4473
Kishanganj,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,20,1,14,13,14,21,8,3,12,10,14,10,140
Kishanganj,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,620,85,1288,810,992,1338,608,679,853,2031,1178,897,11379
Kishanganj,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,1,0,1,2,1,4,1,1,1,0,1,0,13
Kishanganj,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,1319,165,2395,1351,1768,2769,1169,1039,1745,4545,2556,2323,23144
Kishanganj,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,28,4,31,28,28,42,12,11,26,25,36,23,294
Kishanganj,15.2,Number of Widal tests conducted,Number tested,36,53,244,48,10,1232,13,0,11,0,0,5,1652
Kishanganj,15.3.a,Number of VDRL tests conducted on males,Number tested,0,5,0,0,0,0,0,0,0,0,2,0,7
Kishanganj,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,0,0,0,0,0,0,0,0,0,0,1,0,1
Kishanganj,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,21,1,0,0,0,0,61,0,0,0,11,20,114
Kishanganj,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,21,6,0,0,0,0,61,0,0,0,14,20,122
Kishanganj,15.4.1,Number of blood smears examined for Malaria,TOTAL,135,149,135,148,85,138,252,242,173,161,93,112,1823
Kishanganj,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,7,4,6,2,0,3,4,4,0,6,0,0,36
Kishanganj,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,1,0,0,0,0,10,0,0,0,0,0,0,11
Kishanganj,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,1650,1150,NA,700,850,650,NA,NA,NA,NA,NA,NA,5000
Kishanganj,16.1.1,Stock position of DPT vaccines,2. Stocks Received,500,1250,NA,500,500,1500,NA,NA,NA,NA,NA,NA,4250
Kishanganj,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,0
Kishanganj,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,1000,850,NA,350,700,1550,NA,NA,NA,NA,NA,NA,4450
Kishanganj,16.1.1,Stock position of DPT vaccines,5. Total Stock,1150,1550,0,850,650,600,0,0,0,0,0,0,4800
Kishanganj,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,1717,417,NA,950,1150,1250,NA,NA,NA,NA,NA,NA,5484
Kishanganj,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,600,2400,NA,1500,1200,960,NA,NA,NA,NA,NA,NA,6660
Kishanganj,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,0
Kishanganj,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,1900,1017,NA,1300,1200,1250,NA,NA,NA,NA,NA,NA,6667
Kishanganj,16.1.1A,Stock Position of Pentavalent,5. Total Stock,417,1800,0,1150,1150,960,0,0,0,0,0,0,5477
Kishanganj,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,1050,300,NA,675,325,875,NA,NA,NA,NA,NA,NA,3225
Kishanganj,16.1.2,Stock position of OPV vaccines,2. Stocks Received,1000,2225,NA,1500,2000,1250,NA,NA,NA,NA,NA,NA,7975
Kishanganj,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,0
Kishanganj,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,1750,1575,NA,1850,1450,1625,NA,NA,NA,NA,NA,NA,8250
Kishanganj,16.1.2,Stock position of OPV vaccines,5. Total Stock,300,950,0,325,875,500,0,0,0,0,0,0,2950
Kishanganj,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,1250,1200,NA,750,900,1150,NA,NA,NA,NA,NA,NA,5250
Kishanganj,16.1.3,Stock position of TT vaccines,2. Stocks Received,1000,1000,NA,1000,1000,750,NA,NA,NA,NA,NA,NA,4750
Kishanganj,16.1.3,Stock position of TT vaccines,3. Unusable Stock,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,0
Kishanganj,16.1.3,Stock position of TT vaccines,4. Stock Distributed,1050,1150,NA,850,750,1250,NA,NA,NA,NA,NA,NA,5050
Kishanganj,16.1.3,Stock position of TT vaccines,5. Total Stock,1200,1050,0,900,1150,650,0,0,0,0,0,0,4950
Kishanganj,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,0
Kishanganj,16.1.4,Stock position of DT vaccines,2. Stocks Received,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,0
Kishanganj,16.1.4,Stock position of DT vaccines,3. Unusable Stock,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,0
Kishanganj,16.1.4,Stock position of DT vaccines,4. Stock Distributed,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,0
Kishanganj,16.1.4,Stock position of DT vaccines,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Kishanganj,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,2271,1750,NA,1300,1350,1000,NA,NA,NA,NA,NA,NA,7671
Kishanganj,16.1.5,Stock position of BCG vaccines,2. Stocks Received,1000,1000,NA,1000,500,500,NA,NA,NA,NA,NA,NA,4000
Kishanganj,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,0
Kishanganj,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,1521,900,NA,950,850,850,NA,NA,NA,NA,NA,NA,5071
Kishanganj,16.1.5,Stock position of BCG vaccines,5. Total Stock,1750,1850,0,1350,1000,650,0,0,0,0,0,0,6600
Kishanganj,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,300,200,NA,600,650,1100,NA,NA,NA,NA,NA,NA,2850
Kishanganj,16.1.6,Stock position of Measles vaccines,2. Stocks Received,3000,2300,NA,3200,3000,3100,NA,NA,NA,NA,NA,NA,14600
Kishanganj,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,0
Kishanganj,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,3100,2350,NA,3150,2550,3750,NA,NA,NA,NA,NA,NA,14900
Kishanganj,16.1.6,Stock position of Measles vaccines,5. Total Stock,200,150,0,650,1100,450,0,0,0,0,0,0,2550
Kishanganj,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,NA,0,NA,NA,0,0,NA,NA,NA,NA,NA,NA,0
Kishanganj,16.1.7,Stock position of JE vaccines,2. Stocks Received,NA,0,NA,NA,0,0,NA,NA,NA,NA,NA,NA,0
Kishanganj,16.1.7,Stock position of JE vaccines,3. Unusable Stock,NA,0,NA,NA,0,0,NA,NA,NA,NA,NA,NA,0
Kishanganj,16.1.7,Stock position of JE vaccines,4. Stock Distributed,NA,0,NA,NA,0,0,NA,NA,NA,NA,NA,NA,0
Kishanganj,16.1.7,Stock position of JE vaccines,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Kishanganj,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,993,1050,NA,900,900,750,NA,NA,NA,NA,NA,NA,4593
Kishanganj,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,1000,1000,NA,0,0,0,NA,NA,NA,NA,NA,NA,2000
Kishanganj,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,0
Kishanganj,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,943,500,NA,0,150,50,NA,NA,NA,NA,NA,NA,1643
Kishanganj,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,1050,1550,0,900,750,700,0,0,0,0,0,0,4950
Kishanganj,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,10815,5015,NA,4015,NA,NA,NA,NA,NA,NA,NA,NA,19845
Kishanganj,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,9270,0,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,9270
Kishanganj,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,NA,0,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0
Kishanganj,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,5800,1000,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,6800
Kishanganj,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,14285,4015,0,4015,0,0,0,0,0,0,0,0,22315
Kishanganj,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,160034,31414,NA,7714,NA,NA,NA,NA,NA,NA,NA,NA,199162
Kishanganj,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,NA,0,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0
Kishanganj,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,NA,0,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0
Kishanganj,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,128620,22700,NA,1490,NA,NA,NA,NA,NA,NA,NA,NA,152810
Kishanganj,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,31414,8714,0,6224,0,0,0,0,0,0,0,0,46352
Kishanganj,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,30007,5407,NA,407,NA,NA,NA,NA,NA,NA,NA,NA,35821
Kishanganj,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,NA,0,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0
Kishanganj,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,NA,0,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0
Kishanganj,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,24600,4000,NA,407,NA,NA,NA,NA,NA,NA,NA,NA,29007
Kishanganj,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,5407,1407,0,0,0,0,0,0,0,0,0,0,6814
Kishanganj,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,14380,6080,NA,4480,NA,NA,NA,NA,NA,NA,NA,NA,24940
Kishanganj,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,NA,0,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0
Kishanganj,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,NA,0,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0
Kishanganj,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,8300,1600,NA,312,NA,NA,NA,NA,NA,NA,NA,NA,10212
Kishanganj,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,6080,4480,0,4168,0,0,0,0,0,0,0,0,14728
Kishanganj,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0
Kishanganj,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0
Kishanganj,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0
Kishanganj,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0
Kishanganj,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Kishanganj,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Kishanganj,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,16.3.02,Stock Position of Gloves,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,16.3.02,Stock Position of Gloves,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,16.3.02,Stock Position of Gloves,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,16.3.02,Stock Position of Gloves,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Kishanganj,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Kishanganj,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Kishanganj,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Kishanganj,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Kishanganj,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Kishanganj,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Kishanganj,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Kishanganj,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Kishanganj,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Kishanganj,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,12820,4520,NA,4020,NA,NA,NA,NA,14500,NA,NA,NA,35860
Kishanganj,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,NA,8000,NA,0,NA,NA,NA,NA,10000,NA,NA,NA,18000
Kishanganj,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,NA,0,NA,0,NA,NA,NA,NA,0,NA,NA,NA,0
Kishanganj,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,8300,3400,NA,3420,NA,NA,NA,NA,4200,NA,NA,NA,19320
Kishanganj,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,4520,9120,0,600,0,0,0,0,20300,0,0,0,34540
Kishanganj,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,78268,25668,NA,34068,NA,NA,NA,NA,6000,NA,NA,NA,144004
Kishanganj,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,NA,86000,NA,0,NA,NA,NA,NA,80000,NA,NA,NA,166000
Kishanganj,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,NA,0,NA,0,NA,NA,NA,NA,0,NA,NA,NA,0
Kishanganj,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,52600,46200,NA,30268,NA,NA,NA,NA,30000,NA,NA,NA,159068
Kishanganj,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,25668,65468,0,3800,0,0,0,0,56000,0,0,0,150936
Kishanganj,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,5100,700,NA,2100,NA,NA,NA,NA,1100,NA,NA,NA,9000
Kishanganj,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,NA,7500,NA,0,NA,NA,NA,NA,8000,NA,NA,NA,15500
Kishanganj,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,NA,0,NA,0,NA,NA,NA,NA,0,NA,NA,NA,0
Kishanganj,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,4400,4300,NA,2100,NA,NA,NA,NA,2900,NA,NA,NA,13700
Kishanganj,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,700,3900,0,0,0,0,0,0,6200,0,0,0,10800
Kishanganj,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,1
Kishanganj,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,1
Kishanganj,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,1,NA,NA,1,NA,NA,2
Kishanganj,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,1
Kishanganj,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,NA,NA,NA,NA,NA,NA,1,NA,NA,1,1,NA,3
Kishanganj,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,1,1,2,NA,6,2,NA,12
Kishanganj,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,4,2,NA,6
Kishanganj,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,NA,NA,NA,NA,NA,1,1,2,NA,10,4,NA,18
Kishanganj,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,2,NA,NA,3,NA,NA,5
Kishanganj,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1,NA,2
Kishanganj,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,NA,NA,NA,NA,NA,NA,2,NA,NA,4,1,NA,7
Kishanganj,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,1
Kishanganj,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,1
Kishanganj,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,1
Kishanganj,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,1
Kishanganj,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,1
Kishanganj,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,1
Kishanganj,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,2,NA,NA,NA,NA,NA,2
Kishanganj,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,NA,NA,NA,NA,NA,1,1,NA,1,1,1,NA,5
Kishanganj,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,1,1,NA,2,2,6
Kishanganj,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,NA,NA,NA,NA,NA,1,3,1,2,1,3,2,13
Kishanganj,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,1
Kishanganj,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,1
Kishanganj,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,4,1,1,6
Kishanganj,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,4,1,1,6
Kishanganj,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,1
Kishanganj,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,2,NA,1,NA,3
Kishanganj,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,2,1,1,NA,4
Kishanganj,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,1
Kishanganj,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,1
Kishanganj,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,NA,2
Kishanganj,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,1
Kishanganj,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,1,2,NA,2,NA,1,6
Kishanganj,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,NA,NA,NA,NA,NA,1,NA,2,NA,4,NA,3,10
Kishanganj,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,NA,NA,NA,NA,NA,1,2,4,NA,6,NA,4,17
Kishanganj,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Kishanganj,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,3,2,NA,2,NA,NA,7
Kishanganj,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,1,3,NA,NA,1,5
Kishanganj,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,NA,NA,NA,NA,NA,NA,3,3,3,2,NA,1,12
Lakhisarai,1.1,Total number of pregnant women Registered for ANC,TOTAL,2429,2513,2495,2483,2358,2148,2050,1843,2007,2038,2276,2258,26898
Lakhisarai,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,2243,2312,2274,2132,1933,1744,1746,1460,1703,1732,1968,1937,23184
Lakhisarai,1.2,Number of Pregnant women registered under JSY,TOTAL,2429,2513,2495,2483,2358,2148,2050,1848,2007,2037,2274,2258,26900
Lakhisarai,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,2151,2127,2108,2201,2105,2164,2036,1670,1918,1975,1975,1996,24426
Lakhisarai,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,2073,2216,2197,2156,1961,1858,1730,1534,1690,1877,2016,1872,23180
Lakhisarai,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,2295,2485,2274,2387,2351,2092,1939,1558,1899,1919,1990,2157,25346
Lakhisarai,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,2382,2435,2409,2078,1873,1676,1537,1206,1593,1843,2005,1793,22830
Lakhisarai,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,11,2,6,3,77,146,91,179,139,139,152,193,1138
Lakhisarai,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,1,1,2,2,1,2,0,0,0,0,0,0,9
Lakhisarai,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,531,392,588,948,801,472,790,676,826,569,470,590,7653
Lakhisarai,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,8,5,13,12,9,13,6,13,16,7,15,11,128
Lakhisarai,1.8,Number of pregnancy test kits used at SC level,TOTAL,214,336,216,234,440,419,278,275,282,151,150,255,3250
Lakhisarai,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,373,405,323,377,354,420,329,164,216,265,304,298,3828
Lakhisarai,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,273,263,282,335,285,316,269,330,405,319,316,307,3700
Lakhisarai,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,646,668,605,712,639,736,598,494,621,584,620,605,7528
Lakhisarai,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,632,288,569,651,561,644,515,275,446,501,524,470,6076
Lakhisarai,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0,0,450,457,0,0,0,0,0,0,0,0,907
Lakhisarai,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,924,1002,1095,1602,1827,1661,1622,1561,1413,1404,1124,1087,16322
Lakhisarai,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,924,1002,1093,1594,1821,1651,1618,1557,1406,1393,1122,1087,16268
Lakhisarai,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,924,992,1081,1346,1739,1497,803,1429,682,1341,2046,1498,15378
Lakhisarai,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,767,735,840,1168,1357,980,1091,1124,829,637,1221,1905,12654
Lakhisarai,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Lakhisarai,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,NA,NA,NA,NA,98,98,60,107,85,86,80,69,683
Lakhisarai,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0
Lakhisarai,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0
Lakhisarai,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0
Lakhisarai,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Lakhisarai,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,1,1,0,2,0,0,1,0,0,1,1,1,8
Lakhisarai,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,3,5,2,8,6,10,5,4,2,4,0,0,49
Lakhisarai,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Lakhisarai,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,4,6,2,10,6,10,6,4,2,5,1,1,57
Lakhisarai,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,NA,NA,NA,NA,55,55,33,53,37,36,34,39,342
Lakhisarai,4.1.1.a,Number of male live births,TOTAL,822,915,884,1226,1291,1301,1123,1059,1051,1019,937,882,12510
Lakhisarai,4.1.1.b,Number of female live births,TOTAL,758,737,809,1073,1150,1093,1086,991,972,971,803,808,11251
Lakhisarai,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1580,1652,1693,2299,2441,2394,2209,2050,2023,1990,1740,1690,23761
Lakhisarai,4.1.2,Number of still births,TOTAL,22,29,23,35,49,34,34,34,17,16,16,17,326
Lakhisarai,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,2,4,1,3,0,3,10,1,3,0,2,1,30
Lakhisarai,4.2.1,Number of Newborns weighed at birth,TOTAL,1560,1589,2288,2284,2437,2380,2199,2030,2012,1971,1709,1657,24116
Lakhisarai,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,87,63,138,224,257,264,242,190,154,138,112,90,1959
Lakhisarai,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1573,1649,1666,2288,2400,2382,2201,2031,2012,1978,1719,1673,23572
Lakhisarai,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0,0,0,0,0,0,0,0,0,3,3,2,8
Lakhisarai,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,7,0,7
Lakhisarai,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,3,5,27,16,17,18,44,20,11,38,23,23,245
Lakhisarai,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Lakhisarai,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,3,5,27,16,17,18,44,20,11,41,33,25,260
Lakhisarai,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Lakhisarai,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,3,5,3,8,0,0,5,3,2,7,26,25,87
Lakhisarai,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,1,0,3,2,0,2,0,2,0,2,0,0,12
Lakhisarai,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,0,0,3,6,10,22,6,15,10,16,8,13,109
Lakhisarai,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Lakhisarai,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1486,1626,1559,2216,1809,2084,2052,1841,1831,1891,1691,1612,21698
Lakhisarai,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,972,999,1035,1200,1342,1120,973,871,892,1013,974,937,12328
Lakhisarai,6.3,PNC maternal complications attended,TOTAL,0,0,0,0,0,0,0,0,0,358,303,8,669
Lakhisarai,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Lakhisarai,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Lakhisarai,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Lakhisarai,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Lakhisarai,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,0,2,57,32,76,28,88,67,29,32,28,53,492
Lakhisarai,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,0,30,68,71,90,83,110,83,76,83,70,75,839
Lakhisarai,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,0,32,125,103,166,111,198,150,105,115,98,128,1331
Lakhisarai,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Lakhisarai,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,1,1
Lakhisarai,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,3,0,0,0,NA,1,0,1,NA,1,4,0,10
Lakhisarai,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Lakhisarai,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Lakhisarai,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,3,0,0,0,0,1,0,1,0,1,4,1,11
Lakhisarai,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,NA,NA,NA,0,0,1,0,0,0,0,0,0,1
Lakhisarai,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Lakhisarai,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Lakhisarai,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Lakhisarai,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Lakhisarai,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Lakhisarai,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,NA,NA,NA,0,0,0,0,0,0,0,0,0,0
Lakhisarai,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,54,26,14,68,64,227,150,179,421,226,256,196,1881
Lakhisarai,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,12,29,49,80,33,29,57,66,75,60,113,26,629
Lakhisarai,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,33,5,3,38,16,52,83,67,236,100,160,80,873
Lakhisarai,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Lakhisarai,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,99,60,66,186,113,308,290,312,732,386,529,302,3383
Lakhisarai,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,NA,NA,NA,0,49,16,0,18,274,83,16,19,475
Lakhisarai,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,14,6,1,79,46,27,39,29,47,40,33,31,392
Lakhisarai,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,NA,NA,NA,NA,8,8,10,4,7,15,12,4,68
Lakhisarai,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,1,1,1,4,4,9,10,4,12,6,2,2,56
Lakhisarai,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Lakhisarai,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,15,7,2,83,58,44,59,37,66,61,47,37,516
Lakhisarai,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,NA,NA,NA,0,0,0,0,0,0,0,0,0,0
Lakhisarai,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,698,774,612,970,531,470,524,590,470,351,374,368,6732
Lakhisarai,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,213,199,136,296,158,186,203,232,247,148,156,191,2365
Lakhisarai,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,9,2,38,101,67,50,27,62,36,47,38,33,510
Lakhisarai,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,75,106,62,235,84,42,38,33,49,36,25,30,815
Lakhisarai,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Lakhisarai,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,995,1081,848,1602,840,748,792,917,802,582,593,622,10422
Lakhisarai,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,69,140,73,222,160,128,84,113,100,72,82,110,1353
Lakhisarai,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,NA,NA,NA,0,0,0,0,0,0,0,0,0,0
Lakhisarai,9.06,Number of IUCD removals,TOTAL,205,285,183,202,175,136,169,210,237,171,161,126,2260
Lakhisarai,9.07,Number of Oral Pills cycles distributed,TOTAL,2264,1553,1768,1981,1591,1439,1595,1242,980,1068,802,931,17214
Lakhisarai,9.08,Number of Condom pieces distributed,TOTAL,14152,12638,10248,13651,10702,10456,12498,10394,9685,7875,8508,8387,129194
Lakhisarai,9.09,Number of Centchroman (weekly) pills given,TOTAL,10,5,13,13,5,5,5,15,2,0,0,0,73
Lakhisarai,9.1,Number of Emergency Contraceptive Pills distributed,TOTAL,198,102,76,93,103,65,131,115,80,140,168,88,1359
Lakhisarai,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Lakhisarai,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Lakhisarai,9.11.2.a,Number of failures following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Lakhisarai,9.11.2.b,Number of failures following female sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Lakhisarai,9.11.3.a,Number of deaths following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Lakhisarai,9.11.3.b,Number of deaths following female sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Lakhisarai,9.12,Number of Institutions having NSV trained doctors,TOTAL,NA,1,3,3,5,5,4,4,3,4,2,3,Data for this item can not be cumulated
Lakhisarai,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,1753,1899,1793,2426,2737,3075,2548,2449,2394,2300,2142,1966,27482
Lakhisarai,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,0,1,1,0,0,0,2,12,13,0,2,0,31
Lakhisarai,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,92,46,53,19,23,11,7,8,3,1,1,0,264
Lakhisarai,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,364,191,149,69,28,37,12,21,11,2,0,0,884
Lakhisarai,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,1957,1957,1875,1836,1887,2293,2220,2347,2562,2552,2671,2612,26769
Lakhisarai,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,1960,2092,1972,1810,1943,1737,2094,2004,2210,2575,2600,2736,25733
Lakhisarai,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,1738,1979,2002,1942,2099,1810,1780,1673,1924,2297,2635,2610,24489
Lakhisarai,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1553,1575,1673,2222,2404,2285,2048,1907,1862,1689,1426,1229,21873
Lakhisarai,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1987,1755,1892,1801,1846,2246,2178,2302,2488,2509,2629,2575,26208
Lakhisarai,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,2079,1965,2025,1810,1910,1734,2067,2006,2183,2539,2560,2719,25597
Lakhisarai,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,2188,2047,2168,2010,2107,1837,1767,1616,1856,2267,2599,2594,25056
Lakhisarai,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,1401,1392,1379,1974,2088,1498,1454,1439,1437,1233,1052,959,17306
Lakhisarai,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,1,6,8,0,0,0,0,6,26,13,0,0,60
Lakhisarai,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,114,54,58,18,24,11,0,4,36,21,0,0,340
Lakhisarai,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,375,207,147,79,32,34,10,14,64,15,0,0,977
Lakhisarai,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,2148,2149,2263,2363,2254,2409,2214,1953,1767,1578,1727,1773,24598
Lakhisarai,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,1747,1707,1608,1773,1721,1537,1614,1598,1630,1920,2034,2084,20973
Lakhisarai,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,1903,2058,2194,2300,2215,2341,2225,1464,1634,1551,1663,1714,23262
Lakhisarai,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1134,1194,1236,1247,1186,1315,1207,1010,935,850,941,944,13199
Lakhisarai,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,972,1084,993,1115,1068,1091,990,938,834,753,815,809,11462
Lakhisarai,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,2106,2278,2229,2362,2254,2406,2197,1948,1769,1603,1756,1753,24661
Lakhisarai,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1928,1843,1799,1902,1683,1663,1635,1340,1569,1945,2073,1917,21297
Lakhisarai,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1946,1854,1800,1899,1668,1661,1636,1403,1564,1945,2073,1954,21403
Lakhisarai,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,1,0,0,0,0,0,0,0,0,0,0,0,1
Lakhisarai,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,385,503,520,636,556,444,527,659,710,871,962,908,7681
Lakhisarai,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,382,463,472,529,454,420,472,539,626,797,890,848,6892
Lakhisarai,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,767,966,992,1165,1010,864,999,1198,1336,1668,1852,1756,14573
Lakhisarai,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,12,2,7,9,3,9,8,17,27,131,6077,210,6512
Lakhisarai,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,143,222,172,195,174,177,181,205,194,331,431,247,2672
Lakhisarai,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,230,329,277,312,315,268,285,341,340,443,473,339,3952
Lakhisarai,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,201,186,254,218,209,176,149,101,60,66,116,20,1756
Lakhisarai,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Lakhisarai,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,184,195,204,181,178,153,100,95,62,84,102,16,1554
Lakhisarai,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1179,1171,1113,1217,1214,1234,1191,1024,1427,1392,1409,1419,14990
Lakhisarai,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1179,1171,1111,1217,1212,1234,1191,1023,1425,1388,1408,1419,14978
Lakhisarai,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1014,1030,1036,1102,1116,1137,1111,996,996,966,979,1007,12490
Lakhisarai,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,1548,1643,1694,1750,1709,1534,1533,993,1436,1712,1915,1990,19457
Lakhisarai,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,396,388,126,39,25,46,23,52,56,21,27,15,1214
Lakhisarai,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,73,90,47,0,0,0,0,17,26,10,15,0,278
Lakhisarai,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,14,17,5,0,0,0,0,10,8,6,16,0,76
Lakhisarai,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Lakhisarai,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Lakhisarai,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Lakhisarai,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Lakhisarai,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Lakhisarai,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0,5,0,0,0,0,0,0,0,0,0,0,5
Lakhisarai,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,74,174,154,106,155,72,74,31,4,47,72,29,992
Lakhisarai,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0,0,8,0,0,0,0,0,0,0,0,0,8
Lakhisarai,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Lakhisarai,13.1,Number of Patients operated for cataract,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Lakhisarai,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Lakhisarai,13.3,Number of School children detected with Refractive errors,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Lakhisarai,13.4,Number of children provided free glasses,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Lakhisarai,13.5,Number of eyes collected through eye donation,TOTAL,0,0,0,0,0,0,NA,0,0,0,0,0,0
Lakhisarai,13.6,Number of eyes utilised for corneal transplant,TOTAL,0,0,0,0,0,0,NA,0,0,0,0,0,0
Lakhisarai,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,NA,1,2,2,2,2,2,2,2,1,2,2,Data for this item can not be cumulated
Lakhisarai,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,1,NA,7,7,8,7,6,8,5,9,9,7,Data for this item can not be cumulated
Lakhisarai,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,575,575,373,402,232,397,400,514,580,609,586,588,Data for this item can not be cumulated
Lakhisarai,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,NA,1,2,2,1,2,2,2,2,1,2,2,Data for this item can not be cumulated
Lakhisarai,14.05,Number of RKS meetings held during the month,TOTAL,1,4,8,2,2,3,2,2,6,9,7,8,54
Lakhisarai,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,NA,1,7,7,7,7,7,7,5,4,4,5,Data for this item can not be cumulated
Lakhisarai,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,792,985,936,2002,1833,1333,1997,1673,1415,1594,1062,1470,17092
Lakhisarai,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,NA,NA,NA,1,NA,1,1,1,1,1,1,1,Data for this item can not be cumulated
Lakhisarai,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,NA,1,2,1,1,0,0,0,0,0,0,0,Data for this item can not be cumulated
Lakhisarai,14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Lakhisarai,14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Lakhisarai,14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Lakhisarai,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,447,424,665,826,896,830,810,847,690,489,606,428,7958
Lakhisarai,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,1026,746,726,852,840,713,773,732,596,551,736,369,8660
Lakhisarai,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,475,548,582,692,804,795,768,755,617,433,540,395,7404
Lakhisarai,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,1729,1887,1814,2211,1973,1969,2016,1797,1988,1305,1968,1405,22062
Lakhisarai,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,922,972,1247,1518,1700,1625,1578,1602,1307,922,1146,823,15362
Lakhisarai,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,2755,2633,2540,3063,2813,2682,2789,2529,2584,1856,2704,1774,30722
Lakhisarai,14.10.2.a,Number of death cases of Inpatient males,TOTAL,1,0,1,3,1,1,6,0,2,2,3,0,20
Lakhisarai,14.10.2.b,Number of death cases of Inpatient females,TOTAL,1,0,3,1,2,2,1,1,1,1,0,0,13
Lakhisarai,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,2,0,4,4,3,3,7,1,3,3,3,0,33
Lakhisarai,14.11,In-Patient Head Count at midnight,TOTAL,3247,3179,3178,3723,3714,3201,3632,3608,3657,1927,2669,2128,37863
Lakhisarai,14.12.1,OPD attendance (All),TOTAL,61645,57988,57704,58317,62089,63607,59188,53663,56929,41705,54844,51404,679083
Lakhisarai,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,131,317,80,261,192,363,353,324,800,348,593,495,4257
Lakhisarai,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,4,6,2,10,6,10,6,4,2,5,1,1,57
Lakhisarai,14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Lakhisarai,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,1569,1586,1625,1713,1728,1636,1588,1563,1457,1444,1365,892,18166
Lakhisarai,14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Lakhisarai,14.14.a,Number of patients given AYUSH treatment,TOTAL,7196,7846,7636,5453,7516,6712,5677,6120,5323,5479,7103,7269,79330
Lakhisarai,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,1337,1967,2141,2092,2576,2903,2555,2680,2540,1591,2699,2128,27209
Lakhisarai,14.14.c,Number of Adolescents counselled,TOTAL,74,101,58,137,495,497,472,442,506,512,87,338,3719
Lakhisarai,15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Lakhisarai,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,1419,1693,1654,2174,2093,1992,1964,1643,2416,1587,1813,1485,21933
Lakhisarai,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,14,15,25,32,52,28,30,22,44,20,38,30,350
Lakhisarai,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,717,618,566,624,624,465,528,252,567,355,583,370,6269
Lakhisarai,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,0,0,8,5,5,4,2,1,2,0,5,6,38
Lakhisarai,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,947,702,808,744,667,715,933,465,1287,588,1011,642,9509
Lakhisarai,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0,0,6,5,3,3,1,0,2,0,2,1,23
Lakhisarai,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,545,870,419,882,662,870,748,553,461,678,733,562,7983
Lakhisarai,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0,0,0,1,0,0,2,0,0,0,0,2,5
Lakhisarai,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,2209,2190,1793,2250,1953,2050,2209,1270,2315,1621,2327,1574,23761
Lakhisarai,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,0,0,14,11,8,7,5,1,4,0,7,9,66
Lakhisarai,15.2,Number of Widal tests conducted,Number tested,0,0,0,0,0,0,95,0,0,0,0,82,177
Lakhisarai,15.3.a,Number of VDRL tests conducted on males,Number tested,0,0,8,1,0,4,56,48,29,26,16,4,192
Lakhisarai,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,0,28,52,57,0,59,33,39,76,61,99,111,615
Lakhisarai,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,0,0,24,36,79,0,64,45,87,31,141,118,625
Lakhisarai,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,0,28,84,94,79,63,153,132,192,118,256,233,1432
Lakhisarai,15.4.1,Number of blood smears examined for Malaria,TOTAL,356,267,609,474,324,934,465,119,175,141,171,298,4333
Lakhisarai,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,3,4,2,7,0,10,5,0,0,2,1,1,35
Lakhisarai,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,1,0,1,12,5,5,4,0,0,0,1,0,29
Lakhisarai,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,1140,690,885,1335,1035,1430,1830,2430,2175,1875,1725,0,16550
Lakhisarai,16.1.1,Stock position of DPT vaccines,2. Stocks Received,0,500,800,0,800,800,1000,0,0,0,250,500,4650
Lakhisarai,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,275,0,275
Lakhisarai,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,450,305,350,300,405,400,400,255,300,150,1700,500,5515
Lakhisarai,16.1.1,Stock position of DPT vaccines,5. Total Stock,690,885,1335,1035,1430,1830,2430,2175,1875,1725,0,0,15410
Lakhisarai,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,760,NA,1460,1855,2100,2542,1759,2539,2034,1252,1002,1057,18360
Lakhisarai,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,750,NA,1050,600,1152,0,1200,0,0,288,864,768,6672
Lakhisarai,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0,NA,0,0,0,0,0,0,NA,0,0,0,0
Lakhisarai,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,540,NA,655,355,710,783,420,505,782,538,809,864,6961
Lakhisarai,16.1.1A,Stock Position of Pentavalent,5. Total Stock,970,0,1855,2100,2542,1759,2539,2034,1252,1002,1057,961,18071
Lakhisarai,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,0,17,50,25,200,50,0,0,25,275,300,250,1192
Lakhisarai,16.1.2,Stock position of OPV vaccines,2. Stocks Received,642,750,1000,900,575,750,900,800,800,800,600,350,8867
Lakhisarai,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Lakhisarai,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,625,717,1025,725,725,800,900,775,550,775,650,600,8867
Lakhisarai,16.1.2,Stock position of OPV vaccines,5. Total Stock,17,50,25,200,50,0,0,25,275,300,250,0,1192
Lakhisarai,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,1535,1330,2467,1657,2292,2929,2069,2659,2204,1644,1234,982,23002
Lakhisarai,16.1.3,Stock position of TT vaccines,2. Stocks Received,0,1600,0,1250,1200,0,1000,0,0,0,250,250,5550
Lakhisarai,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Lakhisarai,16.1.3,Stock position of TT vaccines,4. Stock Distributed,205,463,810,615,563,860,410,455,560,410,502,810,6663
Lakhisarai,16.1.3,Stock position of TT vaccines,5. Total Stock,1330,2467,1657,2292,2929,2069,2659,2204,1644,1234,982,422,21889
Lakhisarai,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0,0,0,0,0,0,0,0,0,20,0,0,20
Lakhisarai,16.1.4,Stock position of DT vaccines,2. Stocks Received,0,0,0,0,0,0,0,0,300,230,0,0,530
Lakhisarai,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Lakhisarai,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0,0,0,0,0,0,0,0,280,250,0,0,530
Lakhisarai,16.1.4,Stock position of DT vaccines,5. Total Stock,0,0,0,0,0,0,0,0,20,0,0,0,20
Lakhisarai,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,750,640,1115,1300,1550,1700,1650,1350,1150,1000,850,720,13775
Lakhisarai,16.1.5,Stock position of BCG vaccines,2. Stocks Received,450,700,750,750,750,750,200,450,450,500,450,500,6700
Lakhisarai,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Lakhisarai,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,560,225,565,500,600,800,500,650,600,650,580,770,7000
Lakhisarai,16.1.5,Stock position of BCG vaccines,5. Total Stock,640,1115,1300,1550,1700,1650,1350,1150,1000,850,720,450,13475
Lakhisarai,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,80,670,60,450,940,290,580,325,425,865,755,850,6290
Lakhisarai,16.1.6,Stock position of Measles vaccines,2. Stocks Received,1150,700,1750,1750,300,1500,1150,1150,1150,700,1000,1130,13430
Lakhisarai,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Lakhisarai,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,1160,710,1360,1260,950,1210,1405,1050,710,810,905,1105,12635
Lakhisarai,16.1.6,Stock position of Measles vaccines,5. Total Stock,70,660,450,940,290,580,325,425,865,755,850,875,7085
Lakhisarai,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,140,130,375,765,1360,2350,1840,980,470,850,700,490,10450
Lakhisarai,16.1.7,Stock position of JE vaccines,2. Stocks Received,1150,1150,1750,1800,1700,800,400,500,1150,500,800,1100,12800
Lakhisarai,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Lakhisarai,16.1.7,Stock position of JE vaccines,4. Stock Distributed,1160,905,1360,1205,710,1310,1260,1010,770,650,1010,1160,12510
Lakhisarai,16.1.7,Stock position of JE vaccines,5. Total Stock,130,375,765,1360,2350,1840,980,470,850,700,490,430,10740
Lakhisarai,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,NA,1170,1655,1870,2350,2700,2300,3200,3050,2900,2850,2700,26745
Lakhisarai,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,250,750,550,550,550,0,1000,0,0,0,0,250,3900
Lakhisarai,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0,0,0,0,0,0,100,0,0,0,0,0,100
Lakhisarai,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,160,265,335,70,200,400,NA,150,150,50,150,50,1980
Lakhisarai,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,90,1655,1870,2350,2700,2300,3200,3050,2900,2850,2700,2900,28565
Lakhisarai,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,6200,3200,8240,0,0,0,0,0,0,0,3163,3163,23966
Lakhisarai,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0,8240,0,0,0,0,0,0,0,3163,0,NA,11403
Lakhisarai,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Lakhisarai,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,0,0,8240,0,0,0,0,0,0,0,0,NA,8240
Lakhisarai,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,6200,11440,0,0,0,0,0,0,0,3163,3163,3163,27129
Lakhisarai,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,24000,12000,94892,0,0,0,0,0,0,0,53000,5300,189192
Lakhisarai,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0,89542,0,0,0,0,0,0,0,53000,0,NA,142542
Lakhisarai,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Lakhisarai,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,0,0,94892,0,0,0,0,0,0,0,0,NA,94892
Lakhisarai,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,24000,101542,0,0,0,0,0,0,0,53000,53000,5300,236842
Lakhisarai,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,6500,3500,13411,0,0,0,0,0,0,0,3615,3615,30641
Lakhisarai,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0,14371,0,0,0,0,0,0,0,3615,0,NA,17986
Lakhisarai,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Lakhisarai,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0,0,13411,0,0,0,0,0,0,0,0,NA,13411
Lakhisarai,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,6500,17871,0,0,0,0,0,0,0,3615,3615,3615,35216
Lakhisarai,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0,0,5406,0,0,0,0,0,0,0,4044,4044,13494
Lakhisarai,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0,5406,0,0,0,0,0,0,0,4044,0,NA,9450
Lakhisarai,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Lakhisarai,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0,0,5406,0,0,0,0,0,0,0,0,NA,5406
Lakhisarai,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0,5406,0,0,0,0,0,0,0,4044,4044,4044,17538
Lakhisarai,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,0,0,0,0,0,0,0,0,0,0,0,0,0
Lakhisarai,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0,0,0,0,0,0,0,0,0,0,0,0,0
Lakhisarai,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Lakhisarai,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0,0,0,0,0,0,0,0,0,0,0,0,0
Lakhisarai,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Lakhisarai,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,1300,100,0,0,0,0,0,0,0,0,0,0,1400
Lakhisarai,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0,0,0,0,0,0,0,0,0,0,0,0,0
Lakhisarai,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Lakhisarai,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,1200,0,0,0,0,0,0,0,0,0,0,0,1200
Lakhisarai,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,100,100,0,0,0,0,0,0,0,0,0,0,200
Lakhisarai,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,5500,3000,2500,2500,0,0,0,0,0,8100,2000,400,24000
Lakhisarai,16.3.02,Stock Position of Gloves,2. Stocks Received,0,0,0,0,0,0,0,0,0,0,0,0,0
Lakhisarai,16.3.02,Stock Position of Gloves,3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Lakhisarai,16.3.02,Stock Position of Gloves,4. Stock Distributed,2500,500,0,2500,0,0,0,0,0,6100,1600,400,13600
Lakhisarai,16.3.02,Stock Position of Gloves,5. Total Stock,3000,2500,2500,0,0,0,0,0,0,2000,400,0,10400
Lakhisarai,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0,0,0,0,0,0,0,0,0,0,0,0,0
Lakhisarai,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0,0,0,0,0,0,0,0,0,0,0,0,0
Lakhisarai,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Lakhisarai,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0,0,0,0,0,0,0,0,0,0,0,0,0
Lakhisarai,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Lakhisarai,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,7700,5700,500,100,100,100,0,0,0,0,0,0,14200
Lakhisarai,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0,0,0,0,0,0,0,0,0,0,0,0,0
Lakhisarai,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Lakhisarai,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,2000,0,400,0,0,100,0,0,0,0,0,0,2500
Lakhisarai,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,5700,5700,100,100,100,0,0,0,0,0,0,0,11700
Lakhisarai,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0,0,0,0,0,0,0,0,0,0,0,0,0
Lakhisarai,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0,0,0,0,0,0,0,0,0,0,0,0,0
Lakhisarai,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Lakhisarai,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0,0,0,0,0,0,0,0,0,0,0,0,0
Lakhisarai,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Lakhisarai,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0,0,0,0,0,0,0,0,0,0,0,0,0
Lakhisarai,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0,0,0,0,0,0,0,0,0,0,0,0,0
Lakhisarai,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Lakhisarai,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0,0,0,0,0,0,0,0,0,0,0,0,0
Lakhisarai,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Lakhisarai,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,15000,0,0,0,0,0,0,0,0,0,0,0,15000
Lakhisarai,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0,0,0,0,0,0,0,0,0,0,0,0,0
Lakhisarai,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0,0,0,0,0,0,0,NA,0,0,0,0,0
Lakhisarai,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0,0,0,0,0,0,0,0,0,0,0,0,0
Lakhisarai,16.3.07,Stock Position of IFA Tablets,5. Total Stock,15000,0,0,0,0,0,0,0,0,0,0,0,15000
Lakhisarai,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,46,0,0,0,0,0,0,0,0,0,0,0,46
Lakhisarai,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,NA,0,0,0,0,0,0,0,0,0,0,0,0
Lakhisarai,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Lakhisarai,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0,0,0,0,0,0,0,0,0,0,0,0,0
Lakhisarai,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,46,0,0,0,0,0,0,0,0,0,0,0,46
Lakhisarai,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,1505,0,805,100,100,10,10,0,0,0,0,0,2530
Lakhisarai,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0,0,0,0,0,0,0,0,0,0,0,0,0
Lakhisarai,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Lakhisarai,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0,0,405,0,100,0,10,0,0,0,0,0,515
Lakhisarai,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,1505,0,400,100,0,10,0,0,0,0,0,0,2015
Lakhisarai,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,0,0,0,0,0,0,0,0,0,0,0,0,0
Lakhisarai,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0,0,0,0,0,0,0,0,0,0,0,0,0
Lakhisarai,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Lakhisarai,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0,0,0,0,0,0,0,0,0,0,0,0,0
Lakhisarai,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Lakhisarai,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,0,37543,4513,52089,1049,1049,49,49,0,0,0,0,96341
Lakhisarai,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0,50000,52089,0,0,0,0,0,0,0,0,0,102089
Lakhisarai,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Lakhisarai,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,0,28000,0,51040,0,1000,0,49,0,0,0,0,80089
Lakhisarai,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0,59543,56602,1049,1049,49,49,0,0,0,0,0,118341
Lakhisarai,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,5000,3000,4600,4200,7600,5600,9800,7200,14200,9300,6100,4100,80700
Lakhisarai,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0,10000,0,6000,0,8000,0,10000,0,0,0,2500,36500
Lakhisarai,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Lakhisarai,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,2000,8400,400,2600,2000,3800,2600,3000,4900,3200,2000,5100,40000
Lakhisarai,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,3000,4600,4200,7600,5600,9800,7200,14200,9300,6100,4100,1500,77200
Lakhisarai,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,12000,1400,4400,4000,38000,21800,53000,23400,67000,53000,32400,14200,324600
Lakhisarai,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0,50000,0,60000,0,60000,0,60000,0,0,0,34000,264000
Lakhisarai,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Lakhisarai,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,10600,47000,400,26000,16200,28800,29600,16400,14000,20600,18200,24600,252400
Lakhisarai,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,1400,4400,4000,38000,21800,53000,23400,67000,53000,32400,14200,23600,336200
Lakhisarai,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,2100,900,1400,1300,6000,3800,5400,3300,7700,5600,3700,1300,42500
Lakhisarai,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0,6000,0,6000,0,6000,0,6000,0,0,0,3000,27000
Lakhisarai,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Lakhisarai,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,1200,5500,100,1300,2200,4400,2100,1600,2100,1900,2400,2700,27500
Lakhisarai,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,900,1400,1300,6000,3800,5400,3300,7700,5600,3700,1300,1600,42000
Lakhisarai,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Lakhisarai,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Lakhisarai,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Lakhisarai,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Lakhisarai,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1
Lakhisarai,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Lakhisarai,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1
Lakhisarai,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Lakhisarai,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Lakhisarai,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Lakhisarai,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Lakhisarai,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Lakhisarai,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Lakhisarai,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,1
Lakhisarai,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Lakhisarai,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,1
Lakhisarai,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Lakhisarai,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Lakhisarai,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Lakhisarai,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,NA,1
Lakhisarai,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Lakhisarai,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,NA,1
Lakhisarai,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Lakhisarai,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Lakhisarai,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Lakhisarai,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,NA,NA,NA,NA,NA,1,NA,1,NA,NA,NA,NA,2
Lakhisarai,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,NA,NA,NA,NA,NA,1,NA,1,NA,NA,NA,NA,2
Lakhisarai,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,NA,NA,NA,NA,NA,2,NA,2,NA,NA,NA,NA,4
Lakhisarai,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Lakhisarai,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Lakhisarai,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Lakhisarai,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Lakhisarai,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Lakhisarai,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Lakhisarai,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Lakhisarai,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Lakhisarai,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Lakhisarai,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Lakhisarai,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Lakhisarai,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Lakhisarai,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Lakhisarai,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Lakhisarai,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Lakhisarai,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Lakhisarai,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Lakhisarai,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,NA,1
Lakhisarai,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Lakhisarai,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,NA,1
Lakhisarai,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Lakhisarai,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Lakhisarai,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Lakhisarai,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Lakhisarai,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Lakhisarai,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,2,NA,1,NA,NA,1,4
Lakhisarai,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,2,NA,2,NA,NA,NA,4
Lakhisarai,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,NA,NA,NA,NA,NA,NA,4,NA,3,NA,NA,1,8
Lakhisarai,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Lakhisarai,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Lakhisarai,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,1
Lakhisarai,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,1
Lakhisarai,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Lakhisarai,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Lakhisarai,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Lakhisarai,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Lakhisarai,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Lakhisarai,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Lakhisarai,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Lakhisarai,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Lakhisarai,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Lakhisarai,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Lakhisarai,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Lakhisarai,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Lakhisarai,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Lakhisarai,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Lakhisarai,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Lakhisarai,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Lakhisarai,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Lakhisarai,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,1
Lakhisarai,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Lakhisarai,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,1
Lakhisarai,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Lakhisarai,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,NA,NA,NA,NA,NA,2,NA,NA,NA,NA,NA,NA,2
Lakhisarai,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Lakhisarai,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,NA,NA,NA,NA,NA,2,NA,NA,NA,NA,NA,NA,2
Lakhisarai,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Lakhisarai,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,1,2
Lakhisarai,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,NA,1
Lakhisarai,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,NA,NA,NA,NA,NA,1,1,NA,NA,NA,NA,1,3
Lakhisarai,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Lakhisarai,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Lakhisarai,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Lakhisarai,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Lakhisarai,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Lakhisarai,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Lakhisarai,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Lakhisarai,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Lakhisarai,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,NA,NA,NA,NA,NA,1,1,NA,NA,NA,NA,NA,2
Lakhisarai,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,1
Lakhisarai,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,1
Lakhisarai,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,NA,NA,NA,NA,NA,1,2,NA,1,NA,NA,NA,4
Lakhisarai,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Lakhisarai,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Lakhisarai,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,1
Lakhisarai,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,1
Lakhisarai,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,NA,NA,NA,NA,1,1,NA,NA,1,NA,NA,NA,3
Lakhisarai,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,NA,NA,NA,NA,1,6,6,2,NA,5,1,3,24
Lakhisarai,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,NA,NA,NA,NA,NA,1,2,5,16,7,6,7,44
Lakhisarai,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,NA,NA,NA,NA,2,8,8,7,17,12,7,10,71
Madhepura,1.1,Total number of pregnant women Registered for ANC,TOTAL,6398,6941,6392,5871,5499,4785,4952,4834,4861,4731,5033,5474,65771
Madhepura,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,3630,4329,3667,3440,3229,3016,3318,3352,3292,3485,3803,4472,43033
Madhepura,1.2,Number of Pregnant women registered under JSY,TOTAL,6291,6936,6384,5851,5497,4783,4952,4834,4861,4731,5033,5474,65627
Madhepura,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,3435,4096,3933,4041,3885,3846,4021,3871,3960,3839,4064,4531,47522
Madhepura,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,3256,3755,3181,2885,2730,2375,2453,2545,2395,2553,2600,2880,33608
Madhepura,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,5505,6429,5739,5599,5181,4487,4502,4366,4341,4293,4222,4829,59493
Madhepura,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,3514,7694,4061,3866,4257,4066,4108,4158,4334,3907,4236,4385,52586
Madhepura,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,31,148,112,79,73,362,27,23,26,164,71,166,1282
Madhepura,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,3,2,12,16,7,14,9,8,8,2,9,9,99
Madhepura,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,184,157,136,110,134,207,142,216,179,255,390,342,2452
Madhepura,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,3,2,5,2,2,6,3,1,0,0,1,1,26
Madhepura,1.8,Number of pregnancy test kits used at SC level,TOTAL,959,1189,781,908,899,982,900,1137,1177,1266,1369,1808,13375
Madhepura,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,26,9,27,26,52,43,47,63,93,56,43,59,544
Madhepura,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,842,1032,820,967,1359,1558,2050,1800,1548,1320,1289,1057,15642
Madhepura,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,868,1041,847,993,1411,1601,2097,1863,1641,1376,1332,1116,16186
Madhepura,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,359,353,379,368,355,438,505,453,381,330,712,893,5526
Madhepura,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0,0,0,0,0,5,10,0,0,0,0,0,15
Madhepura,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1807,2145,2075,2795,4153,4887,5050,4041,2981,2499,2712,2329,37474
Madhepura,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,1795,2124,2016,2764,3729,4872,4981,4039,2976,2316,2695,2326,36633
Madhepura,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,708,943,1047,1098,2167,5677,6926,4084,3205,3193,2865,2637,34550
Madhepura,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,515,609,957,1130,1771,2769,4340,2245,3367,2852,4825,2525,27905
Madhepura,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Madhepura,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,0,0,0,NA,0,459,342,278,308,365,184,164,2100
Madhepura,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0,0,0,NA,0,0,0,0,0,0,0,0,0
Madhepura,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0,0,0,NA,0,0,0,0,0,0,0,0,0
Madhepura,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0,0,0,NA,0,0,0,0,0,0,0,0,0
Madhepura,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Madhepura,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,6,6,7,14,16,6,4,2,5,2,7,3,78
Madhepura,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,6,6,7,14,16,6,4,2,5,2,7,3,78
Madhepura,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,0,0,0,NA,0,169,68,75,86,65,48,63,574
Madhepura,4.1.1.a,Number of male live births,TOTAL,1362,1619,1467,1989,2898,3492,3815,3140,2500,2172,2151,1845,28450
Madhepura,4.1.1.b,Number of female live births,TOTAL,1289,1548,1429,1775,2613,3269,3579,2998,2395,2027,2053,1730,26705
Madhepura,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,2651,3167,2896,3764,5511,6761,7394,6138,4895,4199,4204,3575,55155
Madhepura,4.1.2,Number of still births,TOTAL,44,36,47,49,74,94,61,65,36,39,37,38,620
Madhepura,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,0,0,0,0,0,5,0,0,0,1,0,0,6
Madhepura,4.2.1,Number of Newborns weighed at birth,TOTAL,2373,2927,2758,3601,5354,6181,6778,5617,4374,3693,4114,3543,51313
Madhepura,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,92,99,136,167,390,454,435,426,252,314,352,355,3472
Madhepura,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,2529,3059,2831,3716,5428,6327,6924,5721,4555,3784,4173,3575,52622
Madhepura,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,99,323,32,73,48,75,68,78,54,265,392,361,1868
Madhepura,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,112,145,147,96,117,165,168,103,66,86,86,143,1434
Madhepura,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,211,468,179,169,165,240,236,181,120,351,478,504,3302
Madhepura,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0,0,0,NA,0,0,0,0,0,0,0,0,0
Madhepura,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,396,257,77,443,162,263,325,372,194,510,634,454,4087
Madhepura,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,3,2,12,16,7,21,12,6,10,267,288,35,679
Madhepura,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,414,299,445,235,140,441,486,325,223,515,748,707,4978
Madhepura,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0,2,5,6,9,3,3,2,0,1,3,1,35
Madhepura,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1868,2251,2240,2902,4293,5048,5420,4409,3222,2853,3009,2633,40148
Madhepura,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,702,1216,954,1122,1347,1852,2150,1919,1548,1579,1765,1438,17592
Madhepura,6.3,PNC maternal complications attended,TOTAL,408,3,74,0,0,2,0,0,0,51,17,5,560
Madhepura,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Madhepura,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Madhepura,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Madhepura,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Madhepura,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,80,60,80,60,72,38,49,46,53,60,92,77,767
Madhepura,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,320,250,330,340,325,307,116,268,307,380,418,445,3806
Madhepura,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,400,310,410,400,397,345,165,314,360,440,510,522,4573
Madhepura,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Madhepura,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0,0,0,1,0,0,0,0,0,0,0,0,1
Madhepura,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,1,1
Madhepura,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0,0,0,1,0,0,0,0,0,0,0,1,2
Madhepura,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0,0,0,NA,0,0,0,0,0,0,0,0,0
Madhepura,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Madhepura,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Madhepura,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Madhepura,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0,0,0,NA,0,0,0,0,0,0,0,0,0
Madhepura,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,48,31,21,712,131,489,580,429,2633,1066,1422,846,8408
Madhepura,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,16,21,12,37,35,83,58,81,192,123,185,211,1054
Madhepura,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,64,52,33,749,166,572,638,510,2825,1189,1607,1057,9462
Madhepura,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,0,0,0,72,0,65,70,175,375,345,524,945,2571
Madhepura,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,7,11,1,0,5,8,1,10,17,10,25,19,114
Madhepura,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,4,2,4,9,4,5,2,1,8,3,5,4,51
Madhepura,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,11,13,5,9,9,13,3,11,25,13,30,23,165
Madhepura,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0,0,0,NA,0,0,9,0,0,0,0,0,9
Madhepura,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,236,317,197,316,227,194,225,326,360,364,458,525,3745
Madhepura,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,65,95,74,135,94,113,142,143,246,300,440,399,2246
Madhepura,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,5,3,75,129,217,195,368,174,152,113,103,148,1682
Madhepura,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,306,415,346,580,538,502,735,643,758,777,1001,1072,7673
Madhepura,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,298,161,111,279,273,284,376,251,306,349,439,455,3582
Madhepura,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,NA,NA,0,NA,0,0,0,0,0,0,0,0,0
Madhepura,9.06,Number of IUCD removals,TOTAL,113,129,104,109,130,135,117,131,151,174,165,246,1704
Madhepura,9.07,Number of Oral Pills cycles distributed,TOTAL,3472,3087,2253,3536,3557,4115,4829,4051,4045,3977,3353,3435,43710
Madhepura,9.08,Number of Condom pieces distributed,TOTAL,8332,9551,9452,12122,9578,10337,12850,11949,14839,13305,13037,14383,139735
Madhepura,9.09,Number of Centchroman (weekly) pills given,TOTAL,27,62,22,298,4,18,12,42,9,24,44,131,693
Madhepura,9.1,Number of Emergency Contraceptive Pills distributed,TOTAL,69,214,156,276,94,198,189,246,205,457,293,445,2842
Madhepura,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0,0,0,0,1,0,0,0,0,0,0,0,1
Madhepura,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Madhepura,9.11.2.a,Number of failures following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Madhepura,9.11.2.b,Number of failures following female sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Madhepura,9.11.3.a,Number of deaths following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Madhepura,9.11.3.b,Number of deaths following female sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Madhepura,9.12,Number of Institutions having NSV trained doctors,TOTAL,NA,NA,NA,1,3,4,5,4,1,2,1,2,Data for this item can not be cumulated
Madhepura,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,3458,3655,4141,4362,6087,7565,8072,6941,5718,4621,4723,4021,63364
Madhepura,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,8,13,15,7,7,3,3,4,0,0,0,0,60
Madhepura,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,720,395,325,170,106,45,20,6,4,1,1,2,1795
Madhepura,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,2245,1445,959,503,301,146,81,29,20,7,4,0,5740
Madhepura,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,3987,3927,3969,3981,4072,4702,6535,6973,7906,6719,5502,4901,63174
Madhepura,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,4014,4354,3809,3887,4301,3828,4481,5212,6556,7220,6466,5648,59776
Madhepura,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,3300,4188,3744,3875,4256,3964,4018,4027,4975,6095,6225,6093,54760
Madhepura,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,2691,2622,2557,3155,4979,6049,6235,5120,4000,3214,3400,2974,46996
Madhepura,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,3936,3879,3972,4132,4089,4695,6493,6942,7906,6719,5502,4876,63141
Madhepura,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,4697,4759,4100,4047,4393,3897,4503,5193,6560,7220,6467,5612,61448
Madhepura,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,5322,5341,4590,4339,4575,4105,4123,4037,4955,6102,6229,6028,59746
Madhepura,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,2009,1662,1873,2285,4131,4807,5013,4013,3037,2304,2727,2291,36152
Madhepura,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,8,4,9,15,55,95,85,31,0,0,0,0,302
Madhepura,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,717,417,318,166,144,88,86,28,4,1,1,0,1970
Madhepura,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,2222,1419,980,666,334,161,118,50,13,7,4,0,5974
Madhepura,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,3164,4551,5456,6331,6392,5509,5538,4420,4845,4202,4197,4005,58610
Madhepura,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,4102,4196,4318,3346,3435,3830,3897,3243,4425,5212,5507,5151,50662
Madhepura,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Madhepura,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1564,2276,2712,3243,3192,2805,2836,2264,2458,2193,2141,2121,29805
Madhepura,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1407,2116,2447,2878,2963,2637,2577,2078,2264,1909,1940,1828,27044
Madhepura,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,2971,4392,5159,6121,6155,5442,5413,4342,4722,4102,4081,3949,56849
Madhepura,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,4756,4672,4484,4234,4097,3885,4106,3415,4666,5270,5576,5273,54434
Madhepura,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,4745,4669,4493,4233,4101,3883,4105,3403,4666,5270,5576,5218,54362
Madhepura,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Madhepura,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1166,1078,1392,1007,941,1027,1271,1064,1235,1888,1573,576,14218
Madhepura,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1084,1020,1234,910,881,946,1140,903,1190,1756,1505,507,13076
Madhepura,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,2250,2098,2626,1917,1822,1973,2411,1967,2425,3644,3078,1083,27294
Madhepura,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,537,588,600,655,635,760,962,894,1313,1549,1430,1239,11162
Madhepura,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,890,835,843,951,837,854,989,983,1179,1298,1374,1257,12290
Madhepura,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1113,1177,1111,1186,1226,1334,1415,1240,1507,1651,1652,1528,16140
Madhepura,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,2,0,10,7,5,1,43,3,0,1,0,0,72
Madhepura,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0,0,0,0,0,0,0,1,0,0,0,0,1
Madhepura,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0,0,1,3,0,0,0,1,0,1,1,0,7
Madhepura,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1586,1719,1763,1785,1785,1809,1847,1857,1843,1855,1857,1856,21562
Madhepura,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1569,1707,1699,1772,1770,1822,1821,1742,1824,1779,1766,1774,21045
Madhepura,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1426,1549,1458,1530,1544,1562,1619,1562,1625,1590,1596,1555,18616
Madhepura,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Madhepura,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,3045,4466,5557,5965,5601,4919,4259,3036,1453,1300,928,357,40886
Madhepura,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,1284,1418,1800,1534,1250,1752,1544,1092,205,433,545,122,12979
Madhepura,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,21,189,39,29,52,2,88,0,0,0,0,101,521
Madhepura,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Madhepura,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Madhepura,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Madhepura,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Madhepura,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Madhepura,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,7,0,6,0,0,19,0,0,0,3,3,5,43
Madhepura,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,1099,871,903,696,966,977,834,764,611,551,502,457,9231
Madhepura,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0,28,0,0,0,0,0,0,0,0,0,0,28
Madhepura,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Madhepura,13.1,Number of Patients operated for cataract,TOTAL,0,0,71,0,0,0,0,0,0,0,0,0,71
Madhepura,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,35,25,26,0,0,11,11,35,194,150,185,0,672
Madhepura,13.3,Number of School children detected with Refractive errors,TOTAL,19,9,0,7,7,0,0,0,0,0,12,9,63
Madhepura,13.4,Number of children provided free glasses,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Madhepura,13.5,Number of eyes collected through eye donation,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Madhepura,13.6,Number of eyes utilised for corneal transplant,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Madhepura,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,NA,NA,1,NA,NA,NA,NA,1,1,1,1,1,Data for this item can not be cumulated
Madhepura,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,NA,NA,8,2,8,14,13,2,3,4,3,3,Data for this item can not be cumulated
Madhepura,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,1231,1520,1357,1481,1351,1392,1484,1486,1587,1548,1528,1558,Data for this item can not be cumulated
Madhepura,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,NA,NA,1,NA,NA,NA,NA,1,1,1,1,1,Data for this item can not be cumulated
Madhepura,14.05,Number of RKS meetings held during the month,TOTAL,6,7,8,7,8,6,6,4,8,6,9,7,82
Madhepura,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,NA,NA,6,1,5,11,10,11,12,13,11,13,Data for this item can not be cumulated
Madhepura,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,524,646,561,449,1315,1399,1516,1020,1225,1095,1552,1970,13272
Madhepura,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,NA,NA,1,NA,NA,NA,NA,1,1,1,1,1,Data for this item can not be cumulated
Madhepura,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,NA,NA,0,NA,NA,NA,NA,0,0,0,0,0,Data for this item can not be cumulated
Madhepura,14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,402,385,313,273,310,340,346,385,284,230,358,336,3962
Madhepura,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,841,883,614,604,801,985,850,923,857,472,515,881,9226
Madhepura,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,418,394,725,357,280,769,596,444,231,176,372,321,5083
Madhepura,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,2101,2427,2332,3105,4675,5020,5438,4398,5283,3806,4287,3455,46327
Madhepura,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,820,779,1038,630,590,1109,942,829,515,406,730,657,9045
Madhepura,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,2942,3310,2946,3709,5476,6005,6288,5321,6140,4278,4802,4336,55553
Madhepura,14.10.2.a,Number of death cases of Inpatient males,TOTAL,7,12,5,0,9,6,6,7,8,6,7,6,79
Madhepura,14.10.2.b,Number of death cases of Inpatient females,TOTAL,5,8,4,0,2,7,5,5,7,6,7,7,63
Madhepura,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,12,20,9,0,11,13,11,12,15,12,14,13,142
Madhepura,14.11,In-Patient Head Count at midnight,TOTAL,6342,6619,6389,3851,8265,9538,9657,8664,9870,7645,8121,7784,92745
Madhepura,14.12.1,OPD attendance (All),TOTAL,126954,129546,119274,121664,136853,159933,148857,130009,150593,145515,149374,157582,1676154
Madhepura,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,312,74,53,541,176,451,820,684,2473,775,1418,1019,8796
Madhepura,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0,0,0,0,0,15,0,0,0,0,0,0,15
Madhepura,14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,869,824,416,660,795,834,880,939,902,1011,1123,917,10170
Madhepura,14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,14.14.a,Number of patients given AYUSH treatment,TOTAL,11811,19126,14464,12728,19197,16396,20103,15382,15516,15987,18642,19450,198802
Madhepura,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,3606,4395,3381,3454,4398,4774,4686,2139,2215,2288,2858,2831,41025
Madhepura,14.14.c,Number of Adolescents counselled,TOTAL,0,40,0,0,20,30,0,0,27,45,86,72,320
Madhepura,15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,486,1146,421,503,658,861,861,627,1722,1126,1660,1183,11254
Madhepura,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,11,17,14,7,10,18,23,8,25,99,115,105,452
Madhepura,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,110,70,371,11,667,349,412,285,336,354,393,360,3718
Madhepura,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,2,0,2,0,9,3,3,1,6,1,1,4,32
Madhepura,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,216,84,574,71,702,690,708,683,1245,864,1068,872,7777
Madhepura,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,3,2,3,0,5,3,7,0,2,0,1,3,29
Madhepura,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,138,64,354,0,271,289,251,212,298,255,335,484,2951
Madhepura,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0,0,2,0,0,0,0,0,0,0,1,1,4
Madhepura,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,464,218,1299,82,1640,1328,1371,1180,1879,1473,1796,1716,14446
Madhepura,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,5,2,7,0,14,6,10,1,8,1,3,8,65
Madhepura,15.2,Number of Widal tests conducted,Number tested,0,0,0,0,0,8,0,0,0,0,0,0,8
Madhepura,15.3.a,Number of VDRL tests conducted on males,Number tested,80,0,0,0,70,38,50,46,57,61,65,87,554
Madhepura,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,100,0,0,0,120,157,5,82,55,149,113,133,914
Madhepura,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,120,0,0,0,0,158,131,198,262,243,328,351,1791
Madhepura,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,300,0,0,0,190,353,186,326,374,453,506,571,3259
Madhepura,15.4.1,Number of blood smears examined for Malaria,TOTAL,140,96,58,19,59,170,153,110,102,75,89,101,1172
Madhepura,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,0,1,0,0,0,1,0,0,5,2,11,0,20
Madhepura,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0,0,0,0,0,2,0,0,1,0,0,0,3
Madhepura,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,1300,1850,2050,2650,1950,3200,2750,2600,2000,NA,450,1150,21950
Madhepura,16.1.1,Stock position of DPT vaccines,2. Stocks Received,1000,1250,1500,0,1500,0,200,0,0,NA,1250,700,7400
Madhepura,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0,0,0,0,0,0,0,0,0,NA,0,0,0
Madhepura,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,450,1050,900,700,250,450,350,600,1000,NA,550,1400,7700
Madhepura,16.1.1,Stock position of DPT vaccines,5. Total Stock,1850,2050,2650,1950,3200,2750,2600,2000,1000,0,1150,450,21650
Madhepura,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,1300,200,500,1300,1700,3100,3854,2620,1468,NA,772,630,17444
Madhepura,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,0,2000,2100,2100,2100,2100,0,0,1500,NA,1850,2592,16342
Madhepura,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0,0,0,0,0,0,0,0,0,NA,0,0,0
Madhepura,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,1100,1700,1300,1700,700,1346,1188,1152,1776,NA,1992,1760,15714
Madhepura,16.1.1A,Stock Position of Pentavalent,5. Total Stock,200,500,1300,1700,3100,3854,2666,1468,1192,0,630,1462,18072
Madhepura,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,783,140,190,790,518,768,793,1146,1203,NA,20,23,6374
Madhepura,16.1.2,Stock position of OPV vaccines,2. Stocks Received,31950,1775,32870,1803,1800,1800,1550,32923,1200,NA,770,1550,109991
Madhepura,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0,0,0,0,0,0,0,0,0,NA,0,0,0
Madhepura,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,32550,1725,32270,2075,1550,1775,1315,32866,2100,NA,644,1543,110413
Madhepura,16.1.2,Stock position of OPV vaccines,5. Total Stock,183,190,790,518,768,793,1028,1203,303,0,146,30,5952
Madhepura,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,2100,3250,4050,3750,2550,4100,2800,4400,3400,NA,2250,2700,35350
Madhepura,16.1.3,Stock position of TT vaccines,2. Stocks Received,2000,2250,1000,0,2500,0,2250,0,0,NA,1000,200,11200
Madhepura,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0,0,0,0,0,0,0,0,0,NA,0,0,0
Madhepura,16.1.3,Stock position of TT vaccines,4. Stock Distributed,850,1450,1300,1200,950,1300,650,100,1400,NA,550,1200,10950
Madhepura,16.1.3,Stock position of TT vaccines,5. Total Stock,3250,4050,3750,2550,4100,2800,4400,4300,2000,0,2700,1700,35600
Madhepura,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0,NA,0,0,0,0,0,0,0,NA,0,0,0
Madhepura,16.1.4,Stock position of DT vaccines,2. Stocks Received,0,NA,0,0,0,0,0,0,0,NA,0,0,0
Madhepura,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0,NA,0,0,0,0,0,0,0,NA,0,0,0
Madhepura,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0,NA,0,0,0,0,0,0,0,NA,0,0,0
Madhepura,16.1.4,Stock position of DT vaccines,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Madhepura,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,2250,2600,2850,2800,1900,2350,1250,500,850,NA,50,350,17750
Madhepura,16.1.5,Stock position of BCG vaccines,2. Stocks Received,1000,1050,1000,0,1400,500,500,1200,300,NA,1150,1000,9100
Madhepura,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0,0,0,0,0,0,0,0,0,NA,0,0,0
Madhepura,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,650,800,1050,900,950,1600,1250,850,1100,NA,850,950,10950
Madhepura,16.1.5,Stock position of BCG vaccines,5. Total Stock,2600,2850,2800,1900,2350,1250,500,850,50,0,350,400,15900
Madhepura,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,0,850,140,1150,1425,2475,2425,725,1525,NA,1275,945,12935
Madhepura,16.1.6,Stock position of Measles vaccines,2. Stocks Received,2950,1500,3450,3450,3450,3450,300,3000,2000,NA,1500,3000,28050
Madhepura,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0,0,0,0,0,0,0,0,0,NA,0,0,0
Madhepura,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,2100,2210,2440,3175,2400,3500,2000,2200,1950,NA,1830,2000,25805
Madhepura,16.1.6,Stock position of Measles vaccines,5. Total Stock,850,140,1150,1425,2475,2425,725,1525,1575,0,945,1945,15180
Madhepura,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0,0,0,0,0,0,0,0,0,NA,0,0,0
Madhepura,16.1.7,Stock position of JE vaccines,2. Stocks Received,0,0,0,0,0,0,0,0,0,NA,0,0,0
Madhepura,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0,0,0,0,0,0,0,0,0,NA,0,0,0
Madhepura,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0,0,0,0,0,0,0,0,0,NA,0,0,0
Madhepura,16.1.7,Stock position of JE vaccines,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Madhepura,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,400,700,750,1300,1803,2456,1656,1206,756,NA,1306,2462,14795
Madhepura,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,700,750,1000,903,903,0,0,0,400,NA,1306,0,5962
Madhepura,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0,0,0,0,0,0,0,0,0,NA,0,0,0
Madhepura,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,400,700,450,400,250,800,450,450,350,NA,150,206,4606
Madhepura,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,700,750,1300,1803,2456,1656,1206,756,806,0,2462,2256,16151
Madhepura,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,NA,6500,0,600,NA,6472,NA,0,NA,NA,0,0,13572
Madhepura,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,NA,0,0,0,NA,0,NA,0,NA,NA,0,0,0
Madhepura,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,NA,0,0,0,NA,0,NA,0,NA,NA,0,0,0
Madhepura,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,NA,2000,0,0,NA,900,NA,0,NA,NA,0,0,2900
Madhepura,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0,4500,0,600,0,5572,0,0,0,0,0,0,10672
Madhepura,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,NA,4800,0,0,NA,108464,NA,0,NA,NA,0,0,113264
Madhepura,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,NA,0,0,0,NA,0,NA,0,NA,NA,NA,0,0
Madhepura,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,NA,0,0,0,NA,0,NA,0,NA,NA,0,0,0
Madhepura,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,NA,2500,0,0,NA,19119,NA,0,NA,NA,0,0,21619
Madhepura,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0,2300,0,0,0,89345,0,0,0,0,0,0,91645
Madhepura,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,NA,4500,0,2400,NA,7119,NA,0,NA,NA,0,0,14019
Madhepura,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,NA,0,0,0,NA,0,NA,0,NA,NA,0,0,0
Madhepura,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,NA,0,0,0,NA,0,NA,0,NA,NA,0,0,0
Madhepura,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,NA,1337,0,0,NA,1343,NA,0,NA,NA,0,0,2680
Madhepura,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0,3163,0,2400,0,5776,0,0,0,0,0,0,11339
Madhepura,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,NA,5000,0,0,NA,1158,NA,0,NA,NA,0,0,6158
Madhepura,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,NA,0,0,0,NA,0,NA,0,NA,NA,0,0,0
Madhepura,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,NA,0,0,0,NA,0,NA,0,NA,NA,0,0,0
Madhepura,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,NA,1300,0,0,NA,160,NA,0,NA,NA,0,0,1460
Madhepura,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0,3700,0,0,0,998,0,0,0,0,0,0,4698
Madhepura,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,NA,0,0,0,NA,0,NA,0,NA,NA,0,0,0
Madhepura,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,NA,0,0,0,NA,0,NA,0,NA,NA,0,0,0
Madhepura,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,NA,0,0,0,NA,0,NA,0,NA,NA,0,0,0
Madhepura,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,NA,0,0,0,NA,0,NA,NA,NA,NA,0,0,0
Madhepura,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Madhepura,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0,0,NA,9750,NA,21450,NA,0,NA,NA,0,NA,31200
Madhepura,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,30080,30000,NA,0,NA,2000,NA,0,NA,NA,0,NA,62080
Madhepura,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0,0,NA,0,NA,0,NA,0,NA,NA,0,NA,0
Madhepura,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0,19500,NA,6700,NA,20400,NA,0,NA,NA,0,NA,46600
Madhepura,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,30080,10500,0,3050,0,3050,0,0,0,0,0,0,46680
Madhepura,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,67750,55750,NA,53750,NA,51850,NA,11500,NA,NA,10700,NA,251300
Madhepura,16.3.02,Stock Position of Gloves,2. Stocks Received,0,0,NA,0,NA,0,NA,0,NA,NA,0,NA,0
Madhepura,16.3.02,Stock Position of Gloves,3. Unusable Stock,0,0,NA,0,NA,0,NA,0,NA,NA,0,NA,0
Madhepura,16.3.02,Stock Position of Gloves,4. Stock Distributed,44900,2500,NA,0,NA,0,NA,3000,NA,NA,0,NA,50400
Madhepura,16.3.02,Stock Position of Gloves,5. Total Stock,22850,53250,0,53750,0,51850,0,8500,0,0,10700,0,200900
Madhepura,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0,0,NA,0,NA,0,NA,0,NA,NA,0,NA,0
Madhepura,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0,0,NA,0,NA,0,NA,0,NA,NA,0,NA,0
Madhepura,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0,0,NA,0,NA,0,NA,0,NA,NA,0,NA,0
Madhepura,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0,0,NA,0,NA,0,NA,0,NA,NA,0,NA,0
Madhepura,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Madhepura,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,30297,9297,NA,900,NA,0,NA,0,NA,NA,0,NA,40494
Madhepura,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0,0,NA,0,NA,0,NA,0,NA,NA,0,NA,0
Madhepura,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0,0,NA,0,NA,0,NA,0,NA,NA,0,NA,0
Madhepura,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,16080,8900,NA,900,NA,0,NA,0,NA,NA,0,NA,25880
Madhepura,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,14217,397,0,0,0,0,0,0,0,0,0,0,14614
Madhepura,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0,0,NA,0,NA,0,NA,0,NA,NA,0,NA,0
Madhepura,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0,0,NA,0,NA,0,NA,0,NA,NA,0,NA,0
Madhepura,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0,0,NA,0,NA,0,NA,0,NA,NA,0,NA,0
Madhepura,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0,0,NA,0,NA,0,NA,0,NA,NA,0,NA,0
Madhepura,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Madhepura,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0,0,NA,0,NA,0,NA,0,NA,NA,0,NA,0
Madhepura,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0,0,NA,0,NA,0,NA,0,NA,NA,0,NA,0
Madhepura,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0,0,NA,0,NA,0,NA,0,NA,NA,0,NA,0
Madhepura,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0,0,NA,0,NA,0,NA,0,NA,NA,0,NA,0
Madhepura,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Madhepura,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,1464000,696000,NA,1294000,NA,531800,NA,172800,NA,NA,2800,NA,4161400
Madhepura,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0,384000,NA,720000,NA,80000,NA,0,NA,NA,0,NA,1184000
Madhepura,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0,0,NA,0,NA,0,NA,0,NA,NA,0,NA,0
Madhepura,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,768000,504000,NA,362200,NA,0,NA,39000,NA,NA,2800,NA,1676000
Madhepura,16.3.07,Stock Position of IFA Tablets,5. Total Stock,696000,576000,0,1651800,0,611800,0,133800,0,0,0,0,3669400
Madhepura,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0,0,NA,110020,NA,62152,NA,50952,NA,NA,0,NA,223124
Madhepura,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0,82380,NA,42100,NA,6000,NA,0,NA,NA,0,NA,130480
Madhepura,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0,0,NA,0,NA,NA,NA,0,NA,NA,0,NA,0
Madhepura,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0,6420,NA,19364,NA,NA,NA,14400,NA,NA,0,NA,40184
Madhepura,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0,75960,0,132756,0,68152,0,36552,0,0,0,0,313420
Madhepura,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0,7850,NA,3100,NA,0,NA,0,NA,NA,0,NA,10950
Madhepura,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0,0,NA,0,NA,0,NA,0,NA,NA,0,NA,0
Madhepura,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0,0,NA,0,NA,0,NA,0,NA,NA,0,NA,0
Madhepura,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0,3800,NA,1900,NA,0,NA,0,NA,NA,0,NA,5700
Madhepura,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0,4050,0,1200,0,0,0,0,0,0,0,0,5250
Madhepura,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,NA,NA,NA,NA,NA,4,4,0,NA,NA,0,NA,8
Madhepura,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,NA,NA,NA,NA,NA,0,0,0,NA,NA,0,NA,0
Madhepura,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,NA,NA,NA,NA,NA,0,0,0,NA,NA,0,NA,0
Madhepura,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,NA,NA,NA,NA,NA,0,0,0,NA,NA,0,NA,0
Madhepura,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0,0,0,0,0,4,4,0,0,0,0,0,8
Madhepura,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,13459,5616,NA,NA,NA,563254,550254,550254,NA,NA,469254,NA,2152091
Madhepura,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0,150000,NA,NA,NA,0,NA,0,NA,NA,0,NA,150000
Madhepura,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0,0,NA,NA,NA,0,NA,0,NA,NA,0,NA,0
Madhepura,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,7843,4200,NA,NA,NA,0,NA,18000,NA,NA,0,NA,30043
Madhepura,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,5616,151416,0,0,0,563254,550254,532254,0,0,469254,0,2272048
Madhepura,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,10100,6700,16000,10000,15200,9200,2600,5600,600,NA,1100,14400,91500
Madhepura,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0,15000,0,12000,0,0,10000,0,15000,NA,16000,0,68000
Madhepura,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0,0,0,0,0,0,0,0,0,NA,0,0,0
Madhepura,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,3400,5700,6000,6800,6000,6600,6800,5000,7400,NA,2700,7200,63600
Madhepura,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,6700,16000,10000,15200,9200,2600,5800,600,8200,0,14400,7200,95900
Madhepura,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,49600,11100,103700,49300,98500,54500,3300,80300,40900,NA,89100,99100,679400
Madhepura,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0,150000,0,100000,0,0,100000,0,145000,NA,60000,0,555000
Madhepura,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0,0,0,0,0,0,0,0,0,NA,0,0,0
Madhepura,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,38500,57400,NA,508000,44000,51200,23000,39400,52800,NA,50000,56000,920300
Madhepura,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,11100,103700,103700,-358700,54500,3300,80300,40900,133100,0,99100,43100,314100
Madhepura,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,3400,400,7600,2800,8600,4500,600,8000,4200,NA,6100,11900,58100
Madhepura,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0,10000,0,100000,0,0,10000,0,10000,NA,10000,0,140000
Madhepura,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0,0,0,0,0,0,0,0,0,NA,0,0,0
Madhepura,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,3000,2800,4800,4200,4100,3900,2800,3800,40000,NA,4200,5000,78600
Madhepura,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,400,7600,2800,98600,4500,600,7800,4200,-25800,0,11900,6900,119500
Madhepura,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,NA,NA,2
Madhepura,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,NA,NA,2
Madhepura,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1
Madhepura,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1
Madhepura,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,1
Madhepura,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,1
Madhepura,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhepura,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,1
Madhepura,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,NA,2
Madhepura,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,1
Madhepura,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,4,NA,4
Madhubani,1.1,Total number of pregnant women Registered for ANC,TOTAL,8840,8871,10154,9015,10398,8600,8251,6519,7157,7557,8018,8875,102255
Madhubani,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,4360,4506,4874,4564,5339,4557,4233,3596,4091,4313,4629,5339,54401
Madhubani,1.2,Number of Pregnant women registered under JSY,TOTAL,8765,8856,10093,9050,10354,8526,8250,6525,7153,7538,7970,8842,101922
Madhubani,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,4444,4737,4973,5209,5645,5467,5521,4840,4877,4768,4957,5495,60933
Madhubani,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,6737,7368,8035,6975,8084,6804,6371,5219,7357,7761,6434,7246,84391
Madhubani,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,6959,7487,8397,8321,9335,8892,7711,9767,9455,11568,6310,7757,101959
Madhubani,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1240,986,939,639,1009,487,302,342,375,591,2347,2738,11995
Madhubani,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,146,217,232,235,193,171,143,142,125,195,214,286,2299
Madhubani,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,1,3,21,2,2,0,4,2,4,6,9,11,65
Madhubani,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,1528,1610,2079,2271,2084,2038,1738,1618,1963,1633,1693,1837,22092
Madhubani,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,25,24,30,22,29,31,18,18,16,7,13,16,249
Madhubani,1.8,Number of pregnancy test kits used at SC level,TOTAL,656,648,751,891,1066,928,911,689,780,882,810,786,9798
Madhubani,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,426,453,458,529,605,580,585,679,585,548,500,535,6483
Madhubani,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,1297,1429,1400,1527,1979,1883,2040,2023,2030,1933,1961,1640,21142
Madhubani,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,1723,1882,1858,2056,2584,2463,2625,2702,2615,2481,2461,2175,27625
Madhubani,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,1069,1253,1282,1289,1727,1706,1706,1734,1775,1704,1605,1538,18388
Madhubani,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,10,48,5,56,22,11,5,4,0,29,0,5,195
Madhubani,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,2498,2706,3195,4151,5285,5149,5803,5635,5443,5165,4680,4231,53941
Madhubani,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,2452,2643,3009,3969,4873,4827,5822,5260,5049,4737,4338,3926,50905
Madhubani,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,765,669,1535,2116,1166,3981,3749,2685,6227,3393,4501,4556,35343
Madhubani,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,177,252,531,1185,478,1533,1514,1205,3145,1974,6333,5225,23552
Madhubani,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Madhubani,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,NA,NA,NA,NA,NA,NA,379,8,230,0,0,NA,617
Madhubani,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,NA,NA,NA,NA,NA,NA,0,NA,0,0,0,NA,0
Madhubani,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,NA,NA,NA,NA,NA,NA,0,NA,0,0,0,NA,0
Madhubani,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,NA,NA,NA,NA,NA,NA,0,NA,0,0,0,NA,0
Madhubani,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0,0,0,0,0,0,0,2,0,0,0,0,2
Madhubani,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Madhubani,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,1,2,2,1,3,0,0,1,0,1,1,3,15
Madhubani,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,1,2,2,1,3,0,0,3,0,1,1,3,17
Madhubani,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,NA,NA,NA,NA,NA,NA,84,3,230,0,0,NA,317
Madhubani,4.1.1.a,Number of male live births,TOTAL,2272,2441,2734,3298,4120,4091,4307,4218,4153,4013,3795,3319,42761
Madhubani,4.1.1.b,Number of female live births,TOTAL,2022,2173,2549,2933,3603,3618,4125,3897,3843,3660,3409,3003,38835
Madhubani,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,4294,4614,5283,6231,7723,7709,8432,8115,7996,7673,7204,6322,81596
Madhubani,4.1.2,Number of still births,TOTAL,51,202,65,65,76,106,106,111,89,63,65,56,1055
Madhubani,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,19,14,17,19,19,10,15,53,16,16,24,11,233
Madhubani,4.2.1,Number of Newborns weighed at birth,TOTAL,3960,4106,4932,5823,7236,7244,7851,7701,7801,7119,6971,5996,76740
Madhubani,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,145,164,190,239,338,306,564,514,359,352,350,458,3979
Madhubani,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,4165,4343,5105,6029,7533,7512,8283,7994,7885,7460,7097,6222,79628
Madhubani,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0,9,15,11,17,13,14,9,13,6,3,4,114
Madhubani,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,NA,NA,NA,0,NA,NA,NA,NA,0,0,0,0,0
Madhubani,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,1,3,6,3,25,11,10,25,21,16,0,10,131
Madhubani,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,1,12,21,14,42,24,24,34,34,22,3,14,245
Madhubani,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,NA,NA,NA,NA,NA,NA,0,NA,0,0,NA,NA,0
Madhubani,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,43,446,111,12,42,190,196,34,34,55,21,14,1198
Madhubani,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,1,3,10,4,5,3,4,2,6,3,5,3,49
Madhubani,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,40,655,47,5,7,346,358,27,7,14,25,7,1538
Madhubani,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,1,21,31,19,14,16,12,13,16,14,12,16,185
Madhubani,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,2334,2777,2730,3604,4316,4193,4232,4549,4766,4656,4764,3924,46845
Madhubani,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1514,1523,1668,1897,2305,2281,2520,2569,2801,2548,2638,2233,26497
Madhubani,6.3,PNC maternal complications attended,TOTAL,5,4,0,0,16,11,12,0,2,0,0,0,50
Madhubani,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,14,35,25,29,9,9,30,31,30,18,23,17,270
Madhubani,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,5,13,11,23,2,6,2,1,0,2,0,0,65
Madhubani,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,19,48,36,52,11,15,32,32,30,20,23,17,335
Madhubani,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0,0,0,0,0,4,0,0,0,0,0,0,4
Madhubani,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,485,445,379,435,347,404,383,271,332,250,264,248,4243
Madhubani,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,1136,773,807,707,686,747,641,877,1259,1152,1174,1205,11164
Madhubani,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,1621,1218,1186,1142,1033,1151,1024,1148,1591,1402,1438,1453,15407
Madhubani,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Madhubani,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,1,0,0,7,2,0,2,7,9,0,0,0,28
Madhubani,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Madhubani,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,1,1,0,1,0,0,0,1,6,2,2,3,17
Madhubani,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,2,1,0,8,2,0,2,8,15,2,2,3,45
Madhubani,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,1,0,0,0,1
Madhubani,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Madhubani,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Madhubani,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Madhubani,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Madhubani,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0
Madhubani,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,137,173,96,724,251,600,606,681,4335,3017,1661,628,12909
Madhubani,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,6,8,0,12,7,8,13,19,73,137,73,34,390
Madhubani,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,23,22,23,23,13,30,19,62,145,86,114,54,614
Madhubani,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,166,203,119,759,271,638,638,762,4553,3240,1848,716,13913
Madhubani,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,48,NA,30,NA,NA,NA,40,NA,2346,622,654,5965,9705
Madhubani,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,20,17,10,25,18,20,33,24,52,55,46,50,370
Madhubani,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Madhubani,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,4,2,1,5,0,0,3,4,5,6,14,8,52
Madhubani,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,24,19,11,30,18,20,36,28,57,61,60,58,422
Madhubani,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,1,0,0,0,1
Madhubani,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,541,470,447,1296,568,616,615,537,567,551,610,725,7543
Madhubani,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,154,267,234,741,209,188,312,266,505,393,403,380,4052
Madhubani,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,4,3,2,9,6,0,2,3,4,3,3,9,48
Madhubani,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,35,43,30,50,47,28,21,21,33,27,33,35,403
Madhubani,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,734,783,713,2096,830,832,950,827,1109,974,1049,1149,12046
Madhubani,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,134,142,100,109,166,97,137,139,170,142,102,127,1565
Madhubani,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,8,NA,8,NA,NA,NA,NA,NA,8,1,14,3,42
Madhubani,9.06,Number of IUCD removals,TOTAL,268,205,223,284,284,258,334,293,302,349,322,397,3519
Madhubani,9.07,Number of Oral Pills cycles distributed,TOTAL,3279,2418,3126,4507,3824,3276,3224,3128,3352,3066,3091,3506,39797
Madhubani,9.08,Number of Condom pieces distributed,TOTAL,15153,13243,15961,21235,17441,15953,16864,18788,19553,16372,17350,17192,205105
Madhubani,9.09,Number of Centchroman (weekly) pills given,TOTAL,511,132,112,191,53,46,58,59,91,63,153,123,1592
Madhubani,9.1,Number of Emergency Contraceptive Pills distributed,TOTAL,370,237,353,445,275,273,317,217,324,270,385,300,3766
Madhubani,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0,0,0,0,1,0,0,0,0,0,0,0,1
Madhubani,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0,0,0,1,0,0,0,0,0,0,0,0,1
Madhubani,9.11.2.a,Number of failures following male sterilization,TOTAL,0,0,0,0,0,1,0,0,0,0,0,0,1
Madhubani,9.11.2.b,Number of failures following female sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Madhubani,9.11.3.a,Number of deaths following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Madhubani,9.11.3.b,Number of deaths following female sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Madhubani,9.12,Number of Institutions having NSV trained doctors,TOTAL,NA,NA,NA,1,2,2,4,2,3,3,2,2,Data for this item can not be cumulated
Madhubani,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,5751,6223,6692,7742,10003,9967,10570,12507,13658,11362,10237,8763,113475
Madhubani,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,18,23,21,61,12,9,10,23,17,6,0,0,200
Madhubani,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,1159,649,470,365,207,126,70,40,51,9,0,6,3152
Madhubani,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,3367,2061,1364,1044,560,353,168,100,180,25,55,6,9283
Madhubani,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,7618,7027,6573,5625,7227,7669,9496,13792,12704,13852,10204,9997,111784
Madhubani,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,8948,8200,9815,6384,6717,6395,7433,11131,11459,13637,9853,10413,110385
Madhubani,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,5952,7466,7648,6610,7063,6196,6556,9429,9830,12987,8629,9623,97989
Madhubani,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,2525,2781,2991,3832,4797,5291,5762,5902,6191,5855,5178,4641,55746
Madhubani,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,7768,6587,6928,5702,6987,7981,9506,13181,11872,13156,10026,10121,109815
Madhubani,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,8667,8673,8354,7145,7126,6599,7454,10854,11449,12232,9912,10372,108837
Madhubani,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,8243,8937,9494,8112,7884,6959,6793,8901,9975,12648,8628,9548,106122
Madhubani,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,2001,2066,2242,3216,3436,3864,3824,4060,4453,4121,3900,3333,40516
Madhubani,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,171,49,22,57,3,1,18,7,54,19,0,0,401
Madhubani,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,1609,783,561,407,275,128,83,18,41,4,0,0,3909
Madhubani,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,3844,2473,1686,1145,723,384,169,85,76,10,47,63,10705
Madhubani,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,5650,8150,9400,8885,10231,9749,9962,11279,9547,9304,6259,6570,104986
Madhubani,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,5533,6310,7057,6786,7043,6497,10036,7974,9017,10730,7667,8115,92765
Madhubani,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Madhubani,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2803,4200,4412,4428,5151,4834,4876,5586,4525,6158,3351,3469,53793
Madhubani,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2534,3666,4143,4011,4530,4269,4345,5009,4089,5660,2877,3009,48142
Madhubani,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,5337,7866,8555,8439,9681,9103,9221,10595,8614,11818,6228,6478,101935
Madhubani,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,6932,7249,8417,8033,7543,6781,8479,7330,8459,9488,7970,8344,95025
Madhubani,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,7070,7164,8426,8048,7432,6801,8511,7304,8366,9498,7895,8279,94794
Madhubani,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0,0,0,0,0,0,0,0,0,0,0,15,15
Madhubani,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1833,1750,2150,1980,1978,1832,1845,1667,1986,2066,2391,2541,24019
Madhubani,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1628,1580,1884,1707,1725,1591,1709,1461,1707,1867,2088,2118,21065
Madhubani,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,3461,3330,4034,3687,3703,3423,3554,3128,3693,3933,4479,4659,45084
Madhubani,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,1258,1236,1301,1555,1572,1801,1798,1569,1858,1794,1582,1895,19219
Madhubani,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,1413,1165,1225,1325,1535,1444,1536,1474,1458,1421,1450,1794,17240
Madhubani,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,2458,2110,2075,2235,2333,2579,2312,2275,2618,2431,2498,2672,28596
Madhubani,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0,0,0,0,0,0,0,0,0,0,1,0,1
Madhubani,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Madhubani,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Madhubani,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,3607,3648,3731,3686,3802,3721,3854,3726,3799,3849,3903,3879,45205
Madhubani,10.4.2,Number of Immunisation sessions held during the month,TOTAL,3539,3576,3595,3656,3764,3638,3772,3509,3718,3787,3807,3869,44230
Madhubani,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,3063,3080,3145,3194,3297,3188,3254,3042,3316,3316,3340,3361,38596
Madhubani,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Madhubani,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,5138,7211,8469,8164,9497,8752,8490,7026,6330,5463,4897,4867,84304
Madhubani,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,2167,2290,2431,2364,2497,2345,2231,1860,2034,2328,2431,2185,27163
Madhubani,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,132,119,160,117,101,116,99,66,53,42,100,93,1198
Madhubani,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Madhubani,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Madhubani,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,3,0,0,3
Madhubani,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Madhubani,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Madhubani,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,20,42,11,7,7,33,33,0,0,1,2,24,180
Madhubani,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,543,486,271,393,396,530,686,428,512,482,520,688,5935
Madhubani,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,5,4,3,2,0,0,2,1,1,1,0,1,20
Madhubani,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,35,10,10,0,2,25,22,32,8,16,16,25,201
Madhubani,13.1,Number of Patients operated for cataract,TOTAL,0,0,0,0,0,0,0,0,0,46,59,453,558
Madhubani,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Madhubani,13.3,Number of School children detected with Refractive errors,TOTAL,42,35,35,0,35,46,48,42,41,242,60,51,677
Madhubani,13.4,Number of children provided free glasses,TOTAL,0,0,0,0,0,0,0,0,0,82,0,0,82
Madhubani,13.5,Number of eyes collected through eye donation,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Madhubani,13.6,Number of eyes utilised for corneal transplant,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Madhubani,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,NA,NA,NA,3,3,3,2,3,3,3,3,3,Data for this item can not be cumulated
Madhubani,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,NA,NA,NA,2,10,14,30,23,24,23,24,23,Data for this item can not be cumulated
Madhubani,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,2718,2774,2727,2774,2610,2804,2619,2611,2680,2757,2687,2674,Data for this item can not be cumulated
Madhubani,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,NA,NA,NA,3,3,2,2,3,3,3,3,3,Data for this item can not be cumulated
Madhubani,14.05,Number of RKS meetings held during the month,TOTAL,11,13,11,12,13,14,17,14,18,15,18,18,174
Madhubani,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,NA,NA,NA,3,11,12,19,19,22,20,20,18,Data for this item can not be cumulated
Madhubani,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,374,234,219,199,869,771,1152,1921,1509,1776,1787,1506,12317
Madhubani,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,NA,NA,NA,1,2,3,2,3,3,3,3,2,Data for this item can not be cumulated
Madhubani,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,NA,NA,NA,0,0,0,NA,NA,0,17,1,0,Data for this item can not be cumulated
Madhubani,14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,1147,1104,1129,1164,1197,1229,1311,1138,1228,1204,1132,1066,14049
Madhubani,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,2277,2641,2357,1724,2390,2373,2243,1971,1863,2298,2337,2144,26618
Madhubani,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,1116,1295,1315,1378,1193,1400,1358,1205,1308,1288,1225,1279,15360
Madhubani,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,3688,3958,3879,4617,5452,5327,5710,5205,7580,7265,5736,5283,63700
Madhubani,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,2263,2399,2444,2542,2390,2629,2669,2343,2536,2492,2357,2345,29409
Madhubani,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,5965,6599,6236,6341,7842,7700,7953,7176,9443,9563,8073,7427,90318
Madhubani,14.10.2.a,Number of death cases of Inpatient males,TOTAL,10,11,10,5,3,7,10,8,11,13,9,13,110
Madhubani,14.10.2.b,Number of death cases of Inpatient females,TOTAL,7,8,8,9,7,4,16,16,7,9,3,6,100
Madhubani,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,17,19,18,14,10,11,26,24,18,22,12,19,210
Madhubani,14.11,In-Patient Head Count at midnight,TOTAL,6367,5962,5965,6925,7351,7886,6229,7077,9001,9408,7992,7243,87406
Madhubani,14.12.1,OPD attendance (All),TOTAL,225564,222957,214021,215880,232503,232504,217891,196996,209591,200671,222821,248586,2639985
Madhubani,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,181,220,126,1573,257,600,501,693,4278,3138,1764,687,14018
Madhubani,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,220,0,54,212,0,0,0,0,0,0,0,0,486
Madhubani,14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,4570,5295,4568,4019,4997,5150,4977,5147,5520,5327,5325,4563,59458
Madhubani,14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,14.14.a,Number of patients given AYUSH treatment,TOTAL,33428,37713,26884,34879,36115,34123,40728,34533,34722,30734,37372,33163,414394
Madhubani,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,9169,10862,8967,9358,9276,11123,9933,8621,10016,9713,10817,11845,119700
Madhubani,14.14.c,Number of Adolescents counselled,TOTAL,0,0,0,80,0,0,9,0,0,0,0,0,89
Madhubani,15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,3411,3412,3853,4434,4658,3826,3318,2987,4653,4756,4657,4492,48457
Madhubani,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,377,41,58,45,81,137,73,68,94,55,56,72,1157
Madhubani,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,723,629,957,1422,940,1011,1047,1271,958,1127,1160,900,12145
Madhubani,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,23,29,29,25,27,31,23,22,20,20,30,18,297
Madhubani,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,837,473,1165,1463,1105,1117,1226,1505,2528,2897,2521,1671,18508
Madhubani,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,14,18,33,19,21,20,50,12,20,18,25,20,270
Madhubani,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,1919,1196,2254,2672,2670,2777,2750,2629,3235,2737,2877,2596,30312
Madhubani,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,3,3,3,5,2,4,27,1,1,1,4,2,56
Madhubani,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,3479,2298,4376,5557,4715,4905,5023,5405,6721,6761,6558,5167,60965
Madhubani,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,40,50,65,49,50,55,100,35,41,39,59,40,623
Madhubani,15.2,Number of Widal tests conducted,Number tested,0,0,0,0,0,0,0,0,0,84,0,0,84
Madhubani,15.3.a,Number of VDRL tests conducted on males,Number tested,21,13,11,9,19,20,12,14,19,14,20,72,244
Madhubani,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,160,90,102,99,96,96,116,116,156,207,420,260,1918
Madhubani,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,323,506,644,880,665,687,1020,584,818,531,1587,1490,9735
Madhubani,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,504,609,757,988,780,803,1148,714,993,752,2027,1822,11897
Madhubani,15.4.1,Number of blood smears examined for Malaria,TOTAL,198,104,108,154,238,251,152,108,235,164,131,87,1930
Madhubani,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,0,2,1,1,0,2,3,0,2,0,1,0,12
Madhubani,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0,0,0,1,0,3,2,0,1,0,0,0,7
Madhubani,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,900,NA,350,200,NA,NA,NA,NA,NA,NA,NA,NA,1450
Madhubani,16.1.1,Stock position of DPT vaccines,2. Stocks Received,750,NA,1000,2000,NA,NA,NA,NA,NA,NA,NA,NA,3750
Madhubani,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,1250,NA,1150,1550,NA,NA,NA,NA,NA,NA,NA,NA,3950
Madhubani,16.1.1,Stock position of DPT vaccines,5. Total Stock,400,0,200,650,0,0,0,0,0,0,0,0,1250
Madhubani,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,1100,NA,450,1050,NA,NA,NA,NA,NA,NA,NA,NA,2600
Madhubani,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,1500,NA,3000,3000,NA,NA,NA,NA,NA,NA,NA,NA,7500
Madhubani,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,2550,NA,2400,2346,NA,NA,NA,NA,NA,NA,NA,NA,7296
Madhubani,16.1.1A,Stock Position of Pentavalent,5. Total Stock,50,0,1050,1704,0,0,0,0,0,0,0,0,2804
Madhubani,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,775,NA,550,450,NA,NA,NA,NA,NA,NA,NA,NA,1775
Madhubani,16.1.2,Stock position of OPV vaccines,2. Stocks Received,2800,NA,3000,3000,NA,NA,NA,NA,NA,NA,NA,NA,8800
Madhubani,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,3075,NA,3100,2900,NA,NA,NA,NA,NA,NA,NA,NA,9075
Madhubani,16.1.2,Stock position of OPV vaccines,5. Total Stock,500,0,450,550,0,0,0,0,0,0,0,0,1500
Madhubani,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,1150,NA,350,1300,NA,NA,NA,NA,NA,NA,NA,NA,2800
Madhubani,16.1.3,Stock position of TT vaccines,2. Stocks Received,1000,NA,3000,2000,NA,NA,NA,NA,NA,NA,NA,NA,6000
Madhubani,16.1.3,Stock position of TT vaccines,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,16.1.3,Stock position of TT vaccines,4. Stock Distributed,1050,NA,2050,3000,NA,NA,NA,NA,NA,NA,NA,NA,6100
Madhubani,16.1.3,Stock position of TT vaccines,5. Total Stock,1100,0,1300,300,0,0,0,0,0,0,0,0,2700
Madhubani,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,16.1.4,Stock position of DT vaccines,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,16.1.4,Stock position of DT vaccines,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,16.1.4,Stock position of DT vaccines,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,16.1.4,Stock position of DT vaccines,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Madhubani,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,750,NA,150,950,NA,NA,NA,NA,NA,NA,NA,NA,1850
Madhubani,16.1.5,Stock position of BCG vaccines,2. Stocks Received,1000,NA,2000,2000,NA,NA,NA,NA,NA,NA,NA,NA,5000
Madhubani,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,1250,NA,1250,2000,NA,NA,NA,NA,NA,NA,NA,NA,4500
Madhubani,16.1.5,Stock position of BCG vaccines,5. Total Stock,500,0,900,950,0,0,0,0,0,0,0,0,2350
Madhubani,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,0,NA,100,1050,NA,NA,NA,NA,NA,NA,NA,NA,1150
Madhubani,16.1.6,Stock position of Measles vaccines,2. Stocks Received,5300,NA,5000,7000,NA,NA,NA,NA,NA,NA,NA,NA,17300
Madhubani,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,4300,NA,4050,5850,NA,NA,NA,NA,NA,NA,NA,NA,14200
Madhubani,16.1.6,Stock position of Measles vaccines,5. Total Stock,1000,0,1050,2200,0,0,0,0,0,0,0,0,4250
Madhubani,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,16.1.7,Stock position of JE vaccines,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,16.1.7,Stock position of JE vaccines,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,16.1.7,Stock position of JE vaccines,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,16.1.7,Stock position of JE vaccines,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Madhubani,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,1150,NA,400,800,NA,NA,NA,NA,NA,NA,NA,NA,2350
Madhubani,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,1000,NA,1000,1000,NA,NA,NA,NA,NA,NA,NA,NA,3000
Madhubani,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,900,NA,600,800,NA,NA,NA,NA,NA,NA,NA,NA,2300
Madhubani,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,1250,0,800,1000,0,0,0,0,0,0,0,0,3050
Madhubani,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Madhubani,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Madhubani,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Madhubani,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Madhubani,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Madhubani,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Madhubani,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,16.3.02,Stock Position of Gloves,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,16.3.02,Stock Position of Gloves,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,16.3.02,Stock Position of Gloves,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,16.3.02,Stock Position of Gloves,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Madhubani,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Madhubani,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Madhubani,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Madhubani,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Madhubani,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Madhubani,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Madhubani,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Madhubani,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Madhubani,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Madhubani,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,25000,NA,4900,20800,NA,NA,NA,NA,NA,NA,NA,NA,50700
Madhubani,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0,NA,23000,0,NA,NA,NA,NA,NA,NA,NA,NA,23000
Madhubani,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,11800,NA,7100,10200,NA,NA,NA,NA,NA,NA,NA,NA,29100
Madhubani,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,13200,0,20800,10600,0,0,0,0,0,0,0,0,44600
Madhubani,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,325100,NA,149300,187500,NA,NA,NA,NA,NA,NA,NA,NA,661900
Madhubani,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0,NA,100000,0,NA,NA,NA,NA,NA,NA,NA,NA,100000
Madhubani,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,89800,NA,61800,88400,NA,NA,NA,NA,NA,NA,NA,NA,240000
Madhubani,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,235300,0,187500,99100,0,0,0,0,0,0,0,0,521900
Madhubani,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,18900,NA,11000,21100,NA,NA,NA,NA,NA,NA,NA,NA,51000
Madhubani,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0,NA,14000,0,NA,NA,NA,NA,NA,NA,NA,NA,14000
Madhubani,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,4400,NA,3900,5100,NA,NA,NA,NA,NA,NA,NA,NA,13400
Madhubani,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,14500,0,21100,16000,0,0,0,0,0,0,0,0,51600
Madhubani,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,1,2,NA,1,4
Madhubani,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,1,NA,2,1,1,1,2,8
Madhubani,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,NA,NA,NA,NA,NA,1,NA,2,1,1,1,2,8
Madhubani,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,NA,NA,2
Madhubani,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,NA,NA,2
Madhubani,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,NA,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1
Madhubani,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,NA,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1
Madhubani,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,1,3,2,1,7
Madhubani,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,NA,NA,NA,NA,NA,NA,NA,NA,1,3,2,1,7
Madhubani,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,1
Madhubani,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,1
Madhubani,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,2,NA,NA,NA,2
Madhubani,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,1,NA,2
Madhubani,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1,NA,2
Madhubani,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,1,1,2,NA,4
Madhubani,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,NA,1,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,2
Madhubani,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,NA,1,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,2
Madhubani,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,1
Madhubani,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,1
Madhubani,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,NA,NA,NA,NA,NA,1,1,NA,NA,1,NA,NA,3
Madhubani,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,NA,NA,NA,NA,NA,1,1,NA,NA,1,NA,NA,3
Madhubani,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1,NA,2
Madhubani,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1,NA,2
Madhubani,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,1
Madhubani,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,1
Madhubani,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,1
Madhubani,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,NA,NA,2
Madhubani,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,1,NA,3
Madhubani,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Madhubani,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,2,1,1,1,1,1,5,NA,1,1,2,8,24
Madhubani,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,5,NA,5,1,11
Madhubani,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,2,1,1,1,1,1,5,NA,6,1,7,9,35
Munger,1.1,Total number of pregnant women Registered for ANC,TOTAL,2868,2703,2946,2736,2268,2328,1952,1676,1829,2057,2993,2485,28841
Munger,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1196,1098,924,968,898,892,768,729,830,1019,1452,1513,12287
Munger,1.2,Number of Pregnant women registered under JSY,TOTAL,2868,2703,2946,2736,2264,2328,1952,1676,1829,2057,2991,2485,28835
Munger,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1706,1635,1844,1899,2077,2321,1765,1749,1624,1553,1753,1804,21730
Munger,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1759,1779,1865,1651,1415,1396,1148,1051,1098,1189,1282,1428,17061
Munger,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,2678,2673,2703,2603,2520,2423,2001,1648,1789,1850,1896,2259,27043
Munger,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1618,1427,1391,1403,1446,1887,1318,1348,1392,1396,1917,1826,18369
Munger,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,0,2,0,13,0,30,9,8,0,6,10,16,94
Munger,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,1,0,0,4,2,4,5,3,2,1,2,0,24
Munger,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,498,505,342,502,719,550,517,515,602,601,611,638,6600
Munger,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,14,19,25,39,28,59,49,29,38,78,36,18,432
Munger,1.8,Number of pregnancy test kits used at SC level,TOTAL,4,2,0,0,0,55,51,8,10,43,5,20,198
Munger,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,44,40,81,67,99,120,133,91,129,94,80,84,1062
Munger,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,83,72,92,158,153,156,192,174,145,140,139,108,1612
Munger,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,127,112,173,225,252,276,325,265,274,234,219,192,2674
Munger,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,80,72,107,111,156,190,186,136,168,162,139,143,1650
Munger,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0,0,0,0,0,2,0,0,0,0,0,0,2
Munger,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,961,1170,1195,1908,2225,2309,2378,2087,1853,1706,1521,1484,20797
Munger,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,959,1165,1185,1903,2216,2294,2375,2083,1843,1697,1513,1476,20709
Munger,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,579,1024,1141,1632,2120,2223,1959,2073,1682,1507,1853,1501,19294
Munger,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,248,211,504,814,967,1262,1283,1405,1079,382,2801,2585,13541
Munger,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Munger,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,152,144,191,208,245,258,220,199,183,193,161,161,2315
Munger,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Munger,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,2,5,4,6,4,4,2,4,10,9,8,5,63
Munger,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,2,5,4,6,4,4,2,4,10,9,8,5,63
Munger,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,93,77,113,99,143,144,148,120,114,120,108,97,1376
Munger,4.1.1.a,Number of male live births,TOTAL,522,644,672,1068,1270,1300,1337,1200,1098,985,937,806,11839
Munger,4.1.1.b,Number of female live births,TOTAL,541,604,668,1028,1165,1233,1326,1111,1018,928,773,842,11237
Munger,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1063,1248,1340,2096,2435,2533,2663,2311,2116,1913,1710,1648,23076
Munger,4.1.2,Number of still births,TOTAL,28,35,25,47,51,56,46,54,29,31,31,34,467
Munger,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,2,1,2,2,2,4,1,2,3,5,5,4,33
Munger,4.2.1,Number of Newborns weighed at birth,TOTAL,1037,1235,1304,2076,2430,2494,2644,2259,2075,1884,1686,1645,22769
Munger,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,55,78,74,134,201,167,184,174,173,148,114,106,1608
Munger,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1050,1222,1300,2057,2416,2498,2637,2270,2078,1890,1686,1634,22738
Munger,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0,0,0,0,1,0,0,0,0,0,0,10,11
Munger,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,24,32,29,28,36,56,58,27,37,39,33,39,438
Munger,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,24,32,29,28,37,56,58,27,37,39,33,49,449
Munger,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,9,14,15,18,14,8,14,14,10,26,18,34,194
Munger,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,3,6,3,3,3,3,3,3,3,3,2,0,35
Munger,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,6,4,7,7,7,5,33,4,5,5,4,21,108
Munger,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,7,7,11,11,12,41,34,21,26,18,20,10,218
Munger,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1021,1214,1259,2023,2353,2461,2531,2216,1951,1830,1626,1561,22046
Munger,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,311,335,431,666,791,930,938,873,793,821,763,535,8187
Munger,6.3,PNC maternal complications attended,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Munger,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,3,0,0,1,2,0,1,0,0,4,4,1,16
Munger,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Munger,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,3,0,0,1,2,0,1,0,0,4,4,1,16
Munger,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Munger,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,90,116,200,267,233,242,235,322,275,256,314,320,2870
Munger,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,170,103,203,342,377,383,327,327,353,405,336,370,3696
Munger,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,260,219,403,609,610,625,562,649,628,661,650,690,6566
Munger,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Munger,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0,0,0,2,0,3,1,0,4,4,2,4,20
Munger,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,1,0,0,1,0,1,0,1,1,4,3,2,14
Munger,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,1,0,0,3,0,4,1,1,5,8,5,6,34
Munger,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0
Munger,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Munger,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Munger,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Munger,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,11,6,12,10,13,17,19,11,56,54,50,14,273
Munger,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,87,21,21,232,41,367,303,208,711,607,657,501,3756
Munger,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,26,28,8,23,21,73,78,45,109,101,203,151,866
Munger,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,113,49,29,255,62,440,381,253,820,708,860,652,4622
Munger,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,25,13,13,141,62,9,225,15,283,105,67,70,1028
Munger,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,1,0,0,6,4,16,18,5,35,22,37,11,155
Munger,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,3,8,2,7,5,8,9,27,16,12,18,15,130
Munger,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,4,8,2,13,9,24,27,32,51,34,55,26,285
Munger,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,NA,NA,NA,3,1,4,4,2,7,5,2,5,33
Munger,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,45,51,28,618,71,284,173,133,343,186,207,187,2326
Munger,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,28,19,29,198,75,67,64,107,109,84,107,105,992
Munger,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,17,11,25,71,54,43,41,54,62,33,53,79,543
Munger,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,90,81,82,887,200,394,278,294,514,303,367,371,3861
Munger,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,43,19,47,118,106,74,79,117,97,60,126,162,1048
Munger,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,5,3,3,NA,NA,NA,NA,NA,0,2,0,0,13
Munger,9.06,Number of IUCD removals,TOTAL,31,28,26,57,69,85,66,73,96,111,61,59,762
Munger,9.07,Number of Oral Pills cycles distributed,TOTAL,599,609,485,1162,700,912,732,926,1235,1056,970,1009,10395
Munger,9.08,Number of Condom pieces distributed,TOTAL,3663,3515,3517,5771,4480,5679,6108,6616,6878,7958,6702,6001,66888
Munger,9.09,Number of Centchroman (weekly) pills given,TOTAL,3,2,1,5,11,12,79,1,6,7,9,2,138
Munger,9.1,Number of Emergency Contraceptive Pills distributed,TOTAL,51,57,76,198,75,190,159,154,189,210,144,165,1668
Munger,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Munger,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Munger,9.11.2.a,Number of failures following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Munger,9.11.2.b,Number of failures following female sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,1,0,1
Munger,9.11.3.a,Number of deaths following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Munger,9.11.3.b,Number of deaths following female sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Munger,9.12,Number of Institutions having NSV trained doctors,TOTAL,NA,NA,NA,NA,1,2,2,2,2,2,2,2,Data for this item can not be cumulated
Munger,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,1464,1573,1867,2688,2948,3333,3241,2989,2859,2441,2224,2061,29688
Munger,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,0,0,26,0,0,0,0,1,0,16,0,0,43
Munger,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,223,84,133,70,18,7,5,13,2,0,0,0,555
Munger,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,853,381,301,216,114,56,30,18,14,3,0,0,1986
Munger,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,2170,1791,1751,1770,1789,2321,2775,2840,3227,2846,2744,2429,28453
Munger,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,2112,2063,1884,1720,1696,1772,1988,2118,2716,3012,2535,2623,26239
Munger,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,1759,1925,2000,1656,1653,1693,1657,1642,2055,2529,2581,2527,23677
Munger,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1010,1138,1213,1986,2362,2560,2510,2212,2000,1713,1593,1508,21805
Munger,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,2225,1765,1777,1797,1807,2351,2758,2863,3244,2847,2641,2434,28509
Munger,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,2338,2174,1990,1812,1710,1811,2012,2143,2712,3014,2526,2654,26896
Munger,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,2545,2269,2308,1879,1769,1774,1687,1656,2053,2528,2582,2535,25585
Munger,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,854,1019,1021,1731,2070,2135,2086,1871,1689,1483,1372,1282,18613
Munger,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,0,0,1,0,0,0,10,0,0,0,0,0,11
Munger,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,206,96,133,67,15,7,7,14,4,1,0,0,550
Munger,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,836,382,285,213,109,57,25,8,11,0,0,0,1926
Munger,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1755,2043,2390,2686,2553,2417,2187,1984,1628,1337,1265,1338,23583
Munger,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,3027,2586,2321,2387,1860,1856,1615,1488,1821,2094,2294,2400,25749
Munger,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Munger,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,880,1041,1195,1366,1270,1235,986,1008,787,672,664,688,11792
Munger,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,857,952,1126,1268,1248,1152,962,938,787,629,572,634,11125
Munger,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1737,1993,2321,2634,2518,2387,1948,1946,1574,1301,1236,1322,22917
Munger,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,2870,2557,2273,2413,1830,1863,1574,1529,1862,2126,2303,2442,25642
Munger,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,2875,2561,2258,2424,1815,1836,1569,1522,1859,2126,2297,2441,25583
Munger,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Munger,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,153,139,140,146,113,125,100,110,127,103,86,127,1469
Munger,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,157,161,160,152,103,95,89,120,120,99,71,103,1430
Munger,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,310,300,300,298,216,220,189,230,247,202,157,230,2899
Munger,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,147,178,116,165,162,270,985,394,472,5179,2019,559,10646
Munger,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,545,235,187,256,211,247,548,301,305,599,417,335,4186
Munger,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,878,335,348,441,249,343,577,498,432,733,568,499,5901
Munger,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Munger,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Munger,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Munger,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1455,1446,1520,1474,1476,1473,1434,1455,1466,1466,1466,1468,17599
Munger,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1455,1422,1521,1474,1421,1455,1430,1329,1465,1465,1431,1466,17334
Munger,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1122,1138,1185,1203,1082,1167,1126,1135,1160,1163,1140,1154,13775
Munger,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Munger,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,102,115,0,0,0,0,6,0,0,0,0,0,223
Munger,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Munger,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Munger,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Munger,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Munger,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Munger,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Munger,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Munger,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,6,0,0,6
Munger,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,1429,1782,1223,2026,2131,2732,2903,2624,2394,2065,2199,2387,25895
Munger,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0,0,0,0,104,106,60,0,0,0,0,0,270
Munger,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,29,28,28,34,39,54,23,56,54,43,43,56,487
Munger,13.1,Number of Patients operated for cataract,TOTAL,101,117,75,131,89,0,139,143,498,312,221,170,1996
Munger,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,101,117,75,131,89,0,139,143,498,312,221,170,1996
Munger,13.3,Number of School children detected with Refractive errors,TOTAL,10,28,7,12,10,0,11,6,14,17,15,9,139
Munger,13.4,Number of children provided free glasses,TOTAL,0,0,0,0,0,0,0,0,0,12,0,0,12
Munger,13.5,Number of eyes collected through eye donation,TOTAL,0,0,0,0,0,0,0,0,10,0,0,0,10
Munger,13.6,Number of eyes utilised for corneal transplant,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Munger,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,1,1,1,1,2,2,2,2,2,2,2,2,Data for this item can not be cumulated
Munger,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,NA,NA,1,NA,8,9,10,10,10,9,9,10,Data for this item can not be cumulated
Munger,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,851,671,808,859,669,877,934,940,967,962,943,969,Data for this item can not be cumulated
Munger,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,1,1,1,1,2,2,2,2,2,2,2,2,Data for this item can not be cumulated
Munger,14.05,Number of RKS meetings held during the month,TOTAL,2,2,3,8,4,5,4,2,4,4,9,6,53
Munger,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,1,1,2,1,9,9,8,7,8,8,8,8,Data for this item can not be cumulated
Munger,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,705,523,656,943,1328,1368,1279,1016,927,1130,978,996,11849
Munger,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,NA,NA,1,1,2,2,2,2,2,2,2,2,Data for this item can not be cumulated
Munger,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,Data for this item can not be cumulated
Munger,14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,343,163,219,298,406,354,395,280,339,201,326,248,3572
Munger,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,688,459,448,616,599,661,736,547,667,443,367,522,6753
Munger,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,196,503,203,288,277,278,303,259,169,182,203,264,3125
Munger,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,1568,1716,1619,2513,2972,3327,3179,2619,2665,2558,2435,2350,29521
Munger,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,539,666,422,586,683,632,698,539,508,383,529,512,6697
Munger,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,2256,2175,2067,3129,3571,3988,3915,3166,3332,3001,2802,2872,36274
Munger,14.10.2.a,Number of death cases of Inpatient males,TOTAL,16,17,17,11,13,16,16,17,21,17,15,13,189
Munger,14.10.2.b,Number of death cases of Inpatient females,TOTAL,3,11,10,12,12,16,10,12,4,11,5,10,116
Munger,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,19,28,27,23,25,32,26,29,25,28,20,23,305
Munger,14.11,In-Patient Head Count at midnight,TOTAL,4182,3877,4162,4749,5018,5018,5295,4789,4704,4901,4783,4770,56248
Munger,14.12.1,OPD attendance (All),TOTAL,85608,83811,74690,93801,95223,109713,97017,90234,97566,91390,100265,96885,1116203
Munger,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,161,90,58,257,96,425,384,258,765,621,771,526,4412
Munger,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Munger,14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,1382,1487,1350,1495,1571,1351,1184,1167,1124,1208,1280,1314,15913
Munger,14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,14.14.a,Number of patients given AYUSH treatment,TOTAL,13863,13399,12886,15868,17113,12482,10809,10158,10029,12165,11410,10781,150963
Munger,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,2589,2138,2676,2920,3011,2402,5430,3209,2857,3975,4028,3993,39228
Munger,14.14.c,Number of Adolescents counselled,TOTAL,602,721,664,735,817,656,646,613,811,733,875,687,8560
Munger,15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,1722,1131,1213,1473,1225,1549,1090,1224,1390,1502,1642,1241,16402
Munger,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,71,45,56,166,92,86,76,66,58,50,54,15,835
Munger,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,198,185,380,423,414,447,386,399,394,339,398,426,4389
Munger,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,2,2,5,3,1,3,3,1,3,1,0,5,29
Munger,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,175,141,292,387,312,419,386,350,436,529,553,465,4445
Munger,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,2,1,5,4,0,2,3,1,1,0,1,3,23
Munger,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,640,218,675,870,901,882,722,667,814,993,1003,1196,9581
Munger,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0,1,0,0,2,0,0,0,1,0,0,0,4
Munger,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,1013,544,1347,1680,1627,1748,1494,1416,1644,1861,1954,2087,18415
Munger,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,4,4,10,7,3,5,6,2,5,1,1,8,56
Munger,15.2,Number of Widal tests conducted,Number tested,0,11,0,0,0,0,0,0,3,2,2,2,20
Munger,15.3.a,Number of VDRL tests conducted on males,Number tested,0,0,0,0,12,14,0,0,0,0,0,0,26
Munger,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,0,16,0,0,0,0,0,0,0,16,24,0,56
Munger,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,0,0,8,8,14,12,12,8,7,0,0,28,97
Munger,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,0,16,8,8,26,26,12,8,7,16,24,28,179
Munger,15.4.1,Number of blood smears examined for Malaria,TOTAL,239,273,220,982,1055,824,465,327,180,80,86,137,4868
Munger,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,2,7,15,119,74,128,23,14,14,1,5,11,413
Munger,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,1,29,18,196,203,67,27,15,4,1,1,6,568
Munger,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,346,NA,446,146,196,896,1396,2396,2246,1996,1696,1496,13256
Munger,16.1.1,Stock position of DPT vaccines,2. Stocks Received,0,NA,0,1000,1000,950,1000,0,0,0,500,750,5200
Munger,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0,NA,0,NA,NA,0,0,0,0,0,0,0,0
Munger,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,250,NA,300,950,300,450,0,150,250,300,700,750,4400
Munger,16.1.1,Stock position of DPT vaccines,5. Total Stock,96,0,146,196,896,1396,2396,2246,1996,1696,1496,1496,14056
Munger,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,250,NA,650,750,550,1016,1848,2660,2084,1504,1212,1596,14120
Munger,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,500,NA,600,1250,864,1224,1152,0,0,576,1152,576,7894
Munger,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0,NA,0,NA,NA,0,0,0,0,0,0,0,0
Munger,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,450,NA,500,1450,398,392,340,576,580,868,768,720,7042
Munger,16.1.1A,Stock Position of Pentavalent,5. Total Stock,300,0,750,550,1016,1848,2660,2084,1504,1212,1596,1452,14972
Munger,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,100,NA,725,1075,500,900,775,1075,125,825,475,750,7325
Munger,16.1.2,Stock position of OPV vaccines,2. Stocks Received,900,NA,1000,1125,1000,1100,900,0,1500,500,900,500,9425
Munger,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0,NA,0,NA,NA,0,0,0,0,0,0,0,0
Munger,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,600,NA,650,1700,600,1225,600,950,800,850,625,375,8975
Munger,16.1.2,Stock position of OPV vaccines,5. Total Stock,400,0,1075,500,900,775,1075,125,825,475,750,875,7775
Munger,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,1884,NA,2284,1884,2084,1784,1534,1984,1334,1084,634,1034,17524
Munger,16.1.3,Stock position of TT vaccines,2. Stocks Received,0,NA,0,1500,0,0,1000,0,0,250,800,1250,4800
Munger,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0,NA,0,NA,NA,0,0,0,0,0,0,0,0
Munger,16.1.3,Stock position of TT vaccines,4. Stock Distributed,300,NA,400,1300,300,250,550,650,250,700,400,600,5700
Munger,16.1.3,Stock position of TT vaccines,5. Total Stock,1584,0,1884,2084,1784,1534,1984,1334,1084,634,1034,1684,16624
Munger,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,NA,NA,0,NA,NA,NA,NA,NA,NA,0,0,NA,0
Munger,16.1.4,Stock position of DT vaccines,2. Stocks Received,NA,NA,0,NA,NA,NA,NA,NA,NA,0,0,NA,0
Munger,16.1.4,Stock position of DT vaccines,3. Unusable Stock,NA,NA,0,NA,NA,NA,NA,NA,NA,0,0,NA,0
Munger,16.1.4,Stock position of DT vaccines,4. Stock Distributed,NA,NA,0,NA,NA,NA,NA,NA,NA,0,0,NA,0
Munger,16.1.4,Stock position of DT vaccines,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Munger,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,1340,NA,1990,1640,1190,790,940,1140,90,500,150,400,10170
Munger,16.1.5,Stock position of BCG vaccines,2. Stocks Received,500,NA,0,850,0,850,800,0,1200,1000,800,700,6700
Munger,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0,NA,0,NA,NA,0,0,0,0,0,0,0,0
Munger,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,300,NA,350,1300,400,700,600,1050,790,1350,550,400,7790
Munger,16.1.5,Stock position of BCG vaccines,5. Total Stock,1540,0,1640,1190,790,940,1140,90,500,150,400,700,9080
Munger,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,320,NA,0,350,100,800,1100,1500,1100,850,1050,1450,8620
Munger,16.1.6,Stock position of Measles vaccines,2. Stocks Received,1600,NA,1600,2050,2000,2050,1600,1000,1000,1600,1600,1000,17100
Munger,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0,NA,0,NA,NA,0,0,0,0,0,0,0,0
Munger,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,1350,NA,1250,2300,1300,1750,1200,1400,1250,1400,1200,1000,15400
Munger,16.1.6,Stock position of Measles vaccines,5. Total Stock,570,0,350,100,800,1100,1500,1100,850,1050,1450,1450,10320
Munger,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,NA,NA,0,NA,NA,NA,NA,NA,NA,0,0,NA,0
Munger,16.1.7,Stock position of JE vaccines,2. Stocks Received,NA,NA,0,NA,NA,NA,NA,NA,NA,0,0,NA,0
Munger,16.1.7,Stock position of JE vaccines,3. Unusable Stock,NA,NA,0,NA,NA,NA,NA,NA,NA,0,0,NA,0
Munger,16.1.7,Stock position of JE vaccines,4. Stock Distributed,NA,NA,0,NA,NA,NA,NA,NA,NA,0,0,NA,0
Munger,16.1.7,Stock position of JE vaccines,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Munger,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,410,NA,1110,1010,310,710,1110,1460,1210,1110,960,960,10360
Munger,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0,NA,0,0,600,600,500,0,0,0,0,250,1950
Munger,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0,NA,0,NA,NA,0,0,0,0,0,0,0,0
Munger,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,150,NA,100,700,200,200,150,250,100,150,0,100,2100
Munger,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,260,0,1010,310,710,1110,1460,1210,1110,960,960,1110,10210
Munger,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,1100,NA,1100,450,450,3000,8433,6783,6383,6333,6333,6283,46648
Munger,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0,NA,0,0,3000,7266,0,0,0,0,0,0,10266
Munger,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0,NA,0,0,NA,0,0,0,0,0,0,0,0
Munger,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,NA,NA,650,0,450,1833,1650,400,50,0,50,100,5183
Munger,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,1100,0,450,450,3000,8433,6783,6383,6333,6333,6283,6183,51731
Munger,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,NA,NA,0,0,0,0,57198,26858,13857,13857,13357,13357,138484
Munger,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,NA,NA,0,0,0,77654,0,0,0,0,0,0,77654
Munger,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,NA,NA,0,0,NA,0,0,0,0,0,0,0,0
Munger,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,NA,NA,0,0,0,20456,30340,13001,0,500,0,100,64397
Munger,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0,0,0,0,0,57198,26858,13857,13857,13357,13357,13257,151741
Munger,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,474,NA,474,374,374,1000,5492,3307,2454,2454,2354,2354,21111
Munger,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0,NA,0,0,1000,5739,0,0,0,0,0,0,6739
Munger,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0,NA,0,0,NA,0,0,0,0,0,0,0,0
Munger,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,NA,NA,100,0,374,1247,2185,853,0,100,0,50,4909
Munger,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,474,0,374,374,1000,5492,3307,2454,2454,2354,2354,2304,22941
Munger,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,NA,NA,2819,2066,2066,1174,6319,4689,3829,3829,3729,3729,34249
Munger,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,NA,NA,0,0,0,6383,0,0,0,0,0,0,6383
Munger,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0,NA,0,0,NA,0,0,0,0,0,0,0,0
Munger,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0,NA,753,0,892,1238,1630,860,0,100,0,20,5493
Munger,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0,0,2066,2066,1174,6319,4689,3829,3829,3729,3729,3709,35139
Munger,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,0,NA,0,0,0,0,0,0,0,0,0,0,0
Munger,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0,NA,0,0,0,0,0,0,0,0,0,0,0
Munger,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0,NA,0,0,NA,0,0,0,0,0,0,0,0
Munger,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0,NA,0,0,0,0,0,0,0,0,0,0,0
Munger,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Munger,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,3000,NA,2800,2000,2000,3200,2700,2200,1600,1100,1100,6600,28300
Munger,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0,NA,0,0,1300,0,0,0,0,0,6000,10000,17300
Munger,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0,NA,0,NA,NA,0,0,0,0,0,0,0,0
Munger,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,200,NA,800,0,100,500,500,600,500,0,500,1200,4900
Munger,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,2800,0,2000,2000,3200,2700,2200,1600,1100,1100,6600,15400,40700
Munger,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,25,NA,347,0,0,0,0,0,0,0,450,0,822
Munger,16.3.02,Stock Position of Gloves,2. Stocks Received,822,NA,0,0,500,400,500,0,0,900,0,450,3572
Munger,16.3.02,Stock Position of Gloves,3. Unusable Stock,0,NA,0,0,NA,0,0,0,0,0,0,0,0
Munger,16.3.02,Stock Position of Gloves,4. Stock Distributed,500,NA,347,0,500,400,500,0,0,450,450,100,3247
Munger,16.3.02,Stock Position of Gloves,5. Total Stock,347,0,0,0,0,0,0,0,0,450,0,350,1147
Munger,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,NA,NA,0,0,0,0,0,0,0,0,0,0,0
Munger,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,NA,NA,0,0,0,0,0,0,0,0,0,0,0
Munger,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,NA,NA,0,0,NA,0,0,0,0,0,0,0,0
Munger,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,NA,NA,0,0,0,0,0,0,0,0,0,0,0
Munger,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Munger,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,50000,NA,45000,40000,38000,47000,43000,41000,39000,37000,35000,31500,446500
Munger,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0,NA,0,0,15000,0,0,0,0,0,2000,100000,117000
Munger,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0,NA,0,0,NA,0,0,0,0,0,0,0,0
Munger,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,5000,NA,5000,2000,6000,4000,2000,2000,2000,2000,5500,25900,61400
Munger,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,45000,0,40000,38000,47000,43000,41000,39000,37000,35000,31500,105600,502100
Munger,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,55,NA,55,55,55,55,55,50,50,50,50,50,580
Munger,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0,NA,0,0,0,0,0,0,0,0,0,0,0
Munger,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0,NA,0,0,NA,0,0,0,0,0,0,0,0
Munger,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0,NA,0,0,0,0,5,0,0,0,0,0,5
Munger,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,55,0,55,55,55,55,50,50,50,50,50,50,575
Munger,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0,NA,0,0,0,0,0,0,0,0,0,0,0
Munger,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0,NA,0,0,0,0,0,0,0,0,0,0,0
Munger,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0,NA,0,0,NA,0,0,0,0,0,0,0,0
Munger,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0,NA,0,0,0,0,0,0,0,0,0,0,0
Munger,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Munger,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,211950,NA,191950,151950,58950,942950,480950,228950,154950,2026950,1742750,1645750,7838050
Munger,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0,NA,0,449000,1290000,0,0,0,2000000,0,0,0,3739000
Munger,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0,NA,0,0,NA,0,0,0,0,0,0,0,0
Munger,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,20000,NA,20000,542000,406000,462000,252000,74000,128000,284200,97000,367000,2652200
Munger,16.3.07,Stock Position of IFA Tablets,5. Total Stock,191950,0,171950,58950,942950,480950,228950,154950,2026950,1742750,1645750,1278750,8924850
Munger,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0,NA,0,0,0,0,0,0,0,0,0,0,0
Munger,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0,NA,0,0,0,0,0,0,0,0,0,0,0
Munger,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0,NA,0,0,NA,0,0,0,0,0,0,0,0
Munger,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0,NA,0,0,0,0,0,0,0,0,0,0,0
Munger,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Munger,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0,NA,0,0,0,500,400,0,0,0,1800,800,3500
Munger,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0,NA,0,0,3000,0,0,0,0,2000,0,0,5000
Munger,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0,NA,0,0,NA,0,0,0,0,0,0,0,0
Munger,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0,NA,0,0,2500,100,400,0,0,200,1000,0,4200
Munger,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0,0,0,0,500,400,0,0,0,1800,800,800,4300
Munger,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,0,NA,0,0,0,0,0,0,0,0,0,0,0
Munger,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0,NA,0,0,0,0,0,0,0,0,0,0,0
Munger,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0,NA,0,0,NA,0,0,0,0,0,0,0,0
Munger,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0,NA,0,0,0,0,0,0,0,0,0,0,0
Munger,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Munger,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,11890,NA,10890,7890,4390,45390,21482,17222,14222,312222,410202,479171,1334971
Munger,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0,NA,0,0,315000,0,0,0,300000,100000,98969,0,813969
Munger,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0,NA,0,0,NA,0,0,0,0,0,0,0,0
Munger,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,1000,NA,3000,3500,274000,23908,4260,3000,2000,2020,30000,30900,377588
Munger,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,10890,0,7890,4390,45390,21482,17222,14222,312222,410202,479171,448271,1771352
Munger,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,4700,NA,8300,7300,11800,10200,9800,8200,11000,9300,9300,14100,104000
Munger,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,4000,NA,0,10000,0,0,0,7000,0,5000,6000,0,32000
Munger,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0,NA,0,NA,NA,0,0,0,0,0,0,0,0
Munger,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,0,NA,1000,5500,1600,400,1600,4200,1700,5000,1200,2800,25000
Munger,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,8700,0,7300,11800,10200,9800,8200,11000,9300,9300,14100,11300,111000
Munger,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,9050,NA,12000,3000,46200,24600,10600,400,43400,37400,84400,145400,416450
Munger,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,50000,NA,0,75000,0,0,0,75000,0,75000,75000,0,350000
Munger,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0,NA,0,NA,NA,0,0,0,0,0,0,0,0
Munger,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,18000,NA,9000,31800,21600,14000,10200,32000,6000,28000,14000,26000,210600
Munger,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,41050,0,3000,46200,24600,10600,400,43400,37400,84400,145400,119400,555850
Munger,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,880,NA,2800,1300,8900,7300,6500,4700,6200,4100,4000,7300,53980
Munger,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,5000,NA,0,10000,0,0,0,5000,0,3000,5000,0,28000
Munger,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0,NA,0,NA,NA,0,0,0,0,0,0,0,0
Munger,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,1000,NA,1500,2400,1600,800,1800,3500,2100,3100,1700,2500,22000
Munger,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,4880,0,1300,8900,7300,6500,4700,6200,4100,4000,7300,4800,59980
Munger,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,1
Munger,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1,2
Munger,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,1,3
Munger,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,2,NA,3
Munger,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,2,NA,3
Munger,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,1
Munger,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,1
Munger,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,NA,NA,2
Munger,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,1
Munger,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,1
Munger,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,2
Munger,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,2
Munger,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1,NA,2
Munger,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1,NA,2
Munger,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,1
Munger,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,1
Munger,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,NA,NA,NA,NA,NA,1,NA,NA,NA,1,NA,NA,2
Munger,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,NA,NA,NA,NA,NA,1,NA,NA,NA,1,NA,NA,2
Munger,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,NA,NA,NA,NA,2,NA,NA,NA,NA,1,5,2,10
Munger,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,NA,NA,NA,NA,2,NA,NA,NA,NA,1,5,2,10
Munger,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,1
Munger,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1
Munger,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,1
Munger,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1,1,3
Munger,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1,1,3
Munger,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1,1,3
Munger,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,1
Munger,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,1
Munger,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Munger,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,NA,1
Munger,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,NA,NA,NA,NA,NA,2,NA,NA,NA,10,6,5,23
Munger,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,7,6,11,24
Munger,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,NA,NA,NA,NA,NA,3,NA,NA,NA,17,12,16,48
Muzaffarpur,1.1,Total number of pregnant women Registered for ANC,TOTAL,9870,9706,9862,11623,9748,10860,9852,8994,10520,10210,10803,10586,122634
Muzaffarpur,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,3875,3578,3780,3799,3471,4123,3674,3941,5293,5121,5285,4949,50889
Muzaffarpur,1.2,Number of Pregnant women registered under JSY,TOTAL,9783,9534,9770,11582,9644,10793,10021,8958,10465,10154,10756,10484,121944
Muzaffarpur,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,4663,4678,4707,4940,4453,4859,4677,4903,5753,5938,5627,5695,60893
Muzaffarpur,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,6919,6453,6198,7685,6279,6951,6613,5435,6488,6142,6605,6682,78450
Muzaffarpur,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,7977,8069,7725,8608,8612,8948,8220,7077,7760,7947,7620,8568,97131
Muzaffarpur,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,2743,3230,5085,5225,3609,3710,3505,3723,5004,4733,4106,3701,48374
Muzaffarpur,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,109,111,136,90,94,32,75,32,589,95,143,97,1603
Muzaffarpur,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,10,13,10,17,13,16,16,8,17,17,13,17,167
Muzaffarpur,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,349,401,323,566,591,436,441,503,593,384,357,417,5361
Muzaffarpur,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,48,45,53,67,48,36,78,65,81,85,84,75,765
Muzaffarpur,1.8,Number of pregnancy test kits used at SC level,TOTAL,903,1210,475,596,669,694,645,614,615,888,1119,966,9394
Muzaffarpur,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,342,319,332,378,606,372,515,382,462,564,718,544,5534
Muzaffarpur,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,1725,1603,1497,1997,1851,2099,1934,2061,2445,2266,2382,2051,23911
Muzaffarpur,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,2067,1922,1829,2375,2457,2471,2449,2443,2907,2830,3100,2595,29445
Muzaffarpur,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,1244,1280,1126,1473,1469,1407,1470,1677,1894,2055,2243,1964,19302
Muzaffarpur,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,16,2,8,27,5,8,30,14,0,21,8,3,142
Muzaffarpur,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,3206,3267,3378,4581,5841,5333,5119,5027,4697,4846,4647,3829,53771
Muzaffarpur,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,2466,2525,2682,3531,4444,3986,3447,2966,3635,3266,3529,3102,39579
Muzaffarpur,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,2240,1548,3139,3851,2565,4609,4515,3606,5275,4112,4670,4397,44527
Muzaffarpur,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1472,1508,2239,2658,2123,3253,3253,3379,4790,4223,3481,5062,37441
Muzaffarpur,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0,0,0,6,0,0,0,0,0,0,2,0,8
Muzaffarpur,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,274,253,284,234,246,268,285,NA,NA,NA,NA,NA,1844
Muzaffarpur,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Muzaffarpur,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Muzaffarpur,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,105,141,113,135,136,157,141,149,148,132,129,114,1600
Muzaffarpur,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,105,141,113,135,136,157,141,149,148,132,129,114,1600
Muzaffarpur,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,56,42,43,31,34,63,63,NA,NA,NA,NA,NA,332
Muzaffarpur,4.1.1.a,Number of male live births,TOTAL,2885,2804,2660,3714,4286,4021,3767,3850,3797,3985,4034,3288,43091
Muzaffarpur,4.1.1.b,Number of female live births,TOTAL,2648,2525,2430,3340,4005,3846,3410,3514,3500,3637,3788,3098,39741
Muzaffarpur,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,5533,5329,5090,7054,8291,7867,7177,7364,7297,7622,7822,6386,82832
Muzaffarpur,4.1.2,Number of still births,TOTAL,93,103,88,118,117,132,107,106,98,102,89,84,1237
Muzaffarpur,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,11,22,5,4,3,18,3,12,6,5,17,16,122
Muzaffarpur,4.2.1,Number of Newborns weighed at birth,TOTAL,4658,4604,4520,6194,7546,6982,6707,7026,6822,6820,7054,5941,74874
Muzaffarpur,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,309,300,299,506,493,450,576,683,534,806,460,626,6042
Muzaffarpur,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,4466,4312,4377,5719,6561,6536,6250,6557,7293,6616,6893,5753,71333
Muzaffarpur,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0,0,0,0,0,0,0,5,9,25,33,11,83
Muzaffarpur,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Muzaffarpur,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,0,0,1,1,0,0,0,0,176,138,33,39,388
Muzaffarpur,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,0,0,1,1,0,0,0,5,185,163,66,50,471
Muzaffarpur,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,1356,1362,1724,1486,2202,2152,1520,1735,1925,1595,1915,1262,20234
Muzaffarpur,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,80,78,60,102,90,100,106,82,151,248,343,199,1639
Muzaffarpur,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,1026,1173,550,313,312,505,800,1497,1352,1701,403,554,10186
Muzaffarpur,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,103,121,136,110,110,98,74,0,122,89,87,101,1151
Muzaffarpur,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1619,1782,1897,2307,3000,2712,2464,2565,2664,2322,2478,2161,27971
Muzaffarpur,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1280,1350,1319,1599,1685,1844,1933,2091,2270,2054,2049,1870,21344
Muzaffarpur,6.3,PNC maternal complications attended,TOTAL,148,186,182,4,317,262,277,265,262,253,264,197,2617
Muzaffarpur,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Muzaffarpur,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,2,8,1,5,0,5,1,1,10,10,8,6,57
Muzaffarpur,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,2,8,1,5,0,5,1,1,10,10,8,6,57
Muzaffarpur,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0,0,0,0,0,0,0,0,0,56,71,0,127
Muzaffarpur,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,186,138,100,243,175,214,220,238,266,297,374,488,2939
Muzaffarpur,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,242,100,40,223,116,276,170,336,158,411,295,516,2883
Muzaffarpur,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,428,238,140,466,291,490,390,574,424,708,669,1004,5822
Muzaffarpur,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Muzaffarpur,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0,1,0,1,0,0,1,2,3,1,1,1,11
Muzaffarpur,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Muzaffarpur,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,1,0,2,0,0,0,0,0,0,0,1,0,4
Muzaffarpur,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,1,1,2,1,0,0,1,2,3,1,2,1,15
Muzaffarpur,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,NA,NA,NA,NA,3,NA,NA,NA,NA,NA,NA,NA,3
Muzaffarpur,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Muzaffarpur,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Muzaffarpur,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Muzaffarpur,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Muzaffarpur,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,81,9,1,740,52,523,521,374,2179,1273,1763,1086,8602
Muzaffarpur,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,20,9,0,76,23,38,26,34,208,118,124,78,754
Muzaffarpur,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,34,16,10,18,14,23,39,56,129,15,101,60,515
Muzaffarpur,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,135,34,11,834,89,584,586,464,2516,1406,1988,1224,9871
Muzaffarpur,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,324,230,125,299,355,412,385,512,1359,823,1156,706,6686
Muzaffarpur,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0,0,0,1,0,0,0,2,9,4,6,9,31
Muzaffarpur,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,6,0,4,9,6,4,6,7,12,13,13,11,91
Muzaffarpur,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,45,36,23,47,6,6,9,50,62,34,32,40,390
Muzaffarpur,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,51,36,27,57,12,10,15,59,83,51,51,60,512
Muzaffarpur,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,276,317,256,458,379,296,203,258,901,1021,996,803,6164
Muzaffarpur,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,121,61,77,197,120,81,138,236,465,350,344,306,2496
Muzaffarpur,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,6,3,54,45,66,54,26,53,84,88,79,51,609
Muzaffarpur,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,277,273,173,185,50,9,NA,45,60,105,33,28,1238
Muzaffarpur,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,680,654,560,885,615,440,367,592,1510,1564,1452,1188,10507
Muzaffarpur,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,156,111,140,258,150,94,63,91,177,398,339,302,2279
Muzaffarpur,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,NA,11,NA,NA,NA,NA,NA,NA,NA,10,13,11,45
Muzaffarpur,9.06,Number of IUCD removals,TOTAL,159,143,148,236,222,220,212,220,320,335,319,292,2826
Muzaffarpur,9.07,Number of Oral Pills cycles distributed,TOTAL,1393,1550,1380,1490,1758,1703,1596,1958,2752,2830,3058,2528,23996
Muzaffarpur,9.08,Number of Condom pieces distributed,TOTAL,10654,11321,9607,11178,6857,8142,3943,5913,6707,11794,11210,9640,106966
Muzaffarpur,9.09,Number of Centchroman (weekly) pills given,TOTAL,160,178,127,127,187,172,55,147,224,252,50,144,1823
Muzaffarpur,9.1,Number of Emergency Contraceptive Pills distributed,TOTAL,160,195,215,251,191,266,268,307,439,453,331,367,3443
Muzaffarpur,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,1,1
Muzaffarpur,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0,0,9,9,0,0,0,0,0,0,0,0,18
Muzaffarpur,9.11.2.a,Number of failures following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Muzaffarpur,9.11.2.b,Number of failures following female sterilization,TOTAL,0,0,0,1,0,0,0,0,0,0,0,0,1
Muzaffarpur,9.11.3.a,Number of deaths following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Muzaffarpur,9.11.3.b,Number of deaths following female sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Muzaffarpur,9.12,Number of Institutions having NSV trained doctors,TOTAL,2,2,2,2,3,2,3,5,3,21,17,21,Data for this item can not be cumulated
Muzaffarpur,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,6667,6284,6352,9005,9915,10385,10269,10118,11215,10425,10471,8785,109891
Muzaffarpur,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,353,114,131,76,58,7,105,0,0,1,0,0,845
Muzaffarpur,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,1594,748,637,438,267,150,156,47,25,19,2,3,4086
Muzaffarpur,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,3919,2155,1684,1270,649,493,330,157,86,36,25,17,10821
Muzaffarpur,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,8553,7036,6280,7604,7306,9041,10008,9975,10767,10465,9767,10261,107063
Muzaffarpur,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,7250,7777,6857,7441,6747,7376,8287,8857,9883,10254,9912,10403,101044
Muzaffarpur,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,5152,6240,6476,7408,6370,7021,7171,7352,8633,9410,9265,10093,90591
Muzaffarpur,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,4405,4331,4618,6093,7007,6749,6161,6952,7122,7133,7257,5325,73153
Muzaffarpur,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,8317,6842,6240,7340,7322,8885,9878,9499,10758,10484,9898,10227,105690
Muzaffarpur,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,8302,8154,7143,7419,6871,7335,8254,8469,9796,10198,10305,10383,102629
Muzaffarpur,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,8241,7951,7536,7934,6787,7164,7215,7183,8750,9012,9537,9848,97158
Muzaffarpur,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,2192,2076,2415,3074,3541,3453,3240,4065,4455,4432,3823,3442,40208
Muzaffarpur,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,97,200,108,193,152,63,409,30,2,64,51,12,1381
Muzaffarpur,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,1554,760,562,494,327,169,173,72,22,63,33,12,4241
Muzaffarpur,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,3976,2214,1668,1216,696,501,314,140,88,102,27,21,10963
Muzaffarpur,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,7081,7926,8195,10008,8342,8918,9552,8384,8906,7647,7294,7395,99648
Muzaffarpur,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,6774,6417,6151,7472,6099,6710,6845,6036,7523,8120,8602,8828,85577
Muzaffarpur,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,6751,7161,7597,9325,8038,8562,8692,7980,8715,7374,7227,7231,94653
Muzaffarpur,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,4370,4738,4218,5734,4966,5826,5828,4389,4612,3983,4664,3796,57124
Muzaffarpur,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,3861,4202,3848,4880,4336,5098,4972,3905,4136,3513,4069,3407,50227
Muzaffarpur,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,8231,8940,8066,10614,9302,10924,10800,8294,8748,7496,8733,7203,107351
Muzaffarpur,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,7380,6618,6051,7531,6045,6769,6875,5970,7588,7982,8594,8592,85995
Muzaffarpur,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,7394,6384,5990,7269,6106,6725,6819,5747,7477,7958,8572,8589,85030
Muzaffarpur,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,25,0,32,22,1,10,3,0,6,5,0,0,104
Muzaffarpur,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1462,1285,1433,1727,1587,1775,1561,1357,1936,1667,1633,1551,18974
Muzaffarpur,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1271,1151,1235,1443,1288,1408,1428,1178,1774,1522,1454,1424,16576
Muzaffarpur,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,2733,2436,2668,3170,2875,3183,2989,2535,3710,3189,3087,2975,35550
Muzaffarpur,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,757,680,642,939,1034,1223,1345,1192,1483,1849,1923,2001,15068
Muzaffarpur,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,2188,1989,1902,2035,2049,2385,2256,2023,2145,2629,2443,2534,26578
Muzaffarpur,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,3074,2791,2660,2883,3035,3409,3248,2971,3520,4002,3744,3868,39205
Muzaffarpur,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,2,0,0,0,0,0,6,4,3,0,0,4,19
Muzaffarpur,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0,0,1,0,0,0,0,0,0,0,0,0,1
Muzaffarpur,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,13,2,6,0,2,3,6,9,13,4,0,5,63
Muzaffarpur,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,3788,3752,3827,3925,3682,3867,3882,3658,3756,3665,3737,3771,45310
Muzaffarpur,10.4.2,Number of Immunisation sessions held during the month,TOTAL,3777,3721,3614,3901,3609,3820,3844,3614,3727,3644,3703,3760,44734
Muzaffarpur,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,3515,3500,3382,3625,3343,3580,3584,3424,3504,3389,3416,3482,41744
Muzaffarpur,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,6976,6426,5923,7252,6067,6532,6397,5884,7776,7779,8435,8442,83889
Muzaffarpur,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,5087,5691,5943,7029,5222,5849,5656,5029,4436,3458,2875,2923,59198
Muzaffarpur,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,2220,2044,2154,2778,1707,2030,2163,1893,1584,1939,1275,1557,23344
Muzaffarpur,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,539,370,408,430,315,311,286,293,249,267,183,200,3851
Muzaffarpur,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Muzaffarpur,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Muzaffarpur,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Muzaffarpur,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Muzaffarpur,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Muzaffarpur,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,2,0,4,0,2,0,0,0,9,4,22,1,44
Muzaffarpur,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,186,218,340,579,519,627,503,533,810,502,412,381,5610
Muzaffarpur,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,2,7,0,0,0,0,41,0,7,4,0,0,61
Muzaffarpur,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Muzaffarpur,13.1,Number of Patients operated for cataract,TOTAL,3916,2437,1960,1714,3091,3643,3496,3488,3689,5803,7073,5986,46296
Muzaffarpur,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,3866,2417,1939,1694,3070,3611,3460,3432,3628,5755,7020,5922,45814
Muzaffarpur,13.3,Number of School children detected with Refractive errors,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Muzaffarpur,13.4,Number of children provided free glasses,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Muzaffarpur,13.5,Number of eyes collected through eye donation,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Muzaffarpur,13.6,Number of eyes utilised for corneal transplant,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Muzaffarpur,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,1,1,2,1,2,2,2,2,2,2,2,2,Data for this item can not be cumulated
Muzaffarpur,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,1,5,7,7,6,12,15,12,14,24,23,25,Data for this item can not be cumulated
Muzaffarpur,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,2370,2771,2125,2600,2076,2442,2258,2486,2636,2612,2640,2643,Data for this item can not be cumulated
Muzaffarpur,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,1,1,2,1,2,2,2,2,3,3,3,2,Data for this item can not be cumulated
Muzaffarpur,14.05,Number of RKS meetings held during the month,TOTAL,4,7,7,5,5,13,16,12,11,10,12,11,113
Muzaffarpur,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,3,4,8,9,8,8,13,13,14,27,25,26,Data for this item can not be cumulated
Muzaffarpur,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,667,854,706,1362,1683,1515,1648,1559,1807,1987,1507,1558,16853
Muzaffarpur,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,NA,NA,NA,NA,1,1,NA,NA,1,NA,NA,NA,Data for this item can not be cumulated
Muzaffarpur,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,NA,NA,0,0,0,0,0,0,0,0,0,1,Data for this item can not be cumulated
Muzaffarpur,14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,786,848,848,983,790,1003,1063,803,950,836,758,903,10571
Muzaffarpur,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,1710,1780,1902,2035,1929,1914,1643,1287,1770,1700,1696,1894,21260
Muzaffarpur,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,697,776,639,776,854,918,997,652,931,768,855,1268,10131
Muzaffarpur,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,4072,4098,4210,6176,6920,6520,6364,5549,7092,7380,6862,5573,70816
Muzaffarpur,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,1483,1624,1487,1759,1644,1921,2060,1455,1881,1604,1613,2171,20702
Muzaffarpur,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,5782,5878,6112,8211,8849,8434,8007,6836,8862,9080,8558,7467,92076
Muzaffarpur,14.10.2.a,Number of death cases of Inpatient males,TOTAL,83,82,120,93,81,87,103,101,105,109,106,108,1178
Muzaffarpur,14.10.2.b,Number of death cases of Inpatient females,TOTAL,58,56,70,62,57,59,67,56,78,68,64,61,756
Muzaffarpur,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,141,138,190,155,138,146,170,157,183,177,170,169,1934
Muzaffarpur,14.11,In-Patient Head Count at midnight,TOTAL,4653,3957,3731,5465,5040,5484,4862,3398,6864,5442,6319,5877,61092
Muzaffarpur,14.12.1,OPD attendance (All),TOTAL,281948,277537,260356,280989,275512,301029,281219,236035,276786,267719,275405,280094,3294629
Muzaffarpur,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,540,441,660,1039,378,774,772,714,2830,1956,2315,1695,14114
Muzaffarpur,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,11,30,39,54,22,285,22,16,62,44,66,59,710
Muzaffarpur,14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,2736,2614,2354,2781,2041,2454,2818,2460,3256,2697,2866,2891,31968
Muzaffarpur,14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,14.14.a,Number of patients given AYUSH treatment,TOTAL,44877,47412,43338,44784,48918,50067,46747,45225,53266,49094,50960,44770,569458
Muzaffarpur,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,6221,7234,5406,6995,6560,7206,8029,6944,7460,7690,7756,7960,85461
Muzaffarpur,14.14.c,Number of Adolescents counselled,TOTAL,55,52,35,70,70,135,65,85,106,105,90,145,1013
Muzaffarpur,15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,3469,3788,1342,3547,2372,4784,4032,2666,5296,5375,6146,6733,49550
Muzaffarpur,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,192,176,46,232,73,287,330,155,189,177,158,158,2173
Muzaffarpur,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,704,362,197,585,399,536,664,639,603,587,789,567,6632
Muzaffarpur,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,37,39,1,39,31,24,23,25,12,15,28,34,308
Muzaffarpur,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,825,396,221,846,449,640,933,1151,1882,1656,2630,1569,13198
Muzaffarpur,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,24,16,2,18,17,17,18,21,16,15,16,21,201
Muzaffarpur,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,1180,1089,541,1381,895,1528,1059,1242,1206,1701,2103,1389,15314
Muzaffarpur,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,1,1,1,3,2,5,2,5,4,3,1,0,28
Muzaffarpur,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,2709,1847,959,2812,1743,2704,2656,3032,3691,3944,5522,3525,35144
Muzaffarpur,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,62,56,4,60,50,46,43,51,32,33,45,55,537
Muzaffarpur,15.2,Number of Widal tests conducted,Number tested,253,257,18,178,261,105,53,59,34,101,124,182,1625
Muzaffarpur,15.3.a,Number of VDRL tests conducted on males,Number tested,58,61,1,612,21,80,8,10,16,113,6,155,1141
Muzaffarpur,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,40,113,0,0,38,196,32,0,37,304,102,396,1258
Muzaffarpur,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,168,164,43,62,60,215,0,5,0,410,238,468,1833
Muzaffarpur,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,266,338,44,674,119,491,40,15,53,827,346,1019,4232
Muzaffarpur,15.4.1,Number of blood smears examined for Malaria,TOTAL,198,170,18,133,203,309,331,290,130,146,98,381,2407
Muzaffarpur,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,13,13,0,0,0,0,0,4,0,0,0,39,69
Muzaffarpur,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,120,105,0,0,0,0,0,0,0,0,0,0,225
Muzaffarpur,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,3826,4200,9200,9300,8000,5690,3450,2450,3950,3450,3450,3450,60416
Muzaffarpur,16.1.1,Stock position of DPT vaccines,2. Stocks Received,1500,5000,5000,0,2000,0,0,3500,0,1000,NA,NA,18000
Muzaffarpur,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0
Muzaffarpur,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,3070,0,4900,1300,4310,2240,1000,3000,500,1000,NA,NA,21320
Muzaffarpur,16.1.1,Stock position of DPT vaccines,5. Total Stock,2256,9200,9300,8000,5690,3450,2450,2950,3450,3450,3450,3450,57096
Muzaffarpur,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,NA,18500,13500,16625,13366,7336,8800,7768,8700,7831,7831,7831,118088
Muzaffarpur,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,NA,0,12384,0,3456,7776,5184,8064,5184,6048,NA,NA,48096
Muzaffarpur,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0
Muzaffarpur,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,NA,5000,9259,3259,9486,6312,6216,7132,6053,6048,NA,NA,58765
Muzaffarpur,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0,13500,16625,13366,7336,8800,7768,8700,7831,7831,7831,7831,107419
Muzaffarpur,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,2007,2150,2150,4625,5080,1290,3050,550,2300,980,980,980,26142
Muzaffarpur,16.1.2,Stock position of OPV vaccines,2. Stocks Received,1600,7000,10000,5000,8000,11100,6000,10000,7000,9000,NA,NA,74700
Muzaffarpur,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0
Muzaffarpur,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,2560,7000,7525,4545,7218,9340,8500,8250,8320,9000,NA,NA,72258
Muzaffarpur,16.1.2,Stock position of OPV vaccines,5. Total Stock,1047,2150,4625,5080,5862,3050,550,2300,980,980,980,980,28584
Muzaffarpur,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,4290,4940,7840,13540,5250,4200,1200,1150,4500,5800,5800,5800,64310
Muzaffarpur,16.1.3,Stock position of TT vaccines,2. Stocks Received,3150,3000,10000,0,7000,4955,8000,10000,8000,10000,NA,NA,64105
Muzaffarpur,16.1.3,Stock position of TT vaccines,3. Unusable Stock,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0
Muzaffarpur,16.1.3,Stock position of TT vaccines,4. Stock Distributed,2050,100,4300,8290,8050,7955,8050,5550,6700,10000,NA,NA,61045
Muzaffarpur,16.1.3,Stock position of TT vaccines,5. Total Stock,5390,7840,13540,5250,4200,1200,1150,5600,5800,5800,5800,5800,67370
Muzaffarpur,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,16.1.4,Stock position of DT vaccines,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,16.1.4,Stock position of DT vaccines,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,16.1.4,Stock position of DT vaccines,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,16.1.4,Stock position of DT vaccines,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Muzaffarpur,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,2918,4200,4200,7000,8450,8150,8320,7320,5450,5950,5950,5950,73858
Muzaffarpur,16.1.5,Stock position of BCG vaccines,2. Stocks Received,1600,5000,8050,4000,7000,6000,4000,5000,6000,5000,NA,NA,51650
Muzaffarpur,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0
Muzaffarpur,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,3870,5000,5250,2550,7300,5830,5000,6870,5500,5000,NA,NA,52170
Muzaffarpur,16.1.5,Stock position of BCG vaccines,5. Total Stock,648,4200,7000,8450,8150,8320,7320,5450,5950,5950,5950,5950,73338
Muzaffarpur,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,998,2540,5290,5000,10000,11200,10350,7250,6100,5250,5250,5250,74478
Muzaffarpur,16.1.6,Stock position of Measles vaccines,2. Stocks Received,3750,12000,15000,10000,17500,12000,8000,8000,13000,10000,NA,NA,109250
Muzaffarpur,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0
Muzaffarpur,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,3890,9250,15290,5000,16300,12850,11100,9150,13850,10000,NA,NA,106680
Muzaffarpur,16.1.6,Stock position of Measles vaccines,5. Total Stock,858,5290,5000,10000,11200,10350,7250,6100,5250,5250,5250,5250,77048
Muzaffarpur,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,2847,2550,2550,1880,4070,3910,100,1100,1050,2700,2700,2700,28157
Muzaffarpur,16.1.7,Stock position of JE vaccines,2. Stocks Received,2500,5000,3000,5000,11000,3900,7000,5000,10000,6000,NA,NA,58400
Muzaffarpur,16.1.7,Stock position of JE vaccines,3. Unusable Stock,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0
Muzaffarpur,16.1.7,Stock position of JE vaccines,4. Stock Distributed,2875,5000,2670,2810,11660,7710,6000,5050,8350,6000,NA,NA,58125
Muzaffarpur,16.1.7,Stock position of JE vaccines,5. Total Stock,2472,2550,2880,4070,3410,100,1100,1050,2700,2700,2700,2700,28432
Muzaffarpur,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,NA,1750,1750,4050,4525,5500,6500,5450,5300,5000,5000,5000,49825
Muzaffarpur,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,NA,2500,5500,2000,4000,2050,0,2000,0,2500,NA,NA,20550
Muzaffarpur,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0
Muzaffarpur,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,NA,2500,3200,1525,3025,1050,1050,2150,300,2500,NA,NA,17300
Muzaffarpur,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0,1750,4050,4525,5500,6500,5450,5300,5000,5000,5000,5000,53075
Muzaffarpur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Muzaffarpur,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Muzaffarpur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Muzaffarpur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Muzaffarpur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Muzaffarpur,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Muzaffarpur,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,16.3.02,Stock Position of Gloves,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,16.3.02,Stock Position of Gloves,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,16.3.02,Stock Position of Gloves,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,16.3.02,Stock Position of Gloves,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Muzaffarpur,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Muzaffarpur,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Muzaffarpur,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Muzaffarpur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Muzaffarpur,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Muzaffarpur,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Muzaffarpur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Muzaffarpur,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Muzaffarpur,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Muzaffarpur,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,6322,9500,9500,2050,10500,20500,35500,15500,20500,20000,19600,19600,189072
Muzaffarpur,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,15000,25000,0,15000,20000,25000,15000,20000,12000,13000,NA,NA,160000
Muzaffarpur,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0
Muzaffarpur,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,11768,25000,7450,6550,10000,10000,35000,15000,12500,13400,NA,NA,146668
Muzaffarpur,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,9554,9500,2050,10500,20500,35500,15500,20500,20000,19600,19600,19600,202404
Muzaffarpur,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,54130,45000,45000,0,20500,42400,31200,43200,90000,102000,102000,102000,677430
Muzaffarpur,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,100000,100000,0,125000,125000,100000,100000,125000,125000,125000,NA,NA,1025000
Muzaffarpur,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0
Muzaffarpur,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,106130,100000,45000,104500,103100,111200,88000,78200,113000,155000,NA,NA,1004130
Muzaffarpur,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,48000,45000,0,20500,42400,31200,43200,90000,102000,72000,102000,102000,698300
Muzaffarpur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,140,6050,10000,1025,210,1100,3250,2300,8310,10900,10900,10900,65085
Muzaffarpur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,8000,10000,0,5000,10000,20000,10000,12000,15000,12000,NA,NA,102000
Muzaffarpur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0
Muzaffarpur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,3090,6050,5025,5815,9110,17850,10950,5990,12410,7300,NA,NA,83590
Muzaffarpur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,5050,10000,4975,210,1100,3250,2300,8310,10900,15600,10900,10900,83495
Muzaffarpur,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,1,NA,NA,1,3,NA,NA,NA,NA,NA,NA,NA,5
Muzaffarpur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,1,NA,3,NA,NA,NA,4
Muzaffarpur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,1,1,NA,NA,2
Muzaffarpur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,NA,NA,NA,NA,NA,NA,1,NA,4,1,NA,NA,6
Muzaffarpur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,NA,NA,NA,1,NA,NA,1,2,NA,NA,1,NA,5
Muzaffarpur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,2,NA,NA,NA,NA,2
Muzaffarpur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,NA,NA,NA,1,NA,NA,1,4,NA,NA,1,NA,7
Muzaffarpur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,4,NA,NA,4
Muzaffarpur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,4,NA,NA,4
Muzaffarpur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,1
Muzaffarpur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,1
Muzaffarpur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,NA,1,NA,NA,NA,1,NA,NA,1,NA,NA,NA,3
Muzaffarpur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,NA,1,NA,NA,NA,1,NA,NA,1,NA,NA,NA,3
Muzaffarpur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,NA,NA,NA,NA,NA,3,2,3,NA,1,6,NA,15
Muzaffarpur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,9,NA,2,11
Muzaffarpur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,NA,NA,NA,NA,NA,3,2,3,NA,10,6,2,26
Muzaffarpur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,1,1,NA,NA,2
Muzaffarpur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,1,1,NA,NA,2
Muzaffarpur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,1
Muzaffarpur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,1
Muzaffarpur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,1
Muzaffarpur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,1
Muzaffarpur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,1
Muzaffarpur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,1
Muzaffarpur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,1,NA,1,NA,NA,1,3
Muzaffarpur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,NA,NA,NA,NA,NA,NA,1,NA,1,NA,NA,1,3
Muzaffarpur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,1,NA,NA,1,NA,NA,2
Muzaffarpur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,NA,NA,NA,NA,NA,NA,1,NA,NA,1,NA,NA,2
Muzaffarpur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,1
Muzaffarpur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,1
Muzaffarpur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,NA,NA,NA,1,NA,NA,NA,NA,NA,NA,NA,NA,1
Muzaffarpur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,NA,NA,NA,1,NA,NA,NA,NA,NA,NA,NA,NA,1
Muzaffarpur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Muzaffarpur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,NA,1,NA,NA,1,1,NA,1,9,1,1,2,17
Muzaffarpur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,NA,2
Muzaffarpur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,NA,1,NA,NA,1,1,NA,1,9,1,3,2,19
Nalanda,1.1,Total number of pregnant women Registered for ANC,TOTAL,5778,5973,5921,6802,5949,4952,4572,4034,4187,4701,5071,5650,63590
Nalanda,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,3610,3605,3549,3878,3154,2649,2911,2282,2449,2939,3253,3734,38013
Nalanda,1.2,Number of Pregnant women registered under JSY,TOTAL,5688,5885,5920,6750,5947,4923,4572,4034,4187,4701,5071,5650,63328
Nalanda,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,3893,3877,3827,4215,4448,4072,4024,3744,4025,4180,3886,4410,48601
Nalanda,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,4707,4857,4309,5129,4442,3855,3402,2653,3042,3372,3592,4213,47573
Nalanda,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,5767,5951,5846,6761,6661,5881,5278,3925,3947,4308,4304,5331,63960
Nalanda,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,3210,3572,3422,4122,2655,1898,1322,1020,975,1333,2491,3201,29221
Nalanda,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,161,157,312,284,140,59,66,41,48,89,170,183,1710
Nalanda,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,19,2,2,7,1,2,1,7,2,2,3,4,52
Nalanda,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,1266,1237,1318,1554,1559,1136,1455,1059,1119,1078,1307,1450,15538
Nalanda,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,47,60,60,43,42,28,29,36,33,40,33,38,489
Nalanda,1.8,Number of pregnancy test kits used at SC level,TOTAL,821,804,799,1011,1277,1155,1101,918,992,918,807,731,11334
Nalanda,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,203,166,200,230,295,254,109,109,69,95,107,122,1959
Nalanda,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,189,205,241,252,435,451,537,489,482,488,486,352,4607
Nalanda,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,392,371,441,482,730,705,646,598,551,583,593,474,6566
Nalanda,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,313,255,304,325,455,478,492,501,493,510,485,429,5040
Nalanda,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0,4,12,0,4,1,0,0,0,0,0,1,22
Nalanda,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,2196,2476,2457,3552,4737,4819,4703,4284,3532,3401,2717,2456,41330
Nalanda,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,2044,2327,2319,3502,4487,4607,4658,4254,3480,3343,2660,2411,40092
Nalanda,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,2060,2345,2417,3533,4604,4809,4676,4294,3532,3401,2717,2454,40842
Nalanda,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1281,1821,1739,2590,3092,3102,3343,2770,2673,2573,2143,2044,29171
Nalanda,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0,0,0,0,94,0,0,0,0,0,0,0,94
Nalanda,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,123,134,107,141,146,171,219,246,257,254,252,812,2862
Nalanda,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0
Nalanda,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0
Nalanda,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0
Nalanda,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,4,1,5,6,4,9,0,0,1,2,2,3,37
Nalanda,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nalanda,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,153,148,134,198,246,199,45,30,45,55,55,42,1350
Nalanda,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nalanda,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,157,149,139,204,250,208,45,30,46,57,57,45,1387
Nalanda,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,63,70,62,84,78,112,159,165,176,178,181,440,1768
Nalanda,4.1.1.a,Number of male live births,TOTAL,1404,1468,1571,2213,2883,2887,2801,2631,2186,2221,1788,1894,25947
Nalanda,4.1.1.b,Number of female live births,TOTAL,1278,1298,1436,1969,2628,2735,2715,2432,2116,1978,1755,1807,24147
Nalanda,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,2682,2766,3007,4182,5511,5622,5516,5063,4302,4199,3543,3701,50094
Nalanda,4.1.2,Number of still births,TOTAL,64,56,50,75,115,94,97,89,61,70,40,55,866
Nalanda,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,22,20,14,16,12,7,13,7,13,12,15,19,170
Nalanda,4.2.1,Number of Newborns weighed at birth,TOTAL,2461,2621,2626,4083,5174,5251,5125,4692,3999,3875,3209,2839,45955
Nalanda,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,254,285,215,396,562,497,549,710,725,471,349,386,5399
Nalanda,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,2340,2387,2483,3824,4864,4955,5066,4687,3930,3815,3169,2787,44307
Nalanda,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,8,29,4,0,7,1,37,20,19,17,22,31,195
Nalanda,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nalanda,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,151,144,134,189,233,203,49,33,52,55,55,42,1340
Nalanda,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nalanda,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,159,173,138,189,240,204,86,53,71,72,77,73,1535
Nalanda,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,NA,NA,NA,NA,NA,NA,159,165,176,178,181,440,1299
Nalanda,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,584,528,450,587,1415,1436,1239,1312,954,714,616,533,10368
Nalanda,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,118,149,3,2,298,294,334,262,4,13,15,36,1528
Nalanda,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,878,855,895,1165,2229,1949,2234,2181,2045,1059,964,767,17221
Nalanda,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,10,7,9,8,8,3,3,5,6,3,3,6,71
Nalanda,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,2073,2001,1184,2741,3260,3813,3983,3616,3371,3030,2444,2315,33831
Nalanda,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1320,1463,1066,1478,3135,2984,2818,2462,2305,2370,1863,1915,25179
Nalanda,6.3,PNC maternal complications attended,TOTAL,2,87,0,16,1,6,15,2,1,6,2,5,143
Nalanda,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,24,35,22,25,32,21,32,12,20,16,26,21,286
Nalanda,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,7,12,0,0,22,0,11,2,3,1,0,0,58
Nalanda,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,31,47,22,25,54,21,43,14,23,17,26,21,344
Nalanda,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0,0,0,0,51,0,0,0,0,0,0,0,51
Nalanda,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,257,81,154,85,31,26,25,0,36,39,63,28,825
Nalanda,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,17,59,181,50,41,44,35,1,72,65,55,49,669
Nalanda,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,274,140,335,135,72,70,60,1,108,104,118,77,1494
Nalanda,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,23,41,0,0,72,64,34,30,90,21,41,39,455
Nalanda,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,2,6,2,2,2,3,5,7,9,1,10,5,54
Nalanda,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nalanda,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0,0,1,0,2,0,0,1,0,1,1,0,6
Nalanda,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nalanda,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,2,6,3,2,4,3,5,8,9,2,11,5,60
Nalanda,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Nalanda,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Nalanda,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nalanda,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Nalanda,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nalanda,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Nalanda,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Nalanda,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,279,266,174,475,325,1435,1097,651,1288,942,896,748,8576
Nalanda,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nalanda,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,149,87,165,130,118,237,233,151,273,229,260,221,2253
Nalanda,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nalanda,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,428,353,339,605,443,1672,1330,802,1561,1171,1156,969,10829
Nalanda,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,49,37,32,119,34,78,274,70,432,385,367,315,2192
Nalanda,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,34,46,32,156,69,93,118,80,65,72,100,59,924
Nalanda,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nalanda,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,1,64,0,0,80,69,74,46,57,47,54,45,537
Nalanda,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nalanda,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,35,110,32,156,149,162,192,126,122,119,154,104,1461
Nalanda,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Nalanda,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,769,707,802,1294,953,971,1058,901,1304,1131,1152,1225,12267
Nalanda,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,242,266,152,583,417,579,784,581,688,456,426,430,5604
Nalanda,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nalanda,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,71,117,67,176,133,168,158,191,213,218,124,146,1782
Nalanda,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nalanda,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,1082,1090,1021,2053,1503,1718,2000,1673,2205,1805,1702,1801,19653
Nalanda,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,183,245,222,311,276,309,435,332,397,310,241,323,3584
Nalanda,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,0,0,0,0,0,0,0,3,0,0,0,0,3
Nalanda,9.06,Number of IUCD removals,TOTAL,495,484,431,686,651,591,637,586,652,632,615,600,7060
Nalanda,9.07,Number of Oral Pills cycles distributed,TOTAL,2218,1906,2184,2382,3234,3504,2773,2371,2466,2736,2199,1900,29873
Nalanda,9.08,Number of Condom pieces distributed,TOTAL,17880,15404,13574,20020,19156,30093,21466,18755,20578,18256,15762,16982,227926
Nalanda,9.09,Number of Centchroman (weekly) pills given,TOTAL,77,272,241,554,93,174,98,77,112,320,127,107,2252
Nalanda,9.1,Number of Emergency Contraceptive Pills distributed,TOTAL,408,437,369,619,667,657,628,405,588,485,440,464,6167
Nalanda,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0,3,2,0,0,0,0,0,0,0,0,0,5
Nalanda,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0,0,0,3,0,0,0,0,0,0,0,0,3
Nalanda,9.11.2.a,Number of failures following male sterilization,TOTAL,0,0,2,0,0,0,0,0,0,0,0,0,2
Nalanda,9.11.2.b,Number of failures following female sterilization,TOTAL,1,1,0,0,0,0,0,0,0,0,0,0,2
Nalanda,9.11.3.a,Number of deaths following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Nalanda,9.11.3.b,Number of deaths following female sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Nalanda,9.12,Number of Institutions having NSV trained doctors,TOTAL,NA,3,NA,NA,6,11,8,13,12,12,13,12,Data for this item can not be cumulated
Nalanda,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,3730,3932,3894,5885,6689,7325,7118,6448,6000,5609,5047,4421,66098
Nalanda,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,6,20,63,38,18,41,0,0,0,0,0,0,186
Nalanda,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,510,291,270,243,131,85,27,10,4,2,1,0,1574
Nalanda,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,2008,902,589,557,369,243,111,45,23,4,2,0,4853
Nalanda,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,5056,4066,4101,4849,5011,6063,6965,7081,7278,7284,6214,5939,69907
Nalanda,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,5300,5105,4230,4200,4657,5131,5568,5919,6588,7282,6625,6710,67315
Nalanda,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,4629,4938,4685,4407,4250,4754,5053,4982,5604,6497,6499,6800,63098
Nalanda,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,2317,2419,2753,4371,4985,5131,5312,4804,3955,3595,3040,2759,45441
Nalanda,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,4768,4027,3595,4886,4966,6200,6943,7034,7252,7253,6198,5909,69031
Nalanda,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,5539,5359,3935,4459,4757,5198,5578,5906,6576,7277,6604,6695,67883
Nalanda,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,6257,5862,4631,4961,4572,4950,5132,4998,5366,6081,6492,6783,66085
Nalanda,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,1722,1924,1918,2884,4021,4342,4289,3826,3188,3124,2707,2373,36318
Nalanda,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,37,29,132,32,14,7,0,0,0,0,0,0,251
Nalanda,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,582,294,300,233,113,56,33,11,3,2,1,0,1628
Nalanda,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,2008,921,747,582,343,244,96,55,32,3,11,0,5042
Nalanda,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,4797,5307,5416,7153,7014,7333,6666,5288,5226,4850,4686,4942,68678
Nalanda,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,5993,4909,3597,5011,4491,4473,4066,3771,4716,5133,5517,5912,57589
Nalanda,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,4767,4959,4747,6606,6884,6520,6589,5273,4853,4670,4537,4818,65223
Nalanda,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2438,2633,2743,3599,3679,3391,3319,2765,2692,2571,2470,2630,34930
Nalanda,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2105,2248,2557,3257,3247,2993,3187,2437,2453,2266,2114,2208,31072
Nalanda,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,4543,4881,5300,6856,6926,6384,6506,5202,5145,4837,4584,4838,66002
Nalanda,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,6284,4871,4284,5149,4566,4279,4110,3778,4678,5151,5582,5999,58731
Nalanda,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,6286,4856,4233,5133,4577,4281,4116,3778,4691,5151,5582,5999,58683
Nalanda,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,334,598,162,366,146,0,0,0,0,0,0,20,1626
Nalanda,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1319,1546,1065,1514,1496,1191,1176,1207,1296,1558,1606,1756,16730
Nalanda,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1142,1313,919,1304,1384,1071,1064,1006,1140,1367,1453,1616,14779
Nalanda,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,2461,2859,1984,2818,2880,2262,2240,2213,2436,2925,3059,3372,31509
Nalanda,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,824,826,1084,946,1014,1242,1218,1180,1403,1451,1204,1458,13850
Nalanda,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,999,942,1150,1248,1275,1125,1312,1340,1297,1334,1479,1228,14729
Nalanda,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1125,984,1482,1739,1709,1429,1538,1383,1550,1711,1721,1614,17985
Nalanda,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,72,67,57,145,1,23,17,18,29,37,32,27,525
Nalanda,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Nalanda,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,324,471,344,240,410,413,387,357,488,411,389,387,4621
Nalanda,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,3772,3058,3494,3477,3437,3762,3602,3452,3587,3591,3510,3591,42333
Nalanda,10.4.2,Number of Immunisation sessions held during the month,TOTAL,3759,3140,3526,3481,3416,3754,3595,3418,3608,3593,3509,3591,42390
Nalanda,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,3019,2893,1873,2855,2915,3168,3056,2940,3118,3131,3022,3118,35108
Nalanda,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,6365,4719,3989,5252,4392,4314,4080,3576,4663,5089,5482,5800,57721
Nalanda,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,2044,1265,2431,3051,1834,1899,1374,560,493,305,161,144,15561
Nalanda,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,262,208,233,287,326,434,258,127,147,104,70,53,2509
Nalanda,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,15,35,30,26,10,32,16,10,13,2,0,4,193
Nalanda,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Nalanda,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Nalanda,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Nalanda,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Nalanda,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Nalanda,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,38,2,13,320,0,4,0,3,8,2,16,0,406
Nalanda,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,3810,4108,3237,4154,4604,4113,3042,2377,2322,2136,2004,2215,38122
Nalanda,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,354,36,41,35,50,26,13,0,0,0,0,4,559
Nalanda,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0,3,0,0,0,0,0,2,31,93,118,143,390
Nalanda,13.1,Number of Patients operated for cataract,TOTAL,7,1,0,0,0,0,0,0,1058,1758,1194,935,4953
Nalanda,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,7,1,0,0,0,0,0,0,0,0,9,7,24
Nalanda,13.3,Number of School children detected with Refractive errors,TOTAL,0,10,0,0,15,18,15,12,12,15,16,12,125
Nalanda,13.4,Number of children provided free glasses,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Nalanda,13.5,Number of eyes collected through eye donation,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Nalanda,13.6,Number of eyes utilised for corneal transplant,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Nalanda,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,NA,1,NA,NA,2,3,3,3,3,3,3,3,Data for this item can not be cumulated
Nalanda,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,1,2,1,NA,19,19,19,21,22,24,26,27,Data for this item can not be cumulated
Nalanda,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,2215,1983,2177,1559,1930,2142,2124,2108,2167,2134,2232,2238,Data for this item can not be cumulated
Nalanda,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,NA,1,NA,NA,2,3,3,3,3,3,3,3,Data for this item can not be cumulated
Nalanda,14.05,Number of RKS meetings held during the month,TOTAL,20,17,14,18,29,25,27,25,25,18,20,21,259
Nalanda,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,1,3,NA,NA,16,20,19,19,19,18,19,18,Data for this item can not be cumulated
Nalanda,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,1162,1198,659,835,2447,3060,3876,3401,2725,2713,2469,2417,26962
Nalanda,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,NA,1,NA,NA,2,2,2,2,3,3,3,2,Data for this item can not be cumulated
Nalanda,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,NA,0,NA,NA,0,0,0,0,0,0,0,0,Data for this item can not be cumulated
Nalanda,14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nalanda,14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nalanda,14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nalanda,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,2284,2490,2444,3277,3722,3416,3496,3324,3211,3429,3223,3140,37456
Nalanda,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,2581,2842,3248,3454,4296,4310,3919,3585,3320,3392,3197,3328,41472
Nalanda,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,2361,2581,2178,3107,3647,3698,3667,3527,3211,3365,3121,3201,37664
Nalanda,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,4027,3911,4987,6921,6839,7105,11737,10492,10984,10584,9686,9286,96559
Nalanda,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,4645,5071,4622,6384,7369,7114,7163,6851,6422,6794,6344,6341,75120
Nalanda,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,6608,6753,8235,10375,11135,11415,15656,14077,14304,13976,12883,12614,138031
Nalanda,14.10.2.a,Number of death cases of Inpatient males,TOTAL,2,61,9,8,9,5,8,4,6,5,2,6,125
Nalanda,14.10.2.b,Number of death cases of Inpatient females,TOTAL,3,124,10,3,4,2,3,1,4,2,2,1,159
Nalanda,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,5,185,19,11,13,7,11,5,10,7,4,7,284
Nalanda,14.11,In-Patient Head Count at midnight,TOTAL,15155,15271,15013,17852,9789,18383,18402,16555,18730,18043,16042,16516,195751
Nalanda,14.12.1,OPD attendance (All),TOTAL,196034,189067,179729,200176,215218,228701,208741,195970,203557,200995,201772,207100,2427060
Nalanda,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,754,639,626,2242,1446,2063,1677,1078,1786,1443,1495,1177,16426
Nalanda,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0,21,0,72,378,399,34,21,40,42,48,36,1091
Nalanda,14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nalanda,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,4526,4849,4442,6092,6075,6550,6681,6381,6476,6706,6750,7050,72578
Nalanda,14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nalanda,14.14.a,Number of patients given AYUSH treatment,TOTAL,31765,25608,28917,31603,36515,39806,39143,40022,39226,37468,34108,35060,419241
Nalanda,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,4423,5055,4762,6042,6554,7444,7193,6051,6318,6462,6671,7118,74093
Nalanda,14.14.c,Number of Adolescents counselled,TOTAL,233,497,144,261,14,28,7,14,22,22,131,134,1507
Nalanda,15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nalanda,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,4400,4299,4173,5399,5991,6663,4556,3824,4430,4120,4317,4460,56632
Nalanda,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,154,128,136,162,97,144,92,83,98,122,115,139,1470
Nalanda,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,233,95,156,60,245,248,152,203,213,323,334,299,2561
Nalanda,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,0,0,5,1,9,8,3,2,0,1,4,3,36
Nalanda,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,211,76,182,186,288,428,397,366,635,588,775,742,4874
Nalanda,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0,0,3,1,4,55,3,3,6,4,10,38,127
Nalanda,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,431,332,529,178,528,668,459,506,638,561,623,692,6145
Nalanda,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0,0,1,1,0,25,0,0,4,0,0,45,76
Nalanda,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,875,503,867,424,1061,1344,1008,1075,1486,1472,1732,1733,13580
Nalanda,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,0,0,9,3,13,88,6,5,10,5,14,86,239
Nalanda,15.2,Number of Widal tests conducted,Number tested,271,17,0,45,804,27,31,47,36,39,42,47,1406
Nalanda,15.3.a,Number of VDRL tests conducted on males,Number tested,84,92,154,41,198,181,110,136,128,164,201,189,1678
Nalanda,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,330,75,181,47,171,196,175,118,260,265,286,278,2382
Nalanda,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,330,332,529,154,463,476,332,307,455,418,490,573,4859
Nalanda,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,744,499,864,242,832,853,617,561,843,847,977,1040,8919
Nalanda,15.4.1,Number of blood smears examined for Malaria,TOTAL,715,484,751,754,443,556,979,763,640,577,467,671,7800
Nalanda,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,26,41,0,18,27,4,0,0,0,0,0,0,116
Nalanda,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,19,0,0,0,14,1,0,0,1,0,0,0,35
Nalanda,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,1050,850,1350,1750,1600,4100,3650,3130,2870,1980,1406,856,24592
Nalanda,16.1.1,Stock position of DPT vaccines,2. Stocks Received,500,1500,1500,1100,3150,0,0,0,0,0,700,6000,14450
Nalanda,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0,0,0,0,0,0,0,0,NA,0,NA,NA,0
Nalanda,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,700,1000,1100,1250,650,450,520,260,840,574,1250,1000,9594
Nalanda,16.1.1,Stock position of DPT vaccines,5. Total Stock,850,1350,1750,1600,4100,3650,3130,2870,2030,1406,856,5856,29448
Nalanda,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,1165,1990,2920,2500,1648,4504,3352,4960,3228,828,2268,868,30231
Nalanda,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,2400,2700,2000,1456,3840,0,3360,0,0,3264,1044,2016,22080
Nalanda,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0,0,0,0,0,0,0,0,NA,0,NA,NA,0
Nalanda,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,1575,1770,2420,2308,984,1152,1752,1732,2160,1824,2840,2250,22767
Nalanda,16.1.1A,Stock Position of Pentavalent,5. Total Stock,1990,2920,2500,1648,4504,3352,4960,3228,1068,2268,472,634,29544
Nalanda,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,2840,3075,3350,2175,1600,2875,2050,3950,1975,775,1075,1050,26790
Nalanda,16.1.2,Stock position of OPV vaccines,2. Stocks Received,2000,2000,1500,1750,3000,1000,3900,0,1200,2000,2000,710,21060
Nalanda,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0,0,0,0,0,0,0,0,NA,0,NA,NA,0
Nalanda,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,1765,1725,2675,2325,1725,1825,2000,1975,2100,1700,2025,1275,23115
Nalanda,16.1.2,Stock position of OPV vaccines,5. Total Stock,3075,3350,2175,1600,2875,2050,3950,1975,1075,1075,1050,485,24735
Nalanda,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,2600,1950,1700,2550,1200,4250,2600,6815,5495,4025,3155,2605,38945
Nalanda,16.1.3,Stock position of TT vaccines,2. Stocks Received,500,1000,3050,1456,4150,0,5635,0,0,0,1450,500,17741
Nalanda,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0,0,0,0,0,0,0,0,NA,0,NA,NA,0
Nalanda,16.1.3,Stock position of TT vaccines,4. Stock Distributed,1150,1250,2200,2308,1100,1650,1420,1320,1270,870,2000,1950,18488
Nalanda,16.1.3,Stock position of TT vaccines,5. Total Stock,1950,1700,2550,1698,4250,2600,6815,5495,4225,3155,2605,1155,38198
Nalanda,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0,0,0,0,0,0,0,0,0,200,376,171,747
Nalanda,16.1.4,Stock position of DT vaccines,2. Stocks Received,0,0,0,0,0,0,0,0,1100,820,860,850,3630
Nalanda,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0,0,0,0,0,0,0,0,NA,0,NA,NA,0
Nalanda,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0,0,0,0,0,0,0,0,1014,644,1065,819,3542
Nalanda,16.1.4,Stock position of DT vaccines,5. Total Stock,0,0,0,0,0,0,0,0,86,376,171,202,835
Nalanda,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,1590,1910,2350,1800,1450,3250,1250,2780,1280,1650,2200,1700,23210
Nalanda,16.1.5,Stock position of BCG vaccines,2. Stocks Received,1400,2000,1500,1400,2700,0,3150,0,2500,2000,1650,500,18800
Nalanda,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0,0,0,0,0,0,0,0,NA,0,NA,NA,0
Nalanda,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,1080,1560,2050,1750,900,2000,1620,1500,1880,1450,2150,1450,19390
Nalanda,16.1.5,Stock position of BCG vaccines,5. Total Stock,1910,2350,1800,1450,3250,1250,2780,1280,1900,2200,1700,750,22620
Nalanda,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,900,1600,770,550,1750,4100,1850,2370,790,650,1000,1750,18080
Nalanda,16.1.6,Stock position of Measles vaccines,2. Stocks Received,4000,3000,4000,4600,6000,1550,4000,2000,3500,3100,4600,2200,42550
Nalanda,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0,0,0,0,0,0,0,0,NA,0,NA,NA,0
Nalanda,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,3300,3830,4220,3400,3650,3800,3480,3580,3290,2750,3850,3400,42550
Nalanda,16.1.6,Stock position of Measles vaccines,5. Total Stock,1600,770,550,1750,4100,1850,2370,790,1000,1000,1750,550,18080
Nalanda,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,1420,1120,500,700,1350,3750,2010,3560,1070,450,1460,290,17680
Nalanda,16.1.7,Stock position of JE vaccines,2. Stocks Received,3000,3000,4500,4000,6000,2050,5000,1000,3000,4000,3000,3500,42050
Nalanda,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0,0,0,0,0,0,0,0,NA,0,NA,NA,0
Nalanda,16.1.7,Stock position of JE vaccines,4. Stock Distributed,3300,3620,4300,3550,3600,3790,3450,3490,3300,2990,4170,3440,43000
Nalanda,16.1.7,Stock position of JE vaccines,5. Total Stock,1120,500,700,1150,3750,2010,3560,1070,770,1460,290,350,16730
Nalanda,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,2250,1800,1450,1800,850,2000,1650,2600,2450,2050,1740,1037,21677
Nalanda,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0,0,1000,0,1300,0,1150,0,0,0,30,100,3580
Nalanda,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0,0,0,0,0,0,0,0,NA,0,NA,NA,0
Nalanda,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,450,350,650,950,150,350,200,150,400,310,733,662,5355
Nalanda,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,1800,1450,1800,850,2000,1650,2600,2450,2050,1740,1037,475,19902
Nalanda,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,NA,NA,NA,NA,NA,0,0,0,6617,NA,4517,NA,11134
Nalanda,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,NA,NA,NA,NA,NA,0,0,0,0,NA,0,NA,0
Nalanda,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,0,0,0,NA,NA,NA,NA,0
Nalanda,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,NA,NA,NA,NA,NA,0,0,0,2100,NA,300,NA,2400
Nalanda,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,4517,0,4217,0,8734
Nalanda,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,NA,NA,NA,NA,NA,0,0,0,42471,NA,2343,NA,44814
Nalanda,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,NA,NA,NA,NA,NA,0,0,0,0,NA,0,NA,0
Nalanda,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,0,0,0,NA,NA,NA,NA,0
Nalanda,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,NA,NA,NA,NA,NA,0,0,0,19040,NA,0,NA,19040
Nalanda,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,23431,0,2343,0,25774
Nalanda,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,NA,NA,NA,NA,NA,0,0,0,3450,NA,2187,NA,5637
Nalanda,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,NA,NA,NA,NA,NA,0,0,0,0,NA,0,NA,0
Nalanda,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,0,0,0,NA,NA,NA,NA,0
Nalanda,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,NA,NA,NA,NA,NA,0,0,0,1263,NA,0,NA,1263
Nalanda,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,2187,0,2187,0,4374
Nalanda,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,NA,NA,NA,NA,NA,0,0,0,4454,NA,3200,NA,7654
Nalanda,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,NA,NA,NA,NA,NA,0,0,0,0,NA,0,NA,0
Nalanda,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,0,0,0,NA,NA,NA,NA,0
Nalanda,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,NA,NA,NA,NA,NA,0,0,0,1204,NA,0,NA,1204
Nalanda,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,3250,0,3200,0,6450
Nalanda,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,NA,NA,NA,NA,NA,0,0,0,2344,NA,0,NA,2344
Nalanda,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,NA,NA,NA,NA,NA,0,0,0,0,NA,0,NA,0
Nalanda,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,0,0,0,NA,NA,NA,NA,0
Nalanda,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,NA,NA,NA,NA,NA,0,0,0,1700,NA,0,NA,1700
Nalanda,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,644,0,0,0,644
Nalanda,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,NA,NA,NA,NA,NA,8000,8000,8000,7850,NA,7850,NA,39700
Nalanda,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,NA,NA,NA,NA,NA,0,0,0,0,NA,24000,NA,24000
Nalanda,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,NA,NA,NA,NA,NA,0,0,0,NA,NA,NA,NA,0
Nalanda,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,NA,NA,NA,NA,NA,0,0,150,0,NA,22350,NA,22500
Nalanda,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0,0,0,0,0,8000,8000,7850,7850,0,9500,0,41200
Nalanda,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,NA,NA,NA,NA,NA,0,0,0,0,NA,0,NA,0
Nalanda,16.3.02,Stock Position of Gloves,2. Stocks Received,NA,NA,NA,NA,NA,0,0,0,0,NA,0,NA,0
Nalanda,16.3.02,Stock Position of Gloves,3. Unusable Stock,NA,NA,NA,NA,NA,0,0,0,NA,NA,NA,NA,0
Nalanda,16.3.02,Stock Position of Gloves,4. Stock Distributed,NA,NA,NA,NA,NA,0,0,0,0,NA,0,NA,0
Nalanda,16.3.02,Stock Position of Gloves,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Nalanda,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,NA,NA,NA,NA,NA,0,0,0,0,NA,0,NA,0
Nalanda,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,NA,NA,NA,NA,NA,0,0,0,0,NA,0,NA,0
Nalanda,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,NA,NA,NA,NA,NA,0,0,0,NA,NA,NA,NA,0
Nalanda,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,NA,NA,NA,NA,NA,0,0,0,0,NA,0,NA,0
Nalanda,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Nalanda,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,NA,NA,NA,NA,NA,700,700,700,200,NA,0,NA,2300
Nalanda,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,NA,NA,NA,NA,NA,0,0,0,0,NA,48000,NA,48000
Nalanda,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,NA,NA,NA,NA,NA,0,0,0,NA,NA,NA,NA,0
Nalanda,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,NA,NA,NA,NA,NA,0,0,700,200,NA,29200,NA,30100
Nalanda,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0,0,0,0,0,700,700,0,0,0,18800,0,20200
Nalanda,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,NA,NA,NA,NA,NA,0,0,0,0,NA,0,NA,0
Nalanda,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,NA,NA,NA,NA,NA,0,0,0,0,NA,0,NA,0
Nalanda,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,NA,NA,NA,NA,NA,0,0,0,NA,NA,NA,NA,0
Nalanda,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,NA,NA,NA,NA,NA,0,0,0,0,NA,0,NA,0
Nalanda,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Nalanda,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,NA,NA,NA,NA,NA,0,0,0,0,NA,0,NA,0
Nalanda,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,NA,NA,NA,NA,NA,0,0,0,0,NA,0,NA,0
Nalanda,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,NA,NA,NA,NA,NA,0,0,0,NA,NA,NA,NA,0
Nalanda,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,NA,NA,NA,NA,NA,0,0,0,0,NA,0,NA,0
Nalanda,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Nalanda,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,NA,NA,NA,NA,NA,0,0,0,0,NA,1000000,NA,1000000
Nalanda,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,NA,NA,NA,NA,NA,0,0,0,2749600,NA,0,NA,2749600
Nalanda,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,NA,NA,NA,NA,NA,0,0,0,NA,NA,NA,NA,0
Nalanda,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,NA,NA,NA,NA,NA,0,0,0,1420800,NA,972200,NA,2393000
Nalanda,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0,0,0,0,0,0,0,0,1328800,0,27800,0,1356600
Nalanda,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,NA,NA,NA,NA,NA,0,0,0,0,NA,0,NA,0
Nalanda,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,NA,NA,NA,NA,NA,0,0,0,0,NA,0,NA,0
Nalanda,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,NA,NA,NA,NA,NA,0,0,0,NA,NA,NA,NA,0
Nalanda,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,NA,NA,NA,NA,NA,0,0,0,0,NA,0,NA,0
Nalanda,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Nalanda,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,NA,NA,NA,NA,NA,0,0,0,0,NA,0,NA,0
Nalanda,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,NA,NA,NA,NA,NA,0,0,0,0,NA,0,NA,0
Nalanda,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,NA,NA,NA,NA,NA,0,0,0,NA,NA,NA,NA,0
Nalanda,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,NA,NA,NA,NA,NA,0,0,0,0,NA,0,NA,0
Nalanda,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Nalanda,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,NA,NA,NA,NA,NA,0,0,0,0,NA,0,NA,0
Nalanda,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,NA,NA,NA,NA,NA,0,0,0,0,NA,0,NA,0
Nalanda,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,NA,NA,NA,NA,NA,0,0,0,NA,NA,NA,NA,0
Nalanda,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,NA,NA,NA,NA,NA,0,0,0,0,NA,0,NA,0
Nalanda,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Nalanda,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,NA,NA,NA,NA,NA,20000,20000,8000,6750,NA,0,NA,54750
Nalanda,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,NA,NA,NA,NA,NA,0,0,0,0,NA,0,NA,0
Nalanda,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,NA,NA,NA,NA,NA,0,0,0,NA,NA,NA,NA,0
Nalanda,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,NA,NA,NA,NA,NA,0,12500,1000,6750,NA,0,NA,20250
Nalanda,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0,0,0,0,0,20000,7500,7000,0,0,0,0,34500
Nalanda,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,13400,8000,5600,6800,9000,12400,5600,9600,21800,NA,6100,11100,109400
Nalanda,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0,6000,8000,10000,10000,0,10000,20000,0,NA,16000,16000,96000
Nalanda,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0,0,0,0,0,0,0,0,NA,NA,NA,NA,0
Nalanda,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,5400,8400,6800,7800,6600,6800,6000,7800,9200,NA,11000,7000,82800
Nalanda,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,8000,5600,6800,9000,12400,5600,9600,21800,12600,0,11100,20100,122600
Nalanda,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,73000,8000,41000,63200,76400,98000,49600,55600,180200,NA,43200,129200,817400
Nalanda,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0,100000,100000,81600,85000,0,85000,180000,0,NA,180000,180000,991600
Nalanda,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0,0,0,0,0,0,0,0,NA,NA,NA,NA,0
Nalanda,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,65000,67000,77800,68400,63400,48400,79000,55400,76000,NA,94000,82000,776400
Nalanda,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,8000,41000,63200,76400,98000,49600,55600,180200,104200,0,129200,227200,1032600
Nalanda,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,8400,1600,3600,3500,7100,11700,2600,7400,20400,NA,2800,12000,81100
Nalanda,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0,10000,7500,12000,12000,0,12000,2000,0,NA,29000,20000,104500
Nalanda,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0,0,0,0,0,0,0,0,NA,NA,NA,NA,0
Nalanda,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,6800,8000,7600,8400,7400,9100,7200,7000,10200,NA,10800,8600,91100
Nalanda,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,1600,3600,3500,7100,11700,2600,7400,2400,10200,0,21000,23400,94500
Nalanda,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,NA,1,3
Nalanda,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,1
Nalanda,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nalanda,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,1
Nalanda,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,NA,1
Nalanda,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nalanda,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,NA,1
Nalanda,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,1,3,NA,NA,4
Nalanda,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,1
Nalanda,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,2,3,NA,NA,5
Nalanda,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,3,NA,NA,6,1,NA,10
Nalanda,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,1
Nalanda,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,NA,NA,NA,NA,NA,NA,3,NA,NA,7,1,NA,11
Nalanda,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nalanda,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nalanda,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nalanda,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,2,NA,NA,NA,NA,NA,2
Nalanda,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nalanda,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,NA,NA,NA,NA,NA,NA,2,NA,NA,NA,NA,NA,2
Nalanda,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nalanda,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nalanda,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nalanda,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nalanda,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nalanda,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nalanda,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1,1,3
Nalanda,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,1
Nalanda,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,1,1,4
Nalanda,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nalanda,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nalanda,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nalanda,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nalanda,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nalanda,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nalanda,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nalanda,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nalanda,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nalanda,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nalanda,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nalanda,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nalanda,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nalanda,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nalanda,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nalanda,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nalanda,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nalanda,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,NA,1
Nalanda,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nalanda,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,NA,1
Nalanda,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nalanda,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nalanda,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nalanda,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nalanda,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nalanda,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,1,2
Nalanda,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nalanda,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,1,2
Nalanda,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nalanda,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nalanda,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nalanda,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nalanda,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nalanda,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,NA,1
Nalanda,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nalanda,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,NA,1
Nalanda,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nalanda,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,1,2,1,NA,NA,NA,4
Nalanda,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nalanda,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,NA,NA,NA,NA,NA,NA,1,2,1,NA,NA,NA,4
Nalanda,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nalanda,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,1
Nalanda,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nalanda,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,1
Nalanda,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nalanda,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,1
Nalanda,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nalanda,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,1
Nalanda,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nalanda,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nalanda,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nalanda,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nalanda,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nalanda,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,NA,NA,NA,NA,NA,1,2,1,NA,NA,1,NA,5
Nalanda,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nalanda,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,NA,NA,NA,NA,NA,1,2,1,NA,NA,1,NA,5
Nalanda,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nalanda,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,NA,1
Nalanda,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nalanda,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,NA,1
Nalanda,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nalanda,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1
Nalanda,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nalanda,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1
Nalanda,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nalanda,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,NA,1
Nalanda,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nalanda,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,NA,1
Nalanda,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nalanda,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,NA,1
Nalanda,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nalanda,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,NA,1
Nalanda,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nalanda,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,1
Nalanda,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nalanda,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,1
Nalanda,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,NA,NA,NA,NA,NA,1,NA,1,NA,NA,1,NA,3
Nalanda,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,NA,NA,NA,NA,NA,5,2,2,1,NA,1,2,13
Nalanda,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,9,4,NA,5,2,1,21
Nalanda,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,NA,NA,NA,NA,NA,6,11,7,1,5,4,3,37
Nawada,1.1,Total number of pregnant women Registered for ANC,TOTAL,4429,4825,5645,5913,6136,4323,3768,3241,3997,4293,4533,4711,55814
Nawada,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,2412,2767,3127,3138,2654,2300,2379,2121,2600,2791,2901,3166,32356
Nawada,1.2,Number of Pregnant women registered under JSY,TOTAL,4429,4825,5645,5913,5925,4323,3768,3241,3997,4293,4533,4711,55603
Nawada,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,2247,2512,2764,3033,4431,3093,2879,2427,2645,3195,3134,3169,35529
Nawada,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,3420,3724,4323,4413,3663,3171,2777,2534,2952,3148,3321,3446,40892
Nawada,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,3882,4175,4889,5590,5061,4813,3824,3034,3368,3517,3654,3984,49791
Nawada,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1507,1334,940,1041,438,0,33,40,1150,2207,3782,3591,16063
Nawada,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,120,75,21,23,67,36,51,47,44,57,49,56,646
Nawada,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0,0,0,2,3,5,16,10,7,9,7,0,59
Nawada,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,200,244,298,603,1211,1196,1202,1108,1499,1385,1559,1408,11913
Nawada,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,15,38,58,52,55,25,45,32,64,69,70,39,562
Nawada,1.8,Number of pregnancy test kits used at SC level,TOTAL,500,696,904,1113,887,853,548,507,593,705,903,749,8958
Nawada,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,22,3,7,11,6,12,3,5,15,11,17,16,128
Nawada,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,591,542,704,743,794,758,750,721,771,764,664,637,8439
Nawada,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,613,545,711,754,800,770,753,726,786,775,681,653,8567
Nawada,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,478,421,577,562,676,647,587,597,594,614,555,474,6782
Nawada,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0,1,0,6,10,0,0,10,7,12,6,0,52
Nawada,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1586,1841,2000,2822,3319,3161,3311,3125,2741,2349,1878,1641,29774
Nawada,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,1565,1807,1967,2794,3097,2971,3294,3105,2720,2337,1864,1619,29140
Nawada,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1781,1974,1789,1691,3587,3440,3716,3265,2742,2138,2308,1764,30195
Nawada,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1148,1328,1029,1354,3002,3474,2466,2006,5586,2341,3044,1771,28549
Nawada,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Nawada,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,0,0,0,0,0,0,0,34,53,45,51,37,220
Nawada,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Nawada,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Nawada,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Nawada,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Nawada,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0,0,0,0,0,0,0,0,0,NA,0,NA,0
Nawada,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,21,37,33,28,36,30,17,19,21,12,14,22,290
Nawada,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,21,37,33,28,36,30,17,19,21,12,14,22,290
Nawada,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,0,0,0,0,0,0,0,19,18,21,18,23,99
Nawada,4.1.1.a,Number of male live births,TOTAL,1103,1211,1336,1887,2090,2026,2087,1999,1807,1641,1291,1235,19713
Nawada,4.1.1.b,Number of female live births,TOTAL,1062,1131,1340,1666,1973,1848,1933,1840,1741,1461,1233,1045,18273
Nawada,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,2165,2342,2676,3553,4063,3874,4020,3839,3548,3102,2524,2280,37986
Nawada,4.1.2,Number of still births,TOTAL,34,60,47,58,70,81,69,62,62,51,42,46,682
Nawada,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,0,1,0,0,0,5,4,3,2,1,6,3,25
Nawada,4.2.1,Number of Newborns weighed at birth,TOTAL,2165,2293,2676,3553,4056,3874,4018,3805,3494,3096,2524,2262,37816
Nawada,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,57,95,84,108,103,128,154,122,118,90,65,58,1182
Nawada,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,2144,2249,2638,3503,3963,3857,3983,3790,3467,3086,2500,2241,37421
Nawada,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0,0,0,30,28,48,41,37,34,16,144,7,385
Nawada,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0,0,0,0,0,0,0,0,0,NA,0,NA,0
Nawada,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,21,0,0,0,36,30,17,3,39,13,20,49,228
Nawada,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,21,0,0,30,64,78,58,40,73,29,164,56,613
Nawada,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0,0,0,0,0,0,0,0,NA,0,0,0,0
Nawada,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,2676,1844,2096,2792,3062,2803,2648,2323,2474,2126,2006,1848,28698
Nawada,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,38,26,34,126,97,126,137,128,152,114,103,89,1170
Nawada,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,1609,2033,2408,3966,3681,3233,3541,3495,3142,1972,2253,2579,33912
Nawada,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,49,0,9,13,14,15,14,8,13,54,8,46,243
Nawada,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1421,1802,1919,2540,3046,2518,2828,2612,2552,2268,1775,1661,26942
Nawada,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,789,949,1054,1347,1657,1283,1461,1539,1391,1235,1156,925,14786
Nawada,6.3,PNC maternal complications attended,TOTAL,21,1,0,5,4,0,0,0,23,13,20,22,109
Nawada,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,3,3,6,5,5,25,23,22,22,28,34,36,212
Nawada,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0,0,0,0,2,73,42,17,48,48,85,74,389
Nawada,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,3,3,6,5,7,98,65,39,70,76,119,110,601
Nawada,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Nawada,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,59,61,18,51,32,0,0,1,53,67,63,28,433
Nawada,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,282,323,346,314,329,0,0,0,425,313,331,429,3092
Nawada,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,341,384,364,365,361,0,0,1,478,380,394,457,3525
Nawada,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0,6,70,75,68,87,55,58,59,55,62,55,650
Nawada,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,9,4,1,14,5,8,10,10,11,6,7,5,90
Nawada,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0,0,0,0,NA,0,0,0,0,NA,0,NA,0
Nawada,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,1,0,0,2,2,4,1,1,2,4,0,1,18
Nawada,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,10,4,1,16,7,12,11,11,13,10,7,6,108
Nawada,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0,0,0,0,0,0,0,0,NA,0,0,0,0
Nawada,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Nawada,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0,0,0,0,0,0,0,0,0,NA,0,NA,0
Nawada,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0,0,0,0,0,0,0,0,0,NA,0,0,0
Nawada,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Nawada,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0,0,0,0,0,0,0,0,NA,0,0,0,0
Nawada,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,263,234,254,815,480,1019,1027,484,1338,923,995,648,8480
Nawada,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0,0,0,0,0,0,0,0,0,NA,0,NA,0
Nawada,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,16,5,4,15,20,15,29,25,63,45,44,26,307
Nawada,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,279,239,258,830,500,1034,1056,509,1401,968,1039,674,8787
Nawada,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,10,9,0,31,0,0,0,0,183,173,196,42,644
Nawada,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0,30,0,0,8,0,0,0,0,0,0,0,38
Nawada,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0,0,0,0,0,0,0,0,0,NA,0,NA,0
Nawada,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,3,1,15,5,11,3,4,3,5,3,4,5,62
Nawada,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,3,31,15,5,19,3,4,3,5,3,4,5,100
Nawada,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0,0,0,0,0,0,0,0,NA,0,0,0,0
Nawada,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,346,324,358,508,409,426,389,386,515,494,473,453,5081
Nawada,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,186,189,179,476,242,293,395,273,378,329,400,374,3714
Nawada,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,0,0,0,0,0,0,0,0,0,NA,0,NA,0
Nawada,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,12,23,27,33,61,109,84,71,72,112,45,82,731
Nawada,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,544,536,564,1017,712,828,868,730,965,935,918,909,9526
Nawada,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,45,49,66,72,74,100,97,80,69,123,80,92,947
Nawada,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,6,6,0,0,0,0,0,0,NA,0,0,0,12
Nawada,9.06,Number of IUCD removals,TOTAL,225,196,232,260,280,248,221,211,236,265,450,246,3070
Nawada,9.07,Number of Oral Pills cycles distributed,TOTAL,1071,1203,1367,2650,1934,1937,1587,1397,1983,1836,1789,1661,20415
Nawada,9.08,Number of Condom pieces distributed,TOTAL,12355,13924,15087,25133,16670,18211,15726,15549,17311,16638,16346,15865,198815
Nawada,9.09,Number of Centchroman (weekly) pills given,TOTAL,75,42,185,213,84,111,95,67,135,153,345,145,1650
Nawada,9.1,Number of Emergency Contraceptive Pills distributed,TOTAL,185,188,196,430,317,258,357,311,401,350,386,385,3764
Nawada,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Nawada,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Nawada,9.11.2.a,Number of failures following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Nawada,9.11.2.b,Number of failures following female sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Nawada,9.11.3.a,Number of deaths following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Nawada,9.11.3.b,Number of deaths following female sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Nawada,9.12,Number of Institutions having NSV trained doctors,TOTAL,NA,1,NA,1,2,2,5,3,4,3,4,2,Data for this item can not be cumulated
Nawada,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,3012,3237,3727,5163,5875,5754,5303,5356,5685,4819,4127,3668,55726
Nawada,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,18,54,15,32,22,6,9,1,7,0,2,0,166
Nawada,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,624,381,370,370,182,113,75,21,5,6,5,0,2152
Nawada,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,1695,1109,834,805,510,296,155,84,1778,3108,3255,3538,17167
Nawada,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,4004,3445,3901,4430,4239,4953,5078,4882,5580,5442,4998,4710,55662
Nawada,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,4048,4111,3704,4233,4225,4272,4407,4424,5248,5420,5116,5490,54698
Nawada,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,3229,3706,3799,3844,3935,4275,3936,3800,4373,4926,4975,5279,50077
Nawada,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1798,1875,2243,3091,3705,3594,3678,2914,3455,2845,2452,2013,33663
Nawada,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,4103,3575,3917,4526,4287,4971,5021,5556,5538,5488,5018,4740,56740
Nawada,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,4566,4523,4035,4539,4339,4358,4412,4443,5260,5401,5096,5798,56770
Nawada,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,4644,4674,4493,4511,4331,4433,3964,3940,4404,4936,4997,5278,54605
Nawada,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,1599,1735,1916,2778,3120,3117,3173,2904,2756,2330,1936,1619,28983
Nawada,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,122,82,61,151,53,6,37,0,1,0,2,0,515
Nawada,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,761,410,383,456,218,103,97,15,5,3,4,0,2455
Nawada,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,1784,1124,871,888,515,393,177,78,40,5,1,0,5876
Nawada,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,3576,4011,4631,5323,5188,5434,5009,3943,4183,3768,3851,3564,52481
Nawada,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,3620,3630,3869,4026,3497,3718,3484,3042,3684,3936,4216,4486,45208
Nawada,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,3543,3750,4499,5209,4883,5115,4811,3813,4122,3648,3739,3595,50727
Nawada,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1813,2084,2345,2735,2592,2786,2529,1994,2184,1922,1942,1828,26754
Nawada,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1692,1845,2104,2551,2474,2588,2363,1814,1916,1777,1790,1651,24565
Nawada,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,3505,3929,4449,5286,5066,5374,4892,3808,4100,3699,3732,3479,51319
Nawada,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,3893,3832,4034,4275,3612,3741,3444,3077,3698,3985,4228,4493,46312
Nawada,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,3910,3830,4040,4288,3677,3745,3440,3069,3707,3973,4213,4480,46372
Nawada,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,77,8,14,65,35,0,0,0,0,45,28,0,272
Nawada,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1515,1455,1561,1810,1562,1725,1634,1508,1773,1878,2043,2156,20620
Nawada,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1354,1383,1465,1587,1433,1556,1488,1361,1628,1688,1863,1970,18776
Nawada,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,2869,2838,3026,3397,2995,3281,3122,2869,3401,3566,3906,4126,39396
Nawada,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,709,547,472,485,416,750,636,692,900,918,936,1010,8471
Nawada,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,1389,1183,1269,1409,1231,1257,1182,1182,1300,1306,1344,1425,15477
Nawada,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1646,1338,1478,1632,1483,1503,1537,1374,1635,1653,1703,1803,18785
Nawada,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0,24,16,11,0,0,0,0,13,10,0,0,74
Nawada,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0,0,0,0,0,0,0,0,1,0,0,0,1
Nawada,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,1,0,0,0,0,0,0,0,0,0,2,5,8
Nawada,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1982,1885,2037,2072,2036,2007,2021,2014,2083,2029,2044,2044,24254
Nawada,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1999,1878,2030,2056,2010,1962,2009,1968,2069,2016,2031,2039,24067
Nawada,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1875,1782,1878,1927,1900,1866,1904,1867,1979,1954,1948,1934,22814
Nawada,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,3849,3754,3850,4122,3399,3510,3269,2905,3653,3663,4054,4069,44097
Nawada,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,2532,3064,3444,4043,3744,3464,2925,2089,2218,1301,1084,1100,31008
Nawada,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,1065,1373,1386,1753,1374,1251,888,963,1425,591,778,846,13693
Nawada,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,214,301,241,329,251,234,179,147,132,91,131,79,2329
Nawada,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Nawada,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Nawada,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Nawada,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Nawada,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Nawada,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0,2,0,0,5,15,0,0,0,0,2,1,25
Nawada,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,465,482,499,436,306,245,178,88,101,104,135,176,3215
Nawada,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,19,87,153,175,177,185,293,162,90,62,186,143,1732
Nawada,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,8,5,7,10,13,15,11,13,11,9,33,19,154
Nawada,13.1,Number of Patients operated for cataract,TOTAL,0,0,0,0,0,0,0,0,106,36,19,30,191
Nawada,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0,0,0,0,0,0,0,0,0,36,0,0,36
Nawada,13.3,Number of School children detected with Refractive errors,TOTAL,198,186,189,183,159,230,134,133,111,212,227,201,2163
Nawada,13.4,Number of children provided free glasses,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Nawada,13.5,Number of eyes collected through eye donation,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Nawada,13.6,Number of eyes utilised for corneal transplant,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Nawada,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,NA,NA,NA,NA,1,NA,NA,1,1,1,1,1,Data for this item can not be cumulated
Nawada,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,NA,NA,NA,NA,5,2,10,10,12,11,12,12,Data for this item can not be cumulated
Nawada,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,1474,1288,1375,1514,1261,1451,1376,1380,1413,1395,1456,1485,Data for this item can not be cumulated
Nawada,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,NA,NA,NA,NA,1,NA,1,1,1,1,1,1,Data for this item can not be cumulated
Nawada,14.05,Number of RKS meetings held during the month,TOTAL,4,5,6,4,82,4,3,4,5,5,4,8,134
Nawada,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,NA,NA,NA,NA,4,2,10,11,12,13,11,12,Data for this item can not be cumulated
Nawada,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,694,798,838,1473,1579,2143,2327,2058,1685,2028,1575,1729,18927
Nawada,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,NA,NA,NA,NA,1,NA,NA,1,NA,1,1,1,Data for this item can not be cumulated
Nawada,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,2,2,2,2,0,2,0,0,0,NA,0,0,Data for this item can not be cumulated
Nawada,14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,655,1013,473,554,657,635,554,554,748,896,706,593,8038
Nawada,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,1421,1272,1018,1478,1488,1264,849,1034,1100,1630,1019,1156,14729
Nawada,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,529,1150,495,900,738,780,645,772,800,908,758,772,9247
Nawada,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,2602,2605,2744,3497,3944,4318,4127,3682,3722,3903,3272,2856,41272
Nawada,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,1184,2163,968,1454,1395,1415,1199,1326,1548,1804,1464,1365,17285
Nawada,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,4023,3877,3762,4975,5432,5582,4976,4716,4822,5533,4291,4012,56001
Nawada,14.10.2.a,Number of death cases of Inpatient males,TOTAL,10,8,18,18,19,16,16,10,15,9,15,12,166
Nawada,14.10.2.b,Number of death cases of Inpatient females,TOTAL,6,11,10,11,12,11,12,8,13,12,10,6,122
Nawada,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,16,19,28,29,31,27,28,18,28,21,25,18,288
Nawada,14.11,In-Patient Head Count at midnight,TOTAL,2908,4380,3114,4123,4312,4355,4161,4022,4353,3977,3979,3905,47589
Nawada,14.12.1,OPD attendance (All),TOTAL,72010,80005,80187,84456,87502,94975,75789,75194,82127,77282,81277,81704,972508
Nawada,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,469,288,219,767,543,1097,864,536,1500,1150,1324,927,9684
Nawada,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,67,16,40,10,8,102,106,0,0,0,0,0,349
Nawada,14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,1255,1553,1811,1679,1754,1632,1509,1773,1782,1670,1812,1740,19970
Nawada,14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,14.14.a,Number of patients given AYUSH treatment,TOTAL,20239,19017,18248,16217,21038,22118,18234,17308,20461,18203,18549,17318,226950
Nawada,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,5136,4588,5847,5110,5214,7152,5939,4877,5332,4694,5082,5077,64048
Nawada,14.14.c,Number of Adolescents counselled,TOTAL,803,450,366,485,516,385,285,301,320,311,302,288,4812
Nawada,15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,1782,1665,1611,2388,2326,2692,2248,1892,2854,2397,2865,2392,27112
Nawada,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,47,49,64,64,85,82,63,52,86,82,87,47,808
Nawada,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,301,383,172,363,37,217,148,155,231,277,227,231,2742
Nawada,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,5,8,7,2,4,0,0,3,6,4,6,6,51
Nawada,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,134,164,139,185,564,321,192,171,360,278,357,260,3125
Nawada,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,3,5,2,1,1,4,1,2,7,6,9,8,49
Nawada,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,340,390,504,503,583,415,415,301,423,406,412,420,5112
Nawada,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0,20,1,1,3,0,0,1,0,0,3,0,29
Nawada,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,775,937,815,1051,1184,953,755,627,1014,961,996,911,10979
Nawada,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,8,33,10,4,8,4,1,6,13,10,18,14,129
Nawada,15.2,Number of Widal tests conducted,Number tested,13,21,28,13,1173,13,13,4,27,19,15,13,1352
Nawada,15.3.a,Number of VDRL tests conducted on males,Number tested,25,13,13,6,31,15,5,2,30,6,50,8,204
Nawada,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,141,14,10,12,74,58,37,22,80,79,103,59,689
Nawada,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,355,44,41,54,44,417,91,255,394,364,77,127,2263
Nawada,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,521,71,64,72,149,490,133,279,504,449,230,194,3156
Nawada,15.4.1,Number of blood smears examined for Malaria,TOTAL,689,651,755,767,779,840,657,571,534,623,808,617,8291
Nawada,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,8,6,3,7,7,8,4,9,7,6,37,6,108
Nawada,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,3,4,1,2,2,3,5,7,6,4,6,9,52
Nawada,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,1465,2035,2530,2310,1860,1960,2810,2635,2435,2170,1895,1395,25500
Nawada,16.1.1,Stock position of DPT vaccines,2. Stocks Received,1100,1100,1100,0,900,1500,0,0,0,0,100,1500,7300
Nawada,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0,0,0,0,0,0,50,0,0,0,0,0,50
Nawada,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,530,605,1320,450,800,650,125,200,265,275,600,975,6795
Nawada,16.1.1,Stock position of DPT vaccines,5. Total Stock,2035,2530,2310,1860,1960,2810,2635,2435,2170,1895,1395,1920,25955
Nawada,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,1233,1673,1953,2203,1328,1870,2678,1504,1575,348,1270,1379,19014
Nawada,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,1650,1800,2300,0,2112,2088,0,960,504,2016,1728,1728,16886
Nawada,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0,0,0,0,0,5,0,0,0,0,0,0,5
Nawada,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,1210,1520,2050,875,1570,1275,1174,889,1731,1094,1619,2019,17026
Nawada,16.1.1A,Stock Position of Pentavalent,5. Total Stock,1673,1953,2203,1328,1870,2678,1504,1575,348,1270,1379,1088,18869
Nawada,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,1957,1962,3457,2332,1987,1782,1842,1767,1482,572,822,832,20794
Nawada,16.1.2,Stock position of OPV vaccines,2. Stocks Received,1400,3145,1400,750,1900,1850,1400,1000,1000,1400,1400,1500,18145
Nawada,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0,0,0,0,0,0,20,30,0,0,0,0,50
Nawada,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,1395,1650,2525,1095,2105,1790,1455,1255,1910,1150,1390,966,18686
Nawada,16.1.2,Stock position of OPV vaccines,5. Total Stock,1962,3457,2332,1987,1782,1842,1767,1482,572,822,832,1366,20203
Nawada,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,1477,2452,3192,4142,2692,3317,3967,2717,2692,2642,1892,1462,32644
Nawada,16.1.3,Stock position of TT vaccines,2. Stocks Received,2150,2100,2600,0,2600,2000,0,1000,1000,0,500,1000,14950
Nawada,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Nawada,16.1.3,Stock position of TT vaccines,4. Stock Distributed,1175,1360,1650,1450,1975,1350,1250,1025,1050,750,930,1175,15140
Nawada,16.1.3,Stock position of TT vaccines,5. Total Stock,2452,3192,4142,2692,3317,3967,2717,2692,2642,1892,1462,1287,32454
Nawada,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,16.1.4,Stock position of DT vaccines,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,16.1.4,Stock position of DT vaccines,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,16.1.4,Stock position of DT vaccines,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,16.1.4,Stock position of DT vaccines,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Nawada,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,1927,2292,2434,2044,1324,654,424,364,504,184,229,154,12534
Nawada,16.1.5,Stock position of BCG vaccines,2. Stocks Received,1000,1000,1000,0,900,850,1000,1000,1000,1000,1000,1000,10750
Nawada,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0,0,0,0,0,20,0,0,0,0,0,0,20
Nawada,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,635,858,1390,720,1570,1060,1060,860,1320,955,1075,1054,12557
Nawada,16.1.5,Stock position of BCG vaccines,5. Total Stock,2292,2434,2044,1324,654,424,364,504,184,229,154,100,10707
Nawada,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,14,84,9,409,1159,1459,2609,1059,1109,1884,1149,250,11194
Nawada,16.1.6,Stock position of Measles vaccines,2. Stocks Received,2600,2000,3500,3500,3550,3500,500,2000,2600,1500,1000,2600,28850
Nawada,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Nawada,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,2530,2075,3100,2750,3250,2350,2050,1950,1825,2235,1899,2625,28639
Nawada,16.1.6,Stock position of Measles vaccines,5. Total Stock,84,9,409,1159,1459,2609,1059,1109,1884,1149,250,225,11405
Nawada,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,155,325,975,1415,2015,2395,3485,1885,1435,910,985,1360,17340
Nawada,16.1.7,Stock position of JE vaccines,2. Stocks Received,2600,3000,3000,3500,3550,3500,500,1500,1500,2000,2600,2000,29250
Nawada,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Nawada,16.1.7,Stock position of JE vaccines,4. Stock Distributed,2430,2350,2560,2900,3170,2410,2100,1950,2025,1925,2225,2295,28340
Nawada,16.1.7,Stock position of JE vaccines,5. Total Stock,325,975,1415,2015,2395,3485,1885,1435,910,985,1360,1065,18250
Nawada,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,1197,1387,1657,1757,1507,2052,1517,1232,1032,747,603,423,15111
Nawada,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,550,550,550,0,1000,0,0,0,0,0,100,550,3300
Nawada,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Nawada,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,360,280,450,250,455,535,285,200,285,144,280,523,4047
Nawada,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,1387,1657,1757,1507,2052,1517,1232,1032,747,603,423,450,14364
Nawada,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Nawada,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,13300,107204,36644,31604,31604,NA,NA,NA,NA,NA,NA,NA,220356
Nawada,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,179584,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,179584
Nawada,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,0
Nawada,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,85680,70560,5040,0,0,NA,NA,NA,NA,NA,NA,NA,161280
Nawada,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,107204,36644,31604,31604,31604,0,0,0,0,0,0,0,238660
Nawada,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,8920,NA,792,792,288,NA,NA,NA,NA,NA,NA,NA,10792
Nawada,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,21472,NA,0,0,0,NA,NA,NA,NA,NA,NA,NA,21472
Nawada,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0,NA,0,0,0,NA,NA,NA,NA,NA,NA,NA,0
Nawada,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,16000,NA,0,504,0,NA,NA,NA,NA,NA,NA,NA,16504
Nawada,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,14392,0,792,288,288,0,0,0,0,0,0,0,15760
Nawada,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,7740,9752,1552,1052,1048,NA,NA,NA,NA,NA,NA,NA,21144
Nawada,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,11712,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,11712
Nawada,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,0
Nawada,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,9700,8200,500,4,0,NA,NA,NA,NA,NA,NA,NA,18404
Nawada,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,9752,1552,1052,1048,1048,0,0,0,0,0,0,0,14452
Nawada,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Nawada,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,9000,9000,5800,4800,1000,NA,NA,NA,NA,NA,NA,NA,29600
Nawada,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,0
Nawada,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,0
Nawada,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0,3200,1000,3800,1000,NA,NA,NA,NA,NA,NA,NA,9000
Nawada,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,9000,5800,4800,1000,0,0,0,0,0,0,0,0,20600
Nawada,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,16.3.02,Stock Position of Gloves,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,16.3.02,Stock Position of Gloves,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,16.3.02,Stock Position of Gloves,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,16.3.02,Stock Position of Gloves,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Nawada,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Nawada,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,5000,5000,5000,2400,550,NA,NA,NA,NA,NA,NA,NA,17950
Nawada,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,0
Nawada,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,0
Nawada,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0,0,2600,1850,0,NA,NA,NA,NA,NA,NA,NA,4450
Nawada,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,5000,5000,2400,550,550,0,0,0,0,0,0,0,13500
Nawada,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Nawada,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Nawada,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Nawada,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,400,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,400
Nawada,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Nawada,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Nawada,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,400,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,400
Nawada,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Nawada,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Nawada,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,124,124,124,74,29,NA,NA,NA,NA,NA,NA,NA,475
Nawada,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,0
Nawada,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,0
Nawada,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0,0,50,45,29,NA,NA,NA,NA,NA,NA,NA,124
Nawada,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,124,124,74,29,0,0,0,0,0,0,0,0,351
Nawada,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,25655,24455,17255,5355,29502,NA,NA,NA,NA,NA,NA,NA,102222
Nawada,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0,0,0,175279,0,NA,NA,NA,NA,NA,NA,NA,175279
Nawada,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,0
Nawada,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,1200,7200,11900,151132,26835,NA,NA,NA,NA,NA,NA,NA,198267
Nawada,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,24455,17255,5355,29502,2667,0,0,0,0,0,0,0,79234
Nawada,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,3753,5753,6553,3853,5153,2953,8853,2953,7953,5503,5903,400,59583
Nawada,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,6000,6000,6000,6000,6000,13000,0,9000,5000,6000,0,5600,68600
Nawada,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Nawada,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,4000,5200,8700,4700,8200,7100,5900,4000,7450,5600,5503,5900,72253
Nawada,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,5753,6553,3853,5153,2953,8853,2953,7953,5503,5903,400,100,55930
Nawada,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,46010,35810,14810,1010,16410,3410,100110,43110,78010,69860,94360,33360,536270
Nawada,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,38000,40000,50000,80000,60000,150000,0,75000,60000,75000,0,80000,708000
Nawada,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Nawada,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,48200,61000,63800,64600,73000,53300,57000,40100,68150,50500,61000,68400,709050
Nawada,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,35810,14810,1010,16410,3410,100110,43110,78010,69860,94360,33360,44960,535220
Nawada,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,7119,6719,5319,2619,3619,1219,7689,2689,6889,7189,7889,1990,60949
Nawada,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,4000,5000,5000,5600,6000,13000,0,9000,7000,6000,0,7000,67600
Nawada,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Nawada,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,4400,6400,7700,4600,8400,6530,5000,4800,6700,5300,5899,6900,72629
Nawada,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,6719,5319,2619,3619,1219,7689,2689,6889,7189,7889,1990,2090,55920
Nawada,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1
Nawada,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,1
Nawada,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,1
Nawada,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,2,NA,2,NA,4
Nawada,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,2,NA,2,NA,4
Nawada,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Nawada,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,1.1,Total number of pregnant women Registered for ANC,TOTAL,11526,11483,12094,12326,11519,11402,10163,9203,10469,10452,10540,12387,133564
Patna,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,5985,5159,5679,4974,4607,4762,4854,4868,6056,7567,8041,10076,72628
Patna,1.2,Number of Pregnant women registered under JSY,TOTAL,11265,10476,11749,12232,11437,10346,8606,6577,8615,9191,9103,10788,120385
Patna,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,4126,5012,5099,5706,5819,6039,5492,5328,5955,7178,8414,8715,72883
Patna,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,6544,6214,6546,6631,5941,6189,5677,5760,5836,6719,6840,7466,76363
Patna,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,9173,10218,8344,8968,8949,8245,7632,6804,7040,7335,6864,8771,98343
Patna,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,6147,4624,5006,4351,2783,3281,2889,2493,2336,2513,2578,1916,40917
Patna,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,95,68,190,337,138,112,127,91,95,129,137,101,1620
Patna,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,16,14,2,21,27,1494,1378,1103,1396,1300,1307,1348,9406
Patna,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,1339,776,1554,1448,876,1310,1496,1050,1373,1533,1627,2367,16749
Patna,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,38,36,153,130,117,113,118,86,77,98,82,97,1145
Patna,1.8,Number of pregnancy test kits used at SC level,TOTAL,258,344,321,349,426,444,420,391,478,419,507,490,4847
Patna,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,20,27,41,46,83,36,32,29,43,49,65,21,492
Patna,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,115,132,127,143,183,261,176,192,173,257,349,336,2444
Patna,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,135,159,168,189,266,297,208,221,216,306,414,357,2936
Patna,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,86,75,76,88,145,165,104,114,145,281,353,316,1948
Patna,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0,6,0,0,0,0,0,0,0,0,0,1,7
Patna,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,3288,3817,3910,5569,7385,6882,7224,6470,5480,5111,4592,4206,63934
Patna,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,3182,3557,3679,5234,7002,6407,6040,5757,5297,4678,4077,3781,58691
Patna,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,2754,2801,3344,4558,6693,6628,5644,5589,5199,4839,5684,4098,57831
Patna,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1214,939,1383,2212,3467,2849,2508,3271,2949,2518,3710,2816,29836
Patna,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0,0,0,0,0,0,0,2,0,0,0,0,2
Patna,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,784,1036,769,NA,NA,NA,305,1051,546,613,710,618,6432
Patna,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0,0,0,0,0,0,0,0,0,0,2,5,7
Patna,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0
Patna,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,258,255,305,364,411,411,440,341,337,356,342,296,4116
Patna,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,258,255,305,364,411,411,440,341,337,356,344,301,4123
Patna,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,64,89,62,NA,NA,NA,70,396,109,137,162,97,1186
Patna,4.1.1.a,Number of male live births,TOTAL,1703,2013,2035,2892,3878,3581,3801,3503,3238,3128,2904,2643,35319
Patna,4.1.1.b,Number of female live births,TOTAL,1584,1797,1862,2651,3526,3313,3557,3207,2942,2848,2756,2477,32520
Patna,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,3287,3810,3897,5543,7404,6894,7358,6710,6180,5976,5660,5120,67839
Patna,4.1.2,Number of still births,TOTAL,62,87,70,100,131,117,166,142,123,110,81,75,1264
Patna,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,33,47,36,61,17,20,21,17,32,51,34,42,411
Patna,4.2.1,Number of Newborns weighed at birth,TOTAL,2557,3311,3838,5535,6865,6931,7368,6733,6075,5832,5602,5095,65742
Patna,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,151,246,233,477,410,540,567,543,493,406,697,647,5410
Patna,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,2685,3708,3782,5446,6828,6888,7283,6377,6012,5835,5437,4849,65130
Patna,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0,0,19,36,41,43,15,7,60,158,301,313,993
Patna,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,11,22,37,62,132
Patna,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,6,3,8,392,40,36,41,119,14,39,87,89,874
Patna,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,6,3,27,428,81,79,56,126,85,219,425,464,1999
Patna,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,43,161,72,98,374
Patna,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,3656,2832,1523,684,586,903,674,217,4242,5540,5607,523,26987
Patna,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,49,10,8,19,114,6,2,1,4,13,58,40,324
Patna,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,546,528,621,1257,1615,1285,382,607,399,498,564,428,8730
Patna,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0,0,0,0,0,229,0,50,0,0,0,0,279
Patna,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,2753,3079,2551,4114,5322,5374,5523,5378,4603,4718,4161,3922,51498
Patna,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1497,1240,1496,1445,1820,1787,2248,2631,2694,3143,2697,2610,25308
Patna,6.3,PNC maternal complications attended,TOTAL,2,25,29,40,45,40,18,6,23,12,40,51,331
Patna,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,14,11,20,40,15,14,125,13,26,16,29,270,593
Patna,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0,0,0,2,2,0,56,1,0,0,0,598,659
Patna,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,14,11,20,42,17,14,181,14,26,16,29,868,1252
Patna,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0,0,0,9,151,194,151,173,162,3,385,0,1228
Patna,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,22,19,2,2,22,21,28,52,7,8,9,5,197
Patna,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,40,41,5,6,55,57,39,48,10,14,14,11,340
Patna,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,62,60,7,8,77,78,67,100,17,22,23,16,537
Patna,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0,0,0,0,2,15,7,5,9,12,17,21,88
Patna,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,3,3,1,2,4,2,3,2,10,5,7,3,45
Patna,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,2,0,1,0,3
Patna,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,2,0,0,2,0,1,1,13,12,2,24,20,77
Patna,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,5,3,1,4,4,3,4,15,24,7,32,23,125
Patna,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,NA,4,NA,8,4,3,4,3,1,0,7,55,89
Patna,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Patna,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0
Patna,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0,0,0,0,0,0,0,1,0,0,1,0,2
Patna,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0,0,0,0,0,0,0,1,0,0,1,0,2
Patna,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,0
Patna,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,517,311,233,1203,474,1301,1325,683,2721,1594,2213,1405,13980
Patna,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,NA,NA,NA,64,24,42,115,10,153,104,105,61,678
Patna,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,150,124,138,199,156,241,216,138,364,354,281,235,2596
Patna,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,667,435,371,1466,654,1584,1656,831,3238,2052,2599,1701,17254
Patna,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,534,478,NA,249,25,188,107,1045,1010,1386,1317,16494,22833
Patna,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,18,46,20,66,114,141,112,175,187,99,98,69,1145
Patna,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0
Patna,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,9,33,47,28,39,71,33,20,26,23,17,16,362
Patna,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,27,79,67,94,153,212,145,195,213,122,115,85,1507
Patna,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,NA,NA,NA,NA,NA,4,NA,NA,NA,NA,68,472,544
Patna,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,351,335,252,583,341,383,438,324,515,521,1015,964,6022
Patna,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,176,165,220,510,274,346,337,390,486,322,1084,629,4939
Patna,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,NA,NA,3,28,26,18,18,22,32,130,111,162,550
Patna,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,118,140,152,275,203,188,200,186,193,274,258,263,2450
Patna,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,645,640,627,1396,844,935,993,922,1226,1247,2468,2018,13961
Patna,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,169,169,224,435,349,397,386,323,253,665,732,1065,5167
Patna,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,698,332,NA,1131,176,308,251,319,513,832,1424,10224,16208
Patna,9.06,Number of IUCD removals,TOTAL,201,243,209,297,219,233,267,210,274,288,338,339,3118
Patna,9.07,Number of Oral Pills cycles distributed,TOTAL,3444,3387,3283,4460,3003,3400,3339,3426,3404,4789,4800,4760,45495
Patna,9.08,Number of Condom pieces distributed,TOTAL,10800,8413,9099,17398,9264,10270,9463,8750,10261,10968,13121,10612,128419
Patna,9.09,Number of Centchroman (weekly) pills given,TOTAL,29,116,29,48,57,49,49,99,434,13,31,34,988
Patna,9.1,Number of Emergency Contraceptive Pills distributed,TOTAL,1881,1285,807,831,408,381,364,248,353,896,463,620,8537
Patna,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,6,0,0,0,0,4,0,0,0,0,0,0,10
Patna,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,6,1,3,0,0,0,0,0,0,0,0,0,10
Patna,9.11.2.a,Number of failures following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Patna,9.11.2.b,Number of failures following female sterilization,TOTAL,0,0,0,1,3,0,0,0,0,0,0,0,4
Patna,9.11.3.a,Number of deaths following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Patna,9.11.3.b,Number of deaths following female sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Patna,9.12,Number of Institutions having NSV trained doctors,TOTAL,1,1,5,4,6,6,4,7,7,9,10,9,Data for this item can not be cumulated
Patna,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,6156,6544,6532,10037,12282,12818,12979,11931,12307,11508,10738,9486,123318
Patna,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,336,289,142,593,818,952,940,788,339,154,155,119,5625
Patna,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,1266,777,460,979,974,1101,1061,922,365,121,145,117,8288
Patna,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,3503,1959,1132,1535,1350,1339,1267,1108,428,100,147,159,14027
Patna,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,8421,7216,6809,8958,8668,9920,11151,11770,12563,13108,12385,11795,122764
Patna,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,8438,8264,7442,9125,7917,8660,9418,9991,11548,13231,12558,12622,119214
Patna,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,6939,7631,7639,8666,7956,8272,8537,8447,9990,12447,12103,12607,111234
Patna,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,4264,4357,4045,7366,9002,9189,9159,8501,8098,7453,6741,5855,84030
Patna,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,8605,7507,6922,8696,9173,10864,12049,12592,12912,13631,12746,11942,127639
Patna,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,9448,8622,7718,9093,8663,9580,10165,10730,11558,13452,12663,12666,124358
Patna,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,9850,9132,8441,9738,9034,9348,9461,9252,9997,12811,12296,12896,122256
Patna,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,2400,2625,2420,4226,5938,6249,6049,5619,4356,5660,4240,3956,53738
Patna,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,585,317,142,640,723,774,556,527,900,1,0,1,5166
Patna,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,1160,543,430,406,601,555,368,275,555,18,1,14,4926
Patna,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,3442,2060,1202,878,660,708,469,362,621,31,0,31,10464
Patna,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,8124,8640,9084,12036,11652,11924,11604,10063,10122,10445,10394,10177,124265
Patna,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,9843,8331,7463,9573,8574,7966,7864,7714,8915,9880,10859,11743,108725
Patna,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,7610,8540,8571,10606,10882,10988,10755,9094,16279,9793,9610,9729,122457
Patna,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,4119,4419,4743,5984,6278,6028,5699,5036,5261,5525,5465,5379,63936
Patna,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,3653,3866,4150,5220,5459,5520,5260,4608,4856,4845,4832,4824,57093
Patna,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,7772,8285,8893,11204,11737,11548,10959,9644,10117,10370,10297,10203,121029
Patna,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,9747,8765,8169,9400,8524,8328,8263,7517,9756,10137,10478,11595,110679
Patna,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,9742,8678,8171,9391,8536,8243,8257,7518,9753,10141,10461,11595,110486
Patna,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0,45,10,65,234,0,176,0,298,0,0,1,829
Patna,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2600,2831,2456,3251,2467,2168,2336,2004,2551,2822,3189,3769,32444
Patna,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2299,2457,2241,2717,2222,1942,2207,1957,2195,2490,2822,3308,28857
Patna,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,4899,5288,4697,5968,4689,4110,4543,3961,4746,5312,6011,7077,61301
Patna,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,1641,1544,1396,1664,1677,1875,2094,2227,2472,2116,2573,2690,23969
Patna,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,2167,1989,1873,2271,1783,1977,2130,2021,2077,2370,2525,2358,25541
Patna,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,3368,2820,2573,3552,2759,2769,2886,2646,2847,2988,3050,3302,35560
Patna,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,133,39,240,358,181,151,171,105,198,125,163,222,2086
Patna,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Patna,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,545,344,733,723,871,999,568,830,961,953,971,830,9328
Patna,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,5099,5085,5126,5205,5190,5342,5302,5126,5342,5309,5351,5387,62864
Patna,10.4.2,Number of Immunisation sessions held during the month,TOTAL,5086,5007,5035,5125,5025,5242,5208,5029,5313,5236,5281,5379,61966
Patna,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,3386,3538,3342,3626,3459,3526,3504,3505,3580,3523,3545,3573,42107
Patna,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,9285,8560,7376,8422,8780,9006,8639,7892,9284,9658,10121,11559,108582
Patna,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,5691,5788,4490,3705,4227,3289,3328,2790,2238,2260,2072,1771,41649
Patna,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,2411,2522,1762,1950,1636,1549,1284,1217,1135,1297,1226,910,18899
Patna,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,494,555,390,260,37,561,780,600,600,598,49,47,4971
Patna,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Patna,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Patna,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Patna,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0,2,0,0,0,0,0,0,0,0,0,0,2
Patna,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Patna,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,5,4,1,3,0,3,0,0,0,0,7,50,73
Patna,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,319,1032,694,811,374,478,397,378,381,435,237,322,5858
Patna,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0,5,2,4,0,1,0,0,0,0,0,0,12
Patna,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,1,5,0,15,13,23,17,35,44,35,46,41,275
Patna,13.1,Number of Patients operated for cataract,TOTAL,338,59,100,124,192,137,120,140,325,380,331,341,2587
Patna,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,2527,2687,1861,1755,1675,1726,1999,2217,444,497,474,474,18336
Patna,13.3,Number of School children detected with Refractive errors,TOTAL,425,516,1294,423,415,1965,355,524,431,375,435,469,7627
Patna,13.4,Number of children provided free glasses,TOTAL,0,0,144,0,1,123,0,0,0,0,0,0,268
Patna,13.5,Number of eyes collected through eye donation,TOTAL,1,0,0,0,0,0,0,0,0,0,0,0,1
Patna,13.6,Number of eyes utilised for corneal transplant,TOTAL,1,0,0,0,0,0,0,0,0,0,0,0,1
Patna,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,1,1,6,5,6,7,7,6,7,6,6,6,Data for this item can not be cumulated
Patna,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,2,2,23,30,28,26,28,30,28,30,32,29,Data for this item can not be cumulated
Patna,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,2533,2376,2411,2576,3075,3091,3097,2999,3102,3117,3121,3117,Data for this item can not be cumulated
Patna,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,2,2,9,8,9,10,11,10,11,10,10,10,Data for this item can not be cumulated
Patna,14.05,Number of RKS meetings held during the month,TOTAL,19,13,23,36,38,36,32,28,33,31,30,30,349
Patna,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,3,2,17,23,23,25,24,26,26,27,26,24,Data for this item can not be cumulated
Patna,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,290,106,808,1057,1792,1777,2121,2129,1974,2041,2460,2455,19010
Patna,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,1,NA,5,5,6,6,7,7,7,7,6,6,Data for this item can not be cumulated
Patna,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,2,2,4,2,2,2,1,0,0,0,0,2,Data for this item can not be cumulated
Patna,14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,459,497,559,698,2310,2368,2313,794,1805,2149,2524,2463,18939
Patna,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,970,733,751,1014,6680,8132,7754,828,6322,6567,6783,8196,54730
Patna,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,511,540,490,784,1758,1769,1923,1502,1404,1836,2428,2274,17219
Patna,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,3848,3428,3727,5482,9578,11256,11038,5732,11169,11281,11894,11063,99496
Patna,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,970,1037,1049,1482,4068,4137,4236,2296,3209,3985,4952,4737,36158
Patna,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,4818,4161,4478,6496,16258,19388,18792,6560,17491,17848,18677,19259,154226
Patna,14.10.2.a,Number of death cases of Inpatient males,TOTAL,433,506,507,482,589,468,540,8,561,533,448,534,5609
Patna,14.10.2.b,Number of death cases of Inpatient females,TOTAL,268,314,312,314,346,352,328,3,340,362,309,301,3549
Patna,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,701,820,819,796,935,820,868,11,901,895,757,835,9158
Patna,14.11,In-Patient Head Count at midnight,TOTAL,3417,6546,6719,7865,6154,6671,9553,8519,10047,9718,18405,17850,111464
Patna,14.12.1,OPD attendance (All),TOTAL,275417,279450,262650,293085,302981,318320,271166,217881,283618,295653,316749,317907,3434877
Patna,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,2877,3072,1370,2985,2752,1739,1593,425,2566,2285,2497,2180,26341
Patna,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,245,127,137,152,0,0,0,0,0,0,1,0,662
Patna,14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,3078,3241,3125,3575,3913,3655,3455,1484,3654,3401,3364,3291,39236
Patna,14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,14.14.a,Number of patients given AYUSH treatment,TOTAL,18847,24675,17146,25435,37566,34981,30643,27388,33719,36748,39721,38333,365202
Patna,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,3583,5192,5052,6190,7020,7700,5349,6251,6388,6750,6513,5743,71731
Patna,14.14.c,Number of Adolescents counselled,TOTAL,1,201,461,410,551,390,394,280,238,255,305,270,3756
Patna,15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,12661,11333,9836,10167,8367,13804,22873,11184,15849,15756,15373,16498,163701
Patna,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,278,234,294,336,415,463,279,207,214,295,300,321,3636
Patna,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,2570,1276,1063,1313,944,589,685,843,2101,3195,3473,3055,21107
Patna,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,11,7,5,4,10,11,4,10,7,12,8,8,97
Patna,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,2097,1259,1070,1475,581,860,1189,653,2871,2907,3361,2780,21103
Patna,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,5,6,5,84,66,6,3,5,340,4,2,3,529
Patna,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,523,219,528,656,1043,875,661,1177,816,1215,1224,1205,10142
Patna,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,15,0,1,23,0,1,0,1,5,3,2,3,54
Patna,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,5190,2754,2661,3444,2568,2324,2535,2673,5788,7317,8058,7040,52352
Patna,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,31,13,11,111,76,18,7,16,352,19,12,14,680
Patna,15.2,Number of Widal tests conducted,Number tested,3,0,32,7,20,75,99,62,22,102,4,45,471
Patna,15.3.a,Number of VDRL tests conducted on males,Number tested,1,0,0,0,3,15,7,0,0,52,24,47,149
Patna,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,0,27,31,24,36,40,23,14,0,19,6,162,382
Patna,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,20,63,59,73,74,47,33,15,8,51,63,86,592
Patna,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,21,90,90,97,113,102,63,29,8,122,93,295,1123
Patna,15.4.1,Number of blood smears examined for Malaria,TOTAL,902,986,787,521,643,602,749,526,532,557,625,552,7982
Patna,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,7,3,3,2,2,21,5,4,2,3,3,3,58
Patna,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0,1,1,1,1,0,1,0,0,1,0,0,6
Patna,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,1987,145,2166,NA,1911,785,2070,3295,NA,1005,NA,702,14066
Patna,16.1.1,Stock position of DPT vaccines,2. Stocks Received,NA,0,1500,NA,1000,2500,2000,0,NA,1000,NA,1000,9000
Patna,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,NA,0,NA,NA,0,0,0,0,NA,0,NA,0,0
Patna,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,1842,145,2140,NA,2126,1065,775,1940,NA,1043,NA,1690,12766
Patna,16.1.1,Stock position of DPT vaccines,5. Total Stock,145,0,1526,0,785,2220,3295,1355,0,962,0,12,10300
Patna,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,3247,139,1755,NA,2092,1809,2952,1639,NA,3402,NA,1683,18718
Patna,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,NA,0,2592,NA,3168,3982,1152,2016,NA,3168,NA,4032,20110
Patna,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,NA,0,NA,NA,0,0,0,0,NA,0,NA,0,0
Patna,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,3108,135,2653,NA,3451,2647,2465,3583,NA,2951,NA,4028,25021
Patna,16.1.1A,Stock Position of Pentavalent,5. Total Stock,139,4,1694,0,1809,3144,1639,72,0,3619,0,1687,13807
Patna,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,4231,93,2370,NA,3627,2316,1660,1146,NA,921,NA,1026,17390
Patna,16.1.2,Stock position of OPV vaccines,2. Stocks Received,NA,0,5000,NA,3000,3200,3000,4000,NA,3500,NA,2500,24200
Patna,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,NA,0,NA,NA,0,0,0,0,NA,0,NA,0,0
Patna,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,4138,90,4185,NA,4311,3581,3514,4305,NA,2954,NA,2545,29623
Patna,16.1.2,Stock position of OPV vaccines,5. Total Stock,93,3,3185,0,2316,1935,1146,841,0,1467,0,981,11967
Patna,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,2076,61,896,NA,1133,88,2025,2122,NA,2557,NA,3046,14004
Patna,16.1.3,Stock position of TT vaccines,2. Stocks Received,NA,0,3000,NA,1000,4650,2000,1000,NA,2000,NA,4000,17650
Patna,16.1.3,Stock position of TT vaccines,3. Unusable Stock,NA,0,NA,NA,0,0,0,0,NA,0,NA,0,0
Patna,16.1.3,Stock position of TT vaccines,4. Stock Distributed,2015,60,2590,NA,2045,2663,2122,2355,NA,1596,NA,2480,17926
Patna,16.1.3,Stock position of TT vaccines,5. Total Stock,61,1,1306,0,88,2075,1903,767,0,2961,0,4566,13728
Patna,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0,0,NA,NA,0,NA,NA,NA,NA,NA,NA,0,0
Patna,16.1.4,Stock position of DT vaccines,2. Stocks Received,NA,0,NA,NA,0,NA,NA,NA,NA,NA,NA,0,0
Patna,16.1.4,Stock position of DT vaccines,3. Unusable Stock,NA,0,NA,NA,0,NA,NA,NA,NA,NA,NA,0,0
Patna,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0,0,NA,NA,0,NA,NA,NA,NA,NA,NA,0,0
Patna,16.1.4,Stock position of DT vaccines,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Patna,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,2876,120,2591,NA,4567,3572,2502,2747,NA,2032,NA,1202,22209
Patna,16.1.5,Stock position of BCG vaccines,2. Stocks Received,NA,0,3600,NA,2000,2300,3000,4000,NA,3000,NA,2500,20400
Patna,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,NA,0,NA,NA,0,0,0,0,NA,0,NA,0,0
Patna,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,2756,120,2520,NA,2995,3020,2755,3710,NA,2062,NA,2690,22628
Patna,16.1.5,Stock position of BCG vaccines,5. Total Stock,120,0,3671,0,3572,2852,2747,3037,0,2970,0,1012,19981
Patna,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,3206,8,3424,NA,468,268,861,2817,NA,3272,NA,2056,16380
Patna,16.1.6,Stock position of Measles vaccines,2. Stocks Received,NA,0,4000,NA,6000,6000,7000,6000,NA,3000,NA,6000,38000
Patna,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,NA,0,NA,NA,0,0,0,0,NA,0,NA,0,0
Patna,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,3198,0,5869,NA,6200,5257,5044,5725,NA,4866,NA,6020,42179
Patna,16.1.6,Stock position of Measles vaccines,5. Total Stock,8,8,1555,0,268,1011,2817,3092,0,1406,0,2036,12201
Patna,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,4210,12,2441,NA,831,571,720,2760,NA,3095,NA,185,14825
Patna,16.1.7,Stock position of JE vaccines,2. Stocks Received,NA,0,8000,NA,6000,6000,7000,6000,NA,5000,NA,6000,44000
Patna,16.1.7,Stock position of JE vaccines,3. Unusable Stock,NA,0,NA,NA,0,0,0,0,NA,0,NA,0,0
Patna,16.1.7,Stock position of JE vaccines,4. Stock Distributed,4198,0,5370,NA,6210,5501,4960,5590,NA,4905,NA,5700,42434
Patna,16.1.7,Stock position of JE vaccines,5. Total Stock,12,12,5071,0,621,1070,2760,3170,0,3190,0,485,16391
Patna,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,1042,10,1748,NA,3317,2150,2791,2496,NA,2376,NA,1888,17818
Patna,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,NA,0,1250,NA,0,1250,1000,0,NA,1000,NA,1250,5750
Patna,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,NA,0,NA,NA,0,0,0,0,NA,0,NA,0,0
Patna,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,1032,0,1110,NA,1167,859,995,575,NA,703,NA,555,6996
Patna,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,10,10,1888,0,2150,2541,2796,1921,0,2673,0,2583,16572
Patna,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Patna,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Patna,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Patna,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Patna,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Patna,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Patna,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,16.3.02,Stock Position of Gloves,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,16.3.02,Stock Position of Gloves,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,16.3.02,Stock Position of Gloves,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,16.3.02,Stock Position of Gloves,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Patna,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Patna,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Patna,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Patna,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Patna,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Patna,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Patna,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Patna,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Patna,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Patna,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,9872,32,10300,NA,22700,10200,16775,4775,NA,13925,NA,102525,191104
Patna,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,NA,NA,10000,NA,0,16000,NA,16000,NA,20000,NA,12000,74000
Patna,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,NA,NA,NA,NA,0,0,NA,0,NA,0,NA,0,0
Patna,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,9840,30,9200,NA,10200,9425,12000,14600,NA,9400,NA,11800,86495
Patna,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,32,2,11100,0,12500,16775,4775,6175,0,24525,0,102725,178609
Patna,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,118560,160,46330,NA,198730,11430,238530,156930,NA,111630,NA,60730,943030
Patna,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,NA,NA,160000,NA,0,280000,NA,200000,NA,200000,NA,250000,1090000
Patna,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,NA,NA,NA,NA,0,0,0,0,NA,0,NA,0,0
Patna,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,118400,150,117400,NA,127300,112900,81600,123200,NA,100900,NA,191930,973780
Patna,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,160,10,88930,0,71430,178530,156930,233730,0,210730,0,118800,1059250
Patna,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,13102,2,6050,NA,19650,6300,21500,10300,NA,2820,NA,6720,86444
Patna,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,NA,NA,10000,NA,0,28000,NA,18000,NA,28000,NA,18000,102000
Patna,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,NA,NA,NA,NA,0,0,0,0,NA,0,NA,0,0
Patna,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,13100,0,8600,NA,13150,12800,11200,13300,NA,10550,NA,12600,95300
Patna,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,2,2,7450,0,6500,21500,10300,15000,0,20270,0,12120,93144
Patna,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,1,1,7,6,15
Patna,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1,2
Patna,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1,2
Patna,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,3,4
Patna,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,3,4
Patna,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,1,2,1,5,5,5,19
Patna,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1
Patna,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,NA,NA,NA,NA,NA,NA,1,2,1,5,5,6,20
Patna,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,5,1,NA,8,24,7,45
Patna,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,1,NA,2,1,9,3,16
Patna,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,NA,NA,NA,NA,NA,NA,6,1,2,9,33,10,61
Patna,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,2,NA,2,5,NA,5,14
Patna,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,2,NA,NA,NA,2
Patna,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,NA,NA,NA,NA,NA,NA,2,NA,4,5,NA,5,16
Patna,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,1,NA,2
Patna,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,1,NA,2
Patna,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,1,NA,5,NA,2,8
Patna,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1
Patna,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,NA,NA,NA,NA,NA,NA,NA,1,NA,5,NA,3,9
Patna,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,2,2,7,14,17,20,62
Patna,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1,6,8
Patna,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,NA,NA,NA,NA,NA,NA,2,2,7,15,18,26,70
Patna,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,NA,NA,1
Patna,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,NA,NA,1
Patna,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,1,NA,1,NA,1,NA,3
Patna,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,NA,NA,NA,NA,NA,NA,1,NA,1,NA,1,NA,3
Patna,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,1,NA,2
Patna,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,1,NA,2
Patna,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,4,4,8
Patna,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,4,4,8
Patna,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,2,NA,3
Patna,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,2,NA,3
Patna,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,3,2,7
Patna,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,3,2,7
Patna,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,1,2,1,NA,NA,NA,4
Patna,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,NA,NA,2
Patna,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,NA,NA,NA,NA,NA,NA,1,2,1,2,NA,NA,6
Patna,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,1
Patna,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,1
Patna,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,1
Patna,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,1
Patna,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,1
Patna,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,1,2
Patna,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,NA,NA,NA,NA,NA,NA,2,NA,NA,NA,NA,1,3
Patna,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,NA,NA,NA,NA,NA,2,NA,NA,NA,NA,NA,NA,2
Patna,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Patna,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,NA,NA,NA,NA,NA,2,NA,NA,NA,NA,NA,NA,2
Patna,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,1
Patna,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,NA,NA,NA,NA,1,2,3,3,4,NA,NA,1,14
Patna,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,6,2,1,3,NA,1,13
Patna,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,NA,NA,NA,NA,1,2,9,5,5,4,NA,2,28
Purnia,1.1,Total number of pregnant women Registered for ANC,TOTAL,10265,10899,9905,8748,10024,7835,7701,6836,6830,7319,7921,9203,103486
Purnia,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,4385,4471,4021,3722,3719,3211,3132,2833,2760,3081,3753,4325,43413
Purnia,1.2,Number of Pregnant women registered under JSY,TOTAL,10265,10899,9905,8748,10024,7810,7706,6830,6831,7319,7891,9203,103431
Purnia,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,5621,6029,5924,5950,6311,5761,5642,4968,4948,4634,4749,5345,65882
Purnia,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,7011,7310,6540,5790,6397,5092,4906,4549,4373,4706,4999,5826,67499
Purnia,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,9172,10466,9301,8761,9914,9039,8093,7386,6725,6827,6831,8209,100724
Purnia,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,6422,6401,4836,3659,1891,911,1026,790,883,911,1095,1458,30283
Purnia,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,16,20,67,46,45,15,35,44,59,19,31,30,427
Purnia,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,7,5,8,4,17,24,12,21,9,9,17,9,142
Purnia,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,458,430,426,548,526,528,432,395,415,547,451,606,5762
Purnia,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,91,76,68,80,88,65,39,52,28,57,46,55,745
Purnia,1.8,Number of pregnancy test kits used at SC level,TOTAL,419,485,466,595,542,481,487,386,462,519,593,762,6197
Purnia,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,151,178,273,203,243,286,335,326,287,253,219,222,2976
Purnia,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,1021,1231,1312,1238,1656,1849,2154,1768,1543,1558,1257,1131,17718
Purnia,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,1172,1409,1585,1441,1899,2135,2489,2094,1830,1811,1476,1353,20694
Purnia,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,673,810,893,991,1150,1114,1157,1167,1038,916,671,702,11282
Purnia,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,1,12,10,0,3,2,3,0,2,5,0,0,38
Purnia,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,3969,4227,3828,5509,7680,8712,8437,6959,5885,5661,5597,4679,71143
Purnia,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,3736,3751,3388,4804,6334,7428,7464,6402,5485,4787,5072,4108,62759
Purnia,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,2841,3217,2681,3337,3915,6633,6606,5629,4886,4688,4275,3501,52209
Purnia,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1606,1665,1363,2096,3476,4837,4214,3537,3374,3571,2791,2547,35077
Purnia,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Purnia,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,NA,NA,NA,NA,NA,NA,1820,1709,948,756,897,17576,23706
Purnia,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,0,0
Purnia,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,0,0
Purnia,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,0,0
Purnia,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0,0,0,0,0,6,0,0,0,0,0,0,6
Purnia,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Purnia,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,109,102,104,121,148,114,118,36,72,86,78,93,1181
Purnia,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Purnia,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,109,102,104,121,148,120,118,36,72,86,78,93,1187
Purnia,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,NA,NA,NA,NA,NA,NA,788,87,296,249,287,1850,3557
Purnia,4.1.1.a,Number of male live births,TOTAL,2612,2924,2693,3622,4930,5545,5731,4634,3883,3929,3513,3073,47089
Purnia,4.1.1.b,Number of female live births,TOTAL,2441,2609,2623,3220,4517,5113,5018,4313,3735,3514,3441,2866,43410
Purnia,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,5053,5533,5316,6842,9447,10658,10749,8947,7618,7443,6954,5939,90499
Purnia,4.1.2,Number of still births,TOTAL,112,107,104,124,164,197,181,121,122,104,97,96,1529
Purnia,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,11,16,10,14,11,12,8,35,11,17,47,48,240
Purnia,4.2.1,Number of Newborns weighed at birth,TOTAL,4881,5406,5107,6547,9148,10104,10465,8711,7432,7181,6783,5806,87571
Purnia,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,186,258,328,558,859,958,1019,807,727,585,485,505,7275
Purnia,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,4764,5273,5043,6371,8955,9977,10273,8592,7239,6932,6698,5680,85797
Purnia,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,7,25,24,27,52,67,74,156,136,93,66,69,796
Purnia,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Purnia,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,122,102,104,121,148,114,149,66,72,129,107,121,1355
Purnia,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Purnia,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,129,127,128,148,200,181,223,222,208,222,173,190,2151
Purnia,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Purnia,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,129,127,179,147,307,297,298,344,379,282,378,509,3376
Purnia,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,9,5,13,4,20,35,37,58,61,44,41,21,348
Purnia,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,146,100,187,155,354,350,306,311,489,236,314,378,3326
Purnia,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,140,75,98,115,275,114,207,125,150,148,184,220,1851
Purnia,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,3079,2544,2669,3528,5449,6733,6840,5231,4315,4084,4089,3418,51979
Purnia,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,2494,2259,2410,2807,3924,3940,4169,3263,2795,2680,2362,2204,35307
Purnia,6.3,PNC maternal complications attended,TOTAL,59,35,45,5,16,8,1,0,10,17,126,123,445
Purnia,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,8,8,3,6,0,0,0,0,1,2,0,2,30
Purnia,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Purnia,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,8,8,3,6,0,0,0,0,1,2,0,2,30
Purnia,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Purnia,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,291,479,495,443,492,373,394,1249,390,306,413,332,5657
Purnia,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,720,1185,1191,1148,1183,1279,1197,305,1130,1109,1205,1174,12826
Purnia,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,1011,1664,1686,1591,1675,1652,1591,1554,1520,1415,1618,1506,18483
Purnia,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Purnia,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,3,2,2,1,1,1,2,3,5,2,3,1,26
Purnia,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Purnia,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0,0,0,0,0,0,1,8,3,1,0,2,15
Purnia,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Purnia,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,3,2,2,1,1,1,3,11,8,3,3,3,41
Purnia,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Purnia,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Purnia,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Purnia,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Purnia,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Purnia,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Purnia,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Purnia,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,368,93,110,519,438,786,1072,1369,3159,1788,2117,1311,13130
Purnia,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,12,7,11,121,27,28,48,115,149,87,109,42,756
Purnia,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,14,3,2,2,0,100,2,12,137,176,24,57,529
Purnia,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Purnia,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,394,103,123,642,465,914,1122,1496,3445,2051,2250,1410,14415
Purnia,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,90,89,0,1342,1521
Purnia,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,64,61,26,72,104,110,99,69,118,114,172,138,1147
Purnia,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0,0,0,17,3,1,3,2,3,3,10,4,46
Purnia,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,34,42,45,45,66,74,97,18,111,211,110,120,973
Purnia,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Purnia,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,98,103,71,134,173,185,199,89,232,328,292,262,2166
Purnia,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,65,164,71,345,645
Purnia,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,1484,1331,1184,1982,1233,1130,1165,1044,1362,1020,1002,991,14928
Purnia,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,249,198,201,327,368,382,448,400,342,412,482,474,4283
Purnia,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,17,23,19,21,8,6,8,7,2,8,10,9,138
Purnia,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,202,189,157,193,208,211,186,176,187,218,83,198,2208
Purnia,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Purnia,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,1952,1741,1561,2523,1817,1729,1807,1627,1893,1658,1577,1672,21557
Purnia,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,327,382,275,484,481,475,408,390,467,520,440,563,5212
Purnia,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Purnia,9.06,Number of IUCD removals,TOTAL,542,472,534,549,431,421,420,467,477,378,388,367,5446
Purnia,9.07,Number of Oral Pills cycles distributed,TOTAL,2799,2762,3082,4014,2910,2669,2855,2266,2852,2055,2148,2230,32642
Purnia,9.08,Number of Condom pieces distributed,TOTAL,21586,22208,21264,30622,19528,16903,15950,15109,19436,14881,13284,14992,225763
Purnia,9.09,Number of Centchroman (weekly) pills given,TOTAL,244,157,416,243,107,253,208,227,143,114,70,70,2252
Purnia,9.1,Number of Emergency Contraceptive Pills distributed,TOTAL,1173,1284,954,1063,484,421,446,353,353,249,250,314,7344
Purnia,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,6,6,0,0,0,0,0,0,2,1,0,0,15
Purnia,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,7,0,0,0,3,0,5,6,18,9,0,0,48
Purnia,9.11.2.a,Number of failures following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Purnia,9.11.2.b,Number of failures following female sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Purnia,9.11.3.a,Number of deaths following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Purnia,9.11.3.b,Number of deaths following female sterilization,TOTAL,1,0,0,0,0,0,0,0,0,0,0,0,1
Purnia,9.12,Number of Institutions having NSV trained doctors,TOTAL,1,8,11,11,5,5,10,11,10,9,9,10,Data for this item can not be cumulated
Purnia,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,5672,6160,6256,7715,10015,11845,12288,10730,9081,8380,7967,7151,103260
Purnia,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,0,0,0,0,0,0,0,1,0,53,0,0,54
Purnia,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,709,364,220,146,37,35,13,14,5,59,0,0,1602
Purnia,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,3091,1575,769,579,281,129,80,50,8,49,1,0,6612
Purnia,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,7173,6467,6151,5942,7083,7523,10004,11351,11077,10146,7865,8216,98998
Purnia,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,7412,7720,6498,5851,6541,6755,7257,8655,9953,10925,8819,8742,95128
Purnia,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,6248,7197,7097,6142,6527,6428,6648,6606,7260,9243,8946,9113,87455
Purnia,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,4710,4773,4877,6415,8624,10074,9934,8228,6933,6361,6326,5332,82587
Purnia,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,7199,6451,6155,5978,7131,8094,10047,11295,11013,9902,7901,8238,99404
Purnia,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,7999,7991,6588,5944,6566,6790,7267,8581,9873,10608,8758,8763,95728
Purnia,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,9081,8576,7708,6534,6690,6499,6711,6579,7237,8995,8884,9168,92662
Purnia,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,3413,3075,3167,4776,6290,6920,6558,5835,4553,4677,4686,3930,57880
Purnia,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,0,0,0,0,0,0,0,0,0,5,7,0,12
Purnia,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,701,377,239,158,65,29,11,8,5,1,22,0,1616
Purnia,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,3101,1509,776,573,297,122,86,46,9,38,15,0,6572
Purnia,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,6860,8179,9188,9515,10456,9462,9213,7873,7132,6290,5851,6015,96034
Purnia,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,6188,4877,5407,6349,6584,6578,6714,5729,6746,7066,7633,8075,77946
Purnia,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0,0,0,0,0,0,0,0,6,0,0,0,6
Purnia,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,3560,4203,4668,5017,5424,4990,4863,4147,3823,3488,3030,3198,50411
Purnia,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,3300,3976,4457,4498,5002,4477,4350,3680,3309,3273,2817,2817,45956
Purnia,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,6860,8179,9125,9515,10426,9467,9213,7827,7132,6761,5847,6015,96367
Purnia,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,7208,6878,6863,6252,7026,6975,6931,5878,6956,7367,7819,8160,84313
Purnia,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,7222,6890,6821,6222,7029,6974,6931,5875,6952,7306,7789,8155,84166
Purnia,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0,0,0,0,0,0,0,3,0,0,0,0,3
Purnia,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1237,1166,1380,1592,790,847,623,585,645,860,795,949,11469
Purnia,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1057,1150,1309,1506,765,797,542,536,592,769,708,820,10551
Purnia,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,2294,2316,2689,3098,1555,1644,1165,1121,1237,1629,1503,1769,22020
Purnia,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,272,297,466,595,521,904,914,741,613,722,808,825,7678
Purnia,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,1369,1465,1339,1321,1496,1525,1675,1361,1259,1274,1369,1332,16785
Purnia,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,2111,1992,1789,1837,2062,2400,2260,1952,1993,1934,2010,1810,24150
Purnia,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,5,12,12,0,3,3,2,0,0,16,0,10,63
Purnia,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0,0,0,0,0,0,0,0,0,0,0,8,8
Purnia,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,3,0,0,1,1,0,0,0,0,28,1,2,36
Purnia,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,3428,3381,3491,3498,3534,3568,3609,3481,3441,3368,3236,3336,41371
Purnia,10.4.2,Number of Immunisation sessions held during the month,TOTAL,3431,3406,3521,3497,3536,3564,3504,3477,3439,3339,3160,3239,41113
Purnia,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,3073,4689,3141,3183,3185,3270,3211,3224,3237,3078,2970,3025,39286
Purnia,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,8,0,0,0,0,0,0,0,0,0,0,2,10
Purnia,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1187,1297,1483,1427,1476,1219,991,855,792,815,867,1181,13590
Purnia,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,784,555,506,446,357,373,313,239,242,226,275,677,4993
Purnia,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,211,122,130,138,52,0,0,3,5,78,84,57,880
Purnia,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Purnia,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Purnia,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,1,0,0,0,1,2
Purnia,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0,0,0,0,0,2,0,0,1,2,2,8,15
Purnia,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Purnia,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,5,24,0,0,0,0,0,22,2,50,22,25,150
Purnia,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,1149,900,1136,1125,1243,1439,1306,1265,1162,1255,672,666,13318
Purnia,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,1,1,0,0,0,0,0,0,0,0,0,0,2
Purnia,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,41,57,43,52,47,32,36,20,91,61,21,34,535
Purnia,13.1,Number of Patients operated for cataract,TOTAL,386,170,196,181,60,45,55,48,621,102,68,736,2668
Purnia,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,341,170,196,181,60,45,55,48,621,102,68,736,2623
Purnia,13.3,Number of School children detected with Refractive errors,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Purnia,13.4,Number of children provided free glasses,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Purnia,13.5,Number of eyes collected through eye donation,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Purnia,13.6,Number of eyes utilised for corneal transplant,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Purnia,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,NA,1,1,1,1,1,1,1,2,1,1,2,Data for this item can not be cumulated
Purnia,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,NA,4,7,7,20,24,24,27,24,21,21,22,Data for this item can not be cumulated
Purnia,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,2639,2438,2633,2594,2524,2485,2512,2523,2488,2466,2431,2482,Data for this item can not be cumulated
Purnia,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,NA,1,1,1,1,2,2,2,3,2,2,3,Data for this item can not be cumulated
Purnia,14.05,Number of RKS meetings held during the month,TOTAL,23,21,22,20,19,19,17,20,23,26,29,28,267
Purnia,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,1,11,15,15,11,12,15,15,15,14,16,17,Data for this item can not be cumulated
Purnia,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,1292,326,55,567,1154,1248,1355,1066,1333,1395,2204,1090,13085
Purnia,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,NA,1,1,1,1,1,2,2,2,2,2,2,Data for this item can not be cumulated
Purnia,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,NA,1,1,1,0,0,0,0,0,0,0,0,Data for this item can not be cumulated
Purnia,14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Purnia,14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Purnia,14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Purnia,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,1052,728,445,667,566,535,560,575,495,386,278,410,6697
Purnia,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,1509,1299,1117,1418,1206,1313,1264,1251,959,993,1085,1102,14516
Purnia,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,908,558,843,801,583,571,723,734,642,597,1620,525,9105
Purnia,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,7633,7839,6897,9701,12546,12181,12837,10363,9368,9382,7836,7696,114279
Purnia,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,1960,1286,1288,1468,1149,1106,1283,1309,1137,983,1898,935,15802
Purnia,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,9142,9138,8014,11119,13752,13494,14101,11614,10327,10375,8921,8798,128795
Purnia,14.10.2.a,Number of death cases of Inpatient males,TOTAL,68,73,50,47,74,74,80,67,66,53,51,66,769
Purnia,14.10.2.b,Number of death cases of Inpatient females,TOTAL,40,45,54,42,55,36,67,60,47,45,29,39,559
Purnia,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,108,118,104,89,129,110,147,127,113,98,80,105,1328
Purnia,14.11,In-Patient Head Count at midnight,TOTAL,15955,15739,13793,17514,20143,21633,20898,18231,15536,16570,15803,16003,207818
Purnia,14.12.1,OPD attendance (All),TOTAL,218526,185442,193541,205976,206926,238326,226750,190480,200817,192791,209668,213210,2482453
Purnia,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,304,216,200,302,370,299,389,345,800,518,557,468,4768
Purnia,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,2,1,1,3,0,0,0,0,1,2,0,1,11
Purnia,14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Purnia,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,2388,2159,2205,2385,1943,1848,1914,2287,2210,2964,2808,3010,28121
Purnia,14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Purnia,14.14.a,Number of patients given AYUSH treatment,TOTAL,22923,21708,20499,23000,17906,24427,21455,13591,16124,16687,19473,17122,234915
Purnia,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,9870,8540,9551,10193,9296,11392,10438,8692,10072,8817,9649,10310,116820
Purnia,14.14.c,Number of Adolescents counselled,TOTAL,1,1,1,1,1,50,1,26,1,11,14,29,137
Purnia,15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Purnia,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,8281,7567,7611,7445,7610,8288,7299,5818,6574,6397,7496,7857,88243
Purnia,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,99,92,76,95,105,172,138,112,93,98,81,53,1214
Purnia,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,447,43,762,184,546,1362,1338,857,981,1880,1531,1483,11414
Purnia,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,3,0,9,8,6,4,5,4,8,9,2,8,66
Purnia,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,299,3,546,206,334,700,873,456,858,1081,1245,1034,7635
Purnia,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,7,0,13,2,6,7,3,2,3,9,1,8,61
Purnia,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,1007,55,1412,721,886,1706,1868,1710,1821,2265,3416,2851,19718
Purnia,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0,0,2,0,0,1,1,0,0,1,2,2,9
Purnia,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,1753,101,2720,1111,1766,3768,4079,3023,3660,5226,6192,5368,38767
Purnia,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,10,0,24,10,12,12,9,6,11,19,5,18,136
Purnia,15.2,Number of Widal tests conducted,Number tested,1482,635,553,839,480,698,1305,542,476,477,634,956,9077
Purnia,15.3.a,Number of VDRL tests conducted on males,Number tested,0,0,458,76,136,601,699,102,22,30,266,796,3186
Purnia,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,0,0,180,124,402,123,235,152,0,0,22,343,1581
Purnia,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,0,0,591,282,47,923,886,126,41,33,363,1399,4691
Purnia,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,0,0,1229,482,585,1647,1820,380,63,63,651,2538,9458
Purnia,15.4.1,Number of blood smears examined for Malaria,TOTAL,546,225,311,395,410,687,57,42,60,56,53,58,2900
Purnia,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,8,8,7,9,12,22,0,0,0,0,0,0,66
Purnia,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,3,2,0,5,2,1,0,0,0,0,0,0,13
Purnia,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,950,600,1900,2000,1100,1200,1250,1300,700,950,500,600,13050
Purnia,16.1.1,Stock position of DPT vaccines,2. Stocks Received,2000,2000,1000,0,1000,1000,1000,500,1000,250,1000,500,11250
Purnia,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0,0,0,0,0,NA,NA,0,NA,NA,NA,NA,0
Purnia,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,2350,700,900,900,900,950,950,1100,750,700,900,600,11700
Purnia,16.1.1,Stock position of DPT vaccines,5. Total Stock,600,1900,2000,1100,1200,1250,1300,700,950,500,600,500,12600
Purnia,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,1200,1150,1700,1700,2050,1600,1300,830,14,38,398,900,12880
Purnia,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,3000,3033,2100,2100,1200,1500,1724,1440,2880,3456,3168,2800,28401
Purnia,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0,0,0,0,0,NA,NA,0,NA,NA,NA,NA,0
Purnia,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,3050,2483,2100,1750,1650,1800,2194,2256,2856,3096,2666,2712,28613
Purnia,16.1.1A,Stock Position of Pentavalent,5. Total Stock,1150,1700,1700,2050,1600,1300,830,14,38,398,900,988,12668
Purnia,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,100,250,325,1025,1175,1550,1400,1375,1020,1290,805,1092,11407
Purnia,16.1.2,Stock position of OPV vaccines,2. Stocks Received,52500,3000,52700,2500,2500,2600,3000,52695,3250,151700,52350,1700,380495
Purnia,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0,0,0,0,0,NA,NA,0,NA,NA,NA,NA,0
Purnia,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,52350,2925,51925,2425,2125,2750,3025,53050,2980,152185,52063,1700,379503
Purnia,16.1.2,Stock position of OPV vaccines,5. Total Stock,250,325,1100,1100,1550,1400,1375,1020,1290,805,1092,1092,12399
Purnia,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,1050,2500,3400,2950,600,1450,850,1200,1250,1600,2500,1850,21200
Purnia,16.1.3,Stock position of TT vaccines,2. Stocks Received,3500,3400,2000,0,2500,1600,2250,1750,2000,2500,1000,1500,24000
Purnia,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,0
Purnia,16.1.3,Stock position of TT vaccines,4. Stock Distributed,2050,2500,2450,2350,1650,2200,1900,1700,1650,1600,1650,1500,23200
Purnia,16.1.3,Stock position of TT vaccines,5. Total Stock,2500,3400,2950,600,1450,850,1200,1250,1600,2500,1850,1850,22000
Purnia,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,0
Purnia,16.1.4,Stock position of DT vaccines,2. Stocks Received,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,0
Purnia,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,0
Purnia,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,0
Purnia,16.1.4,Stock position of DT vaccines,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Purnia,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,900,1100,3000,3475,1675,2075,1725,1562,1062,1712,1612,1512,21410
Purnia,16.1.5,Stock position of BCG vaccines,2. Stocks Received,2000,3000,2000,0,2000,2000,2500,1700,2800,2000,1500,1700,23200
Purnia,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0,0,0,0,0,NA,NA,0,NA,NA,NA,NA,0
Purnia,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,1800,1100,1525,1800,1600,2350,2663,2200,2150,2100,1600,1600,22488
Purnia,16.1.5,Stock position of BCG vaccines,5. Total Stock,1100,3000,3475,1675,2075,1725,1562,1062,1712,1612,1512,1612,22122
Purnia,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,37,37,37,1337,1987,2037,2187,2587,1087,887,1037,1750,15007
Purnia,16.1.6,Stock position of Measles vaccines,2. Stocks Received,4500,4500,5000,5000,4000,4950,4500,2500,4000,4000,3713,3500,50163
Purnia,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,0
Purnia,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,4500,4500,3700,4350,3950,4800,4100,4000,4200,3850,3000,3150,48100
Purnia,16.1.6,Stock position of Measles vaccines,5. Total Stock,37,37,1337,1987,2037,2187,2587,1087,887,1037,1750,2100,17070
Purnia,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,0
Purnia,16.1.7,Stock position of JE vaccines,2. Stocks Received,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,0
Purnia,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,0
Purnia,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,0
Purnia,16.1.7,Stock position of JE vaccines,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Purnia,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,1250,1100,3350,4557,4127,3627,3027,2077,1427,877,477,527,26423
Purnia,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,1000,2800,2000,0,0,0,0,NA,0,0,500,0,6300
Purnia,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0,0,0,0,0,NA,NA,NA,NA,0,NA,NA,0
Purnia,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,1150,550,793,430,500,600,950,650,550,400,450,450,7473
Purnia,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,1100,3350,4557,4127,3627,3027,2077,1427,877,477,527,77,25250
Purnia,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,850,350,200,20100,15900,13500,11700,11100,9900,9300,17074,17364,127338
Purnia,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0,0,20600,0,0,NA,NA,NA,NA,10174,300,NA,31074
Purnia,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0,0,NA,0,0,NA,NA,NA,NA,NA,NA,NA,0
Purnia,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,500,150,700,4200,2400,1800,600,1800,600,2400,10,600,15760
Purnia,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,350,200,20100,15900,13500,11700,11100,9300,9300,17074,17364,16764,142652
Purnia,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,4520,420,420,153570,30650,11950,5950,3450,950,950,18968,14968,246766
Purnia,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0,0,267890,0,0,NA,NA,NA,NA,39518,NA,NA,307408
Purnia,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0,0,NA,0,0,NA,NA,NA,NA,NA,NA,NA,0
Purnia,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,4100,0,114240,122920,18700,6000,2500,2500,0,21500,4000,NA,296460
Purnia,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,420,420,154070,30650,11950,5950,3450,950,950,18968,14968,14968,257714
Purnia,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0,0,0,28625,12680,8480,6480,5480,2480,1980,9101,9752,85058
Purnia,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0,0,43025,0,0,NA,NA,NA,NA,9621,2351,NA,54997
Purnia,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0,0,NA,0,0,NA,NA,NA,NA,NA,NA,NA,0
Purnia,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0,0,14400,15945,4200,2000,1000,3000,500,2500,1700,NA,45245
Purnia,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0,0,28625,12680,8480,6480,5480,2480,1980,9101,9752,9752,94810
Purnia,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,1440,1440,840,20970,15960,14060,14060,13960,13660,13060,13134,12534,135118
Purnia,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0,0,27330,0,0,NA,NA,NA,NA,1874,NA,NA,29204
Purnia,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0,0,NA,0,0,NA,NA,NA,NA,NA,NA,NA,0
Purnia,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0,600,7200,5010,1900,0,100,300,600,1800,600,NA,18110
Purnia,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,1440,840,20970,15960,14060,14060,13960,13660,13060,13134,12534,12534,146212
Purnia,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,0,0,NA,0,0,NA,NA,NA,NA,NA,NA,NA,0
Purnia,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0,0,NA,0,0,NA,NA,NA,NA,NA,NA,NA,0
Purnia,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0,0,NA,0,0,NA,NA,NA,NA,NA,NA,NA,0
Purnia,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0,0,NA,0,0,NA,NA,NA,NA,NA,NA,NA,0
Purnia,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Purnia,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,100100,76800,39300,35800,30800,28800,18800,12100,33900,24800,15800,4700,421700
Purnia,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0,0,NA,0,0,NA,NA,50000,NA,NA,NA,NA,50000
Purnia,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0,0,NA,0,0,NA,NA,NA,NA,NA,NA,NA,0
Purnia,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,23300,37500,3500,5000,2000,10000,6700,28200,9100,9000,11100,900,146300
Purnia,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,76800,39300,35800,30800,28800,18800,12100,33900,24800,15800,4700,3800,325400
Purnia,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,111000,96000,88000,85000,75000,52500,47300,29700,14400,2900,NA,NA,601800
Purnia,16.3.02,Stock Position of Gloves,2. Stocks Received,0,0,NA,0,0,NA,NA,NA,NA,NA,NA,NA,0
Purnia,16.3.02,Stock Position of Gloves,3. Unusable Stock,0,0,NA,0,0,NA,NA,NA,NA,NA,NA,NA,0
Purnia,16.3.02,Stock Position of Gloves,4. Stock Distributed,15000,8000,3000,10000,22500,5200,17600,15300,11500,2900,NA,NA,111000
Purnia,16.3.02,Stock Position of Gloves,5. Total Stock,96000,88000,85000,75000,52500,47300,29700,14400,2900,0,0,0,490800
Purnia,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0,0,NA,0,0,NA,NA,NA,NA,NA,NA,NA,0
Purnia,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0,0,NA,0,0,NA,NA,NA,NA,NA,NA,NA,0
Purnia,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0,0,NA,0,0,NA,NA,NA,NA,NA,NA,NA,0
Purnia,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0,0,NA,0,0,NA,NA,NA,NA,NA,NA,NA,0
Purnia,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Purnia,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,160103,153103,143100,141100,133100,110100,108100,94100,60600,53600,49100,9100,1215206
Purnia,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0,0,NA,0,0,NA,NA,NA,NA,NA,NA,NA,0
Purnia,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0,0,NA,0,0,NA,NA,NA,NA,NA,NA,NA,0
Purnia,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,7000,10003,2000,800,23000,2000,14000,33500,7000,4500,40000,3000,146803
Purnia,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,153103,143100,141100,140300,110100,108100,94100,60600,53600,49100,9100,6100,1068403
Purnia,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,4075,4075,4075,4075,4075,NA,NA,1000,1000,NA,NA,NA,22375
Purnia,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0,0,NA,0,0,NA,2000,NA,NA,NA,NA,NA,2000
Purnia,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0,0,NA,0,0,NA,NA,NA,NA,NA,NA,NA,0
Purnia,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0,0,0,0,1075,NA,1000,0,NA,NA,NA,NA,2075
Purnia,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,4075,4075,4075,4075,3000,0,1000,1000,1000,0,0,0,22300
Purnia,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0,0,NA,0,0,NA,NA,NA,NA,NA,NA,NA,0
Purnia,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0,0,NA,0,0,NA,NA,NA,NA,NA,NA,NA,0
Purnia,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0,0,NA,0,0,NA,NA,NA,NA,NA,NA,NA,0
Purnia,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0,0,NA,0,0,NA,NA,NA,NA,NA,NA,NA,0
Purnia,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Purnia,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,207050,120050,19050,8050,5050,4100,4100,4100,410000,380000,165000,131000,1457550
Purnia,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0,0,NA,0,0,NA,NA,500000,NA,NA,NA,3519200,4019200
Purnia,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0,0,NA,0,0,NA,NA,NA,NA,NA,NA,NA,0
Purnia,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,87000,101000,11000,3000,950,0,NA,94100,30000,215000,34000,28000,604050
Purnia,16.3.07,Stock Position of IFA Tablets,5. Total Stock,120050,19050,8050,5050,4100,4100,4100,410000,380000,165000,131000,3622200,4872700
Purnia,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0,0,NA,0,0,NA,NA,NA,NA,NA,NA,NA,0
Purnia,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0,0,NA,0,0,NA,NA,NA,NA,NA,NA,NA,0
Purnia,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0,0,NA,0,0,NA,NA,NA,NA,NA,NA,NA,0
Purnia,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0,0,NA,0,0,NA,NA,NA,NA,NA,NA,NA,0
Purnia,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Purnia,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0,0,NA,0,0,NA,NA,NA,NA,NA,NA,NA,0
Purnia,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0,0,NA,0,0,NA,NA,NA,NA,NA,NA,NA,0
Purnia,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0,0,NA,0,0,NA,NA,NA,NA,NA,NA,NA,0
Purnia,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0,0,NA,0,0,NA,NA,NA,NA,NA,NA,NA,0
Purnia,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Purnia,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,0,0,NA,0,0,NA,NA,NA,NA,NA,NA,NA,0
Purnia,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0,0,NA,0,0,NA,NA,NA,NA,NA,NA,NA,0
Purnia,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0,0,NA,0,0,NA,NA,NA,NA,NA,NA,NA,0
Purnia,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0,0,NA,0,0,NA,NA,NA,NA,NA,NA,NA,0
Purnia,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Purnia,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,34046,4046,4046,4046,74072,18672,16472,10922,8922,8922,4922,0,189088
Purnia,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0,0,NA,267926,0,NA,NA,NA,NA,NA,NA,20000,287926
Purnia,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0,0,NA,0,0,NA,NA,NA,NA,NA,NA,NA,0
Purnia,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,30000,0,0,197900,55400,2200,5550,2000,NA,4000,4922,NA,301972
Purnia,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,4046,4046,4046,74072,18672,16472,10922,8922,8922,4922,0,20000,175042
Purnia,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,7800,9600,10800,12200,4600,14900,3200,10200,0,11400,2600,12700,100000
Purnia,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,10000,10000,8000,0,19500,NA,19500,200,22000,NA,20000,0,109200
Purnia,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0,0,0,0,0,NA,NA,NA,NA,NA,NA,0,0
Purnia,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,8200,8800,6600,7600,9200,11700,1250,10400,10600,8800,9900,10400,103450
Purnia,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,9600,10800,12200,4600,14900,3200,21450,0,11400,2600,12700,2300,105750
Purnia,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,69800,38800,11200,101200,19200,154200,67000,203200,125200,91200,23000,151000,1055000
Purnia,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,60000,52800,167200,0,215000,NA,210000,0,50000,NA,200000,0,955000
Purnia,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0,0,0,0,0,NA,NA,NA,NA,NA,NA,86000,86000
Purnia,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,91000,80400,77200,82000,80000,87200,80000,78000,84000,68200,72000,NA,880000
Purnia,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,38800,11200,101200,19200,154200,67000,197000,125200,91200,23000,151000,65000,1044000
Purnia,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,224000,195000,149500,132200,87600,66100,36350,209050,132150,119550,97650,350450,1799600
Purnia,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,4000,6000,8000,0,13000,NA,215000,NA,NA,NA,313000,87630,646630
Purnia,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0,0,0,0,0,NA,NA,NA,NA,NA,NA,0,0
Purnia,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,33000,51500,25300,44600,34500,23550,42300,72600,12600,21900,60200,52300,474350
Purnia,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,195000,149500,132200,87600,66100,42550,209050,136450,119550,97650,350450,385780,1971880
Purnia,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Purnia,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Purnia,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Purnia,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Purnia,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,7,7
Purnia,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1
Purnia,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,8,8
Purnia,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,2,3
Purnia,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Purnia,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,2,3
Purnia,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,1,5,NA,19,25
Purnia,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,1,2,5
Purnia,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,NA,NA,NA,NA,NA,NA,NA,NA,1,7,1,21,30
Purnia,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,5,1,NA,NA,6
Purnia,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,1,5,NA,NA,NA,6
Purnia,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,NA,NA,NA,NA,NA,NA,NA,1,10,1,NA,NA,12
Purnia,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1
Purnia,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,2,NA,1,NA,3
Purnia,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,2,NA,1,1,4
Purnia,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,1,2
Purnia,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1
Purnia,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,2,3
Purnia,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Purnia,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Purnia,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Purnia,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,5,6
Purnia,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,2,3
Purnia,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,1,7,9
Purnia,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1
Purnia,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,2,3
Purnia,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Purnia,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,3,4
Purnia,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Purnia,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Purnia,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Purnia,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Purnia,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Purnia,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,7,7
Purnia,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,6,6
Purnia,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,13,13
Purnia,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Purnia,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Purnia,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Purnia,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Purnia,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Purnia,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,2
Purnia,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Purnia,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,2
Purnia,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Purnia,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Purnia,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Purnia,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Purnia,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1
Purnia,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1
Purnia,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,3,3
Purnia,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,5
Purnia,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Purnia,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,4,5
Purnia,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,3,4
Purnia,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1,7,9
Purnia,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Purnia,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Purnia,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Purnia,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Purnia,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Purnia,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,1
Purnia,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Purnia,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,1
Purnia,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Purnia,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,NA,1
Purnia,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Purnia,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,NA,1
Purnia,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Purnia,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,1
Purnia,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Purnia,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,1
Purnia,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Purnia,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Purnia,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Purnia,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Purnia,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Purnia,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,1,1,NA,NA,1,3
Purnia,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Purnia,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,NA,NA,NA,NA,NA,NA,NA,1,1,NA,NA,1,3
Purnia,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Purnia,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,6,6
Purnia,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1
Purnia,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,7,7
Purnia,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Purnia,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1
Purnia,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Purnia,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1
Purnia,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Purnia,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,1
Purnia,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Purnia,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,1
Purnia,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1
Purnia,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,9,9
Purnia,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,9,9
Purnia,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,19,19
Purnia,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Purnia,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,7,7
Purnia,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,4,4
Purnia,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,11,11
Purnia,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,NA,NA,NA,NA,1,1,NA,NA,NA,NA,NA,NA,2
Purnia,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,NA,NA,NA,NA,13,NA,NA,NA,NA,1,1,6,21
Purnia,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,NA,NA,NA,NA,NA,3,1,NA,2,1,1,NA,8
Purnia,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,NA,NA,NA,NA,14,4,1,NA,2,2,2,6,31
Rohtas,1.1,Total number of pregnant women Registered for ANC,TOTAL,6352,6100,6579,6578,6554,5492,5330,5120,5174,5401,5255,6026,69961
Rohtas,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,4029,3827,3984,4234,4342,3881,3797,3736,3745,3995,3900,4579,48049
Rohtas,1.2,Number of Pregnant women registered under JSY,TOTAL,6352,6100,6579,6578,6554,5492,5330,5114,5170,5396,5255,6002,69922
Rohtas,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,4953,5129,5311,5563,5984,5443,5228,4835,4797,4794,4299,5158,61494
Rohtas,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,4299,4174,4536,4431,4356,3807,3744,3703,3732,3941,3618,3989,48330
Rohtas,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,5743,5802,6160,6428,6539,5286,4682,4166,4710,4932,4425,5238,64111
Rohtas,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,2679,2215,3084,4936,3248,1557,1455,1239,1002,833,765,821,23834
Rohtas,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,67,38,8,60,106,11,88,10,7,5,5,23,428
Rohtas,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0,0,0,0,0,0,0,0,2,0,2,0,4
Rohtas,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,377,400,519,446,383,310,310,268,550,474,523,497,5057
Rohtas,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,4,0,2,0,0,0,0,6,6,2,8,4,32
Rohtas,1.8,Number of pregnancy test kits used at SC level,TOTAL,52,34,47,224,285,236,156,169,138,158,184,266,1949
Rohtas,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,27,50,60,83,82,72,102,91,86,37,77,76,843
Rohtas,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,324,334,384,444,515,467,470,443,385,387,405,340,4898
Rohtas,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,351,384,444,527,597,539,572,534,471,424,482,416,5741
Rohtas,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,180,171,195,209,264,211,243,220,195,175,198,186,2447
Rohtas,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0,4,0,0,0,0,0,0,0,0,0,0,4
Rohtas,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1533,1526,1607,2264,2814,2859,2997,2471,2661,2305,1844,1654,26535
Rohtas,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,1524,1514,1589,2235,2803,2491,2780,2453,2657,2301,1826,1711,25884
Rohtas,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1294,1546,1696,2030,2421,2168,952,874,2451,1844,1595,2098,20969
Rohtas,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,995,1428,1572,1909,2409,1704,897,943,2244,1839,1555,2255,19750
Rohtas,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0,0,0,0,0,0,0,0,0,0,0,50,50
Rohtas,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,NA,0,0,0,0,1843,1056,568,633,756,655,913,6424
Rohtas,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,NA,0,0,0,0,0,0,NA,NA,NA,NA,NA,0
Rohtas,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,NA,0,0,0,0,0,0,NA,NA,NA,NA,NA,0
Rohtas,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,NA,0,0,0,0,0,0,NA,NA,NA,NA,NA,0
Rohtas,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0,0,0,4,7,5,5,5,3,8,10,4,51
Rohtas,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Rohtas,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,0,0,0,3,6,4,5,0,4,9,4,7,42
Rohtas,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,0,0,0,7,13,9,10,5,7,17,14,11,93
Rohtas,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,NA,0,0,0,0,252,105,39,49,56,49,82,632
Rohtas,4.1.1.a,Number of male live births,TOTAL,1001,946,1067,1406,1718,1761,2031,1574,1637,1441,1232,1147,16961
Rohtas,4.1.1.b,Number of female live births,TOTAL,868,932,961,1354,1670,1601,1923,1385,1435,1269,1065,1064,15527
Rohtas,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1869,1878,2028,2760,3388,3362,3954,2959,3072,2710,2297,2211,32488
Rohtas,4.1.2,Number of still births,TOTAL,23,25,27,48,52,42,53,28,49,49,18,25,439
Rohtas,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,0,3,1,0,0,0,2,0,0,0,0,0,6
Rohtas,4.2.1,Number of Newborns weighed at birth,TOTAL,1805,1820,1965,2677,3292,2929,3878,2877,2997,2650,2245,1975,31110
Rohtas,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,77,72,94,142,360,176,221,162,178,215,230,198,2125
Rohtas,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1810,1824,1802,2690,3125,2933,3890,2905,3006,2649,2251,1972,30857
Rohtas,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,6,4,1,1,2,3,1,0,6,4,19,26,73
Rohtas,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Rohtas,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,5,8,5,5,4,10,20,6,8,8,32,27,138
Rohtas,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,11,12,6,6,6,13,21,6,14,12,51,53,211
Rohtas,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,NA,0,0,0,0,0,0,NA,NA,NA,NA,NA,0
Rohtas,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,3,6,6,20,10,11,21,30,29,10,22,32,200
Rohtas,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0,1,1,0,0,0,0,0,1,0,2,4,9
Rohtas,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,1,1,1,5,7,20,0,12,19,9,122,146,343
Rohtas,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0,0,0,0,0,0,0,0,0,0,0,4,4
Rohtas,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1715,1590,1809,2570,2997,2388,3213,2713,2801,2222,1814,1643,27475
Rohtas,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1348,1267,1271,1888,1770,1937,1928,2057,2122,1834,1482,1507,20411
Rohtas,6.3,PNC maternal complications attended,TOTAL,0,0,0,0,7,0,54,0,3,3,6,6,79
Rohtas,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Rohtas,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Rohtas,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Rohtas,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Rohtas,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,276,233,310,288,286,379,286,0,202,199,4,224,2687
Rohtas,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,471,408,706,666,750,836,750,0,578,491,7,536,6199
Rohtas,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,747,641,1016,954,1036,1215,1036,0,780,690,11,760,8886
Rohtas,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Rohtas,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0,1,0,12,7,12,3,7,2,1,6,7,58
Rohtas,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0,0,0,1,1,0,1,1,1,2,0,2,9
Rohtas,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0,2,0,16,0,12,0,6,10,7,7,3,63
Rohtas,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0,3,0,29,8,24,4,14,13,10,13,12,130
Rohtas,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,NA,NA,0,0,NA,0,0,NA,0,NA,NA,8,8
Rohtas,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0,0,0,6,0,0,0,0,0,0,0,0,6
Rohtas,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Rohtas,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0,0,0,0,26,0,0,0,0,0,0,0,26
Rohtas,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0,0,0,6,26,0,0,0,0,0,0,0,32
Rohtas,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,NA,NA,0,0,NA,0,0,NA,0,NA,NA,NA,0
Rohtas,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,52,22,5,363,321,496,526,440,685,668,738,542,4858
Rohtas,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,16,3,0,53,55,55,72,51,101,107,98,78,689
Rohtas,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,72,32,0,146,54,110,239,132,253,297,380,291,2006
Rohtas,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,140,57,5,562,430,661,837,623,1039,1072,1216,911,7553
Rohtas,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,87,NA,0,30,NA,138,353,168,371,447,435,1259,3288
Rohtas,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0,0,0,0,0,0,0,1,2,2,1,2,8
Rohtas,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Rohtas,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0,0,9,3,2,2,3,1,1,3,3,4,31
Rohtas,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0,0,9,3,2,2,3,2,3,5,4,6,39
Rohtas,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,NA,NA,0,0,NA,0,0,NA,NA,NA,NA,NA,0
Rohtas,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,759,829,807,1537,937,990,887,834,1080,808,671,904,11043
Rohtas,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,248,281,184,653,278,329,323,417,428,552,358,479,4530
Rohtas,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,2,1,7,75,13,23,14,19,31,23,16,16,240
Rohtas,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,7,11,6,70,18,25,31,17,58,67,71,49,430
Rohtas,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,1016,1122,1004,2335,1246,1367,1255,1287,1597,1450,1116,1448,16243
Rohtas,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,83,77,45,86,147,106,108,52,104,109,80,157,1154
Rohtas,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,NA,NA,0,0,NA,0,0,NA,NA,NA,NA,NA,0
Rohtas,9.06,Number of IUCD removals,TOTAL,423,487,464,567,523,545,461,475,489,422,344,449,5649
Rohtas,9.07,Number of Oral Pills cycles distributed,TOTAL,1265,1199,920,2511,1565,1748,1542,1308,1363,1335,1194,1171,17121
Rohtas,9.08,Number of Condom pieces distributed,TOTAL,2263,1956,1984,5469,2826,5012,3031,2703,4480,4072,2695,5057,41548
Rohtas,9.09,Number of Centchroman (weekly) pills given,TOTAL,19,23,0,0,0,0,2,30,30,45,26,3,178
Rohtas,9.1,Number of Emergency Contraceptive Pills distributed,TOTAL,328,350,171,399,256,310,355,305,333,263,394,315,3779
Rohtas,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,12,12
Rohtas,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,10,10
Rohtas,9.11.2.a,Number of failures following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Rohtas,9.11.2.b,Number of failures following female sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Rohtas,9.11.3.a,Number of deaths following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Rohtas,9.11.3.b,Number of deaths following female sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Rohtas,9.12,Number of Institutions having NSV trained doctors,TOTAL,NA,NA,2,2,11,8,9,20,18,15,18,15,Data for this item can not be cumulated
Rohtas,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,4051,4093,4164,5432,6293,6164,6190,6264,6277,5849,4784,4977,64538
Rohtas,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,24,16,41,34,26,7,6,24,24,3,1,55,261
Rohtas,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,521,235,344,209,103,50,38,41,44,5,5,57,1652
Rohtas,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,1731,978,576,473,234,154,106,86,66,40,10,83,4537
Rohtas,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,5194,4867,4817,4998,5621,5466,6024,6070,6569,6764,5828,5958,68176
Rohtas,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,5417,5469,4749,4962,5184,5076,5149,5463,6317,6476,5963,6687,66912
Rohtas,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,4904,5447,5018,5007,5267,4762,5017,4766,5542,5919,5586,6565,63800
Rohtas,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,2700,2435,2808,3807,4364,4498,4454,4342,4158,3680,2959,3369,43574
Rohtas,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,5042,4922,4983,5024,5387,5503,6068,6176,6590,6812,5823,5934,68264
Rohtas,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,5804,5688,4893,5134,5136,5103,5171,5524,6210,6501,5944,6629,67737
Rohtas,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,6499,6109,5336,5340,5365,4845,5026,4802,5574,5992,5578,6538,67004
Rohtas,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,1600,1455,1780,2414,3106,2845,2955,2851,2700,2431,1947,2073,28157
Rohtas,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,48,100,49,18,55,6,3,80,41,0,1,192,593
Rohtas,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,519,260,257,201,118,50,36,70,39,7,1,343,1901
Rohtas,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,1698,955,576,439,292,167,93,84,51,54,4,62,4475
Rohtas,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,4993,5456,6041,6407,6654,6091,6221,5767,5525,5150,4711,5402,68418
Rohtas,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,4753,4437,4287,4516,4314,4040,4158,4260,4934,5229,5215,5824,55967
Rohtas,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0,0,0,0,0,0,0,0,0,0,0,1,1
Rohtas,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2701,2819,3238,3315,3472,3308,3212,3044,2902,2766,2477,2743,35997
Rohtas,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2342,2411,2693,3020,3134,2858,2944,2640,2588,2354,2224,2637,31845
Rohtas,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,5043,5230,5931,6335,6606,6166,6156,5684,5490,5120,4701,5380,67842
Rohtas,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,5171,4923,4787,5126,4826,4433,4266,4381,5033,5359,5330,5999,59634
Rohtas,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,5180,4936,4876,5157,4775,4438,4274,4382,5032,5364,5330,6006,59750
Rohtas,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0,0,0,0,0,0,0,0,83,0,137,349,569
Rohtas,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,283,186,556,882,807,564,615,780,802,711,682,820,7688
Rohtas,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,256,171,486,607,681,475,579,749,738,651,670,799,6862
Rohtas,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,539,357,1042,1489,1488,1039,1194,1529,1540,1362,1352,1619,14550
Rohtas,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,332,240,251,276,633,639,672,806,1299,1125,1044,1117,8434
Rohtas,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,1157,1111,1010,1121,1194,1302,1360,1710,1847,1514,1463,1711,16500
Rohtas,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1526,1494,1429,1709,1729,1747,1718,2080,2251,1956,1989,2229,21857
Rohtas,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0,12,0,2,0,0,0,0,0,0,0,0,14
Rohtas,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Rohtas,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0,2,0,2,0,0,7,8,9,10,9,5,52
Rohtas,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,2851,2823,2841,2874,2834,2826,2781,2750,2778,2803,2550,2691,33402
Rohtas,10.4.2,Number of Immunisation sessions held during the month,TOTAL,2849,2815,2811,2855,2825,2755,2753,2702,2731,2762,2508,2685,33051
Rohtas,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,2441,2415,2227,2485,2458,2282,2384,2371,2394,2332,2162,2331,28282
Rohtas,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Rohtas,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,3930,4336,4612,4329,4566,3666,3652,3222,2344,2197,1700,1717,40271
Rohtas,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,1721,1359,1482,1589,1425,1333,1182,859,1007,1134,1322,1122,15535
Rohtas,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,31,11,59,84,64,9,6,36,28,34,62,20,444
Rohtas,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Rohtas,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Rohtas,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0,0,0,9,0,0,0,6,4,0,0,0,19
Rohtas,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0,0,0,6,0,0,0,0,0,0,0,0,6
Rohtas,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Rohtas,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Rohtas,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,29,86,29,41,17,2,27,6,10,5,5,16,273
Rohtas,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,2,0,0,4,2,0,0,0,8,6,3,1,26
Rohtas,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0,2,0,5,25,0,25,0,9,4,4,2,76
Rohtas,13.1,Number of Patients operated for cataract,TOTAL,68,0,0,0,0,0,0,0,63,0,40,0,171
Rohtas,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,68,0,0,0,0,0,0,0,63,127,40,0,298
Rohtas,13.3,Number of School children detected with Refractive errors,TOTAL,0,5,0,6,4,9,0,2,0,0,0,4,30
Rohtas,13.4,Number of children provided free glasses,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Rohtas,13.5,Number of eyes collected through eye donation,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Rohtas,13.6,Number of eyes utilised for corneal transplant,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Rohtas,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,NA,NA,2,NA,NA,1,3,2,3,3,4,4,Data for this item can not be cumulated
Rohtas,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,NA,NA,1,1,12,18,22,28,26,25,25,22,Data for this item can not be cumulated
Rohtas,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,1925,1742,1737,1915,1795,1509,1432,1455,1432,1310,1426,1474,Data for this item can not be cumulated
Rohtas,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,NA,NA,2,1,1,2,4,4,5,5,4,4,Data for this item can not be cumulated
Rohtas,14.05,Number of RKS meetings held during the month,TOTAL,18,20,22,19,22,20,21,14,13,11,12,18,210
Rohtas,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,NA,NA,4,4,5,10,16,18,18,20,23,19,Data for this item can not be cumulated
Rohtas,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,64,23,303,417,720,930,731,728,734,704,737,591,6682
Rohtas,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,NA,NA,2,1,1,2,3,2,3,3,3,2,Data for this item can not be cumulated
Rohtas,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,NA,NA,1,1,1,1,1,0,0,0,0,0,Data for this item can not be cumulated
Rohtas,14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,1130,1122,1103,1267,1533,1621,1481,1355,1712,1309,1089,1210,15932
Rohtas,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,1944,1556,1417,1412,1615,1949,1733,964,1737,1516,1146,1819,18808
Rohtas,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,1124,1147,1017,1277,1654,1630,1607,1268,1715,1321,1225,1025,16010
Rohtas,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,3183,3170,2707,3940,4141,4521,4433,4313,4573,4283,3743,3667,46674
Rohtas,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,2254,2269,2120,2544,3187,3251,3088,2623,3427,2630,2314,2235,31942
Rohtas,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,5127,4726,4124,5352,5756,6470,6166,5277,6310,5799,4889,5486,65482
Rohtas,14.10.2.a,Number of death cases of Inpatient males,TOTAL,4,3,4,2,2,4,2,0,3,1,3,0,28
Rohtas,14.10.2.b,Number of death cases of Inpatient females,TOTAL,1,0,1,0,2,1,1,1,2,0,1,2,12
Rohtas,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,5,3,5,2,4,5,3,1,5,1,4,2,40
Rohtas,14.11,In-Patient Head Count at midnight,TOTAL,6410,5916,5286,6547,6687,7831,7276,6373,7359,7031,6205,6761,79682
Rohtas,14.12.1,OPD attendance (All),TOTAL,175811,166540,174211,185868,201026,198804,179535,144506,154667,149239,140142,143366,2013715
Rohtas,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,992,276,20,517,478,868,1037,634,909,1060,1120,801,8712
Rohtas,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0,0,0,61,183,5,5,5,3,8,50,4,324
Rohtas,14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,3502,3214,2970,3078,2450,3311,2958,2773,3234,3287,3087,2723,36587
Rohtas,14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,14.14.a,Number of patients given AYUSH treatment,TOTAL,31899,26896,32738,32062,37515,37910,33913,25065,27524,23502,23622,24025,356671
Rohtas,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,1862,2120,2214,2465,2911,2905,2547,2050,2240,2524,2116,2007,27961
Rohtas,14.14.c,Number of Adolescents counselled,TOTAL,0,0,0,0,0,0,0,0,0,0,0,32,32
Rohtas,15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,2354,2542,2811,2691,2995,3324,2860,2227,2663,2414,2724,2437,32042
Rohtas,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,34,39,47,42,45,48,45,30,39,33,30,32,464
Rohtas,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,272,24,341,356,363,512,455,201,378,428,368,205,3903
Rohtas,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,5,1,5,4,6,11,6,0,2,2,3,188,233
Rohtas,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,143,8,107,148,168,285,181,99,583,613,644,103,3082
Rohtas,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,3,0,1,4,4,4,3,1,3,1,2,172,198
Rohtas,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,321,50,536,591,559,838,585,58,585,569,70,67,4829
Rohtas,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,1,0,0,1,1,2,1,0,0,0,0,454,460
Rohtas,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,736,82,984,1095,1090,1635,1221,358,1546,1610,1082,375,11814
Rohtas,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,9,1,6,9,11,17,10,1,5,3,5,814,891
Rohtas,15.2,Number of Widal tests conducted,Number tested,2,3,2,0,1,6,28,13,13,10,12,55,145
Rohtas,15.3.a,Number of VDRL tests conducted on males,Number tested,6,4,179,6,9,5,8,0,2,5,6,7,237
Rohtas,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,22,11,99,4,6,8,6,0,13,4,8,8,189
Rohtas,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,186,34,496,467,510,534,510,0,373,291,342,360,4103
Rohtas,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,214,49,774,477,525,547,524,0,388,300,356,375,4529
Rohtas,15.4.1,Number of blood smears examined for Malaria,TOTAL,597,482,403,529,919,2245,1329,608,642,486,633,675,9548
Rohtas,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,2,2,4,9,21,136,41,9,5,2,2,7,240
Rohtas,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0,4,1,42,9,16,5,2,7,0,0,0,86
Rohtas,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,1550,2150,3550,3550,2100,1550,1550,1100,1250,NA,750,NA,19100
Rohtas,16.1.1,Stock position of DPT vaccines,2. Stocks Received,1500,2000,NA,NA,0,500,0,500,0,NA,500,NA,5000
Rohtas,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0,0,NA,NA,0,0,0,0,0,NA,0,NA,0
Rohtas,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,900,600,NA,1450,550,50,450,350,600,NA,525,NA,5475
Rohtas,16.1.1,Stock position of DPT vaccines,5. Total Stock,2150,3550,3550,2100,1550,2000,1100,1250,650,0,725,0,18625
Rohtas,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,1550,1550,2850,2850,3880,2788,2236,770,914,NA,410,NA,19798
Rohtas,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,2300,2500,NA,1100,0,576,0,1392,1440,NA,2304,NA,11612
Rohtas,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0,0,NA,NA,0,0,0,0,0,NA,0,NA,0
Rohtas,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,2300,1200,NA,600,1092,1178,1466,1248,1656,NA,1800,NA,12540
Rohtas,16.1.1A,Stock Position of Pentavalent,5. Total Stock,1550,2850,2850,3350,2788,2186,770,914,698,0,914,0,18870
Rohtas,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,975,1000,1625,1625,2775,2150,550,375,775,NA,75,NA,11925
Rohtas,16.1.2,Stock position of OPV vaccines,2. Stocks Received,1900,2200,NA,1200,1000,400,1000,1400,1800,NA,2000,NA,12900
Rohtas,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0,0,NA,NA,0,0,0,0,0,NA,0,NA,0
Rohtas,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,1875,1575,NA,100,1625,2000,1175,1000,2225,NA,1025,NA,12600
Rohtas,16.1.2,Stock position of OPV vaccines,5. Total Stock,1000,1625,1625,2725,2150,550,375,775,350,0,1050,0,12225
Rohtas,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,1450,1700,3450,3450,2600,1600,3500,2450,1650,NA,1750,NA,23600
Rohtas,16.1.3,Stock position of TT vaccines,2. Stocks Received,2000,2900,NA,0,0,3350,0,300,1000,NA,1250,NA,10800
Rohtas,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0,0,NA,NA,0,0,0,0,0,NA,0,NA,0
Rohtas,16.1.3,Stock position of TT vaccines,4. Stock Distributed,1750,1150,NA,800,1000,1450,1050,1100,1100,NA,900,NA,10300
Rohtas,16.1.3,Stock position of TT vaccines,5. Total Stock,1700,3450,3450,2650,1600,3500,2450,1650,1550,0,2100,0,24100
Rohtas,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0,0,0,0,0,0,0,0,0,NA,0,NA,0
Rohtas,16.1.4,Stock position of DT vaccines,2. Stocks Received,0,0,NA,NA,0,0,0,0,0,NA,0,NA,0
Rohtas,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0,0,NA,NA,0,0,0,0,0,NA,0,NA,0
Rohtas,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0,0,NA,NA,0,0,0,0,0,NA,0,NA,0
Rohtas,16.1.4,Stock position of DT vaccines,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Rohtas,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,2000,1500,2750,2750,2250,1100,1380,630,1086,NA,390,NA,15836
Rohtas,16.1.5,Stock position of BCG vaccines,2. Stocks Received,1400,2000,NA,NA,0,1800,500,1400,1000,NA,1400,NA,9500
Rohtas,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0,0,NA,NA,0,0,0,0,0,NA,0,NA,0
Rohtas,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,1900,700,NA,500,1150,1520,1250,950,1700,NA,900,NA,10570
Rohtas,16.1.5,Stock position of BCG vaccines,5. Total Stock,1500,2800,2750,2250,1100,1380,630,1080,386,0,890,0,14766
Rohtas,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,600,850,650,650,2000,3350,4550,2300,450,NA,1500,NA,16900
Rohtas,16.1.6,Stock position of Measles vaccines,2. Stocks Received,3600,1800,NA,2000,4000,4450,0,700,3300,NA,2200,NA,22050
Rohtas,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0,0,NA,NA,0,0,0,0,0,NA,0,NA,0
Rohtas,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,3350,2000,NA,650,2650,3250,2250,0,2450,NA,1800,NA,18400
Rohtas,16.1.6,Stock position of Measles vaccines,5. Total Stock,850,650,650,2000,3350,4550,2300,3000,1300,0,1900,0,20550
Rohtas,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0,0,0,NA,0,0,0,0,0,NA,0,NA,0
Rohtas,16.1.7,Stock position of JE vaccines,2. Stocks Received,0,0,NA,NA,0,0,0,0,0,NA,0,NA,0
Rohtas,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0,0,NA,NA,0,0,0,0,0,NA,0,NA,0
Rohtas,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0,0,NA,NA,0,0,0,0,0,NA,0,NA,0
Rohtas,16.1.7,Stock position of JE vaccines,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Rohtas,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,925,875,2875,2875,1975,1775,1375,1025,1025,NA,650,NA,15375
Rohtas,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,750,2300,NA,NA,0,0,0,0,0,NA,200,NA,3250
Rohtas,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0,0,NA,NA,0,0,0,0,0,NA,0,NA,0
Rohtas,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,800,300,NA,900,1150,400,350,0,375,NA,50,NA,4325
Rohtas,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,875,2875,2875,1975,825,1375,1025,1025,650,0,800,0,14300
Rohtas,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Rohtas,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Rohtas,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Rohtas,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Rohtas,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Rohtas,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Rohtas,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,16.3.02,Stock Position of Gloves,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,16.3.02,Stock Position of Gloves,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,16.3.02,Stock Position of Gloves,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,16.3.02,Stock Position of Gloves,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Rohtas,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Rohtas,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Rohtas,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Rohtas,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Rohtas,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Rohtas,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Rohtas,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Rohtas,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Rohtas,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Rohtas,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,0,200,4600,4600,9200,6000,9000,3000,9900,NA,1200,NA,47700
Rohtas,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,9000,10000,NA,4600,0,10000,0,10000,8000,NA,10000,NA,61600
Rohtas,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0,0,NA,NA,0,0,0,0,0,NA,0,NA,0
Rohtas,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,8800,5600,NA,NA,1092,7000,6000,3100,8900,NA,5200,NA,45692
Rohtas,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,200,4600,4600,9200,8108,9000,3000,9900,9000,0,6000,0,63608
Rohtas,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,6000,9000,63600,6360,72000,480000,63200,33800,30800,NA,5000,NA,769760
Rohtas,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,83000,100000,NA,65000,0,60000,0,25000,65000,NA,70000,NA,468000
Rohtas,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0,0,NA,NA,0,0,0,0,0,NA,0,NA,0
Rohtas,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,80000,45400,NA,NA,24000,44800,29400,53000,30800,NA,43000,NA,350400
Rohtas,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,9000,63600,63600,71360,48000,495200,33800,5800,65000,0,32000,0,887360
Rohtas,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,0,600,3600,3600,4400,2000,6700,3200,8300,NA,2200,NA,34600
Rohtas,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,6500,6600,NA,800,0,8000,0,8000,4000,NA,8000,NA,41900
Rohtas,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0,0,NA,NA,0,0,0,0,0,NA,0,NA,0
Rohtas,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,5900,3600,NA,NA,2400,3300,2500,2900,4000,NA,3800,NA,28400
Rohtas,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,600,3600,3600,4400,2000,6700,4200,8300,8300,0,6400,0,48100
Rohtas,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,1
Rohtas,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,1
Rohtas,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Rohtas,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,1.1,Total number of pregnant women Registered for ANC,TOTAL,6970,6806,5746,6429,6041,4104,4127,3363,4079,4100,4686,5131,61582
Saharsa,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,3247,3047,2559,2735,2625,2008,1897,1488,2032,2320,2798,2942,29698
Saharsa,1.2,Number of Pregnant women registered under JSY,TOTAL,6970,6855,5738,6429,6038,4104,4127,3363,4079,4100,4686,5131,61620
Saharsa,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,2834,2979,2799,2907,2834,2698,2660,1971,2565,2790,2800,3037,32874
Saharsa,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,3254,3223,2389,2588,2292,1847,1940,1517,1879,1902,2257,2405,27493
Saharsa,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,5449,6161,4897,5225,4825,4170,4150,3159,3619,3831,3929,4494,53909
Saharsa,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,3832,3871,3183,3315,3400,2570,2574,1741,1596,883,786,990,28741
Saharsa,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,199,144,61,68,102,56,21,17,23,29,47,29,796
Saharsa,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,8,5,4,6,4,6,7,4,7,4,22,17,94
Saharsa,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,560,628,519,531,496,555,521,444,496,542,568,765,6625
Saharsa,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,23,26,33,34,38,33,32,23,31,36,22,27,358
Saharsa,1.8,Number of pregnancy test kits used at SC level,TOTAL,19,125,75,140,40,91,90,69,49,113,169,133,1113
Saharsa,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,27,43,33,42,34,154,197,133,122,134,95,53,1067
Saharsa,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,264,332,245,324,418,406,495,473,517,433,545,525,4977
Saharsa,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,291,375,278,366,452,560,692,606,639,567,640,578,6044
Saharsa,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,186,249,193,243,205,430,534,458,536,509,572,523,4638
Saharsa,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0,0,0,9,0,0,0,0,5,0,0,0,14
Saharsa,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,2223,2325,2323,3158,4180,4681,5050,4164,3259,3087,2895,2578,39923
Saharsa,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,1360,1467,1495,2136,2483,2521,3669,2870,1926,2046,1912,1808,25693
Saharsa,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,992,1517,1298,317,10,5784,2922,7721,3667,7935,4834,3955,40952
Saharsa,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,137,85,14,25,0,2756,2549,2764,744,2071,3813,13097,28055
Saharsa,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Saharsa,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,143,294,1784,1961,2017,1763,NA,NA,NA,0,298,109,8369
Saharsa,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,0,0
Saharsa,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,0,0
Saharsa,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,0,0
Saharsa,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0,1,0,0,0,0,0,0,0,0,0,0,1
Saharsa,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,62,60,61,53,22,27,35,51,25,43,57,62,558
Saharsa,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,62,61,61,53,22,27,35,51,25,43,57,62,559
Saharsa,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,23,17,39,48,23,33,NA,NA,NA,0,NA,0,183
Saharsa,4.1.1.a,Number of male live births,TOTAL,1342,1375,1332,1760,2291,2694,2836,2455,2018,1825,1838,1609,23375
Saharsa,4.1.1.b,Number of female live births,TOTAL,1230,1296,1253,1684,2159,2490,2850,2355,1815,1785,1680,1540,22137
Saharsa,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,2572,2671,2585,3444,4450,5184,5686,4810,3833,3610,3518,3149,45512
Saharsa,4.1.2,Number of still births,TOTAL,47,67,62,71,92,84,80,75,67,60,53,53,811
Saharsa,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,8,9,13,1,4,1,3,1,4,12,10,9,75
Saharsa,4.2.1,Number of Newborns weighed at birth,TOTAL,2499,2548,2466,3354,4343,5105,5601,4694,3774,3544,3471,3120,44519
Saharsa,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,194,180,193,302,393,452,488,363,340,318,352,342,3917
Saharsa,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,2516,2599,2504,3361,4348,4890,5587,4531,3714,3550,3463,3102,44165
Saharsa,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,16,16,22,69,33,48,33,30,35,57,64,51,474
Saharsa,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,6,4,6,9,6,4,3,2,3,4,61,62,170
Saharsa,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,22,20,28,78,39,52,36,32,38,61,125,113,644
Saharsa,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,0
Saharsa,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,154,170,172,184,191,161,181,154,190,166,155,138,2016
Saharsa,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,19,30,26,34,30,17,22,21,20,18,99,126,462
Saharsa,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,448,544,463,544,663,490,444,437,442,433,471,516,5895
Saharsa,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,16,14,16,21,24,31,27,28,24,29,23,12,265
Saharsa,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1958,1875,1645,2635,2800,3810,5091,4243,3457,3295,2921,2512,36242
Saharsa,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1129,999,1030,1226,1704,1887,2425,1893,1736,1718,1696,1776,19219
Saharsa,6.3,PNC maternal complications attended,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Saharsa,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,7,9,13,1,4,1,3,1,4,12,10,9,74
Saharsa,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Saharsa,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,7,9,13,1,4,1,3,1,4,12,10,9,74
Saharsa,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0,0,19,11,11,24,0,0,31,17,0,0,113
Saharsa,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,2,2,3,2,3,2,2,3,3,2,2,2,28
Saharsa,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,2,2,3,3,3,3,2,3,2,2,2,3,30
Saharsa,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,4,4,6,5,6,5,4,6,5,4,4,5,58
Saharsa,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Saharsa,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0,0,0,1,0,0,1,0,1,3,1,1,8
Saharsa,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0,NA,0,1,0,0,0,0,0,0,0,1,2
Saharsa,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0,0,0,2,0,0,1,0,1,3,1,2,10
Saharsa,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0,0,NA,NA,0,NA,NA,NA,0,0,NA,NA,0
Saharsa,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Saharsa,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0,NA,0,0,0,0,0,0,0,0,0,0,0
Saharsa,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Saharsa,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,NA,0,NA,NA,0,NA,NA,NA,0,0,NA,NA,0
Saharsa,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,125,71,57,540,292,755,628,427,1779,1049,1143,942,7808
Saharsa,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,55,42,15,36,37,25,30,27,60,57,77,80,541
Saharsa,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,180,113,72,576,329,780,658,454,1839,1106,1220,1022,8349
Saharsa,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,101,65,28,41,65,124,NA,NA,233,238,545,276,1716
Saharsa,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,22,21,8,27,54,48,43,25,47,68,52,47,462
Saharsa,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,29,21,28,27,13,14,18,8,8,16,21,25,228
Saharsa,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,51,42,36,54,67,62,61,33,55,84,73,72,690
Saharsa,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,NA,0,NA,NA,0,NA,NA,NA,0,0,NA,NA,0
Saharsa,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,82,126,145,164,131,111,143,104,285,311,282,264,2148
Saharsa,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,31,57,50,82,74,190,88,96,129,235,174,156,1362
Saharsa,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,77,113,6,5,8,8,5,15,10,11,8,16,282
Saharsa,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,190,296,201,251,213,309,236,215,424,557,464,436,3792
Saharsa,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,135,157,215,156,175,172,114,125,131,170,153,206,1909
Saharsa,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,3,7,NA,NA,3,NA,NA,NA,11,9,22,3,58
Saharsa,9.06,Number of IUCD removals,TOTAL,59,91,68,108,88,77,115,80,96,119,171,177,1249
Saharsa,9.07,Number of Oral Pills cycles distributed,TOTAL,390,567,739,977,809,674,658,657,1395,935,1771,1432,11004
Saharsa,9.08,Number of Condom pieces distributed,TOTAL,3853,4065,4180,6123,11045,5951,5916,5959,8898,8161,11417,7942,83510
Saharsa,9.09,Number of Centchroman (weekly) pills given,TOTAL,9,17,23,31,28,34,17,177,15,18,13,149,531
Saharsa,9.1,Number of Emergency Contraceptive Pills distributed,TOTAL,23,82,95,77,43,82,54,50,108,93,84,106,897
Saharsa,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Saharsa,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,5,5
Saharsa,9.11.2.a,Number of failures following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Saharsa,9.11.2.b,Number of failures following female sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Saharsa,9.11.3.a,Number of deaths following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Saharsa,9.11.3.b,Number of deaths following female sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Saharsa,9.12,Number of Institutions having NSV trained doctors,TOTAL,NA,NA,1,1,1,NA,1,4,3,4,4,6,Data for this item can not be cumulated
Saharsa,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,3661,3736,3282,4266,5164,6022,7349,5948,5693,4711,4339,4052,58223
Saharsa,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,67,41,23,27,16,0,3,2,6,4,6,3,198
Saharsa,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,870,438,201,121,73,21,33,12,13,8,8,6,1804
Saharsa,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,2350,1403,726,554,299,129,128,41,24,20,18,10,5702
Saharsa,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,4382,3828,3069,3458,3424,3485,5590,6003,6997,6316,4881,4572,56005
Saharsa,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,4526,4827,3269,3670,3295,3216,3652,4422,5570,6831,5803,5557,54638
Saharsa,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,3643,4548,3876,3841,3427,3117,3500,3172,4155,5511,5461,6028,50279
Saharsa,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,2434,2565,2330,3328,4425,5057,5715,4459,3841,3417,3273,2914,43758
Saharsa,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,4576,3777,3110,3426,3410,4415,6475,6725,7465,6882,5556,5094,60911
Saharsa,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,5337,5034,3619,3742,3335,3158,3660,4401,5487,6832,5911,5516,56032
Saharsa,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,5873,5845,4634,4319,3743,3280,3585,3165,4120,5543,5584,5995,55686
Saharsa,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,1970,2072,2065,2826,3813,4317,4626,3878,2905,2996,2840,2507,36815
Saharsa,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,28,8,21,3,16,0,8,1,0,52,27,0,164
Saharsa,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,778,457,199,91,68,23,42,6,8,85,45,3,1805
Saharsa,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,2299,1344,705,491,301,129,118,34,23,56,63,3,5566
Saharsa,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,3832,4983,4785,5651,5836,5038,5406,3906,3954,3271,3187,3387,53236
Saharsa,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,5405,5309,3366,3492,3839,3542,3858,2919,3865,4435,5323,5702,51055
Saharsa,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Saharsa,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1897,2512,2435,2830,2870,2458,2610,1925,1923,1607,1618,1781,26466
Saharsa,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1739,2346,2202,2601,2812,2361,2644,1898,1889,1507,1529,1581,25109
Saharsa,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,3636,4858,4637,5431,5682,4819,5254,3823,3812,3114,3147,3362,51575
Saharsa,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,5939,5371,3828,4035,3756,3510,3939,2920,3749,4396,5317,5724,52484
Saharsa,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,5848,5098,3816,3997,3778,3491,3943,2921,3715,4406,5252,5626,51891
Saharsa,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Saharsa,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,980,487,537,678,641,445,603,353,451,550,388,399,6512
Saharsa,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,855,453,471,690,628,433,521,352,428,576,351,368,6126
Saharsa,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,1835,940,1008,1368,1269,878,1124,705,879,1126,739,767,12638
Saharsa,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,94,93,57,26,54,284,268,392,543,757,698,473,3739
Saharsa,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,758,457,412,569,452,438,515,414,774,595,557,562,6503
Saharsa,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1580,1091,733,1089,946,777,995,928,1217,1207,1035,1107,12705
Saharsa,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,2,0,1,0,1,0,3,0,0,0,0,0,7
Saharsa,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Saharsa,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,1,0,0,0,0,0,0,0,0,0,2,0,3
Saharsa,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,2043,2153,2083,2124,1981,1948,1976,1942,2013,1995,1986,1997,24241
Saharsa,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1997,2117,1891,2076,1832,1729,1878,1785,1957,1877,1914,1962,23015
Saharsa,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1615,1567,1528,1607,1465,1424,1549,1492,1608,1550,1560,1579,18544
Saharsa,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Saharsa,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1543,3065,2602,3603,3777,2992,3873,3047,3168,2607,2334,2275,34886
Saharsa,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,117,247,193,285,327,213,572,452,678,825,1106,638,5653
Saharsa,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,0,29,0,0,6,1,21,7,19,7,16,17,123
Saharsa,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Saharsa,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Saharsa,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0,0,0,1,0,0,0,0,0,0,0,0,1
Saharsa,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Saharsa,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Saharsa,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,14,0,0,0,2,0,15,0,0,0,4,8,43
Saharsa,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,1541,1625,1499,1614,1598,1458,1254,827,794,607,748,805,14370
Saharsa,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,16,26,2,0,0,0,2,0,0,3,0,3,52
Saharsa,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,84,234,60,56,173,53,58,12,34,27,0,18,809
Saharsa,13.1,Number of Patients operated for cataract,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Saharsa,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Saharsa,13.3,Number of School children detected with Refractive errors,TOTAL,5,5,5,4,7,7,5,4,6,6,5,4,63
Saharsa,13.4,Number of children provided free glasses,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Saharsa,13.5,Number of eyes collected through eye donation,TOTAL,0,NA,0,0,0,0,0,0,0,0,0,0,0
Saharsa,13.6,Number of eyes utilised for corneal transplant,TOTAL,0,NA,0,0,0,0,0,0,0,0,0,0,0
Saharsa,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,NA,NA,NA,NA,NA,NA,1,1,1,1,1,1,Data for this item can not be cumulated
Saharsa,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,NA,NA,1,1,1,3,7,13,11,12,12,12,Data for this item can not be cumulated
Saharsa,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,1363,1336,1292,1390,1356,1264,1401,1142,1297,1294,1280,1334,Data for this item can not be cumulated
Saharsa,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,NA,NA,NA,NA,NA,NA,1,1,1,1,1,1,Data for this item can not be cumulated
Saharsa,14.05,Number of RKS meetings held during the month,TOTAL,4,6,4,3,198,5,5,4,5,6,5,5,250
Saharsa,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,NA,NA,1,1,1,3,7,10,10,9,9,10,Data for this item can not be cumulated
Saharsa,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,883,1132,954,853,1341,1500,1760,1318,1365,1345,1095,1014,14560
Saharsa,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,NA,NA,NA,NA,NA,NA,1,1,1,1,1,1,Data for this item can not be cumulated
Saharsa,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,NA,NA,NA,NA,NA,NA,1,0,0,0,0,0,Data for this item can not be cumulated
Saharsa,14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,1715,1859,1772,2053,2466,2782,2575,2256,1946,1829,1714,1641,24608
Saharsa,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,1404,1673,1459,1730,2102,1857,2001,1655,1405,1117,1479,1504,19386
Saharsa,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,1709,1860,1695,2109,2419,2792,2751,2207,1743,1966,1676,1780,24707
Saharsa,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,3242,3019,3075,3842,4507,5285,5162,4277,4732,4137,3614,3263,48155
Saharsa,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,3424,3719,3467,4162,4885,5574,5326,4463,3689,3795,3390,3421,49315
Saharsa,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,4646,4692,4534,5572,6609,7142,7163,5932,6137,5254,5093,4767,67541
Saharsa,14.10.2.a,Number of death cases of Inpatient males,TOTAL,14,17,9,9,8,6,11,11,18,18,16,13,150
Saharsa,14.10.2.b,Number of death cases of Inpatient females,TOTAL,10,8,9,6,10,9,8,12,10,15,22,19,138
Saharsa,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,24,25,18,15,18,15,19,23,28,33,38,32,288
Saharsa,14.11,In-Patient Head Count at midnight,TOTAL,7428,7666,7221,8983,10667,11599,9568,8457,8430,7569,6473,6229,100290
Saharsa,14.12.1,OPD attendance (All),TOTAL,84538,85677,77138,87895,85997,94094,82143,62612,67186,64714,64231,65001,921226
Saharsa,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,239,169,480,642,381,799,673,493,1830,1222,1223,1084,9235
Saharsa,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,8,6,3,1,1,2,2,0,6,1,127,3,160
Saharsa,14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,2968,3408,2935,3638,3653,3578,3391,3110,2974,2733,2358,2823,37569
Saharsa,14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,14.14.a,Number of patients given AYUSH treatment,TOTAL,31385,29858,27408,25719,25855,32459,29887,22335,25000,21934,22451,22448,316739
Saharsa,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,3088,3227,2607,3179,3245,2227,1585,1238,1315,1070,1818,1614,26213
Saharsa,14.14.c,Number of Adolescents counselled,TOTAL,79,88,28,42,9,25,41,0,5,29,276,306,928
Saharsa,15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,248,833,830,1064,1066,898,1005,1031,1327,1575,1622,1639,13138
Saharsa,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,30,36,34,42,53,39,60,37,51,36,31,23,472
Saharsa,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,214,183,435,491,511,514,462,352,493,516,569,529,5269
Saharsa,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,2,1,0,1,1,2,3,1,7,2,1,1,22
Saharsa,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,48,14,146,150,153,158,80,58,171,185,210,204,1577
Saharsa,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0,0,0,0,0,1,2,2,0,2,0,1,8
Saharsa,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,141,130,240,334,290,338,319,240,283,337,204,367,3223
Saharsa,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0,0,0,0,0,0,0,0,0,0,0,0,0
Saharsa,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,403,327,821,975,954,1010,861,650,947,1038,983,1100,10069
Saharsa,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,2,1,0,1,1,3,5,3,7,4,1,2,30
Saharsa,15.2,Number of Widal tests conducted,Number tested,20,340,0,2,14,10,0,4,2,7,3,2,404
Saharsa,15.3.a,Number of VDRL tests conducted on males,Number tested,200,300,201,302,201,201,202,204,206,205,309,208,2739
Saharsa,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,214,205,301,201,303,211,302,301,304,305,303,301,3251
Saharsa,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,0,0,302,111,304,241,351,325,333,327,331,242,2867
Saharsa,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,414,505,804,614,808,653,855,830,843,837,943,751,8857
Saharsa,15.4.1,Number of blood smears examined for Malaria,TOTAL,59,93,71,153,58,92,123,63,89,76,86,74,1037
Saharsa,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,1,4,2,7,2,1,2,1,0,1,11,2,34
Saharsa,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,2,4,0,0,0,0,2,1,0,0,0,1,10
Saharsa,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,2250,2050,2120,2620,3250,2850,2300,3350,NA,2600,2250,1600,27240
Saharsa,16.1.1,Stock position of DPT vaccines,2. Stocks Received,500,1500,1000,1250,0,0,1250,0,NA,0,100,100,5700
Saharsa,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0,0,0,0,0,0,0,0,NA,0,0,0,0
Saharsa,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,700,1430,500,620,400,550,200,400,NA,350,750,1000,6900
Saharsa,16.1.1,Stock position of DPT vaccines,5. Total Stock,2050,2120,2620,3250,2850,2300,3350,2950,0,2250,1600,700,26040
Saharsa,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,1450,1700,1850,3020,4020,2928,2029,2931,NA,57,547,272,20804
Saharsa,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,2100,2100,2000,2550,0,0,1850,0,NA,1850,1850,1850,16150
Saharsa,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0,0,0,0,0,0,0,0,NA,0,0,0,0
Saharsa,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,1850,1950,830,1550,1092,899,948,1450,NA,1360,2125,2075,16129
Saharsa,16.1.1A,Stock Position of Pentavalent,5. Total Stock,1700,1850,3020,4020,2928,2029,2931,1481,0,547,272,47,20825
Saharsa,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,555,535,1185,1105,1590,2675,1350,1000,NA,0,500,540,11035
Saharsa,16.1.2,Stock position of OPV vaccines,2. Stocks Received,1800,2200,1600,2250,2550,0,1000,700,NA,1550,1000,1500,16150
Saharsa,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0,0,0,0,0,0,0,0,NA,0,0,0,0
Saharsa,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,1820,1550,1680,1765,1465,1325,1350,1475,NA,1050,1485,1280,16245
Saharsa,16.1.2,Stock position of OPV vaccines,5. Total Stock,535,1185,1105,1590,2675,1350,1000,225,0,500,15,760,10940
Saharsa,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,400,2200,2950,3820,4920,3370,2370,2170,NA,1220,1120,1370,25910
Saharsa,16.1.3,Stock position of TT vaccines,2. Stocks Received,2750,2500,2000,2250,0,0,500,200,NA,700,1500,1000,13400
Saharsa,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0,0,0,0,0,0,0,0,NA,0,0,0,0
Saharsa,16.1.3,Stock position of TT vaccines,4. Stock Distributed,950,1750,1130,1150,1550,1000,700,1250,NA,800,1250,800,12330
Saharsa,16.1.3,Stock position of TT vaccines,5. Total Stock,2200,2950,3820,4920,3370,2370,2170,1120,0,1120,1370,1570,26980
Saharsa,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0,0,0,0,0,0,0,0,NA,0,0,0,0
Saharsa,16.1.4,Stock position of DT vaccines,2. Stocks Received,0,0,0,0,0,0,0,0,NA,0,0,0,0
Saharsa,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0,0,0,0,0,0,0,0,NA,0,0,0,0
Saharsa,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0,0,0,0,0,0,0,0,NA,0,0,0,0
Saharsa,16.1.4,Stock position of DT vaccines,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Saharsa,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,1450,1881,2621,3111,3271,2291,1291,1316,NA,716,716,416,19080
Saharsa,16.1.5,Stock position of BCG vaccines,2. Stocks Received,1400,2000,1200,1100,0,0,1100,200,NA,1100,1100,1100,10300
Saharsa,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0,0,0,0,0,0,0,0,NA,0,0,0,0
Saharsa,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,969,1260,710,940,980,1000,1075,1400,NA,1100,1400,1050,11884
Saharsa,16.1.5,Stock position of BCG vaccines,5. Total Stock,1881,2621,3111,3271,2291,1291,1316,116,0,716,416,466,17496
Saharsa,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,0,450,950,1470,3070,3370,970,1060,NA,810,1010,260,13420
Saharsa,16.1.6,Stock position of Measles vaccines,2. Stocks Received,3200,3600,3000,4350,2950,0,2500,1800,NA,2000,2000,2950,28350
Saharsa,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0,0,0,0,0,0,0,0,NA,0,0,0,0
Saharsa,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,2750,3100,2480,2750,2650,2400,2410,2150,NA,1800,2750,3000,28240
Saharsa,16.1.6,Stock position of Measles vaccines,5. Total Stock,450,950,1470,3070,3370,970,1060,710,0,1010,260,210,13530
Saharsa,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0,0,0,0,NA,0,0,0,NA,0,0,0,0
Saharsa,16.1.7,Stock position of JE vaccines,2. Stocks Received,0,0,0,0,0,0,0,0,NA,0,0,0,0
Saharsa,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0,0,0,0,0,0,0,0,NA,0,0,0,0
Saharsa,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0,0,0,0,0,0,0,0,NA,0,0,0,0
Saharsa,16.1.7,Stock position of JE vaccines,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Saharsa,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,1350,1755,3045,3355,3055,2795,2345,2170,NA,1220,1020,720,22830
Saharsa,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,1000,2200,1000,0,0,0,0,0,NA,0,100,100,4400
Saharsa,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0,0,0,0,0,0,0,0,NA,0,0,0,0
Saharsa,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,595,910,690,300,260,450,175,350,NA,200,400,200,4530
Saharsa,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,1755,3045,3355,3055,2795,2345,2170,1820,0,1020,720,620,22700
Saharsa,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,100,100,100,100,100,100,100,100,100,NA,6030,3430,10360
Saharsa,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0,0,0,0,0,0,0,0,0,NA,0,0,0
Saharsa,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0,0,0,0,0,0,0,0,0,NA,0,0,0
Saharsa,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,0,0,0,0,0,0,0,0,0,NA,3000,1430,4430
Saharsa,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,100,100,100,100,100,100,100,100,100,0,3030,2000,5930
Saharsa,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,31084,31084,31084,31084,31084,31084,31084,31084,31084,NA,101057,39057,419870
Saharsa,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0,0,0,0,0,0,0,0,0,NA,0,0,0
Saharsa,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0,0,0,0,0,0,0,0,0,NA,0,0,0
Saharsa,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,0,0,0,0,0,0,0,0,0,NA,64000,36605,100605
Saharsa,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,31084,31084,31084,31084,31084,31084,31084,31084,31084,0,37057,2452,319265
Saharsa,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,16181,16181,16181,16181,16181,16181,161810,16181,16181,NA,6893,2574,300725
Saharsa,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0,0,0,0,0,0,0,0,0,NA,0,0,0
Saharsa,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0,0,0,0,0,0,0,0,0,NA,0,0,0
Saharsa,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0,0,0,0,0,0,0,0,0,NA,4319,2384,6703
Saharsa,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,16181,16181,16181,16181,16181,16181,161810,16181,16181,0,2574,190,294022
Saharsa,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,4760,4760,4760,4760,4760,4760,4760,4760,4760,NA,7711,2769,53320
Saharsa,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0,0,0,0,0,0,0,0,0,NA,0,0,0
Saharsa,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0,0,0,0,0,0,0,0,0,NA,0,0,0
Saharsa,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0,0,0,0,0,0,0,0,0,NA,4942,2630,7572
Saharsa,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,4760,4760,4760,4760,4760,4760,4760,4760,4760,0,2769,139,45748
Saharsa,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,0,0,0,0,0,0,0,0,0,NA,0,0,0
Saharsa,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0,0,0,0,0,0,0,0,0,NA,0,0,0
Saharsa,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0,0,0,0,0,0,0,0,0,NA,0,0,0
Saharsa,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0,0,0,0,0,0,0,0,0,NA,0,0,0
Saharsa,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Saharsa,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Saharsa,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,16.3.02,Stock Position of Gloves,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,16.3.02,Stock Position of Gloves,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,16.3.02,Stock Position of Gloves,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,16.3.02,Stock Position of Gloves,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Saharsa,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Saharsa,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Saharsa,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Saharsa,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Saharsa,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Saharsa,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Saharsa,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Saharsa,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0
Saharsa,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0
Saharsa,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0
Saharsa,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0
Saharsa,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Saharsa,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,6500,6500
Saharsa,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0
Saharsa,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0
Saharsa,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1000,1000
Saharsa,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,5500,5500
Saharsa,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,4000,11725,6725,2125,3975,1475,6075,0,NA,1700,0,1800,39600
Saharsa,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,12500,0,700,8000,2000,10500,0,13500,NA,2000,10000,3000,62200
Saharsa,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0,0,0,0,0,0,0,0,NA,0,0,0,0
Saharsa,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,4775,5000,5300,6150,4500,5900,6075,5600,NA,3700,8200,4700,59900
Saharsa,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,11725,6725,2125,3975,1475,6075,0,7900,0,0,1800,100,41900
Saharsa,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,65000,90400,28000,64600,102600,47000,113200,74800,NA,107000,124600,66600,883800
Saharsa,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,80000,0,80000,100000,0,115000,0,130000,NA,60000,0,110000,675000
Saharsa,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0,0,0,0,0,0,0,0,NA,0,0,0,0
Saharsa,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,54600,62400,43400,62000,55600,48800,38400,44000,NA,42400,58000,64000,573600
Saharsa,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,90400,28000,64600,102600,47000,113200,74800,160800,0,124600,66600,112600,985200
Saharsa,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,3400,6300,3500,4700,5000,1300,4700,700,NA,2600,5700,1350,39250
Saharsa,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,5500,0,5000,4000,0,7000,0,8000,NA,6000,0,7000,42500
Saharsa,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0,0,0,0,0,0,0,0,NA,0,0,0,0
Saharsa,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,2600,2800,3800,3700,3700,3600,4000,2100,NA,2900,4350,4200,37750
Saharsa,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,6300,3500,4700,5000,1300,4700,700,6600,0,5700,1350,4150,44000
Saharsa,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,1
Saharsa,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,1
Saharsa,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1
Saharsa,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1
Saharsa,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,2
Saharsa,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,1,2
Saharsa,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,1,2,1,NA,4
Saharsa,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,NA,NA,NA,NA,NA,NA,NA,1,1,2,1,1,6
Saharsa,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,1
Saharsa,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,1
Saharsa,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saharsa,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Samastipur,1.1,Total number of pregnant women Registered for ANC,TOTAL,10039,9877,9024,10234,9903,9248,9097,7539,8083,8735,9325,9403,110507
Samastipur,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,4251,4042,3711,4131,4275,4744,4436,3837,4218,4585,5378,5550,53158
Samastipur,1.2,Number of Pregnant women registered under JSY,TOTAL,10039,9877,8997,10234,9871,9248,9097,7527,8083,8729,9315,9403,110420
Samastipur,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,5600,5735,5420,5860,6126,6542,6586,5859,5850,5765,6191,6348,71882
Samastipur,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,6424,6212,5595,6183,5900,5327,5416,4313,4719,5121,5504,5556,66270
Samastipur,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,9131,10117,7477,8657,9615,8942,8621,7527,6895,7710,7646,8478,100816
Samastipur,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,4129,4062,3476,3567,3004,2592,2702,2057,1444,1319,1544,1764,31660
Samastipur,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,91,164,82,408,116,191,238,138,115,175,213,181,2112
Samastipur,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0,1,2,1,2,1,2,1,2,2,100,90,204
Samastipur,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,1423,1188,1122,956,915,1420,1279,1035,1542,1338,1690,1800,15708
Samastipur,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,7,1,1,7,2,1,0,0,0,0,2,2,23
Samastipur,1.8,Number of pregnancy test kits used at SC level,TOTAL,2135,2414,2210,2324,2490,2142,2443,1951,1754,1650,2162,2321,25996
Samastipur,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,138,92,117,81,106,93,153,94,103,134,104,113,1328
Samastipur,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,663,749,867,888,1033,996,1067,1028,910,1047,1009,718,10975
Samastipur,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,801,841,984,969,1139,1089,1220,1122,1013,1181,1113,831,12303
Samastipur,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,478,525,603,639,801,759,868,786,711,822,1024,748,8764
Samastipur,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0,2,0,0,0,1,0,0,0,8,0,0,11
Samastipur,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,4892,5112,5570,8527,9396,8541,8584,8019,7755,7884,7231,6118,87629
Samastipur,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,4065,4285,4697,6713,7684,7424,7423,7102,6830,6920,6524,5455,75122
Samastipur,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,59,85,27,169,31,13744,14158,13985,14066,4584,8251,13445,82604
Samastipur,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,8,85,113,795,45,12634,14934,9925,7376,2819,5652,22504,76890
Samastipur,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Samastipur,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,10,49,68,48,78,51,6,35,16,0,0,NA,361
Samastipur,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0,0,0,0,0,0,0,0,0,0,0,NA,0
Samastipur,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0,0,0,0,0,0,0,0,0,0,0,NA,0
Samastipur,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0,0,0,0,0,0,0,0,0,0,0,NA,0
Samastipur,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Samastipur,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Samastipur,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,28,27,15,29,23,30,22,9,12,12,8,13,228
Samastipur,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Samastipur,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,28,27,15,29,23,30,22,9,12,12,8,13,228
Samastipur,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,9,5,7,4,6,7,6,4,10,0,0,NA,58
Samastipur,4.1.1.a,Number of male live births,TOTAL,2993,3133,3451,4907,5449,4898,5119,4834,4653,4780,4335,3487,52039
Samastipur,4.1.1.b,Number of female live births,TOTAL,2658,2808,3095,4543,5072,4694,4619,4405,4073,4265,3991,3417,47640
Samastipur,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,5651,5941,6546,9450,10521,9592,9738,9239,8726,9045,8326,6904,99679
Samastipur,4.1.2,Number of still births,TOTAL,68,85,91,125,121,118,119,96,89,85,63,69,1129
Samastipur,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,3,7,7,3,8,8,4,3,11,15,11,6,86
Samastipur,4.2.1,Number of Newborns weighed at birth,TOTAL,5522,5634,6312,9234,10028,9318,9360,8840,8518,8800,8071,6805,96442
Samastipur,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,535,638,695,780,703,782,706,707,573,574,552,536,7781
Samastipur,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,5605,5732,6423,9364,10165,9365,9477,8920,8653,8986,8173,6892,97755
Samastipur,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,9,17,12,13,22,13,19,16,8,8,117,199,453
Samastipur,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,2,2,2,6,3,3,5,2,3,3,4,3,38
Samastipur,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,0,9,8,35,23,11,25,6,0,11,11,43,182
Samastipur,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Samastipur,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,11,28,22,54,48,27,49,24,11,22,132,245,673
Samastipur,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,NA,NA,NA,NA,NA,NA,NA,0,10,NA,NA,NA,10
Samastipur,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,11,28,22,38,33,32,49,24,29,22,599,348,1235
Samastipur,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0,9,8,21,11,10,25,6,0,11,57,37,195
Samastipur,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,2,17,12,40,33,269,37,9,3,11,460,122,1015
Samastipur,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Samastipur,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1887,2097,2300,2645,3016,2872,3008,3098,2823,2907,3469,3535,33657
Samastipur,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1775,1910,1993,2620,2883,2575,2528,2670,2705,2734,3393,2930,30716
Samastipur,6.3,PNC maternal complications attended,TOTAL,0,0,0,0,0,0,0,0,0,0,40,36,76
Samastipur,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Samastipur,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Samastipur,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Samastipur,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0,0,0,0,0,2,0,0,0,0,0,0,2
Samastipur,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,10,43,6,10,11,14,15,12,16,28,9,5,179
Samastipur,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,273,308,237,258,282,263,237,246,248,268,282,223,3125
Samastipur,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,283,351,243,268,293,277,252,258,264,296,291,228,3304
Samastipur,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Samastipur,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,1,0,0,3,2,0,4,0,6,6,3,5,30
Samastipur,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0,0,0,0,0,0,0,0,0,1,0,0,1
Samastipur,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,1,0,0,1,1,1,0,0,4,4,3,1,16
Samastipur,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Samastipur,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,2,0,0,4,3,1,4,0,10,11,6,6,47
Samastipur,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Samastipur,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Samastipur,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Samastipur,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Samastipur,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Samastipur,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Samastipur,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Samastipur,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,210,153,140,898,330,741,657,803,3360,1546,1866,1110,11814
Samastipur,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,23,15,12,29,38,36,51,77,210,110,172,88,861
Samastipur,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,93,50,23,157,84,225,205,295,884,453,626,337,3432
Samastipur,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Samastipur,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,326,218,175,1084,452,1002,913,1175,4454,2109,2664,1535,16107
Samastipur,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,18,28,28,52,36,65,36,90,233,91,30,31,738
Samastipur,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,10,8,4,27,15,29,33,25,67,45,55,55,373
Samastipur,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0,2,3,1,2,2,0,3,1,1,4,1,20
Samastipur,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,6,6,7,29,16,18,21,26,21,18,21,18,207
Samastipur,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Samastipur,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,16,16,14,57,33,49,54,54,89,64,80,74,600
Samastipur,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Samastipur,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,870,1003,782,1556,1196,1212,1159,1064,1349,1128,1073,1134,13526
Samastipur,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,135,186,125,270,338,415,300,326,411,355,402,342,3605
Samastipur,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,2,4,34,119,62,61,70,54,115,79,97,75,772
Samastipur,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,45,24,121,288,258,201,244,404,230,223,120,98,2256
Samastipur,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Samastipur,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,1052,1217,1062,2233,1854,1889,1773,1848,2105,1785,1692,1649,20159
Samastipur,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,175,249,222,533,580,520,472,575,482,457,447,385,5097
Samastipur,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Samastipur,9.06,Number of IUCD removals,TOTAL,322,285,239,310,304,317,288,271,313,266,331,333,3579
Samastipur,9.07,Number of Oral Pills cycles distributed,TOTAL,2802,2978,2793,3954,3556,4257,3389,3425,3235,3236,3409,3296,40330
Samastipur,9.08,Number of Condom pieces distributed,TOTAL,25354,22439,23773,36714,30454,41634,39129,27246,26997,23189,27227,26847,351003
Samastipur,9.09,Number of Centchroman (weekly) pills given,TOTAL,277,1,33,35,0,113,170,0,36,196,30,3,894
Samastipur,9.1,Number of Emergency Contraceptive Pills distributed,TOTAL,156,223,280,444,331,333,250,198,147,251,273,263,3149
Samastipur,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0,0,0,0,0,12,0,0,0,0,0,0,12
Samastipur,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Samastipur,9.11.2.a,Number of failures following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Samastipur,9.11.2.b,Number of failures following female sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Samastipur,9.11.3.a,Number of deaths following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Samastipur,9.11.3.b,Number of deaths following female sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Samastipur,9.12,Number of Institutions having NSV trained doctors,TOTAL,NA,NA,5,5,6,8,6,6,6,6,6,6,Data for this item can not be cumulated
Samastipur,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,7323,7176,7475,11051,11985,11307,11527,10857,10647,10596,9914,8190,118048
Samastipur,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,20,12,7,6,0,1,112,3,3,1,0,0,165
Samastipur,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,1027,599,278,217,69,35,107,18,10,4,4,1,2369
Samastipur,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,3900,2584,1285,923,415,186,233,58,40,25,9,4,9662
Samastipur,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,9066,7949,6760,7390,7942,9411,11646,10126,10330,10650,10298,9731,111299
Samastipur,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,8643,9413,7498,7316,7282,7884,9213,9027,9740,10516,10063,10088,106683
Samastipur,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,6489,8101,7968,7668,7365,7534,7974,7230,8393,9619,9703,9673,97717
Samastipur,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,5501,5525,6167,9248,10113,9453,9658,9084,8772,8678,8107,6613,96919
Samastipur,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,9507,8033,6459,7360,7647,9405,11375,9601,10402,10543,10300,9675,110307
Samastipur,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,10322,10624,7578,7507,7282,7838,9123,8706,9824,10404,9931,10058,109197
Samastipur,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,10617,10983,8920,8680,7586,7734,8197,7024,8557,9689,9856,9758,107601
Samastipur,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,4894,5120,5457,8479,9670,8523,8632,8092,7922,8018,7431,5997,88235
Samastipur,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,29,17,9,5,2,2,101,0,0,28,1,0,194
Samastipur,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,1065,746,320,186,63,27,94,9,4,1,3,1,2519
Samastipur,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,3949,2672,1342,794,386,199,232,35,43,33,6,5,9696
Samastipur,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,9330,10641,9398,10216,9954,9618,10328,8700,8320,7391,7455,7411,108762
Samastipur,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,9930,9515,7436,8695,7424,7398,7588,6570,7705,8405,8959,8332,97957
Samastipur,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,8213,9189,8228,9554,9411,9028,9692,7968,7752,7058,7095,7112,100300
Samastipur,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,4796,5576,4723,5221,5015,4908,5257,4375,4321,3856,3843,3938,55829
Samastipur,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,4219,4820,4364,4723,4643,4487,4853,4053,3787,3399,3471,3335,50154
Samastipur,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,9015,10396,9087,9944,9658,9395,10110,8428,8108,7255,7314,7273,105983
Samastipur,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,10150,9465,7651,8880,7267,7225,7592,6589,7578,8443,9206,8621,98667
Samastipur,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,10541,9466,7450,8866,7134,7218,7682,6154,7684,8390,9226,8512,98323
Samastipur,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0,0,0,0,0,0,0,0,0,0,0,3,3
Samastipur,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,614,566,568,570,446,490,449,353,389,436,495,587,5963
Samastipur,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,568,587,531,518,418,511,435,336,407,425,461,534,5731
Samastipur,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,1182,1153,1099,1088,864,1001,884,689,796,861,956,1121,11694
Samastipur,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,1365,1329,1062,1168,1260,1581,1719,1416,1669,1772,1710,1794,17845
Samastipur,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,1028,1249,942,1021,893,1044,1066,886,989,933,956,1149,12156
Samastipur,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1467,1522,1378,1531,1543,1626,1634,1530,1651,1686,1636,1749,18953
Samastipur,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0,0,0,0,0,0,2,0,0,0,0,0,2
Samastipur,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Samastipur,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0,0,31,0,7,0,15,0,0,0,0,0,53
Samastipur,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,4228,4404,4364,4350,4030,4029,4041,4037,4026,4037,4030,4043,49619
Samastipur,10.4.2,Number of Immunisation sessions held during the month,TOTAL,4228,4404,4364,4350,4028,4025,4037,4001,4026,3989,4028,4043,49523
Samastipur,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,4030,4228,4176,4185,3856,3841,3856,3831,3871,3820,3890,3910,47494
Samastipur,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,8531,7845,6144,7781,6536,6856,6785,6052,7087,7982,8276,8078,87953
Samastipur,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,3276,3733,2619,2349,2122,1764,1828,1454,1200,1093,1727,1616,24781
Samastipur,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,752,797,500,634,515,432,443,388,337,376,566,480,6220
Samastipur,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,52,61,25,41,17,11,25,4,27,0,0,0,263
Samastipur,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Samastipur,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Samastipur,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Samastipur,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Samastipur,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Samastipur,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0,0,7,0,0,1,0,0,0,0,50,0,58
Samastipur,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,3297,3915,3522,4010,4166,3749,3060,2829,2790,2644,2115,2253,38350
Samastipur,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0,0,24,10,0,0,0,0,0,5,0,0,39
Samastipur,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,5,6,7,78,78,92,78,69,52,47,56,48,616
Samastipur,13.1,Number of Patients operated for cataract,TOTAL,0,0,0,10,0,0,0,0,166,165,149,319,809
Samastipur,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0,0,0,10,0,0,0,3,166,31,149,121,480
Samastipur,13.3,Number of School children detected with Refractive errors,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Samastipur,13.4,Number of children provided free glasses,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Samastipur,13.5,Number of eyes collected through eye donation,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Samastipur,13.6,Number of eyes utilised for corneal transplant,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Samastipur,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,NA,NA,5,4,3,5,5,5,4,5,5,5,Data for this item can not be cumulated
Samastipur,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,NA,NA,23,17,20,21,19,20,19,20,18,19,Data for this item can not be cumulated
Samastipur,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,3100,3134,3028,3123,3136,3232,3149,3179,3148,3091,3125,3136,Data for this item can not be cumulated
Samastipur,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,NA,NA,5,4,4,5,5,5,5,5,5,5,Data for this item can not be cumulated
Samastipur,14.05,Number of RKS meetings held during the month,TOTAL,13,15,18,26,17,19,13,12,17,30,20,14,214
Samastipur,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,NA,NA,23,21,22,22,20,20,19,21,19,19,Data for this item can not be cumulated
Samastipur,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,1827,2208,2313,3007,2813,2355,3725,3816,3489,3544,3286,3414,35797
Samastipur,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,NA,NA,3,3,2,3,4,3,4,4,3,3,Data for this item can not be cumulated
Samastipur,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,NA,NA,1,0,0,0,0,0,0,0,0,0,Data for this item can not be cumulated
Samastipur,14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Samastipur,14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Samastipur,14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Samastipur,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,2809,2783,2954,4126,4244,4269,4276,4125,4038,4134,3639,3249,44646
Samastipur,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,1699,2080,1827,2136,1984,1981,2139,1887,1591,1819,2091,2248,23482
Samastipur,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,2452,2527,2663,3790,3828,3980,3938,3783,3606,3459,3303,3070,40399
Samastipur,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,5998,6191,6598,9895,9556,10040,9839,9392,11779,10250,9826,8450,107814
Samastipur,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,5261,5310,5617,7916,8072,8249,8214,7908,7644,7593,6942,6319,85045
Samastipur,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,7697,8271,8425,12031,11540,12021,11978,11279,13370,12069,11917,10698,131296
Samastipur,14.10.2.a,Number of death cases of Inpatient males,TOTAL,1,1,2,2,2,1,1,1,1,1,3,0,16
Samastipur,14.10.2.b,Number of death cases of Inpatient females,TOTAL,2,0,2,4,5,3,3,0,1,0,1,0,21
Samastipur,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,3,1,4,6,7,4,4,1,2,1,4,0,37
Samastipur,14.11,In-Patient Head Count at midnight,TOTAL,9268,8675,9182,11978,11901,12815,13045,11850,13796,13017,11274,10551,137352
Samastipur,14.12.1,OPD attendance (All),TOTAL,247878,243041,235969,291039,296298,327713,288435,259275,281514,248263,255273,245767,3220465
Samastipur,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,367,308,211,1226,477,1064,968,1261,4666,2216,2766,1605,17135
Samastipur,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Samastipur,14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Samastipur,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,4883,5357,5138,6093,5689,6003,5707,5547,6138,5156,5021,4857,65589
Samastipur,14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Samastipur,14.14.a,Number of patients given AYUSH treatment,TOTAL,50227,50321,46686,63158,69774,74667,65563,65533,69313,61492,58773,63399,738906
Samastipur,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,8736,10075,11140,11438,12300,14286,11308,9585,10303,9170,9265,9202,126808
Samastipur,14.14.c,Number of Adolescents counselled,TOTAL,87,92,353,523,474,364,295,394,523,475,485,365,4430
Samastipur,15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Samastipur,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,4074,4135,3888,4747,5037,5416,5189,4459,6176,5867,6608,5588,61184
Samastipur,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,152,79,123,99,205,227,145,68,112,56,76,67,1409
Samastipur,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,153,75,344,428,323,249,285,303,244,240,319,307,3270
Samastipur,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,9,0,32,16,25,17,10,13,18,11,14,10,175
Samastipur,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,234,62,348,524,406,346,341,575,1180,621,790,592,6019
Samastipur,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,9,0,20,12,17,15,7,7,17,11,8,6,129
Samastipur,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,250,168,595,512,442,616,499,555,681,544,441,696,5999
Samastipur,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,1,0,1,2,3,0,1,0,1,3,1,0,13
Samastipur,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,637,305,1287,1464,1171,1211,1125,1433,2105,1405,1550,1595,15288
Samastipur,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,19,0,53,30,45,32,18,20,36,25,23,16,317
Samastipur,15.2,Number of Widal tests conducted,Number tested,83,88,154,83,0,1,13,152,171,0,14,7,766
Samastipur,15.3.a,Number of VDRL tests conducted on males,Number tested,10,9,6,13,9,8,13,2,9,25,7,4,115
Samastipur,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,271,287,224,259,234,211,196,210,197,243,275,193,2800
Samastipur,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,224,166,390,265,273,305,165,267,245,300,265,280,3145
Samastipur,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,505,462,620,537,516,524,374,479,451,568,547,477,6060
Samastipur,15.4.1,Number of blood smears examined for Malaria,TOTAL,1,2,2,1,6,9,33,11,6,9,6,3,89
Samastipur,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,0,0,10,0,0,0,1,0,0,0,0,1,12
Samastipur,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0,0,1,0,0,0,0,0,0,0,0,0,1
Samastipur,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,1900,2100,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,4000
Samastipur,16.1.1,Stock position of DPT vaccines,2. Stocks Received,1800,3500,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,5300
Samastipur,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Samastipur,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,1600,2350,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,3950
Samastipur,16.1.1,Stock position of DPT vaccines,5. Total Stock,2100,3250,0,0,0,0,0,0,0,0,0,0,5350
Samastipur,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,3200,1850,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,5050
Samastipur,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,800,4200,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,5000
Samastipur,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Samastipur,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,2100,3100,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,5200
Samastipur,16.1.1A,Stock Position of Pentavalent,5. Total Stock,1900,2950,0,0,0,0,0,0,0,0,0,0,4850
Samastipur,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,0,200,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,200
Samastipur,16.1.2,Stock position of OPV vaccines,2. Stocks Received,3600,4000,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,7600
Samastipur,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Samastipur,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,3400,3700,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,7100
Samastipur,16.1.2,Stock position of OPV vaccines,5. Total Stock,200,500,0,0,0,0,0,0,0,0,0,0,700
Samastipur,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,1717,667,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2384
Samastipur,16.1.3,Stock position of TT vaccines,2. Stocks Received,800,4500,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,5300
Samastipur,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Samastipur,16.1.3,Stock position of TT vaccines,4. Stock Distributed,1050,3000,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,4050
Samastipur,16.1.3,Stock position of TT vaccines,5. Total Stock,1467,2167,0,0,0,0,0,0,0,0,0,0,3634
Samastipur,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Samastipur,16.1.4,Stock position of DT vaccines,2. Stocks Received,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Samastipur,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Samastipur,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Samastipur,16.1.4,Stock position of DT vaccines,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Samastipur,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,1100,1650,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2750
Samastipur,16.1.5,Stock position of BCG vaccines,2. Stocks Received,1800,2000,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,3800
Samastipur,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Samastipur,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,1250,1800,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,3050
Samastipur,16.1.5,Stock position of BCG vaccines,5. Total Stock,1650,1850,0,0,0,0,0,0,0,0,0,0,3500
Samastipur,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,0,600,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,600
Samastipur,16.1.6,Stock position of Measles vaccines,2. Stocks Received,6600,5200,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,11800
Samastipur,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Samastipur,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,5950,5500,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,11450
Samastipur,16.1.6,Stock position of Measles vaccines,5. Total Stock,650,300,0,0,0,0,0,0,0,0,0,0,950
Samastipur,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,350,2170,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2520
Samastipur,16.1.7,Stock position of JE vaccines,2. Stocks Received,6600,6000,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,12600
Samastipur,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Samastipur,16.1.7,Stock position of JE vaccines,4. Stock Distributed,4780,5870,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,10650
Samastipur,16.1.7,Stock position of JE vaccines,5. Total Stock,2170,2300,0,0,0,0,0,0,0,0,0,0,4470
Samastipur,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,2712,2362,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,5074
Samastipur,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,800,2000,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2800
Samastipur,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Samastipur,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,1850,1500,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,3350
Samastipur,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,1662,2862,0,0,0,0,0,0,0,0,0,0,4524
Samastipur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Samastipur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Samastipur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Samastipur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Samastipur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Samastipur,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Samastipur,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Samastipur,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Samastipur,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Samastipur,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Samastipur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Samastipur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Samastipur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Samastipur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Samastipur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Samastipur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Samastipur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Samastipur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Samastipur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Samastipur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Samastipur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Samastipur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Samastipur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Samastipur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Samastipur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Samastipur,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Samastipur,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Samastipur,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Samastipur,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Samastipur,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Samastipur,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,4900,79900,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,84800
Samastipur,16.3.02,Stock Position of Gloves,2. Stocks Received,75000,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,75000
Samastipur,16.3.02,Stock Position of Gloves,3. Unusable Stock,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Samastipur,16.3.02,Stock Position of Gloves,4. Stock Distributed,0,2400,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2400
Samastipur,16.3.02,Stock Position of Gloves,5. Total Stock,79900,77500,0,0,0,0,0,0,0,0,0,0,157400
Samastipur,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Samastipur,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Samastipur,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Samastipur,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Samastipur,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Samastipur,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Samastipur,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Samastipur,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Samastipur,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Samastipur,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Samastipur,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,2000,2000,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,4000
Samastipur,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Samastipur,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Samastipur,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0,1100,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1100
Samastipur,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,2000,900,0,0,0,0,0,0,0,0,0,0,2900
Samastipur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Samastipur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Samastipur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Samastipur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Samastipur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Samastipur,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,173400,97460,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,270860
Samastipur,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,155500,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,155500
Samastipur,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Samastipur,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,231440,85700,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,317140
Samastipur,16.3.07,Stock Position of IFA Tablets,5. Total Stock,97460,11760,0,0,0,0,0,0,0,0,0,0,109220
Samastipur,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,14075,30401,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,44476
Samastipur,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,30000,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,30000
Samastipur,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Samastipur,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,13674,1280,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,14954
Samastipur,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,30401,29121,0,0,0,0,0,0,0,0,0,0,59522
Samastipur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,3200,7100,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,10300
Samastipur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,7000,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,7000
Samastipur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Samastipur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,3100,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,3110
Samastipur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,7100,7090,0,0,0,0,0,0,0,0,0,0,14190
Samastipur,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Samastipur,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Samastipur,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Samastipur,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Samastipur,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Samastipur,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,37836,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,37836
Samastipur,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Samastipur,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Samastipur,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,37836,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,37836
Samastipur,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Samastipur,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,8995,700,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,9695
Samastipur,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0,25000,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,25000
Samastipur,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Samastipur,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,8295,10600,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,18895
Samastipur,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,700,15100,0,0,0,0,0,0,0,0,0,0,15800
Samastipur,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,91138,29735,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,120873
Samastipur,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,60000,210000,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,270000
Samastipur,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Samastipur,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,121400,134200,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,255600
Samastipur,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,29738,105535,0,0,0,0,0,0,0,0,0,0,135273
Samastipur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,9698,4598,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,14296
Samastipur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,5000,18000,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,23000
Samastipur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Samastipur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,10100,11500,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,21600
Samastipur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,4598,11098,0,0,0,0,0,0,0,0,0,0,15696
Samastipur,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,NA,NA,NA,1,NA,1,1,1,2,NA,NA,4,10
Samastipur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,2,2,NA,NA,NA,NA,4
Samastipur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,1,2
Samastipur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,NA,NA,NA,NA,NA,NA,2,2,NA,1,NA,1,6
Samastipur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,1,NA,NA,1,NA,1,3
Samastipur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,1
Samastipur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,NA,NA,NA,NA,NA,NA,1,NA,NA,2,NA,1,4
Samastipur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,NA,1,1,2,NA,1,5,3,3,1,7,3,27
Samastipur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,NA,NA,NA,1,NA,1,NA,2,NA,1,NA,NA,5
Samastipur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,NA,1,1,3,NA,2,5,5,3,2,7,3,32
Samastipur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,1,2,NA,2,2,4,4,10,15,16,21,17,94
Samastipur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,3,2,3,10,4,2,24
Samastipur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,1,2,NA,2,2,4,7,12,18,26,25,19,118
Samastipur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,NA,NA,NA,NA,1,NA,NA,1,2,3,1,1,9
Samastipur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,1,NA,2,1,1,5
Samastipur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,NA,NA,NA,NA,1,NA,NA,2,2,5,2,2,14
Samastipur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,1,1,NA,1,3
Samastipur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Samastipur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,1,1,NA,1,3
Samastipur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,2,1,1,NA,2,1,1,8
Samastipur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,NA,NA,NA,1,NA,1,NA,NA,1,NA,1,1,5
Samastipur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,NA,NA,NA,1,NA,3,1,1,1,2,2,2,13
Samastipur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1
Samastipur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Samastipur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1
Samastipur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,1,NA,1,NA,1,2,1,8,32,22,22,12,102
Samastipur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,NA,NA,2,2,NA,NA,1,NA,4,8,5,3,25
Samastipur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,1,NA,3,2,1,2,2,8,36,30,27,15,127
Samastipur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,2,NA,NA,NA,2
Samastipur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1
Samastipur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,NA,NA,NA,NA,1,NA,NA,NA,1,NA,NA,NA,2
Samastipur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,NA,NA,NA,NA,1,NA,NA,NA,3,NA,NA,1,5
Samastipur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Samastipur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,NA,NA,1,NA,NA,NA,NA,NA,NA,1,NA,2,4
Samastipur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,1,1,NA,NA,NA,2
Samastipur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,NA,NA,1,NA,NA,NA,NA,1,1,1,NA,2,6
Samastipur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Samastipur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1
Samastipur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,NA,NA,2,NA,NA,NA,NA,NA,NA,1,NA,1,4
Samastipur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,NA,NA,2,NA,NA,NA,NA,NA,NA,1,NA,2,5
Samastipur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Samastipur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Samastipur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,1
Samastipur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,1
Samastipur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Samastipur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,NA,2
Samastipur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,NA,NA,NA,NA,1,1,NA,NA,4,NA,NA,2,8
Samastipur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,NA,NA,NA,NA,1,1,NA,NA,4,NA,2,2,10
Samastipur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Samastipur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Samastipur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Samastipur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Samastipur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Samastipur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,NA,NA,1,NA,2,NA,NA,2,NA,1,1,NA,7
Samastipur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,NA,NA,1,NA,1,1,2,1,NA,NA,NA,2,8
Samastipur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,NA,NA,2,NA,3,1,2,3,NA,1,1,2,15
Samastipur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Samastipur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Samastipur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,1
Samastipur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,1
Samastipur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Samastipur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,1
Samastipur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Samastipur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,1
Samastipur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Samastipur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,1
Samastipur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Samastipur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,1
Samastipur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Samastipur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,1,1,NA,NA,2
Samastipur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Samastipur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,1,1,NA,NA,2
Samastipur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Samastipur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,3,NA,NA,NA,1,NA,3,NA,1,1,1,NA,10
Samastipur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Samastipur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,3,NA,NA,NA,1,NA,3,NA,1,1,1,NA,10
Samastipur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Samastipur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Samastipur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Samastipur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Samastipur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Samastipur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,1,1,3,3,5,1,14
Samastipur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Samastipur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,NA,NA,NA,NA,NA,NA,1,1,3,3,5,1,14
Samastipur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,NA,NA,NA,1,NA,1,NA,NA,NA,NA,NA,NA,2
Samastipur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,NA,NA,2,8,2,3,3,4,2,NA,NA,6,30
Samastipur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,NA,NA,NA,NA,1,1,NA,1,NA,NA,1,1,5
Samastipur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,NA,NA,2,9,3,5,3,5,2,NA,1,7,37
Samastipur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Samastipur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,NA,NA,1,NA,NA,NA,NA,NA,NA,2,NA,1,4
Samastipur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Samastipur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,NA,NA,1,NA,NA,NA,NA,NA,NA,2,NA,1,4
Samastipur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,NA,NA,2,NA,1,NA,NA,NA,NA,NA,NA,NA,3
Samastipur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,NA,NA,1,NA,2,NA,NA,NA,NA,NA,NA,1,4
Samastipur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Samastipur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,NA,NA,3,NA,3,NA,NA,NA,NA,NA,NA,1,7
Samastipur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Samastipur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,3,NA,NA,NA,1,NA,4
Samastipur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,NA,NA,NA,NA,NA,3,3,NA,NA,NA,NA,1,7
Samastipur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,NA,NA,NA,NA,NA,3,6,NA,NA,NA,1,1,11
Samastipur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Samastipur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,NA,NA,NA,1,1,1,NA,1,2,2,NA,NA,8
Samastipur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,NA,NA,1,1,1,NA,NA,1,NA,2,NA,1,7
Samastipur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,NA,NA,1,2,2,1,NA,2,2,4,NA,1,15
Samastipur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,NA,NA,2,NA,3,3,2,3,1,1,1,NA,16
Samastipur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,NA,NA,10,12,12,12,16,18,17,11,18,13,139
Samastipur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,NA,NA,21,19,31,20,33,39,64,58,39,45,369
Samastipur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,NA,NA,33,31,46,35,51,60,82,70,58,58,524
Saran,1.1,Total number of pregnant women Registered for ANC,TOTAL,8379,8283,7499,8355,8262,7304,7276,6282,6817,7080,7539,8006,91082
Saran,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,4300,4514,4026,4230,4453,3880,3862,3374,3714,3830,4330,4430,48943
Saran,1.2,Number of Pregnant women registered under JSY,TOTAL,8352,8250,7508,8325,8250,7281,7265,6240,6783,7078,7517,8036,90885
Saran,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,6167,6444,5704,6066,6363,5866,6083,5832,5677,5489,5703,6019,71413
Saran,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,6535,6531,5686,6303,6306,5500,5433,4747,5459,5445,5618,5932,69495
Saran,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,8211,8545,7261,7252,8107,7257,6741,6274,6265,6368,6421,7283,85985
Saran,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,4179,4330,3580,3327,3075,2918,2388,1378,1658,1198,1833,3042,32906
Saran,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,55,140,560,271,88,107,89,137,74,10,2,51,1584
Saran,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0,11,0,1,2,3,2,0,2,4,3,0,28
Saran,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,107,148,233,517,275,153,254,205,180,203,365,301,2941
Saran,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,26,41,39,49,48,59,46,38,56,35,43,98,578
Saran,1.8,Number of pregnancy test kits used at SC level,TOTAL,154,161,221,391,376,478,344,210,240,238,251,327,3391
Saran,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,441,472,484,591,713,485,807,733,608,627,896,619,7476
Saran,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,945,1189,1075,1350,1687,1525,1521,1390,1397,1617,1584,1434,16714
Saran,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,1386,1661,1559,1941,2400,2010,2328,2123,2005,2244,2480,2053,24190
Saran,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,744,956,860,1041,1185,1118,1404,1233,1135,1342,1695,1323,14036
Saran,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0,0,0,0,10,0,37,7,0,0,0,0,54
Saran,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,3179,3118,2967,4737,5138,4524,4022,4292,3981,4201,4056,3743,47958
Saran,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,2788,2675,2592,4223,4538,3973,3501,3352,3203,3344,3294,1626,39109
Saran,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,489,302,148,331,402,3451,2811,476,952,1370,1727,3520,15979
Saran,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,351,181,104,315,386,2032,2176,613,789,888,1241,2441,11517
Saran,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0,0,0,0,0,0,66,0,0,0,0,0,66
Saran,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,0,NA,0,0,387,453,111,108,122,81,61,33,1356
Saran,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0,NA,0,0,0,0,0,0,0,0,0,0,0
Saran,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0,NA,0,0,0,0,0,0,0,0,0,0,0
Saran,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0,NA,0,0,0,0,0,0,0,0,0,0,0
Saran,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Saran,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Saran,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,26,21,22,38,21,26,21,18,14,19,28,24,278
Saran,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,26,21,22,38,21,26,21,18,14,19,28,24,278
Saran,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,0,NA,0,0,157,40,61,51,40,29,20,1,399
Saran,4.1.1.a,Number of male live births,TOTAL,2351,2394,2293,3560,4125,3372,3241,3434,3044,3353,3344,2945,37456
Saran,4.1.1.b,Number of female live births,TOTAL,2187,2356,2135,3047,3714,3176,3127,3251,2803,3044,3101,2723,34664
Saran,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,4538,4750,4428,6607,7839,6548,6368,6685,5847,6397,6445,5668,72120
Saran,4.1.2,Number of still births,TOTAL,47,72,61,84,74,85,77,55,60,70,66,59,810
Saran,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,2,0,1,1,5,1,4,4,2,1,1,4,26
Saran,4.2.1,Number of Newborns weighed at birth,TOTAL,4485,4582,4245,6358,7654,6247,6186,6536,5734,6295,6086,5511,69919
Saran,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,83,178,123,182,260,248,255,195,126,150,174,348,2322
Saran,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,4520,4626,4285,6579,7725,6312,6236,6633,5805,6375,6189,5636,70921
Saran,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,10,12,22
Saran,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0,0,0,0,4,0,0,0,9,0,0,27,40
Saran,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,23,131,134,114,702,713,58,419,377,385,336,315,3707
Saran,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,23,131,134,114,706,713,58,419,386,385,346,354,3769
Saran,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0,NA,0,0,0,0,0,0,0,0,0,0,0
Saran,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,23,96,126,78,666,286,384,595,488,484,523,328,4077
Saran,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0,0,0,0,0,3,2,0,0,6,9,91,111
Saran,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,44,116,58,113,923,533,386,768,648,1406,1306,1017,7318
Saran,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,14,13,10,15,10,5,9,6,7,5,4,15,113
Saran,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,2898,2720,2170,3670,4102,3341,3528,3275,2904,3605,3760,3342,39315
Saran,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,2658,2247,2465,3253,3552,3327,3133,3078,3475,3561,3859,3231,37839
Saran,6.3,PNC maternal complications attended,TOTAL,24,0,0,0,0,0,305,0,0,0,24,27,380
Saran,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Saran,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Saran,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Saran,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0,0,0,0,0,0,69,24,82,91,94,91,451
Saran,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,17,17,19,18,16,16,15,0,12,16,24,15,185
Saran,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,19,27,32,19,15,17,15,3,15,13,12,16,203
Saran,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,36,44,51,37,31,33,30,3,27,29,36,31,388
Saran,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Saran,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0,1,1,0,0,0,0,38,0,0,2,0,42
Saran,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0,0,0,0,1,0,0,0,0,0,0,1,2
Saran,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0,NA,0,0,0,0,0,0,0,0,0,1,1
Saran,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0,1,1,0,1,0,0,38,0,0,2,2,45
Saran,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0,NA,0,0,0,0,0,0,0,0,0,0,0
Saran,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Saran,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Saran,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0,NA,0,0,0,0,0,0,0,0,0,0,0
Saran,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Saran,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0,NA,0,0,0,0,0,0,0,0,0,0,0
Saran,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,155,30,26,281,197,440,219,254,1414,735,1334,836,5921
Saran,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,125,12,1,67,31,51,43,54,359,147,306,291,1487
Saran,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,62,23,9,67,15,21,20,116,593,143,248,152,1469
Saran,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,342,65,36,415,243,512,282,424,2366,1025,1888,1279,8877
Saran,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,200,NA,85,370,258,405,366,314,4777,4509,507,6053,17844
Saran,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Saran,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,14,0,0,0,0,0,0,1,2,1,5,0,23
Saran,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,8,4,5,12,17,53,15,9,8,13,6,6,156
Saran,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,22,4,5,12,17,53,15,10,10,14,11,6,179
Saran,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0,NA,0,0,0,0,0,0,0,0,0,0,0
Saran,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,831,874,801,1122,937,832,810,749,806,734,817,839,10152
Saran,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,213,210,190,253,233,276,198,187,256,228,252,330,2826
Saran,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,10,1,3,42,3,0,10,14,5,9,39,14,150
Saran,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,83,80,33,87,80,111,87,102,67,107,90,97,1024
Saran,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,1137,1165,1027,1504,1253,1219,1105,1052,1134,1078,1198,1280,14152
Saran,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,143,157,97,210,221,186,107,128,105,159,202,329,2044
Saran,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,NA,NA,0,0,0,0,0,0,10,0,0,0,10
Saran,9.06,Number of IUCD removals,TOTAL,417,454,409,568,473,445,405,381,379,388,357,461,5137
Saran,9.07,Number of Oral Pills cycles distributed,TOTAL,3124,2803,2654,2948,3126,2899,2679,2416,2871,2673,3586,3425,35204
Saran,9.08,Number of Condom pieces distributed,TOTAL,22616,22944,21558,21903,23584,21817,17293,15119,18021,17009,27590,16220,245674
Saran,9.09,Number of Centchroman (weekly) pills given,TOTAL,105,113,226,224,208,65,120,91,54,41,35,47,1329
Saran,9.1,Number of Emergency Contraceptive Pills distributed,TOTAL,573,478,405,433,321,597,361,283,408,356,526,569,5310
Saran,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0,0,0,0,0,0,0,7,0,0,0,0,7
Saran,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Saran,9.11.2.a,Number of failures following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Saran,9.11.2.b,Number of failures following female sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Saran,9.11.3.a,Number of deaths following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Saran,9.11.3.b,Number of deaths following female sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Saran,9.12,Number of Institutions having NSV trained doctors,TOTAL,NA,NA,NA,NA,1,NA,8,7,11,9,9,9,Data for this item can not be cumulated
Saran,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,7193,6754,6232,7987,9718,8730,8348,8677,8353,8609,8573,7619,96793
Saran,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,65,35,29,14,16,22,4,4,10,5,2,2,208
Saran,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,1233,726,404,333,230,110,74,41,46,35,16,8,3256
Saran,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,3678,2285,1344,970,647,308,203,116,107,67,50,33,9808
Saran,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,8046,7215,6334,6636,7537,7983,8970,8412,8898,8881,8329,8417,95658
Saran,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,7191,7718,6470,6794,7399,6770,7762,7918,8744,8742,8375,8863,92746
Saran,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,5172,6451,6296,6786,7346,6782,7053,7087,7973,8643,8322,8788,86699
Saran,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,4014,3809,3734,5160,6435,5790,5309,5483,5135,5455,5119,4545,59988
Saran,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,7961,7210,6373,6745,7498,7838,9025,8445,8655,8957,8386,8431,95524
Saran,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,8046,8166,6509,6930,7492,6858,7744,7885,8408,8701,8380,8857,93976
Saran,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,8320,8288,7163,7422,7680,6982,7147,7079,7696,8662,8342,8865,93646
Saran,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,2559,2028,2003,3391,3428,3214,3361,3652,3509,3600,3582,3066,37393
Saran,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,70,101,55,98,87,75,45,110,42,4,1,0,688
Saran,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,1273,787,437,368,245,173,91,137,76,29,9,5,3630
Saran,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,3618,2460,1367,1086,647,359,201,184,116,80,28,19,10165
Saran,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,7539,8193,7916,8111,8977,7900,7868,7387,7465,7431,6666,7070,92523
Saran,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,7354,7017,6438,6919,7059,6140,6553,6118,6853,7549,7452,7951,83403
Saran,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,7419,7886,7632,8184,8809,7735,7725,7054,7425,7275,6699,6959,90802
Saran,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,3994,4397,4121,4274,4740,4127,4195,3842,3823,3848,3526,3631,48518
Saran,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,3686,3864,3710,3818,4180,3761,3722,3444,3213,3443,3066,3234,43141
Saran,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,7680,8261,7831,8092,8920,7888,7917,7286,7036,7291,6592,6865,91659
Saran,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,7496,7089,6868,7374,7263,6236,6549,5923,6679,7528,7659,7664,84328
Saran,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,7558,7073,6785,7383,7199,6238,6542,5888,6694,7516,7659,7662,84197
Saran,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0,0,9,0,2,0,0,30,4,7,0,0,52
Saran,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2048,2027,2196,1994,2290,2086,1852,1270,1454,1918,1716,1950,22801
Saran,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1835,1846,1971,1686,1995,1856,1601,1107,1260,1697,1420,1654,19928
Saran,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,3883,3873,4167,3680,4285,3942,3453,2377,2714,3615,3136,3604,42729
Saran,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,1844,1826,1522,1585,1527,1530,1742,1770,2196,2157,2180,2445,22324
Saran,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,2756,2790,2794,2560,2449,2394,2524,2585,2601,2802,2916,2743,31914
Saran,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,4434,4191,4100,4358,3792,3670,4005,4054,4486,4467,4576,4019,50152
Saran,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0,0,0,1,11,0,0,0,0,0,2,0,14
Saran,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Saran,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0,8,0,4,0,4,0,11,0,0,4,2,33
Saran,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,3688,3734,3480,3548,3511,3369,3444,3444,3527,3528,3533,3579,42385
Saran,10.4.2,Number of Immunisation sessions held during the month,TOTAL,3683,3709,3375,3537,3503,3332,3424,3381,3502,3504,3492,3536,41978
Saran,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,3083,3136,2818,3077,3114,2959,3075,2977,3137,3126,3071,3187,36760
Saran,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,7017,6902,6684,7413,7297,6363,6212,5910,6325,7133,7471,7575,82302
Saran,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,5845,5915,6071,5755,6449,6430,5815,5149,4979,4500,3965,3888,64761
Saran,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,3616,3331,3256,3083,3376,3346,2985,2614,2679,2640,2575,2474,35975
Saran,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,816,966,906,756,800,897,862,748,823,712,612,570,9468
Saran,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Saran,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Saran,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Saran,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Saran,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Saran,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0,28,9,1,0,59,0,0,2,2,0,14,115
Saran,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,2018,2375,2366,2942,2686,2360,1964,1565,1302,1298,1502,1574,23952
Saran,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,5,410,0,0,9,0,0,5,0,0,0,0,429
Saran,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Saran,13.1,Number of Patients operated for cataract,TOTAL,274,0,149,237,0,0,322,442,925,671,1014,757,4791
Saran,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0,0,0,0,270,517,0,0,0,0,0,0,787
Saran,13.3,Number of School children detected with Refractive errors,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Saran,13.4,Number of children provided free glasses,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Saran,13.5,Number of eyes collected through eye donation,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Saran,13.6,Number of eyes utilised for corneal transplant,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Saran,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,NA,NA,NA,NA,NA,NA,3,5,5,5,4,5,Data for this item can not be cumulated
Saran,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,NA,NA,NA,1,2,2,19,29,28,27,27,27,Data for this item can not be cumulated
Saran,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,3194,2915,2380,2897,2810,2653,2680,2638,2756,2750,2740,2744,Data for this item can not be cumulated
Saran,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,NA,NA,NA,NA,NA,NA,3,5,5,5,4,5,Data for this item can not be cumulated
Saran,14.05,Number of RKS meetings held during the month,TOTAL,11,20,12,11,12,9,11,13,13,11,10,12,145
Saran,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,NA,NA,NA,NA,1,2,14,17,21,20,19,21,Data for this item can not be cumulated
Saran,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,186,205,199,114,231,301,619,1323,562,1015,981,1072,6808
Saran,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,NA,NA,NA,NA,NA,NA,3,4,4,4,4,4,Data for this item can not be cumulated
Saran,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,Data for this item can not be cumulated
Saran,14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,2156,1907,1865,2654,2824,2417,2208,2291,2409,2486,2310,2525,28052
Saran,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,2021,1980,1795,2051,1684,1887,1816,1694,1976,1967,1866,2158,22895
Saran,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,1973,2156,1929,2440,2832,2564,2145,2425,2459,2526,2444,2443,28336
Saran,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,3946,4416,3343,4801,4907,4403,4071,4889,4643,4836,4907,4884,54046
Saran,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,4129,4063,3794,5094,5656,4981,4353,4716,4868,5012,4754,4968,56388
Saran,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,5967,6396,5138,6852,6591,6290,5887,6583,6619,6803,6773,7042,76941
Saran,14.10.2.a,Number of death cases of Inpatient males,TOTAL,14,23,22,15,24,20,16,11,19,16,14,22,216
Saran,14.10.2.b,Number of death cases of Inpatient females,TOTAL,13,19,11,12,12,18,7,1,13,8,9,7,130
Saran,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,27,42,33,27,36,38,23,12,32,24,23,29,346
Saran,14.11,In-Patient Head Count at midnight,TOTAL,8907,7999,6983,10074,10401,9174,8499,8483,8730,8813,9014,9420,106497
Saran,14.12.1,OPD attendance (All),TOTAL,278445,258887,231734,263896,276751,261235,244416,236478,240567,243386,260109,281992,3077896
Saran,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,431,468,134,571,293,647,290,522,1821,717,1532,892,8318
Saran,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0,0,0,0,0,0,17,8,0,0,0,0,25
Saran,14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,5806,4662,4338,4776,4096,3691,3708,3352,4620,4151,4317,4680,52197
Saran,14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,14.14.a,Number of patients given AYUSH treatment,TOTAL,45677,35147,33726,42425,45404,41531,40604,37544,37464,40834,42110,43185,485651
Saran,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,11871,11224,8908,12282,11713,12451,10349,10131,12034,11394,12192,12788,137337
Saran,14.14.c,Number of Adolescents counselled,TOTAL,80,101,96,134,356,97,58,111,87,95,97,36,1348
Saran,15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,2128,2303,2292,2658,2411,2126,1471,2039,2274,1928,2310,2175,26115
Saran,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,26,51,39,71,71,65,61,51,69,36,46,46,632
Saran,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,50,23,162,157,136,199,111,171,498,218,358,365,2448
Saran,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,0,0,33,30,22,27,19,46,29,17,24,38,285
Saran,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,1,19,230,202,180,278,159,260,364,362,557,472,3084
Saran,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0,0,32,19,21,14,17,16,19,10,19,20,187
Saran,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,84,47,415,467,367,363,245,301,504,417,537,600,4347
Saran,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0,0,2,0,0,4,2,1,3,2,4,2,20
Saran,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,135,89,807,826,683,840,515,732,1366,997,1452,1437,9879
Saran,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,0,0,67,49,43,45,38,63,51,29,47,60,492
Saran,15.2,Number of Widal tests conducted,Number tested,24,44,29,30,20,0,48,9,20,14,28,58,324
Saran,15.3.a,Number of VDRL tests conducted on males,Number tested,0,45,13,0,0,0,0,14,143,58,8,5,286
Saran,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,0,40,1,0,0,0,0,0,0,0,30,0,71
Saran,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,583,0,1046,1046,843,871,0,0,0,0,28,139,4556
Saran,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,583,85,1060,1046,843,871,0,14,143,58,66,144,4913
Saran,15.4.1,Number of blood smears examined for Malaria,TOTAL,603,35,1101,1097,941,1047,941,949,933,864,904,1055,10470
Saran,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,0,0,1,1,6,2,0,0,0,0,0,1,11
Saran,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0,0,0,0,0,2,0,0,0,0,0,0,2
Saran,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,654,NA,2154,NA,4,4,204,154,NA,254,NA,54,3482
Saran,16.1.1,Stock position of DPT vaccines,2. Stocks Received,4000,NA,0,NA,1100,1200,1000,1000,NA,1000,NA,1000,10300
Saran,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,1700,NA,1150,NA,1100,1000,1050,900,NA,1000,NA,1050,8950
Saran,16.1.1,Stock position of DPT vaccines,5. Total Stock,2954,0,1004,0,4,204,154,254,0,254,0,4,4832
Saran,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,2400,NA,2800,NA,34,14,32,52,NA,56,NA,144,5532
Saran,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,2600,NA,0,NA,2050,2250,2300,2684,NA,2236,NA,3276,17396
Saran,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,2550,NA,2150,NA,2070,2232,2280,2616,NA,2280,NA,1360,17538
Saran,16.1.1A,Stock Position of Pentavalent,5. Total Stock,2450,0,650,0,14,32,52,120,0,12,0,2060,5390
Saran,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,100,NA,5,NA,30,205,205,55,NA,5,NA,180,785
Saran,16.1.2,Stock position of OPV vaccines,2. Stocks Received,2200,NA,2550,NA,3050,3250,2800,2600,NA,2025,NA,1500,19975
Saran,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,2150,NA,2525,NA,2875,3250,2950,2500,NA,2025,NA,1525,19800
Saran,16.1.2,Stock position of OPV vaccines,5. Total Stock,150,0,30,0,205,205,55,155,0,5,0,155,960
Saran,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,80,NA,2430,NA,30,30,230,80,NA,29,NA,29,2938
Saran,16.1.3,Stock position of TT vaccines,2. Stocks Received,7100,NA,900,NA,2700,3000,2600,2800,NA,2550,NA,3000,24650
Saran,16.1.3,Stock position of TT vaccines,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,16.1.3,Stock position of TT vaccines,4. Stock Distributed,2400,NA,3300,NA,2700,2800,2750,2850,NA,2300,NA,3000,22100
Saran,16.1.3,Stock position of TT vaccines,5. Total Stock,4780,0,30,0,30,230,80,30,0,279,0,29,5488
Saran,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,16.1.4,Stock position of DT vaccines,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,16.1.4,Stock position of DT vaccines,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,16.1.4,Stock position of DT vaccines,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,16.1.4,Stock position of DT vaccines,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Saran,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,0,NA,0,NA,0,0,50,0,NA,150,NA,100,300
Saran,16.1.5,Stock position of BCG vaccines,2. Stocks Received,2500,NA,2200,NA,3400,3200,2700,2900,NA,2700,NA,2950,22550
Saran,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,2400,NA,2150,NA,3400,3150,2750,2850,NA,2800,NA,2900,22400
Saran,16.1.5,Stock position of BCG vaccines,5. Total Stock,100,0,50,0,0,50,0,50,0,50,0,150,450
Saran,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,0,NA,0,NA,0,0,350,150,NA,0,NA,100,600
Saran,16.1.6,Stock position of Measles vaccines,2. Stocks Received,4400,NA,4100,NA,4050,4500,3400,3700,NA,3250,NA,4700,32100
Saran,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,4150,NA,4100,NA,4050,4150,3600,3700,NA,3250,NA,4800,31800
Saran,16.1.6,Stock position of Measles vaccines,5. Total Stock,250,0,0,0,0,350,150,150,0,0,0,0,900
Saran,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0,NA,50,NA,0,50,250,150,NA,0,NA,100,600
Saran,16.1.7,Stock position of JE vaccines,2. Stocks Received,3650,NA,4800,NA,3700,4500,3600,3600,NA,3600,NA,4100,31550
Saran,16.1.7,Stock position of JE vaccines,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,16.1.7,Stock position of JE vaccines,4. Stock Distributed,3600,NA,4800,NA,3650,4300,3700,3650,NA,3400,NA,4200,31300
Saran,16.1.7,Stock position of JE vaccines,5. Total Stock,50,0,50,0,50,250,150,100,0,200,0,0,850
Saran,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,48,NA,998,NA,448,98,498,48,NA,348,NA,698,3184
Saran,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,3000,NA,200,NA,500,1000,700,1000,NA,800,NA,0,7200
Saran,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,1100,NA,1150,NA,850,600,1150,750,NA,700,NA,250,6550
Saran,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,1948,0,48,0,98,498,48,298,0,448,0,448,3834
Saran,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,NA,NA,8467,NA,6847,6847,6847,19170,19170,10333,NA,NA,77681
Saran,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,NA,NA,0,NA,0,0,12323,0,0,0,NA,NA,12323
Saran,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,NA,NA,1620,NA,0,NA,0,0,8837,902,NA,NA,11359
Saran,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0,0,6847,0,6847,6847,19170,19170,10333,9431,0,0,78645
Saran,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,NA,NA,1990,NA,1990,28757,28757,48485,48485,34633,NA,NA,193097
Saran,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,NA,NA,0,NA,0,0,206520,0,0,0,NA,NA,206520
Saran,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,NA,NA,0,NA,0,NA,0,0,13852,0,NA,NA,13852
Saran,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0,0,1990,0,1990,28757,235277,48485,34633,34633,0,0,385765
Saran,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,NA,NA,5676,NA,5676,7396,13072,18716,18716,18336,NA,NA,87588
Saran,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,NA,NA,0,NA,0,0,14086,0,0,0,NA,NA,14086
Saran,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,NA,NA,5676,NA,0,NA,0,0,6380,2824,NA,NA,14880
Saran,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0,0,0,0,5676,7396,27158,18716,12336,15512,0,0,86794
Saran,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,NA,NA,5232,NA,5232,7609,7609,15931,15931,14864,NA,NA,72408
Saran,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,NA,NA,0,NA,0,0,15759,0,0,0,NA,NA,15759
Saran,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,NA,NA,0,NA,0,NA,0,0,6380,2824,NA,NA,9204
Saran,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0,0,5232,0,5232,7609,23368,15931,9551,12040,0,0,78963
Saran,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Saran,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0,NA,0,NA,0,0,0,NA,NA,NA,NA,NA,0
Saran,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0,NA,0,NA,0,135,0,NA,NA,NA,NA,NA,135
Saran,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0,NA,0,NA,0,135,0,NA,NA,NA,NA,NA,135
Saran,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Saran,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,200,NA,175,175,175,175,100,100,NA,NA,NA,NA,1100
Saran,16.3.02,Stock Position of Gloves,2. Stocks Received,0,NA,0,0,0,0,0,0,NA,NA,NA,NA,0
Saran,16.3.02,Stock Position of Gloves,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,16.3.02,Stock Position of Gloves,4. Stock Distributed,25,NA,0,75,75,75,0,0,NA,NA,NA,NA,250
Saran,16.3.02,Stock Position of Gloves,5. Total Stock,175,0,175,100,100,100,100,100,0,0,0,0,850
Saran,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Saran,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,7500,NA,1800,400,300,300,200,200,NA,NA,NA,NA,10700
Saran,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0,NA,NA,0,0,0,0,0,NA,NA,NA,NA,0
Saran,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,5000,NA,1400,100,100,100,0,0,NA,NA,NA,NA,6700
Saran,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,2500,0,400,300,200,200,200,200,0,0,0,0,4000
Saran,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0,NA,0,0,NA,0,0,0,NA,NA,NA,NA,0
Saran,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0,NA,0,0,NA,0,0,0,NA,NA,NA,NA,0
Saran,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0,NA,0,0,NA,0,0,0,NA,NA,NA,NA,0
Saran,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Saran,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Saran,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,4000,NA,2000,NA,10600,10600,10600,0,NA,NA,NA,NA,37800
Saran,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0,NA,0,NA,0,0,0,0,NA,NA,NA,NA,0
Saran,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,2000,NA,0,NA,10600,10600,10600,0,NA,NA,NA,NA,33800
Saran,16.3.07,Stock Position of IFA Tablets,5. Total Stock,2000,0,2000,0,0,0,0,0,0,0,0,0,4000
Saran,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,100,NA,0,NA,0,0,0,0,NA,NA,NA,NA,100
Saran,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0,NA,0,NA,0,0,0,0,NA,NA,NA,NA,0
Saran,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,0
Saran,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,100,NA,0,NA,0,0,0,0,NA,NA,NA,NA,100
Saran,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Saran,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,NA,NA,700,NA,100,100,100,0,NA,NA,NA,NA,1000
Saran,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,NA,NA,0,NA,0,0,0,0,NA,NA,NA,NA,0
Saran,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,NA,NA,200,NA,100,100,100,0,NA,NA,NA,NA,500
Saran,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0,0,500,0,0,0,0,0,0,0,0,0,500
Saran,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,337,NA,337,NA,137,137,137,0,NA,NA,NA,NA,1085
Saran,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0,NA,0,NA,0,0,0,0,NA,NA,NA,NA,0
Saran,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0,NA,0,NA,137,137,137,0,NA,NA,NA,NA,411
Saran,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,337,0,337,0,0,0,0,0,0,0,0,0,674
Saran,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,282201,NA,28200,NA,41681,41681,40681,28681,NA,NA,NA,NA,463125
Saran,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0,NA,0,NA,0,0,0,0,NA,NA,NA,NA,0
Saran,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,124856,NA,10000,NA,1000,1000,12000,0,NA,NA,NA,NA,148856
Saran,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,157345,0,18200,0,40681,40681,28681,28681,0,0,0,0,314269
Saran,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,4600,NA,7600,NA,7200,13800,10000,13200,NA,12000,NA,6800,75200
Saran,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,12000,NA,10000,NA,20000,10000,15000,0,NA,10000,NA,10000,87000
Saran,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,11400,NA,12600,NA,13400,13800,11800,11400,NA,10400,NA,12600,97400
Saran,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,5200,0,5000,0,13800,10000,13200,1800,0,11600,0,4200,64800
Saran,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,26000,NA,23000,NA,26800,66000,51000,92000,NA,61000,NA,64000,409800
Saran,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,80000,NA,80000,NA,120000,80000,100000,0,NA,80000,NA,75000,615000
Saran,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,86600,NA,76000,NA,80800,95000,59000,84600,NA,84000,NA,110000,676000
Saran,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,19400,0,27000,0,66000,51000,92000,7400,0,57000,0,29000,348800
Saran,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,1600,NA,1800,NA,600,9600,6500,8400,NA,5800,NA,7700,42000
Saran,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,8000,NA,8000,NA,18000,10000,10000,0,NA,10000,NA,10000,74000
Saran,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,800,NA,8300,NA,9000,13100,10500,8400,NA,8700,NA,11700,70500
Saran,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,8800,0,1500,0,9600,6500,6000,0,0,7100,0,6000,45500
Saran,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,2,NA,3,2,1,NA,8
Saran,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,NA,NA,NA,NA,NA,NA,2,NA,3,2,1,NA,8
Saran,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,2,1,NA,2,1,6
Saran,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,NA,NA,NA,NA,NA,NA,NA,2,1,NA,2,1,6
Saran,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,1
Saran,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,1
Saran,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,1
Saran,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,2,1,NA,NA,3
Saran,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,NA,NA,NA,NA,NA,NA,NA,NA,3,1,NA,NA,4
Saran,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,1
Saran,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,2
Saran,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,2,3
Saran,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,1
Saran,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,1
Saran,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,1
Saran,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,1
Saran,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,2,NA,NA,1,NA,3
Saran,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,2,1,4
Saran,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,NA,NA,NA,NA,NA,NA,NA,3,NA,NA,3,1,7
Saran,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,1
Saran,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,1
Saran,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,1,2
Saran,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,1,2
Saran,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,NA,NA,2
Saran,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,NA,NA,2
Saran,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,1
Saran,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,1
Saran,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,NA,NA,NA,NA,NA,NA,1,NA,1,NA,NA,NA,2
Saran,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,1
Saran,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,1
Saran,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,1
Saran,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1
Saran,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,1,2
Saran,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Saran,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,2,4,2,6,2,7,23
Saran,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,5,5,16,21,8,11,66
Saran,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,NA,NA,NA,NA,NA,NA,7,9,18,27,10,18,89
Sheikhpura,1.1,Total number of pregnant women Registered for ANC,TOTAL,1537,1609,1658,1795,1614,1281,1006,881,959,1074,1207,1162,15783
Sheikhpura,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,910,960,960,1178,1027,831,599,583,653,663,732,783,9879
Sheikhpura,1.2,Number of Pregnant women registered under JSY,TOTAL,1537,1609,1658,1795,1614,1271,1006,881,959,1074,1207,1162,15773
Sheikhpura,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,848,882,892,1003,1048,1112,959,800,754,839,835,820,10792
Sheikhpura,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1344,1402,1462,1452,1340,1075,784,712,750,834,946,893,12994
Sheikhpura,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,1272,1467,1463,1718,1796,1468,1242,938,955,1016,958,1090,15383
Sheikhpura,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,777,777,661,461,152,96,179,186,184,253,260,243,4229
Sheikhpura,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,0,9,0,13,3,0,0,6,2,2,4,0,39
Sheikhpura,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0,0,0,1,2,3,2,6,2,2,4,5,27
Sheikhpura,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,59,98,103,191,36,23,112,131,104,85,88,95,1125
Sheikhpura,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,0,0,0,0,0,1,0,1,1,0,1,0,4
Sheikhpura,1.8,Number of pregnancy test kits used at SC level,TOTAL,0,5,0,7,3,3,7,0,1,0,5,13,44
Sheikhpura,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,149,121,164,162,184,143,159,171,185,192,158,116,1904
Sheikhpura,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,11,17,13,20,24,18,31,26,7,10,17,30,224
Sheikhpura,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,160,138,177,182,208,161,190,197,192,202,175,146,2128
Sheikhpura,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,152,135,171,181,198,161,189,197,192,202,175,145,2098
Sheikhpura,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheikhpura,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,658,771,846,1267,1535,1530,1539,1346,1176,1087,861,707,13323
Sheikhpura,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,530,527,733,1046,1187,1192,1252,1086,910,855,632,525,10475
Sheikhpura,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,609,756,653,1251,1526,1478,1464,669,1553,1081,443,560,12043
Sheikhpura,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,521,264,174,412,588,543,560,464,351,1775,488,973,7113
Sheikhpura,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,NA,0,NA,0,0,0,0,0,0,0,0,0,0
Sheikhpura,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,NA,NA,NA,NA,0,NA,10,386,2,6,4,NA,408
Sheikhpura,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,NA,NA,NA,NA,0,NA,0,NA,NA,NA,NA,NA,0
Sheikhpura,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,NA,NA,NA,NA,0,NA,0,NA,NA,NA,NA,NA,0
Sheikhpura,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,NA,NA,NA,NA,0,NA,0,NA,NA,NA,NA,NA,0
Sheikhpura,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0,3,0,0,3,5,0,0,0,0,0,0,11
Sheikhpura,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,NA,NA,NA,NA,0,0,0,0,0,1,0,0,1
Sheikhpura,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,6,15,12,22,19,13,12,9,16,17,17,24,182
Sheikhpura,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,6,18,12,22,22,18,12,9,16,18,17,24,194
Sheikhpura,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,NA,NA,NA,NA,0,NA,10,82,1,3,4,NA,100
Sheikhpura,4.1.1.a,Number of male live births,TOTAL,426,480,531,761,890,906,930,798,729,652,541,466,8110
Sheikhpura,4.1.1.b,Number of female live births,TOTAL,382,412,485,680,832,775,778,725,623,629,485,375,7181
Sheikhpura,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,808,892,1016,1441,1722,1681,1708,1523,1352,1281,1026,841,15291
Sheikhpura,4.1.2,Number of still births,TOTAL,12,21,12,16,26,23,36,23,21,17,11,15,233
Sheikhpura,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,1,0,0,1,2,0,0,0,0,0,0,1,5
Sheikhpura,4.2.1,Number of Newborns weighed at birth,TOTAL,579,888,1015,1441,1722,1680,1708,1522,1350,1281,1026,836,15048
Sheikhpura,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,61,87,198,83,286,327,402,248,220,165,157,133,2367
Sheikhpura,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,806,886,1015,1439,1720,1680,1703,1523,1347,1275,987,815,15196
Sheikhpura,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0,3,0,0,3,1,0,0,0,0,0,0,7
Sheikhpura,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,NA,NA,NA,NA,0,0,0,0,1,0,12,13,26
Sheikhpura,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,6,15,12,22,20,13,12,9,16,23,21,39,208
Sheikhpura,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,6,18,12,22,23,14,12,9,17,23,33,52,241
Sheikhpura,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,NA,NA,NA,NA,0,NA,10,NA,NA,NA,NA,NA,10
Sheikhpura,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,210,299,495,818,613,741,689,538,656,410,33,52,5554
Sheikhpura,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,4,4,4,2,2,2,2,6,2,2,4,5,39
Sheikhpura,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,0,356,712,1636,1220,1235,1192,1572,1350,648,66,104,10091
Sheikhpura,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,NA,0,0,0,0,0,0,0,0,0,0,0,0
Sheikhpura,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,350,650,834,654,479,459,440,467,1129,1055,790,739,8046
Sheikhpura,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,123,186,88,199,258,277,383,292,296,237,219,181,2739
Sheikhpura,6.3,PNC maternal complications attended,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheikhpura,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheikhpura,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheikhpura,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheikhpura,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheikhpura,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,33,22,18,16,40,27,36,97,122,119,62,39,631
Sheikhpura,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,200,180,241,282,218,213,245,198,213,258,254,296,2798
Sheikhpura,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,233,202,259,298,258,240,281,295,335,377,316,335,3429
Sheikhpura,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0,23,0,0,0,0,0,0,0,0,0,0,23
Sheikhpura,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0,0,0,1,0,0,1,1,5,2,0,0,10
Sheikhpura,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,NA,NA,NA,NA,0,0,0,0,0,0,0,1,1
Sheikhpura,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0,1,0,0,0,0,0,0,0,0,0,0,1
Sheikhpura,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0,1,0,1,0,0,1,1,5,2,0,1,12
Sheikhpura,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,0
Sheikhpura,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheikhpura,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0
Sheikhpura,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheikhpura,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheikhpura,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,0
Sheikhpura,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,60,61,116,177,92,398,230,178,352,205,361,178,2408
Sheikhpura,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,NA,NA,NA,NA,0,0,0,0,87,48,55,51,241
Sheikhpura,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,6,7,7,13,11,1,2,1,4,3,3,6,64
Sheikhpura,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,66,68,123,190,103,399,232,179,443,256,419,235,2713
Sheikhpura,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,NA,NA,NA,NA,NA,NA,NA,99,NA,56,NA,NA,155
Sheikhpura,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,7,1,17,9,16,39,19,37,19,29,28,20,241
Sheikhpura,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,NA,NA,NA,NA,0,0,0,0,0,1,0,0,1
Sheikhpura,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0,0,0,0,6,0,4,5,3,8,1,8,35
Sheikhpura,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,7,1,17,9,22,39,23,42,22,38,29,28,277
Sheikhpura,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,0
Sheikhpura,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,110,84,93,130,85,85,70,129,169,157,138,118,1368
Sheikhpura,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,46,39,33,717,80,115,113,109,205,104,100,106,1767
Sheikhpura,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,NA,NA,NA,NA,0,0,0,0,25,30,26,48,129
Sheikhpura,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,3,3,2,1,10,7,5,5,8,21,24,18,107
Sheikhpura,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,159,126,128,848,175,207,188,243,407,312,288,290,3371
Sheikhpura,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,35,50,35,81,60,81,70,79,77,86,89,112,855
Sheikhpura,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,NA,NA,NA,NA,NA,NA,NA,5,NA,NA,NA,NA,5
Sheikhpura,9.06,Number of IUCD removals,TOTAL,33,42,41,56,51,43,41,53,87,69,64,69,649
Sheikhpura,9.07,Number of Oral Pills cycles distributed,TOTAL,187,123,177,263,273,180,199,209,453,470,422,553,3509
Sheikhpura,9.08,Number of Condom pieces distributed,TOTAL,387,526,637,2576,803,2073,1073,1444,1470,2191,2087,2349,17616
Sheikhpura,9.09,Number of Centchroman (weekly) pills given,TOTAL,15,1,24,9,28,4,4,28,32,75,68,51,339
Sheikhpura,9.1,Number of Emergency Contraceptive Pills distributed,TOTAL,25,18,33,59,148,132,72,67,83,93,106,95,931
Sheikhpura,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheikhpura,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0,0,0,0,0,0,0,1,0,0,0,0,1
Sheikhpura,9.11.2.a,Number of failures following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheikhpura,9.11.2.b,Number of failures following female sterilization,TOTAL,0,1,0,0,0,0,0,0,0,0,0,0,1
Sheikhpura,9.11.3.a,Number of deaths following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheikhpura,9.11.3.b,Number of deaths following female sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheikhpura,9.12,Number of Institutions having NSV trained doctors,TOTAL,NA,NA,1,8,4,4,3,4,3,3,4,4,Data for this item can not be cumulated
Sheikhpura,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,894,990,1134,1684,1950,1940,1928,1791,1653,1582,1245,1022,17813
Sheikhpura,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,0,0,0,0,0,2,0,0,0,0,0,0,2
Sheikhpura,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,124,80,54,49,31,10,8,5,2,0,0,0,363
Sheikhpura,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,365,236,120,113,75,26,16,11,9,2,4,0,977
Sheikhpura,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,1240,958,896,1085,1166,1344,1591,1549,1636,1713,1578,1245,16001
Sheikhpura,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,1141,1255,949,956,1113,1112,1199,1274,1444,1579,1652,1440,15114
Sheikhpura,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,983,1090,1068,1017,1076,1079,1041,1078,1199,1420,1377,1470,13898
Sheikhpura,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,669,743,822,1270,1576,1582,1524,1298,1223,1075,856,690,13328
Sheikhpura,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1229,962,892,1105,1125,1344,1591,1528,1590,1698,1578,1245,15887
Sheikhpura,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1238,1336,1004,1003,1122,1122,1208,1268,1408,1564,1652,1442,15367
Sheikhpura,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1337,1312,1171,1113,1103,1104,1058,1067,1192,1401,1377,1470,14705
Sheikhpura,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,580,595,736,1056,1283,1404,1225,1181,1078,947,768,563,11416
Sheikhpura,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,104,0,2,0,0,0,0,0,0,0,0,0,106
Sheikhpura,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,117,66,55,47,26,10,8,5,2,0,0,0,336
Sheikhpura,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,360,219,118,110,62,26,16,11,9,2,4,0,937
Sheikhpura,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1161,1169,1236,1612,1576,1598,1479,1235,1074,1001,1016,927,15084
Sheikhpura,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,1242,1085,1014,1274,992,988,1016,853,1089,1299,1285,1324,13461
Sheikhpura,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,1095,1133,1139,1612,1576,1598,1479,1235,1074,1001,1016,927,14885
Sheikhpura,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,613,602,640,851,838,846,798,658,585,551,544,511,8037
Sheikhpura,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,548,567,596,761,738,752,681,577,489,450,472,416,7047
Sheikhpura,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1161,1169,1236,1612,1576,1598,1479,1235,1074,1001,1016,927,15084
Sheikhpura,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1242,1085,1014,1274,992,988,1016,853,1089,1299,1285,1324,13461
Sheikhpura,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1242,1085,1014,1274,992,988,1016,853,1089,1299,1285,1324,13461
Sheikhpura,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheikhpura,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,672,595,511,686,546,526,521,470,593,673,640,707,7140
Sheikhpura,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,570,490,503,588,446,462,495,367,496,626,645,617,6305
Sheikhpura,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,1242,1085,1014,1274,992,988,1016,837,1089,1299,1285,1324,13445
Sheikhpura,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,185,121,173,750,197,210,284,349,305,375,432,466,3847
Sheikhpura,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,158,112,224,266,216,187,226,316,248,322,376,355,3006
Sheikhpura,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,179,113,198,236,235,242,289,313,317,495,563,497,3677
Sheikhpura,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,15,0,0,0,0,0,0,0,2,0,0,0,17
Sheikhpura,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheikhpura,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0,0,0,0,0,0,0,0,143,0,0,0,143
Sheikhpura,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,675,673,647,688,676,697,665,672,679,683,665,680,8100
Sheikhpura,10.4.2,Number of Immunisation sessions held during the month,TOTAL,675,673,642,688,677,690,664,663,676,681,662,667,8058
Sheikhpura,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,581,561,513,564,549,568,557,556,566,571,535,578,6699
Sheikhpura,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,1207,1046,938,1274,992,988,1016,853,1089,1299,1285,1324,13311
Sheikhpura,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,85,141,99,117,117,85,39,20,9,0,5,2,719
Sheikhpura,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,55,118,35,30,14,11,9,3,0,0,6,3,284
Sheikhpura,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,5,0,5,9,2,2,2,0,0,0,0,2,27
Sheikhpura,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheikhpura,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheikhpura,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheikhpura,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheikhpura,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheikhpura,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,2,0,0,0,0,0,0,0,0,0,2,0,4
Sheikhpura,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,1039,767,866,1328,788,522,598,288,166,88,143,174,6767
Sheikhpura,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,273,0,0,0,0,0,0,0,0,0,0,0,273
Sheikhpura,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheikhpura,13.1,Number of Patients operated for cataract,TOTAL,9,0,6,2,3,0,0,6,227,162,0,0,415
Sheikhpura,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,9,3,6,2,3,8,0,6,227,162,19,16,461
Sheikhpura,13.3,Number of School children detected with Refractive errors,TOTAL,0,0,0,221,5,4,2,2,0,0,5,3,242
Sheikhpura,13.4,Number of children provided free glasses,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheikhpura,13.5,Number of eyes collected through eye donation,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheikhpura,13.6,Number of eyes utilised for corneal transplant,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheikhpura,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,NA,NA,1,2,2,2,2,2,2,2,2,2,Data for this item can not be cumulated
Sheikhpura,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,NA,NA,NA,NA,7,7,8,6,7,7,8,7,Data for this item can not be cumulated
Sheikhpura,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,548,546,551,553,570,573,562,542,564,570,564,552,Data for this item can not be cumulated
Sheikhpura,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,NA,NA,1,2,2,1,1,1,1,1,1,1,Data for this item can not be cumulated
Sheikhpura,14.05,Number of RKS meetings held during the month,TOTAL,2,5,4,6,11,9,8,7,8,7,9,11,87
Sheikhpura,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,NA,NA,1,7,7,7,7,6,6,6,6,6,Data for this item can not be cumulated
Sheikhpura,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,320,301,739,842,983,969,1083,706,835,654,662,637,8731
Sheikhpura,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,NA,NA,1,1,2,2,2,2,1,1,1,1,Data for this item can not be cumulated
Sheikhpura,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,NA,NA,1,2,1,1,0,0,0,0,1,0,Data for this item can not be cumulated
Sheikhpura,14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,49,63,34,121,79,147,120,81,86,69,68,134,1051
Sheikhpura,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,165,244,275,757,261,305,249,191,143,183,154,171,3098
Sheikhpura,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,75,78,60,257,124,205,101,99,117,77,79,113,1385
Sheikhpura,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,511,465,713,2567,1340,1395,1182,1169,1662,1497,1416,1079,14996
Sheikhpura,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,124,141,94,378,203,352,221,180,203,146,147,247,2436
Sheikhpura,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,676,709,988,3324,1601,1700,1431,1360,1805,1680,1570,1250,18094
Sheikhpura,14.10.2.a,Number of death cases of Inpatient males,TOTAL,2,7,2,0,1,2,2,1,1,1,0,0,19
Sheikhpura,14.10.2.b,Number of death cases of Inpatient females,TOTAL,1,4,1,0,1,1,1,0,1,0,1,1,12
Sheikhpura,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,3,11,3,0,2,3,3,1,2,1,1,1,31
Sheikhpura,14.11,In-Patient Head Count at midnight,TOTAL,1649,2462,2543,3685,3743,3972,3268,3080,3009,2430,2122,1682,33645
Sheikhpura,14.12.1,OPD attendance (All),TOTAL,49714,46594,45891,53495,53447,51651,39934,36181,36214,34334,32645,30132,510232
Sheikhpura,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,85,83,140,231,148,440,266,225,483,315,465,283,3164
Sheikhpura,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0,0,0,0,0,0,0,0,0,0,1,0,1
Sheikhpura,14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,469,496,644,687,625,647,574,607,658,711,598,627,7343
Sheikhpura,14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,14.14.a,Number of patients given AYUSH treatment,TOTAL,10642,11582,11457,12534,12950,13076,11428,9942,9862,8285,7494,6758,126010
Sheikhpura,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,997,1554,1830,1796,1831,1810,1349,1203,1350,1267,1359,1400,17746
Sheikhpura,14.14.c,Number of Adolescents counselled,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheikhpura,15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,388,440,477,768,976,1044,591,588,668,707,895,824,8366
Sheikhpura,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,9,4,7,4,8,13,2,2,7,7,10,5,78
Sheikhpura,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,162,54,89,99,11,77,81,77,99,105,107,102,1063
Sheikhpura,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,3,1,4,1,2,1,0,1,1,0,0,3,17
Sheikhpura,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,309,91,81,259,91,317,249,261,361,305,575,330,3229
Sheikhpura,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0,2,0,1,0,0,0,2,0,2,0,2,9
Sheikhpura,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,255,28,197,107,32,88,142,115,129,206,231,239,1769
Sheikhpura,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0,2,0,0,0,0,0,0,0,0,0,0,2
Sheikhpura,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,726,173,367,465,134,482,472,453,589,616,913,671,6061
Sheikhpura,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,3,5,4,2,2,1,0,3,1,2,0,5,28
Sheikhpura,15.2,Number of Widal tests conducted,Number tested,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheikhpura,15.3.a,Number of VDRL tests conducted on males,Number tested,0,0,0,0,0,0,0,0,0,40,56,4,100
Sheikhpura,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,28,0,0,40,70,0,0,46,0,0,0,0,184
Sheikhpura,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,28,23,58,12,147,90,66,0,42,171,198,155,990
Sheikhpura,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,56,23,58,52,217,90,66,46,42,211,254,159,1274
Sheikhpura,15.4.1,Number of blood smears examined for Malaria,TOTAL,2,5,50,82,194,333,0,24,10,10,11,4,725
Sheikhpura,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,0,0,0,0,0,19,1,0,0,0,0,0,20
Sheikhpura,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0,0,0,0,0,0,1,0,0,0,0,0,1
Sheikhpura,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,620,310,560,460,410,1190,940,740,740,640,385,485,7480
Sheikhpura,16.1.1,Stock position of DPT vaccines,2. Stocks Received,0,500,0,0,55,0,0,0,0,0,250,250,1055
Sheikhpura,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0,0,0,0,NA,0,0,0,0,0,NA,0,0
Sheikhpura,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,310,250,100,50,346,250,200,0,100,255,150,250,2261
Sheikhpura,16.1.1,Stock position of DPT vaccines,5. Total Stock,310,560,460,410,119,940,740,740,640,385,485,485,6274
Sheikhpura,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,220,436,136,662,464,1460,1244,692,978,1002,498,618,8410
Sheikhpura,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,600,0,1176,0,74,0,0,504,552,0,576,600,4082
Sheikhpura,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0,0,0,0,NA,0,0,0,0,0,NA,0,0
Sheikhpura,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,384,300,650,198,393,216,552,218,528,504,456,696,5095
Sheikhpura,16.1.1A,Stock Position of Pentavalent,5. Total Stock,436,136,662,464,145,1244,692,978,1002,498,618,522,7397
Sheikhpura,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,915,1330,680,1830,1380,1275,825,735,510,785,285,660,11210
Sheikhpura,16.1.2,Stock position of OPV vaccines,2. Stocks Received,915,0,2200,0,65,0,300,200,500,10200,10500,100,24980
Sheikhpura,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0,0,0,0,NA,0,0,0,0,0,NA,0,0
Sheikhpura,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,500,650,1050,450,170,450,390,425,225,10700,10125,710,25845
Sheikhpura,16.1.2,Stock position of OPV vaccines,5. Total Stock,1330,680,1830,1380,1275,825,735,510,785,285,660,50,10345
Sheikhpura,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,750,450,250,600,350,1450,1050,1000,1400,1200,1050,800,10350
Sheikhpura,16.1.3,Stock position of TT vaccines,2. Stocks Received,0,0,1000,0,65,0,400,500,0,0,0,500,2465
Sheikhpura,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0,0,0,0,NA,0,0,0,0,0,NA,0,0
Sheikhpura,16.1.3,Stock position of TT vaccines,4. Stock Distributed,300,200,650,250,270,400,450,100,200,150,250,360,3580
Sheikhpura,16.1.3,Stock position of TT vaccines,5. Total Stock,450,250,600,350,145,1050,1000,1400,1200,1050,800,940,9235
Sheikhpura,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,NA,NA,NA,NA,NA,0,0,NA,NA,0,NA,NA,0
Sheikhpura,16.1.4,Stock position of DT vaccines,2. Stocks Received,NA,NA,NA,NA,NA,0,0,NA,NA,0,NA,NA,0
Sheikhpura,16.1.4,Stock position of DT vaccines,3. Unusable Stock,NA,NA,NA,NA,NA,0,0,NA,NA,0,NA,NA,0
Sheikhpura,16.1.4,Stock position of DT vaccines,4. Stock Distributed,NA,NA,NA,NA,NA,0,0,NA,NA,0,NA,NA,0
Sheikhpura,16.1.4,Stock position of DT vaccines,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheikhpura,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,1150,850,600,1000,675,1000,450,550,575,725,575,625,8775
Sheikhpura,16.1.5,Stock position of BCG vaccines,2. Stocks Received,0,0,900,0,50,0,500,500,500,350,500,400,3700
Sheikhpura,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0,0,0,0,NA,0,0,0,0,0,NA,0,0
Sheikhpura,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,300,250,500,325,625,550,400,475,350,500,450,500,5225
Sheikhpura,16.1.5,Stock position of BCG vaccines,5. Total Stock,850,600,1000,675,100,450,550,575,725,575,625,525,7250
Sheikhpura,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,515,760,535,335,160,950,100,300,840,1100,1250,1350,8195
Sheikhpura,16.1.6,Stock position of Measles vaccines,2. Stocks Received,500,175,350,0,100,0,1000,1000,910,900,700,900,6535
Sheikhpura,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,NA,0,0
Sheikhpura,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,255,400,550,175,165,850,800,450,650,750,600,1050,6695
Sheikhpura,16.1.6,Stock position of Measles vaccines,5. Total Stock,760,535,335,160,95,100,300,850,1100,1250,1350,1200,8035
Sheikhpura,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,710,880,700,250,0,1100,200,0,840,1140,1220,1490,8530
Sheikhpura,16.1.7,Stock position of JE vaccines,2. Stocks Received,500,200,0,0,1700,0,0,1400,900,500,1000,500,6700
Sheikhpura,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,NA,0,0
Sheikhpura,16.1.7,Stock position of JE vaccines,4. Stock Distributed,330,380,450,250,660,900,200,560,600,420,730,750,6230
Sheikhpura,16.1.7,Stock position of JE vaccines,5. Total Stock,880,700,250,0,1040,200,0,840,1140,1220,1490,1240,9000
Sheikhpura,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,510,590,1350,1275,1275,1700,1550,1400,1200,1150,1040,1240,14280
Sheikhpura,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,300,845,0,0,675,0,0,0,0,0,250,0,2070
Sheikhpura,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0,0,0,0,NA,0,0,0,0,0,NA,0,0
Sheikhpura,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,220,85,75,0,250,150,150,200,50,110,50,50,1390
Sheikhpura,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,590,1350,1275,1275,1700,1550,1400,1200,1150,1040,1240,1190,14960
Sheikhpura,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,123,NA,NA,NA,NA,5790,5790,5790,5290,4290,3290,3290,33653
Sheikhpura,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0,NA,NA,NA,NA,0,0,0,0,0,NA,0,0
Sheikhpura,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0,NA,NA,NA,NA,0,0,0,0,0,NA,0,0
Sheikhpura,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,123,NA,NA,NA,NA,0,0,500,1000,1000,NA,3290,5913
Sheikhpura,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0,0,0,0,0,5790,5790,5290,4290,3290,3290,0,27740
Sheikhpura,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,1000,NA,NA,NA,NA,44322,44322,44182,39142,34102,13942,0,221012
Sheikhpura,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0,NA,NA,NA,NA,0,0,0,0,0,NA,0,0
Sheikhpura,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0,NA,NA,NA,NA,0,0,0,0,0,NA,0,0
Sheikhpura,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,1000,NA,NA,NA,NA,0,140,5040,5040,20160,13942,0,45322
Sheikhpura,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0,0,0,0,0,44322,44182,39142,34102,13942,0,0,175690
Sheikhpura,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,800,NA,NA,NA,NA,7296,7296,7196,6696,5696,0,4696,39676
Sheikhpura,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0,NA,NA,NA,NA,0,0,0,0,0,4696,0,4696
Sheikhpura,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0,NA,NA,NA,NA,0,0,0,0,0,NA,0,0
Sheikhpura,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,800,NA,NA,NA,NA,0,100,500,1000,5696,NA,4696,12792
Sheikhpura,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0,0,0,0,0,7296,7196,6696,5696,0,4696,0,31580
Sheikhpura,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,500,NA,NA,NA,NA,5776,5776,5776,4976,3776,3376,2598,32554
Sheikhpura,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0,NA,NA,NA,NA,0,0,0,0,0,0,0,0
Sheikhpura,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0,NA,NA,NA,NA,0,0,0,0,0,NA,0,0
Sheikhpura,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,500,NA,NA,NA,NA,0,0,800,1200,0,778,2598,5876
Sheikhpura,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0,0,0,0,0,5776,5776,4976,3776,3776,2598,0,26678
Sheikhpura,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,10
Sheikhpura,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Sheikhpura,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Sheikhpura,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,10,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,10
Sheikhpura,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheikhpura,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheikhpura,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,16.3.02,Stock Position of Gloves,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,16.3.02,Stock Position of Gloves,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,16.3.02,Stock Position of Gloves,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,16.3.02,Stock Position of Gloves,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheikhpura,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,0,100,NA,NA,100
Sheikhpura,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,3300,0,NA,NA,3300
Sheikhpura,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,0,0,NA,NA,0
Sheikhpura,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,3200,100,NA,NA,3300
Sheikhpura,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0,0,0,0,0,0,0,0,100,0,0,0,100
Sheikhpura,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,20000,8800,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,28800
Sheikhpura,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Sheikhpura,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Sheikhpura,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,11200,8800,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,20000
Sheikhpura,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,8800,0,0,0,0,0,0,0,0,0,0,0,8800
Sheikhpura,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheikhpura,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheikhpura,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheikhpura,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheikhpura,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,1800,1700,1200,NA,NA,NA,NA,NA,NA,NA,NA,NA,4700
Sheikhpura,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Sheikhpura,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Sheikhpura,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,100,500,1200,NA,NA,NA,NA,NA,NA,NA,NA,NA,1800
Sheikhpura,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,1700,1200,0,0,0,0,0,0,0,0,0,0,2900
Sheikhpura,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheikhpura,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,18730,5230,NA,NA,NA,23714,NA,NA,0,15444,10714,10714,84546
Sheikhpura,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0,0,NA,NA,NA,0,NA,NA,70844,50400,NA,0,121244
Sheikhpura,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0,0,NA,NA,NA,0,NA,NA,0,0,NA,0,0
Sheikhpura,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,13500,5230,NA,NA,NA,5000,NA,NA,55400,55130,NA,9340,143600
Sheikhpura,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,5230,0,0,0,0,18714,0,0,15444,10714,10714,1374,62190
Sheikhpura,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,0,13000,13000,13000,13000,NA,6300,13700,11900,9300,11100,9100,113400
Sheikhpura,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,14300,0,NA,NA,NA,NA,10000,0,0,3600,0,0,27900
Sheikhpura,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0,0,NA,NA,NA,NA,0,0,0,0,NA,0,0
Sheikhpura,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,1300,0,NA,0,NA,NA,2600,1800,2600,1800,2000,2000,14100
Sheikhpura,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,13000,13000,13000,13000,13000,0,13700,11900,9300,11100,9100,7100,127200
Sheikhpura,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,0,37900,32900,32800,32800,NA,0,32800,22000,7400,42800,26000,267400
Sheikhpura,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,46500,0,NA,NA,NA,NA,50000,0,0,50000,0,20000,166500
Sheikhpura,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0,0,NA,NA,NA,NA,0,0,0,0,NA,0,0
Sheikhpura,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,8600,5000,100,0,NA,NA,17200,10800,14600,14600,16800,18400,106100
Sheikhpura,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,37900,32900,32800,32800,32800,0,32800,22000,7400,42800,26000,27600,327800
Sheikhpura,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,0,4900,4400,3000,3000,NA,0,2400,1700,0,3500,700,23600
Sheikhpura,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,6700,NA,NA,NA,NA,NA,5000,0,0,5000,0,6000,22700
Sheikhpura,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0,NA,NA,NA,NA,NA,0,0,0,0,0,0,0
Sheikhpura,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,1800,500,1400,0,NA,NA,2600,700,1700,1500,2800,900,13900
Sheikhpura,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,4900,4400,3000,3000,3000,0,2400,1700,0,3500,700,5800,32400
Sheikhpura,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,1
Sheikhpura,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,1
Sheikhpura,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,1,NA,NA,NA,1,NA,NA,2
Sheikhpura,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,NA,NA,NA,NA,NA,1,NA,NA,NA,1,NA,NA,2
Sheikhpura,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,1
Sheikhpura,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,1
Sheikhpura,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,2,NA,NA,NA,1,NA,3
Sheikhpura,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,1
Sheikhpura,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,NA,NA,NA,NA,NA,NA,2,NA,NA,1,1,NA,4
Sheikhpura,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,1
Sheikhpura,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,1
Sheikhpura,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,1
Sheikhpura,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,1
Sheikhpura,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1,NA,2
Sheikhpura,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheikhpura,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1,NA,2
Sheohar,1.1,Total number of pregnant women Registered for ANC,TOTAL,1731,1900,1951,1906,1825,1628,1484,1330,1434,1444,1549,1750,19932
Sheohar,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1151,1159,1149,1146,1154,993,928,808,933,967,1068,1147,12603
Sheohar,1.2,Number of Pregnant women registered under JSY,TOTAL,1731,1900,1989,1906,1825,1628,1484,1329,1434,1444,1549,1752,19971
Sheohar,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1125,1262,1260,1274,1366,1228,1232,1111,1088,1059,1146,1277,14428
Sheohar,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1393,1559,1617,1517,1435,1337,1206,1115,1202,1190,1285,1388,16244
Sheohar,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,1605,1804,1819,1812,2113,1523,1374,1220,1245,1288,1261,1428,18492
Sheohar,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,630,376,237,180,125,56,59,61,63,66,48,46,1947
Sheohar,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,0,0,0,2,16,9,93,0,32,20,104,20,296
Sheohar,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0,0,0,2,0,0,0,0,0,1,1,2,6
Sheohar,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,3,3,3,3,4,3,1,4,0,0,0,0,24
Sheohar,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,0,0,0,0,NA,0,0,0,0,0,0,0,0
Sheohar,1.8,Number of pregnancy test kits used at SC level,TOTAL,0,0,0,0,5,0,34,11,4,0,0,0,54
Sheohar,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,47,57,66,46,53,46,59,69,24,30,20,20,537
Sheohar,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,207,189,268,270,356,324,363,297,294,302,296,181,3347
Sheohar,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,254,246,334,316,409,370,422,366,318,332,316,201,3884
Sheohar,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,225,217,275,233,364,337,361,310,232,247,258,218,3277
Sheohar,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0,0,9,0,0,0,0,0,0,0,0,0,9
Sheohar,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,526,603,580,793,941,924,976,960,865,729,770,580,9247
Sheohar,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,424,480,469,639,781,786,828,812,726,615,666,488,7714
Sheohar,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,89,206,247,286,180,119,118,110,370,318,666,356,3065
Sheohar,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,84,78,43,111,176,116,113,104,110,162,163,121,1381
Sheohar,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheohar,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0
Sheohar,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0
Sheohar,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0
Sheohar,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0
Sheohar,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheohar,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheohar,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheohar,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0
Sheohar,4.1.1.a,Number of male live births,TOTAL,437,442,264,577,660,640,744,729,632,553,542,445,6665
Sheohar,4.1.1.b,Number of female live births,TOTAL,346,407,256,528,668,640,642,621,554,522,540,384,6108
Sheohar,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,783,849,520,1105,1328,1280,1386,1350,1186,1075,1082,829,12773
Sheohar,4.1.2,Number of still births,TOTAL,3,7,1,20,26,19,23,14,18,18,22,12,183
Sheohar,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,0,0,0,0,0,0,2,0,1,5,0,0,8
Sheohar,4.2.1,Number of Newborns weighed at birth,TOTAL,750,827,867,644,1294,1249,1348,1320,1126,969,983,739,12116
Sheohar,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,61,93,91,141,162,158,112,104,104,68,72,52,1218
Sheohar,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,770,849,908,1097,1326,1280,1386,1325,1154,1018,1021,765,12899
Sheohar,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0,0,0,20,25,30,30,50,50,45,1,27,278
Sheohar,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,12,4,10,31,0,17,5,12,16,6,0,22,135
Sheohar,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,12,4,10,51,25,47,35,62,66,51,1,49,413
Sheohar,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0
Sheohar,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,12,4,10,67,55,40,30,62,66,51,5,45,447
Sheohar,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,4,0,4,5,25,4,10,0,0,0,0,0,52
Sheohar,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,0,0,20,470,600,305,510,12,2,0,0,87,2006
Sheohar,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheohar,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,236,285,268,362,454,438,528,466,357,309,420,698,4821
Sheohar,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,29,22,28,51,53,55,95,58,48,59,51,56,605
Sheohar,6.3,PNC maternal complications attended,TOTAL,0,0,0,0,0,0,0,0,130,110,0,0,240
Sheohar,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheohar,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheohar,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheohar,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheohar,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,57,102,63,30,58,80,45,50,30,80,150,75,820
Sheohar,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,151,298,305,260,225,324,427,243,745,550,854,722,5104
Sheohar,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,208,400,368,290,283,404,472,293,775,630,1004,797,5924
Sheohar,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheohar,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0,0,0,0,0,0,0,6,0,0,0,2,8
Sheohar,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheohar,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0,0,0,0,0,0,0,6,0,0,0,2,8
Sheohar,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0
Sheohar,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheohar,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheohar,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheohar,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0
Sheohar,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,6,0,0,162,53,138,150,184,538,390,312,86,2019
Sheohar,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,0,0,0,3,0,0,0,5,15,0,84,126,233
Sheohar,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,6,0,0,165,53,138,150,189,553,390,396,212,2252
Sheohar,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0
Sheohar,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0,0,0,9,0,0,0,0,0,0,0,2,11
Sheohar,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheohar,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0,0,0,9,0,0,0,0,0,0,0,2,11
Sheohar,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0
Sheohar,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,28,40,25,87,87,47,31,27,33,50,64,151,670
Sheohar,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,24,29,27,220,35,47,91,13,26,49,41,57,659
Sheohar,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,4,2,4,12,2,13,8,0,0,0,1,1,47
Sheohar,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,56,71,56,319,124,107,130,40,59,99,106,209,1376
Sheohar,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,10,16,15,22,28,40,40,30,42,42,78,113,476
Sheohar,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,NA,NA,NA,NA,NA,0,0,NA,NA,NA,NA,NA,0
Sheohar,9.06,Number of IUCD removals,TOTAL,49,41,33,48,43,29,32,36,32,31,43,51,468
Sheohar,9.07,Number of Oral Pills cycles distributed,TOTAL,537,540,458,568,416,1199,561,377,270,270,276,362,5834
Sheohar,9.08,Number of Condom pieces distributed,TOTAL,1750,2395,1705,1825,1845,2643,1533,1481,1954,3638,2936,3005,26710
Sheohar,9.09,Number of Centchroman (weekly) pills given,TOTAL,134,301,9,62,205,52,31,7,22,15,5,5,848
Sheohar,9.1,Number of Emergency Contraceptive Pills distributed,TOTAL,229,193,108,162,134,152,186,238,113,103,136,218,1972
Sheohar,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,1,7,0,8
Sheohar,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0,0,0,6,0,0,0,0,3,2,1,0,12
Sheohar,9.11.2.a,Number of failures following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheohar,9.11.2.b,Number of failures following female sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheohar,9.11.3.a,Number of deaths following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheohar,9.11.3.b,Number of deaths following female sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheohar,9.12,Number of Institutions having NSV trained doctors,TOTAL,NA,NA,1,1,1,NA,NA,1,NA,2,2,2,Data for this item can not be cumulated
Sheohar,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,1207,1531,1547,1611,1826,1921,2144,2068,1877,1548,1670,1250,20200
Sheohar,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,8,10,4,1,1,2,1,2,2,4,0,1,36
Sheohar,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,193,111,101,57,22,24,15,6,6,4,4,5,548
Sheohar,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,633,436,258,159,124,58,33,17,13,6,8,3,1748
Sheohar,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,1407,1367,1485,1376,1468,1562,1741,1692,1858,1879,1714,1603,19152
Sheohar,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,1395,1548,1471,1405,1404,1386,1456,1505,1645,1802,1686,1829,18532
Sheohar,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,1098,1385,1482,1360,1380,1372,1368,1316,1427,1575,1664,1770,17197
Sheohar,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1076,1229,1271,1385,1586,1587,1741,1631,1400,1143,1247,850,16146
Sheohar,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1260,1203,1471,1336,1468,1537,1752,1707,1855,1875,1724,1614,18802
Sheohar,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1439,1419,1406,1431,1419,1382,1484,1506,1656,1805,1691,1831,18469
Sheohar,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1604,1560,1560,1487,1460,1418,1413,1323,1432,1574,1671,1775,18277
Sheohar,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,735,834,818,979,1098,801,991,914,830,675,737,556,9968
Sheohar,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,7,0,3,0,1,2,1,1,12,4,0,0,31
Sheohar,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,176,99,87,50,15,15,5,3,13,2,1,1,467
Sheohar,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,603,418,250,139,102,54,16,9,13,25,4,3,1636
Sheohar,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1468,1558,1868,1791,1706,1833,1612,1379,1372,1193,1251,1206,18237
Sheohar,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,1559,1516,1643,1491,1244,1417,1270,1129,1300,1328,1435,1516,16848
Sheohar,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0,0,0,0,0,0,0,0,0,0,5,1,6
Sheohar,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,791,798,981,923,858,918,802,673,685,573,650,591,9243
Sheohar,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,649,699,825,790,779,836,695,574,605,519,603,536,8110
Sheohar,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1440,1497,1806,1713,1637,1754,1497,1247,1290,1092,1253,1127,17353
Sheohar,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1556,1486,1613,1489,1274,1431,1295,1135,1358,1398,1473,1526,17034
Sheohar,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1553,1472,1623,1491,1277,1427,1292,1135,1357,1399,1473,1533,17032
Sheohar,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0,0,0,0,0,0,6,0,29,5,6,3,49
Sheohar,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,651,524,604,496,268,451,475,476,540,517,602,610,6214
Sheohar,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,517,479,570,448,261,423,410,402,456,505,541,579,5591
Sheohar,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,1168,1003,1174,944,529,874,885,878,996,1022,1143,1189,11805
Sheohar,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,88,79,149,107,68,101,142,89,134,171,270,327,1725
Sheohar,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,150,146,143,168,204,166,223,175,136,175,174,252,2112
Sheohar,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,306,282,233,328,330,260,308,245,271,244,276,312,3395
Sheohar,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0,0,0,0,0,0,0,0,0,2,0,0,2
Sheohar,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0,0,0,0,0,0,0,0,0,2,0,0,2
Sheohar,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0,0,0,1,0,0,0,0,0,0,0,0,1
Sheohar,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,958,947,890,968,926,941,912,885,866,851,852,855,10851
Sheohar,10.4.2,Number of Immunisation sessions held during the month,TOTAL,944,942,898,961,912,919,897,834,828,797,779,790,10501
Sheohar,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,783,886,732,819,778,774,766,730,700,704,690,691,9053
Sheohar,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheohar,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1430,1555,1484,1321,1287,1359,1171,943,772,713,595,519,13149
Sheohar,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,322,275,250,239,129,160,166,91,144,134,142,143,2195
Sheohar,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,16,52,63,52,32,30,49,30,32,36,14,15,421
Sheohar,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheohar,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheohar,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheohar,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheohar,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheohar,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0,22,0,0,0,10,0,16,21,11,0,0,80
Sheohar,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,785,764,793,875,915,763,647,585,374,161,134,330,7126
Sheohar,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,16,17,15,0,0,0,48
Sheohar,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0,0,0,2,0,0,0,0,0,0,0,0,2
Sheohar,13.1,Number of Patients operated for cataract,TOTAL,0,0,0,0,0,0,0,0,117,63,0,26,206
Sheohar,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0,0,0,0,0,0,0,0,117,63,0,26,206
Sheohar,13.3,Number of School children detected with Refractive errors,TOTAL,0,0,0,0,20,25,25,30,0,30,50,0,180
Sheohar,13.4,Number of children provided free glasses,TOTAL,0,0,0,0,0,0,0,0,0,0,0,180,180
Sheohar,13.5,Number of eyes collected through eye donation,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheohar,13.6,Number of eyes utilised for corneal transplant,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheohar,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,NA,NA,NA,NA,NA,1,1,1,1,1,1,1,Data for this item can not be cumulated
Sheohar,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,NA,NA,NA,NA,NA,4,4,5,4,5,5,5,Data for this item can not be cumulated
Sheohar,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,483,487,358,488,488,331,369,358,318,310,310,288,Data for this item can not be cumulated
Sheohar,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,NA,NA,1,1,1,1,1,1,1,1,1,1,Data for this item can not be cumulated
Sheohar,14.05,Number of RKS meetings held during the month,TOTAL,1,1,1,1,2,3,3,2,2,2,2,2,22
Sheohar,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,NA,1,4,4,4,4,4,4,4,6,6,6,Data for this item can not be cumulated
Sheohar,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,281,244,170,675,570,754,586,723,616,526,438,392,5975
Sheohar,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,NA,NA,1,1,1,NA,NA,NA,NA,NA,NA,NA,Data for this item can not be cumulated
Sheohar,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,NA,NA,1,1,1,0,0,0,0,0,0,0,Data for this item can not be cumulated
Sheohar,14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,69,169,88,84,107,97,63,77,64,17,21,29,885
Sheohar,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,243,136,318,276,335,302,246,190,174,98,78,143,2539
Sheohar,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,57,603,59,73,69,91,76,96,98,19,24,22,1287
Sheohar,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,695,248,709,976,1116,1020,1119,1056,978,326,913,806,9962
Sheohar,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,126,772,147,157,176,188,139,173,162,36,45,51,2172
Sheohar,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,938,384,1027,1252,1451,1322,1365,1246,1152,424,991,949,12501
Sheohar,14.10.2.a,Number of death cases of Inpatient males,TOTAL,9,2,3,5,3,4,2,4,4,4,4,4,48
Sheohar,14.10.2.b,Number of death cases of Inpatient females,TOTAL,4,5,5,2,1,1,4,2,2,2,2,2,32
Sheohar,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,13,7,8,7,4,5,6,6,6,6,6,6,80
Sheohar,14.11,In-Patient Head Count at midnight,TOTAL,1003,1049,248,1376,1498,1426,1468,1297,1351,1012,1002,989,13719
Sheohar,14.12.1,OPD attendance (All),TOTAL,36163,32932,29440,33827,34217,39333,30270,22577,23848,20687,20663,23697,347654
Sheohar,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,6,0,0,68,44,62,130,139,448,309,373,198,1777
Sheohar,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheohar,14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,286,326,342,305,313,316,234,289,235,185,235,224,3290
Sheohar,14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,14.14.a,Number of patients given AYUSH treatment,TOTAL,5111,4696,5029,5098,6460,5643,5673,3996,4524,4572,3593,4302,58697
Sheohar,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,1274,1493,794,1731,1309,1995,1412,1171,1210,1508,818,1040,15755
Sheohar,14.14.c,Number of Adolescents counselled,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheohar,15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,0,0,0,0,0,0,0,0,320,150,244,224,938
Sheohar,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,0,0,0,0,0,0,0,0,3,2,0,0,5
Sheohar,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,117,177,175,156,102,203,219,72,98,349,343,207,2218
Sheohar,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,3,5,2,1,0,1,4,4,0,0,1,2,23
Sheohar,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,92,94,51,180,88,196,192,267,477,432,392,306,2767
Sheohar,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,3,3,0,2,0,1,2,1,0,0,1,4,17
Sheohar,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,115,245,236,200,148,204,319,158,445,400,584,522,3576
Sheohar,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheohar,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,324,516,462,536,338,603,730,497,1020,1181,1319,1035,8561
Sheohar,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,6,8,2,3,0,2,6,5,0,0,2,6,40
Sheohar,15.2,Number of Widal tests conducted,Number tested,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheohar,15.3.a,Number of VDRL tests conducted on males,Number tested,40,57,35,30,30,80,45,50,30,80,90,25,592
Sheohar,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,30,50,40,60,50,120,110,85,300,150,185,100,1280
Sheohar,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,102,234,236,200,148,204,317,158,445,400,584,522,3550
Sheohar,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,172,341,311,290,228,404,472,293,775,630,859,647,5422
Sheohar,15.4.1,Number of blood smears examined for Malaria,TOTAL,29,30,29,0,0,0,35,14,0,0,0,0,137
Sheohar,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheohar,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheohar,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.1.1,Stock position of DPT vaccines,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.1.1,Stock position of DPT vaccines,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheohar,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheohar,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.1.2,Stock position of OPV vaccines,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.1.2,Stock position of OPV vaccines,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheohar,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.1.3,Stock position of TT vaccines,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.1.3,Stock position of TT vaccines,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.1.3,Stock position of TT vaccines,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.1.3,Stock position of TT vaccines,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheohar,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.1.4,Stock position of DT vaccines,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.1.4,Stock position of DT vaccines,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.1.4,Stock position of DT vaccines,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.1.4,Stock position of DT vaccines,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheohar,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.1.5,Stock position of BCG vaccines,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.1.5,Stock position of BCG vaccines,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheohar,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.1.6,Stock position of Measles vaccines,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.1.6,Stock position of Measles vaccines,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheohar,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.1.7,Stock position of JE vaccines,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.1.7,Stock position of JE vaccines,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.1.7,Stock position of JE vaccines,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.1.7,Stock position of JE vaccines,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheohar,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheohar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheohar,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheohar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheohar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheohar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheohar,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheohar,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.3.02,Stock Position of Gloves,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.3.02,Stock Position of Gloves,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.3.02,Stock Position of Gloves,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.3.02,Stock Position of Gloves,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheohar,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheohar,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheohar,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheohar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheohar,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheohar,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheohar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheohar,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheohar,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheohar,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheohar,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheohar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Sheohar,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,NA,NA,NA,NA,NA,NA,3,1,NA,4,2,1,11
Sheohar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,2,NA,NA,NA,NA,1,3
Sheohar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,1
Sheohar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,NA,NA,NA,NA,NA,NA,3,NA,NA,NA,NA,1,4
Sheohar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,4,4,NA,2,3,2,15
Sheohar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,3,NA,NA,3
Sheohar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,NA,NA,NA,NA,NA,NA,4,4,NA,5,3,2,18
Sheohar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,1,1,2,2,1,NA,7
Sheohar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,NA,NA,NA,NA,NA,NA,1,1,2,2,1,NA,7
Sheohar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,1
Sheohar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,1
Sheohar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,1
Sheohar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,1
Sheohar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,1,NA,2,5,2,2,12
Sheohar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,1,3,2,2,NA,NA,8
Sheohar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,NA,NA,NA,NA,NA,NA,2,3,4,7,2,2,20
Sheohar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,1,1,NA,1,NA,3
Sheohar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1
Sheohar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,NA,NA,NA,NA,NA,NA,NA,1,1,NA,1,1,4
Sheohar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,1,1,NA,NA,NA,1,3
Sheohar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,1
Sheohar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,NA,NA,NA,NA,NA,NA,1,1,NA,NA,1,1,4
Sheohar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,2
Sheohar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,2
Sheohar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,1
Sheohar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,1
Sheohar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,1,NA,2
Sheohar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,1,NA,2
Sheohar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,NA,1
Sheohar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,NA,NA,NA,NA,NA,4,1,NA,NA,NA,NA,2,7
Sheohar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,NA,NA,NA,NA,NA,5,1,NA,NA,NA,NA,2,8
Sheohar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,1
Sheohar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,1
Sheohar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,NA,2
Sheohar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,NA,2
Sheohar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,1,NA,1,NA,NA,NA,2
Sheohar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,1
Sheohar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,2,NA,NA,NA,NA,1,3
Sheohar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,NA,NA,NA,NA,NA,NA,3,NA,1,1,NA,1,6
Sheohar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,1
Sheohar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,1
Sheohar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,1
Sheohar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,3,1,2,2,NA,8
Sheohar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,NA,NA,NA,NA,NA,NA,NA,3,1,3,2,NA,9
Sheohar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sheohar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,1,1,1,2,NA,5
Sheohar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,6,NA,4,2,1,2,15
Sheohar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,3,5,NA,9,5,5,27
Sheohar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,NA,NA,NA,NA,NA,NA,9,6,5,12,8,7,47
Sitamarhi,1.1,Total number of pregnant women Registered for ANC,TOTAL,8239,8045,7830,8983,8318,7978,6942,6455,7052,7623,7740,8072,93277
Sitamarhi,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,4842,4645,4472,4903,4385,4135,3770,3610,3895,4863,5836,6131,55487
Sitamarhi,1.2,Number of Pregnant women registered under JSY,TOTAL,8239,8040,7827,8978,8317,7981,6957,6452,7052,7623,7737,8061,93264
Sitamarhi,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,5436,5149,5098,5914,5642,5658,5299,5143,5136,5966,6578,6425,67444
Sitamarhi,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,6508,6329,10561,6811,6235,5728,5322,4949,5458,5830,6444,7044,77219
Sitamarhi,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,6723,7282,6873,7990,8042,7077,5952,5314,5343,6022,6105,6748,79471
Sitamarhi,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,4109,3862,4246,4113,3245,3144,2930,2596,2286,2486,2674,3174,38865
Sitamarhi,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,6,1,9,16,60,17,7,24,19,75,19,65,318
Sitamarhi,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0,3,4,2,1,5,4,4,9,4,12,9,57
Sitamarhi,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,1190,1358,1302,1340,1104,1451,1257,1142,1597,1493,1814,1906,16954
Sitamarhi,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,21,18,14,11,11,14,18,12,16,12,19,16,182
Sitamarhi,1.8,Number of pregnancy test kits used at SC level,TOTAL,95,71,48,229,174,94,115,181,260,442,481,619,2809
Sitamarhi,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,130,121,111,158,147,137,160,154,170,184,217,159,1848
Sitamarhi,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,744,726,697,746,985,1033,1070,1098,1095,1128,1077,855,11254
Sitamarhi,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,874,847,808,904,1132,1170,1230,1252,1265,1312,1294,1014,13102
Sitamarhi,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,364,363,307,428,444,417,624,583,547,631,896,616,6220
Sitamarhi,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,2,4,3,9,0,0,0,0,0,0,0,0,18
Sitamarhi,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,2326,2439,2372,3754,4522,4350,4241,4402,4125,3892,3549,3010,42982
Sitamarhi,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,2148,2390,2340,3707,4505,4339,4190,4334,4106,3881,3539,2985,42464
Sitamarhi,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1933,2176,2302,3355,2881,4017,5082,3461,2899,1595,4255,2987,36943
Sitamarhi,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1384,1774,1968,2945,2238,2878,3739,3592,4206,1484,3879,3410,33497
Sitamarhi,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0,0,0,0,0,0,0,0,0,13,0,0,13
Sitamarhi,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,NA,NA,NA,NA,0,NA,178,147,64,47,42,0,478
Sitamarhi,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Sitamarhi,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Sitamarhi,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,24,19,10,13,13,8,9,4,13,11,9,9,142
Sitamarhi,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,24,19,10,13,13,8,9,4,13,11,9,9,142
Sitamarhi,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,NA,NA,NA,NA,NA,NA,97,88,37,14,16,0,252
Sitamarhi,4.1.1.a,Number of male live births,TOTAL,1654,1678,1648,2423,2860,2827,2678,2847,2690,2636,2476,2104,28521
Sitamarhi,4.1.1.b,Number of female live births,TOTAL,1535,1595,1489,2168,2779,2655,2697,2760,2680,2497,2338,1883,27076
Sitamarhi,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,3189,3273,3137,4591,5639,5482,5375,5607,5370,5133,4814,3987,55597
Sitamarhi,4.1.2,Number of still births,TOTAL,54,52,49,80,94,96,91,99,78,74,57,58,882
Sitamarhi,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,7,0,0,4,7,6,6,3,4,7,5,11,60
Sitamarhi,4.2.1,Number of Newborns weighed at birth,TOTAL,2675,2949,2843,4211,5075,4831,4816,4989,4728,4499,4325,3708,49649
Sitamarhi,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,256,231,222,309,333,353,377,429,305,303,391,394,3903
Sitamarhi,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,3023,3159,3023,4453,5090,5097,5128,5318,5054,5063,4752,3938,53098
Sitamarhi,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,43,37,16,12,15,12,8,17,11,196,274,235,876
Sitamarhi,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Sitamarhi,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,11,9,16,8,30,17,19,20,26,18,59,47,280
Sitamarhi,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,54,46,32,20,45,29,27,37,37,214,333,282,1156
Sitamarhi,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,26,29,19,16,38,23,21,24,115,405,158,148,1022
Sitamarhi,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,5,7,2,2,1,0,3,3,10,4,8,15,60
Sitamarhi,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,159,171,83,314,41,20,25,33,137,853,573,403,2812
Sitamarhi,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,3,2,1,4,1,2,2,2,2,1,1,1,22
Sitamarhi,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,2352,2452,2302,3759,4525,4399,4315,4432,4163,4060,4007,3350,44116
Sitamarhi,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,907,966,687,1169,1513,1169,1454,1543,1504,1986,1615,1285,15798
Sitamarhi,6.3,PNC maternal complications attended,TOTAL,0,0,0,74,1,0,0,0,1,79,10,28,193
Sitamarhi,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Sitamarhi,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Sitamarhi,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Sitamarhi,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Sitamarhi,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,75,43,30,47,22,27,40,38,92,107,143,141,805
Sitamarhi,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,640,329,640,405,791,613,579,532,928,998,1041,939,8435
Sitamarhi,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,715,372,670,452,813,640,619,570,1020,1105,1184,1080,9240
Sitamarhi,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Sitamarhi,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0,0,0,11,1,4,5,15,8,6,6,8,64
Sitamarhi,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Sitamarhi,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0,0,0,2,0,1,0,0,0,0,5,0,8
Sitamarhi,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0,0,0,13,1,5,5,15,8,6,11,8,72
Sitamarhi,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,0
Sitamarhi,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Sitamarhi,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Sitamarhi,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Sitamarhi,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Sitamarhi,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,0
Sitamarhi,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,66,27,14,942,100,455,566,707,3603,2199,1790,569,11038
Sitamarhi,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Sitamarhi,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,27,3,4,3,6,7,17,26,306,207,194,97,897
Sitamarhi,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,93,30,18,945,106,462,583,733,3909,2406,1984,666,11935
Sitamarhi,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,11,10,0,0,0,NA,118,299,401,662,741,1012,3254
Sitamarhi,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,6,4,2,9,4,1,3,6,19,6,8,2,70
Sitamarhi,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Sitamarhi,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,4,5,5,5,5,2,3,2,7,5,4,4,51
Sitamarhi,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,10,9,7,14,9,3,6,8,26,11,12,6,121
Sitamarhi,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,0
Sitamarhi,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,562,580,475,1274,667,853,719,777,1168,981,1003,901,9960
Sitamarhi,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,243,184,165,1154,161,297,338,363,464,462,656,443,4930
Sitamarhi,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,NA,NA,0,0,0,0,0,0,0,0,0,0,0
Sitamarhi,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,31,33,27,43,20,15,3,3,10,0,1,1,187
Sitamarhi,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,836,797,667,2471,848,1165,1060,1143,1642,1443,1660,1345,15077
Sitamarhi,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,50,33,37,187,177,176,110,100,214,134,125,120,1463
Sitamarhi,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,0
Sitamarhi,9.06,Number of IUCD removals,TOTAL,289,256,269,356,324,249,242,259,281,292,359,384,3560
Sitamarhi,9.07,Number of Oral Pills cycles distributed,TOTAL,2006,2401,1826,4463,2506,2671,2152,2029,2516,2168,1933,2256,28927
Sitamarhi,9.08,Number of Condom pieces distributed,TOTAL,7197,8009,6325,12871,7503,7826,8169,7477,9103,10835,10075,9832,105222
Sitamarhi,9.09,Number of Centchroman (weekly) pills given,TOTAL,345,101,95,161,135,72,160,57,86,79,183,205,1679
Sitamarhi,9.1,Number of Emergency Contraceptive Pills distributed,TOTAL,952,931,790,2162,896,870,646,852,880,699,587,833,11098
Sitamarhi,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Sitamarhi,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Sitamarhi,9.11.2.a,Number of failures following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Sitamarhi,9.11.2.b,Number of failures following female sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Sitamarhi,9.11.3.a,Number of deaths following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Sitamarhi,9.11.3.b,Number of deaths following female sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Sitamarhi,9.12,Number of Institutions having NSV trained doctors,TOTAL,NA,NA,2,NA,NA,1,4,4,4,5,2,1,Data for this item can not be cumulated
Sitamarhi,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,6085,5869,5447,7277,9025,8994,9036,9053,9426,8401,9432,8244,96289
Sitamarhi,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,11,30,26,2,19,5,4,0,0,0,0,1,98
Sitamarhi,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,1373,597,301,274,135,77,30,23,33,20,5,7,2875
Sitamarhi,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,3350,1798,913,858,484,239,106,84,76,39,16,10,7973
Sitamarhi,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,7393,5624,4600,5622,5687,6881,8090,8344,9107,9632,9278,9178,89436
Sitamarhi,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,6733,6646,5433,5550,5449,5361,6341,6600,8207,8893,9093,10121,84427
Sitamarhi,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,5106,5794,5550,5802,5308,5074,5390,5528,6918,8018,8392,9993,76873
Sitamarhi,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,2839,2804,2903,4459,5607,5396,5509,5509,5327,4870,4648,4332,54203
Sitamarhi,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,7467,5475,4584,5565,5795,6824,8075,8660,9211,9684,9001,9255,89596
Sitamarhi,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,7692,6901,5523,5655,5517,5367,6454,6879,8209,8900,8850,9684,85631
Sitamarhi,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,7873,6881,6094,6406,5726,5296,5680,5821,6965,8040,8248,9245,82275
Sitamarhi,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,1426,1673,1752,2876,3406,3573,3231,3570,3580,3439,2967,2902,34395
Sitamarhi,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,22,3,3,9,12,48,0,15,0,1,0,0,113
Sitamarhi,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,1285,585,355,255,142,149,20,20,25,7,1,0,2844
Sitamarhi,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,3397,1806,1014,816,489,306,91,86,55,32,5,0,8097
Sitamarhi,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,6336,6661,6478,8099,7673,7620,7954,6800,7103,7336,8343,8578,88981
Sitamarhi,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,6549,3558,3685,5688,4647,4338,4871,4542,5848,6874,8530,8214,67344
Sitamarhi,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0,0,0,0,0,0,0,0,0,0,51,0,51
Sitamarhi,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,3186,3391,3363,4136,3968,3842,4036,3463,3683,3734,4382,4392,45576
Sitamarhi,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2886,3116,3013,3811,3534,3676,3828,3209,3391,3585,3899,4132,42080
Sitamarhi,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,6072,6507,6376,7947,7502,7518,7864,6672,7074,7319,8281,8524,87656
Sitamarhi,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,7445,5580,5034,6037,4949,4602,4911,4585,5949,7048,8550,8044,72734
Sitamarhi,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,7300,5568,4930,5948,4938,4512,4891,4601,5947,7037,8359,8083,72114
Sitamarhi,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0,0,0,0,0,0,26,0,0,0,0,0,26
Sitamarhi,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1542,1151,1155,1237,989,1108,1263,1182,1545,1789,2398,2086,17445
Sitamarhi,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1298,1051,915,1145,878,929,1114,1052,1405,1686,2142,1984,15599
Sitamarhi,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,2840,2202,2070,2382,1867,2037,2377,2234,2950,3475,4540,4070,33044
Sitamarhi,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,444,292,379,375,474,428,563,701,891,2042,2957,1791,11337
Sitamarhi,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,943,818,831,937,970,779,1126,1312,1329,1512,1691,1475,13723
Sitamarhi,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,2382,1644,1829,1984,1979,1784,2384,2300,2697,3150,3564,2976,28673
Sitamarhi,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0,0,0,0,0,12,4,0,0,0,0,0,16
Sitamarhi,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0,0,0,0,0,0,1,0,0,0,0,0,1
Sitamarhi,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Sitamarhi,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,2989,2924,2900,2972,2986,2980,3013,2970,2980,3016,2998,2976,35704
Sitamarhi,10.4.2,Number of Immunisation sessions held during the month,TOTAL,2915,2773,2680,2924,2884,2855,3000,2864,2961,2969,2951,2937,34713
Sitamarhi,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,2296,2229,2161,2480,2431,2368,2353,2348,2398,2408,2417,2371,28260
Sitamarhi,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Sitamarhi,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,2491,2461,2272,2800,2031,1784,1346,1161,1278,946,1078,1040,20688
Sitamarhi,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,764,683,440,426,472,337,286,288,478,129,220,175,4698
Sitamarhi,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,32,59,58,11,21,5,0,9,22,2,14,17,250
Sitamarhi,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,5,0,0,0,25,30
Sitamarhi,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Sitamarhi,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Sitamarhi,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Sitamarhi,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Sitamarhi,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,5,13,10,16,2,0,0,15,4,21,50,23,159
Sitamarhi,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,2391,3676,2194,3245,3420,2670,2573,1741,1192,918,923,984,25927
Sitamarhi,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0,2,0,14,7,0,70,25,0,0,0,0,118
Sitamarhi,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0,0,0,0,0,0,103,1,0,0,0,0,104
Sitamarhi,13.1,Number of Patients operated for cataract,TOTAL,4,0,0,3,0,191,193,274,539,412,417,423,2456
Sitamarhi,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Sitamarhi,13.3,Number of School children detected with Refractive errors,TOTAL,0,0,0,0,0,14,30,25,38,6,0,0,113
Sitamarhi,13.4,Number of children provided free glasses,TOTAL,0,0,0,0,0,0,29,0,0,0,0,21,50
Sitamarhi,13.5,Number of eyes collected through eye donation,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Sitamarhi,13.6,Number of eyes utilised for corneal transplant,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Sitamarhi,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,NA,NA,NA,NA,NA,NA,2,1,1,1,1,1,Data for this item can not be cumulated
Sitamarhi,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,NA,NA,3,NA,NA,4,19,17,18,20,20,20,Data for this item can not be cumulated
Sitamarhi,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,2148,2161,2091,2112,2193,2184,1968,2105,1921,1921,1957,1932,Data for this item can not be cumulated
Sitamarhi,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,NA,NA,NA,NA,NA,NA,2,1,1,1,1,1,Data for this item can not be cumulated
Sitamarhi,14.05,Number of RKS meetings held during the month,TOTAL,15,14,10,8,207,7,8,9,12,13,8,11,322
Sitamarhi,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,NA,NA,3,NA,NA,4,15,14,18,15,16,14,Data for this item can not be cumulated
Sitamarhi,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,914,1066,930,1595,1526,1934,2443,2708,2681,2647,2490,2700,23634
Sitamarhi,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,Data for this item can not be cumulated
Sitamarhi,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,Data for this item can not be cumulated
Sitamarhi,14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,847,1114,930,967,912,1008,892,892,884,858,700,873,10877
Sitamarhi,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,1490,1487,1467,1571,1553,1520,1648,1753,1610,2081,1833,1211,19224
Sitamarhi,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,1013,1263,1042,1553,1076,987,1032,1049,1542,1009,901,900,13367
Sitamarhi,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,2951,2938,3055,4729,4649,4882,4482,4402,6543,4683,4807,3852,51973
Sitamarhi,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,1860,2377,1972,2520,1988,1995,1924,1941,2426,1867,1601,1773,24244
Sitamarhi,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,4441,4425,4522,6300,6202,6402,6130,6155,8153,6764,6640,5063,71197
Sitamarhi,14.10.2.a,Number of death cases of Inpatient males,TOTAL,6,3,10,11,5,12,7,5,3,3,3,6,74
Sitamarhi,14.10.2.b,Number of death cases of Inpatient females,TOTAL,8,4,8,8,6,6,6,3,3,6,2,2,62
Sitamarhi,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,14,7,18,19,11,18,13,8,6,9,5,8,136
Sitamarhi,14.11,In-Patient Head Count at midnight,TOTAL,4996,5098,4690,6432,6146,6221,6132,6155,8687,7206,6296,5447,73506
Sitamarhi,14.12.1,OPD attendance (All),TOTAL,145564,148159,139049,148044,147532,152654,131592,120159,128164,124016,138787,140594,1664314
Sitamarhi,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,142,42,45,987,123,439,578,742,3953,2528,2019,678,12276
Sitamarhi,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0,0,0,0,5,0,0,0,0,0,0,0,5
Sitamarhi,14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,4894,4517,5399,6022,6168,5794,5834,5417,6370,5414,5161,4530,65520
Sitamarhi,14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,14.14.a,Number of patients given AYUSH treatment,TOTAL,37341,38552,33605,35881,32639,35721,32491,29127,33306,30049,33852,33835,406399
Sitamarhi,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,3346,3796,3657,3250,4946,3738,2858,2349,2856,2814,3109,3044,39763
Sitamarhi,14.14.c,Number of Adolescents counselled,TOTAL,242,119,148,97,161,224,145,139,141,125,88,103,1732
Sitamarhi,15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,1602,2169,2217,2070,2111,2390,2136,1922,3133,2771,2924,2801,28246
Sitamarhi,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,28,30,17,18,21,21,29,26,38,37,28,39,332
Sitamarhi,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,1056,96,612,696,1368,1134,988,810,665,1192,1436,1197,11250
Sitamarhi,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,2,1,62,21,24,42,251,17,26,20,28,26,520
Sitamarhi,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,1175,91,634,821,1173,1026,1214,1102,1234,2396,2235,1685,14786
Sitamarhi,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0,1,33,17,22,22,11,12,13,14,18,20,183
Sitamarhi,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,1326,52,1197,715,1978,1810,1492,1033,930,2132,2199,1723,16587
Sitamarhi,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,5,1,2,1,2,3,1,2,3,1,2,0,23
Sitamarhi,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,3557,239,2443,2232,4519,3970,3694,2945,2829,5720,5870,4605,42623
Sitamarhi,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,7,3,97,39,48,67,263,31,42,35,48,46,726
Sitamarhi,15.2,Number of Widal tests conducted,Number tested,428,0,0,0,0,0,27,0,0,0,0,0,455
Sitamarhi,15.3.a,Number of VDRL tests conducted on males,Number tested,0,0,0,0,0,0,40,38,39,64,226,404,811
Sitamarhi,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,0,0,0,0,0,0,576,526,1064,742,306,1201,4415
Sitamarhi,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,0,0,0,0,0,0,417,360,351,726,1062,793,3709
Sitamarhi,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,0,0,0,0,0,0,1033,924,1454,1532,1594,2398,8935
Sitamarhi,15.4.1,Number of blood smears examined for Malaria,TOTAL,284,304,228,252,290,186,257,208,203,207,154,107,2680
Sitamarhi,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,0,0,0,1,0,11,25,0,6,0,0,0,43
Sitamarhi,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0,0,0,1,0,0,0,0,0,0,0,0,1
Sitamarhi,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,NA,NA,NA,6191,NA,4116,3716,3616,3316,2716,NA,NA,23671
Sitamarhi,16.1.1,Stock position of DPT vaccines,2. Stocks Received,NA,NA,NA,0,NA,0,0,0,0,0,NA,NA,0
Sitamarhi,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,NA,NA,NA,0,NA,0,0,0,0,0,NA,NA,0
Sitamarhi,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,NA,NA,NA,1325,NA,400,100,300,600,1500,NA,NA,4225
Sitamarhi,16.1.1,Stock position of DPT vaccines,5. Total Stock,0,0,0,4866,0,3716,3616,3316,2716,1216,0,0,19446
Sitamarhi,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,NA,NA,NA,3150,NA,2675,4175,3351,2002,1727,NA,NA,17080
Sitamarhi,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,NA,NA,NA,0,NA,2950,1000,0,2400,2000,NA,NA,8350
Sitamarhi,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,NA,NA,NA,0,NA,0,0,0,0,0,NA,NA,0
Sitamarhi,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,NA,NA,NA,2050,NA,1450,1824,1349,2675,2700,NA,NA,12048
Sitamarhi,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0,0,0,1100,0,4175,3351,2002,1727,1027,0,0,13382
Sitamarhi,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,NA,NA,NA,3140,NA,1265,1693,1593,2318,975,NA,NA,10984
Sitamarhi,16.1.2,Stock position of OPV vaccines,2. Stocks Received,NA,NA,NA,0,NA,2500,2500,2500,1500,2500,NA,NA,11500
Sitamarhi,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,NA,NA,NA,0,NA,0,0,0,0,0,NA,NA,0
Sitamarhi,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,NA,NA,NA,2625,NA,2072,2600,1775,2843,1607,NA,NA,13522
Sitamarhi,16.1.2,Stock position of OPV vaccines,5. Total Stock,0,0,0,515,0,1693,1593,2318,975,1868,0,0,8962
Sitamarhi,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,NA,NA,NA,3821,NA,1461,1537,3137,2657,2657,NA,NA,15270
Sitamarhi,16.1.3,Stock position of TT vaccines,2. Stocks Received,NA,NA,NA,0,NA,2000,3550,800,2000,2000,NA,NA,10350
Sitamarhi,16.1.3,Stock position of TT vaccines,3. Unusable Stock,NA,NA,NA,0,NA,0,0,0,0,0,NA,NA,0
Sitamarhi,16.1.3,Stock position of TT vaccines,4. Stock Distributed,NA,NA,NA,2760,NA,1924,1950,1280,2000,2056,NA,NA,11970
Sitamarhi,16.1.3,Stock position of TT vaccines,5. Total Stock,0,0,0,1061,0,1537,3137,2657,2657,2601,0,0,13650
Sitamarhi,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,NA,NA,NA,NA,NA,0,0,0,0,0,NA,NA,0
Sitamarhi,16.1.4,Stock position of DT vaccines,2. Stocks Received,NA,NA,NA,NA,NA,0,0,0,0,0,NA,NA,0
Sitamarhi,16.1.4,Stock position of DT vaccines,3. Unusable Stock,NA,NA,NA,NA,NA,0,0,0,0,0,NA,NA,0
Sitamarhi,16.1.4,Stock position of DT vaccines,4. Stock Distributed,NA,NA,NA,NA,NA,0,0,0,0,0,NA,NA,0
Sitamarhi,16.1.4,Stock position of DT vaccines,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Sitamarhi,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,NA,NA,NA,3952,NA,2117,1705,705,255,35,NA,NA,8769
Sitamarhi,16.1.5,Stock position of BCG vaccines,2. Stocks Received,NA,NA,NA,0,NA,1800,1800,1000,1800,1800,NA,NA,8200
Sitamarhi,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,NA,NA,NA,0,NA,0,0,0,0,0,NA,NA,0
Sitamarhi,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,NA,NA,NA,2135,NA,2212,2800,1450,2020,1735,NA,NA,12352
Sitamarhi,16.1.5,Stock position of BCG vaccines,5. Total Stock,0,0,0,1817,0,1705,705,255,35,100,0,0,4617
Sitamarhi,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,NA,NA,NA,4840,NA,1748,3253,3200,2600,2800,NA,NA,18441
Sitamarhi,16.1.6,Stock position of Measles vaccines,2. Stocks Received,NA,NA,NA,0,NA,4700,3100,2000,4000,2000,NA,NA,15800
Sitamarhi,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,NA,NA,NA,0,NA,0,0,0,0,0,NA,NA,0
Sitamarhi,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,NA,NA,NA,4485,NA,3195,3153,2600,3800,3650,NA,NA,20883
Sitamarhi,16.1.6,Stock position of Measles vaccines,5. Total Stock,0,0,0,355,0,3253,3200,2600,2800,1150,0,0,13358
Sitamarhi,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,NA,NA,NA,NA,NA,0,NA,NA,0,NA,NA,NA,0
Sitamarhi,16.1.7,Stock position of JE vaccines,2. Stocks Received,NA,NA,NA,NA,NA,0,NA,NA,0,NA,NA,NA,0
Sitamarhi,16.1.7,Stock position of JE vaccines,3. Unusable Stock,NA,NA,NA,NA,NA,0,NA,NA,0,NA,NA,NA,0
Sitamarhi,16.1.7,Stock position of JE vaccines,4. Stock Distributed,NA,NA,NA,NA,NA,0,NA,NA,0,NA,NA,NA,0
Sitamarhi,16.1.7,Stock position of JE vaccines,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Sitamarhi,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,NA,NA,NA,3151,NA,2166,1916,1666,1516,1266,NA,NA,11681
Sitamarhi,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,NA,NA,NA,0,NA,0,0,0,0,0,NA,NA,0
Sitamarhi,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,NA,NA,NA,0,NA,0,0,0,0,0,NA,NA,0
Sitamarhi,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,NA,NA,NA,560,NA,250,250,150,250,560,NA,NA,2020
Sitamarhi,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0,0,0,2591,0,1916,1666,1516,1266,706,0,0,9661
Sitamarhi,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Sitamarhi,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Sitamarhi,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Sitamarhi,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Sitamarhi,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Sitamarhi,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Sitamarhi,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,16.3.02,Stock Position of Gloves,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,16.3.02,Stock Position of Gloves,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,16.3.02,Stock Position of Gloves,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,16.3.02,Stock Position of Gloves,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Sitamarhi,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Sitamarhi,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Sitamarhi,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Sitamarhi,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Sitamarhi,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Sitamarhi,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Sitamarhi,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Sitamarhi,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Sitamarhi,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Sitamarhi,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,NA,NA,NA,12006,NA,9406,26206,16006,8806,18406,NA,NA,90836
Sitamarhi,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,NA,NA,NA,0,NA,24000,24000,0,20000,0,NA,NA,68000
Sitamarhi,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,NA,NA,NA,0,NA,0,0,0,0,0,NA,NA,0
Sitamarhi,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,NA,NA,NA,6700,NA,7200,34200,7200,10400,13900,NA,NA,79600
Sitamarhi,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0,0,0,5306,0,26206,16006,8806,18406,4506,0,0,79236
Sitamarhi,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,NA,NA,NA,228730,NA,209130,329730,276130,233930,341730,NA,NA,1619380
Sitamarhi,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,NA,NA,NA,0,NA,175000,175000,0,170000,0,NA,NA,520000
Sitamarhi,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,NA,NA,NA,0,NA,0,0,0,0,0,NA,NA,0
Sitamarhi,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,NA,NA,NA,69600,NA,54400,228600,42200,62200,84600,NA,NA,541600
Sitamarhi,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0,0,0,159130,0,329730,276130,233930,341730,257130,0,0,1597780
Sitamarhi,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,NA,NA,NA,7037,NA,7037,15837,10437,6037,16737,NA,NA,63122
Sitamarhi,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,NA,NA,NA,0,NA,15000,15000,0,15000,0,NA,NA,45000
Sitamarhi,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,NA,NA,NA,0,NA,0,0,0,0,0,NA,NA,0
Sitamarhi,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,NA,NA,NA,4900,NA,6200,20400,4400,4300,6100,NA,NA,46300
Sitamarhi,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0,0,0,2137,0,15837,10437,6037,16737,10637,0,0,61822
Sitamarhi,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,NA,NA,NA,NA,NA,NA,2,NA,NA,1,NA,NA,3
Sitamarhi,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,1,NA,2,1,NA,4
Sitamarhi,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,NA,NA,NA,NA,NA,NA,NA,1,NA,2,1,NA,4
Sitamarhi,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,3,1,1,5
Sitamarhi,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,1
Sitamarhi,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,4,1,1,6
Sitamarhi,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,1
Sitamarhi,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,1
Sitamarhi,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,1,NA,2
Sitamarhi,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,3,1,NA,1,1,1,7
Sitamarhi,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,NA,NA,NA,NA,NA,NA,3,1,NA,1,1,1,7
Sitamarhi,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,1,NA,2
Sitamarhi,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,1,NA,2
Sitamarhi,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,1
Sitamarhi,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,1
Sitamarhi,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1
Sitamarhi,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1
Sitamarhi,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,1
Sitamarhi,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,1
Sitamarhi,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,NA,NA,NA,NA,NA,NA,1,NA,1,NA,NA,NA,2
Sitamarhi,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,1
Sitamarhi,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,1
Sitamarhi,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,1
Sitamarhi,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,1
Sitamarhi,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,4,1,NA,5
Sitamarhi,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,4,1,NA,5
Sitamarhi,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,1
Sitamarhi,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,1
Sitamarhi,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,1,NA,NA,2,NA,1,4
Sitamarhi,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,NA,NA,NA,NA,NA,NA,1,NA,NA,2,NA,1,4
Sitamarhi,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,1
Sitamarhi,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,1,2
Sitamarhi,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,2,NA,NA,1,3
Sitamarhi,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,2,NA,NA,NA,NA,NA,2
Sitamarhi,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,NA,NA,NA,NA,NA,NA,2,NA,NA,NA,NA,NA,2
Sitamarhi,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,1
Sitamarhi,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1
Sitamarhi,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,1,2
Sitamarhi,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Sitamarhi,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,1,1,NA,NA,NA,NA,2
Sitamarhi,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,1
Sitamarhi,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,NA,NA,NA,NA,NA,NA,1,1,NA,1,NA,NA,3
Sitamarhi,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,2,NA,NA,NA,NA,NA,2
Sitamarhi,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,2,1,5,3,1,NA,12
Sitamarhi,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,4,2,NA,1,NA,NA,7
Sitamarhi,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,NA,NA,NA,NA,NA,NA,8,3,5,4,1,NA,21
Siwan,1.1,Total number of pregnant women Registered for ANC,TOTAL,7486,7182,7287,7787,7429,7602,7092,6541,7209,7175,7913,8202,88905
Siwan,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,4203,4083,4185,4451,4359,4710,4437,4103,4537,4789,5270,5433,54560
Siwan,1.2,Number of Pregnant women registered under JSY,TOTAL,7486,7179,7282,7762,7433,7602,7077,6544,7209,7175,7913,8202,88864
Siwan,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,5994,5861,5793,5895,6168,6308,6113,6078,6130,6028,6326,6605,73299
Siwan,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,6451,6201,6190,6653,6253,6463,6051,5629,6201,6224,6932,7167,76415
Siwan,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,7066,6889,6611,6931,7402,6905,6913,6486,6467,6257,6580,7647,82154
Siwan,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,5270,5319,5268,4935,5076,5926,5691,5230,5158,5744,6240,6248,66105
Siwan,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,19,42,203,129,120,96,103,156,137,109,110,136,1360
Siwan,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,1,1,0,1,1,0,2,0,3,3,2,7,21
Siwan,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,2338,2040,2216,2161,2153,2149,1914,1835,1948,1790,2093,2033,24670
Siwan,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Siwan,1.8,Number of pregnancy test kits used at SC level,TOTAL,2390,2501,2505,2881,2504,2726,2531,2390,2437,2553,2500,2771,30689
Siwan,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,484,467,577,570,657,694,642,634,605,552,623,582,7087
Siwan,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,486,461,571,598,692,650,647,564,592,590,582,494,6927
Siwan,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,970,928,1148,1168,1349,1344,1289,1198,1197,1142,1205,1076,14014
Siwan,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,429,384,467,517,602,537,517,442,498,499,459,427,5778
Siwan,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0,1,0,1,0,0,0,0,0,0,0,0,2
Siwan,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,2120,2459,2424,3670,4047,3627,3415,3693,3403,3562,3388,2951,38759
Siwan,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,1997,2224,2298,3461,3845,3446,2939,3112,2987,3144,3037,2669,35159
Siwan,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,2020,2463,2271,2339,1139,3132,3414,2938,4054,3661,4647,2872,34950
Siwan,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1016,1550,1332,1064,716,1690,1909,2264,2822,3151,4632,3250,25396
Siwan,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Siwan,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,120,NA,125,135,122,138,140,136,128,116,105,98,1363
Siwan,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Siwan,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Siwan,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Siwan,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Siwan,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,3,2,0,2,1,6,5,2,1,1,1,2,26
Siwan,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,5,0,0,0,0,1,4,5,4,12,17,10,58
Siwan,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Siwan,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,8,2,0,2,1,7,9,7,5,13,18,12,84
Siwan,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,8,NA,9,10,9,11,13,11,8,6,5,3,93
Siwan,4.1.1.a,Number of male live births,TOTAL,1586,1796,1876,2519,2850,2556,2379,2546,2303,2486,2400,2134,27431
Siwan,4.1.1.b,Number of female live births,TOTAL,1495,1615,1675,2269,2518,2395,2294,2365,2279,2210,2179,1897,25191
Siwan,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,3081,3411,3551,4788,5368,4951,4673,4911,4582,4696,4579,4031,52622
Siwan,4.1.2,Number of still births,TOTAL,39,53,38,86,69,74,66,65,63,68,53,50,724
Siwan,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,60,45,47,56,58,61,73,63,64,48,51,59,685
Siwan,4.2.1,Number of Newborns weighed at birth,TOTAL,2955,3248,3428,4679,5229,4796,4508,4764,4433,4550,4466,3947,51003
Siwan,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,61,72,88,177,169,188,206,238,208,204,171,145,1927
Siwan,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,2959,3307,3396,4599,5161,4756,4422,4724,4432,4563,4434,3891,50644
Siwan,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,157,181,40,210,215,239,74,57,121,102,32,39,1467
Siwan,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,7,7,3,7,8,10,5,2,3,3,5,5,65
Siwan,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,76,64,75,64,91,104,120,50,78,64,91,82,959
Siwan,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Siwan,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,240,252,118,281,314,353,199,109,202,169,128,126,2491
Siwan,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Siwan,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,152,166,96,248,355,345,345,436,351,331,262,376,3463
Siwan,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,7,4,2,4,9,2,14,3,6,6,2,5,64
Siwan,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,162,169,49,218,266,246,239,214,217,227,76,283,2366
Siwan,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,76,64,75,64,91,104,120,45,78,64,72,67,920
Siwan,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1360,1388,1483,1810,2112,2140,1953,2243,2132,2324,2090,1991,23026
Siwan,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1605,1595,1790,2088,2302,2509,2361,2033,2090,1941,2117,2017,24448
Siwan,6.3,PNC maternal complications attended,TOTAL,0,0,0,2,1,0,4,2,3,3,2,5,22
Siwan,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Siwan,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Siwan,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Siwan,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Siwan,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,55,68,42,66,49,46,58,49,65,44,65,63,670
Siwan,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,141,161,208,196,206,213,197,162,204,221,211,198,2318
Siwan,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,196,229,250,262,255,259,255,211,269,265,276,261,2988
Siwan,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,31,45,0,68,61,60,73,47,47,51,711,716,1910
Siwan,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0,1,1,2,0,1,0,1,4,2,2,0,14
Siwan,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0,0,0,0,0,0,1,0,0,0,0,0,1
Siwan,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0,0,0,0,0,0,0,0,2,0,1,0,3
Siwan,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Siwan,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0,1,1,2,0,1,1,1,6,2,3,0,18
Siwan,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,1,0,0,0,0,0,0,0,0,3,1,0,5
Siwan,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Siwan,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
Siwan,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,NA,NA,NA,0,NA,NA,0,0,0,0,0,0,0
Siwan,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Siwan,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Siwan,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0,0,NA,0,0,0,0,0,0,0,0,0,0
Siwan,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,159,71,53,321,190,340,449,409,1317,881,1120,786,6096
Siwan,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,77,26,26,95,51,98,79,94,265,179,227,146,1363
Siwan,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,20,24,15,13,18,24,36,28,60,64,82,58,442
Siwan,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Siwan,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,256,121,94,429,259,462,564,531,1642,1124,1429,990,7901
Siwan,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,147,127,2,18,14,1077,861,2042,298,291,142,113,5132
Siwan,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,7,12,5,4,4,0,5,4,10,13,10,12,86
Siwan,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0,1,0,2,1,2,0,0,3,0,0,0,9
Siwan,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0,0,0,0,1,0,1,0,4,6,2,3,17
Siwan,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Siwan,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,7,13,5,6,6,2,6,4,17,19,12,15,112
Siwan,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0,0,NA,0,0,0,0,0,0,0,0,0,0
Siwan,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,1707,1637,1676,2145,1804,2132,1956,1879,1923,1875,2091,1968,22793
Siwan,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,299,282,303,536,323,453,411,385,587,555,538,553,5225
Siwan,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,24,16,14,177,127,90,105,72,113,140,190,136,1204
Siwan,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,35,46,45,51,74,133,160,162,178,165,175,166,1390
Siwan,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Siwan,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,2065,1981,2038,2909,2328,2808,2632,2498,2801,2735,2994,2823,30612
Siwan,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,62,94,93,243,224,221,209,131,208,240,329,304,2358
Siwan,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,5,2,1,2,1,426,113,857,4,4,2,2,1419
Siwan,9.06,Number of IUCD removals,TOTAL,599,543,583,661,715,674,687,675,668,623,665,676,7769
Siwan,9.07,Number of Oral Pills cycles distributed,TOTAL,3511,3581,4245,5227,4530,8317,5504,5391,5862,5877,6276,7004,65325
Siwan,9.08,Number of Condom pieces distributed,TOTAL,34534,33052,33591,44951,40963,42716,39696,40255,42490,47494,49984,62231,511957
Siwan,9.09,Number of Centchroman (weekly) pills given,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Siwan,9.1,Number of Emergency Contraceptive Pills distributed,TOTAL,1523,1465,1480,1802,1729,1536,1579,1283,1356,1568,1530,1671,18522
Siwan,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Siwan,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Siwan,9.11.2.a,Number of failures following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Siwan,9.11.2.b,Number of failures following female sterilization,TOTAL,1,0,0,0,0,0,0,0,0,0,0,0,1
Siwan,9.11.3.a,Number of deaths following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Siwan,9.11.3.b,Number of deaths following female sterilization,TOTAL,0,0,0,0,0,1,0,0,0,0,0,0,1
Siwan,9.12,Number of Institutions having NSV trained doctors,TOTAL,NA,NA,NA,1,1,1,5,4,5,5,4,5,Data for this item can not be cumulated
Siwan,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,4516,4731,4558,6679,7429,7733,7216,6771,7114,7062,7180,6580,77569
Siwan,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,18,25,22,37,3,7,0,0,0,0,0,0,112
Siwan,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,590,279,236,203,82,37,13,17,12,5,2,0,1476
Siwan,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,2123,1005,700,564,248,94,42,50,31,10,4,6,4877
Siwan,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,6422,5769,5574,5849,5899,7099,7822,7298,7435,7288,7117,7595,81167
Siwan,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,5987,6048,5760,5958,5772,6145,6739,7208,7431,7070,7012,7651,78781
Siwan,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,4905,5649,6047,6147,5865,6096,6269,6392,7088,7089,7043,7751,76341
Siwan,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,2894,3146,2773,4390,5167,5092,4682,4767,4687,4955,4958,4596,52107
Siwan,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,6188,5830,5514,5737,5772,7102,7775,7247,7260,7262,7068,7592,80347
Siwan,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,6282,6212,5870,5979,5678,6189,6664,7128,7133,7030,7021,7760,78946
Siwan,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,6584,6524,6485,6524,5960,6206,6421,6406,7070,7090,7017,7739,80026
Siwan,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,1884,2147,1880,3328,3834,3554,3278,3590,3451,3523,3307,3118,36894
Siwan,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,231,86,62,20,16,22,30,0,38,0,0,0,505
Siwan,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,804,354,276,190,85,49,42,20,17,4,1,0,1842
Siwan,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,2295,1060,733,534,260,114,65,37,28,12,2,0,5140
Siwan,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,5989,7281,7734,8047,6625,7917,7329,5964,5933,6406,4931,6990,81146
Siwan,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,5487,5950,6923,7086,5772,6671,6131,5147,5618,6344,5180,7269,73578
Siwan,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,6136,7102,5406,7412,6728,7555,6828,5879,6091,6167,5391,6812,77507
Siwan,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,3095,3828,4005,4220,3467,4094,3809,3053,3065,3307,2603,3630,42176
Siwan,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2776,3378,3579,3765,3089,3614,3410,2722,2730,2989,2262,3292,37606
Siwan,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,5871,7206,7584,7985,6556,7708,7219,5775,5795,6296,4865,6922,79782
Siwan,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,6299,5946,7084,7200,5887,6377,6023,5407,6375,6433,6883,7083,76997
Siwan,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,6266,5959,7087,7197,5864,6342,6011,5387,6271,6416,6839,7302,76941
Siwan,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Siwan,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,920,996,1212,1188,1025,834,851,764,894,986,989,1102,11761
Siwan,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,758,902,1077,1122,963,783,813,720,840,946,915,975,10814
Siwan,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,1678,1898,2289,2310,1988,1617,1664,1484,1734,1932,1904,2077,22575
Siwan,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,2629,2754,2641,2889,2655,3105,3594,3208,3485,3134,3432,3621,37147
Siwan,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,2120,2123,2200,2240,1911,2463,2503,2240,2378,2336,2546,2576,27636
Siwan,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,3258,3151,3099,3462,3104,3646,3723,3369,3752,3586,3809,3812,41771
Siwan,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,200,188,199,232,305,267,228,292,270,234,228,185,2828
Siwan,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Siwan,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,742,702,887,924,996,1038,898,922,910,759,786,845,10409
Siwan,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,3900,3767,3698,4153,3697,3912,3747,3501,3707,3746,3525,3694,45047
Siwan,10.4.2,Number of Immunisation sessions held during the month,TOTAL,3829,3646,3691,4047,3631,3867,3678,3384,3624,3620,3454,3668,44139
Siwan,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,3185,3109,3087,3489,3131,3324,3183,2907,3180,3131,3042,3166,37934
Siwan,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,5919,5713,4938,6595,5888,6397,5926,5309,6096,6242,6457,7091,72571
Siwan,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,5099,6245,6056,6178,5221,5709,5102,4104,3990,3564,2565,3017,56850
Siwan,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,1965,2086,1893,2290,1796,1648,1548,1325,1216,1094,833,823,18517
Siwan,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,847,996,867,1166,908,1113,982,849,900,754,506,494,10382
Siwan,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Siwan,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Siwan,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Siwan,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Siwan,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Siwan,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,2,0,0,0,0,0,0,0,0,0,0,0,2
Siwan,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,1778,2008,1900,3825,1992,2095,1999,1739,1716,1524,1557,1533,23666
Siwan,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Siwan,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,31,0,27,0,24,0,27,0,0,0,0,0,109
Siwan,13.1,Number of Patients operated for cataract,TOTAL,258,241,256,532,206,168,160,330,782,460,572,423,4388
Siwan,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,258,241,256,532,206,168,160,330,782,460,572,423,4388
Siwan,13.3,Number of School children detected with Refractive errors,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Siwan,13.4,Number of children provided free glasses,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Siwan,13.5,Number of eyes collected through eye donation,TOTAL,0,0,0,NA,NA,0,0,0,0,0,0,0,0
Siwan,13.6,Number of eyes utilised for corneal transplant,TOTAL,0,0,0,NA,NA,0,0,0,0,0,0,0,0
Siwan,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,NA,NA,1,1,1,1,3,3,3,3,3,3,Data for this item can not be cumulated
Siwan,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,NA,NA,NA,NA,NA,NA,12,16,14,15,14,15,Data for this item can not be cumulated
Siwan,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,2272,2263,2160,2213,2204,2226,2192,2250,2375,2386,2426,2435,Data for this item can not be cumulated
Siwan,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,NA,NA,1,1,1,1,4,4,4,4,4,4,Data for this item can not be cumulated
Siwan,14.05,Number of RKS meetings held during the month,TOTAL,15,17,11,13,11,10,11,9,10,10,12,11,140
Siwan,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,NA,NA,1,1,1,1,14,13,13,15,14,14,Data for this item can not be cumulated
Siwan,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,1071,1155,988,1303,1588,1187,1867,1726,1667,1669,1764,1586,17571
Siwan,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,NA,NA,NA,1,1,1,3,3,3,3,3,3,Data for this item can not be cumulated
Siwan,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,NA,1,NA,1,1,1,0,0,0,0,0,0,Data for this item can not be cumulated
Siwan,14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Siwan,14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Siwan,14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Siwan,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,1493,1195,1209,1201,1111,1294,1408,1639,1512,1593,1574,1409,16638
Siwan,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,1531,1803,1429,1583,1506,1720,1859,2682,3029,3383,3728,3543,27796
Siwan,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,981,1017,988,1242,1264,1553,1387,1506,1572,1537,1564,1666,16277
Siwan,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,3286,3939,3555,4544,5196,4988,4893,5926,6184,5321,5245,4929,58006
Siwan,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,2474,2212,2197,2443,2375,2847,2795,3145,3084,3130,3138,3075,32915
Siwan,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,4817,5742,4984,6127,6702,6708,6752,8608,9213,8704,8973,8472,85802
Siwan,14.10.2.a,Number of death cases of Inpatient males,TOTAL,5,1,4,5,3,4,4,0,4,4,8,3,45
Siwan,14.10.2.b,Number of death cases of Inpatient females,TOTAL,8,1,1,3,5,1,1,1,1,1,4,2,29
Siwan,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,13,2,5,8,8,5,5,1,5,5,12,5,74
Siwan,14.11,In-Patient Head Count at midnight,TOTAL,5922,6302,5940,7068,7259,8228,8473,10019,10818,10103,10418,10332,100882
Siwan,14.12.1,OPD attendance (All),TOTAL,178689,168081,172866,165852,180668,199851,202872,186685,196742,193470,194856,199507,2240139
Siwan,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,152,100,68,257,165,339,329,349,855,643,852,565,4674
Siwan,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Siwan,14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Siwan,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,1523,1698,1614,1755,1484,1814,2042,1892,2331,2249,2088,2232,22722
Siwan,14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Siwan,14.14.a,Number of patients given AYUSH treatment,TOTAL,27981,24629,24376,26245,27138,31626,31358,34336,32625,34364,34348,33952,362978
Siwan,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,2438,2599,2504,1961,2511,3627,2863,2790,2282,2594,2951,2811,31931
Siwan,14.14.c,Number of Adolescents counselled,TOTAL,350,375,327,381,206,576,325,460,345,350,527,468,4690
Siwan,15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Siwan,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,3257,2685,2908,3062,3278,3843,3530,2620,3434,2875,2910,2978,37380
Siwan,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,15,15,12,23,26,64,44,21,38,22,22,44,346
Siwan,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,86,113,148,150,91,88,136,408,251,120,226,149,1966
Siwan,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,19,17,20,21,12,19,16,17,14,16,17,17,205
Siwan,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,187,150,199,304,277,461,280,700,850,681,990,837,5916
Siwan,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,10,12,15,10,13,14,134,8,13,10,15,7,261
Siwan,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,37,104,506,282,454,604,602,475,538,676,1194,1054,6526
Siwan,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0,0,1,1,1,1,5,3,2,1,0,3,18
Siwan,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,310,367,853,736,822,1153,1018,1583,1639,1477,2410,2040,14408
Siwan,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,29,29,36,32,26,34,155,28,29,27,32,27,484
Siwan,15.2,Number of Widal tests conducted,Number tested,0,0,0,0,0,0,0,0,0,0,0,0,0
Siwan,15.3.a,Number of VDRL tests conducted on males,Number tested,48,66,42,61,49,45,57,77,60,38,61,59,663
Siwan,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,137,159,208,194,230,210,205,250,200,217,209,195,2414
Siwan,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,85,45,150,200,415,584,504,443,508,629,757,712,5032
Siwan,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,270,270,400,455,694,839,766,770,768,884,1027,966,8109
Siwan,15.4.1,Number of blood smears examined for Malaria,TOTAL,872,1005,892,856,845,883,994,959,983,929,903,919,11040
Siwan,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Siwan,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Siwan,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,750,800,1250,150,1000,650,700,150,400,750,750,1100,8450
Siwan,16.1.1,Stock position of DPT vaccines,2. Stocks Received,1000,1500,1000,1500,500,1000,0,1000,1500,500,500,1000,11000
Siwan,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,800,1200,1400,650,550,700,50,250,750,400,400,700,7850
Siwan,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,950,1100,850,1000,950,950,650,900,1150,850,850,1400,11600
Siwan,16.1.1,Stock position of DPT vaccines,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Siwan,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,1600,4400,1900,850,2294,1200,1475,827,655,400,400,1801,17802
Siwan,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,4000,0,1000,3744,0,2212,1152,1128,2352,2016,2016,2016,21636
Siwan,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,4400,1900,1150,1700,1200,1475,677,405,300,700,700,1850,16457
Siwan,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,1200,2500,1750,2894,1094,1937,1950,1550,2707,1716,1716,1967,22981
Siwan,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Siwan,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,1250,650,500,700,675,725,750,425,75,25,25,25,5825
Siwan,16.1.2,Stock position of OPV vaccines,2. Stocks Received,1000,2000,3000,3000,2500,2700,1500,1000,2500,2000,2000,2675,25875
Siwan,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,650,500,1275,400,725,750,275,25,0,200,200,1550,6550
Siwan,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,1600,2150,2225,3300,2450,2675,1975,1400,2575,1825,1825,1150,25150
Siwan,16.1.2,Stock position of OPV vaccines,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Siwan,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,550,750,500,0,550,500,1050,1400,1450,850,850,800,9250
Siwan,16.1.3,Stock position of TT vaccines,2. Stocks Received,2000,2000,2000,3000,2700,3500,2000,2000,3000,1750,1750,2500,28200
Siwan,16.1.3,Stock position of TT vaccines,3. Unusable Stock,750,500,300,600,350,1050,1200,1150,850,550,550,1400,9250
Siwan,16.1.3,Stock position of TT vaccines,4. Stock Distributed,1800,2250,2200,2400,2900,2950,1850,2250,3600,2050,2050,1900,28200
Siwan,16.1.3,Stock position of TT vaccines,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Siwan,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Siwan,16.1.4,Stock position of DT vaccines,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Siwan,16.1.4,Stock position of DT vaccines,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Siwan,16.1.4,Stock position of DT vaccines,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Siwan,16.1.4,Stock position of DT vaccines,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Siwan,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,750,1250,1550,2200,2550,1250,1300,750,350,300,300,750,13300
Siwan,16.1.5,Stock position of BCG vaccines,2. Stocks Received,1500,2000,2500,2500,500,2000,1000,1000,1500,2200,2200,2500,21400
Siwan,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,1250,1550,2450,1500,1150,1300,600,200,250,500,500,1600,12850
Siwan,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,1000,1700,1600,3200,1900,1950,1700,1550,1600,2000,2000,1650,21850
Siwan,16.1.5,Stock position of BCG vaccines,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Siwan,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,200,0,200,200,350,730,400,350,420,50,50,400,3350
Siwan,16.1.6,Stock position of Measles vaccines,2. Stocks Received,4000,2000,4000,4000,3500,4200,2000,2300,2500,3000,3000,3000,37500
Siwan,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,2000,200,550,500,580,400,200,50,50,150,150,1300,6130
Siwan,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,2200,1800,3650,3700,3270,4530,2200,2600,2870,2900,2900,2100,34720
Siwan,16.1.6,Stock position of Measles vaccines,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Siwan,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,750,100,350,0,200,630,1300,1100,400,700,700,1400,7630
Siwan,16.1.7,Stock position of JE vaccines,2. Stocks Received,3200,2000,1000,2000,3500,4500,2500,2000,4500,3000,3000,3000,34200
Siwan,16.1.7,Stock position of JE vaccines,3. Unusable Stock,1900,350,0,500,680,1300,900,100,700,1050,1050,1500,10030
Siwan,16.1.7,Stock position of JE vaccines,4. Stock Distributed,2050,1750,1350,1500,3020,3830,2900,3000,4200,2650,2650,2900,31800
Siwan,16.1.7,Stock position of JE vaccines,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Siwan,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,1350,1550,700,1100,800,800,650,1050,1000,300,300,950,10550
Siwan,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,1000,0,1000,500,500,1000,500,0,0,0,0,0,4500
Siwan,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,1550,500,1150,1050,800,1150,1000,600,300,0,0,750,8850
Siwan,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,800,1050,550,550,500,650,150,450,700,300,300,200,6200
Siwan,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Siwan,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,800,800,4720,4720,3350,3350,2250,2250,2250,11621,8881,2721,47713
Siwan,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0,24720,0,0,0,0,0,0,10421,0,0,0,35141
Siwan,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,800,4720,4720,1370,3350,2250,2250,2250,11621,8881,2721,2000,46933
Siwan,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,0,20800,0,3350,0,1100,0,0,1050,2740,6160,721,35921
Siwan,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Siwan,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,20760,0,94809,94809,50400,50400,35280,35280,35280,192646,137646,41566,788876
Siwan,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0,276249,0,0,0,0,0,0,174646,0,0,0,450895
Siwan,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,1500,94809,94809,38824,50400,35280,35280,35280,192646,137646,40846,34420,791740
Siwan,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,19260,181440,0,55985,0,15120,0,0,17280,55000,96800,7146,448031
Siwan,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Siwan,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0,0,19617,19617,14017,9517,6517,6517,5517,14912,10832,4012,111075
Siwan,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0,42192,0,0,0,0,0,0,11912,0,0,0,54104
Siwan,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0,19657,19617,5100,8017,6517,6517,5517,14912,10832,4012,2900,103598
Siwan,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0,22575,0,14517,6000,3000,0,1000,2517,4080,6820,1112,61621
Siwan,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0,-40,0,0,0,0,0,0,0,0,0,0,-40
Siwan,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,2660,0,10212,10212,7062,7062,5462,5462,5262,16238,12958,4488,87078
Siwan,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0,26232,0,0,0,0,0,0,13326,0,0,0,39558
Siwan,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0,10212,10212,2650,7062,5462,5462,5262,16238,12956,4488,3744,83748
Siwan,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,2660,16020,0,7562,0,1600,0,200,2350,3282,8470,744,42888
Siwan,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Siwan,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,0,0,0,0,0,0,0,0,0,0,0,0,0
Siwan,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0,0,0,0,0,0,0,0,0,0,0,0,0
Siwan,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Siwan,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0,0,0,0,0,0,0,0,0,0,0,0,0
Siwan,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Siwan,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,300,300,100,0,0,0,0,0,0,0,0,3400,4100
Siwan,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0,0,0,0,0,0,0,0,0,0,5000,0,5000
Siwan,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,100,200,100,0,0,0,0,0,0,0,3400,510,4310
Siwan,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,200,100,0,0,0,0,0,0,0,0,1600,2890,4790
Siwan,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Siwan,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,25000,18000,8500,7500,5000,0,10550,5050,300,0,0,19500,99400
Siwan,16.3.02,Stock Position of Gloves,2. Stocks Received,0,0,0,0,20000,20000,0,0,0,0,30000,20000,90000
Siwan,16.3.02,Stock Position of Gloves,3. Unusable Stock,17500,9000,6500,5000,23500,10550,5050,300,0,0,19500,8475,105375
Siwan,16.3.02,Stock Position of Gloves,4. Stock Distributed,7500,9000,2000,2500,1500,9450,5500,4750,300,0,10500,31025,84025
Siwan,16.3.02,Stock Position of Gloves,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Siwan,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0,0,0,0,0,0,0,0,0,0,0,0,0
Siwan,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0,0,0,0,0,0,0,0,0,0,0,0,0
Siwan,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Siwan,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0,0,0,0,0,0,0,0,0,0,0,0,0
Siwan,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Siwan,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,31000,21000,12000,10000,0,0,0,0,0,0,0,145800,219800
Siwan,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0,0,0,0,0,0,0,0,0,0,145800,54150,199950
Siwan,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,20000,17000,12000,0,0,0,0,0,0,0,145800,102400,297200
Siwan,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,11000,4000,0,10000,0,0,0,0,0,0,0,97550,122550
Siwan,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Siwan,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0,0,0,0,0,0,0,0,0,0,0,0,0
Siwan,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0,0,0,0,0,0,0,0,0,0,0,0,0
Siwan,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Siwan,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0,0,0,0,0,0,0,0,0,0,0,0,0
Siwan,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Siwan,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0,0,0,0,0,0,0,0,0,0,0,0,0
Siwan,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0,0,0,0,0,0,0,0,0,0,0,0,0
Siwan,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Siwan,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0,0,0,0,0,0,0,0,0,0,0,0,0
Siwan,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Siwan,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,399700,149700,19000,0,0,621000,112000,0,0,959200,379200,2000200,4640000
Siwan,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0,0,0,1000000,1000000,0,0,0,1000000,0,2000200,900800,5901000
Siwan,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,188900,0,0,1000000,621000,112000,0,0,959200,379200,2000200,1912800,7173300
Siwan,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,210800,149700,19000,0,379000,509000,112000,0,40800,580000,379200,1087200,3466700
Siwan,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,-99000,-99000
Siwan,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0,0,0,0,0,0,0,0,0,0,0,0,0
Siwan,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0,0,0,0,0,0,0,0,0,0,0,0,0
Siwan,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0,0,0,NA,0,0,0,0,0,0,0,0,0
Siwan,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0,0,0,NA,0,0,0,0,0,0,0,0,0
Siwan,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Siwan,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,1500,900,400,NA,0,0,9500,100000,9500,9500,10000,9500,150800
Siwan,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0,0,0,NA,10000,0,0,0,0,0,0,0,10000
Siwan,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,900,0,400,NA,10000,0,9500,60000,9500,9500,9500,500,109800
Siwan,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,600,900,0,NA,0,0,0,40000,0,0,500,9500,51500
Siwan,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,-500,-500
Siwan,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,100,54,54,NA,12,12,0,0,0,0,0,0,232
Siwan,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0,0,0,NA,0,0,0,0,0,0,0,0,0
Siwan,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,44,54,34,NA,12,0,0,0,0,0,0,0,144
Siwan,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,56,0,20,NA,0,12,0,0,0,0,0,0,88
Siwan,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Siwan,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,72468,0,0,NA,84246,71246,49246,40846,30846,25346,24846,24346,423436
Siwan,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0,0,0,NA,0,0,0,0,0,0,0,0,0
Siwan,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,58668,0,0,NA,71246,49246,35846,30846,25346,24346,23846,14746,334136
Siwan,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,13800,0,0,NA,13000,22000,13400,10000,5500,1000,1000,9600,89300
Siwan,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Siwan,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,6800,1600,4800,200,10200,1700,9700,4400,25300,13000,13000,15700,106400
Siwan,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0,10000,10000,10000,0,20000,0,26000,0,0,0,0,76000
Siwan,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,1600,4800,9500,5600,1600,9600,3900,24300,13000,6300,6300,7500,94000
Siwan,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,5200,6800,5300,4600,8600,12100,5800,6100,12300,6700,6700,8200,88400
Siwan,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Siwan,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,65400,16400,52800,18000,108000,27000,84000,400,141000,42200,42200,74600,672000
Siwan,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0,100000,150000,90000,0,150000,0,150000,0,0,0,0,640000
Siwan,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,16400,52800,147600,73600,25000,83800,29000,130600,42000,8000,8000,18200,635000
Siwan,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,49000,63600,55200,34400,83000,93200,55000,19800,99000,34200,34200,56400,677000
Siwan,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Siwan,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,9700,1900,5400,400,10400,2400,3400,0,19300,10200,10200,14400,87700
Siwan,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0,10000,10000,10000,0,10000,0,20000,0,0,0,0,60000
Siwan,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,1900,5400,10200,6900,2200,3400,0,18400,10200,4700,4700,8600,76600
Siwan,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,7800,6500,5200,3500,8200,9000,3400,1600,10200,5500,5500,5800,72200
Siwan,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0,0,0,0,0,0,0,0,-1100,0,0,0,-1100
Siwan,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,NA,NA,NA,NA,NA,NA,7,2,NA,9,11,9,38
Siwan,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Siwan,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,2,NA,NA,NA,2
Siwan,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,2,NA,NA,NA,2
Siwan,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,1
Siwan,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Siwan,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,1
Siwan,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,1
Siwan,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,2
Siwan,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,2,3
Siwan,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,34,31,54,19,NA,1,139
Siwan,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,1,NA,2
Siwan,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,NA,NA,NA,NA,NA,NA,35,31,54,19,1,1,141
Siwan,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Siwan,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Siwan,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Siwan,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Siwan,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Siwan,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Siwan,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,1
Siwan,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Siwan,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,1
Siwan,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Siwan,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Siwan,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Siwan,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,1,1,1,1,4
Siwan,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,1
Siwan,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,NA,NA,NA,NA,NA,NA,1,NA,1,1,1,1,5
Siwan,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Siwan,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Siwan,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,2,NA,NA,NA,NA,2
Siwan,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,NA,NA,NA,NA,NA,NA,NA,2,NA,NA,NA,NA,2
Siwan,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Siwan,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Siwan,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,1,1,NA,NA,2
Siwan,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,1,1,NA,NA,2
Siwan,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Siwan,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,2
Siwan,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,2,NA,NA,4,6
Siwan,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,2,NA,NA,6,8
Siwan,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Siwan,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Siwan,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Siwan,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Siwan,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,1
Siwan,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,2,1,NA,1,1,5
Siwan,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,1,2,1,8,3,2,17
Siwan,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,NA,NA,NA,NA,NA,NA,1,4,2,8,5,3,23
Siwan,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Siwan,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,NA,2
Siwan,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Siwan,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,NA,2
Siwan,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Siwan,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,1,5,3,3,1,13
Siwan,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,1,2,NA,3,4,1,11
Siwan,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,NA,NA,NA,NA,NA,NA,1,3,5,6,7,2,24
Siwan,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Siwan,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Siwan,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Siwan,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Siwan,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Siwan,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,1
Siwan,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Siwan,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,1
Siwan,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Siwan,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,1
Siwan,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Siwan,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,1
Siwan,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Siwan,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,1
Siwan,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Siwan,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,1
Siwan,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Siwan,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,1,NA,NA,1,1,NA,3
Siwan,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Siwan,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,NA,NA,NA,NA,NA,NA,1,NA,NA,1,1,NA,3
Siwan,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Siwan,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Siwan,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Siwan,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Siwan,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Siwan,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Siwan,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Siwan,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Siwan,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Siwan,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,1,1,2,1,NA,6,11
Siwan,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,1,2
Siwan,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,NA,NA,NA,NA,NA,NA,1,1,2,2,NA,7,13
Siwan,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1
Siwan,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Siwan,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Siwan,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1
Siwan,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Siwan,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,1,NA,1,NA,NA,NA,2
Siwan,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,1,1,NA,NA,NA,NA,2
Siwan,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,NA,NA,NA,NA,NA,NA,2,1,1,NA,NA,NA,4
Siwan,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Siwan,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,1
Siwan,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Siwan,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,1
Siwan,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Siwan,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,2,NA,NA,NA,2
Siwan,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,1,NA,NA,2,NA,1,4
Siwan,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,NA,NA,NA,NA,NA,NA,1,NA,2,2,NA,1,6
Siwan,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1,1,3
Siwan,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,22,15,11,10,9,10,77
Siwan,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,44,40,73,66,51,50,324
Siwan,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,NA,NA,NA,NA,NA,NA,66,55,84,77,61,61,404
Supaul,1.1,Total number of pregnant women Registered for ANC,TOTAL,6999,7754,6570,5721,5287,4480,4800,3666,4551,4529,5141,5874,65372
Supaul,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,3362,3532,3007,2758,2482,2086,2225,1778,2114,2145,2722,3076,31287
Supaul,1.2,Number of Pregnant women registered under JSY,TOTAL,6999,7754,6570,5721,5287,4480,4781,3656,4551,4529,5141,5874,65343
Supaul,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,2966,3563,3196,3515,3471,3272,3124,2800,2932,3035,2856,2964,37694
Supaul,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,3844,4220,3712,3050,2758,2440,2437,1922,2336,2379,2650,3091,34839
Supaul,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,5851,7203,6100,6001,5085,4074,4225,3512,3827,4124,4195,4922,59119
Supaul,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,3279,3005,982,582,998,589,563,438,518,1209,1418,1260,14841
Supaul,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,90,119,9,125,93,112,114,39,56,107,180,199,1243
Supaul,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0,7,0,3,1,1,7,5,5,6,3,3,41
Supaul,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,1965,2208,1999,2039,1770,1555,1618,1221,1608,1500,1564,1496,20543
Supaul,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,7,6,5,6,6,6,5,5,6,5,7,9,73
Supaul,1.8,Number of pregnancy test kits used at SC level,TOTAL,122,221,213,341,312,309,366,296,304,380,401,366,3631
Supaul,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,44,36,67,71,97,92,124,88,155,81,70,84,1009
Supaul,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,490,487,526,551,606,699,933,783,998,709,603,526,7911
Supaul,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,534,523,593,622,703,791,1057,871,1153,790,673,610,8920
Supaul,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,225,219,279,235,259,255,391,326,410,379,293,234,3505
Supaul,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0,0,0,0,0,0,0,0,0,8,0,0,8
Supaul,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,2487,2638,2785,3543,4519,5377,5819,5134,4222,3512,3116,2922,46074
Supaul,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,2445,2318,2355,3195,4014,4748,5110,4161,3590,2996,2712,2462,40106
Supaul,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1317,1403,486,989,516,2338,2494,971,1281,3423,2474,2722,20414
Supaul,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,726,214,327,305,457,570,1906,558,322,586,1795,2368,10134
Supaul,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0,0,0,0,0,1,0,0,0,0,0,0,1
Supaul,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,NA,NA,NA,NA,0,NA,102,114,56,78,56,44,450
Supaul,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,NA,NA,NA,NA,0,NA,0,0,0,0,0,0,0
Supaul,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,NA,NA,NA,NA,0,NA,0,0,0,0,0,0,0
Supaul,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,NA,NA,NA,NA,0,NA,0,0,0,0,0,0,0
Supaul,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Supaul,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,3,10,4,6,2,0,2,2,3,3,7,3,45
Supaul,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,18,10,19,16,15,19,18,19,16,8,10,23,191
Supaul,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,21,20,23,22,17,19,20,21,19,11,17,26,236
Supaul,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,NA,NA,NA,NA,0,NA,16,12,13,8,7,8,64
Supaul,4.1.1.a,Number of male live births,TOTAL,1487,1623,1681,2154,2645,3145,3462,2894,2768,2170,2016,1834,27879
Supaul,4.1.1.b,Number of female live births,TOTAL,1496,1512,1665,1984,2526,2984,3412,2808,2609,2148,1815,1680,26639
Supaul,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,2983,3135,3346,4138,5171,6129,6874,5702,5377,4318,3831,3514,54518
Supaul,4.1.2,Number of still births,TOTAL,47,50,54,52,79,74,89,76,69,60,34,57,741
Supaul,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,14,5,4,7,8,7,10,7,4,4,5,6,81
Supaul,4.2.1,Number of Newborns weighed at birth,TOTAL,2888,3030,3245,4056,5022,6046,6652,5512,5226,4163,3703,3425,52968
Supaul,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,161,185,180,228,227,373,592,397,381,258,240,231,3453
Supaul,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,2894,2941,3294,4047,5030,6043,6597,5518,5180,4140,3669,3400,52753
Supaul,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,9,10,211,9,11,13,14,15,11,16,14,13,346
Supaul,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,11,25,20,30,30,25,10,5,12,12,9,12,201
Supaul,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,18,10,19,16,15,19,18,NA,0,0,0,0,115
Supaul,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,38,45,250,55,56,57,42,20,23,28,23,25,662
Supaul,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,NA,NA,NA,NA,0,NA,2,0,0,0,0,0,2
Supaul,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,23,29,35,56,52,53,41,20,25,27,27,22,410
Supaul,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0,0,3,0,1,1,1,1,0,1,1,1,10
Supaul,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,16,30,32,37,38,36,16,11,16,20,12,16,280
Supaul,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,11,6,8,10,4,12,13,0,4,2,0,0,70
Supaul,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1167,1229,1256,1544,2372,2959,3267,2840,2574,2208,1919,1834,25169
Supaul,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,550,450,525,620,864,947,1506,1197,1359,999,935,852,10804
Supaul,6.3,PNC maternal complications attended,TOTAL,14,11,15,7,5,30,5,4,3,4,15,4,117
Supaul,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Supaul,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Supaul,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Supaul,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Supaul,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,88,67,72,114,105,110,115,76,52,56,62,63,980
Supaul,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,220,260,186,118,175,157,149,115,76,116,121,125,1818
Supaul,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,308,327,258,232,280,267,264,191,128,172,183,188,2798
Supaul,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Supaul,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,25,41,27,65,36,12,1,3,1,0,0,0,211
Supaul,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,3,1,0,0,0,0,0,0,0,0,0,0,4
Supaul,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0,1,1,1,0,1,2,1,0,1,1,1,10
Supaul,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,28,43,28,66,36,13,3,4,1,1,1,1,225
Supaul,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0
Supaul,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Supaul,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Supaul,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Supaul,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Supaul,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0
Supaul,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,64,71,29,509,226,465,479,477,2214,1634,1040,626,7834
Supaul,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,50,63,23,133,73,239,194,169,515,721,515,199,2894
Supaul,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,53,74,42,81,100,124,120,117,268,221,273,125,1598
Supaul,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,167,208,94,723,399,828,793,763,2997,2576,1828,950,12326
Supaul,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,NA,NA,NA,NA,0,0,0,0,0,32,72,129,233
Supaul,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,1,0,0,3,2,4,1,3,8,10,4,5,41
Supaul,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,11,18,11,19,13,15,12,7,11,9,15,12,153
Supaul,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0,0,0,0,0,14,25,31,18,16,19,17,140
Supaul,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,12,18,11,22,15,33,38,41,37,35,38,34,334
Supaul,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0
Supaul,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,231,235,228,430,298,289,329,259,388,312,342,343,3684
Supaul,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,69,87,46,236,160,137,152,86,248,108,188,206,1723
Supaul,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,2,1,4,3,2,4,0,2,163,1,0,50,232
Supaul,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,50,49,46,41,16,27,21,26,31,23,25,17,372
Supaul,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,352,372,324,710,476,457,502,373,830,444,555,616,6011
Supaul,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,161,127,181,223,229,176,174,114,183,144,213,292,2217
Supaul,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,NA,NA,NA,NA,0,0,0,0,0,0,5,26,31
Supaul,9.06,Number of IUCD removals,TOTAL,146,123,124,343,130,128,143,123,157,152,161,251,1981
Supaul,9.07,Number of Oral Pills cycles distributed,TOTAL,452,839,616,1354,1252,1472,1692,1308,1596,1399,1252,1205,14437
Supaul,9.08,Number of Condom pieces distributed,TOTAL,4213,6862,6080,8664,7233,7728,7381,7383,8938,7870,8713,7269,88334
Supaul,9.09,Number of Centchroman (weekly) pills given,TOTAL,0,9,204,93,0,6,0,7,7,0,17,14,357
Supaul,9.1,Number of Emergency Contraceptive Pills distributed,TOTAL,143,221,409,276,282,219,210,213,217,230,285,236,2941
Supaul,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,3,3
Supaul,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,1,1,2
Supaul,9.11.2.a,Number of failures following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Supaul,9.11.2.b,Number of failures following female sterilization,TOTAL,0,0,0,0,0,0,0,0,0,1,0,0,1
Supaul,9.11.3.a,Number of deaths following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Supaul,9.11.3.b,Number of deaths following female sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Supaul,9.12,Number of Institutions having NSV trained doctors,TOTAL,NA,NA,1,NA,2,1,1,2,1,1,1,2,Data for this item can not be cumulated
Supaul,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,3760,3907,3841,4866,5845,7223,8136,7148,6941,5414,4892,4183,66156
Supaul,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,43,136,68,21,5,2,3,2,2,3,4,2,291
Supaul,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,759,543,289,224,132,83,69,37,27,20,8,11,2202
Supaul,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,2294,1699,856,750,401,274,196,96,107,61,58,22,6814
Supaul,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,4096,3709,3352,3606,3873,4282,5800,6268,7795,7076,5316,5092,60265
Supaul,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,4317,4772,3453,3624,3795,3631,4036,4347,5992,7026,5854,5687,56534
Supaul,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,3288,4572,3737,3543,3786,3695,3768,3343,4290,5309,5446,5896,50673
Supaul,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,2562,2768,2703,3627,4609,5766,6190,5398,4858,3808,3475,3142,48906
Supaul,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,4447,4025,3378,3632,3877,4346,5754,6275,7784,7031,5293,4834,60676
Supaul,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,5276,5495,3870,3943,3944,3773,4137,4405,5977,7040,5862,5535,59257
Supaul,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,5450,6345,4814,4510,4297,4105,4045,3429,4416,5289,5538,5734,57972
Supaul,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,2204,2478,2446,3178,4006,5189,5438,4544,3960,3259,3083,2698,42483
Supaul,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,103,77,34,30,0,0,8,1,1,1,1,6,262
Supaul,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,802,530,332,256,135,80,70,29,25,11,4,14,2288
Supaul,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,2356,1711,1048,772,448,317,194,100,103,36,20,25,7130
Supaul,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,3434,4525,5545,6338,6535,5893,6166,3840,4370,3716,3870,4052,58284
Supaul,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,4922,5513,4664,4767,3887,3721,4085,2933,3985,4512,5602,5829,54420
Supaul,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Supaul,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1723,2261,2656,3085,3207,2970,2951,1896,2191,1896,1864,2039,28739
Supaul,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1575,2168,2468,2895,3068,2761,2918,1826,2031,1728,1938,1966,27342
Supaul,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,3298,4429,5124,5980,6275,5731,5869,3722,4222,3624,3802,4005,56081
Supaul,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,5354,5450,5131,4721,3871,3717,4156,2937,3976,4486,5518,5812,55129
Supaul,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,5384,5469,5181,4738,3895,3733,4164,2956,3985,4448,5512,5706,55171
Supaul,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,635,201,244,168,120,209,208,106,126,141,438,0,2596
Supaul,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,535,292,313,431,262,296,310,313,339,240,310,369,4010
Supaul,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,544,257,311,388,223,303,271,325,318,223,263,393,3819
Supaul,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,1079,549,624,819,485,599,581,638,657,463,573,762,7829
Supaul,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,76,26,37,27,10,330,1196,1083,1446,2286,1745,1207,9469
Supaul,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,471,427,437,516,438,432,566,782,822,1173,1027,874,7965
Supaul,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1066,956,1034,1183,1080,1040,1307,1277,1477,1986,1925,1752,16083
Supaul,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,4,0,0,1,1,0,0,0,0,0,17,19,42
Supaul,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Supaul,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,1,0,0,0,0,0,0,0,0,0,0,23,24
Supaul,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1810,1904,1792,1934,1942,1932,1928,1932,1929,1934,1902,1887,22826
Supaul,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1789,1840,1716,1876,1881,1870,1877,1765,1895,1866,1766,1775,21916
Supaul,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1619,1718,1579,1773,1782,1746,1744,1643,1779,1757,1693,1717,20550
Supaul,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Supaul,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,3093,3955,4768,4468,4462,3715,2762,1552,1988,1662,1503,1426,35354
Supaul,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,550,638,389,291,409,399,220,78,22,31,0,0,3027
Supaul,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,52,35,64,85,69,66,0,16,0,28,11,0,426
Supaul,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Supaul,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Supaul,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Supaul,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Supaul,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Supaul,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,2,2,0,9,0,0,0,0,5,0,40,2,60
Supaul,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,1858,1644,2052,1583,1596,1380,1502,1353,1423,1292,541,527,16751
Supaul,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0,0,0,0,1,0,0,1,0,0,0,0,2
Supaul,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0,0,0,0,1,2,0,1,4,7,5,4,24
Supaul,13.1,Number of Patients operated for cataract,TOTAL,0,0,0,0,0,0,0,2,183,161,63,0,409
Supaul,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0,0,0,0,0,0,0,0,183,161,0,0,344
Supaul,13.3,Number of School children detected with Refractive errors,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Supaul,13.4,Number of children provided free glasses,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Supaul,13.5,Number of eyes collected through eye donation,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Supaul,13.6,Number of eyes utilised for corneal transplant,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Supaul,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,NA,NA,NA,NA,2,2,2,2,2,2,2,2,Data for this item can not be cumulated
Supaul,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,NA,NA,1,1,11,9,10,12,11,11,10,11,Data for this item can not be cumulated
Supaul,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,1630,1644,1575,1684,1683,1659,1693,1597,1676,1648,1591,1567,Data for this item can not be cumulated
Supaul,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,NA,NA,NA,NA,2,2,2,2,3,2,2,1,Data for this item can not be cumulated
Supaul,14.05,Number of RKS meetings held during the month,TOTAL,4,3,3,2,5,1,3,1,8,1,8,8,47
Supaul,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,NA,NA,1,1,10,8,10,11,10,11,10,10,Data for this item can not be cumulated
Supaul,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,1053,960,895,997,992,1347,1914,1906,1597,1449,1094,1162,15366
Supaul,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,Data for this item can not be cumulated
Supaul,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,NA,NA,NA,NA,0,0,0,0,0,1,1,1,Data for this item can not be cumulated
Supaul,14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,1896,2254,2199,2686,2918,2900,3067,2835,2824,2526,2318,2199,30622
Supaul,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,2537,2856,2474,3070,3259,3126,3284,2896,2748,2687,2672,2919,34528
Supaul,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,2255,2445,2475,2755,3199,2758,3426,2940,3229,2860,2558,2402,33302
Supaul,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,4367,4797,4632,5864,6451,7568,8073,6774,7749,6720,6095,5078,74168
Supaul,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,4151,4699,4674,5441,6117,5658,6493,5775,6053,5386,4876,4601,63924
Supaul,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,6904,7653,7106,8934,9710,10694,11357,9670,10497,9407,8767,7997,108696
Supaul,14.10.2.a,Number of death cases of Inpatient males,TOTAL,3,3,3,3,3,2,3,3,2,2,2,4,33
Supaul,14.10.2.b,Number of death cases of Inpatient females,TOTAL,1,0,0,1,0,0,1,0,0,1,0,0,4
Supaul,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,4,3,3,4,3,2,4,3,2,3,2,4,37
Supaul,14.11,In-Patient Head Count at midnight,TOTAL,6357,6895,6502,7231,7472,6973,7030,7183,7373,6583,6150,6338,82087
Supaul,14.12.1,OPD attendance (All),TOTAL,125503,125915,116463,126929,135807,140841,137234,119647,124309,120964,120679,125748,1520039
Supaul,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,336,694,159,717,423,810,860,819,2952,2427,1892,1000,13089
Supaul,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Supaul,14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,4053,3817,3589,3922,2956,3216,3824,3714,3838,3496,3509,3565,43499
Supaul,14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,14.14.a,Number of patients given AYUSH treatment,TOTAL,14714,15362,15538,16731,14338,17620,15334,13251,14849,13333,13031,12719,176820
Supaul,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,2800,2901,2387,2922,3095,4619,3923,3052,3959,3266,4385,3493,40802
Supaul,14.14.c,Number of Adolescents counselled,TOTAL,18,15,25,17,10,15,2,21,15,13,21,25,197
Supaul,15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,3892,4308,3848,4173,3582,3467,3636,3041,3543,3908,3853,4354,45605
Supaul,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,109,18,13,26,25,21,23,20,35,52,73,89,504
Supaul,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,3,11,102,124,103,207,251,233,302,315,470,403,2524
Supaul,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,0,0,3,2,1,2,3,2,7,3,4,4,31
Supaul,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,10,9,120,113,158,294,208,289,409,471,629,571,3281
Supaul,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,1,0,3,0,2,2,3,2,6,6,3,3,31
Supaul,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,8,17,227,138,254,338,322,363,259,366,628,718,3638
Supaul,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0,0,0,0,0,0,0,0,0,1,1,0,2
Supaul,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,21,37,449,375,515,839,781,885,970,1152,1727,1692,9443
Supaul,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,1,0,6,2,3,4,6,4,13,10,8,7,64
Supaul,15.2,Number of Widal tests conducted,Number tested,6,11,10,11,0,8,4,14,0,0,0,2,66
Supaul,15.3.a,Number of VDRL tests conducted on males,Number tested,53,93,91,126,168,209,245,191,196,232,375,367,2346
Supaul,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,89,302,2,116,236,347,224,228,239,240,442,445,2910
Supaul,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,249,283,132,138,238,294,343,327,239,300,545,628,3716
Supaul,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,391,678,225,380,642,850,812,746,674,772,1362,1440,8972
Supaul,15.4.1,Number of blood smears examined for Malaria,TOTAL,33,34,33,47,27,15,87,35,20,10,20,12,373
Supaul,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,0,0,1,0,0,0,14,6,0,0,0,0,21
Supaul,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Supaul,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,3635,3285,2885,4585,4810,4560,4410,3360,2960,2660,1903,1503,40556
Supaul,16.1.1,Stock position of DPT vaccines,2. Stocks Received,500,1000,2000,1625,0,0,0,0,0,0,100,100,5325
Supaul,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,0
Supaul,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,850,1400,600,1100,250,150,1050,400,300,1903,1100,800,9903
Supaul,16.1.1,Stock position of DPT vaccines,5. Total Stock,3285,2885,4285,5110,4560,4410,3360,2960,2660,757,903,803,35978
Supaul,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,1050,2500,2650,3650,4579,6163,4791,3591,2617,649,190,382,32812
Supaul,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,3000,2100,2100,2279,2304,0,0,0,0,1200,1950,2016,16949
Supaul,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,0
Supaul,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,1550,1950,1100,1350,750,1342,1200,974,1968,1659,1758,1582,17183
Supaul,16.1.1A,Stock Position of Pentavalent,5. Total Stock,2500,2650,3650,4579,6133,4821,3591,2617,649,190,382,816,32578
Supaul,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,384,1500,1300,1750,1775,2200,1610,535,148,150,20,14,11386
Supaul,16.1.2,Stock position of OPV vaccines,2. Stocks Received,3200,2000,1600,1925,1925,1000,600,1000,1600,1600,1600,1775,19825
Supaul,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,0
Supaul,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,1875,2200,1150,1900,1500,1590,1675,1387,1598,1730,1601,1489,19695
Supaul,16.1.2,Stock position of OPV vaccines,5. Total Stock,1709,1300,1750,1775,2200,1610,535,148,150,20,19,300,11516
Supaul,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,1890,1140,2190,4440,4440,3969,2219,2069,2180,2030,1130,1430,29127
Supaul,16.1.3,Stock position of TT vaccines,2. Stocks Received,500,3000,2500,329,329,0,1000,1000,1300,0,1400,500,11858
Supaul,16.1.3,Stock position of TT vaccines,3. Unusable Stock,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,0
Supaul,16.1.3,Stock position of TT vaccines,4. Stock Distributed,1250,1950,1200,800,800,1750,1150,889,1450,900,1100,1150,14389
Supaul,16.1.3,Stock position of TT vaccines,5. Total Stock,1140,2190,3490,3969,3969,2219,2069,2180,2030,1130,1430,780,26596
Supaul,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,NA,0,0,0,0,0,0,0,0,0,0,0,0
Supaul,16.1.4,Stock position of DT vaccines,2. Stocks Received,NA,0,0,0,0,0,0,0,0,0,0,0,0
Supaul,16.1.4,Stock position of DT vaccines,3. Unusable Stock,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,0
Supaul,16.1.4,Stock position of DT vaccines,4. Stock Distributed,NA,0,0,0,0,0,0,0,0,0,0,0,0
Supaul,16.1.4,Stock position of DT vaccines,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Supaul,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,2750,2950,2650,3050,4050,3830,2330,1080,980,330,580,1030,25610
Supaul,16.1.5,Stock position of BCG vaccines,2. Stocks Received,1000,1000,1200,1500,330,0,0,1200,800,1200,1200,1200,10630
Supaul,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,800,1300,800,500,550,1500,1250,1300,1450,950,750,800,11950
Supaul,16.1.5,Stock position of BCG vaccines,5. Total Stock,2950,2650,3050,4050,3830,2330,1080,980,330,580,1030,1430,24290
Supaul,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,950,1838,938,1488,1710,3310,1410,1860,2310,910,1260,1207,19191
Supaul,16.1.6,Stock position of Measles vaccines,2. Stocks Received,4500,2000,3000,3750,3750,1000,2600,2500,1000,2100,2000,2100,30300
Supaul,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,0
Supaul,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,2700,2900,2450,3528,2150,2900,2150,2050,2400,1750,2050,2350,29378
Supaul,16.1.6,Stock position of Measles vaccines,5. Total Stock,2750,938,1488,1710,3310,1410,1860,2310,910,1260,1210,957,20113
Supaul,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,NA,0,0,0,0,0,0,0,0,0,0,0,0
Supaul,16.1.7,Stock position of JE vaccines,2. Stocks Received,NA,0,0,0,0,0,0,0,0,0,0,0,0
Supaul,16.1.7,Stock position of JE vaccines,3. Unusable Stock,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,0
Supaul,16.1.7,Stock position of JE vaccines,4. Stock Distributed,NA,0,0,0,0,0,0,0,0,0,0,0,0
Supaul,16.1.7,Stock position of JE vaccines,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Supaul,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,60,630,1405,1905,2105,2805,2355,2005,1410,1610,1810,1510,19610
Supaul,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,1150,2000,1200,950,1000,0,0,0,650,650,0,0,7600
Supaul,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,0
Supaul,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,580,1225,700,750,300,450,350,595,450,450,300,200,6350
Supaul,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,630,1405,1905,2105,2805,2355,2005,1410,1610,1810,1510,1310,20860
Supaul,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Supaul,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Supaul,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Supaul,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Supaul,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Supaul,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Supaul,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,16.3.02,Stock Position of Gloves,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,16.3.02,Stock Position of Gloves,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,16.3.02,Stock Position of Gloves,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,16.3.02,Stock Position of Gloves,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Supaul,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Supaul,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Supaul,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Supaul,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Supaul,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Supaul,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Supaul,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Supaul,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Supaul,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Supaul,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,6100,1600,21700,14600,8200,25400,27600,19300,27700,18500,12100,6200,189000
Supaul,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0,25000,0,0,22000,10000,0,15000,0,0,0,15000,87000
Supaul,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,0
Supaul,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,4500,4900,7100,6400,4800,7800,8400,6600,9200,6400,5900,5500,77500
Supaul,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,1600,21700,14600,8200,25400,27600,19200,27700,18500,12100,6200,15700,198500
Supaul,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,106800,60800,173600,124000,54400,183600,233200,194800,249200,183600,144000,89600,1797600
Supaul,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0,180000,0,0,170000,100000,0,100000,0,0,0,100000,650000
Supaul,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,0
Supaul,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,46000,67200,49600,69600,40800,50400,38400,45600,65600,39600,54400,61600,628800
Supaul,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,60800,173600,124000,54400,183600,233200,194800,249200,183600,144000,89600,128000,1818800
Supaul,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,200,0,12400,7100,2900,14800,14800,10700,16700,12100,9300,6500,107500
Supaul,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0,16000,0,0,15000,5000,0,10000,0,0,0,10000,56000
Supaul,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,0
Supaul,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,200,3600,5300,4200,3100,5000,4000,4000,4600,2800,2800,4100,43700
Supaul,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0,12400,7100,2900,14800,14800,10800,16700,12100,9300,6500,12400,119800
Supaul,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,1
Supaul,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,1,2
Supaul,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,1,2
Supaul,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,2,3
Supaul,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,2,3
Supaul,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1
Supaul,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1
Supaul,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,1
Supaul,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,1,2
Supaul,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,NA,NA,NA,NA,NA,NA,1,NA,NA,1,NA,1,3
Supaul,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,1
Supaul,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,1
Supaul,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,2,1,NA,NA,3
Supaul,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,2,1,NA,NA,3
Supaul,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,1,1,NA,NA,NA,NA,2
Supaul,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,NA,NA,NA,NA,NA,NA,1,1,NA,NA,NA,NA,2
Supaul,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Supaul,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,3,1,5,3,NA,2,14
Supaul,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,4,4
Supaul,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,NA,NA,NA,NA,NA,NA,3,1,5,3,NA,6,18
Vaishali,1.1,Total number of pregnant women Registered for ANC,TOTAL,7722,7837,7539,8269,8396,7965,7412,6488,7047,7394,8002,8136,92207
Vaishali,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,3970,4436,4156,4465,4941,4938,4487,4323,4656,4809,5196,4973,55350
Vaishali,1.2,Number of Pregnant women registered under JSY,TOTAL,7722,7837,7539,8269,8396,7902,7412,6488,7047,7415,8002,8136,92165
Vaishali,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,4849,5497,4728,5236,6155,6164,6241,5830,6317,6008,5955,6066,69046
Vaishali,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,5144,5122,4899,5438,5720,5224,4811,4346,4750,4986,5247,5119,60806
Vaishali,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,7336,7828,6699,7402,7831,7519,7476,6362,6556,6626,6299,7070,85004
Vaishali,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,4673,5261,4154,4673,5317,5479,4689,5035,6270,5870,5939,5790,63150
Vaishali,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,110,157,152,160,122,138,123,160,224,157,210,368,2081
Vaishali,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,4,6,0,2,2,4,12,7,5,7,15,6,70
Vaishali,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,1233,2422,2440,2411,2743,2688,2337,2156,2774,2430,2572,2534,28740
Vaishali,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,3,2,3,3,2,2,3,4,2,3,1,1,29
Vaishali,1.8,Number of pregnancy test kits used at SC level,TOTAL,828,825,680,745,705,727,665,621,823,784,705,821,8929
Vaishali,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,44,90,69,78,80,52,51,50,27,25,13,39,618
Vaishali,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,467,430,390,410,465,455,426,438,473,513,540,437,5444
Vaishali,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,511,520,459,488,545,507,477,488,500,538,553,476,6062
Vaishali,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,372,381,372,354,451,345,356,396,399,415,392,378,4611
Vaishali,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Vaishali,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,3432,3474,3833,5921,6406,5708,5804,5561,5406,5414,4919,4151,60029
Vaishali,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,3362,3412,3783,5816,6203,5444,5504,5335,5148,5101,4635,4066,57809
Vaishali,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1040,791,1379,4653,1800,12278,6820,5694,4715,3809,4931,9729,57639
Vaishali,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,810,290,765,3014,1775,8587,7361,9449,5435,3933,4895,11684,57998
Vaishali,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Vaishali,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,NA,NA,NA,NA,91,26,186,266,184,291,247,154,1445
Vaishali,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Vaishali,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Vaishali,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Vaishali,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Vaishali,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Vaishali,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,62,55,43,52,83,52,47,64,76,82,84,36,736
Vaishali,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Vaishali,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,62,55,43,52,83,52,47,64,76,82,84,36,736
Vaishali,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,NA,NA,NA,NA,0,0,11,81,60,87,92,60,391
Vaishali,4.1.1.a,Number of male live births,TOTAL,2054,2067,2313,3472,3682,3264,3337,3381,3165,3282,3081,2492,35590
Vaishali,4.1.1.b,Number of female live births,TOTAL,1876,1910,1947,2909,3344,2954,3064,2894,2874,2921,2625,2265,31583
Vaishali,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,3930,3977,4260,6381,7026,6218,6401,6275,6039,6203,5706,4757,67173
Vaishali,4.1.2,Number of still births,TOTAL,28,35,59,69,55,61,73,55,73,61,33,39,641
Vaishali,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,6,11,4,59,58,32,70,77,127,127,134,127,832
Vaishali,4.2.1,Number of Newborns weighed at birth,TOTAL,3860,3933,4234,6314,6875,6116,6184,6238,5995,6152,5563,4718,66182
Vaishali,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,108,184,249,291,391,386,337,304,306,237,262,312,3367
Vaishali,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,3717,3876,4169,6287,6775,6141,6149,5931,5778,6120,5620,4659,65222
Vaishali,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0,256,4,6,452,18,36,9,4,14,16,56,871
Vaishali,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,2,2,0,3,4,5,6,5,50,73,131,13,294
Vaishali,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,72,69,56,74,111,74,67,94,106,112,122,106,1063
Vaishali,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Vaishali,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,74,327,60,83,567,97,109,108,160,199,269,175,2228
Vaishali,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Vaishali,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,74,72,62,77,117,85,83,106,166,199,273,139,1453
Vaishali,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0,0,0,2,2,8,14,8,5,7,15,6,67
Vaishali,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,74,72,62,991,1025,542,1149,108,156,185,256,137,4757
Vaishali,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0,0,0,0,0,0,0,0,0,0,1,0,1
Vaishali,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,2841,3184,3246,5395,6070,5242,4940,4811,4661,4718,4271,3949,53328
Vaishali,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,2028,2208,2271,3111,3596,3081,2801,2725,2650,2754,2557,2458,32240
Vaishali,6.3,PNC maternal complications attended,TOTAL,0,3,5,139,239,283,36,44,41,48,80,90,1008
Vaishali,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,5,3,3,10,4,15,20,17,33,20,21,26,177
Vaishali,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Vaishali,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,5,3,3,10,4,15,20,17,33,20,21,26,177
Vaishali,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0,NA,0,48,49,23,48,65,107,108,99,95,642
Vaishali,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,281,180,161,245,256,245,233,331,401,453,374,331,3491
Vaishali,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,735,538,660,627,632,629,1009,1050,1235,1246,987,1097,10445
Vaishali,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,1016,718,821,872,888,874,1242,1381,1636,1699,1361,1428,13936
Vaishali,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,27,8,42,49,57,47,0,0,2,0,0,0,232
Vaishali,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0,1,0,1,1,1,1,0,2,1,1,0,9
Vaishali,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0,0,0,2,2,0,1,0,1,0,0,0,6
Vaishali,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0,0,0,0,0,2,0,1,1,2,0,0,6
Vaishali,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Vaishali,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0,1,0,3,3,3,2,1,4,3,1,0,21
Vaishali,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,1,0,0,0,0,8,0,3,16,3,13,6,50
Vaishali,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Vaishali,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Vaishali,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Vaishali,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Vaishali,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Vaishali,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0,0,0,0,0,0,0,0,0,0,0,9,9
Vaishali,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,217,135,101,1054,311,644,798,576,2795,1302,1774,1341,11048
Vaishali,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,31,14,16,198,68,156,166,137,467,287,479,433,2452
Vaishali,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,67,31,30,105,55,167,116,134,383,220,307,134,1749
Vaishali,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Vaishali,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,315,180,147,1357,434,967,1080,847,3645,1809,2560,1908,15249
Vaishali,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,60,0,100,76,177,174,153,149,270,439,208,158,1964
Vaishali,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,1,9,0,19,9,11,4,3,6,9,12,8,91
Vaishali,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,1,1
Vaishali,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,10,27,15,20,29,26,21,21,34,35,48,17,303
Vaishali,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Vaishali,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,11,36,15,39,38,37,25,24,40,44,60,26,395
Vaishali,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0,0,0,0,0,0,0,0,2,3,0,0,5
Vaishali,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,571,538,377,1246,521,647,499,546,754,586,576,589,7450
Vaishali,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,222,188,246,688,427,445,483,454,615,470,498,463,5199
Vaishali,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,32,11,24,121,107,64,37,52,125,92,98,77,840
Vaishali,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,354,268,312,609,370,307,402,359,317,424,298,310,4330
Vaishali,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Vaishali,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,1179,1005,959,2664,1425,1463,1421,1411,1811,1572,1470,1439,17819
Vaishali,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,456,344,432,691,681,535,687,618,674,807,663,678,7266
Vaishali,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,NA,0,0,21,18,23,9,9,29,74,51,48,282
Vaishali,9.06,Number of IUCD removals,TOTAL,228,179,199,339,200,183,184,172,215,184,249,214,2546
Vaishali,9.07,Number of Oral Pills cycles distributed,TOTAL,3145,2754,2551,6415,3806,3930,3908,2923,3437,3275,3303,3182,42629
Vaishali,9.08,Number of Condom pieces distributed,TOTAL,22628,19289,19927,48224,28769,26562,25125,22929,27443,30076,26512,23250,320734
Vaishali,9.09,Number of Centchroman (weekly) pills given,TOTAL,61,31,76,113,35,90,115,55,273,75,132,107,1163
Vaishali,9.1,Number of Emergency Contraceptive Pills distributed,TOTAL,246,233,168,310,273,269,250,218,466,600,548,743,4324
Vaishali,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Vaishali,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Vaishali,9.11.2.a,Number of failures following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Vaishali,9.11.2.b,Number of failures following female sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Vaishali,9.11.3.a,Number of deaths following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Vaishali,9.11.3.b,Number of deaths following female sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Vaishali,9.12,Number of Institutions having NSV trained doctors,TOTAL,NA,NA,6,3,2,2,5,4,6,6,6,5,Data for this item can not be cumulated
Vaishali,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,5143,5180,5543,8053,9192,8334,8032,7736,7827,7811,7677,6442,86970
Vaishali,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,30,18,38,5,21,3,0,2,1,0,0,2,120
Vaishali,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,852,455,415,262,153,63,59,27,18,11,19,16,2350
Vaishali,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,2717,1634,1173,794,443,258,146,105,69,47,19,20,7425
Vaishali,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,6382,5564,5144,5785,6399,7493,8582,7675,7961,8442,7987,7665,85079
Vaishali,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,6009,6355,5448,5686,6117,6225,7088,7201,7530,8221,7778,8146,81804
Vaishali,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,4486,5708,5395,5669,6047,5899,6363,5979,6890,7734,7395,7748,75313
Vaishali,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,4048,4083,4478,6817,7402,6785,6962,6308,6653,6636,6185,4965,71322
Vaishali,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,6138,5150,5048,5857,6454,7538,8540,7713,7978,8413,7967,7672,84468
Vaishali,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,6561,6336,5546,5892,6214,6302,7125,7190,7498,8107,7609,8461,82841
Vaishali,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,6643,6812,6200,6293,6341,6040,6099,6050,6948,7782,7401,7620,80229
Vaishali,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,3130,3049,3683,5714,5848,5487,5702,5209,5173,5276,4759,3927,56957
Vaishali,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,29,45,33,27,6,3,0,2,0,0,0,0,145
Vaishali,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,858,483,503,256,152,55,43,18,14,9,13,7,2411
Vaishali,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,2867,1805,1210,825,412,246,149,94,62,69,63,13,7815
Vaishali,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,5661,6748,6735,7876,7966,7673,7820,6790,5633,6469,6044,6104,81519
Vaishali,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,5548,5400,5832,6612,6295,6210,6250,5197,5504,6848,7300,6879,73875
Vaishali,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,4651,6109,5350,7596,7532,7312,7688,6660,5536,6263,5811,5909,76417
Vaishali,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2919,3431,3448,4133,4089,3964,4131,3555,2945,3433,3223,3218,42489
Vaishali,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2560,3130,3126,3661,3794,3618,3620,3118,2640,3004,2814,2860,37945
Vaishali,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,5479,6561,6574,7794,7883,7582,7751,6673,5585,6437,6037,6078,80434
Vaishali,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,6267,6128,6095,6575,6515,6259,6645,5298,6065,6926,7299,6982,77054
Vaishali,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,6231,6208,6042,6545,6476,6246,6611,5298,6061,6916,7296,6970,76900
Vaishali,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Vaishali,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2018,2111,2195,2540,2478,2502,2660,2372,2423,2692,2889,2834,29714
Vaishali,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1721,1829,1938,2254,2243,2203,2327,1863,2125,2342,2601,2484,25930
Vaishali,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,3739,3940,4133,4794,4721,4705,4987,4235,4548,5034,5490,5318,55644
Vaishali,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,2006,2135,1845,2046,2024,2256,2725,2407,2863,2634,2443,2504,27888
Vaishali,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,2287,1951,1665,2022,1816,2128,2610,2207,2444,2415,2458,2398,26401
Vaishali,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,4172,2714,2516,3340,2848,3169,3780,3403,3581,4213,3613,3771,41120
Vaishali,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0,0,0,4,0,0,0,0,0,4,0,0,8
Vaishali,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0,0,0,0,0,0,0,0,0,1,0,0,1
Vaishali,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0,0,1,0,0,1,0,0,0,0,0,0,2
Vaishali,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,3522,3429,3390,3593,3578,3578,3499,3445,3470,3472,3442,3472,41890
Vaishali,10.4.2,Number of Immunisation sessions held during the month,TOTAL,3483,3417,3169,3575,3568,3568,3458,3361,3386,3418,3400,3467,41270
Vaishali,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,3207,3127,2929,3317,3292,3290,3207,3124,3137,3172,3188,3220,38210
Vaishali,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,5203,5523,4406,6106,5897,5856,6207,4982,5552,6535,6886,6767,69920
Vaishali,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,4801,5663,5574,6756,6961,7067,7362,6383,5577,6151,5733,5860,73888
Vaishali,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,1616,1563,1652,1947,2472,2280,2105,1829,2436,2736,3404,3473,27513
Vaishali,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,360,398,348,506,510,587,540,454,626,668,776,947,6720
Vaishali,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Vaishali,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Vaishali,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Vaishali,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Vaishali,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Vaishali,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0,32,0,0,2,0,0,0,0,0,100,0,134
Vaishali,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,838,826,954,998,1175,1130,1105,895,914,762,606,861,11064
Vaishali,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,311,8,0,0,0,0,0,0,0,0,4,2,325
Vaishali,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,27,35,42,48,47,63,45,34,42,48,35,33,499
Vaishali,13.1,Number of Patients operated for cataract,TOTAL,0,0,0,0,0,0,0,0,3,19,19,19,60
Vaishali,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,0,0,0,0,0,0,0,0,3,19,19,19,60
Vaishali,13.3,Number of School children detected with Refractive errors,TOTAL,66,62,62,70,72,164,96,64,46,75,65,57,899
Vaishali,13.4,Number of children provided free glasses,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Vaishali,13.5,Number of eyes collected through eye donation,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Vaishali,13.6,Number of eyes utilised for corneal transplant,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Vaishali,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,NA,NA,4,5,4,5,5,5,5,5,5,5,Data for this item can not be cumulated
Vaishali,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,NA,NA,19,22,21,17,19,16,15,15,15,14,Data for this item can not be cumulated
Vaishali,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,2463,2497,2392,2639,2646,2658,2700,2650,2672,2700,2689,2737,Data for this item can not be cumulated
Vaishali,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,NA,NA,4,5,5,4,4,4,4,4,4,5,Data for this item can not be cumulated
Vaishali,14.05,Number of RKS meetings held during the month,TOTAL,7,8,10,9,13,11,13,7,10,9,8,7,112
Vaishali,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,NA,NA,19,21,22,21,21,20,20,21,21,21,Data for this item can not be cumulated
Vaishali,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,2730,3070,3246,4615,4790,4182,4935,4752,4389,4545,3763,3853,48870
Vaishali,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,NA,NA,1,1,1,1,1,1,1,1,2,2,Data for this item can not be cumulated
Vaishali,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,NA,NA,0,0,0,0,0,0,0,0,0,0,Data for this item can not be cumulated
Vaishali,14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Vaishali,14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Vaishali,14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Vaishali,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,1785,2176,2176,2686,2926,2875,2906,2786,2808,2636,2522,2746,31028
Vaishali,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,2705,2934,2720,3116,2894,2848,2671,2774,2807,3065,2590,3050,34174
Vaishali,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,2145,2047,2033,2278,2791,2714,2979,2559,2935,2606,2518,2807,30412
Vaishali,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,5900,5739,6279,9109,8434,8624,9235,8933,10306,8777,9336,8060,98732
Vaishali,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,3930,4223,4209,4964,5717,5589,5885,5345,5743,5242,5040,5553,61440
Vaishali,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,8605,8673,8999,12225,11328,11472,11906,11707,13113,11842,11926,11110,132906
Vaishali,14.10.2.a,Number of death cases of Inpatient males,TOTAL,11,8,5,5,10,6,4,5,6,4,2,5,71
Vaishali,14.10.2.b,Number of death cases of Inpatient females,TOTAL,4,7,5,7,2,2,2,4,4,3,2,3,45
Vaishali,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,15,15,10,12,12,8,6,9,10,7,4,8,116
Vaishali,14.11,In-Patient Head Count at midnight,TOTAL,7489,7632,8147,10893,10737,10812,11186,10633,12044,11378,10893,9904,121748
Vaishali,14.12.1,OPD attendance (All),TOTAL,205415,199911,182314,213006,269108,262608,234894,231183,248419,244403,244741,249780,2785782
Vaishali,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,419,303,233,1379,539,1029,1092,907,3767,1906,2701,1701,15976
Vaishali,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
Vaishali,14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Vaishali,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,5886,5569,5294,6404,6928,8235,7524,7039,6631,5771,6278,6623,78182
Vaishali,14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Vaishali,14.14.a,Number of patients given AYUSH treatment,TOTAL,22506,30964,19436,23210,23666,28129,23191,20813,23361,22869,21291,20400,279836
Vaishali,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,5643,6279,5150,6165,6625,8156,7867,6980,7863,7511,9001,7802,85042
Vaishali,14.14.c,Number of Adolescents counselled,TOTAL,311,207,271,342,266,342,334,315,296,314,255,226,3479
Vaishali,15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Vaishali,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,7625,7270,7164,8703,8054,9161,8244,7757,9612,8436,8970,9165,100161
Vaishali,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,66,44,50,80,74,70,67,78,167,60,43,52,851
Vaishali,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,49,30,319,267,240,300,261,466,309,366,556,541,3704
Vaishali,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,3,0,26,34,22,10,1,32,18,15,25,25,211
Vaishali,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,236,108,263,969,528,845,895,909,2603,1453,2205,1678,12692
Vaishali,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0,0,39,35,21,17,3,23,8,16,15,20,197
Vaishali,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,161,409,636,410,1152,786,1569,1398,1933,1650,1790,1867,13761
Vaishali,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0,0,1,4,3,1,2,1,4,3,7,5,31
Vaishali,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,446,547,1218,1646,1920,1931,2725,2773,4845,3469,4551,4086,30157
Vaishali,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,3,0,66,73,46,28,6,56,30,34,47,50,439
Vaishali,15.2,Number of Widal tests conducted,Number tested,39,46,42,78,78,58,96,96,97,96,63,82,871
Vaishali,15.3.a,Number of VDRL tests conducted on males,Number tested,8,20,0,0,0,0,122,3,3,3,4,0,163
Vaishali,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,12,22,0,0,0,0,6,0,0,0,6,19,65
Vaishali,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,131,62,0,70,118,153,115,75,75,82,119,210,1210
Vaishali,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,151,104,0,70,118,153,243,78,78,85,129,229,1438
Vaishali,15.4.1,Number of blood smears examined for Malaria,TOTAL,218,180,152,202,191,187,318,219,125,53,143,163,2151
Vaishali,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,2,7,2,3,0,1,1,0,0,0,2,0,18
Vaishali,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0,0,0,1,0,0,3,4,0,1,0,0,9
Vaishali,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,3067,3617,4417,6167,5117,6567,5817,5517,7517,6467,6017,4867,65154
Vaishali,16.1.1,Stock position of DPT vaccines,2. Stocks Received,2000,2000,2500,0,2000,0,0,2500,0,0,0,0,11000
Vaishali,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Vaishali,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,1450,1200,750,1050,550,750,300,500,1050,450,1150,1050,10250
Vaishali,16.1.1,Stock position of DPT vaccines,5. Total Stock,3617,4417,6167,5117,6567,5817,5517,7517,6467,6017,4867,3817,65904
Vaishali,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,1975,175,1425,2831,4787,5903,3761,4024,4849,2339,2820,1290,36179
Vaishali,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,0,3300,3456,3456,3456,0,2016,2880,1000,2016,1440,3168,26188
Vaishali,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Vaishali,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,1800,2050,2050,1500,2340,2142,1753,2055,3510,1535,2970,2626,26331
Vaishali,16.1.1A,Stock Position of Pentavalent,5. Total Stock,175,1425,2831,4787,5903,3761,4024,4849,2339,2820,1290,1832,36036
Vaishali,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,92,320,895,895,620,570,720,1770,1770,145,1458,3258,12513
Vaishali,16.1.2,Stock position of OPV vaccines,2. Stocks Received,1000,3600,3000,3000,3000,3000,3000,0,2400,45000,45000,1725,113725
Vaishali,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Vaishali,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,772,3025,3000,3275,3050,2850,1950,0,4025,43687,43200,890,109724
Vaishali,16.1.2,Stock position of OPV vaccines,5. Total Stock,320,895,895,620,570,720,1770,1770,145,1458,3258,4093,16514
Vaishali,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,1915,3765,5265,6315,3515,2615,3315,3365,4315,1315,1265,1075,38040
Vaishali,16.1.3,Stock position of TT vaccines,2. Stocks Received,4000,3600,4000,0,2000,2000,2000,3000,0,2000,3000,3485,29085
Vaishali,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Vaishali,16.1.3,Stock position of TT vaccines,4. Stock Distributed,2150,2100,2950,2800,2900,1300,1950,2050,3000,2050,3190,2560,29000
Vaishali,16.1.3,Stock position of TT vaccines,5. Total Stock,3765,5265,6315,3515,2615,3315,3365,4315,1315,1265,1075,2000,38125
Vaishali,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0,0,0,0,0,0,0,0,0,0,0,0,0
Vaishali,16.1.4,Stock position of DT vaccines,2. Stocks Received,0,0,0,0,0,0,0,0,0,0,0,0,0
Vaishali,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Vaishali,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0,0,0,0,0,0,0,0,0,0,0,0,0
Vaishali,16.1.4,Stock position of DT vaccines,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Vaishali,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,1945,1995,1045,1945,2545,2645,2045,1745,1845,120,345,20,18240
Vaishali,16.1.5,Stock position of BCG vaccines,2. Stocks Received,1750,2700,2300,2300,2300,2000,1000,1500,500,3200,1600,1800,22950
Vaishali,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Vaishali,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,1700,3650,1400,1700,2200,2600,1300,1400,2225,2975,1925,1700,24775
Vaishali,16.1.5,Stock position of BCG vaccines,5. Total Stock,1995,1045,1945,2545,2645,2045,1745,1845,120,345,20,120,16415
Vaishali,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,300,950,235,1120,2270,3620,2060,2210,510,1310,1310,500,16395
Vaishali,16.1.6,Stock position of Measles vaccines,2. Stocks Received,4500,2285,5000,5400,5400,4000,3000,2000,5000,6000,4000,4600,51185
Vaishali,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Vaishali,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,3850,3000,4115,4250,4050,5560,2850,3700,4200,6000,4810,3725,50110
Vaishali,16.1.6,Stock position of Measles vaccines,5. Total Stock,950,235,1120,2270,3620,2060,2210,510,1310,1310,500,1375,17470
Vaishali,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,30,430,1730,1930,3830,5930,3940,3640,1140,1270,220,250,24340
Vaishali,16.1.7,Stock position of JE vaccines,2. Stocks Received,4600,4600,4000,6000,6000,4000,2000,1000,4000,4000,8000,4500,52700
Vaishali,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Vaishali,16.1.7,Stock position of JE vaccines,4. Stock Distributed,4200,3300,3800,4100,3900,5990,2300,3500,3870,5050,7970,4200,52180
Vaishali,16.1.7,Stock position of JE vaccines,5. Total Stock,430,1730,1930,3830,5930,3940,3640,1140,1270,220,250,550,24860
Vaishali,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,2780,2480,2130,2480,2980,3580,2830,2480,3080,2030,2480,2260,31590
Vaishali,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,1000,1000,1500,1750,1750,0,0,1000,0,1000,500,500,10000
Vaishali,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Vaishali,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,1300,1350,1150,1250,1150,750,350,400,1050,550,720,620,10640
Vaishali,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,2480,2130,2480,2980,3580,2830,2480,3080,2030,2480,2260,2140,30950
Vaishali,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,600,0,0,0,0,0,0,0,0,0,0,0,600
Vaishali,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0,0,0,0,0,0,0,0,0,0,0,2800,2800
Vaishali,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Vaishali,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,600,0,0,0,0,0,0,0,0,0,0,0,600
Vaishali,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,2800,2800
Vaishali,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,12000,0,0,0,0,0,0,0,0,0,0,0,12000
Vaishali,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0,0,0,0,0,0,0,0,0,0,0,6000,6000
Vaishali,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Vaishali,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,12000,0,0,0,0,0,0,0,0,0,0,0,12000
Vaishali,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,6000,6000
Vaishali,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,1500,0,0,0,0,0,0,0,0,0,0,0,1500
Vaishali,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0,0,0,0,0,0,0,0,0,0,0,600,600
Vaishali,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Vaishali,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,1500,0,0,0,0,0,0,0,0,0,0,0,1500
Vaishali,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,600,600
Vaishali,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,240,0,0,0,0,0,0,0,0,0,0,0,240
Vaishali,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0,0,0,0,0,0,0,0,0,0,0,500,500
Vaishali,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Vaishali,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,240,0,0,0,0,0,0,0,0,0,0,0,240
Vaishali,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,500,500
Vaishali,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,0,0,0,0,0,0,0,0,0,0,0,0,0
Vaishali,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0,0,0,0,0,0,0,0,0,0,0,0,0
Vaishali,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Vaishali,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0,0,0,0,0,0,0,0,0,0,0,0,0
Vaishali,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Vaishali,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0,0,0,0,0,0,0,0,0,0,0,0,0
Vaishali,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0,0,0,0,0,0,0,0,0,0,0,30000,30000
Vaishali,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Vaishali,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0,0,0,0,0,0,0,0,0,0,0,0,0
Vaishali,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,30000,30000
Vaishali,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0,0,0,0,0,0,0,0,0,0,0,0,0
Vaishali,16.3.02,Stock Position of Gloves,2. Stocks Received,0,0,0,0,0,0,0,0,0,0,0,0,0
Vaishali,16.3.02,Stock Position of Gloves,3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Vaishali,16.3.02,Stock Position of Gloves,4. Stock Distributed,0,0,0,0,0,0,0,0,0,0,0,0,0
Vaishali,16.3.02,Stock Position of Gloves,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Vaishali,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0,0,0,0,0,0,0,0,0,0,0,0,0
Vaishali,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0,0,0,0,0,0,0,0,0,0,0,0,0
Vaishali,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Vaishali,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0,0,0,0,0,0,0,0,0,0,0,0,0
Vaishali,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Vaishali,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,200000,200000,200000,200000,100000,100000,100000,100000,100000,100000,100000,100000,1600000
Vaishali,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0,0,0,0,0,0,NA,0,0,0,0,0,0
Vaishali,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0,0,0,0,0,0,NA,0,0,0,0,86000,86000
Vaishali,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0,0,0,100000,0,0,NA,0,0,0,0,0,100000
Vaishali,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,200000,200000,200000,100000,100000,100000,100000,100000,100000,100000,100000,14000,1414000
Vaishali,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0,0,0,0,0,0,0,0,0,0,0,0,0
Vaishali,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0,0,0,0,0,0,0,0,0,0,0,0,0
Vaishali,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Vaishali,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0,0,0,0,0,0,0,0,0,0,0,0,0
Vaishali,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Vaishali,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0,0,0,0,0,0,0,0,0,0,0,0,0
Vaishali,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0,0,0,0,0,0,0,0,0,0,0,0,0
Vaishali,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Vaishali,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0,0,0,0,0,0,0,0,0,0,0,0,0
Vaishali,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Vaishali,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,200000,200000,200000,200000,5000,5000,5000,5000,5000,5000,5000,5000,840000
Vaishali,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0,0,0,0,0,0,0,0,0,0,0,795000,795000
Vaishali,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Vaishali,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0,0,0,195000,0,0,0,0,0,0,0,0,195000
Vaishali,16.3.07,Stock Position of IFA Tablets,5. Total Stock,200000,200000,200000,5000,5000,5000,5000,5000,5000,5000,5000,800000,1440000
Vaishali,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0,0,0,0,0,0,0,0,0,0,0,0,0
Vaishali,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0,0,0,0,0,0,0,0,0,0,0,0,0
Vaishali,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Vaishali,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0,0,0,0,0,0,NA,0,0,0,0,0,0
Vaishali,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Vaishali,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0,0,0,0,0,0,0,0,0,0,0,0,0
Vaishali,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0,0,0,0,0,0,0,0,0,0,0,400000,400000
Vaishali,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Vaishali,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0,0,0,0,0,0,0,0,0,0,0,0,0
Vaishali,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,400000,400000
Vaishali,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,7500,7500,7500,7500,0,0,0,0,0,0,0,0,30000
Vaishali,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0,0,0,0,0,0,0,0,0,0,0,0,0
Vaishali,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Vaishali,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0,0,0,7500,0,0,0,0,0,0,0,0,7500
Vaishali,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,7500,7500,7500,0,0,0,0,0,0,0,0,0,22500
Vaishali,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,29000,29000,29000,29000,0,0,0,0,0,0,0,0,116000
Vaishali,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0,0,0,0,0,0,0,0,0,0,0,60000,60000
Vaishali,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Vaishali,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,0,0,0,29000,0,0,0,0,0,0,0,0,29000
Vaishali,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,29000,29000,29000,0,0,0,0,0,0,0,0,60000,147000
Vaishali,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,8800,2800,6200,5900,16900,5900,16500,10300,23100,11100,21100,10100,138700
Vaishali,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0,10000,10000,20000,0,20000,0,20000,0,20000,0,10000,110000
Vaishali,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Vaishali,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,6000,6600,10300,9000,11000,9400,6200,7200,12000,10000,11000,9600,108300
Vaishali,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,2800,6200,5900,16900,5900,16500,10300,23100,11100,21100,10100,10500,140400
Vaishali,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,56895,57895,34495,40995,151795,33395,150195,98995,76995,135796,137596,36296,1011343
Vaishali,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,60000,60000,120000,189600,0,200000,0,50000,150000,70000,0,100000,999600
Vaishali,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Vaishali,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,59000,83400,113500,78800,118400,83200,51200,72000,91199,68200,101300,94400,1014599
Vaishali,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,57895,34495,40995,151795,33395,150195,98995,76995,135796,137596,36296,41896,996344
Vaishali,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,2967,4367,5167,3067,13967,2567,14967,9667,22867,9767,20967,7867,118204
Vaishali,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,8000,10000,10000,20000,0,20000,0,20000,0,20000,0,10000,118000
Vaishali,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
Vaishali,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,6600,9200,12100,9100,11400,7600,5300,6800,13100,8800,13100,9100,112200
Vaishali,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,4367,5167,3067,13967,2567,14967,9667,22867,9767,20967,7867,8767,124004
Vaishali,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Vaishali,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,NA,NA,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,1
Vaishali,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Vaishali,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,NA,NA,1,NA,NA,NA,NA,NA,NA,NA,NA,NA,1
Vaishali,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Vaishali,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Vaishali,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Vaishali,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,NA,NA,2,NA,NA,NA,2,NA,NA,NA,NA,1,5
Vaishali,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Vaishali,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,NA,NA,2,NA,NA,NA,2,NA,NA,NA,NA,1,5
Vaishali,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,2,3,NA,2,NA,NA,7
Vaishali,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,1,NA,3,NA,1,5
Vaishali,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,NA,NA,NA,NA,NA,NA,2,4,NA,5,NA,1,12
Vaishali,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,1
Vaishali,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Vaishali,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,1
Vaishali,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Vaishali,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Vaishali,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Vaishali,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1,2
Vaishali,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,NA,NA,1
Vaishali,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,1,1,3
Vaishali,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Vaishali,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Vaishali,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Vaishali,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,NA,NA,1,NA,NA,NA,NA,3,1,6,NA,NA,11
Vaishali,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,1,NA,1,1,NA,NA,3
Vaishali,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,NA,NA,1,NA,NA,NA,1,3,2,7,NA,NA,14
Vaishali,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Vaishali,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Vaishali,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Vaishali,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Vaishali,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Vaishali,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Vaishali,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,NA,NA,1
Vaishali,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,NA,NA,1
Vaishali,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Vaishali,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Vaishali,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Vaishali,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Vaishali,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Vaishali,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Vaishali,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Vaishali,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Vaishali,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Vaishali,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,1
Vaishali,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Vaishali,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,1
Vaishali,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Vaishali,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,1
Vaishali,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Vaishali,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,1
Vaishali,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Vaishali,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,NA,NA,NA,NA,1,NA,NA,2,NA,NA,1,NA,4
Vaishali,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,1
Vaishali,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,NA,NA,NA,NA,1,NA,NA,3,NA,NA,1,NA,5
Vaishali,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Vaishali,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Vaishali,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Vaishali,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Vaishali,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Vaishali,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Vaishali,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Vaishali,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Vaishali,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Vaishali,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,1
Vaishali,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Vaishali,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,1
Vaishali,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Vaishali,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1
Vaishali,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Vaishali,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1
Vaishali,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Vaishali,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,NA,NA,NA,2,NA,NA,1,NA,1,1,1,NA,6
Vaishali,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Vaishali,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,NA,NA,NA,2,NA,NA,1,NA,1,1,1,NA,6
Vaishali,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Vaishali,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Vaishali,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Vaishali,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Vaishali,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Vaishali,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,1,NA,NA,1,NA,NA,2
Vaishali,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Vaishali,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,NA,NA,NA,NA,NA,NA,1,NA,NA,1,NA,NA,2
Vaishali,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Vaishali,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,NA,NA,1,1,NA,NA,NA,1,NA,NA,NA,NA,3
Vaishali,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,1
Vaishali,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,NA,NA,1,1,NA,NA,NA,1,1,NA,NA,NA,4
Vaishali,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Vaishali,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,1
Vaishali,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Vaishali,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,1
Vaishali,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Vaishali,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Vaishali,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,1
Vaishali,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,NA,NA,NA,NA,NA,NA,1,NA,NA,NA,NA,NA,1
Vaishali,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Vaishali,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,NA,NA,NA,1,NA,NA,NA,NA,NA,NA,NA,NA,1
Vaishali,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Vaishali,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,NA,NA,NA,1,NA,NA,NA,NA,NA,NA,NA,NA,1
Vaishali,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
Vaishali,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,NA,NA,NA,2,NA,2,NA,NA,NA,2,2,NA,8
Vaishali,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,NA,NA,NA,NA,NA,3,2,NA,NA,3,2,NA,10
Vaishali,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,NA,NA,NA,2,NA,5,2,NA,NA,5,4,NA,18
Vaishali,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,NA,NA,NA,1,NA,NA,NA,NA,NA,NA,NA,NA,1
Vaishali,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,NA,NA,NA,2,7,4,3,3,4,3,2,4,32
Vaishali,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,NA,NA,NA,7,3,NA,3,3,8,1,1,4,30
Vaishali,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,NA,NA,NA,10,10,4,6,6,12,4,3,8,63
West Champaran,1.1,Total number of pregnant women Registered for ANC,TOTAL,9134,8627,7596,9787,9260,8726,8062,6547,6821,7134,8025,8716,98435
West Champaran,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,4132,3975,3494,4149,3962,3890,3818,3241,3060,3650,4431,5529,47331
West Champaran,1.2,Number of Pregnant women registered under JSY,TOTAL,9134,8635,7596,9615,9080,8496,8001,6376,6821,7080,7855,8453,97142
West Champaran,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,4118,4010,3478,3953,4040,4185,4365,3853,3825,3881,4025,5484,49217
West Champaran,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,5924,5310,4748,5883,5704,5551,4984,3882,4318,4426,4874,4957,60561
West Champaran,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,7494,8064,6774,6781,7662,7565,6959,5961,5666,5682,6079,7099,81786
West Champaran,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,2596,2789,1960,1986,1658,1670,1299,972,359,133,82,430,15934
West Champaran,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,55,18,26,61,19,9,15,23,13,46,14,22,321
West Champaran,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,3,1,4,4,0,1,2,4,4,8,3,5,39
West Champaran,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,85,138,67,135,123,12,34,38,23,15,17,64,751
West Champaran,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,0,6,0,0,0,24,0,0,0,0,0,0,30
West Champaran,1.8,Number of pregnancy test kits used at SC level,TOTAL,308,178,86,201,367,271,214,147,103,111,88,252,2326
West Champaran,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,91,3,18,9,74,61,106,73,51,11,2,38,537
West Champaran,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,1593,1335,1052,1661,1652,1757,2070,1923,2100,2250,2193,1812,21398
West Champaran,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,1684,1338,1070,1670,1726,1818,2176,1996,2151,2261,2195,1850,21935
West Champaran,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,337,272,297,260,291,188,349,274,341,509,441,385,3944
West Champaran,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0,0,0,9,0,0,0,0,0,0,48,20,77
West Champaran,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,3756,3753,3969,5829,6497,6688,6604,6888,6340,6170,5625,5151,67270
West Champaran,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,3419,3463,3696,5725,6408,6656,6526,6783,6254,6102,5563,4933,65528
West Champaran,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1182,1007,452,1045,965,7311,1862,1458,13142,4617,5206,9149,47396
West Champaran,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,917,722,116,457,552,3689,1942,1024,8622,2709,4626,7354,32730
West Champaran,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
West Champaran,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,NA,NA,NA,NA,NA,NA,23,139,NA,NA,NA,NA,162
West Champaran,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
West Champaran,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,18,9,23,28,21,15,17,16,28,20,22,17,234
West Champaran,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,18,9,23,28,21,15,17,16,28,20,22,17,234
West Champaran,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,NA,NA,NA,NA,NA,NA,4,NA,NA,NA,NA,NA,4
West Champaran,4.1.1.a,Number of male live births,TOTAL,2800,2638,2581,3781,4107,4312,4430,4656,4358,4350,4187,3593,45793
West Champaran,4.1.1.b,Number of female live births,TOTAL,2599,2389,2430,3682,4042,4130,4286,4305,4076,4035,3563,3230,42767
West Champaran,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,5399,5027,5011,7463,8149,8442,8716,8961,8434,8385,7750,6823,88560
West Champaran,4.1.2,Number of still births,TOTAL,46,56,61,89,106,109,129,92,87,84,54,68,981
West Champaran,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,6,17,6,13,11,8,4,9,6,3,1,14,98
West Champaran,4.2.1,Number of Newborns weighed at birth,TOTAL,3304,4206,3723,6212,6931,7290,6363,7342,7402,7180,6667,6006,72626
West Champaran,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,115,149,539,194,166,191,385,235,314,216,119,162,2785
West Champaran,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,4404,4221,4077,6638,7417,7464,6678,8027,7707,7514,6961,5301,76409
West Champaran,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,3,0,2,0,0,0,2,0,7,1,16,56,87
West Champaran,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
West Champaran,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,3,0,2,0,0,0,2,0,7,1,16,56,87
West Champaran,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,3,0,2,0,0,0,0,0,7,1,2,53,68
West Champaran,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,3,0,2,0,0,0,0,0,0,0,2,49,56
West Champaran,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,3,0,2,0,0,0,0,0,0,0,72,108,185
West Champaran,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,13,6,0,19,8,24,21,19,16,25,21,0,172
West Champaran,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,835,776,1098,1296,1223,2015,2874,1992,1826,1737,2047,2150,19869
West Champaran,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,677,690,629,966,783,859,1207,1149,1156,1175,1109,1255,11655
West Champaran,6.3,PNC maternal complications attended,TOTAL,0,0,150,0,0,0,0,0,0,0,0,0,150
West Champaran,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,7,0,6,4,0,8,4,6,0,0,0,0,35
West Champaran,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0,2,0,0,0,0,0,0,0,0,0,14,16
West Champaran,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,7,2,6,4,0,8,4,6,0,0,0,14,51
West Champaran,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
West Champaran,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,213,200,258,237,199,215,181,183,244,69,67,51,2117
West Champaran,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,886,849,754,819,793,904,904,814,1135,354,345,254,8811
West Champaran,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,1099,1049,1012,1056,992,1119,1085,997,1379,423,412,305,10928
West Champaran,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
West Champaran,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
West Champaran,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0,0,0,0,0,NA,0,0,0,0,0,0,0
West Champaran,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
West Champaran,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,14,20,NA,23,0,26,0,NA,35,8,NA,NA,126
West Champaran,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
West Champaran,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,0,0,0,0,0,NA,0,0,0,0,0,0,0
West Champaran,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
West Champaran,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0
West Champaran,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,394,80,15,1078,200,512,609,228,2321,1267,1872,1347,9923
West Champaran,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,406,157,12,364,7,7,168,62,251,417,568,424,2843
West Champaran,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,800,237,27,1442,207,519,777,290,2572,1684,2440,1771,12766
West Champaran,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,96,99,58,1046,1519,532,418,346,1674,1941,1805,4834,14368
West Champaran,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
West Champaran,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
West Champaran,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
West Champaran,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,0
West Champaran,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,92,92,66,352,288,246,189,182,280,242,163,370,2562
West Champaran,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,96,40,61,294,133,280,211,163,501,483,461,474,3197
West Champaran,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,4,5,4,13,5,3,3,4,13,11,10,27,102
West Champaran,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,192,137,131,659,426,529,403,349,794,736,634,871,5861
West Champaran,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,127,124,145,233,192,289,250,227,342,444,306,414,3093
West Champaran,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,2,9,NA,2,2,4,3,2,260,125,190,71,670
West Champaran,9.06,Number of IUCD removals,TOTAL,44,34,46,74,73,111,74,84,79,86,101,71,877
West Champaran,9.07,Number of Oral Pills cycles distributed,TOTAL,2383,1762,1487,2290,2398,2018,1799,1326,1869,1729,1659,1885,22605
West Champaran,9.08,Number of Condom pieces distributed,TOTAL,4642,4098,3690,6225,8647,9873,11379,4178,4116,7683,7620,9962,82113
West Champaran,9.09,Number of Centchroman (weekly) pills given,TOTAL,0,0,0,10,0,0,0,0,0,0,0,375,385
West Champaran,9.1,Number of Emergency Contraceptive Pills distributed,TOTAL,6,34,0,4,251,216,45,78,56,275,516,403,1884
West Champaran,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,19,19
West Champaran,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,19,19
West Champaran,9.11.2.a,Number of failures following male sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
West Champaran,9.11.2.b,Number of failures following female sterilization,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
West Champaran,9.11.3.a,Number of deaths following male sterilization,TOTAL,0,0,0,1,0,0,0,0,0,0,0,0,1
West Champaran,9.11.3.b,Number of deaths following female sterilization,TOTAL,0,0,0,2,0,0,1,0,0,0,0,0,3
West Champaran,9.12,Number of Institutions having NSV trained doctors,TOTAL,NA,NA,NA,3,2,3,6,6,5,4,5,5,Data for this item can not be cumulated
West Champaran,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,7258,6782,6442,9440,10643,10911,11924,11821,12042,11024,10349,8351,116987
West Champaran,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,126,45,28,54,7,37,22,14,29,8,7,258,635
West Champaran,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,1536,995,549,456,283,203,122,73,91,79,54,62,4503
West Champaran,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,3637,2528,1221,1119,682,437,277,162,220,115,115,84,10597
West Champaran,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,8180,6521,5231,6534,6564,7951,9642,9157,10540,10490,9957,9431,100198
West Champaran,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,7738,7630,5858,6313,6318,6374,7747,7903,9139,10156,9612,10359,95147
West Champaran,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,5589,6683,6015,6378,6177,6268,6505,6613,7884,8884,9125,9874,85995
West Champaran,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,4992,5315,5700,7667,8653,8910,9323,9389,9521,7780,7686,6510,91446
West Champaran,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,8643,6523,5080,6582,6397,7960,9750,9234,10238,10535,10163,10498,101603
West Champaran,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,8624,8039,6051,6346,6367,6436,7850,7901,9136,10150,9618,10355,96873
West Champaran,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,8411,8192,6693,6970,6732,6678,6646,6646,7913,8901,9033,9832,92647
West Champaran,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,3016,3189,3322,4974,6797,6560,7039,7253,7063,5875,6087,4977,66152
West Champaran,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,923,266,160,70,75,31,68,44,55,71,53,23,1839
West Champaran,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,1617,1030,591,469,300,161,148,99,142,90,67,21,4735
West Champaran,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,3590,2622,1441,1097,659,403,303,282,245,133,128,74,10977
West Champaran,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,7999,7774,6580,8638,8545,8915,10190,8369,9115,8330,8110,8749,101314
West Champaran,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,8368,6038,4109,6704,6316,6864,7587,6537,7984,8620,8724,9023,86874
West Champaran,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,7796,7397,6064,7965,8158,8790,9923,8226,8623,8205,7706,7880,96733
West Champaran,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,4012,3939,3384,4483,4434,4615,5321,4349,4809,4359,4145,4542,52392
West Champaran,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,3511,3477,2961,4004,3978,4055,4666,3887,4277,3907,3821,4029,46573
West Champaran,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,7523,7416,6345,8487,8412,8670,9987,8236,9086,8266,7966,8571,98965
West Champaran,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,11045,7312,5647,7027,6626,6949,7498,6503,8034,8766,9022,9136,93565
West Champaran,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,8814,7285,5626,6998,6660,6951,7730,6502,8034,8767,9027,9026,91420
West Champaran,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0,0,0,0,0,0,0,0,0,0,0,19,19
West Champaran,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2600,2881,1889,2519,2461,2836,2933,2572,3154,3205,3036,2988,33074
West Champaran,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2456,2618,1683,2171,2113,2383,2516,2170,2877,2752,2612,2581,28932
West Champaran,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,5056,5499,3572,4690,4574,5219,5449,4742,6031,5957,5648,5569,62006
West Champaran,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,1001,801,610,974,965,1298,1395,1385,1711,1820,1986,2346,16292
West Champaran,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,2981,2298,1846,2680,2081,3085,2759,2251,3179,3312,3378,3617,33467
West Champaran,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,5622,4099,3459,4498,3936,4601,4873,4097,4858,5857,5559,5788,57247
West Champaran,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,24,5,1,16,2,0,0,0,0,27,34,0,109
West Champaran,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
West Champaran,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0,11,0,0,6,0,1,0,0,0,5,0,23
West Champaran,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,4022,4044,4132,4013,3892,3944,4034,3916,3942,4041,3890,3997,47867
West Champaran,10.4.2,Number of Immunisation sessions held during the month,TOTAL,3921,3957,3935,3970,3843,3894,3919,3803,3984,3987,3809,3898,46920
West Champaran,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,3265,3392,3168,3228,3280,3392,3422,3287,3399,3448,3338,3351,39970
West Champaran,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,8800,7136,5277,6261,5939,6334,7094,6010,7507,8492,8625,8600,86075
West Champaran,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,5605,4858,3885,4924,4126,4663,5019,3910,3872,3803,3470,3940,52075
West Champaran,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,2248,1686,910,1315,1281,1497,1493,1293,1758,1766,2265,2554,20066
West Champaran,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,49,67,36,27,20,33,31,36,26,42,46,63,476
West Champaran,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
West Champaran,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
West Champaran,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
West Champaran,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
West Champaran,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
West Champaran,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0,1,0,8,0,0,0,0,11,0,2,0,22
West Champaran,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,1223,1234,850,918,1207,894,1104,1138,1136,504,413,341,10962
West Champaran,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0,4,0,11,0,0,0,0,0,0,0,28,43
West Champaran,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
West Champaran,13.1,Number of Patients operated for cataract,TOTAL,39,0,20,25,43,52,58,42,51,43,39,53,465
West Champaran,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,39,0,20,25,43,52,58,42,51,43,39,53,465
West Champaran,13.3,Number of School children detected with Refractive errors,TOTAL,0,0,0,0,0,0,58,16,31,10,18,25,158
West Champaran,13.4,Number of children provided free glasses,TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
West Champaran,13.5,Number of eyes collected through eye donation,TOTAL,0,0,0,0,0,NA,0,0,0,0,0,0,0
West Champaran,13.6,Number of eyes utilised for corneal transplant,TOTAL,0,0,0,0,0,NA,0,0,0,0,0,0,0
West Champaran,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,NA,NA,NA,NA,1,NA,1,1,1,1,1,1,Data for this item can not be cumulated
West Champaran,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,NA,NA,NA,20,17,19,16,12,16,16,18,19,Data for this item can not be cumulated
West Champaran,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,2815,2609,2752,2630,2612,2589,2638,2651,2619,2641,2653,2682,Data for this item can not be cumulated
West Champaran,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,NA,NA,NA,NA,1,NA,1,1,1,1,NA,1,Data for this item can not be cumulated
West Champaran,14.05,Number of RKS meetings held during the month,TOTAL,7,7,6,11,12,15,3,5,5,6,3,5,85
West Champaran,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,NA,NA,NA,16,18,17,16,15,16,13,14,18,Data for this item can not be cumulated
West Champaran,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,1216,846,700,890,1171,1297,2020,1496,1720,1557,1844,1497,16254
West Champaran,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,NA,NA,NA,NA,1,NA,1,1,1,1,1,1,Data for this item can not be cumulated
West Champaran,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,NA,NA,NA,NA,7,NA,NA,NA,NA,NA,NA,NA,Data for this item can not be cumulated
West Champaran,14.09.a,Health Facility Services/Patient Services/Stock out rate of essential Drugs,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,14.09.b,Health Facility Services/Patient Services/Blood Units Issued on replacement,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,14.09.c,Health Facility Services/Patient Services/Total no. of blood units issued in year,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,771,485,486,501,360,312,998,786,543,600,352,695,6889
West Champaran,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,4066,2133,1689,1984,2003,1882,2641,2197,2188,2062,2077,2659,27581
West Champaran,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,978,411,403,419,317,270,797,2136,385,455,339,731,7641
West Champaran,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,8446,4075,3659,6239,6044,4837,7028,6458,7067,5867,6566,5330,71616
West Champaran,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,1749,896,889,920,677,582,1795,2922,928,1055,691,1426,14530
West Champaran,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,12512,6208,5348,8223,8047,6719,9669,8655,9255,7929,8643,7989,99197
West Champaran,14.10.2.a,Number of death cases of Inpatient males,TOTAL,31,33,45,37,49,45,37,39,40,31,34,30,451
West Champaran,14.10.2.b,Number of death cases of Inpatient females,TOTAL,27,19,20,19,18,33,26,22,20,15,22,24,265
West Champaran,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,58,52,65,56,67,78,63,61,60,46,56,54,716
West Champaran,14.11,In-Patient Head Count at midnight,TOTAL,7340,5718,5823,7396,8117,7580,8752,8038,8901,8008,7648,7833,91154
West Champaran,14.12.1,OPD attendance (All),TOTAL,145633,128107,116601,126778,124102,127685,112808,102619,106101,90809,100624,113490,1395357
West Champaran,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,527,209,3105,674,210,290,525,342,1564,1203,1405,1074,11128
West Champaran,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,46,0,362,348,2,1,2,2,2,2,1,1,769
West Champaran,14.13.1.B,"Patient Services/Operation major (General and spinal anaesthesia)/Major Surgeries excluding Obstetrics, Gynaecology and Opthalmology etc",TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,1256,832,940,1036,1681,1563,1684,1263,1690,1467,1254,1520,16186
West Champaran,14.13.3,Health Facility Services/Patient Services/Number of post operative Surgical Site infection,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,14.14.a,Number of patients given AYUSH treatment,TOTAL,14055,10951,12235,9397,13837,15851,10827,9390,9903,8992,9064,8320,132822
West Champaran,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,4520,4283,4500,4302,4925,4170,4403,3960,4341,6315,3798,4267,53784
West Champaran,14.14.c,Number of Adolescents counselled,TOTAL,0,0,38,76,74,70,61,22,97,49,81,74,642
West Champaran,15.1.a,Health Facility Services/Laboratory Testing/Total Number of lab Tests Done,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,0,0,4,305,25,42,51,65,476,285,318,336,1907
West Champaran,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,0,0,0,3,0,0,0,0,1,4,1,0,9
West Champaran,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,114,25,484,324,650,669,498,517,554,1017,732,573,6157
West Champaran,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,2,0,14,2,7,13,2,7,9,6,10,5,77
West Champaran,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,25,43,279,295,732,814,695,869,971,4263,1589,1145,11720
West Champaran,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,0,0,5,6,3,7,7,3,4,4,10,1,50
West Champaran,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,175,217,799,270,453,643,682,994,861,1250,1783,1147,9274
West Champaran,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0,0,1,2,3,0,0,2,1,0,0,0,9
West Champaran,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,314,285,1562,889,1835,2126,1875,2380,2386,6530,4104,2865,27151
West Champaran,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,2,0,20,10,13,20,9,12,14,10,20,6,136
West Champaran,15.2,Number of Widal tests conducted,Number tested,0,0,0,0,655,0,0,0,0,0,0,57,712
West Champaran,15.3.a,Number of VDRL tests conducted on males,Number tested,0,0,2,2,2,3,1,1,0,0,39,101,151
West Champaran,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,0,0,2,0,2,3,0,0,0,0,201,93,301
West Champaran,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,0,0,6,29,50,51,59,39,0,62,316,310,922
West Champaran,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,0,0,10,31,54,57,60,40,0,62,556,504,1374
West Champaran,15.4.1,Number of blood smears examined for Malaria,TOTAL,0,0,0,0,0,7,0,0,0,0,0,0,7
West Champaran,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
West Champaran,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0,0,0,0,0,0,0,0,0,0,0,0,0
West Champaran,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,3650,2500,2000,200,1850,2700,2600,2000,1850,1450,1700,650,23150
West Champaran,16.1.1,Stock position of DPT vaccines,2. Stocks Received,NA,1000,1000,3000,3000,2000,1000,1000,NA,1000,1000,500,14500
West Champaran,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,1150,1500,2800,1350,2150,2100,1600,1150,400,750,2050,250,17250
West Champaran,16.1.1,Stock position of DPT vaccines,5. Total Stock,2500,2000,200,1850,2700,2600,2000,1850,1450,1700,650,900,20400
West Champaran,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,5850,3080,2030,1700,2150,3150,3480,4430,3130,2180,2550,750,34480
West Champaran,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,NA,1000,2000,3000,3000,3000,4000,1000,2000,2000,2000,2880,25880
West Champaran,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,2770,2050,2330,2550,2000,2670,3050,2300,2950,1630,3800,2950,31050
West Champaran,16.1.1A,Stock Position of Pentavalent,5. Total Stock,3080,2030,1700,2150,3150,3480,4430,3130,2180,2550,750,680,29310
West Champaran,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,2175,350,465,1540,1900,1850,1325,2500,2450,500,1225,2200,18480
West Champaran,16.1.2,Stock position of OPV vaccines,2. Stocks Received,NA,3500,4000,4000,3000,4000,3000,3000,1000,2900,2900,1000,32300
West Champaran,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,1825,3385,2925,3640,3050,4525,1825,3050,2950,2175,1925,2350,33625
West Champaran,16.1.2,Stock position of OPV vaccines,5. Total Stock,350,465,1540,1900,1850,1325,2500,2450,500,1225,2200,850,17155
West Champaran,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,4925,2725,2975,500,1675,2950,2100,3250,1150,1650,2600,1600,28100
West Champaran,16.1.3,Stock position of TT vaccines,2. Stocks Received,2000,3000,2000,3000,4000,3000,4000,1000,3000,2000,2200,2500,31700
West Champaran,16.1.3,Stock position of TT vaccines,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,16.1.3,Stock position of TT vaccines,4. Stock Distributed,4200,2750,4475,1825,2725,3850,2850,3100,2500,1050,3200,3500,36025
West Champaran,16.1.3,Stock position of TT vaccines,5. Total Stock,2725,2975,500,1675,2950,2100,3250,1150,1650,2600,1600,600,23775
West Champaran,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,0
West Champaran,16.1.4,Stock position of DT vaccines,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,16.1.4,Stock position of DT vaccines,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,16.1.4,Stock position of DT vaccines,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,16.1.4,Stock position of DT vaccines,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
West Champaran,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,2850,1640,440,1500,1550,1850,1100,2150,1250,450,100,650,15530
West Champaran,16.1.5,Stock position of BCG vaccines,2. Stocks Received,NA,3000,3000,3000,2500,2000,4000,2500,2000,2100,4000,2200,30300
West Champaran,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,1210,4200,1940,2950,2200,2750,2950,3400,2800,2450,3450,2450,32750
West Champaran,16.1.5,Stock position of BCG vaccines,5. Total Stock,1640,440,1500,1550,1850,1100,2150,1250,450,100,650,400,13080
West Champaran,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,2850,1490,100,100,100,800,800,1000,1150,600,0,400,9390
West Champaran,16.1.6,Stock position of Measles vaccines,2. Stocks Received,2000,4000,4000,5000,5000,5000,5000,5000,4000,3000,5000,3500,50500
West Champaran,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,3360,5390,4000,5000,4300,5000,4800,4850,4550,3600,4600,3750,53200
West Champaran,16.1.6,Stock position of Measles vaccines,5. Total Stock,1490,100,100,100,800,800,1000,1150,600,0,400,150,6690
West Champaran,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,2900,1490,150,200,100,850,600,1100,1050,100,200,100,8840
West Champaran,16.1.7,Stock position of JE vaccines,2. Stocks Received,2000,4000,4000,5000,5000,5000,5000,5000,3000,3900,4300,5000,51200
West Champaran,16.1.7,Stock position of JE vaccines,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,16.1.7,Stock position of JE vaccines,4. Stock Distributed,3410,5340,3950,5100,4250,5250,4500,5050,3950,3800,4400,4900,53900
West Champaran,16.1.7,Stock position of JE vaccines,5. Total Stock,1490,150,200,100,850,600,1100,1050,100,200,100,200,6140
West Champaran,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,4800,2390,2790,790,1400,1090,1450,1150,1400,1250,950,1150,20610
West Champaran,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,NA,1000,0,2000,1000,1000,1000,1000,NA,0,1000,200,8200
West Champaran,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,2410,600,2000,1390,1310,640,1300,750,150,300,800,100,11750
West Champaran,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,2390,2790,790,1400,1090,1450,1150,1400,1250,950,1150,1250,17060
West Champaran,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
West Champaran,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
West Champaran,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
West Champaran,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
West Champaran,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
West Champaran,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
West Champaran,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,16.3.02,Stock Position of Gloves,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,16.3.02,Stock Position of Gloves,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,16.3.02,Stock Position of Gloves,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,16.3.02,Stock Position of Gloves,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
West Champaran,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
West Champaran,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
West Champaran,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
West Champaran,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
West Champaran,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
West Champaran,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
West Champaran,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
West Champaran,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
West Champaran,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0,0,0,0,0,0,0,0,0,0,0,0,0
West Champaran,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,900,9600,17400,7100,15100,6300,12400,20300,6200,20200,27400,13000,155900
West Champaran,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,10000,22500,0,20000,NA,20000,20000,NA,26000,20000,NA,30000,168500
West Champaran,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
West Champaran,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,1300,14700,10300,12000,8800,13900,12100,14100,12000,12800,14400,13400,139800
West Champaran,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,9600,17400,7100,15100,6300,12400,20300,6200,20200,27400,13000,29600,184600
West Champaran,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,34600,62800,157200,87400,253400,146400,128800,112200,34200,140200,244000,106000,1507200
West Champaran,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,70000,300000,0,300000,NA,100000,100000,NA,200000,200000,NA,240000,1510000
West Champaran,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
West Champaran,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,41800,205600,69800,134000,107000,117600,116600,78000,94000,96200,138000,142000,1340600
West Champaran,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,62800,157200,87400,253400,146400,128800,112200,34200,140200,244000,106000,204000,1676600
West Champaran,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,5200,6700,13500,7400,16700,9500,16800,19300,8200,13900,21400,9000,147600
West Champaran,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,5000,24000,0,20000,NA,20000,16000,NA,20000,20000,NA,30000,155000
West Champaran,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,0
West Champaran,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,3500,17200,6100,10700,7200,12700,13500,11100,14300,12500,12400,14600,135800
West Champaran,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,6700,13500,7400,16700,9500,16800,19300,8200,13900,21400,9000,24400,166800
West Champaran,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1
West Champaran,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1
West Champaran,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,1
West Champaran,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,NA,NA,2
West Champaran,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,1,NA,3
West Champaran,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1
West Champaran,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1
West Champaran,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,NA,NA,2
West Champaran,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,NA,NA,2
West Champaran,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,1
West Champaran,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,NA,NA,1
West Champaran,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1
West Champaran,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,NA,NA,NA,1,NA,NA,NA,NA,NA,NA,NA,NA,1
West Champaran,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,NA,NA,NA,1,NA,NA,NA,NA,NA,NA,NA,1,2
West Champaran,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1
West Champaran,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1
West Champaran,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,NA,2
West Champaran,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
West Champaran,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,NA,2
